gene1s	O
Themis2	O
gene1e	O
/	O
gene1s	O
ICB1	O
gene1e	O
is	O
a	O
signaling	O
scaffold	O
that	O
selectively	O
regulates	O
macrophage	O
gene1s	O
Toll	O
-	O
like	O
receptor	O
gene1e	O
signaling	O
and	O
gene1s	ARG2
cytokine	ARG2
gene1e	ARG2
production	O
.	O
BACKGROUND	O
:	O
gene1s	O
Thymocyte	O
expressed	O
molecule	O
involved	O
in	O
selection	O
1	O
gene1e	O
(	O
gene1s	O
Themis1	O
gene1e	O
,	O
SwissProt	O
accession	O
number	O
Q8BGW0	O
)	O
is	O
the	O
recently	O
characterised	O
founder	O
member	O
of	O
a	O
novel	O
family	O
of	O
proteins	O
.	O
A	O
second	O
member	O
of	O
this	O
family	O
,	O
gene1s	O
Themis2	O
gene1e	O
(	O
Q91YX0	O
)	O
,	O
also	O
known	O
as	O
gene1s	O
ICB1	O
gene1e	O
(	O
gene1s	O
Induced	O
on	O
contact	O
with	O
basement	O
membrane	O
1	O
gene1e	O
)	O
,	O
remains	O
unreported	O
at	O
the	O
protein	O
level	O
despite	O
microarray	O
and	O
EST	O
databases	O
reporting	O
gene1s	O
Themis2	O
gene1e	O
mRNA	O
expression	O
in	O
B	O
cells	O
and	O
macrophages	O
.	O
METHODOLOGY	O
/	O
PRINCIPAL	O
FINDINGS	O
:	O
Here	O
we	O
characterise	O
gene1s	O
Themis2	O
gene1e	O
protein	O
for	O
the	O
first	O
time	O
and	O
show	O
that	O
it	O
acts	O
as	O
a	O
macrophage	O
signalling	O
scaffold	O
,	O
exerting	O
a	O
receptor-	O
,	O
mediator-	O
and	O
signalling	O
pathway	O
-	O
specific	O
effect	O
on	O
gene1s	O
TLR	O
gene1e	O
responses	O
in	O
RAW	O
264.7	O
macrophages	O
.	O
gene1s	O
Themis2	O
gene1e	O
over	O
-	O
expression	O
enhanced	O
the	O
LPS	O
-	O
induced	O
production	O
of	O
gene1s	O
TNF	O
gene1e	O
but	O
not	O
gene1s	O
IL-6	O
gene1e	O
or	O
gene1s	O
Cox-2	O
gene1e	O
,	O
nor	O
gene1s	O
TNF	O
gene1e	O
production	O
induced	O
by	O
ligands	O
for	O
gene1s	O
TLR2	O
gene1e	O
(	O
PAM3	O
)	O
or	O
gene1s	O
TLR3	O
gene1e	O
(	O
poly	O
IratioC	O
)	O
.	O
Moreover	O
,	O
LPS	O
-	O
induced	O
activation	O
of	O
the	O
gene1s	O
MAP	O
kinases	O
gene1e	O
gene1s	O
ERK	O
gene1e	O
and	O
gene1s	O
p38	O
gene1e	O
was	O
enhanced	O
in	O
cells	O
over	O
-	O
expressing	O
gene1s	O
Themis2	O
gene1e	O
whereas	O
the	O
activation	O
of	O
gene1s	O
JNK	O
gene1e	O
,	O
gene1s	O
IRF3	O
gene1e	O
or	O
gene1s	O
NF	O
-	O
kappaB	O
p65	O
gene1e	O
,	O
was	O
unaffected	O
.	O
Depletion	O
of	O
gene1s	ARG2
Themis2	ARG2
gene1e	ARG2
protein	O
by	O
RNA	O
inteference	O
inhibited	O
LPS	O
-	O
induced	O
gene1s	ARG2
TNF	ARG2
gene1e	ARG2
production	O
in	O
primary	O
arg1s	O
human	O
arg1e	O
macrophages	O
demonstrating	O
a	O
requirement	O
for	O
gene1s	ARG2
Themis2	ARG2
gene1e	ARG2
in	O
this	O
event	O
.	O
gene1s	O
Themis2	O
gene1e	O
was	O
inducibly	O
tyrosine	O
phosphorylated	O
upon	O
LPS	O
challenge	O
and	O
interacted	O
with	O
gene1s	O
Lyn	O
kinase	O
gene1e	O
(	O
P25911	O
)	O
,	O
the	O
gene1s	O
Rho	O
guanine	O
nucleotide	O
exchange	O
factor	O
gene1e	O
,	O
gene1s	O
Vav	O
gene1e	O
(	O
P27870	O
)	O
,	O
and	O
the	O
adaptor	O
protein	O
gene1s	O
Grb2	O
gene1e	O
(	O
Q60631	O
)	O
.	O
Mutation	O
of	O
either	O
tyrosine	O
660	O
or	O
a	O
proline	O
-	O
rich	O
sequence	O
(	O
PPPRPPK	O
)	O
simultaneously	O
interrupted	O
this	O
complex	O
and	O
reduced	O
by	O
approximately	O
50	O
%	O
the	O
capacity	O
of	O
gene1s	O
Themis2	O
gene1e	O
to	O
promote	O
LPS	O
-	O
induced	O
gene1s	O
TNF	O
gene1e	O
production	O
.	O
Finally	O
,	O
gene1s	O
Themis2	O
gene1e	O
protein	O
expression	O
was	O
induced	O
during	O
macrophage	O
development	O
from	O
species1s	O
murine	O
species1e	O
bone	O
marrow	O
precursors	O
and	O
was	O
regulated	O
by	O
inflammatory	O
stimuli	O
both	O
in	O
vitro	O
and	O
in	O
vivo	O
.	O
CONCLUSIONS	O
/	O
SIGNIFICANCE	O
:	O
We	O
hypothesise	O
that	O
gene1s	O
Themis2	O
gene1e	O
may	O
constitute	O
a	O
novel	O
,	O
physiological	O
control	O
point	O
in	O
macrophage	O
inflammatory	O
responses	O
.	O

gene1s	ARG2
Themis2	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
ICB1	ARG2
gene1e	ARG2
is	O
a	O
signaling	O
scaffold	O
that	O
selectively	O
regulates	O
macrophage	O
gene1s	ARG2
Toll	ARG2
-	ARG2
like	ARG2
receptor	ARG2
gene1e	ARG2
signaling	O
and	O
gene1s	ARG2
cytokine	ARG2
gene1e	ARG2
production	O
.	O
BACKGROUND	O
:	O
gene1s	ARG2
Thymocyte	ARG2
expressed	ARG2
molecule	ARG2
involved	ARG2
in	ARG2
selection	ARG2
1	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
Themis1	ARG2
gene1e	ARG2
,	O
SwissProt	O
accession	O
number	O
Q8BGW0	O
)	O
is	O
the	O
recently	O
characterised	O
founder	O
member	O
of	O
a	O
novel	O
family	O
of	O
proteins	O
.	O
A	O
second	O
member	O
of	O
this	O
family	O
,	O
gene1s	ARG2
Themis2	ARG2
gene1e	ARG2
(	O
Q91YX0	O
)	O
,	O
also	O
known	O
as	O
gene1s	ARG2
ICB1	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
Induced	ARG2
on	ARG2
contact	ARG2
with	ARG2
basement	ARG2
membrane	ARG2
1	ARG2
gene1e	ARG2
)	O
,	O
remains	O
unreported	O
at	O
the	O
protein	O
level	O
despite	O
microarray	O
and	O
EST	O
databases	O
reporting	O
gene1s	ARG2
Themis2	ARG2
gene1e	ARG2
mRNA	O
expression	O
in	O
B	O
cells	O
and	O
macrophages	O
.	O
METHODOLOGY	O
/	O
PRINCIPAL	O
FINDINGS	O
:	O
Here	O
we	O
characterise	O
gene1s	ARG2
Themis2	ARG2
gene1e	ARG2
protein	O
for	O
the	O
first	O
time	O
and	O
show	O
that	O
it	O
acts	O
as	O
a	O
macrophage	O
signalling	O
scaffold	O
,	O
exerting	O
a	O
receptor-	O
,	O
mediator-	O
and	O
signalling	O
pathway	O
-	O
specific	O
effect	O
on	O
gene1s	ARG2
TLR	ARG2
gene1e	ARG2
responses	O
in	O
RAW	O
264.7	O
macrophages	O
.	O
gene1s	ARG2
Themis2	ARG2
gene1e	ARG2
over	O
-	O
expression	O
enhanced	O
the	O
LPS	O
-	O
induced	O
production	O
of	O
gene1s	ARG2
TNF	ARG2
gene1e	ARG2
but	O
not	O
gene1s	ARG2
IL-6	ARG2
gene1e	ARG2
or	O
gene1s	ARG2
Cox-2	ARG2
gene1e	ARG2
,	O
nor	O
gene1s	ARG2
TNF	ARG2
gene1e	ARG2
production	O
induced	O
by	O
ligands	O
for	O
gene1s	ARG2
TLR2	ARG2
gene1e	ARG2
(	O
PAM3	O
)	O
or	O
gene1s	ARG2
TLR3	ARG2
gene1e	ARG2
(	O
poly	O
IratioC	O
)	O
.	O
Moreover	O
,	O
LPS	O
-	O
induced	O
activation	O
of	O
the	O
gene1s	ARG2
MAP	ARG2
kinases	ARG2
gene1e	ARG2
gene1s	ARG2
ERK	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
p38	ARG2
gene1e	ARG2
was	O
enhanced	O
in	O
cells	O
over	O
-	O
expressing	O
gene1s	ARG2
Themis2	ARG2
gene1e	ARG2
whereas	O
the	O
activation	O
of	O
gene1s	ARG2
JNK	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IRF3	ARG2
gene1e	ARG2
or	O
gene1s	ARG2
NF	ARG2
-	ARG2
kappaB	ARG2
p65	ARG2
gene1e	ARG2
,	O
was	O
unaffected	O
.	O
Depletion	O
of	O
gene1s	O
Themis2	O
gene1e	O
protein	O
by	O
RNA	O
inteference	O
inhibited	O
LPS	O
-	O
induced	O
gene1s	O
TNF	O
gene1e	O
production	O
in	O
primary	O
species1s	O
human	O
species1e	O
macrophages	O
demonstrating	O
a	O
requirement	O
for	O
gene1s	O
Themis2	O
gene1e	O
in	O
this	O
event	O
.	O
gene1s	ARG2
Themis2	ARG2
gene1e	ARG2
was	O
inducibly	O
tyrosine	O
phosphorylated	O
upon	O
LPS	O
challenge	O
and	O
interacted	O
with	O
gene1s	ARG2
Lyn	ARG2
kinase	ARG2
gene1e	ARG2
(	O
P25911	O
)	O
,	O
the	O
gene1s	ARG2
Rho	ARG2
guanine	ARG2
nucleotide	ARG2
exchange	ARG2
factor	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Vav	ARG2
gene1e	ARG2
(	O
P27870	O
)	O
,	O
and	O
the	O
adaptor	O
protein	O
gene1s	ARG2
Grb2	ARG2
gene1e	ARG2
(	O
Q60631	O
)	O
.	O
Mutation	O
of	O
either	O
tyrosine	O
660	O
or	O
a	O
proline	O
-	O
rich	O
sequence	O
(	O
PPPRPPK	O
)	O
simultaneously	O
interrupted	O
this	O
complex	O
and	O
reduced	O
by	O
approximately	O
50	O
%	O
the	O
capacity	O
of	O
gene1s	ARG2
Themis2	ARG2
gene1e	ARG2
to	O
promote	O
LPS	O
-	O
induced	O
gene1s	ARG2
TNF	ARG2
gene1e	ARG2
production	O
.	O
Finally	O
,	O
gene1s	ARG2
Themis2	ARG2
gene1e	ARG2
protein	O
expression	O
was	O
induced	O
during	O
macrophage	O
development	O
from	O
arg1s	O
murine	O
arg1e	O
bone	O
marrow	O
precursors	O
and	O
was	O
regulated	O
by	O
inflammatory	O
stimuli	O
both	O
in	O
vitro	O
and	O
in	O
vivo	O
.	O
CONCLUSIONS	O
/	O
SIGNIFICANCE	O
:	O
We	O
hypothesise	O
that	O
gene1s	ARG2
Themis2	ARG2
gene1e	ARG2
may	O
constitute	O
a	O
novel	O
,	O
physiological	O
control	O
point	O
in	O
macrophage	O
inflammatory	O
responses	O
.	O

arg1s	O
U2OS	O
arg1e	O
cells	O
lacking	O
gene1s	ARG2
Chk1	ARG2
gene1e	ARG2
undergo	O
aberrant	O
mitosis	O
and	O
fail	O
to	O
activate	O
the	O
spindle	O
checkpoint	O
.	O
gene1s	ARG2
Chk1	ARG2
gene1e	ARG2
is	O
a	O
conserved	O
gene1s	ARG2
protein	ARG2
kinase	ARG2
gene1e	ARG2
originally	O
identified	O
in	O
species1s	O
fission	O
yeast	O
species1e	O
,	O
required	O
to	O
delay	O
entry	O
of	O
cells	O
with	O
damaged	O
or	O
unreplicated	O
DNA	O
into	O
mitosis	O
.	O
The	O
requirement	O
of	O
gene1s	ARG2
Chk1	ARG2
gene1e	ARG2
for	O
both	O
S	O
and	O
G2	O
/	O
M	O
checkpoints	O
has	O
been	O
elucidated	O
while	O
only	O
few	O
studies	O
have	O
connected	O
gene1s	ARG2
Chk1	ARG2
gene1e	ARG2
to	O
the	O
mitotic	O
spindle	O
checkpoint	O
.	O
We	O
used	O
a	O
small	O
interference	O
RNA	O
strategy	O
to	O
investigate	O
the	O
role	O
of	O
gene1s	ARG2
Chk1	ARG2
gene1e	ARG2
in	O
unstressed	O
conditions	O
.	O
gene1s	ARG2
Chk1	ARG2
gene1e	ARG2
depletion	O
in	O
arg1s	O
U2OS	O
arg1e	O
arg1s	O
human	O
arg1e	O
osteosarcoma	O
cells	O
inhibited	O
cell	O
proliferation	O
and	O
raised	O
the	O
percentage	O
of	O
cells	O
with	O
a	O
4N	O
DNA	O
content	O
,	O
which	O
correlated	O
with	O
accumulation	O
of	O
giant	O
polynucleated	O
cells	O
morphologically	O
distinct	O
from	O
apoptotic	O
cells	O
,	O
while	O
no	O
increased	O
number	O
of	O
cells	O
in	O
G2	O
or	O
mitosis	O
could	O
be	O
detected	O
.	O
Down	O
-	O
regulation	O
of	O
gene1s	ARG2
Chk1	ARG2
gene1e	ARG2
also	O
caused	O
accumulation	O
of	O
cells	O
in	O
the	O
last	O
step	O
of	O
cytokinesis	O
,	O
and	O
of	O
tetraploid	O
cells	O
in	O
G1	O
phase	O
,	O
which	O
coincided	O
with	O
activation	O
of	O
gene1s	ARG2
p53	ARG2
gene1e	ARG2
and	O
increased	O
levels	O
of	O
gene1s	ARG2
p21	ARG2
gene1e	ARG2
.	O
In	O
addition	O
,	O
gene1s	ARG2
Chk1	ARG2
gene1e	ARG2
-depleted	O
arg1s	O
U2OS	O
arg1e	O
cells	O
failed	O
to	O
arrest	O
in	O
mitosis	O
after	O
spindle	O
disruption	O
by	O
nocodazole	O
and	O
showed	O
decreased	O
protein	O
levels	O
of	O
gene1s	ARG2
Mad2	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
BubR1	ARG2
gene1e	ARG2
.	O
These	O
studies	O
show	O
that	O
arg1s	O
U2OS	O
arg1e	O
cells	O
lacking	O
gene1s	ARG2
Chk1	ARG2
gene1e	ARG2
undergo	O
abnormal	O
mitosis	O
and	O
fail	O
to	O
activate	O
the	O
spindle	O
checkpoint	O
,	O
suggesting	O
a	O
role	O
of	O
gene1s	ARG2
Chk1	ARG2
gene1e	ARG2
in	O
this	O
checkpoint	O
.	O

species1s	O
U2OS	O
species1e	O
cells	O
lacking	O
gene1s	O
Chk1	O
gene1e	O
undergo	O
aberrant	O
mitosis	O
and	O
fail	O
to	O
activate	O
the	O
spindle	O
checkpoint	O
.	O
gene1s	O
Chk1	O
gene1e	O
is	O
a	O
conserved	O
gene1s	O
protein	O
kinase	O
gene1e	O
originally	O
identified	O
in	O
arg1s	O
fission	O
yeast	O
arg1e	O
,	O
required	O
to	O
delay	O
entry	O
of	O
cells	O
with	O
damaged	O
or	O
unreplicated	O
DNA	O
into	O
mitosis	O
.	O
The	O
requirement	O
of	O
gene1s	O
Chk1	O
gene1e	O
for	O
both	O
S	O
and	O
G2	O
/	O
M	O
checkpoints	O
has	O
been	O
elucidated	O
while	O
only	O
few	O
studies	O
have	O
connected	O
gene1s	O
Chk1	O
gene1e	O
to	O
the	O
mitotic	O
spindle	O
checkpoint	O
.	O
We	O
used	O
a	O
small	O
interference	O
RNA	O
strategy	O
to	O
investigate	O
the	O
role	O
of	O
gene1s	O
Chk1	O
gene1e	O
in	O
unstressed	O
conditions	O
.	O
gene1s	O
Chk1	O
gene1e	O
depletion	O
in	O
species1s	O
U2OS	O
species1e	O
species1s	O
human	O
species1e	O
osteosarcoma	O
cells	O
inhibited	O
cell	O
proliferation	O
and	O
raised	O
the	O
percentage	O
of	O
cells	O
with	O
a	O
4N	O
DNA	O
content	O
,	O
which	O
correlated	O
with	O
accumulation	O
of	O
giant	O
polynucleated	O
cells	O
morphologically	O
distinct	O
from	O
apoptotic	O
cells	O
,	O
while	O
no	O
increased	O
number	O
of	O
cells	O
in	O
G2	O
or	O
mitosis	O
could	O
be	O
detected	O
.	O
Down	O
-	O
regulation	O
of	O
gene1s	O
Chk1	O
gene1e	O
also	O
caused	O
accumulation	O
of	O
cells	O
in	O
the	O
last	O
step	O
of	O
cytokinesis	O
,	O
and	O
of	O
tetraploid	O
cells	O
in	O
G1	O
phase	O
,	O
which	O
coincided	O
with	O
activation	O
of	O
gene1s	O
p53	O
gene1e	O
and	O
increased	O
levels	O
of	O
gene1s	O
p21	O
gene1e	O
.	O
In	O
addition	O
,	O
gene1s	O
Chk1	O
gene1e	O
-depleted	O
species1s	O
U2OS	O
species1e	O
cells	O
failed	O
to	O
arrest	O
in	O
mitosis	O
after	O
spindle	O
disruption	O
by	O
nocodazole	O
and	O
showed	O
decreased	O
protein	O
levels	O
of	O
gene1s	O
Mad2	O
gene1e	O
and	O
gene1s	O
BubR1	O
gene1e	O
.	O
These	O
studies	O
show	O
that	O
species1s	O
U2OS	O
species1e	O
cells	O
lacking	O
gene1s	O
Chk1	O
gene1e	O
undergo	O
abnormal	O
mitosis	O
and	O
fail	O
to	O
activate	O
the	O
spindle	O
checkpoint	O
,	O
suggesting	O
a	O
role	O
of	O
gene1s	O
Chk1	O
gene1e	O
in	O
this	O
checkpoint	O
.	O

gene1s	O
Leptin	O
gene1e	O
activation	O
of	O
gene1s	O
mTOR	O
gene1e	O
pathway	O
in	O
intestinal	O
epithelial	O
cell	O
triggers	O
lipid	O
droplet	O
formation	O
,	O
gene1s	O
cytokine	O
gene1e	O
production	O
and	O
increased	O
cell	O
proliferation	O
.	O
Accumulating	O
evidence	O
suggests	O
that	O
obesity	O
and	O
enhanced	O
inflammatory	O
reactions	O
are	O
predisposing	O
conditions	O
for	O
developing	O
colon	O
cancer	O
.	O
Obesity	O
is	O
associated	O
with	O
high	O
levels	O
of	O
circulating	O
gene1s	ARG2
leptin	ARG2
gene1e	ARG2
.	O
gene1s	O
Leptin	O
gene1e	O
is	O
an	O
gene1s	O
adipocytokine	O
gene1e	O
that	O
is	O
secreted	O
by	O
adipose	O
tissue	O
and	O
modulates	O
immune	O
response	O
and	O
inflammation	O
.	O
Lipid	O
droplets	O
(	O
LD	O
)	O
are	O
organelles	O
involved	O
in	O
lipid	O
metabolism	O
and	O
production	O
of	O
inflammatory	O
mediators	O
,	O
and	O
increased	O
numbers	O
of	O
LD	O
were	O
observed	O
in	O
arg1s	O
human	O
arg1e	O
colon	O
cancer	O
.	O
gene1s	O
Leptin	O
gene1e	O
induces	O
the	O
formation	O
of	O
LD	O
in	O
macrophages	O
in	O
a	O
gene1s	O
PI3K	O
gene1e	O
/	O
gene1s	O
mTOR	O
gene1e	O
pathway	O
-	O
dependent	O
manner	O
.	O
Moreover	O
,	O
the	O
gene1s	O
mTOR	O
gene1e	O
is	O
a	O
gene1s	O
serine	O
/	O
threonine	O
kinase	O
gene1e	O
that	O
plays	O
a	O
key	O
role	O
in	O
cellular	O
growth	O
and	O
is	O
frequently	O
altered	O
in	O
tumors	O
.	O
We	O
therefore	O
investigated	O
the	O
role	O
of	O
gene1s	O
leptin	O
gene1e	O
in	O
the	O
modulation	O
of	O
gene1s	O
mTOR	O
gene1e	O
pathway	O
and	O
regulation	O
of	O
lipid	O
metabolism	O
and	O
inflammatory	O
phenotype	O
in	O
intestinal	O
epithelial	O
cells	O
(	O
species1s	O
IEC-6	O
species1e	O
cells	O
)	O
.	O
We	O
show	O
that	O
gene1s	O
leptin	O
gene1e	O
promotes	O
a	O
dose-	O
and	O
time	O
-	O
dependent	O
enhancement	O
of	O
LD	O
formation	O
.	O
The	O
biogenesis	O
of	O
LD	O
was	O
accompanied	O
by	O
enhanced	O
gene1s	O
CXCL1	O
gene1e	O
/	O
gene1s	O
CINC-1	O
gene1e	O
,	O
gene1s	O
CCL2	O
gene1e	O
/	O
gene1s	O
MCP-1	O
gene1e	O
and	O
gene1s	O
TGF	O
-	O
b	O
gene1e	O
production	O
and	O
increased	O
gene1s	O
COX-2	O
gene1e	O
expression	O
in	O
these	O
cells	O
.	O
We	O
demonstrated	O
that	O
gene1s	O
leptin	O
gene1e	O
-	O
induced	O
increased	O
phosphorylation	O
of	O
gene1s	O
STAT3	O
gene1e	O
and	O
gene1s	O
AKT	O
gene1e	O
and	O
a	O
dose	O
and	O
time	O
-	O
dependent	O
gene1s	O
mTORC	O
gene1e	O
activation	O
with	O
enhanced	O
phosphorilation	O
of	O
the	O
downstream	O
protein	O
gene1s	O
P70S6	O
K	O
gene1e	O
protein	O
.	O
Pre	O
-	O
treatment	O
with	O
rapamycin	O
significantly	O
inhibited	O
gene1s	O
leptin	O
gene1e	O
effects	O
in	O
LD	O
formation	O
,	O
gene1s	O
COX-2	O
gene1e	O
and	O
gene1s	O
TGF	O
-	O
b	O
gene1e	O
production	O
in	O
species1s	O
IEC-6	O
species1e	O
cells	O
.	O
Moreover	O
,	O
gene1s	O
leptin	O
gene1e	O
was	O
able	O
to	O
stimulate	O
the	O
proliferation	O
of	O
epithelial	O
cells	O
on	O
a	O
gene1s	O
mTOR	O
gene1e	O
-	O
dependent	O
manner	O
.	O
We	O
conclude	O
that	O
gene1s	O
leptin	O
gene1e	O
regulates	O
lipid	O
metabolism	O
,	O
gene1s	O
cytokine	O
gene1e	O
production	O
and	O
proliferation	O
of	O
intestinal	O
cells	O
through	O
a	O
mechanism	O
largely	O
dependent	O
on	O
activation	O
of	O
the	O
gene1s	O
mTOR	O
gene1e	O
pathway	O
,	O
thus	O
suggesting	O
that	O
gene1s	O
leptin	O
gene1e	O
-	O
induced	O
gene1s	O
mTOR	O
gene1e	O
activation	O
may	O
contribute	O
to	O
the	O
obesity	O
-	O
related	O
enhanced	O
susceptibility	O
to	O
colon	O
carcinoma	O
.	O

gene1s	ARG2
Leptin	ARG2
gene1e	ARG2
activation	O
of	O
gene1s	ARG2
mTOR	ARG2
gene1e	ARG2
pathway	O
in	O
intestinal	O
epithelial	O
cell	O
triggers	O
lipid	O
droplet	O
formation	O
,	O
gene1s	ARG2
cytokine	ARG2
gene1e	ARG2
production	O
and	O
increased	O
cell	O
proliferation	O
.	O
Accumulating	O
evidence	O
suggests	O
that	O
obesity	O
and	O
enhanced	O
inflammatory	O
reactions	O
are	O
predisposing	O
conditions	O
for	O
developing	O
colon	O
cancer	O
.	O
Obesity	O
is	O
associated	O
with	O
high	O
levels	O
of	O
circulating	O
gene1s	O
leptin	O
gene1e	O
.	O
gene1s	ARG2
Leptin	ARG2
gene1e	ARG2
is	O
an	O
gene1s	ARG2
adipocytokine	ARG2
gene1e	ARG2
that	O
is	O
secreted	O
by	O
adipose	O
tissue	O
and	O
modulates	O
immune	O
response	O
and	O
inflammation	O
.	O
Lipid	O
droplets	O
(	O
LD	O
)	O
are	O
organelles	O
involved	O
in	O
lipid	O
metabolism	O
and	O
production	O
of	O
inflammatory	O
mediators	O
,	O
and	O
increased	O
numbers	O
of	O
LD	O
were	O
observed	O
in	O
species1s	O
human	O
species1e	O
colon	O
cancer	O
.	O
gene1s	ARG2
Leptin	ARG2
gene1e	ARG2
induces	O
the	O
formation	O
of	O
LD	O
in	O
macrophages	O
in	O
a	O
gene1s	ARG2
PI3K	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
mTOR	ARG2
gene1e	ARG2
pathway	O
-	O
dependent	O
manner	O
.	O
Moreover	O
,	O
the	O
gene1s	ARG2
mTOR	ARG2
gene1e	ARG2
is	O
a	O
gene1s	ARG2
serine	ARG2
/	ARG2
threonine	ARG2
kinase	ARG2
gene1e	ARG2
that	O
plays	O
a	O
key	O
role	O
in	O
cellular	O
growth	O
and	O
is	O
frequently	O
altered	O
in	O
tumors	O
.	O
We	O
therefore	O
investigated	O
the	O
role	O
of	O
gene1s	ARG2
leptin	ARG2
gene1e	ARG2
in	O
the	O
modulation	O
of	O
gene1s	ARG2
mTOR	ARG2
gene1e	ARG2
pathway	O
and	O
regulation	O
of	O
lipid	O
metabolism	O
and	O
inflammatory	O
phenotype	O
in	O
intestinal	O
epithelial	O
cells	O
(	O
arg1s	O
IEC-6	O
arg1e	O
cells	O
)	O
.	O
We	O
show	O
that	O
gene1s	ARG2
leptin	ARG2
gene1e	ARG2
promotes	O
a	O
dose-	O
and	O
time	O
-	O
dependent	O
enhancement	O
of	O
LD	O
formation	O
.	O
The	O
biogenesis	O
of	O
LD	O
was	O
accompanied	O
by	O
enhanced	O
gene1s	ARG2
CXCL1	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
CINC-1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
CCL2	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
MCP-1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
TGF	ARG2
-	ARG2
b	ARG2
gene1e	ARG2
production	O
and	O
increased	O
gene1s	ARG2
COX-2	ARG2
gene1e	ARG2
expression	O
in	O
these	O
cells	O
.	O
We	O
demonstrated	O
that	O
gene1s	ARG2
leptin	ARG2
gene1e	ARG2
-	O
induced	O
increased	O
phosphorylation	O
of	O
gene1s	ARG2
STAT3	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
AKT	ARG2
gene1e	ARG2
and	O
a	O
dose	O
and	O
time	O
-	O
dependent	O
gene1s	ARG2
mTORC	ARG2
gene1e	ARG2
activation	O
with	O
enhanced	O
phosphorilation	O
of	O
the	O
downstream	O
protein	O
gene1s	ARG2
P70S6	ARG2
K	ARG2
gene1e	ARG2
protein	O
.	O
Pre	O
-	O
treatment	O
with	O
rapamycin	O
significantly	O
inhibited	O
gene1s	ARG2
leptin	ARG2
gene1e	ARG2
effects	O
in	O
LD	O
formation	O
,	O
gene1s	ARG2
COX-2	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
TGF	ARG2
-	ARG2
b	ARG2
gene1e	ARG2
production	O
in	O
arg1s	O
IEC-6	O
arg1e	O
cells	O
.	O
Moreover	O
,	O
gene1s	ARG2
leptin	ARG2
gene1e	ARG2
was	O
able	O
to	O
stimulate	O
the	O
proliferation	O
of	O
epithelial	O
cells	O
on	O
a	O
gene1s	ARG2
mTOR	ARG2
gene1e	ARG2
-	O
dependent	O
manner	O
.	O
We	O
conclude	O
that	O
gene1s	ARG2
leptin	ARG2
gene1e	ARG2
regulates	O
lipid	O
metabolism	O
,	O
gene1s	ARG2
cytokine	ARG2
gene1e	ARG2
production	O
and	O
proliferation	O
of	O
intestinal	O
cells	O
through	O
a	O
mechanism	O
largely	O
dependent	O
on	O
activation	O
of	O
the	O
gene1s	ARG2
mTOR	ARG2
gene1e	ARG2
pathway	O
,	O
thus	O
suggesting	O
that	O
gene1s	ARG2
leptin	ARG2
gene1e	ARG2
-	O
induced	O
gene1s	ARG2
mTOR	ARG2
gene1e	ARG2
activation	O
may	O
contribute	O
to	O
the	O
obesity	O
-	O
related	O
enhanced	O
susceptibility	O
to	O
colon	O
carcinoma	O
.	O

gene1s	O
Leukemia	O
inhibitory	O
factor	O
gene1e	O
protects	O
the	O
lung	O
during	O
arg1s	O
respiratory	O
arg1e	O
syncytial	O
viral	O
infection	O
.	O
BACKGROUND	O
:	O
arg1s	O
Respiratory	O
syncytial	O
virus	O
arg1e	O
(	O
arg1s	O
RSV	O
arg1e	O
)	O
infects	O
the	O
lung	O
epithelium	O
where	O
it	O
stimulates	O
the	O
production	O
of	O
numerous	O
host	O
cytokines	O
that	O
are	O
associated	O
with	O
disease	O
burden	O
and	O
acute	O
lung	O
injury	O
.	O
Characterizing	O
the	O
host	O
cytokine	O
response	O
to	O
arg1s	O
RSV	O
arg1e	O
infection	O
,	O
the	O
regulation	O
of	O
host	O
cytokines	O
and	O
the	O
impact	O
of	O
neutralizing	O
an	O
arg1s	O
RSV	O
arg1e	O
-	O
inducible	O
cytokine	O
during	O
infection	O
were	O
undertaken	O
in	O
this	O
study	O
.	O
METHODS	O
:	O
A549	O
,	O
primary	O
species1s	O
human	O
species1e	O
small	O
airway	O
epithelial	O
(	O
species1s	O
SAE	O
species1e	O
)	O
cells	O
and	O
wild	O
-	O
type	O
,	O
gene1s	O
TIR	O
-	O
domain	O
-	O
containing	O
adapter	O
-	O
inducing	O
interferon	O
-	O
b	O
gene1e	O
(	O
gene1s	O
Trif	O
gene1e	O
)	O
and	O
gene1s	O
mitochondrial	O
antiviral	O
-	O
signaling	O
protein	O
gene1e	O
(	O
gene1s	O
Mavs	O
gene1e	O
)	O
knockout	O
(	O
KO	O
)	O
species1s	O
mice	O
species1e	O
were	O
infected	O
with	O
arg1s	O
RSV	O
arg1e	O
and	O
cytokine	O
responses	O
were	O
investigated	O
by	O
ELISA	O
,	O
multiplex	O
analysis	O
and	O
qPCR	O
.	O
Neutralizing	O
anti	O
-	O
gene1s	O
leukemia	O
inhibitory	O
factor	O
gene1e	O
(	O
gene1s	O
LIF	O
gene1e	O
)	O
IgG	O
or	O
control	O
IgG	O
was	O
administered	O
to	O
a	O
group	O
of	O
wild	O
-	O
type	O
animals	O
prior	O
to	O
arg1s	O
RSV	O
arg1e	O
infection	O
.	O
RESULTS	O
AND	O
DISCUSSION	O
:	O
arg1s	O
RSV	O
arg1e	O
-	O
infected	O
A549	O
and	O
species1s	O
SAE	O
species1e	O
cells	O
release	O
a	O
network	O
of	O
cytokines	O
,	O
including	O
newly	O
identified	O
arg1s	O
RSV	O
arg1e	O
-	O
inducible	O
cytokines	O
gene1s	O
LIF	O
gene1e	O
,	O
gene1s	O
migration	O
inhibitory	O
factor	O
gene1e	O
(	O
gene1s	O
MIF	O
gene1e	O
)	O
,	O
gene1s	O
stem	O
cell	O
factor	O
gene1e	O
(	O
gene1s	O
SCF	O
gene1e	O
)	O
,	O
gene1s	O
CCL27	O
,	O
gene1e	O
gene1s	O
CXCL12	O
gene1e	O
and	O
gene1s	O
stem	O
cell	O
growth	O
factor	O
beta	O
gene1e	O
(	O
gene1s	O
SCGF	O
-	O
b	O
gene1e	O
)	O
.	O
These	O
arg1s	O
RSV	O
arg1e	O
-	O
inducible	O
cytokines	O
were	O
also	O
observed	O
in	O
the	O
airways	O
of	O
species1s	O
mice	O
species1e	O
during	O
an	O
infection	O
.	O
To	O
identify	O
the	O
regulation	O
of	O
arg1s	O
RSV	O
arg1e	O
inducible	O
cytokines	O
,	O
gene1s	O
Mavs	O
gene1e	O
and	O
gene1s	O
Trif	O
gene1e	O
deficient	O
animals	O
were	O
infected	O
with	O
arg1s	O
RSV	O
arg1e	O
.	O
In	O
vivo	O
induction	O
of	O
airway	O
gene1s	O
IL-1b	O
gene1e	O
,	O
gene1s	O
IL-4	O
gene1e	O
,	O
gene1s	O
IL-5	O
gene1e	O
,	O
gene1s	O
IL-6	O
gene1e	O
,	O
gene1s	O
IL-12	O
gene1e	O
(	O
gene1s	O
p40	O
gene1e	O
)	O
,	O
gene1s	O
IFN	O
-	O
g	O
gene1e	O
,	O
gene1s	O
CCL2	O
gene1e	O
,	O
gene1s	O
CCL5	O
gene1e	O
,	O
gene1s	O
CCL3	O
gene1e	O
,	O
gene1s	O
CXCL1	O
gene1e	O
,	O
gene1s	O
IP-10	O
gene1e	O
/	O
gene1s	O
CXCL10	O
gene1e	O
,	O
gene1s	O
IL-22	O
gene1e	O
,	O
gene1s	O
MIG	O
gene1e	O
/	O
gene1s	O
CXCL9	O
gene1e	O
and	O
gene1s	O
MIF	O
gene1e	O
were	O
dependent	O
on	O
gene1s	O
Mavs	O
gene1e	O
expression	O
in	O
species1s	O
mice	O
species1e	O
.	O
Loss	O
of	O
gene1s	O
Trif	O
gene1e	O
expression	O
in	O
species1s	O
mice	O
species1e	O
altered	O
the	O
arg1s	O
RSV	O
arg1e	O
induction	O
of	O
gene1s	O
IL-1b	O
gene1e	O
,	O
gene1s	O
IL-5	O
gene1e	O
,	O
gene1s	O
CXCL12	O
gene1e	O
,	O
gene1s	O
MIF	O
gene1e	O
,	O
gene1s	O
LIF	O
gene1e	O
,	O
gene1s	O
CXCL12	O
gene1e	O
and	O
gene1s	O
IFN	O
-	O
g	O
gene1e	O
.	O
Silencing	O
of	O
gene1s	O
retinoic	O
acid	O
-	O
inducible	O
gene-1	O
gene1e	O
(	O
gene1s	O
RIG	O
-	O
I	O
gene1e	O
)	O
expression	O
in	O
A549	O
cells	O
had	O
a	O
greater	O
impact	O
on	O
arg1s	O
RSV	O
arg1e	O
-	O
inducible	O
cytokines	O
than	O
gene1s	O
melanoma	O
differentiation	O
-	O
associated	O
protein	O
5	O
gene1e	O
(	O
gene1s	O
MDA5	O
gene1e	O
)	O
and	O
gene1s	O
laboratory	O
of	O
genetics	O
and	O
physiology	O
2	O
gene1e	O
(	O
gene1s	O
LGP2	O
gene1e	O
)	O
,	O
and	O
gene1s	O
Trif	O
gene1e	O
expression	O
.	O
To	O
evaluate	O
the	O
role	O
of	O
gene1s	O
LIF	O
gene1e	O
in	O
the	O
airways	O
during	O
arg1s	O
RSV	O
arg1e	O
infection	O
,	O
animals	O
were	O
treated	O
with	O
neutralizing	O
anti	O
-	O
gene1s	O
LIF	O
gene1e	O
IgG	O
,	O
which	O
enhanced	O
arg1s	O
RSV	O
arg1e	O
pathology	O
observed	O
with	O
increased	O
airspace	O
protein	O
content	O
,	O
apoptosis	O
and	O
airway	O
hyperresponsiveness	O
compared	O
to	O
control	O
IgG	O
treatment	O
.	O
CONCLUSIONS	O
:	O
arg1s	O
RSV	O
arg1e	O
infection	O
in	O
the	O
epithelium	O
induces	O
a	O
network	O
of	O
immune	O
factors	O
to	O
counter	O
infection	O
,	O
primarily	O
in	O
a	O
gene1s	O
RIG	O
-	O
I	O
gene1e	O
dependent	O
manner	O
.	O
Expression	O
of	O
gene1s	O
LIF	O
gene1e	O
protects	O
the	O
lung	O
from	O
lung	O
injury	O
and	O
enhanced	O
pathology	O
during	O
arg1s	O
RSV	O
arg1e	O
infection	O
.	O

gene1s	ARG2
Leukemia	ARG2
inhibitory	ARG2
factor	ARG2
gene1e	ARG2
protects	O
the	O
lung	O
during	O
species1s	O
respiratory	O
species1e	O
syncytial	O
viral	O
infection	O
.	O
BACKGROUND	O
:	O
species1s	O
Respiratory	O
syncytial	O
virus	O
species1e	O
(	O
species1s	O
RSV	O
species1e	O
)	O
infects	O
the	O
lung	O
epithelium	O
where	O
it	O
stimulates	O
the	O
production	O
of	O
numerous	O
host	O
cytokines	O
that	O
are	O
associated	O
with	O
disease	O
burden	O
and	O
acute	O
lung	O
injury	O
.	O
Characterizing	O
the	O
host	O
cytokine	O
response	O
to	O
species1s	O
RSV	O
species1e	O
infection	O
,	O
the	O
regulation	O
of	O
host	O
cytokines	O
and	O
the	O
impact	O
of	O
neutralizing	O
an	O
species1s	O
RSV	O
species1e	O
-	O
inducible	O
cytokine	O
during	O
infection	O
were	O
undertaken	O
in	O
this	O
study	O
.	O
METHODS	O
:	O
A549	O
,	O
primary	O
arg1s	O
human	O
arg1e	O
small	O
airway	O
epithelial	O
(	O
species1s	O
SAE	O
species1e	O
)	O
cells	O
and	O
wild	O
-	O
type	O
,	O
gene1s	O
TIR	O
-	O
domain	O
-	O
containing	O
adapter	O
-	O
inducing	O
interferon	O
-	O
b	O
gene1e	O
(	O
gene1s	O
Trif	O
gene1e	O
)	O
and	O
gene1s	O
mitochondrial	O
antiviral	O
-	O
signaling	O
protein	O
gene1e	O
(	O
gene1s	O
Mavs	O
gene1e	O
)	O
knockout	O
(	O
KO	O
)	O
species1s	O
mice	O
species1e	O
were	O
infected	O
with	O
species1s	O
RSV	O
species1e	O
and	O
cytokine	O
responses	O
were	O
investigated	O
by	O
ELISA	O
,	O
multiplex	O
analysis	O
and	O
qPCR	O
.	O
Neutralizing	O
anti	O
-	O
gene1s	ARG2
leukemia	ARG2
inhibitory	ARG2
factor	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
LIF	ARG2
gene1e	ARG2
)	O
IgG	O
or	O
control	O
IgG	O
was	O
administered	O
to	O
a	O
group	O
of	O
wild	O
-	O
type	O
animals	O
prior	O
to	O
species1s	O
RSV	O
species1e	O
infection	O
.	O
RESULTS	O
AND	O
DISCUSSION	O
:	O
species1s	O
RSV	O
species1e	O
-	O
infected	O
A549	O
and	O
species1s	O
SAE	O
species1e	O
cells	O
release	O
a	O
network	O
of	O
cytokines	O
,	O
including	O
newly	O
identified	O
species1s	O
RSV	O
species1e	O
-	O
inducible	O
cytokines	O
gene1s	ARG2
LIF	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
migration	ARG2
inhibitory	ARG2
factor	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
MIF	ARG2
gene1e	ARG2
)	O
,	O
gene1s	ARG2
stem	ARG2
cell	ARG2
factor	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
SCF	ARG2
gene1e	ARG2
)	O
,	O
gene1s	ARG2
CCL27	ARG2
,	ARG2
gene1e	ARG2
gene1s	ARG2
CXCL12	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
stem	ARG2
cell	ARG2
growth	ARG2
factor	ARG2
beta	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
SCGF	ARG2
-	ARG2
b	ARG2
gene1e	ARG2
)	O
.	O
These	O
species1s	O
RSV	O
species1e	O
-	O
inducible	O
cytokines	O
were	O
also	O
observed	O
in	O
the	O
airways	O
of	O
species1s	O
mice	O
species1e	O
during	O
an	O
infection	O
.	O
To	O
identify	O
the	O
regulation	O
of	O
species1s	O
RSV	O
species1e	O
inducible	O
cytokines	O
,	O
gene1s	O
Mavs	O
gene1e	O
and	O
gene1s	O
Trif	O
gene1e	O
deficient	O
animals	O
were	O
infected	O
with	O
species1s	O
RSV	O
species1e	O
.	O
In	O
vivo	O
induction	O
of	O
airway	O
gene1s	O
IL-1b	O
gene1e	O
,	O
gene1s	O
IL-4	O
gene1e	O
,	O
gene1s	O
IL-5	O
gene1e	O
,	O
gene1s	O
IL-6	O
gene1e	O
,	O
gene1s	O
IL-12	O
gene1e	O
(	O
gene1s	O
p40	O
gene1e	O
)	O
,	O
gene1s	O
IFN	O
-	O
g	O
gene1e	O
,	O
gene1s	O
CCL2	O
gene1e	O
,	O
gene1s	O
CCL5	O
gene1e	O
,	O
gene1s	O
CCL3	O
gene1e	O
,	O
gene1s	O
CXCL1	O
gene1e	O
,	O
gene1s	O
IP-10	O
gene1e	O
/	O
gene1s	O
CXCL10	O
gene1e	O
,	O
gene1s	O
IL-22	O
gene1e	O
,	O
gene1s	O
MIG	O
gene1e	O
/	O
gene1s	O
CXCL9	O
gene1e	O
and	O
gene1s	O
MIF	O
gene1e	O
were	O
dependent	O
on	O
gene1s	O
Mavs	O
gene1e	O
expression	O
in	O
species1s	O
mice	O
species1e	O
.	O
Loss	O
of	O
gene1s	O
Trif	O
gene1e	O
expression	O
in	O
species1s	O
mice	O
species1e	O
altered	O
the	O
species1s	O
RSV	O
species1e	O
induction	O
of	O
gene1s	O
IL-1b	O
gene1e	O
,	O
gene1s	O
IL-5	O
gene1e	O
,	O
gene1s	O
CXCL12	O
gene1e	O
,	O
gene1s	O
MIF	O
gene1e	O
,	O
gene1s	O
LIF	O
gene1e	O
,	O
gene1s	O
CXCL12	O
gene1e	O
and	O
gene1s	O
IFN	O
-	O
g	O
gene1e	O
.	O
Silencing	O
of	O
gene1s	ARG2
retinoic	ARG2
acid	ARG2
-	ARG2
inducible	ARG2
gene-1	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
RIG	ARG2
-	ARG2
I	ARG2
gene1e	ARG2
)	O
expression	O
in	O
A549	O
cells	O
had	O
a	O
greater	O
impact	O
on	O
species1s	O
RSV	O
species1e	O
-	O
inducible	O
cytokines	O
than	O
gene1s	ARG2
melanoma	ARG2
differentiation	ARG2
-	ARG2
associated	ARG2
protein	ARG2
5	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
MDA5	ARG2
gene1e	ARG2
)	O
and	O
gene1s	ARG2
laboratory	ARG2
of	ARG2
genetics	ARG2
and	ARG2
physiology	ARG2
2	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
LGP2	ARG2
gene1e	ARG2
)	O
,	O
and	O
gene1s	ARG2
Trif	ARG2
gene1e	ARG2
expression	O
.	O
To	O
evaluate	O
the	O
role	O
of	O
gene1s	O
LIF	O
gene1e	O
in	O
the	O
airways	O
during	O
species1s	O
RSV	O
species1e	O
infection	O
,	O
animals	O
were	O
treated	O
with	O
neutralizing	O
anti	O
-	O
gene1s	O
LIF	O
gene1e	O
IgG	O
,	O
which	O
enhanced	O
species1s	O
RSV	O
species1e	O
pathology	O
observed	O
with	O
increased	O
airspace	O
protein	O
content	O
,	O
apoptosis	O
and	O
airway	O
hyperresponsiveness	O
compared	O
to	O
control	O
IgG	O
treatment	O
.	O
CONCLUSIONS	O
:	O
species1s	O
RSV	O
species1e	O
infection	O
in	O
the	O
epithelium	O
induces	O
a	O
network	O
of	O
immune	O
factors	O
to	O
counter	O
infection	O
,	O
primarily	O
in	O
a	O
gene1s	ARG2
RIG	ARG2
-	ARG2
I	ARG2
gene1e	ARG2
dependent	O
manner	O
.	O
Expression	O
of	O
gene1s	ARG2
LIF	ARG2
gene1e	ARG2
protects	O
the	O
lung	O
from	O
lung	O
injury	O
and	O
enhanced	O
pathology	O
during	O
species1s	O
RSV	O
species1e	O
infection	O
.	O

gene1s	O
Leukemia	O
inhibitory	O
factor	O
gene1e	O
protects	O
the	O
lung	O
during	O
species1s	O
respiratory	O
species1e	O
syncytial	O
viral	O
infection	O
.	O
BACKGROUND	O
:	O
species1s	O
Respiratory	O
syncytial	O
virus	O
species1e	O
(	O
species1s	O
RSV	O
species1e	O
)	O
infects	O
the	O
lung	O
epithelium	O
where	O
it	O
stimulates	O
the	O
production	O
of	O
numerous	O
host	O
cytokines	O
that	O
are	O
associated	O
with	O
disease	O
burden	O
and	O
acute	O
lung	O
injury	O
.	O
Characterizing	O
the	O
host	O
cytokine	O
response	O
to	O
species1s	O
RSV	O
species1e	O
infection	O
,	O
the	O
regulation	O
of	O
host	O
cytokines	O
and	O
the	O
impact	O
of	O
neutralizing	O
an	O
species1s	O
RSV	O
species1e	O
-	O
inducible	O
cytokine	O
during	O
infection	O
were	O
undertaken	O
in	O
this	O
study	O
.	O
METHODS	O
:	O
A549	O
,	O
primary	O
species1s	O
human	O
species1e	O
small	O
airway	O
epithelial	O
(	O
arg1s	O
SAE	O
arg1e	O
)	O
cells	O
and	O
wild	O
-	O
type	O
,	O
gene1s	O
TIR	O
-	O
domain	O
-	O
containing	O
adapter	O
-	O
inducing	O
interferon	O
-	O
b	O
gene1e	O
(	O
gene1s	O
Trif	O
gene1e	O
)	O
and	O
gene1s	O
mitochondrial	O
antiviral	O
-	O
signaling	O
protein	O
gene1e	O
(	O
gene1s	O
Mavs	O
gene1e	O
)	O
knockout	O
(	O
KO	O
)	O
species1s	O
mice	O
species1e	O
were	O
infected	O
with	O
species1s	O
RSV	O
species1e	O
and	O
cytokine	O
responses	O
were	O
investigated	O
by	O
ELISA	O
,	O
multiplex	O
analysis	O
and	O
qPCR	O
.	O
Neutralizing	O
anti	O
-	O
gene1s	O
leukemia	O
inhibitory	O
factor	O
gene1e	O
(	O
gene1s	O
LIF	O
gene1e	O
)	O
IgG	O
or	O
control	O
IgG	O
was	O
administered	O
to	O
a	O
group	O
of	O
wild	O
-	O
type	O
animals	O
prior	O
to	O
species1s	O
RSV	O
species1e	O
infection	O
.	O
RESULTS	O
AND	O
DISCUSSION	O
:	O
species1s	O
RSV	O
species1e	O
-	O
infected	O
A549	O
and	O
arg1s	O
SAE	O
arg1e	O
cells	O
release	O
a	O
network	O
of	O
cytokines	O
,	O
including	O
newly	O
identified	O
species1s	O
RSV	O
species1e	O
-	O
inducible	O
cytokines	O
gene1s	O
LIF	O
gene1e	O
,	O
gene1s	O
migration	O
inhibitory	O
factor	O
gene1e	O
(	O
gene1s	O
MIF	O
gene1e	O
)	O
,	O
gene1s	O
stem	O
cell	O
factor	O
gene1e	O
(	O
gene1s	O
SCF	O
gene1e	O
)	O
,	O
gene1s	O
CCL27	O
,	O
gene1e	O
gene1s	O
CXCL12	O
gene1e	O
and	O
gene1s	O
stem	O
cell	O
growth	O
factor	O
beta	O
gene1e	O
(	O
gene1s	O
SCGF	O
-	O
b	O
gene1e	O
)	O
.	O
These	O
species1s	O
RSV	O
species1e	O
-	O
inducible	O
cytokines	O
were	O
also	O
observed	O
in	O
the	O
airways	O
of	O
species1s	O
mice	O
species1e	O
during	O
an	O
infection	O
.	O
To	O
identify	O
the	O
regulation	O
of	O
species1s	O
RSV	O
species1e	O
inducible	O
cytokines	O
,	O
gene1s	O
Mavs	O
gene1e	O
and	O
gene1s	O
Trif	O
gene1e	O
deficient	O
animals	O
were	O
infected	O
with	O
species1s	O
RSV	O
species1e	O
.	O
In	O
vivo	O
induction	O
of	O
airway	O
gene1s	O
IL-1b	O
gene1e	O
,	O
gene1s	O
IL-4	O
gene1e	O
,	O
gene1s	O
IL-5	O
gene1e	O
,	O
gene1s	O
IL-6	O
gene1e	O
,	O
gene1s	O
IL-12	O
gene1e	O
(	O
gene1s	O
p40	O
gene1e	O
)	O
,	O
gene1s	O
IFN	O
-	O
g	O
gene1e	O
,	O
gene1s	O
CCL2	O
gene1e	O
,	O
gene1s	O
CCL5	O
gene1e	O
,	O
gene1s	O
CCL3	O
gene1e	O
,	O
gene1s	O
CXCL1	O
gene1e	O
,	O
gene1s	O
IP-10	O
gene1e	O
/	O
gene1s	O
CXCL10	O
gene1e	O
,	O
gene1s	O
IL-22	O
gene1e	O
,	O
gene1s	O
MIG	O
gene1e	O
/	O
gene1s	O
CXCL9	O
gene1e	O
and	O
gene1s	O
MIF	O
gene1e	O
were	O
dependent	O
on	O
gene1s	O
Mavs	O
gene1e	O
expression	O
in	O
species1s	O
mice	O
species1e	O
.	O
Loss	O
of	O
gene1s	O
Trif	O
gene1e	O
expression	O
in	O
species1s	O
mice	O
species1e	O
altered	O
the	O
species1s	O
RSV	O
species1e	O
induction	O
of	O
gene1s	O
IL-1b	O
gene1e	O
,	O
gene1s	O
IL-5	O
gene1e	O
,	O
gene1s	O
CXCL12	O
gene1e	O
,	O
gene1s	O
MIF	O
gene1e	O
,	O
gene1s	O
LIF	O
gene1e	O
,	O
gene1s	O
CXCL12	O
gene1e	O
and	O
gene1s	O
IFN	O
-	O
g	O
gene1e	O
.	O
Silencing	O
of	O
gene1s	O
retinoic	O
acid	O
-	O
inducible	O
gene-1	O
gene1e	O
(	O
gene1s	O
RIG	O
-	O
I	O
gene1e	O
)	O
expression	O
in	O
A549	O
cells	O
had	O
a	O
greater	O
impact	O
on	O
species1s	O
RSV	O
species1e	O
-	O
inducible	O
cytokines	O
than	O
gene1s	O
melanoma	O
differentiation	O
-	O
associated	O
protein	O
5	O
gene1e	O
(	O
gene1s	O
MDA5	O
gene1e	O
)	O
and	O
gene1s	O
laboratory	O
of	O
genetics	O
and	O
physiology	O
2	O
gene1e	O
(	O
gene1s	O
LGP2	O
gene1e	O
)	O
,	O
and	O
gene1s	O
Trif	O
gene1e	O
expression	O
.	O
To	O
evaluate	O
the	O
role	O
of	O
gene1s	O
LIF	O
gene1e	O
in	O
the	O
airways	O
during	O
species1s	O
RSV	O
species1e	O
infection	O
,	O
animals	O
were	O
treated	O
with	O
neutralizing	O
anti	O
-	O
gene1s	O
LIF	O
gene1e	O
IgG	O
,	O
which	O
enhanced	O
species1s	O
RSV	O
species1e	O
pathology	O
observed	O
with	O
increased	O
airspace	O
protein	O
content	O
,	O
apoptosis	O
and	O
airway	O
hyperresponsiveness	O
compared	O
to	O
control	O
IgG	O
treatment	O
.	O
CONCLUSIONS	O
:	O
species1s	O
RSV	O
species1e	O
infection	O
in	O
the	O
epithelium	O
induces	O
a	O
network	O
of	O
immune	O
factors	O
to	O
counter	O
infection	O
,	O
primarily	O
in	O
a	O
gene1s	O
RIG	O
-	O
I	O
gene1e	O
dependent	O
manner	O
.	O
Expression	O
of	O
gene1s	O
LIF	O
gene1e	O
protects	O
the	O
lung	O
from	O
lung	O
injury	O
and	O
enhanced	O
pathology	O
during	O
species1s	O
RSV	O
species1e	O
infection	O
.	O

gene1s	ARG2
Leukemia	ARG2
inhibitory	ARG2
factor	ARG2
gene1e	ARG2
protects	O
the	O
lung	O
during	O
species1s	O
respiratory	O
species1e	O
syncytial	O
viral	O
infection	O
.	O
BACKGROUND	O
:	O
species1s	O
Respiratory	O
syncytial	O
virus	O
species1e	O
(	O
species1s	O
RSV	O
species1e	O
)	O
infects	O
the	O
lung	O
epithelium	O
where	O
it	O
stimulates	O
the	O
production	O
of	O
numerous	O
host	O
cytokines	O
that	O
are	O
associated	O
with	O
disease	O
burden	O
and	O
acute	O
lung	O
injury	O
.	O
Characterizing	O
the	O
host	O
cytokine	O
response	O
to	O
species1s	O
RSV	O
species1e	O
infection	O
,	O
the	O
regulation	O
of	O
host	O
cytokines	O
and	O
the	O
impact	O
of	O
neutralizing	O
an	O
species1s	O
RSV	O
species1e	O
-	O
inducible	O
cytokine	O
during	O
infection	O
were	O
undertaken	O
in	O
this	O
study	O
.	O
METHODS	O
:	O
A549	O
,	O
primary	O
species1s	O
human	O
species1e	O
small	O
airway	O
epithelial	O
(	O
species1s	O
SAE	O
species1e	O
)	O
cells	O
and	O
wild	O
-	O
type	O
,	O
gene1s	ARG2
TIR	ARG2
-	ARG2
domain	ARG2
-	ARG2
containing	ARG2
adapter	ARG2
-	ARG2
inducing	ARG2
interferon	ARG2
-	ARG2
b	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
Trif	ARG2
gene1e	ARG2
)	O
and	O
gene1s	ARG2
mitochondrial	ARG2
antiviral	ARG2
-	ARG2
signaling	ARG2
protein	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
Mavs	ARG2
gene1e	ARG2
)	O
knockout	O
(	O
KO	O
)	O
arg1s	O
mice	O
arg1e	O
were	O
infected	O
with	O
species1s	O
RSV	O
species1e	O
and	O
cytokine	O
responses	O
were	O
investigated	O
by	O
ELISA	O
,	O
multiplex	O
analysis	O
and	O
qPCR	O
.	O
Neutralizing	O
anti	O
-	O
gene1s	O
leukemia	O
inhibitory	O
factor	O
gene1e	O
(	O
gene1s	O
LIF	O
gene1e	O
)	O
IgG	O
or	O
control	O
IgG	O
was	O
administered	O
to	O
a	O
group	O
of	O
wild	O
-	O
type	O
animals	O
prior	O
to	O
species1s	O
RSV	O
species1e	O
infection	O
.	O
RESULTS	O
AND	O
DISCUSSION	O
:	O
species1s	O
RSV	O
species1e	O
-	O
infected	O
A549	O
and	O
species1s	O
SAE	O
species1e	O
cells	O
release	O
a	O
network	O
of	O
cytokines	O
,	O
including	O
newly	O
identified	O
species1s	O
RSV	O
species1e	O
-	O
inducible	O
cytokines	O
gene1s	O
LIF	O
gene1e	O
,	O
gene1s	O
migration	O
inhibitory	O
factor	O
gene1e	O
(	O
gene1s	O
MIF	O
gene1e	O
)	O
,	O
gene1s	O
stem	O
cell	O
factor	O
gene1e	O
(	O
gene1s	O
SCF	O
gene1e	O
)	O
,	O
gene1s	O
CCL27	O
,	O
gene1e	O
gene1s	O
CXCL12	O
gene1e	O
and	O
gene1s	O
stem	O
cell	O
growth	O
factor	O
beta	O
gene1e	O
(	O
gene1s	O
SCGF	O
-	O
b	O
gene1e	O
)	O
.	O
These	O
species1s	O
RSV	O
species1e	O
-	O
inducible	O
cytokines	O
were	O
also	O
observed	O
in	O
the	O
airways	O
of	O
arg1s	O
mice	O
arg1e	O
during	O
an	O
infection	O
.	O
To	O
identify	O
the	O
regulation	O
of	O
species1s	O
RSV	O
species1e	O
inducible	O
cytokines	O
,	O
gene1s	ARG2
Mavs	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
Trif	ARG2
gene1e	ARG2
deficient	O
animals	O
were	O
infected	O
with	O
species1s	O
RSV	O
species1e	O
.	O
In	O
vivo	O
induction	O
of	O
airway	O
gene1s	ARG2
IL-1b	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IL-4	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IL-5	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IL-6	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IL-12	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
p40	ARG2
gene1e	ARG2
)	O
,	O
gene1s	ARG2
IFN	ARG2
-	ARG2
g	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
CCL2	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
CCL5	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
CCL3	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
CXCL1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IP-10	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
CXCL10	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IL-22	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
MIG	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
CXCL9	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
MIF	ARG2
gene1e	ARG2
were	O
dependent	O
on	O
gene1s	ARG2
Mavs	ARG2
gene1e	ARG2
expression	O
in	O
arg1s	O
mice	O
arg1e	O
.	O
Loss	O
of	O
gene1s	ARG2
Trif	ARG2
gene1e	ARG2
expression	O
in	O
arg1s	O
mice	O
arg1e	O
altered	O
the	O
species1s	O
RSV	O
species1e	O
induction	O
of	O
gene1s	ARG2
IL-1b	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IL-5	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
CXCL12	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
MIF	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
LIF	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
CXCL12	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
IFN	ARG2
-	ARG2
g	ARG2
gene1e	ARG2
.	O
Silencing	O
of	O
gene1s	O
retinoic	O
acid	O
-	O
inducible	O
gene-1	O
gene1e	O
(	O
gene1s	O
RIG	O
-	O
I	O
gene1e	O
)	O
expression	O
in	O
A549	O
cells	O
had	O
a	O
greater	O
impact	O
on	O
species1s	O
RSV	O
species1e	O
-	O
inducible	O
cytokines	O
than	O
gene1s	O
melanoma	O
differentiation	O
-	O
associated	O
protein	O
5	O
gene1e	O
(	O
gene1s	O
MDA5	O
gene1e	O
)	O
and	O
gene1s	O
laboratory	O
of	O
genetics	O
and	O
physiology	O
2	O
gene1e	O
(	O
gene1s	O
LGP2	O
gene1e	O
)	O
,	O
and	O
gene1s	O
Trif	O
gene1e	O
expression	O
.	O
To	O
evaluate	O
the	O
role	O
of	O
gene1s	ARG2
LIF	ARG2
gene1e	ARG2
in	O
the	O
airways	O
during	O
species1s	O
RSV	O
species1e	O
infection	O
,	O
animals	O
were	O
treated	O
with	O
neutralizing	O
anti	O
-	O
gene1s	ARG2
LIF	ARG2
gene1e	ARG2
IgG	O
,	O
which	O
enhanced	O
species1s	O
RSV	O
species1e	O
pathology	O
observed	O
with	O
increased	O
airspace	O
protein	O
content	O
,	O
apoptosis	O
and	O
airway	O
hyperresponsiveness	O
compared	O
to	O
control	O
IgG	O
treatment	O
.	O
CONCLUSIONS	O
:	O
species1s	O
RSV	O
species1e	O
infection	O
in	O
the	O
epithelium	O
induces	O
a	O
network	O
of	O
immune	O
factors	O
to	O
counter	O
infection	O
,	O
primarily	O
in	O
a	O
gene1s	O
RIG	O
-	O
I	O
gene1e	O
dependent	O
manner	O
.	O
Expression	O
of	O
gene1s	ARG2
LIF	ARG2
gene1e	ARG2
protects	O
the	O
lung	O
from	O
lung	O
injury	O
and	O
enhanced	O
pathology	O
during	O
species1s	O
RSV	O
species1e	O
infection	O
.	O

The	O
gene1s	ARG2
kinesin	ARG2
superfamily	ARG2
protein	ARG2
gene1e	ARG2
gene1s	ARG2
KIF17	ARG2
gene1e	ARG2
is	O
regulated	O
by	O
the	O
same	O
gene1s	ARG2
transcription	ARG2
factor	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
NRF-1	ARG2
gene1e	ARG2
)	O
as	O
its	O
cargo	O
gene1s	ARG2
NR2B	ARG2
gene1e	ARG2
in	O
neurons	O
.	O
The	O
gene1s	ARG2
kinesin	ARG2
gene1e	ARG2
superfamily	O
of	O
motor	O
proteins	O
is	O
known	O
to	O
be	O
gene1s	ARG2
ATP	ARG2
-	ARG2
dependent	ARG2
transporters	ARG2
gene1e	ARG2
of	O
various	O
types	O
of	O
cargoes	O
.	O
In	O
neurons	O
,	O
gene1s	ARG2
KIF17	ARG2
gene1e	ARG2
is	O
found	O
to	O
transport	O
vesicles	O
containing	O
the	O
gene1s	ARG2
N	ARG2
-	ARG2
methyl	ARG2
-	ARG2
D	ARG2
-	ARG2
aspartate	ARG2
receptor	ARG2
gene1e	ARG2
gene1s	ARG2
NR2B	ARG2
gene1e	ARG2
subunit	O
from	O
the	O
cell	O
body	O
specifically	O
to	O
the	O
dendrites	O
.	O
These	O
subunits	O
are	O
intimately	O
associated	O
with	O
glutamatergic	O
neurotransmission	O
as	O
well	O
as	O
with	O
learning	O
and	O
memory	O
.	O
Glutamatergic	O
synapses	O
are	O
highly	O
energy	O
-	O
dependent	O
,	O
and	O
recently	O
we	O
found	O
that	O
the	O
same	O
transcription	O
factor	O
,	O
gene1s	ARG2
nuclear	ARG2
respiratory	ARG2
factor	ARG2
1	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
NRF-1	ARG2
gene1e	ARG2
)	O
,	O
co	O
-	O
regulates	O
energy	O
metabolism	O
(	O
via	O
its	O
regulation	O
of	O
gene1s	ARG2
cytochrome	ARG2
c	ARG2
oxidase	ARG2
gene1e	ARG2
and	O
other	O
mitochondrial	O
enzymes	O
)	O
and	O
neurochemicals	O
of	O
glutamatergic	O
transmission	O
(	O
gene1s	ARG2
NR1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
NR2B	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
GluR2	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
nNOS	ARG2
gene1e	ARG2
)	O
.	O
The	O
present	O
study	O
tested	O
our	O
hypothesis	O
that	O
gene1s	ARG2
NRF-1	ARG2
gene1e	ARG2
also	O
transcriptionally	O
regulates	O
gene1s	ARG2
KIF17	ARG2
gene1e	ARG2
.	O
By	O
means	O
of	O
in	O
silico	O
analysis	O
,	O
electrophoretic	O
mobility	O
shift	O
and	O
supershift	O
assays	O
,	O
in	O
vivo	O
chromatin	O
immunoprecipitation	O
assays	O
,	O
promoter	O
mutations	O
,	O
and	O
real	O
-	O
time	O
quantitative	O
PCR	O
,	O
we	O
found	O
that	O
gene1s	ARG2
NRF-1	ARG2
gene1e	ARG2
(	O
but	O
not	O
gene1s	ARG2
NRF-2	ARG2
gene1e	ARG2
)	O
functionally	O
regulates	O
gene1s	ARG2
Kif17	ARG2
gene1e	ARG2
,	O
but	O
not	O
gene1s	ARG2
Kif1a	ARG2
gene1e	ARG2
,	O
gene	O
.	O
gene1s	ARG2
NRF-1	ARG2
gene1e	ARG2
binding	O
sites	O
on	O
gene1s	ARG2
Kif17	ARG2
gene1e	ARG2
gene	O
are	O
highly	O
conserved	O
among	O
arg1s	O
mice	O
arg1e	O
,	O
species1s	O
rats	O
species1e	O
,	O
and	O
species1s	O
humans	O
species1e	O
.	O
Silencing	O
of	O
gene1s	ARG2
NRF-1	ARG2
gene1e	ARG2
with	O
small	O
interference	O
RNA	O
blocked	O
the	O
up	O
-	O
regulation	O
of	O
gene1s	ARG2
Kif17	ARG2
gene1e	ARG2
mRNA	O
and	O
proteins	O
(	O
and	O
of	O
gene1s	ARG2
Grin1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
Grin2b	ARG2
gene1e	ARG2
)	O
induced	O
by	O
KCl	O
-	O
mediated	O
depolarization	O
,	O
whereas	O
over	O
-	O
expressing	O
gene1s	ARG2
NRF-1	ARG2
gene1e	ARG2
rescued	O
these	O
transcripts	O
and	O
proteins	O
from	O
being	O
suppressed	O
by	O
TTX	O
.	O
Thus	O
,	O
gene1s	ARG2
NRF-1	ARG2
gene1e	ARG2
co	O
-	O
regulates	O
gene1s	ARG2
oxidative	ARG2
enzymes	ARG2
gene1e	ARG2
that	O
generate	O
energy	O
and	O
neurochemicals	O
that	O
consume	O
energy	O
related	O
to	O
glutamatergic	O
neurotransmission	O
,	O
such	O
as	O
gene1s	ARG2
KIF17	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
NR1	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
NR2B	ARG2
gene1e	ARG2
,	O
thereby	O
ensuring	O
that	O
energy	O
production	O
matches	O
energy	O
utilization	O
at	O
the	O
molecular	O
and	O
cellular	O
levels	O
.	O

The	O
gene1s	ARG2
kinesin	ARG2
superfamily	ARG2
protein	ARG2
gene1e	ARG2
gene1s	ARG2
KIF17	ARG2
gene1e	ARG2
is	O
regulated	O
by	O
the	O
same	O
gene1s	ARG2
transcription	ARG2
factor	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
NRF-1	ARG2
gene1e	ARG2
)	O
as	O
its	O
cargo	O
gene1s	ARG2
NR2B	ARG2
gene1e	ARG2
in	O
neurons	O
.	O
The	O
gene1s	ARG2
kinesin	ARG2
gene1e	ARG2
superfamily	O
of	O
motor	O
proteins	O
is	O
known	O
to	O
be	O
gene1s	ARG2
ATP	ARG2
-	ARG2
dependent	ARG2
transporters	ARG2
gene1e	ARG2
of	O
various	O
types	O
of	O
cargoes	O
.	O
In	O
neurons	O
,	O
gene1s	ARG2
KIF17	ARG2
gene1e	ARG2
is	O
found	O
to	O
transport	O
vesicles	O
containing	O
the	O
gene1s	ARG2
N	ARG2
-	ARG2
methyl	ARG2
-	ARG2
D	ARG2
-	ARG2
aspartate	ARG2
receptor	ARG2
gene1e	ARG2
gene1s	ARG2
NR2B	ARG2
gene1e	ARG2
subunit	O
from	O
the	O
cell	O
body	O
specifically	O
to	O
the	O
dendrites	O
.	O
These	O
subunits	O
are	O
intimately	O
associated	O
with	O
glutamatergic	O
neurotransmission	O
as	O
well	O
as	O
with	O
learning	O
and	O
memory	O
.	O
Glutamatergic	O
synapses	O
are	O
highly	O
energy	O
-	O
dependent	O
,	O
and	O
recently	O
we	O
found	O
that	O
the	O
same	O
transcription	O
factor	O
,	O
gene1s	ARG2
nuclear	ARG2
respiratory	ARG2
factor	ARG2
1	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
NRF-1	ARG2
gene1e	ARG2
)	O
,	O
co	O
-	O
regulates	O
energy	O
metabolism	O
(	O
via	O
its	O
regulation	O
of	O
gene1s	ARG2
cytochrome	ARG2
c	ARG2
oxidase	ARG2
gene1e	ARG2
and	O
other	O
mitochondrial	O
enzymes	O
)	O
and	O
neurochemicals	O
of	O
glutamatergic	O
transmission	O
(	O
gene1s	ARG2
NR1	ARG2
gene1e	ARG2
,	O
gene1s	O
NR2B	O
gene1e	O
,	O
gene1s	ARG2
GluR2	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
nNOS	ARG2
gene1e	ARG2
)	O
.	O
The	O
present	O
study	O
tested	O
our	O
hypothesis	O
that	O
gene1s	ARG2
NRF-1	ARG2
gene1e	ARG2
also	O
transcriptionally	O
regulates	O
gene1s	ARG2
KIF17	ARG2
gene1e	ARG2
.	O
By	O
means	O
of	O
in	O
silico	O
analysis	O
,	O
electrophoretic	O
mobility	O
shift	O
and	O
supershift	O
assays	O
,	O
in	O
vivo	O
chromatin	O
immunoprecipitation	O
assays	O
,	O
promoter	O
mutations	O
,	O
and	O
real	O
-	O
time	O
quantitative	O
PCR	O
,	O
we	O
found	O
that	O
gene1s	ARG2
NRF-1	ARG2
gene1e	ARG2
(	O
but	O
not	O
gene1s	ARG2
NRF-2	ARG2
gene1e	ARG2
)	O
functionally	O
regulates	O
gene1s	ARG2
Kif17	ARG2
gene1e	ARG2
,	O
but	O
not	O
gene1s	ARG2
Kif1a	ARG2
gene1e	ARG2
,	O
gene	O
.	O
gene1s	ARG2
NRF-1	ARG2
gene1e	ARG2
binding	O
sites	O
on	O
gene1s	ARG2
Kif17	ARG2
gene1e	ARG2
gene	O
are	O
highly	O
conserved	O
among	O
species1s	O
mice	O
species1e	O
,	O
arg1s	O
rats	O
arg1e	O
,	O
and	O
species1s	O
humans	O
species1e	O
.	O
Silencing	O
of	O
gene1s	ARG2
NRF-1	ARG2
gene1e	ARG2
with	O
small	O
interference	O
RNA	O
blocked	O
the	O
up	O
-	O
regulation	O
of	O
gene1s	ARG2
Kif17	ARG2
gene1e	ARG2
mRNA	O
and	O
proteins	O
(	O
and	O
of	O
gene1s	ARG2
Grin1	ARG2
gene1e	ARG2
and	O
gene1s	O
Grin2b	O
gene1e	O
)	O
induced	O
by	O
KCl	O
-	O
mediated	O
depolarization	O
,	O
whereas	O
over	O
-	O
expressing	O
gene1s	ARG2
NRF-1	ARG2
gene1e	ARG2
rescued	O
these	O
transcripts	O
and	O
proteins	O
from	O
being	O
suppressed	O
by	O
TTX	O
.	O
Thus	O
,	O
gene1s	ARG2
NRF-1	ARG2
gene1e	ARG2
co	O
-	O
regulates	O
gene1s	ARG2
oxidative	ARG2
enzymes	ARG2
gene1e	ARG2
that	O
generate	O
energy	O
and	O
neurochemicals	O
that	O
consume	O
energy	O
related	O
to	O
glutamatergic	O
neurotransmission	O
,	O
such	O
as	O
gene1s	ARG2
KIF17	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
NR1	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
NR2B	ARG2
gene1e	ARG2
,	O
thereby	O
ensuring	O
that	O
energy	O
production	O
matches	O
energy	O
utilization	O
at	O
the	O
molecular	O
and	O
cellular	O
levels	O
.	O

The	O
gene1s	ARG2
kinesin	ARG2
superfamily	ARG2
protein	ARG2
gene1e	ARG2
gene1s	ARG2
KIF17	ARG2
gene1e	ARG2
is	O
regulated	O
by	O
the	O
same	O
gene1s	ARG2
transcription	ARG2
factor	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
NRF-1	ARG2
gene1e	ARG2
)	O
as	O
its	O
cargo	O
gene1s	ARG2
NR2B	ARG2
gene1e	ARG2
in	O
neurons	O
.	O
The	O
gene1s	ARG2
kinesin	ARG2
gene1e	ARG2
superfamily	O
of	O
motor	O
proteins	O
is	O
known	O
to	O
be	O
gene1s	ARG2
ATP	ARG2
-	ARG2
dependent	ARG2
transporters	ARG2
gene1e	ARG2
of	O
various	O
types	O
of	O
cargoes	O
.	O
In	O
neurons	O
,	O
gene1s	ARG2
KIF17	ARG2
gene1e	ARG2
is	O
found	O
to	O
transport	O
vesicles	O
containing	O
the	O
gene1s	ARG2
N	ARG2
-	ARG2
methyl	ARG2
-	ARG2
D	ARG2
-	ARG2
aspartate	ARG2
receptor	ARG2
gene1e	ARG2
gene1s	ARG2
NR2B	ARG2
gene1e	ARG2
subunit	O
from	O
the	O
cell	O
body	O
specifically	O
to	O
the	O
dendrites	O
.	O
These	O
subunits	O
are	O
intimately	O
associated	O
with	O
glutamatergic	O
neurotransmission	O
as	O
well	O
as	O
with	O
learning	O
and	O
memory	O
.	O
Glutamatergic	O
synapses	O
are	O
highly	O
energy	O
-	O
dependent	O
,	O
and	O
recently	O
we	O
found	O
that	O
the	O
same	O
transcription	O
factor	O
,	O
gene1s	ARG2
nuclear	ARG2
respiratory	ARG2
factor	ARG2
1	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
NRF-1	ARG2
gene1e	ARG2
)	O
,	O
co	O
-	O
regulates	O
energy	O
metabolism	O
(	O
via	O
its	O
regulation	O
of	O
gene1s	ARG2
cytochrome	ARG2
c	ARG2
oxidase	ARG2
gene1e	ARG2
and	O
other	O
mitochondrial	O
enzymes	O
)	O
and	O
neurochemicals	O
of	O
glutamatergic	O
transmission	O
(	O
gene1s	ARG2
NR1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
NR2B	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
GluR2	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
nNOS	ARG2
gene1e	ARG2
)	O
.	O
The	O
present	O
study	O
tested	O
our	O
hypothesis	O
that	O
gene1s	ARG2
NRF-1	ARG2
gene1e	ARG2
also	O
transcriptionally	O
regulates	O
gene1s	ARG2
KIF17	ARG2
gene1e	ARG2
.	O
By	O
means	O
of	O
in	O
silico	O
analysis	O
,	O
electrophoretic	O
mobility	O
shift	O
and	O
supershift	O
assays	O
,	O
in	O
vivo	O
chromatin	O
immunoprecipitation	O
assays	O
,	O
promoter	O
mutations	O
,	O
and	O
real	O
-	O
time	O
quantitative	O
PCR	O
,	O
we	O
found	O
that	O
gene1s	ARG2
NRF-1	ARG2
gene1e	ARG2
(	O
but	O
not	O
gene1s	ARG2
NRF-2	ARG2
gene1e	ARG2
)	O
functionally	O
regulates	O
gene1s	ARG2
Kif17	ARG2
gene1e	ARG2
,	O
but	O
not	O
gene1s	ARG2
Kif1a	ARG2
gene1e	ARG2
,	O
gene	O
.	O
gene1s	ARG2
NRF-1	ARG2
gene1e	ARG2
binding	O
sites	O
on	O
gene1s	ARG2
Kif17	ARG2
gene1e	ARG2
gene	O
are	O
highly	O
conserved	O
among	O
species1s	O
mice	O
species1e	O
,	O
species1s	O
rats	O
species1e	O
,	O
and	O
arg1s	O
humans	O
arg1e	O
.	O
Silencing	O
of	O
gene1s	ARG2
NRF-1	ARG2
gene1e	ARG2
with	O
small	O
interference	O
RNA	O
blocked	O
the	O
up	O
-	O
regulation	O
of	O
gene1s	ARG2
Kif17	ARG2
gene1e	ARG2
mRNA	O
and	O
proteins	O
(	O
and	O
of	O
gene1s	ARG2
Grin1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
Grin2b	ARG2
gene1e	ARG2
)	O
induced	O
by	O
KCl	O
-	O
mediated	O
depolarization	O
,	O
whereas	O
over	O
-	O
expressing	O
gene1s	ARG2
NRF-1	ARG2
gene1e	ARG2
rescued	O
these	O
transcripts	O
and	O
proteins	O
from	O
being	O
suppressed	O
by	O
TTX	O
.	O
Thus	O
,	O
gene1s	ARG2
NRF-1	ARG2
gene1e	ARG2
co	O
-	O
regulates	O
gene1s	ARG2
oxidative	ARG2
enzymes	ARG2
gene1e	ARG2
that	O
generate	O
energy	O
and	O
neurochemicals	O
that	O
consume	O
energy	O
related	O
to	O
glutamatergic	O
neurotransmission	O
,	O
such	O
as	O
gene1s	ARG2
KIF17	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
NR1	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
NR2B	ARG2
gene1e	ARG2
,	O
thereby	O
ensuring	O
that	O
energy	O
production	O
matches	O
energy	O
utilization	O
at	O
the	O
molecular	O
and	O
cellular	O
levels	O
.	O

gene1s	O
STAT3	O
gene1e	O
regulates	O
proliferation	O
and	O
survival	O
of	O
gene1s	O
CD8	O
gene1e	O
+	O
T	O
cells	O
:	O
enhances	O
effector	O
responses	O
to	O
arg1s	O
HSV-1	O
arg1e	O
infection	O
,	O
and	O
inhibits	O
gene1s	O
IL-10	O
gene1e	O
+	O
regulatory	O
gene1s	O
CD8	O
gene1e	O
+	O
T	O
cells	O
in	O
autoimmune	O
uveitis	O
.	O
gene1s	O
STAT3	O
gene1e	O
regulates	O
gene1s	O
CD4	O
gene1e	O
+	O
T	O
cell	O
survival	O
and	O
differentiation	O
.	O
However	O
,	O
its	O
effects	O
on	O
gene1s	O
CD8	O
gene1e	O
+	O
T	O
cells	O
are	O
not	O
well	O
understood	O
.	O
Here	O
,	O
we	O
show	O
that	O
in	O
comparison	O
to	O
WT	O
gene1s	O
CD8	O
gene1e	O
+	O
T	O
cells	O
,	O
gene1s	O
STAT3	O
gene1e	O
-deficient	O
gene1s	O
CD8	O
gene1e	O
+	O
T	O
cells	O
exhibit	O
a	O
preactivated	O
memory	O
-	O
like	O
phenotype	O
,	O
produce	O
more	O
gene1s	O
IL-2	O
gene1e	O
,	O
proliferate	O
faster	O
,	O
and	O
are	O
more	O
sensitive	O
to	O
activation	O
-	O
induced	O
cell	O
death	O
(	O
AICD	O
)	O
.	O
The	O
enhanced	O
proliferation	O
and	O
sensitivity	O
to	O
AICD	O
correlated	O
with	O
downregulation	O
of	O
gene1s	O
class	O
-	O
O	O
forkhead	O
transcription	O
factors	O
gene1e	O
(	O
gene1s	O
FoxO1	O
gene1e	O
,	O
gene1s	O
FoxO3A	O
gene1e	O
)	O
,	O
gene1s	O
p21	O
gene1e	O
(	O
gene1s	O
waf1	O
gene1e	O
)	O
,	O
gene1s	O
p27(KIP1	O
)	O
gene1e	O
,	O
gene1s	O
Bcl-2	O
gene1e	O
,	O
gene1s	O
OX-40	O
gene1e	O
,	O
and	O
upregulation	O
of	O
gene1s	O
FasL	O
gene1e	O
,	O
gene1s	O
Bax	O
gene1e	O
,	O
and	O
gene1s	O
Bad	O
gene1e	O
.	O
We	O
examined	O
whether	O
gene1s	O
STAT3	O
gene1e	O
-deficient	O
gene1s	O
CD8	O
gene1e	O
+	O
T	O
cells	O
can	O
mount	O
effective	O
response	O
during	O
arg1s	O
herpes	O
simplex	O
virus	O
(	O
HSV-1	O
)	O
arg1e	O
infection	O
and	O
experimental	O
autoimmune	O
uveitis	O
(	O
EAU	O
)	O
.	O
Compared	O
to	O
WT	O
species1s	O
mice	O
species1e	O
,	O
arg1s	O
HSV-1	O
arg1e	O
-infected	O
gene1s	O
STAT3	O
gene1e	O
-deficient	O
species1s	O
mice	O
species1e	O
(	O
gene1s	O
STAT3KO	O
gene1e	O
)	O
produced	O
less	O
gene1s	O
IFN	O
-	O
gamma	O
gene1e	O
and	O
virus	O
-	O
specific	O
gene1s	O
KLRG-1	O
gene1e	O
+	O
gene1s	O
CD8	O
gene1e	O
+	O
T	O
cells	O
.	O
gene1s	O
STAT3KO	O
gene1e	O
species1s	O
mice	O
species1e	O
are	O
also	O
resistant	O
to	O
EAU	O
and	O
produced	O
less	O
gene1s	O
IL-17	O
gene1e	O
-producing	O
Tc17	O
cells	O
.	O
Resistance	O
of	O
gene1s	O
STAT3KO	O
gene1e	O
to	O
EAU	O
correlated	O
with	O
marked	O
expansion	O
of	O
gene1s	O
IL-10	O
gene1e	O
-producing	O
regulatory	O
gene1s	O
CD8	O
gene1e	O
+	O
T	O
cells	O
(	O
gene1s	O
CD8	O
gene1e	O
-Treg	O
)	O
implicated	O
in	O
recovery	O
from	O
autoimmune	O
encephalomyelitis	O
.	O
Thus	O
,	O
increases	O
of	O
gene1s	O
IL-6	O
gene1e	O
-induced	O
gene1s	O
STAT3	O
gene1e	O
activation	O
observed	O
during	O
inflammation	O
may	O
inhibit	O
expansion	O
of	O
gene1s	O
CD8	O
gene1e	O
-Tregs	O
,	O
thereby	O
impeding	O
recovery	O
from	O
uveitis	O
.	O
These	O
results	O
suggest	O
that	O
gene1s	O
STAT3	O
gene1e	O
is	O
a	O
potential	O
therapeutic	O
target	O
for	O
upregulating	O
gene1s	O
CD8	O
gene1e	O
+	O
T	O
cell	O
-	O
mediated	O
responses	O
to	O
viruses	O
and	O
suggest	O
the	O
successful	O
therapeutic	O
targeting	O
of	O
gene1s	O
STAT3	O
gene1e	O
as	O
treatment	O
for	O
uveitis	O
,	O
derived	O
,	O
in	O
part	O
,	O
from	O
promoting	O
gene1s	O
CD8	O
gene1e	O
-Treg	O
expansion	O
.	O

gene1s	ARG2
STAT3	ARG2
gene1e	ARG2
regulates	O
proliferation	O
and	O
survival	O
of	O
gene1s	ARG2
CD8	ARG2
gene1e	ARG2
+	O
T	O
cells	O
:	O
enhances	O
effector	O
responses	O
to	O
species1s	O
HSV-1	O
species1e	O
infection	O
,	O
and	O
inhibits	O
gene1s	ARG2
IL-10	ARG2
gene1e	ARG2
+	O
regulatory	O
gene1s	ARG2
CD8	ARG2
gene1e	ARG2
+	O
T	O
cells	O
in	O
autoimmune	O
uveitis	O
.	O
gene1s	ARG2
STAT3	ARG2
gene1e	ARG2
regulates	O
gene1s	ARG2
CD4	ARG2
gene1e	ARG2
+	O
T	O
cell	O
survival	O
and	O
differentiation	O
.	O
However	O
,	O
its	O
effects	O
on	O
gene1s	ARG2
CD8	ARG2
gene1e	ARG2
+	O
T	O
cells	O
are	O
not	O
well	O
understood	O
.	O
Here	O
,	O
we	O
show	O
that	O
in	O
comparison	O
to	O
WT	O
gene1s	ARG2
CD8	ARG2
gene1e	ARG2
+	O
T	O
cells	O
,	O
gene1s	ARG2
STAT3	ARG2
gene1e	ARG2
-deficient	O
gene1s	ARG2
CD8	ARG2
gene1e	ARG2
+	O
T	O
cells	O
exhibit	O
a	O
preactivated	O
memory	O
-	O
like	O
phenotype	O
,	O
produce	O
more	O
gene1s	ARG2
IL-2	ARG2
gene1e	ARG2
,	O
proliferate	O
faster	O
,	O
and	O
are	O
more	O
sensitive	O
to	O
activation	O
-	O
induced	O
cell	O
death	O
(	O
AICD	O
)	O
.	O
The	O
enhanced	O
proliferation	O
and	O
sensitivity	O
to	O
AICD	O
correlated	O
with	O
downregulation	O
of	O
gene1s	ARG2
class	ARG2
-	ARG2
O	ARG2
forkhead	ARG2
transcription	ARG2
factors	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
FoxO1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
FoxO3A	ARG2
gene1e	ARG2
)	O
,	O
gene1s	ARG2
p21	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
waf1	ARG2
gene1e	ARG2
)	O
,	O
gene1s	ARG2
p27(KIP1	ARG2
)	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Bcl-2	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
OX-40	ARG2
gene1e	ARG2
,	O
and	O
upregulation	O
of	O
gene1s	ARG2
FasL	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Bax	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
Bad	ARG2
gene1e	ARG2
.	O
We	O
examined	O
whether	O
gene1s	ARG2
STAT3	ARG2
gene1e	ARG2
-deficient	O
gene1s	ARG2
CD8	ARG2
gene1e	ARG2
+	O
T	O
cells	O
can	O
mount	O
effective	O
response	O
during	O
species1s	O
herpes	O
simplex	O
virus	O
(	O
HSV-1	O
)	O
species1e	O
infection	O
and	O
experimental	O
autoimmune	O
uveitis	O
(	O
EAU	O
)	O
.	O
Compared	O
to	O
WT	O
arg1s	O
mice	O
arg1e	O
,	O
species1s	O
HSV-1	O
species1e	O
-infected	O
gene1s	ARG2
STAT3	ARG2
gene1e	ARG2
-deficient	O
arg1s	O
mice	O
arg1e	O
(	O
gene1s	ARG2
STAT3KO	ARG2
gene1e	ARG2
)	O
produced	O
less	O
gene1s	ARG2
IFN	ARG2
-	ARG2
gamma	ARG2
gene1e	ARG2
and	O
virus	O
-	O
specific	O
gene1s	ARG2
KLRG-1	ARG2
gene1e	ARG2
+	O
gene1s	ARG2
CD8	ARG2
gene1e	ARG2
+	O
T	O
cells	O
.	O
gene1s	ARG2
STAT3KO	ARG2
gene1e	ARG2
arg1s	O
mice	O
arg1e	O
are	O
also	O
resistant	O
to	O
EAU	O
and	O
produced	O
less	O
gene1s	ARG2
IL-17	ARG2
gene1e	ARG2
-producing	O
Tc17	O
cells	O
.	O
Resistance	O
of	O
gene1s	ARG2
STAT3KO	ARG2
gene1e	ARG2
to	O
EAU	O
correlated	O
with	O
marked	O
expansion	O
of	O
gene1s	ARG2
IL-10	ARG2
gene1e	ARG2
-producing	O
regulatory	O
gene1s	ARG2
CD8	ARG2
gene1e	ARG2
+	O
T	O
cells	O
(	O
gene1s	ARG2
CD8	ARG2
gene1e	ARG2
-Treg	O
)	O
implicated	O
in	O
recovery	O
from	O
autoimmune	O
encephalomyelitis	O
.	O
Thus	O
,	O
increases	O
of	O
gene1s	ARG2
IL-6	ARG2
gene1e	ARG2
-induced	O
gene1s	ARG2
STAT3	ARG2
gene1e	ARG2
activation	O
observed	O
during	O
inflammation	O
may	O
inhibit	O
expansion	O
of	O
gene1s	ARG2
CD8	ARG2
gene1e	ARG2
-Tregs	O
,	O
thereby	O
impeding	O
recovery	O
from	O
uveitis	O
.	O
These	O
results	O
suggest	O
that	O
gene1s	ARG2
STAT3	ARG2
gene1e	ARG2
is	O
a	O
potential	O
therapeutic	O
target	O
for	O
upregulating	O
gene1s	ARG2
CD8	ARG2
gene1e	ARG2
+	O
T	O
cell	O
-	O
mediated	O
responses	O
to	O
viruses	O
and	O
suggest	O
the	O
successful	O
therapeutic	O
targeting	O
of	O
gene1s	ARG2
STAT3	ARG2
gene1e	ARG2
as	O
treatment	O
for	O
uveitis	O
,	O
derived	O
,	O
in	O
part	O
,	O
from	O
promoting	O
gene1s	ARG2
CD8	ARG2
gene1e	ARG2
-Treg	O
expansion	O
.	O

Gene	O
profile	O
of	O
gene1s	ARG2
chemokines	ARG2
gene1e	ARG2
on	O
hepatic	O
stellate	O
cells	O
of	O
schistosome	O
-	O
infected	O
arg1s	O
mice	O
arg1e	O
and	O
antifibrotic	O
roles	O
of	O
gene1s	ARG2
CXCL9/10	ARG2
gene1e	ARG2
on	O
liver	O
non	O
-	O
parenchymal	O
cells	O
.	O
Hepatic	O
stellate	O
cells	O
(	O
HSCs	O
)	O
play	O
a	O
key	O
role	O
in	O
the	O
development	O
of	O
liver	O
fibrosis	O
caused	O
by	O
schistosomiasis	O
.	O
gene1s	ARG2
Chemokines	ARG2
gene1e	ARG2
were	O
widely	O
expressed	O
and	O
involved	O
in	O
cellular	O
activation	O
,	O
proliferation	O
and	O
migration	O
in	O
inflammatory	O
and	O
infectious	O
diseases	O
.	O
However	O
,	O
little	O
is	O
known	O
about	O
the	O
expressions	O
of	O
gene1s	ARG2
chemokines	ARG2
gene1e	ARG2
on	O
HSCs	O
in	O
the	O
species1s	O
schistosoma	O
species1e	O
infection	O
.	O
In	O
addition	O
,	O
the	O
roles	O
of	O
gene1s	ARG2
chemokines	ARG2
gene1e	ARG2
in	O
pathogenesis	O
of	O
liver	O
fibrosis	O
are	O
not	O
totally	O
clear	O
.	O
In	O
our	O
study	O
,	O
we	O
used	O
microarray	O
to	O
analyze	O
the	O
temporal	O
gene	O
expressions	O
of	O
primary	O
HSCs	O
isolated	O
from	O
arg1s	O
mice	O
arg1e	O
with	O
both	O
acute	O
and	O
chronic	O
schistosomiasis	O
.	O
Our	O
microarray	O
data	O
showed	O
that	O
most	O
of	O
the	O
gene1s	ARG2
chemokines	ARG2
gene1e	ARG2
expressed	O
on	O
HSCs	O
were	O
upregulated	O
at	O
3	O
weeks	O
post	O
-	O
infection	O
(	O
p.i	O
)	O
when	O
the	O
egg	O
granulomatous	O
response	O
was	O
not	O
obviously	O
evoked	O
in	O
the	O
liver	O
.	O
However	O
,	O
some	O
of	O
them	O
like	O
gene1s	ARG2
CXCL9	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
CXCL10	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
CXCL11	ARG2
gene1e	ARG2
were	O
subsequently	O
decreased	O
at	O
6	O
weeks	O
p.i	O
when	O
the	O
granulomatous	O
response	O
reached	O
the	O
peak	O
.	O
In	O
the	O
chronic	O
stage	O
,	O
most	O
of	O
the	O
differentially	O
expressed	O
gene1s	ARG2
chemokines	ARG2
gene1e	ARG2
maintained	O
persistent	O
high	O
-	O
abundances	O
.	O
Furthermore	O
,	O
several	O
gene1s	ARG2
chemokines	ARG2
gene1e	ARG2
including	O
gene1s	ARG2
CCR2	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
CCR5	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
CCR7	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
CXCR3	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
CXCR4	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
CCL2	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
CCL5	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
CCL21	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
CXCL9	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
CXCL10	ARG2
gene1e	ARG2
were	O
expressed	O
by	O
HCSs	O
and	O
the	O
abundances	O
of	O
them	O
were	O
changed	O
following	O
the	O
praziquantel	O
treatment	O
in	O
the	O
chronic	O
stage	O
,	O
indicating	O
that	O
gene1s	ARG2
chemokines	ARG2
gene1e	ARG2
were	O
possibly	O
necessary	O
for	O
the	O
persistence	O
of	O
the	O
chronic	O
stage	O
.	O
In	O
vitro	O
experiments	O
,	O
hepatic	O
non	O
-	O
parenchymal	O
cells	O
,	O
primary	O
HSCs	O
and	O
species1s	O
human	O
species1e	O
HSCs	O
line	O
LX-2	O
were	O
stimulated	O
by	O
gene1s	ARG2
chemokines	ARG2
gene1e	ARG2
.	O
The	O
results	O
showed	O
that	O
gene1s	ARG2
CXCL9	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
CXCL10	ARG2
gene1e	ARG2
,	O
but	O
not	O
gene1s	O
CXCL11	O
gene1e	O
or	O
gene1s	ARG2
CXCL4	ARG2
gene1e	ARG2
,	O
significantly	O
inhibited	O
the	O
gene	O
expressions	O
of	O
gene1s	ARG2
Col1a1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Col3a1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
a	ARG2
-	ARG2
SMA	ARG2
gene1e	ARG2
,	O
indicating	O
the	O
potential	O
anti	O
-	O
fibrosis	O
effect	O
of	O
gene1s	ARG2
CXCL9	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
CXCL10	ARG2
gene1e	ARG2
in	O
schistosomiasis	O
.	O
More	O
interestingly	O
,	O
soluble	O
egg	O
antigen	O
(	O
SEA	O
)	O
of	O
species1s	O
Schistosoma	O
japonicum	O
species1e	O
was	O
able	O
to	O
inhibit	O
transcriptional	O
expressions	O
of	O
some	O
gene1s	ARG2
chemokines	ARG2
gene1e	ARG2
by	O
species1s	O
LX-2	O
species1e	O
cells	O
,	O
suggesting	O
that	O
SEA	O
was	O
capable	O
of	O
regulating	O
the	O
expression	O
pattern	O
of	O
gene1s	ARG2
chemokine	ARG2
gene1e	ARG2
family	O
and	O
modulating	O
the	O
hepatic	O
immune	O
microenvironment	O
in	O
schistosomiasis	O
.	O

Gene	O
profile	O
of	O
gene1s	O
chemokines	O
gene1e	O
on	O
hepatic	O
stellate	O
cells	O
of	O
schistosome	O
-	O
infected	O
species1s	O
mice	O
species1e	O
and	O
antifibrotic	O
roles	O
of	O
gene1s	O
CXCL9/10	O
gene1e	O
on	O
liver	O
non	O
-	O
parenchymal	O
cells	O
.	O
Hepatic	O
stellate	O
cells	O
(	O
HSCs	O
)	O
play	O
a	O
key	O
role	O
in	O
the	O
development	O
of	O
liver	O
fibrosis	O
caused	O
by	O
schistosomiasis	O
.	O
gene1s	O
Chemokines	O
gene1e	O
were	O
widely	O
expressed	O
and	O
involved	O
in	O
cellular	O
activation	O
,	O
proliferation	O
and	O
migration	O
in	O
inflammatory	O
and	O
infectious	O
diseases	O
.	O
However	O
,	O
little	O
is	O
known	O
about	O
the	O
expressions	O
of	O
gene1s	O
chemokines	O
gene1e	O
on	O
HSCs	O
in	O
the	O
arg1s	O
schistosoma	O
arg1e	O
infection	O
.	O
In	O
addition	O
,	O
the	O
roles	O
of	O
gene1s	O
chemokines	O
gene1e	O
in	O
pathogenesis	O
of	O
liver	O
fibrosis	O
are	O
not	O
totally	O
clear	O
.	O
In	O
our	O
study	O
,	O
we	O
used	O
microarray	O
to	O
analyze	O
the	O
temporal	O
gene	O
expressions	O
of	O
primary	O
HSCs	O
isolated	O
from	O
species1s	O
mice	O
species1e	O
with	O
both	O
acute	O
and	O
chronic	O
schistosomiasis	O
.	O
Our	O
microarray	O
data	O
showed	O
that	O
most	O
of	O
the	O
gene1s	O
chemokines	O
gene1e	O
expressed	O
on	O
HSCs	O
were	O
upregulated	O
at	O
3	O
weeks	O
post	O
-	O
infection	O
(	O
p.i	O
)	O
when	O
the	O
egg	O
granulomatous	O
response	O
was	O
not	O
obviously	O
evoked	O
in	O
the	O
liver	O
.	O
However	O
,	O
some	O
of	O
them	O
like	O
gene1s	O
CXCL9	O
gene1e	O
,	O
gene1s	O
CXCL10	O
gene1e	O
and	O
gene1s	O
CXCL11	O
gene1e	O
were	O
subsequently	O
decreased	O
at	O
6	O
weeks	O
p.i	O
when	O
the	O
granulomatous	O
response	O
reached	O
the	O
peak	O
.	O
In	O
the	O
chronic	O
stage	O
,	O
most	O
of	O
the	O
differentially	O
expressed	O
gene1s	O
chemokines	O
gene1e	O
maintained	O
persistent	O
high	O
-	O
abundances	O
.	O
Furthermore	O
,	O
several	O
gene1s	O
chemokines	O
gene1e	O
including	O
gene1s	O
CCR2	O
gene1e	O
,	O
gene1s	O
CCR5	O
gene1e	O
,	O
gene1s	O
CCR7	O
gene1e	O
,	O
gene1s	O
CXCR3	O
gene1e	O
,	O
gene1s	O
CXCR4	O
gene1e	O
,	O
gene1s	O
CCL2	O
gene1e	O
,	O
gene1s	O
CCL5	O
gene1e	O
,	O
gene1s	O
CCL21	O
gene1e	O
,	O
gene1s	O
CXCL9	O
gene1e	O
and	O
gene1s	O
CXCL10	O
gene1e	O
were	O
expressed	O
by	O
HCSs	O
and	O
the	O
abundances	O
of	O
them	O
were	O
changed	O
following	O
the	O
praziquantel	O
treatment	O
in	O
the	O
chronic	O
stage	O
,	O
indicating	O
that	O
gene1s	O
chemokines	O
gene1e	O
were	O
possibly	O
necessary	O
for	O
the	O
persistence	O
of	O
the	O
chronic	O
stage	O
.	O
In	O
vitro	O
experiments	O
,	O
hepatic	O
non	O
-	O
parenchymal	O
cells	O
,	O
primary	O
HSCs	O
and	O
species1s	O
human	O
species1e	O
HSCs	O
line	O
LX-2	O
were	O
stimulated	O
by	O
gene1s	O
chemokines	O
gene1e	O
.	O
The	O
results	O
showed	O
that	O
gene1s	O
CXCL9	O
gene1e	O
and	O
gene1s	O
CXCL10	O
gene1e	O
,	O
but	O
not	O
gene1s	O
CXCL11	O
gene1e	O
or	O
gene1s	O
CXCL4	O
gene1e	O
,	O
significantly	O
inhibited	O
the	O
gene	O
expressions	O
of	O
gene1s	O
Col1a1	O
gene1e	O
,	O
gene1s	O
Col3a1	O
gene1e	O
and	O
gene1s	O
a	O
-	O
SMA	O
gene1e	O
,	O
indicating	O
the	O
potential	O
anti	O
-	O
fibrosis	O
effect	O
of	O
gene1s	O
CXCL9	O
gene1e	O
and	O
gene1s	O
CXCL10	O
gene1e	O
in	O
schistosomiasis	O
.	O
More	O
interestingly	O
,	O
soluble	O
egg	O
antigen	O
(	O
SEA	O
)	O
of	O
arg1s	O
Schistosoma	O
japonicum	O
arg1e	O
was	O
able	O
to	O
inhibit	O
transcriptional	O
expressions	O
of	O
some	O
gene1s	O
chemokines	O
gene1e	O
by	O
species1s	O
LX-2	O
species1e	O
cells	O
,	O
suggesting	O
that	O
SEA	O
was	O
capable	O
of	O
regulating	O
the	O
expression	O
pattern	O
of	O
gene1s	O
chemokine	O
gene1e	O
family	O
and	O
modulating	O
the	O
hepatic	O
immune	O
microenvironment	O
in	O
schistosomiasis	O
.	O

Gene	O
profile	O
of	O
gene1s	O
chemokines	O
gene1e	O
on	O
hepatic	O
stellate	O
cells	O
of	O
schistosome	O
-	O
infected	O
species1s	O
mice	O
species1e	O
and	O
antifibrotic	O
roles	O
of	O
gene1s	O
CXCL9/10	O
gene1e	O
on	O
liver	O
non	O
-	O
parenchymal	O
cells	O
.	O
Hepatic	O
stellate	O
cells	O
(	O
HSCs	O
)	O
play	O
a	O
key	O
role	O
in	O
the	O
development	O
of	O
liver	O
fibrosis	O
caused	O
by	O
schistosomiasis	O
.	O
gene1s	O
Chemokines	O
gene1e	O
were	O
widely	O
expressed	O
and	O
involved	O
in	O
cellular	O
activation	O
,	O
proliferation	O
and	O
migration	O
in	O
inflammatory	O
and	O
infectious	O
diseases	O
.	O
However	O
,	O
little	O
is	O
known	O
about	O
the	O
expressions	O
of	O
gene1s	O
chemokines	O
gene1e	O
on	O
HSCs	O
in	O
the	O
species1s	O
schistosoma	O
species1e	O
infection	O
.	O
In	O
addition	O
,	O
the	O
roles	O
of	O
gene1s	O
chemokines	O
gene1e	O
in	O
pathogenesis	O
of	O
liver	O
fibrosis	O
are	O
not	O
totally	O
clear	O
.	O
In	O
our	O
study	O
,	O
we	O
used	O
microarray	O
to	O
analyze	O
the	O
temporal	O
gene	O
expressions	O
of	O
primary	O
HSCs	O
isolated	O
from	O
species1s	O
mice	O
species1e	O
with	O
both	O
acute	O
and	O
chronic	O
schistosomiasis	O
.	O
Our	O
microarray	O
data	O
showed	O
that	O
most	O
of	O
the	O
gene1s	O
chemokines	O
gene1e	O
expressed	O
on	O
HSCs	O
were	O
upregulated	O
at	O
3	O
weeks	O
post	O
-	O
infection	O
(	O
p.i	O
)	O
when	O
the	O
egg	O
granulomatous	O
response	O
was	O
not	O
obviously	O
evoked	O
in	O
the	O
liver	O
.	O
However	O
,	O
some	O
of	O
them	O
like	O
gene1s	O
CXCL9	O
gene1e	O
,	O
gene1s	O
CXCL10	O
gene1e	O
and	O
gene1s	O
CXCL11	O
gene1e	O
were	O
subsequently	O
decreased	O
at	O
6	O
weeks	O
p.i	O
when	O
the	O
granulomatous	O
response	O
reached	O
the	O
peak	O
.	O
In	O
the	O
chronic	O
stage	O
,	O
most	O
of	O
the	O
differentially	O
expressed	O
gene1s	O
chemokines	O
gene1e	O
maintained	O
persistent	O
high	O
-	O
abundances	O
.	O
Furthermore	O
,	O
several	O
gene1s	O
chemokines	O
gene1e	O
including	O
gene1s	O
CCR2	O
gene1e	O
,	O
gene1s	O
CCR5	O
gene1e	O
,	O
gene1s	O
CCR7	O
gene1e	O
,	O
gene1s	O
CXCR3	O
gene1e	O
,	O
gene1s	O
CXCR4	O
gene1e	O
,	O
gene1s	O
CCL2	O
gene1e	O
,	O
gene1s	O
CCL5	O
gene1e	O
,	O
gene1s	O
CCL21	O
gene1e	O
,	O
gene1s	O
CXCL9	O
gene1e	O
and	O
gene1s	O
CXCL10	O
gene1e	O
were	O
expressed	O
by	O
HCSs	O
and	O
the	O
abundances	O
of	O
them	O
were	O
changed	O
following	O
the	O
praziquantel	O
treatment	O
in	O
the	O
chronic	O
stage	O
,	O
indicating	O
that	O
gene1s	O
chemokines	O
gene1e	O
were	O
possibly	O
necessary	O
for	O
the	O
persistence	O
of	O
the	O
chronic	O
stage	O
.	O
In	O
vitro	O
experiments	O
,	O
hepatic	O
non	O
-	O
parenchymal	O
cells	O
,	O
primary	O
HSCs	O
and	O
arg1s	O
human	O
arg1e	O
HSCs	O
line	O
LX-2	O
were	O
stimulated	O
by	O
gene1s	O
chemokines	O
gene1e	O
.	O
The	O
results	O
showed	O
that	O
gene1s	O
CXCL9	O
gene1e	O
and	O
gene1s	O
CXCL10	O
gene1e	O
,	O
but	O
not	O
gene1s	ARG2
CXCL11	ARG2
gene1e	ARG2
or	O
gene1s	O
CXCL4	O
gene1e	O
,	O
significantly	O
inhibited	O
the	O
gene	O
expressions	O
of	O
gene1s	ARG2
Col1a1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Col3a1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
a	ARG2
-	ARG2
SMA	ARG2
gene1e	ARG2
,	O
indicating	O
the	O
potential	O
anti	O
-	O
fibrosis	O
effect	O
of	O
gene1s	ARG2
CXCL9	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
CXCL10	ARG2
gene1e	ARG2
in	O
schistosomiasis	O
.	O
More	O
interestingly	O
,	O
soluble	O
egg	O
antigen	O
(	O
SEA	O
)	O
of	O
species1s	O
Schistosoma	O
japonicum	O
species1e	O
was	O
able	O
to	O
inhibit	O
transcriptional	O
expressions	O
of	O
some	O
gene1s	O
chemokines	O
gene1e	O
by	O
arg1s	O
LX-2	O
arg1e	O
cells	O
,	O
suggesting	O
that	O
SEA	O
was	O
capable	O
of	O
regulating	O
the	O
expression	O
pattern	O
of	O
gene1s	O
chemokine	O
gene1e	O
family	O
and	O
modulating	O
the	O
hepatic	O
immune	O
microenvironment	O
in	O
schistosomiasis	O
.	O

gene1s	ARG2
RhBMP-2	ARG2
gene1e	ARG2
Activates	O
Hippo	O
Signaling	O
through	O
gene1s	ARG2
RASSF1	ARG2
gene1e	ARG2
in	O
Esophageal	O
Cancer	O
Cells	O
.	O
Despite	O
that	O
recombinant	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
bone	ARG2
morphogenetic	ARG2
protein-2	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
rhBMP-2	ARG2
gene1e	ARG2
)	O
has	O
been	O
reported	O
as	O
a	O
stimulatory	O
effecter	O
of	O
cancer	O
cell	O
growth	O
because	O
of	O
its	O
characteristic	O
like	O
morphogen	O
,	O
the	O
biological	O
functions	O
of	O
gene1s	ARG2
rhBMP-2	ARG2
gene1e	ARG2
in	O
arg1s	O
human	O
arg1e	O
esophageal	O
cancer	O
cells	O
are	O
unknown	O
.	O
The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
investigate	O
whether	O
gene1s	ARG2
rhBMP-2	ARG2
gene1e	ARG2
has	O
an	O
inhibitory	O
effect	O
on	O
the	O
growth	O
of	O
arg1s	O
human	O
arg1e	O
esophageal	O
squamous	O
carcinoma	O
cells	O
(	O
ESCC	O
)	O
.	O
Rh	O
gene1s	ARG2
BMP-2	ARG2
gene1e	ARG2
significantly	O
inhibited	O
proliferation	O
of	O
ESCC	O
cells	O
in	O
a	O
dose	O
-	O
dependent	O
manner	O
in	O
the	O
MTT	O
assay	O
.	O
Cell	O
cycle	O
arrest	O
at	O
the	O
G1	O
phase	O
was	O
induced	O
24	O
h	O
after	O
gene1s	ARG2
rhBMP2	ARG2
gene1e	ARG2
treatment	O
.	O
gene1s	ARG2
RhBMP-2	ARG2
gene1e	ARG2
also	O
reduced	O
gene1s	ARG2
cyclin	ARG2
D1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
cyclin	ARG2
-	ARG2
dependent	ARG2
kinase	ARG2
(	ARG2
CDK	ARG2
)	ARG2
4	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
CDK	ARG2
6	ARG2
gene1e	ARG2
activities	O
,	O
and	O
stimulated	O
p	O
-	O
gene1s	ARG2
Smad1/5/8	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
p53	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
p21	ARG2
gene1e	ARG2
levels	O
at	O
12	O
h.	O
In	O
contrast	O
,	O
rh	O
gene1s	ARG2
BMP-2	ARG2
gene1e	ARG2
diminished	O
gene1s	ARG2
poly	ARG2
(	ARG2
ADP	ARG2
-	ARG2
ribose	ARG2
)	ARG2
polymerase	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
PARP	ARG2
gene1e	ARG2
)	O
protein	O
expression	O
levels	O
and	O
activated	O
cleaved	O
gene1s	ARG2
PARP	ARG2
gene1e	ARG2
,	O
cleaved	O
gene1s	ARG2
caspase-7	ARG2
gene1e	ARG2
,	O
and	O
cleaved	O
-	O
gene1s	ARG2
caspase	ARG2
9	ARG2
gene1e	ARG2
levels	O
in	O
ESCC	O
cells	O
.	O
In	O
addition	O
,	O
gene1s	ARG2
rhBMP-2	ARG2
gene1e	ARG2
increased	O
gene1s	ARG2
MST1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
MOB1	ARG2
gene1e	ARG2
,	O
and	O
p	O
-	O
gene1s	ARG2
YAP	ARG2
gene1e	ARG2
protein	O
levels	O
and	O
the	O
gene1s	ARG2
RASSF1	ARG2
gene1e	ARG2
binds	O
gene1s	ARG2
Mst1	ARG2
gene1e	ARG2
more	O
upon	O
treatment	O
with	O
rh	O
gene1s	ARG2
BMP2	ARG2
gene1e	ARG2
.	O
The	O
induced	O
p	O
-	O
gene1s	ARG2
YAP	ARG2
gene1e	ARG2
expression	O
in	O
species1s	O
TE-8	O
species1e	O
and	O
arg1s	O
TE-12	O
arg1e	O
cells	O
by	O
gene1s	ARG2
rhBMP-2	ARG2
gene1e	ARG2
was	O
reversed	O
by	O
the	O
gene1s	ARG2
RASSF1	ARG2
gene1e	ARG2
knockdown	O
.	O
In	O
vivo	O
study	O
,	O
gene1s	ARG2
rhBMP-2	ARG2
gene1e	ARG2
decreased	O
tumor	O
volume	O
following	O
subcutaneous	O
implantation	O
and	O
showed	O
higher	O
radiologic	O
score	O
(	O
less	O
bony	O
destruction	O
)	O
after	O
femoral	O
implantation	O
compared	O
to	O
those	O
in	O
a	O
control	O
group	O
.	O
These	O
results	O
suggest	O
that	O
gene1s	ARG2
rhBMP-2	ARG2
gene1e	ARG2
inhibits	O
rather	O
than	O
activates	O
proliferation	O
of	O
arg1s	O
human	O
arg1e	O
esophageal	O
cancer	O
cells	O
which	O
is	O
mediated	O
through	O
activating	O
the	O
hippo	O
signaling	O
pathway	O
.	O

gene1s	O
RhBMP-2	O
gene1e	O
Activates	O
Hippo	O
Signaling	O
through	O
gene1s	O
RASSF1	O
gene1e	O
in	O
Esophageal	O
Cancer	O
Cells	O
.	O
Despite	O
that	O
recombinant	O
species1s	O
human	O
species1e	O
gene1s	O
bone	O
morphogenetic	O
protein-2	O
gene1e	O
(	O
gene1s	O
rhBMP-2	O
gene1e	O
)	O
has	O
been	O
reported	O
as	O
a	O
stimulatory	O
effecter	O
of	O
cancer	O
cell	O
growth	O
because	O
of	O
its	O
characteristic	O
like	O
morphogen	O
,	O
the	O
biological	O
functions	O
of	O
gene1s	O
rhBMP-2	O
gene1e	O
in	O
species1s	O
human	O
species1e	O
esophageal	O
cancer	O
cells	O
are	O
unknown	O
.	O
The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
investigate	O
whether	O
gene1s	O
rhBMP-2	O
gene1e	O
has	O
an	O
inhibitory	O
effect	O
on	O
the	O
growth	O
of	O
species1s	O
human	O
species1e	O
esophageal	O
squamous	O
carcinoma	O
cells	O
(	O
ESCC	O
)	O
.	O
Rh	O
gene1s	O
BMP-2	O
gene1e	O
significantly	O
inhibited	O
proliferation	O
of	O
ESCC	O
cells	O
in	O
a	O
dose	O
-	O
dependent	O
manner	O
in	O
the	O
MTT	O
assay	O
.	O
Cell	O
cycle	O
arrest	O
at	O
the	O
G1	O
phase	O
was	O
induced	O
24	O
h	O
after	O
gene1s	O
rhBMP2	O
gene1e	O
treatment	O
.	O
gene1s	O
RhBMP-2	O
gene1e	O
also	O
reduced	O
gene1s	O
cyclin	O
D1	O
gene1e	O
,	O
gene1s	O
cyclin	O
-	O
dependent	O
kinase	O
(	O
CDK	O
)	O
4	O
gene1e	O
and	O
gene1s	O
CDK	O
6	O
gene1e	O
activities	O
,	O
and	O
stimulated	O
p	O
-	O
gene1s	O
Smad1/5/8	O
gene1e	O
,	O
gene1s	O
p53	O
gene1e	O
,	O
and	O
gene1s	O
p21	O
gene1e	O
levels	O
at	O
12	O
h.	O
In	O
contrast	O
,	O
rh	O
gene1s	O
BMP-2	O
gene1e	O
diminished	O
gene1s	O
poly	O
(	O
ADP	O
-	O
ribose	O
)	O
polymerase	O
gene1e	O
(	O
gene1s	O
PARP	O
gene1e	O
)	O
protein	O
expression	O
levels	O
and	O
activated	O
cleaved	O
gene1s	O
PARP	O
gene1e	O
,	O
cleaved	O
gene1s	O
caspase-7	O
gene1e	O
,	O
and	O
cleaved	O
-	O
gene1s	O
caspase	O
9	O
gene1e	O
levels	O
in	O
ESCC	O
cells	O
.	O
In	O
addition	O
,	O
gene1s	O
rhBMP-2	O
gene1e	O
increased	O
gene1s	O
MST1	O
gene1e	O
,	O
gene1s	O
MOB1	O
gene1e	O
,	O
and	O
p	O
-	O
gene1s	O
YAP	O
gene1e	O
protein	O
levels	O
and	O
the	O
gene1s	O
RASSF1	O
gene1e	O
binds	O
gene1s	O
Mst1	O
gene1e	O
more	O
upon	O
treatment	O
with	O
rh	O
gene1s	O
BMP2	O
gene1e	O
.	O
The	O
induced	O
p	O
-	O
gene1s	O
YAP	O
gene1e	O
expression	O
in	O
arg1s	O
TE-8	O
arg1e	O
and	O
species1s	O
TE-12	O
species1e	O
cells	O
by	O
gene1s	O
rhBMP-2	O
gene1e	O
was	O
reversed	O
by	O
the	O
gene1s	O
RASSF1	O
gene1e	O
knockdown	O
.	O
In	O
vivo	O
study	O
,	O
gene1s	O
rhBMP-2	O
gene1e	O
decreased	O
tumor	O
volume	O
following	O
subcutaneous	O
implantation	O
and	O
showed	O
higher	O
radiologic	O
score	O
(	O
less	O
bony	O
destruction	O
)	O
after	O
femoral	O
implantation	O
compared	O
to	O
those	O
in	O
a	O
control	O
group	O
.	O
These	O
results	O
suggest	O
that	O
gene1s	O
rhBMP-2	O
gene1e	O
inhibits	O
rather	O
than	O
activates	O
proliferation	O
of	O
species1s	O
human	O
species1e	O
esophageal	O
cancer	O
cells	O
which	O
is	O
mediated	O
through	O
activating	O
the	O
hippo	O
signaling	O
pathway	O
.	O

A	O
heptameric	O
peptide	O
purified	O
from	O
arg1s	O
Spirulina	O
sp	O
arg1e	O
.	O
gastrointestinal	O
hydrolysate	O
inhibits	O
gene1s	O
angiotensin	O
I	O
-	O
converting	O
enzyme	O
gene1e	O
-	O
and	O
gene1s	O
angiotensin	O
II	O
gene1e	O
-	O
induced	O
vascular	O
dysfunction	O
in	O
species1s	O
human	O
species1e	O
endothelial	O
cells	O
.	O
In	O
this	O
study	O
,	O
a	O
marine	O
microalga	O
arg1s	O
Spirulina	O
sp	O
arg1e	O
.-derived	O
protein	O
was	O
hydrolyzed	O
using	O
gastrointestinal	O
enzymes	O
to	O
produce	O
an	O
gene1s	O
angiotensin	O
I	O
(	O
Ang	O
I)-converting	O
enzyme	O
gene1e	O
(	O
gene1s	O
ACE	O
gene1e	O
)	O
inhibitory	O
peptide	O
.	O
Following	O
consecutive	O
purification	O
,	O
the	O
potent	O
gene1s	O
ACE	O
gene1e	O
inhibitory	O
peptide	O
was	O
composed	O
of	O
7	O
amino	O
acids	O
,	O
Thr	O
-	O
Met	O
-	O
Glu	O
-	O
Pro	O
-	O
Gly	O
-	O
Lys	O
-	O
Pro	O
(	O
molecular	O
weight	O
,	O
759	O
Da	O
)	O
.	O
Analysis	O
using	O
the	O
Lineweaver	O
-	O
Burk	O
plot	O
and	O
molecular	O
modeling	O
suggested	O
that	O
the	O
purified	O
peptide	O
acted	O
as	O
a	O
mixed	O
non	O
-	O
competitive	O
inhibitor	O
of	O
gene1s	O
ACE	O
gene1e	O
.	O
The	O
inhibitory	O
effects	O
of	O
the	O
peptide	O
against	O
the	O
cellular	O
production	O
of	O
vascular	O
dysfunction	O
-	O
related	O
factors	O
induced	O
by	O
gene1s	O
Ang	O
II	O
gene1e	O
were	O
also	O
investigated	O
.	O
In	O
species1s	O
human	O
species1e	O
endothelial	O
cells	O
,	O
the	O
gene1s	O
Ang	O
II	O
gene1e	O
-	O
induced	O
production	O
of	O
nitric	O
oxide	O
and	O
reactive	O
oxygen	O
species	O
was	O
inhibited	O
,	O
and	O
the	O
expression	O
of	O
gene1s	O
inducible	O
nitric	O
oxide	O
synthase	O
gene1e	O
(	O
gene1s	O
iNOS	O
gene1e	O
)	O
and	O
gene1s	O
endothelin-1	O
gene1e	O
(	O
gene1s	O
ET-1	O
gene1e	O
)	O
was	O
downregulated	O
when	O
the	O
cells	O
were	O
cultured	O
with	O
the	O
purified	O
peptide	O
.	O
Moreover	O
,	O
the	O
peptide	O
blocked	O
the	O
activation	O
of	O
gene1s	O
p38	O
mitogen	O
-	O
activated	O
protein	O
kinase	O
gene1e	O
.	O
These	O
results	O
indicated	O
that	O
this	O
arg1s	O
Spirulina	O
sp	O
arg1e	O
.-derived	O
peptide	O
warrants	O
further	O
investigation	O
as	O
a	O
potential	O
pharmacological	O
inhibitor	O
of	O
gene1s	O
ACE	O
gene1e	O
and	O
vascular	O
dysfunction	O
.	O

A	O
heptameric	O
peptide	O
purified	O
from	O
species1s	O
Spirulina	O
sp	O
species1e	O
.	O
gastrointestinal	O
hydrolysate	O
inhibits	O
gene1s	ARG2
angiotensin	ARG2
I	ARG2
-	ARG2
converting	ARG2
enzyme	ARG2
gene1e	ARG2
-	O
and	O
gene1s	ARG2
angiotensin	ARG2
II	ARG2
gene1e	ARG2
-	O
induced	O
vascular	O
dysfunction	O
in	O
arg1s	O
human	O
arg1e	O
endothelial	O
cells	O
.	O
In	O
this	O
study	O
,	O
a	O
marine	O
microalga	O
species1s	O
Spirulina	O
sp	O
species1e	O
.-derived	O
protein	O
was	O
hydrolyzed	O
using	O
gastrointestinal	O
enzymes	O
to	O
produce	O
an	O
gene1s	ARG2
angiotensin	ARG2
I	ARG2
(	ARG2
Ang	ARG2
I)-converting	ARG2
enzyme	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
ACE	ARG2
gene1e	ARG2
)	O
inhibitory	O
peptide	O
.	O
Following	O
consecutive	O
purification	O
,	O
the	O
potent	O
gene1s	ARG2
ACE	ARG2
gene1e	ARG2
inhibitory	O
peptide	O
was	O
composed	O
of	O
7	O
amino	O
acids	O
,	O
Thr	O
-	O
Met	O
-	O
Glu	O
-	O
Pro	O
-	O
Gly	O
-	O
Lys	O
-	O
Pro	O
(	O
molecular	O
weight	O
,	O
759	O
Da	O
)	O
.	O
Analysis	O
using	O
the	O
Lineweaver	O
-	O
Burk	O
plot	O
and	O
molecular	O
modeling	O
suggested	O
that	O
the	O
purified	O
peptide	O
acted	O
as	O
a	O
mixed	O
non	O
-	O
competitive	O
inhibitor	O
of	O
gene1s	ARG2
ACE	ARG2
gene1e	ARG2
.	O
The	O
inhibitory	O
effects	O
of	O
the	O
peptide	O
against	O
the	O
cellular	O
production	O
of	O
vascular	O
dysfunction	O
-	O
related	O
factors	O
induced	O
by	O
gene1s	ARG2
Ang	ARG2
II	ARG2
gene1e	ARG2
were	O
also	O
investigated	O
.	O
In	O
arg1s	O
human	O
arg1e	O
endothelial	O
cells	O
,	O
the	O
gene1s	ARG2
Ang	ARG2
II	ARG2
gene1e	ARG2
-	O
induced	O
production	O
of	O
nitric	O
oxide	O
and	O
reactive	O
oxygen	O
species	O
was	O
inhibited	O
,	O
and	O
the	O
expression	O
of	O
gene1s	ARG2
inducible	ARG2
nitric	ARG2
oxide	ARG2
synthase	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
iNOS	ARG2
gene1e	ARG2
)	O
and	O
gene1s	ARG2
endothelin-1	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
ET-1	ARG2
gene1e	ARG2
)	O
was	O
downregulated	O
when	O
the	O
cells	O
were	O
cultured	O
with	O
the	O
purified	O
peptide	O
.	O
Moreover	O
,	O
the	O
peptide	O
blocked	O
the	O
activation	O
of	O
gene1s	ARG2
p38	ARG2
mitogen	ARG2
-	ARG2
activated	ARG2
protein	ARG2
kinase	ARG2
gene1e	ARG2
.	O
These	O
results	O
indicated	O
that	O
this	O
species1s	O
Spirulina	O
sp	O
species1e	O
.-derived	O
peptide	O
warrants	O
further	O
investigation	O
as	O
a	O
potential	O
pharmacological	O
inhibitor	O
of	O
gene1s	ARG2
ACE	ARG2
gene1e	ARG2
and	O
vascular	O
dysfunction	O
.	O

gene1s	ARG2
TAK1	ARG2
gene1e	ARG2
is	O
an	O
essential	O
regulator	O
of	O
gene1s	ARG2
BMP	ARG2
gene1e	ARG2
signalling	O
in	O
cartilage	O
.	O
gene1s	ARG2
TGFbeta	ARG2
activated	ARG2
kinase	ARG2
1	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
TAK1	ARG2
gene1e	ARG2
)	O
,	O
a	O
member	O
of	O
the	O
gene1s	ARG2
MAPKKK	ARG2
gene1e	ARG2
family	O
,	O
controls	O
diverse	O
functions	O
ranging	O
from	O
innate	O
and	O
adaptive	O
immune	O
system	O
activation	O
to	O
vascular	O
development	O
and	O
apoptosis	O
.	O
To	O
analyse	O
the	O
in	O
vivo	O
function	O
of	O
gene1s	ARG2
TAK1	ARG2
gene1e	ARG2
in	O
cartilage	O
,	O
we	O
generated	O
arg1s	O
mice	O
arg1e	O
with	O
a	O
conditional	O
deletion	O
of	O
gene1s	ARG2
Tak1	ARG2
gene1e	ARG2
driven	O
by	O
the	O
collagen	O
2	O
promoter	O
.	O
gene1s	ARG2
Tak1	ARG2
gene1e	ARG2
(col2	O
)	O
arg1s	O
mice	O
arg1e	O
displayed	O
severe	O
chondrodysplasia	O
with	O
runting	O
,	O
impaired	O
formation	O
of	O
secondary	O
centres	O
of	O
ossification	O
,	O
and	O
joint	O
abnormalities	O
including	O
elbow	O
dislocation	O
and	O
tarsal	O
fusion	O
.	O
This	O
phenotype	O
resembled	O
that	O
of	O
gene1s	ARG2
bone	ARG2
morphogenetic	ARG2
protein	ARG2
receptor	ARG2
(	ARG2
BMPR)1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
Gdf5	ARG2
gene1e	ARG2
-deficient	O
arg1s	O
mice	O
arg1e	O
.	O
gene1s	ARG2
BMPR	ARG2
gene1e	ARG2
signalling	O
was	O
markedly	O
impaired	O
in	O
gene1s	ARG2
TAK1	ARG2
gene1e	ARG2
-deficient	O
chondrocytes	O
as	O
evidenced	O
by	O
reduced	O
expression	O
of	O
known	O
gene1s	ARG2
BMP	ARG2
gene1e	ARG2
target	O
genes	O
as	O
well	O
as	O
reduced	O
phosphorylation	O
of	O
gene1s	ARG2
Smad1/5/8	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
p38	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
Jnk	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
Erk	ARG2
gene1e	ARG2
gene1s	ARG2
MAP	ARG2
kinases	ARG2
gene1e	ARG2
.	O
gene1s	ARG2
TAK1	ARG2
gene1e	ARG2
mediates	O
gene1s	ARG2
Smad1	ARG2
gene1e	ARG2
phosphorylation	O
at	O
C	O
-	O
terminal	O
serine	O
residues	O
.	O
These	O
findings	O
provide	O
the	O
first	O
in	O
vivo	O
evidence	O
in	O
a	O
species1s	O
mammalian	O
species1e	O
system	O
that	O
gene1s	ARG2
TAK1	ARG2
gene1e	ARG2
is	O
required	O
for	O
gene1s	ARG2
BMP	ARG2
gene1e	ARG2
signalling	O
and	O
functions	O
as	O
an	O
upstream	O
activating	O
kinase	O
for	O
gene1s	ARG2
Smad1/5/8	ARG2
gene1e	ARG2
in	O
addition	O
to	O
its	O
known	O
role	O
in	O
regulating	O
gene1s	ARG2
MAP	ARG2
kinase	ARG2
gene1e	ARG2
pathways	O
.	O
Our	O
experiments	O
reveal	O
an	O
essential	O
role	O
for	O
gene1s	ARG2
TAK1	ARG2
gene1e	ARG2
in	O
the	O
morphogenesis	O
,	O
growth	O
,	O
and	O
maintenance	O
of	O
cartilage	O
.	O

gene1s	O
TAK1	O
gene1e	O
is	O
an	O
essential	O
regulator	O
of	O
gene1s	O
BMP	O
gene1e	O
signalling	O
in	O
cartilage	O
.	O
gene1s	O
TGFbeta	O
activated	O
kinase	O
1	O
gene1e	O
(	O
gene1s	O
TAK1	O
gene1e	O
)	O
,	O
a	O
member	O
of	O
the	O
gene1s	O
MAPKKK	O
gene1e	O
family	O
,	O
controls	O
diverse	O
functions	O
ranging	O
from	O
innate	O
and	O
adaptive	O
immune	O
system	O
activation	O
to	O
vascular	O
development	O
and	O
apoptosis	O
.	O
To	O
analyse	O
the	O
in	O
vivo	O
function	O
of	O
gene1s	O
TAK1	O
gene1e	O
in	O
cartilage	O
,	O
we	O
generated	O
species1s	O
mice	O
species1e	O
with	O
a	O
conditional	O
deletion	O
of	O
gene1s	O
Tak1	O
gene1e	O
driven	O
by	O
the	O
collagen	O
2	O
promoter	O
.	O
gene1s	O
Tak1	O
gene1e	O
(col2	O
)	O
species1s	O
mice	O
species1e	O
displayed	O
severe	O
chondrodysplasia	O
with	O
runting	O
,	O
impaired	O
formation	O
of	O
secondary	O
centres	O
of	O
ossification	O
,	O
and	O
joint	O
abnormalities	O
including	O
elbow	O
dislocation	O
and	O
tarsal	O
fusion	O
.	O
This	O
phenotype	O
resembled	O
that	O
of	O
gene1s	O
bone	O
morphogenetic	O
protein	O
receptor	O
(	O
BMPR)1	O
gene1e	O
and	O
gene1s	O
Gdf5	O
gene1e	O
-deficient	O
species1s	O
mice	O
species1e	O
.	O
gene1s	O
BMPR	O
gene1e	O
signalling	O
was	O
markedly	O
impaired	O
in	O
gene1s	O
TAK1	O
gene1e	O
-deficient	O
chondrocytes	O
as	O
evidenced	O
by	O
reduced	O
expression	O
of	O
known	O
gene1s	O
BMP	O
gene1e	O
target	O
genes	O
as	O
well	O
as	O
reduced	O
phosphorylation	O
of	O
gene1s	O
Smad1/5/8	O
gene1e	O
and	O
gene1s	O
p38	O
gene1e	O
/	O
gene1s	O
Jnk	O
gene1e	O
/	O
gene1s	O
Erk	O
gene1e	O
gene1s	O
MAP	O
kinases	O
gene1e	O
.	O
gene1s	O
TAK1	O
gene1e	O
mediates	O
gene1s	O
Smad1	O
gene1e	O
phosphorylation	O
at	O
C	O
-	O
terminal	O
serine	O
residues	O
.	O
These	O
findings	O
provide	O
the	O
first	O
in	O
vivo	O
evidence	O
in	O
a	O
arg1s	O
mammalian	O
arg1e	O
system	O
that	O
gene1s	O
TAK1	O
gene1e	O
is	O
required	O
for	O
gene1s	O
BMP	O
gene1e	O
signalling	O
and	O
functions	O
as	O
an	O
upstream	O
activating	O
kinase	O
for	O
gene1s	O
Smad1/5/8	O
gene1e	O
in	O
addition	O
to	O
its	O
known	O
role	O
in	O
regulating	O
gene1s	O
MAP	O
kinase	O
gene1e	O
pathways	O
.	O
Our	O
experiments	O
reveal	O
an	O
essential	O
role	O
for	O
gene1s	O
TAK1	O
gene1e	O
in	O
the	O
morphogenesis	O
,	O
growth	O
,	O
and	O
maintenance	O
of	O
cartilage	O
.	O

gene1s	ARG2
Gankyrin	ARG2
gene1e	ARG2
induces	O
gene1s	ARG2
STAT3	ARG2
gene1e	ARG2
activation	O
in	O
tumor	O
microenvironment	O
and	O
sorafenib	O
resistance	O
in	O
hepatocellular	O
carcinoma	O
.	O
Most	O
hepatocellular	O
carcinomas	O
(	O
HCC	O
)	O
develop	O
as	O
a	O
result	O
of	O
chronic	O
liver	O
inflammation	O
.	O
We	O
have	O
shown	O
that	O
the	O
gene1s	ARG2
oncoprotein	ARG2
gene1e	ARG2
gene1s	ARG2
gankyrin	ARG2
gene1e	ARG2
is	O
critical	O
for	O
inflammation	O
-	O
induced	O
tumorigenesis	O
in	O
the	O
colon	O
.	O
Although	O
the	O
in	O
vitro	O
function	O
of	O
gene1s	O
gankyrin	O
gene1e	O
is	O
well	O
known	O
,	O
its	O
role	O
in	O
vivo	O
remains	O
to	O
be	O
elucidated	O
.	O
We	O
investigated	O
the	O
effect	O
of	O
gene1s	ARG2
gankyrin	ARG2
gene1e	ARG2
in	O
the	O
tumor	O
microenvironment	O
of	O
arg1s	O
mice	O
arg1e	O
with	O
liver	O
parenchymal	O
cell	O
-	O
specific	O
gene1s	ARG2
gankyrin	ARG2
gene1e	ARG2
ablation	O
(	O
gene1s	ARG2
Alb	ARG2
gene1e	ARG2
-	O
Cre;	O
gene1s	ARG2
gankyrin	ARG2
gene1e	ARG2
(f	O
/	O
f	O
)	O
)	O
and	O
gene1s	ARG2
gankyrin	ARG2
gene1e	ARG2
deletion	O
both	O
in	O
liver	O
parenchymal	O
and	O
non	O
-	O
parenchymal	O
cells	O
(	O
Mx1-Cre;	O
gene1s	ARG2
gankyrin	ARG2
gene1e	ARG2
(f	O
/	O
f	O
)	O
)	O
.	O
gene1s	O
Gankyrin	O
gene1e	O
upregulates	O
gene1s	ARG2
vascular	ARG2
endothelial	ARG2
growth	ARG2
factor	ARG2
gene1e	ARG2
expression	O
in	O
tumor	O
cells	O
.	O
gene1s	ARG2
Gankyrin	ARG2
gene1e	ARG2
binds	O
to	O
gene1s	ARG2
Src	ARG2
homology	ARG2
2	ARG2
domain	ARG2
-	ARG2
containing	ARG2
protein	ARG2
tyrosine	ARG2
phosphatase-1	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
SHP-1	ARG2
gene1e	ARG2
)	O
,	O
mainly	O
expressed	O
in	O
liver	O
non	O
-	O
parenchymal	O
cells	O
,	O
resulting	O
in	O
phosphorylation	O
and	O
activation	O
of	O
gene1s	ARG2
signal	ARG2
transducer	ARG2
and	ARG2
activator	ARG2
of	ARG2
transcription	ARG2
3	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
STAT3	ARG2
gene1e	ARG2
)	O
.	O
gene1s	ARG2
Gankyrin	ARG2
gene1e	ARG2
deficiency	O
in	O
non	O
-	O
parenchymal	O
cells	O
,	O
but	O
not	O
in	O
parenchymal	O
cells	O
,	O
reduced	O
gene1s	ARG2
STAT3	ARG2
gene1e	ARG2
activity	O
,	O
gene1s	ARG2
interleukin	ARG2
(	ARG2
IL)-6	ARG2
gene1e	ARG2
production	O
,	O
and	O
cancer	O
stem	O
cell	O
marker	O
(	O
gene1s	ARG2
Bmi1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
epithelial	ARG2
cell	ARG2
adhesion	ARG2
molecule	ARG2
gene1e	ARG2
[	O
gene1s	ARG2
EpCAM	ARG2
gene1e	ARG2
]	O
)	O
expression	O
,	O
leading	O
to	O
attenuated	O
tumorigenic	O
potential	O
.	O
Chronic	O
inflammation	O
enhances	O
gene1s	O
gankyrin	O
gene1e	O
expression	O
in	O
the	O
species1s	O
human	O
species1e	O
liver	O
.	O
gene1s	O
Gankyrin	O
gene1e	O
expression	O
in	O
the	O
tumor	O
microenvironment	O
is	O
negatively	O
correlated	O
with	O
progression	O
-	O
free	O
survival	O
in	O
species1s	O
patients	O
species1e	O
undergoing	O
sorafenib	O
treatment	O
for	O
HCC	O
.	O
Thus	O
,	O
gene1s	ARG2
gankyrin	ARG2
gene1e	ARG2
appears	O
to	O
play	O
a	O
critical	O
oncogenic	O
function	O
in	O
tumor	O
microenvironment	O
and	O
may	O
be	O
a	O
potential	O
target	O
for	O
developing	O
therapeutic	O
and	O
preventive	O
strategies	O
against	O
HCC	O
.	O

gene1s	O
Gankyrin	O
gene1e	O
induces	O
gene1s	O
STAT3	O
gene1e	O
activation	O
in	O
tumor	O
microenvironment	O
and	O
sorafenib	O
resistance	O
in	O
hepatocellular	O
carcinoma	O
.	O
Most	O
hepatocellular	O
carcinomas	O
(	O
HCC	O
)	O
develop	O
as	O
a	O
result	O
of	O
chronic	O
liver	O
inflammation	O
.	O
We	O
have	O
shown	O
that	O
the	O
gene1s	O
oncoprotein	O
gene1e	O
gene1s	O
gankyrin	O
gene1e	O
is	O
critical	O
for	O
inflammation	O
-	O
induced	O
tumorigenesis	O
in	O
the	O
colon	O
.	O
Although	O
the	O
in	O
vitro	O
function	O
of	O
gene1s	ARG2
gankyrin	ARG2
gene1e	ARG2
is	O
well	O
known	O
,	O
its	O
role	O
in	O
vivo	O
remains	O
to	O
be	O
elucidated	O
.	O
We	O
investigated	O
the	O
effect	O
of	O
gene1s	O
gankyrin	O
gene1e	O
in	O
the	O
tumor	O
microenvironment	O
of	O
species1s	O
mice	O
species1e	O
with	O
liver	O
parenchymal	O
cell	O
-	O
specific	O
gene1s	O
gankyrin	O
gene1e	O
ablation	O
(	O
gene1s	O
Alb	O
gene1e	O
-	O
Cre;	O
gene1s	O
gankyrin	O
gene1e	O
(f	O
/	O
f	O
)	O
)	O
and	O
gene1s	O
gankyrin	O
gene1e	O
deletion	O
both	O
in	O
liver	O
parenchymal	O
and	O
non	O
-	O
parenchymal	O
cells	O
(	O
Mx1-Cre;	O
gene1s	O
gankyrin	O
gene1e	O
(f	O
/	O
f	O
)	O
)	O
.	O
gene1s	ARG2
Gankyrin	ARG2
gene1e	ARG2
upregulates	O
gene1s	O
vascular	O
endothelial	O
growth	O
factor	O
gene1e	O
expression	O
in	O
tumor	O
cells	O
.	O
gene1s	O
Gankyrin	O
gene1e	O
binds	O
to	O
gene1s	O
Src	O
homology	O
2	O
domain	O
-	O
containing	O
protein	O
tyrosine	O
phosphatase-1	O
gene1e	O
(	O
gene1s	O
SHP-1	O
gene1e	O
)	O
,	O
mainly	O
expressed	O
in	O
liver	O
non	O
-	O
parenchymal	O
cells	O
,	O
resulting	O
in	O
phosphorylation	O
and	O
activation	O
of	O
gene1s	O
signal	O
transducer	O
and	O
activator	O
of	O
transcription	O
3	O
gene1e	O
(	O
gene1s	O
STAT3	O
gene1e	O
)	O
.	O
gene1s	O
Gankyrin	O
gene1e	O
deficiency	O
in	O
non	O
-	O
parenchymal	O
cells	O
,	O
but	O
not	O
in	O
parenchymal	O
cells	O
,	O
reduced	O
gene1s	O
STAT3	O
gene1e	O
activity	O
,	O
gene1s	O
interleukin	O
(	O
IL)-6	O
gene1e	O
production	O
,	O
and	O
cancer	O
stem	O
cell	O
marker	O
(	O
gene1s	O
Bmi1	O
gene1e	O
and	O
gene1s	O
epithelial	O
cell	O
adhesion	O
molecule	O
gene1e	O
[	O
gene1s	O
EpCAM	O
gene1e	O
]	O
)	O
expression	O
,	O
leading	O
to	O
attenuated	O
tumorigenic	O
potential	O
.	O
Chronic	O
inflammation	O
enhances	O
gene1s	ARG2
gankyrin	ARG2
gene1e	ARG2
expression	O
in	O
the	O
arg1s	O
human	O
arg1e	O
liver	O
.	O
gene1s	ARG2
Gankyrin	ARG2
gene1e	ARG2
expression	O
in	O
the	O
tumor	O
microenvironment	O
is	O
negatively	O
correlated	O
with	O
progression	O
-	O
free	O
survival	O
in	O
arg1s	O
patients	O
arg1e	O
undergoing	O
sorafenib	O
treatment	O
for	O
HCC	O
.	O
Thus	O
,	O
gene1s	O
gankyrin	O
gene1e	O
appears	O
to	O
play	O
a	O
critical	O
oncogenic	O
function	O
in	O
tumor	O
microenvironment	O
and	O
may	O
be	O
a	O
potential	O
target	O
for	O
developing	O
therapeutic	O
and	O
preventive	O
strategies	O
against	O
HCC	O
.	O

Loss	O
of	O
gene1s	O
solute	O
carrier	O
family	O
7	O
member	O
2	O
gene1e	O
exacerbates	O
inflammation	O
-	O
associated	O
colon	O
tumorigenesis	O
.	O
gene1s	O
Solute	O
carrier	O
family	O
7	O
member	O
2	O
gene1e	O
(	O
gene1s	O
SLC7A2	O
gene1e	O
,	O
also	O
known	O
as	O
gene1s	O
CAT2	O
gene1e	O
)	O
is	O
an	O
inducible	O
transporter	O
of	O
the	O
semi	O
-	O
essential	O
amino	O
acid	O
L	O
-	O
arginine	O
(	O
L	O
-	O
Arg	O
)	O
,	O
which	O
has	O
been	O
implicated	O
in	O
wound	O
repair	O
.	O
We	O
have	O
reported	O
that	O
both	O
gene1s	ARG2
SLC7A2	ARG2
gene1e	ARG2
expression	O
and	O
L	O
-	O
Arg	O
availability	O
are	O
decreased	O
in	O
colonic	O
tissues	O
from	O
inflammatory	O
bowel	O
disease	O
arg1s	O
patients	O
arg1e	O
and	O
that	O
species1s	O
mice	O
species1e	O
lacking	O
gene1s	O
Slc7a2	O
gene1e	O
exhibit	O
a	O
more	O
severe	O
disease	O
course	O
when	O
exposed	O
to	O
dextran	O
sulfate	O
sodium	O
(	O
DSS	O
)	O
compared	O
to	O
wild	O
-	O
type	O
(	O
WT	O
)	O
species1s	O
mice	O
species1e	O
.	O
Here	O
,	O
we	O
present	O
evidence	O
that	O
gene1s	O
SLC7A2	O
gene1e	O
plays	O
a	O
role	O
in	O
modulating	O
colon	O
tumorigenesis	O
in	O
the	O
azoxymethane	O
(	O
AOM)-DSS	O
model	O
of	O
colitis	O
-	O
associated	O
carcinogenesis	O
(	O
CAC	O
)	O
.	O
gene1s	O
SLC7A2	O
gene1e	O
was	O
localized	O
predominantly	O
to	O
colonic	O
epithelial	O
cells	O
in	O
WT	O
species1s	O
mice	O
species1e	O
.	O
Utilizing	O
the	O
AOM	O
-	O
DSS	O
model	O
,	O
gene1s	O
Slc7a2	O
gene1e	O
-/-	O
species1s	O
mice	O
species1e	O
had	O
significantly	O
increased	O
tumor	O
number	O
,	O
burden	O
,	O
and	O
risk	O
of	O
high	O
-	O
grade	O
dysplasia	O
vs.	O
WT	O
species1s	O
mice	O
species1e	O
.	O
Tumors	O
from	O
gene1s	O
Slc7a2	O
gene1e	O
-/-	O
species1s	O
mice	O
species1e	O
exhibited	O
significantly	O
increased	O
levels	O
of	O
the	O
proinflammatory	O
gene1s	ARG2
cytokines	ARG2
gene1e	ARG2
/	O
gene1s	O
chemokines	O
gene1e	O
gene1s	O
IL-1beta	O
gene1e	O
,	O
gene1s	O
CXCL1	O
gene1e	O
,	O
gene1s	O
CXCL5	O
gene1e	O
,	O
gene1s	O
IL-3	O
gene1e	O
,	O
gene1s	O
CXCL2	O
gene1e	O
,	O
gene1s	O
CCL3	O
gene1e	O
,	O
and	O
gene1s	O
CCL4	O
gene1e	O
,	O
but	O
decreased	O
levels	O
of	O
gene1s	O
IL-4	O
gene1e	O
,	O
gene1s	O
CXCL9	O
gene1e	O
,	O
and	O
gene1s	O
CXCL10	O
gene1e	O
compared	O
to	O
tumors	O
from	O
WT	O
species1s	O
mice	O
species1e	O
.	O
This	O
was	O
accompanied	O
by	O
a	O
shift	O
toward	O
pro	O
-	O
tumorigenic	O
M2	O
macrophage	O
activation	O
in	O
gene1s	O
Slc7a2	O
gene1e	O
-deficient	O
species1s	O
mice	O
species1e	O
,	O
as	O
marked	O
by	O
increased	O
colonic	O
gene1s	ARG2
CD11b	ARG2
gene1e	ARG2
+	O
species1s	O
F4/80	O
species1e	O
+	O
gene1s	O
ARG1	O
gene1e	O
+	O
cells	O
with	O
no	O
alteration	O
in	O
gene1s	ARG2
CD11b	ARG2
gene1e	ARG2
+	O
species1s	O
F4/80	O
species1e	O
+NOS2	O
+	O
cells	O
by	O
flow	O
cytometry	O
and	O
immunofluorescence	O
microscopy	O
.	O
The	O
shift	O
toward	O
M2	O
macrophage	O
activation	O
was	O
confirmed	O
in	O
bone	O
marrow	O
-	O
derived	O
macrophages	O
from	O
gene1s	O
Slc7a2	O
gene1e	O
-/-	O
species1s	O
mice	O
species1e	O
.	O
In	O
bone	O
marrow	O
chimeras	O
between	O
gene1s	O
Slc7a2	O
gene1e	O
-/-	O
and	O
WT	O
species1s	O
mice	O
species1e	O
,	O
the	O
recipient	O
genotype	O
drove	O
the	O
CAC	O
phenotype	O
,	O
suggesting	O
the	O
importance	O
of	O
epithelial	O
gene1s	O
SLC7A2	O
gene1e	O
in	O
abrogating	O
neoplastic	O
risk	O
.	O
These	O
data	O
reveal	O
that	O
gene1s	O
SLC7A2	O
gene1e	O
has	O
a	O
significant	O
role	O
in	O
the	O
protection	O
from	O
CAC	O
in	O
the	O
setting	O
of	O
chronic	O
colitis	O
,	O
and	O
suggest	O
that	O
the	O
decreased	O
gene1s	O
SLC7A2	O
gene1e	O
in	O
inflammatory	O
bowel	O
disease	O
(	O
IBD	O
)	O
may	O
contribute	O
to	O
CAC	O
risk	O
.	O
Strategies	O
to	O
enhance	O
L	O
-	O
Arg	O
availability	O
by	O
supplementing	O
L	O
-	O
Arg	O
and/or	O
increasing	O
L	O
-	O
Arg	O
uptake	O
could	O
represent	O
a	O
therapeutic	O
approach	O
in	O
IBD	O
to	O
reduce	O
the	O
substantial	O
long	O
-	O
term	O
risk	O
of	O
colorectal	O
carcinoma	O
.	O

Loss	O
of	O
gene1s	ARG2
solute	ARG2
carrier	ARG2
family	ARG2
7	ARG2
member	ARG2
2	ARG2
gene1e	ARG2
exacerbates	O
inflammation	O
-	O
associated	O
colon	O
tumorigenesis	O
.	O
gene1s	ARG2
Solute	ARG2
carrier	ARG2
family	ARG2
7	ARG2
member	ARG2
2	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
SLC7A2	ARG2
gene1e	ARG2
,	O
also	O
known	O
as	O
gene1s	ARG2
CAT2	ARG2
gene1e	ARG2
)	O
is	O
an	O
inducible	O
transporter	O
of	O
the	O
semi	O
-	O
essential	O
amino	O
acid	O
L	O
-	O
arginine	O
(	O
L	O
-	O
Arg	O
)	O
,	O
which	O
has	O
been	O
implicated	O
in	O
wound	O
repair	O
.	O
We	O
have	O
reported	O
that	O
both	O
gene1s	O
SLC7A2	O
gene1e	O
expression	O
and	O
L	O
-	O
Arg	O
availability	O
are	O
decreased	O
in	O
colonic	O
tissues	O
from	O
inflammatory	O
bowel	O
disease	O
species1s	O
patients	O
species1e	O
and	O
that	O
arg1s	O
mice	O
arg1e	O
lacking	O
gene1s	ARG2
Slc7a2	ARG2
gene1e	ARG2
exhibit	O
a	O
more	O
severe	O
disease	O
course	O
when	O
exposed	O
to	O
dextran	O
sulfate	O
sodium	O
(	O
DSS	O
)	O
compared	O
to	O
wild	O
-	O
type	O
(	O
WT	O
)	O
arg1s	O
mice	O
arg1e	O
.	O
Here	O
,	O
we	O
present	O
evidence	O
that	O
gene1s	ARG2
SLC7A2	ARG2
gene1e	ARG2
plays	O
a	O
role	O
in	O
modulating	O
colon	O
tumorigenesis	O
in	O
the	O
azoxymethane	O
(	O
AOM)-DSS	O
model	O
of	O
colitis	O
-	O
associated	O
carcinogenesis	O
(	O
CAC	O
)	O
.	O
gene1s	ARG2
SLC7A2	ARG2
gene1e	ARG2
was	O
localized	O
predominantly	O
to	O
colonic	O
epithelial	O
cells	O
in	O
WT	O
arg1s	O
mice	O
arg1e	O
.	O
Utilizing	O
the	O
AOM	O
-	O
DSS	O
model	O
,	O
gene1s	ARG2
Slc7a2	ARG2
gene1e	ARG2
-/-	O
arg1s	O
mice	O
arg1e	O
had	O
significantly	O
increased	O
tumor	O
number	O
,	O
burden	O
,	O
and	O
risk	O
of	O
high	O
-	O
grade	O
dysplasia	O
vs.	O
WT	O
arg1s	O
mice	O
arg1e	O
.	O
Tumors	O
from	O
gene1s	ARG2
Slc7a2	ARG2
gene1e	ARG2
-/-	O
arg1s	O
mice	O
arg1e	O
exhibited	O
significantly	O
increased	O
levels	O
of	O
the	O
proinflammatory	O
gene1s	ARG2
cytokines	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
chemokines	ARG2
gene1e	ARG2
gene1s	ARG2
IL-1beta	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
CXCL1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
CXCL5	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IL-3	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
CXCL2	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
CCL3	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
CCL4	ARG2
gene1e	ARG2
,	O
but	O
decreased	O
levels	O
of	O
gene1s	ARG2
IL-4	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
CXCL9	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
CXCL10	ARG2
gene1e	ARG2
compared	O
to	O
tumors	O
from	O
WT	O
arg1s	O
mice	O
arg1e	O
.	O
This	O
was	O
accompanied	O
by	O
a	O
shift	O
toward	O
pro	O
-	O
tumorigenic	O
M2	O
macrophage	O
activation	O
in	O
gene1s	ARG2
Slc7a2	ARG2
gene1e	ARG2
-deficient	O
arg1s	O
mice	O
arg1e	O
,	O
as	O
marked	O
by	O
increased	O
colonic	O
gene1s	O
CD11b	O
gene1e	O
+	O
arg1s	O
F4/80	O
arg1e	O
+	O
gene1s	ARG2
ARG1	ARG2
gene1e	ARG2
+	O
cells	O
with	O
no	O
alteration	O
in	O
gene1s	O
CD11b	O
gene1e	O
+	O
arg1s	O
F4/80	O
arg1e	O
+NOS2	O
+	O
cells	O
by	O
flow	O
cytometry	O
and	O
immunofluorescence	O
microscopy	O
.	O
The	O
shift	O
toward	O
M2	O
macrophage	O
activation	O
was	O
confirmed	O
in	O
bone	O
marrow	O
-	O
derived	O
macrophages	O
from	O
gene1s	ARG2
Slc7a2	ARG2
gene1e	ARG2
-/-	O
arg1s	O
mice	O
arg1e	O
.	O
In	O
bone	O
marrow	O
chimeras	O
between	O
gene1s	ARG2
Slc7a2	ARG2
gene1e	ARG2
-/-	O
and	O
WT	O
arg1s	O
mice	O
arg1e	O
,	O
the	O
recipient	O
genotype	O
drove	O
the	O
CAC	O
phenotype	O
,	O
suggesting	O
the	O
importance	O
of	O
epithelial	O
gene1s	ARG2
SLC7A2	ARG2
gene1e	ARG2
in	O
abrogating	O
neoplastic	O
risk	O
.	O
These	O
data	O
reveal	O
that	O
gene1s	ARG2
SLC7A2	ARG2
gene1e	ARG2
has	O
a	O
significant	O
role	O
in	O
the	O
protection	O
from	O
CAC	O
in	O
the	O
setting	O
of	O
chronic	O
colitis	O
,	O
and	O
suggest	O
that	O
the	O
decreased	O
gene1s	ARG2
SLC7A2	ARG2
gene1e	ARG2
in	O
inflammatory	O
bowel	O
disease	O
(	O
IBD	O
)	O
may	O
contribute	O
to	O
CAC	O
risk	O
.	O
Strategies	O
to	O
enhance	O
L	O
-	O
Arg	O
availability	O
by	O
supplementing	O
L	O
-	O
Arg	O
and/or	O
increasing	O
L	O
-	O
Arg	O
uptake	O
could	O
represent	O
a	O
therapeutic	O
approach	O
in	O
IBD	O
to	O
reduce	O
the	O
substantial	O
long	O
-	O
term	O
risk	O
of	O
colorectal	O
carcinoma	O
.	O

gene1s	ARG2
MicroRNA-203	ARG2
gene1e	ARG2
mimics	O
age	O
-	O
related	O
aortic	O
smooth	O
muscle	O
dysfunction	O
of	O
cytoskeletal	O
pathways	O
.	O
Increased	O
aortic	O
stiffness	O
is	O
a	O
biomarker	O
for	O
subsequent	O
adverse	O
cardiovascular	O
events	O
.	O
We	O
have	O
previously	O
reported	O
that	O
vascular	O
smooth	O
muscle	O
gene1s	ARG2
Src	ARG2
gene1e	ARG2
-	O
dependent	O
cytoskeletal	O
remodelling	O
,	O
which	O
contributes	O
to	O
aortic	O
plasticity	O
,	O
is	O
impaired	O
with	O
ageing	O
.	O
Here	O
,	O
we	O
use	O
a	O
multi	O
-	O
scale	O
approach	O
to	O
determine	O
the	O
molecular	O
mechanisms	O
behind	O
defective	O
gene1s	ARG2
Src	ARG2
gene1e	ARG2
-	O
dependent	O
signalling	O
in	O
an	O
aged	O
C57BL/6	O
male	O
arg1s	O
mouse	O
arg1e	O
model	O
.	O
Increased	O
aortic	O
stiffness	O
,	O
as	O
measured	O
in	O
vivo	O
by	O
pulse	O
wave	O
velocity	O
,	O
was	O
found	O
to	O
have	O
a	O
comparable	O
time	O
course	O
to	O
that	O
in	O
species1s	O
humans	O
species1e	O
.	O
Bioinformatic	O
analyses	O
predicted	O
several	O
miRs	O
to	O
regulate	O
gene1s	ARG2
Src	ARG2
gene1e	ARG2
-	O
dependent	O
cytoskeletal	O
remodelling	O
.	O
qRT	O
-	O
PCR	O
was	O
used	O
to	O
determine	O
the	O
relative	O
levels	O
of	O
predicted	O
miRs	O
in	O
aortas	O
and	O
,	O
notably	O
,	O
the	O
expression	O
of	O
gene1s	ARG2
miR-203	ARG2
gene1e	ARG2
increased	O
almost	O
twofold	O
in	O
aged	O
aorta	O
.	O
Increased	O
gene1s	ARG2
miR-203	ARG2
gene1e	ARG2
expression	O
was	O
associated	O
with	O
a	O
decrease	O
in	O
both	O
mRNA	O
and	O
protein	O
expression	O
of	O
gene1s	ARG2
Src	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
caveolin-1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
paxillin	ARG2
gene1e	ARG2
in	O
aged	O
aorta	O
.	O
Probing	O
with	O
phospho	O
-	O
specific	O
antibodies	O
confirmed	O
that	O
overexpression	O
of	O
gene1s	ARG2
miR-203	ARG2
gene1e	ARG2
significantly	O
attenuated	O
gene1s	ARG2
Src	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
extracellular	ARG2
signal	ARG2
regulated	ARG2
kinase	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
ERK	ARG2
gene1e	ARG2
)	O
signalling	O
,	O
which	O
we	O
have	O
previously	O
found	O
to	O
regulate	O
vascular	O
smooth	O
muscle	O
stiffness	O
.	O
In	O
addition	O
,	O
transfection	O
of	O
gene1s	ARG2
miR-203	ARG2
gene1e	ARG2
into	O
aortic	O
tissue	O
from	O
young	O
arg1s	O
mice	O
arg1e	O
increased	O
phenylephrine	O
-	O
induced	O
aortic	O
stiffness	O
ex	O
vivo	O
,	O
mimicking	O
the	O
aged	O
phenotype	O
.	O
Upstream	O
of	O
gene1s	ARG2
miR-203	ARG2
gene1e	ARG2
,	O
we	O
found	O
that	O
gene1s	ARG2
DNA	ARG2
methyltransferases	ARG2
(	ARG2
DNMT	ARG2
)	ARG2
1	ARG2
,	ARG2
3a	ARG2
,	ARG2
and	ARG2
3b	ARG2
gene1e	ARG2
are	O
also	O
significantly	O
decreased	O
in	O
the	O
aged	O
arg1s	O
mouse	O
arg1e	O
aorta	O
and	O
that	O
gene1s	ARG2
DNMT	ARG2
gene1e	ARG2
inhibition	O
significantly	O
increases	O
gene1s	ARG2
miR-203	ARG2
gene1e	ARG2
expression	O
.	O
Thus	O
,	O
the	O
age	O
-	O
induced	O
increase	O
in	O
gene1s	ARG2
miR-203	ARG2
gene1e	ARG2
may	O
be	O
caused	O
by	O
epigenetic	O
promoter	O
hypomethylation	O
in	O
the	O
aorta	O
.	O
These	O
findings	O
indicate	O
that	O
gene1s	ARG2
miR-203	ARG2
gene1e	ARG2
promotes	O
a	O
re	O
-	O
programming	O
of	O
gene1s	ARG2
Src	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
ERK	ARG2
gene1e	ARG2
signalling	O
pathways	O
in	O
vascular	O
smooth	O
muscle	O
,	O
impairing	O
the	O
regulation	O
of	O
stiffness	O
in	O
aged	O
aorta	O
.	O

gene1s	O
MicroRNA-203	O
gene1e	O
mimics	O
age	O
-	O
related	O
aortic	O
smooth	O
muscle	O
dysfunction	O
of	O
cytoskeletal	O
pathways	O
.	O
Increased	O
aortic	O
stiffness	O
is	O
a	O
biomarker	O
for	O
subsequent	O
adverse	O
cardiovascular	O
events	O
.	O
We	O
have	O
previously	O
reported	O
that	O
vascular	O
smooth	O
muscle	O
gene1s	O
Src	O
gene1e	O
-	O
dependent	O
cytoskeletal	O
remodelling	O
,	O
which	O
contributes	O
to	O
aortic	O
plasticity	O
,	O
is	O
impaired	O
with	O
ageing	O
.	O
Here	O
,	O
we	O
use	O
a	O
multi	O
-	O
scale	O
approach	O
to	O
determine	O
the	O
molecular	O
mechanisms	O
behind	O
defective	O
gene1s	O
Src	O
gene1e	O
-	O
dependent	O
signalling	O
in	O
an	O
aged	O
C57BL/6	O
male	O
species1s	O
mouse	O
species1e	O
model	O
.	O
Increased	O
aortic	O
stiffness	O
,	O
as	O
measured	O
in	O
vivo	O
by	O
pulse	O
wave	O
velocity	O
,	O
was	O
found	O
to	O
have	O
a	O
comparable	O
time	O
course	O
to	O
that	O
in	O
arg1s	O
humans	O
arg1e	O
.	O
Bioinformatic	O
analyses	O
predicted	O
several	O
miRs	O
to	O
regulate	O
gene1s	O
Src	O
gene1e	O
-	O
dependent	O
cytoskeletal	O
remodelling	O
.	O
qRT	O
-	O
PCR	O
was	O
used	O
to	O
determine	O
the	O
relative	O
levels	O
of	O
predicted	O
miRs	O
in	O
aortas	O
and	O
,	O
notably	O
,	O
the	O
expression	O
of	O
gene1s	O
miR-203	O
gene1e	O
increased	O
almost	O
twofold	O
in	O
aged	O
aorta	O
.	O
Increased	O
gene1s	O
miR-203	O
gene1e	O
expression	O
was	O
associated	O
with	O
a	O
decrease	O
in	O
both	O
mRNA	O
and	O
protein	O
expression	O
of	O
gene1s	O
Src	O
gene1e	O
,	O
gene1s	O
caveolin-1	O
gene1e	O
and	O
gene1s	O
paxillin	O
gene1e	O
in	O
aged	O
aorta	O
.	O
Probing	O
with	O
phospho	O
-	O
specific	O
antibodies	O
confirmed	O
that	O
overexpression	O
of	O
gene1s	O
miR-203	O
gene1e	O
significantly	O
attenuated	O
gene1s	O
Src	O
gene1e	O
and	O
gene1s	O
extracellular	O
signal	O
regulated	O
kinase	O
gene1e	O
(	O
gene1s	O
ERK	O
gene1e	O
)	O
signalling	O
,	O
which	O
we	O
have	O
previously	O
found	O
to	O
regulate	O
vascular	O
smooth	O
muscle	O
stiffness	O
.	O
In	O
addition	O
,	O
transfection	O
of	O
gene1s	O
miR-203	O
gene1e	O
into	O
aortic	O
tissue	O
from	O
young	O
species1s	O
mice	O
species1e	O
increased	O
phenylephrine	O
-	O
induced	O
aortic	O
stiffness	O
ex	O
vivo	O
,	O
mimicking	O
the	O
aged	O
phenotype	O
.	O
Upstream	O
of	O
gene1s	O
miR-203	O
gene1e	O
,	O
we	O
found	O
that	O
gene1s	O
DNA	O
methyltransferases	O
(	O
DNMT	O
)	O
1	O
,	O
3a	O
,	O
and	O
3b	O
gene1e	O
are	O
also	O
significantly	O
decreased	O
in	O
the	O
aged	O
species1s	O
mouse	O
species1e	O
aorta	O
and	O
that	O
gene1s	O
DNMT	O
gene1e	O
inhibition	O
significantly	O
increases	O
gene1s	O
miR-203	O
gene1e	O
expression	O
.	O
Thus	O
,	O
the	O
age	O
-	O
induced	O
increase	O
in	O
gene1s	O
miR-203	O
gene1e	O
may	O
be	O
caused	O
by	O
epigenetic	O
promoter	O
hypomethylation	O
in	O
the	O
aorta	O
.	O
These	O
findings	O
indicate	O
that	O
gene1s	O
miR-203	O
gene1e	O
promotes	O
a	O
re	O
-	O
programming	O
of	O
gene1s	O
Src	O
gene1e	O
/	O
gene1s	O
ERK	O
gene1e	O
signalling	O
pathways	O
in	O
vascular	O
smooth	O
muscle	O
,	O
impairing	O
the	O
regulation	O
of	O
stiffness	O
in	O
aged	O
aorta	O
.	O

Reciprocal	O
effects	O
of	O
NNK	O
and	O
gene1s	O
SLURP-1	O
gene1e	O
on	O
oncogene	O
expression	O
in	O
target	O
epithelial	O
cells	O
.	O
AIMS	O
:	O
To	O
elucidate	O
how	O
the	O
gene1s	O
nicotinic	O
acetylcholine	O
receptors	O
gene1e	O
expressed	O
on	O
bronchial	O
and	O
oral	O
epithelial	O
cells	O
targeted	O
by	O
the	O
arg1s	O
tobacco	O
arg1e	O
nitrosamine	O
(	O
4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone	O
)	O
(	O
NNK	O
)	O
facilitate	O
carcinogenic	O
transformation	O
.	O
MAIN	O
METHODS	O
:	O
Since	O
NNK	O
-	O
dependent	O
transformation	O
can	O
be	O
abolished	O
by	O
the	O
nicotinergic	O
secreted	O
species1s	O
mammalian	O
species1e	O
gene1s	O
Ly-6	O
/	O
urokinase	O
plasminogen	O
activator	O
receptor	O
related	O
protein-1	O
gene1e	O
(	O
gene1s	O
SLURP-1	O
gene1e	O
)	O
,	O
we	O
compared	O
effects	O
of	O
NNK	O
and	O
recombinant	O
(	O
r)	O
gene1s	O
SLURP-1	O
gene1e	O
on	O
the	O
expression	O
of	O
genes	O
related	O
to	O
tumorigenesis	O
in	O
species1s	O
human	O
species1e	O
immortalized	O
bronchial	O
and	O
oral	O
epithelial	O
cell	O
lines	O
BEP2D	O
and	O
Het-1A	O
,	O
respectively	O
.	O
KEY	O
FINDINGS	O
:	O
NNK	O
stimulated	O
expression	O
of	O
oncogenic	O
genes	O
,	O
including	O
gene1s	O
MYB	O
gene1e	O
and	O
gene1s	O
PIK3CA	O
gene1e	O
in	O
BEP2D	O
,	O
gene1s	O
ETS1	O
gene1e	O
,	O
gene1s	O
NRAS	O
gene1e	O
and	O
gene1s	O
SRC	O
gene1e	O
in	O
species1s	O
Het-1A	O
species1e	O
,	O
and	O
gene1s	O
AKT1	O
gene1e	O
,	O
gene1s	O
KIT	O
gene1e	O
and	O
gene1s	O
RB1	O
gene1e	O
in	O
both	O
cell	O
types	O
,	O
which	O
could	O
be	O
abolished	O
in	O
the	O
presence	O
of	O
r	O
gene1s	O
SLURP-1	O
gene1e	O
.	O
Other	O
cancer	O
-	O
related	O
genes	O
whose	O
upregulation	O
by	O
NNK	O
was	O
abolishable	O
by	O
r	O
gene1s	O
SLURP-1	O
gene1e	O
were	O
the	O
gene1s	O
growth	O
factors	O
gene1e	O
gene1s	O
EGF	O
gene1e	O
in	O
species1s	O
BEP2D	O
species1e	O
cells	O
and	O
gene1s	O
HGF	O
gene1e	O
in	O
species1s	O
Het-1A	O
species1e	O
cells	O
,	O
and	O
the	O
gene1s	O
transcription	O
factors	O
gene1e	O
gene1s	O
CDKN2A	O
gene1e	O
and	O
gene1s	O
STAT3	O
gene1e	O
(	O
Het-1A	O
only	O
)	O
.	O
NNK	O
also	O
upregulated	O
the	O
anti	O
-	O
apoptotic	O
gene1s	O
BCL2	O
gene1e	O
(	O
Het-1A	O
)	O
and	O
downregulated	O
the	O
pro	O
-	O
apoptotic	O
gene1s	O
TNF	O
gene1e	O
(	O
Het-1A	O
)	O
,	O
gene1s	O
BAX	O
gene1e	O
and	O
gene1s	O
CASP8	O
gene1e	O
(	O
BEP2D	O
)	O
,	O
all	O
of	O
which	O
could	O
be	O
abolished	O
,	O
in	O
part	O
,	O
by	O
gene1s	O
rSLURP-1	O
gene1e	O
.	O
NNK	O
decreased	O
expression	O
of	O
the	O
gene1s	O
CTNNB1	O
gene1e	O
gene	O
encoding	O
the	O
intercellular	O
adhesion	O
molecule	O
gene1s	O
beta	O
-	O
catenin	O
gene1e	O
(	O
BEP2D	O
)	O
,	O
as	O
well	O
as	O
tumor	O
suppressors	O
gene1s	O
CDKN3	O
gene1e	O
and	O
gene1s	O
FOXD3	O
gene1e	O
in	O
species1s	O
BEP2D	O
species1e	O
cells	O
and	O
gene1s	O
SERPINB5	O
gene1e	O
in	O
species1s	O
Het-1A	O
species1e	O
cells	O
.	O
These	O
pro	O
-	O
oncogenic	O
effects	O
of	O
NNK	O
were	O
abolished	O
by	O
gene1s	O
rSLURP-1	O
gene1e	O
that	O
also	O
upregulated	O
gene1s	O
RUNX3	O
gene1e	O
.	O
SIGNIFICANCE	O
:	O
The	O
obtained	O
results	O
identified	O
target	O
genes	O
for	O
both	O
NNK	O
and	O
gene1s	O
SLURP-1	O
gene1e	O
and	O
shed	O
light	O
on	O
the	O
molecular	O
mechanism	O
of	O
their	O
reciprocal	O
effects	O
on	O
tumorigenic	O
transformation	O
of	O
bronchial	O
and	O
oral	O
epithelial	O
cells	O
.	O

Reciprocal	O
effects	O
of	O
NNK	O
and	O
gene1s	ARG2
SLURP-1	ARG2
gene1e	ARG2
on	O
oncogene	O
expression	O
in	O
target	O
epithelial	O
cells	O
.	O
AIMS	O
:	O
To	O
elucidate	O
how	O
the	O
gene1s	ARG2
nicotinic	ARG2
acetylcholine	ARG2
receptors	ARG2
gene1e	ARG2
expressed	O
on	O
bronchial	O
and	O
oral	O
epithelial	O
cells	O
targeted	O
by	O
the	O
species1s	O
tobacco	O
species1e	O
nitrosamine	O
(	O
4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone	O
)	O
(	O
NNK	O
)	O
facilitate	O
carcinogenic	O
transformation	O
.	O
MAIN	O
METHODS	O
:	O
Since	O
NNK	O
-	O
dependent	O
transformation	O
can	O
be	O
abolished	O
by	O
the	O
nicotinergic	O
secreted	O
arg1s	O
mammalian	O
arg1e	O
gene1s	ARG2
Ly-6	ARG2
/	ARG2
urokinase	ARG2
plasminogen	ARG2
activator	ARG2
receptor	ARG2
related	ARG2
protein-1	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
SLURP-1	ARG2
gene1e	ARG2
)	O
,	O
we	O
compared	O
effects	O
of	O
NNK	O
and	O
recombinant	O
(	O
r)	O
gene1s	ARG2
SLURP-1	ARG2
gene1e	ARG2
on	O
the	O
expression	O
of	O
genes	O
related	O
to	O
tumorigenesis	O
in	O
arg1s	O
human	O
arg1e	O
immortalized	O
bronchial	O
and	O
oral	O
epithelial	O
cell	O
lines	O
BEP2D	O
and	O
Het-1A	O
,	O
respectively	O
.	O
KEY	O
FINDINGS	O
:	O
NNK	O
stimulated	O
expression	O
of	O
oncogenic	O
genes	O
,	O
including	O
gene1s	ARG2
MYB	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
PIK3CA	ARG2
gene1e	ARG2
in	O
BEP2D	O
,	O
gene1s	ARG2
ETS1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
NRAS	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
SRC	ARG2
gene1e	ARG2
in	O
arg1s	O
Het-1A	O
arg1e	O
,	O
and	O
gene1s	ARG2
AKT1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
KIT	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
RB1	ARG2
gene1e	ARG2
in	O
both	O
cell	O
types	O
,	O
which	O
could	O
be	O
abolished	O
in	O
the	O
presence	O
of	O
r	O
gene1s	ARG2
SLURP-1	ARG2
gene1e	ARG2
.	O
Other	O
cancer	O
-	O
related	O
genes	O
whose	O
upregulation	O
by	O
NNK	O
was	O
abolishable	O
by	O
r	O
gene1s	ARG2
SLURP-1	ARG2
gene1e	ARG2
were	O
the	O
gene1s	ARG2
growth	ARG2
factors	ARG2
gene1e	ARG2
gene1s	ARG2
EGF	ARG2
gene1e	ARG2
in	O
arg1s	O
BEP2D	O
arg1e	O
cells	O
and	O
gene1s	ARG2
HGF	ARG2
gene1e	ARG2
in	O
arg1s	O
Het-1A	O
arg1e	O
cells	O
,	O
and	O
the	O
gene1s	ARG2
transcription	ARG2
factors	ARG2
gene1e	ARG2
gene1s	ARG2
CDKN2A	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
STAT3	ARG2
gene1e	ARG2
(	O
Het-1A	O
only	O
)	O
.	O
NNK	O
also	O
upregulated	O
the	O
anti	O
-	O
apoptotic	O
gene1s	ARG2
BCL2	ARG2
gene1e	ARG2
(	O
Het-1A	O
)	O
and	O
downregulated	O
the	O
pro	O
-	O
apoptotic	O
gene1s	ARG2
TNF	ARG2
gene1e	ARG2
(	O
Het-1A	O
)	O
,	O
gene1s	ARG2
BAX	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
CASP8	ARG2
gene1e	ARG2
(	O
BEP2D	O
)	O
,	O
all	O
of	O
which	O
could	O
be	O
abolished	O
,	O
in	O
part	O
,	O
by	O
gene1s	ARG2
rSLURP-1	ARG2
gene1e	ARG2
.	O
NNK	O
decreased	O
expression	O
of	O
the	O
gene1s	ARG2
CTNNB1	ARG2
gene1e	ARG2
gene	O
encoding	O
the	O
intercellular	O
adhesion	O
molecule	O
gene1s	ARG2
beta	ARG2
-	ARG2
catenin	ARG2
gene1e	ARG2
(	O
BEP2D	O
)	O
,	O
as	O
well	O
as	O
tumor	O
suppressors	O
gene1s	ARG2
CDKN3	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
FOXD3	ARG2
gene1e	ARG2
in	O
arg1s	O
BEP2D	O
arg1e	O
cells	O
and	O
gene1s	ARG2
SERPINB5	ARG2
gene1e	ARG2
in	O
arg1s	O
Het-1A	O
arg1e	O
cells	O
.	O
These	O
pro	O
-	O
oncogenic	O
effects	O
of	O
NNK	O
were	O
abolished	O
by	O
gene1s	ARG2
rSLURP-1	ARG2
gene1e	ARG2
that	O
also	O
upregulated	O
gene1s	ARG2
RUNX3	ARG2
gene1e	ARG2
.	O
SIGNIFICANCE	O
:	O
The	O
obtained	O
results	O
identified	O
target	O
genes	O
for	O
both	O
NNK	O
and	O
gene1s	ARG2
SLURP-1	ARG2
gene1e	ARG2
and	O
shed	O
light	O
on	O
the	O
molecular	O
mechanism	O
of	O
their	O
reciprocal	O
effects	O
on	O
tumorigenic	O
transformation	O
of	O
bronchial	O
and	O
oral	O
epithelial	O
cells	O
.	O

gene1s	ARG2
Thyroid	ARG2
hormone	ARG2
receptor	ARG2
a	ARG2
gene1e	ARG2
mutation	O
causes	O
a	O
severe	O
and	O
thyroxine	O
-	O
resistant	O
skeletal	O
dysplasia	O
in	O
female	O
arg1s	O
mice	O
arg1e	O
.	O
A	O
new	O
genetic	O
disorder	O
has	O
been	O
identified	O
that	O
results	O
from	O
mutation	O
of	O
gene1s	O
THRA	O
gene1e	O
,	O
encoding	O
gene1s	O
thyroid	O
hormone	O
receptor	O
a1	O
gene1e	O
(	O
gene1s	O
TRa1	O
gene1e	O
)	O
.	O
Affected	O
species1s	O
children	O
species1e	O
have	O
a	O
high	O
serum	O
T3	O
:	O
T4	O
ratio	O
and	O
variable	O
degrees	O
of	O
intellectual	O
deficit	O
and	O
constipation	O
but	O
exhibit	O
a	O
consistently	O
severe	O
skeletal	O
dysplasia	O
.	O
In	O
an	O
attempt	O
to	O
improve	O
developmental	O
delay	O
and	O
alleviate	O
symptoms	O
of	O
hypothyroidism	O
,	O
species1s	O
patients	O
species1e	O
are	O
receiving	O
varying	O
doses	O
and	O
durations	O
of	O
T4	O
treatment	O
,	O
but	O
responses	O
have	O
been	O
inconsistent	O
so	O
far	O
.	O
gene1s	ARG2
Thra1	ARG2
gene1e	ARG2
(PV/+	O
)	O
arg1s	O
mice	O
arg1e	O
express	O
a	O
similar	O
potent	O
dominant	O
-	O
negative	O
mutant	O
gene1s	ARG2
TRa1	ARG2
gene1e	ARG2
to	O
affected	O
individuals	O
,	O
and	O
thus	O
represent	O
an	O
excellent	O
disease	O
model	O
.	O
We	O
hypothesized	O
that	O
gene1s	ARG2
Thra1	ARG2
gene1e	ARG2
(PV/+	O
)	O
arg1s	O
mice	O
arg1e	O
could	O
be	O
used	O
to	O
predict	O
the	O
skeletal	O
outcome	O
of	O
species1s	O
human	O
species1e	O
gene1s	O
THRA	O
gene1e	O
mutations	O
and	O
determine	O
whether	O
prolonged	O
treatment	O
with	O
a	O
supraphysiological	O
dose	O
of	O
T4	O
ameliorates	O
the	O
skeletal	O
abnormalities	O
.	O
Adult	O
female	O
gene1s	ARG2
Thra1	ARG2
gene1e	ARG2
(PV/+	O
)	O
arg1s	O
mice	O
arg1e	O
had	O
short	O
stature	O
,	O
grossly	O
abnormal	O
bone	O
morphology	O
but	O
normal	O
bone	O
strength	O
despite	O
high	O
bone	O
mass	O
.	O
Although	O
T4	O
treatment	O
suppressed	O
gene1s	ARG2
TSH	ARG2
gene1e	ARG2
secretion	O
,	O
it	O
had	O
no	O
effect	O
on	O
skeletal	O
maturation	O
,	O
linear	O
growth	O
,	O
or	O
bone	O
mineralization	O
,	O
thus	O
demonstrating	O
profound	O
tissue	O
resistance	O
to	O
thyroid	O
hormone	O
.	O
Despite	O
this	O
,	O
prolonged	O
T4	O
treatment	O
abnormally	O
increased	O
bone	O
stiffness	O
and	O
strength	O
,	O
suggesting	O
the	O
potential	O
for	O
detrimental	O
consequences	O
in	O
the	O
long	O
term	O
.	O
Our	O
studies	O
establish	O
that	O
gene1s	ARG2
TRa1	ARG2
gene1e	ARG2
has	O
an	O
essential	O
role	O
in	O
the	O
developing	O
and	O
adult	O
skeleton	O
and	O
predict	O
that	O
species1s	O
patients	O
species1e	O
with	O
different	O
gene1s	O
THRA	O
gene1e	O
mutations	O
will	O
display	O
variable	O
responses	O
to	O
T4	O
treatment	O
,	O
which	O
depend	O
on	O
the	O
severity	O
of	O
the	O
causative	O
mutation	O
.	O

gene1s	O
Thyroid	O
hormone	O
receptor	O
a	O
gene1e	O
mutation	O
causes	O
a	O
severe	O
and	O
thyroxine	O
-	O
resistant	O
skeletal	O
dysplasia	O
in	O
female	O
species1s	O
mice	O
species1e	O
.	O
A	O
new	O
genetic	O
disorder	O
has	O
been	O
identified	O
that	O
results	O
from	O
mutation	O
of	O
gene1s	ARG2
THRA	ARG2
gene1e	ARG2
,	O
encoding	O
gene1s	ARG2
thyroid	ARG2
hormone	ARG2
receptor	ARG2
a1	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
TRa1	ARG2
gene1e	ARG2
)	O
.	O
Affected	O
arg1s	O
children	O
arg1e	O
have	O
a	O
high	O
serum	O
T3	O
:	O
T4	O
ratio	O
and	O
variable	O
degrees	O
of	O
intellectual	O
deficit	O
and	O
constipation	O
but	O
exhibit	O
a	O
consistently	O
severe	O
skeletal	O
dysplasia	O
.	O
In	O
an	O
attempt	O
to	O
improve	O
developmental	O
delay	O
and	O
alleviate	O
symptoms	O
of	O
hypothyroidism	O
,	O
arg1s	O
patients	O
arg1e	O
are	O
receiving	O
varying	O
doses	O
and	O
durations	O
of	O
T4	O
treatment	O
,	O
but	O
responses	O
have	O
been	O
inconsistent	O
so	O
far	O
.	O
gene1s	O
Thra1	O
gene1e	O
(PV/+	O
)	O
species1s	O
mice	O
species1e	O
express	O
a	O
similar	O
potent	O
dominant	O
-	O
negative	O
mutant	O
gene1s	O
TRa1	O
gene1e	O
to	O
affected	O
individuals	O
,	O
and	O
thus	O
represent	O
an	O
excellent	O
disease	O
model	O
.	O
We	O
hypothesized	O
that	O
gene1s	O
Thra1	O
gene1e	O
(PV/+	O
)	O
species1s	O
mice	O
species1e	O
could	O
be	O
used	O
to	O
predict	O
the	O
skeletal	O
outcome	O
of	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
THRA	ARG2
gene1e	ARG2
mutations	O
and	O
determine	O
whether	O
prolonged	O
treatment	O
with	O
a	O
supraphysiological	O
dose	O
of	O
T4	O
ameliorates	O
the	O
skeletal	O
abnormalities	O
.	O
Adult	O
female	O
gene1s	O
Thra1	O
gene1e	O
(PV/+	O
)	O
species1s	O
mice	O
species1e	O
had	O
short	O
stature	O
,	O
grossly	O
abnormal	O
bone	O
morphology	O
but	O
normal	O
bone	O
strength	O
despite	O
high	O
bone	O
mass	O
.	O
Although	O
T4	O
treatment	O
suppressed	O
gene1s	O
TSH	O
gene1e	O
secretion	O
,	O
it	O
had	O
no	O
effect	O
on	O
skeletal	O
maturation	O
,	O
linear	O
growth	O
,	O
or	O
bone	O
mineralization	O
,	O
thus	O
demonstrating	O
profound	O
tissue	O
resistance	O
to	O
thyroid	O
hormone	O
.	O
Despite	O
this	O
,	O
prolonged	O
T4	O
treatment	O
abnormally	O
increased	O
bone	O
stiffness	O
and	O
strength	O
,	O
suggesting	O
the	O
potential	O
for	O
detrimental	O
consequences	O
in	O
the	O
long	O
term	O
.	O
Our	O
studies	O
establish	O
that	O
gene1s	O
TRa1	O
gene1e	O
has	O
an	O
essential	O
role	O
in	O
the	O
developing	O
and	O
adult	O
skeleton	O
and	O
predict	O
that	O
arg1s	O
patients	O
arg1e	O
with	O
different	O
gene1s	ARG2
THRA	ARG2
gene1e	ARG2
mutations	O
will	O
display	O
variable	O
responses	O
to	O
T4	O
treatment	O
,	O
which	O
depend	O
on	O
the	O
severity	O
of	O
the	O
causative	O
mutation	O
.	O

Activation	O
of	O
gene1s	ARG2
MAPK	ARG2
gene1e	ARG2
pathways	O
due	O
to	O
gene1s	ARG2
DUSP4	ARG2
gene1e	ARG2
loss	O
promotes	O
cancer	O
stem	O
cell	O
-	O
like	O
phenotypes	O
in	O
basal	O
-	O
like	O
breast	O
cancer	O
.	O
Basal	O
-	O
like	O
breast	O
cancer	O
(	O
BLBC	O
)	O
is	O
an	O
aggressive	O
disease	O
that	O
lacks	O
a	O
clinically	O
approved	O
targeted	O
therapy	O
.	O
Traditional	O
chemotherapy	O
is	O
effective	O
in	O
BLBC	O
,	O
but	O
it	O
spares	O
the	O
cancer	O
stem	O
cell	O
(	O
CSC)-like	O
population	O
,	O
which	O
is	O
likely	O
to	O
contribute	O
to	O
cancer	O
recurrence	O
after	O
the	O
initial	O
treatment	O
.	O
gene1s	ARG2
Dual	ARG2
specificity	ARG2
phosphatase-4	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
DUSP4	ARG2
gene1e	ARG2
)	O
is	O
a	O
negative	O
regulator	O
of	O
the	O
gene1s	ARG2
mitogen	ARG2
-	ARG2
activated	ARG2
protein	ARG2
kinase	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
MAPK	ARG2
gene1e	ARG2
)	O
pathway	O
that	O
is	O
deficient	O
in	O
highly	O
aggressive	O
BLBCs	O
treated	O
with	O
chemotherapy	O
,	O
leading	O
to	O
aberrant	O
gene1s	ARG2
MAPK	ARG2
gene1e	ARG2
activation	O
and	O
resistance	O
to	O
taxane	O
-	O
induced	O
apoptosis	O
.	O
Herein	O
,	O
we	O
investigated	O
how	O
gene1s	ARG2
DUSP4	ARG2
gene1e	ARG2
regulates	O
the	O
gene1s	ARG2
MAP	ARG2
-	ARG2
ERK	ARG2
kinase	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
MEK	ARG2
gene1e	ARG2
)	O
and	O
gene1s	ARG2
c	ARG2
-	ARG2
jun	ARG2
-	ARG2
NH2-kinase	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
JNK	ARG2
gene1e	ARG2
)	O
pathways	O
in	O
modifying	O
CSC	O
-	O
like	O
behavior	O
.	O
gene1s	ARG2
DUSP4	ARG2
gene1e	ARG2
loss	O
increased	O
mammosphere	O
formation	O
and	O
the	O
expression	O
of	O
the	O
CSC	O
-	O
promoting	O
gene1s	ARG2
cytokines	ARG2
gene1e	ARG2
gene1s	ARG2
interleukin	ARG2
(	ARG2
IL)-6	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
IL-8	ARG2
gene1e	ARG2
.	O
These	O
effects	O
were	O
caused	O
in	O
part	O
by	O
loss	O
of	O
control	O
of	O
the	O
gene1s	ARG2
MEK	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
JNK	ARG2
gene1e	ARG2
pathways	O
and	O
involved	O
downstream	O
activation	O
of	O
the	O
gene1s	ARG2
ETS-1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
c	ARG2
-	ARG2
JUN	ARG2
gene1e	ARG2
transcription	O
factors	O
.	O
Enforced	O
expression	O
of	O
gene1s	ARG2
DUSP4	ARG2
gene1e	ARG2
reduced	O
the	O
gene1s	ARG2
CD44	ARG2
gene1e	ARG2
(+)/	O
gene1s	ARG2
CD24	ARG2
gene1e	ARG2
(-	O
)	O
population	O
in	O
multiple	O
BLBC	O
cell	O
lines	O
in	O
a	O
gene1s	ARG2
MEK	ARG2
gene1e	ARG2
-	O
dependent	O
manner	O
,	O
limiting	O
tumor	O
formation	O
of	O
gene1s	ARG2
claudin	ARG2
gene1e	ARG2
-	O
low	O
arg1s	O
SUM159PT	O
arg1e	O
cells	O
in	O
species1s	O
mice	O
species1e	O
.	O
Our	O
findings	O
support	O
the	O
evaluation	O
of	O
gene1s	ARG2
MEK	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
JNK	ARG2
gene1e	ARG2
pathway	O
inhibitors	O
as	O
therapeutic	O
agents	O
in	O
BLBC	O
to	O
eliminate	O
the	O
CSC	O
population	O
.	O

Activation	O
of	O
gene1s	O
MAPK	O
gene1e	O
pathways	O
due	O
to	O
gene1s	O
DUSP4	O
gene1e	O
loss	O
promotes	O
cancer	O
stem	O
cell	O
-	O
like	O
phenotypes	O
in	O
basal	O
-	O
like	O
breast	O
cancer	O
.	O
Basal	O
-	O
like	O
breast	O
cancer	O
(	O
BLBC	O
)	O
is	O
an	O
aggressive	O
disease	O
that	O
lacks	O
a	O
clinically	O
approved	O
targeted	O
therapy	O
.	O
Traditional	O
chemotherapy	O
is	O
effective	O
in	O
BLBC	O
,	O
but	O
it	O
spares	O
the	O
cancer	O
stem	O
cell	O
(	O
CSC)-like	O
population	O
,	O
which	O
is	O
likely	O
to	O
contribute	O
to	O
cancer	O
recurrence	O
after	O
the	O
initial	O
treatment	O
.	O
gene1s	O
Dual	O
specificity	O
phosphatase-4	O
gene1e	O
(	O
gene1s	O
DUSP4	O
gene1e	O
)	O
is	O
a	O
negative	O
regulator	O
of	O
the	O
gene1s	O
mitogen	O
-	O
activated	O
protein	O
kinase	O
gene1e	O
(	O
gene1s	O
MAPK	O
gene1e	O
)	O
pathway	O
that	O
is	O
deficient	O
in	O
highly	O
aggressive	O
BLBCs	O
treated	O
with	O
chemotherapy	O
,	O
leading	O
to	O
aberrant	O
gene1s	O
MAPK	O
gene1e	O
activation	O
and	O
resistance	O
to	O
taxane	O
-	O
induced	O
apoptosis	O
.	O
Herein	O
,	O
we	O
investigated	O
how	O
gene1s	O
DUSP4	O
gene1e	O
regulates	O
the	O
gene1s	O
MAP	O
-	O
ERK	O
kinase	O
gene1e	O
(	O
gene1s	O
MEK	O
gene1e	O
)	O
and	O
gene1s	O
c	O
-	O
jun	O
-	O
NH2-kinase	O
gene1e	O
(	O
gene1s	O
JNK	O
gene1e	O
)	O
pathways	O
in	O
modifying	O
CSC	O
-	O
like	O
behavior	O
.	O
gene1s	O
DUSP4	O
gene1e	O
loss	O
increased	O
mammosphere	O
formation	O
and	O
the	O
expression	O
of	O
the	O
CSC	O
-	O
promoting	O
gene1s	O
cytokines	O
gene1e	O
gene1s	O
interleukin	O
(	O
IL)-6	O
gene1e	O
and	O
gene1s	O
IL-8	O
gene1e	O
.	O
These	O
effects	O
were	O
caused	O
in	O
part	O
by	O
loss	O
of	O
control	O
of	O
the	O
gene1s	O
MEK	O
gene1e	O
and	O
gene1s	O
JNK	O
gene1e	O
pathways	O
and	O
involved	O
downstream	O
activation	O
of	O
the	O
gene1s	O
ETS-1	O
gene1e	O
and	O
gene1s	O
c	O
-	O
JUN	O
gene1e	O
transcription	O
factors	O
.	O
Enforced	O
expression	O
of	O
gene1s	O
DUSP4	O
gene1e	O
reduced	O
the	O
gene1s	O
CD44	O
gene1e	O
(+)/	O
gene1s	O
CD24	O
gene1e	O
(-	O
)	O
population	O
in	O
multiple	O
BLBC	O
cell	O
lines	O
in	O
a	O
gene1s	O
MEK	O
gene1e	O
-	O
dependent	O
manner	O
,	O
limiting	O
tumor	O
formation	O
of	O
gene1s	O
claudin	O
gene1e	O
-	O
low	O
species1s	O
SUM159PT	O
species1e	O
cells	O
in	O
arg1s	O
mice	O
arg1e	O
.	O
Our	O
findings	O
support	O
the	O
evaluation	O
of	O
gene1s	O
MEK	O
gene1e	O
and	O
gene1s	O
JNK	O
gene1e	O
pathway	O
inhibitors	O
as	O
therapeutic	O
agents	O
in	O
BLBC	O
to	O
eliminate	O
the	O
CSC	O
population	O
.	O

The	O
novel	O
gene1s	ARG2
mitochondrial	ARG2
matrix	ARG2
protease	ARG2
gene1e	ARG2
gene1s	ARG2
Ste23	ARG2
gene1e	ARG2
is	O
required	O
for	O
efficient	O
presequence	O
degradation	O
and	O
processing	O
.	O
Around	O
70	O
%	O
of	O
mitochondrial	O
precursor	O
proteins	O
are	O
imported	O
from	O
the	O
cytosol	O
via	O
N	O
-	O
terminal	O
presequences	O
,	O
which	O
are	O
cleaved	O
upon	O
exposure	O
to	O
the	O
gene1s	ARG2
mitochondrial	ARG2
processing	ARG2
protease	ARG2
gene1e	ARG2
gene1s	ARG2
MPP	ARG2
gene1e	ARG2
in	O
the	O
matrix	O
.	O
Cleaved	O
presequence	O
peptides	O
then	O
need	O
to	O
be	O
efficiently	O
degraded	O
and	O
impairment	O
of	O
this	O
clearance	O
step	O
e.g.	O
by	O
gene1s	O
amyloid	O
beta	O
gene1e	O
peptides	O
causes	O
a	O
feedback	O
inhibition	O
of	O
gene1s	ARG2
MPP	ARG2
gene1e	ARG2
leading	O
ultimately	O
to	O
accumulation	O
of	O
immature	O
precursor	O
proteins	O
within	O
mitochondria	O
.	O
Degradation	O
of	O
mitochondrial	O
peptides	O
is	O
performed	O
by	O
gene1s	ARG2
Cym1	ARG2
gene1e	ARG2
in	O
arg1s	O
yeast	O
arg1e	O
and	O
its	O
homolog	O
gene1s	O
PreP	O
gene1e	O
in	O
species1s	O
humans	O
species1e	O
.	O
Here	O
we	O
identify	O
the	O
novel	O
gene1s	ARG2
mitochondrial	ARG2
matrix	ARG2
protease	ARG2
gene1e	ARG2
gene1s	ARG2
Ste23	ARG2
gene1e	ARG2
in	O
arg1s	O
yeast	O
arg1e	O
,	O
a	O
homolog	O
of	O
species1s	O
human	O
species1e	O
gene1s	O
insulin	O
degrading	O
enzyme	O
gene1e	O
,	O
which	O
is	O
required	O
for	O
efficient	O
peptide	O
degradation	O
.	O
gene1s	ARG2
Ste23	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
Cym1	ARG2
gene1e	ARG2
tightly	O
cooperate	O
to	O
ensure	O
the	O
correct	O
functioning	O
of	O
the	O
essential	O
presequence	O
processing	O
machinery	O
.	O

The	O
novel	O
gene1s	O
mitochondrial	O
matrix	O
protease	O
gene1e	O
gene1s	O
Ste23	O
gene1e	O
is	O
required	O
for	O
efficient	O
presequence	O
degradation	O
and	O
processing	O
.	O
Around	O
70	O
%	O
of	O
mitochondrial	O
precursor	O
proteins	O
are	O
imported	O
from	O
the	O
cytosol	O
via	O
N	O
-	O
terminal	O
presequences	O
,	O
which	O
are	O
cleaved	O
upon	O
exposure	O
to	O
the	O
gene1s	O
mitochondrial	O
processing	O
protease	O
gene1e	O
gene1s	O
MPP	O
gene1e	O
in	O
the	O
matrix	O
.	O
Cleaved	O
presequence	O
peptides	O
then	O
need	O
to	O
be	O
efficiently	O
degraded	O
and	O
impairment	O
of	O
this	O
clearance	O
step	O
e.g.	O
by	O
gene1s	ARG2
amyloid	ARG2
beta	ARG2
gene1e	ARG2
peptides	O
causes	O
a	O
feedback	O
inhibition	O
of	O
gene1s	O
MPP	O
gene1e	O
leading	O
ultimately	O
to	O
accumulation	O
of	O
immature	O
precursor	O
proteins	O
within	O
mitochondria	O
.	O
Degradation	O
of	O
mitochondrial	O
peptides	O
is	O
performed	O
by	O
gene1s	O
Cym1	O
gene1e	O
in	O
species1s	O
yeast	O
species1e	O
and	O
its	O
homolog	O
gene1s	ARG2
PreP	ARG2
gene1e	ARG2
in	O
arg1s	O
humans	O
arg1e	O
.	O
Here	O
we	O
identify	O
the	O
novel	O
gene1s	O
mitochondrial	O
matrix	O
protease	O
gene1e	O
gene1s	O
Ste23	O
gene1e	O
in	O
species1s	O
yeast	O
species1e	O
,	O
a	O
homolog	O
of	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
insulin	ARG2
degrading	ARG2
enzyme	ARG2
gene1e	ARG2
,	O
which	O
is	O
required	O
for	O
efficient	O
peptide	O
degradation	O
.	O
gene1s	O
Ste23	O
gene1e	O
and	O
gene1s	O
Cym1	O
gene1e	O
tightly	O
cooperate	O
to	O
ensure	O
the	O
correct	O
functioning	O
of	O
the	O
essential	O
presequence	O
processing	O
machinery	O
.	O

Localization	O
of	O
a	O
gene1s	ARG2
guanylyl	ARG2
cyclase	ARG2
gene1e	ARG2
to	O
chemosensory	O
cilia	O
requires	O
the	O
novel	O
ciliary	O
MYND	O
domain	O
protein	O
gene1s	ARG2
DAF-25	ARG2
gene1e	ARG2
.	O
In	O
harsh	O
conditions	O
,	O
arg1s	O
Caenorhabditis	O
elegans	O
arg1e	O
arrests	O
development	O
to	O
enter	O
a	O
non	O
-	O
aging	O
,	O
resistant	O
diapause	O
state	O
called	O
the	O
dauer	O
larva	O
.	O
Olfactory	O
sensation	O
modulates	O
the	O
gene1s	ARG2
TGF	ARG2
-	ARG2
beta	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
insulin	ARG2
gene1e	ARG2
signaling	O
pathways	O
to	O
control	O
this	O
developmental	O
decision	O
.	O
Four	O
mutant	O
alleles	O
of	O
gene1s	ARG2
daf-25	ARG2
gene1e	ARG2
(	O
abnormal	O
DAuer	O
Formation	O
)	O
were	O
isolated	O
from	O
screens	O
for	O
mutants	O
exhibiting	O
constitutive	O
dauer	O
formation	O
and	O
found	O
to	O
be	O
defective	O
in	O
olfaction	O
.	O
The	O
gene1s	ARG2
daf-25	ARG2
gene1e	ARG2
dauer	O
phenotype	O
is	O
suppressed	O
by	O
gene1s	ARG2
daf-10	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
IFT122	ARG2
gene1e	ARG2
mutations	O
(	O
which	O
disrupt	O
ciliogenesis	O
)	O
,	O
but	O
not	O
by	O
gene1s	ARG2
daf-6	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
PTCHD3	ARG2
gene1e	ARG2
mutations	O
(	O
which	O
prevent	O
environmental	O
exposure	O
of	O
sensory	O
cilia	O
)	O
,	O
implying	O
that	O
gene1s	ARG2
DAF-25	ARG2
gene1e	ARG2
functions	O
in	O
the	O
cilia	O
themselves	O
.	O
gene1s	ARG2
daf-25	ARG2
gene1e	ARG2
encodes	O
the	O
arg1s	O
C.	O
elegans	O
arg1e	O
ortholog	O
of	O
species1s	O
mammalian	O
species1e	O
gene1s	O
Ankmy2	O
gene1e	O
,	O
a	O
MYND	O
domain	O
protein	O
of	O
unknown	O
function	O
.	O
Disruption	O
of	O
gene1s	ARG2
DAF-25	ARG2
gene1e	ARG2
,	O
which	O
localizes	O
to	O
sensory	O
cilia	O
,	O
produces	O
no	O
apparent	O
cilia	O
structure	O
anomalies	O
,	O
as	O
determined	O
by	O
light	O
and	O
electron	O
microscopy	O
.	O
Hinting	O
at	O
its	O
potential	O
function	O
,	O
the	O
dauer	O
phenotype	O
,	O
epistatic	O
order	O
,	O
and	O
expression	O
profile	O
of	O
gene1s	ARG2
daf-25	ARG2
gene1e	ARG2
are	O
similar	O
to	O
gene1s	ARG2
daf-11	ARG2
gene1e	ARG2
,	O
which	O
encodes	O
a	O
cilium	O
-	O
localized	O
gene1s	ARG2
guanylyl	ARG2
cyclase	ARG2
gene1e	ARG2
.	O
Indeed	O
,	O
we	O
demonstrate	O
that	O
gene1s	ARG2
DAF-25	ARG2
gene1e	ARG2
is	O
required	O
for	O
proper	O
gene1s	ARG2
DAF-11	ARG2
gene1e	ARG2
ciliary	O
localization	O
.	O
Furthermore	O
,	O
the	O
functional	O
interaction	O
is	O
evolutionarily	O
conserved	O
,	O
as	O
species1s	O
mouse	O
species1e	O
gene1s	O
Ankmy2	O
gene1e	O
interacts	O
with	O
gene1s	O
guanylyl	O
cyclase	O
gene1e	O
gene1s	O
GC1	O
gene1e	O
from	O
ciliary	O
photoreceptors	O
.	O
The	O
interaction	O
may	O
be	O
specific	O
because	O
gene1s	ARG2
daf-25	ARG2
gene1e	ARG2
mutants	O
have	O
normally	O
-	O
localized	O
gene1s	ARG2
OSM-9	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
TRPV4	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
TAX-4	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
CNGA1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
CHE-2	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
IFT80	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
CHE-11	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
IFT140	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
CHE-13	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
IFT57	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
BBS-8	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
OSM-5	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
IFT88	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
XBX-1	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
D2LIC	ARG2
gene1e	ARG2
in	O
the	O
cilia	O
.	O
Intraflagellar	O
transport	O
(	O
IFT	O
)	O
(	O
required	O
to	O
build	O
cilia	O
)	O
is	O
not	O
defective	O
in	O
gene1s	ARG2
daf-25	ARG2
gene1e	ARG2
mutants	O
,	O
although	O
the	O
ciliary	O
localization	O
of	O
gene1s	ARG2
DAF-25	ARG2
gene1e	ARG2
itself	O
is	O
influenced	O
in	O
gene1s	ARG2
che-11	ARG2
gene1e	ARG2
mutants	O
,	O
which	O
are	O
defective	O
in	O
retrograde	O
IFT	O
.	O
In	O
summary	O
,	O
we	O
have	O
discovered	O
a	O
novel	O
ciliary	O
protein	O
that	O
plays	O
an	O
important	O
role	O
in	O
cGMP	O
signaling	O
by	O
localizing	O
a	O
gene1s	ARG2
guanylyl	ARG2
cyclase	ARG2
gene1e	ARG2
to	O
the	O
sensory	O
organelle	O
.	O

Localization	O
of	O
a	O
gene1s	O
guanylyl	O
cyclase	O
gene1e	O
to	O
chemosensory	O
cilia	O
requires	O
the	O
novel	O
ciliary	O
MYND	O
domain	O
protein	O
gene1s	O
DAF-25	O
gene1e	O
.	O
In	O
harsh	O
conditions	O
,	O
species1s	O
Caenorhabditis	O
elegans	O
species1e	O
arrests	O
development	O
to	O
enter	O
a	O
non	O
-	O
aging	O
,	O
resistant	O
diapause	O
state	O
called	O
the	O
dauer	O
larva	O
.	O
Olfactory	O
sensation	O
modulates	O
the	O
gene1s	O
TGF	O
-	O
beta	O
gene1e	O
and	O
gene1s	O
insulin	O
gene1e	O
signaling	O
pathways	O
to	O
control	O
this	O
developmental	O
decision	O
.	O
Four	O
mutant	O
alleles	O
of	O
gene1s	O
daf-25	O
gene1e	O
(	O
abnormal	O
DAuer	O
Formation	O
)	O
were	O
isolated	O
from	O
screens	O
for	O
mutants	O
exhibiting	O
constitutive	O
dauer	O
formation	O
and	O
found	O
to	O
be	O
defective	O
in	O
olfaction	O
.	O
The	O
gene1s	O
daf-25	O
gene1e	O
dauer	O
phenotype	O
is	O
suppressed	O
by	O
gene1s	O
daf-10	O
gene1e	O
/	O
gene1s	O
IFT122	O
gene1e	O
mutations	O
(	O
which	O
disrupt	O
ciliogenesis	O
)	O
,	O
but	O
not	O
by	O
gene1s	O
daf-6	O
gene1e	O
/	O
gene1s	O
PTCHD3	O
gene1e	O
mutations	O
(	O
which	O
prevent	O
environmental	O
exposure	O
of	O
sensory	O
cilia	O
)	O
,	O
implying	O
that	O
gene1s	O
DAF-25	O
gene1e	O
functions	O
in	O
the	O
cilia	O
themselves	O
.	O
gene1s	O
daf-25	O
gene1e	O
encodes	O
the	O
species1s	O
C.	O
elegans	O
species1e	O
ortholog	O
of	O
arg1s	O
mammalian	O
arg1e	O
gene1s	O
Ankmy2	O
gene1e	O
,	O
a	O
MYND	O
domain	O
protein	O
of	O
unknown	O
function	O
.	O
Disruption	O
of	O
gene1s	O
DAF-25	O
gene1e	O
,	O
which	O
localizes	O
to	O
sensory	O
cilia	O
,	O
produces	O
no	O
apparent	O
cilia	O
structure	O
anomalies	O
,	O
as	O
determined	O
by	O
light	O
and	O
electron	O
microscopy	O
.	O
Hinting	O
at	O
its	O
potential	O
function	O
,	O
the	O
dauer	O
phenotype	O
,	O
epistatic	O
order	O
,	O
and	O
expression	O
profile	O
of	O
gene1s	O
daf-25	O
gene1e	O
are	O
similar	O
to	O
gene1s	O
daf-11	O
gene1e	O
,	O
which	O
encodes	O
a	O
cilium	O
-	O
localized	O
gene1s	O
guanylyl	O
cyclase	O
gene1e	O
.	O
Indeed	O
,	O
we	O
demonstrate	O
that	O
gene1s	O
DAF-25	O
gene1e	O
is	O
required	O
for	O
proper	O
gene1s	O
DAF-11	O
gene1e	O
ciliary	O
localization	O
.	O
Furthermore	O
,	O
the	O
functional	O
interaction	O
is	O
evolutionarily	O
conserved	O
,	O
as	O
species1s	O
mouse	O
species1e	O
gene1s	O
Ankmy2	O
gene1e	O
interacts	O
with	O
gene1s	O
guanylyl	O
cyclase	O
gene1e	O
gene1s	O
GC1	O
gene1e	O
from	O
ciliary	O
photoreceptors	O
.	O
The	O
interaction	O
may	O
be	O
specific	O
because	O
gene1s	O
daf-25	O
gene1e	O
mutants	O
have	O
normally	O
-	O
localized	O
gene1s	O
OSM-9	O
gene1e	O
/	O
gene1s	O
TRPV4	O
gene1e	O
,	O
gene1s	O
TAX-4	O
gene1e	O
/	O
gene1s	O
CNGA1	O
gene1e	O
,	O
gene1s	O
CHE-2	O
gene1e	O
/	O
gene1s	O
IFT80	O
gene1e	O
,	O
gene1s	O
CHE-11	O
gene1e	O
/	O
gene1s	O
IFT140	O
gene1e	O
,	O
gene1s	O
CHE-13	O
gene1e	O
/	O
gene1s	O
IFT57	O
gene1e	O
,	O
gene1s	O
BBS-8	O
gene1e	O
,	O
gene1s	O
OSM-5	O
gene1e	O
/	O
gene1s	O
IFT88	O
gene1e	O
,	O
and	O
gene1s	O
XBX-1	O
gene1e	O
/	O
gene1s	O
D2LIC	O
gene1e	O
in	O
the	O
cilia	O
.	O
Intraflagellar	O
transport	O
(	O
IFT	O
)	O
(	O
required	O
to	O
build	O
cilia	O
)	O
is	O
not	O
defective	O
in	O
gene1s	O
daf-25	O
gene1e	O
mutants	O
,	O
although	O
the	O
ciliary	O
localization	O
of	O
gene1s	O
DAF-25	O
gene1e	O
itself	O
is	O
influenced	O
in	O
gene1s	O
che-11	O
gene1e	O
mutants	O
,	O
which	O
are	O
defective	O
in	O
retrograde	O
IFT	O
.	O
In	O
summary	O
,	O
we	O
have	O
discovered	O
a	O
novel	O
ciliary	O
protein	O
that	O
plays	O
an	O
important	O
role	O
in	O
cGMP	O
signaling	O
by	O
localizing	O
a	O
gene1s	O
guanylyl	O
cyclase	O
gene1e	O
to	O
the	O
sensory	O
organelle	O
.	O

Localization	O
of	O
a	O
gene1s	ARG2
guanylyl	ARG2
cyclase	ARG2
gene1e	ARG2
to	O
chemosensory	O
cilia	O
requires	O
the	O
novel	O
ciliary	O
MYND	O
domain	O
protein	O
gene1s	O
DAF-25	O
gene1e	O
.	O
In	O
harsh	O
conditions	O
,	O
species1s	O
Caenorhabditis	O
elegans	O
species1e	O
arrests	O
development	O
to	O
enter	O
a	O
non	O
-	O
aging	O
,	O
resistant	O
diapause	O
state	O
called	O
the	O
dauer	O
larva	O
.	O
Olfactory	O
sensation	O
modulates	O
the	O
gene1s	O
TGF	O
-	O
beta	O
gene1e	O
and	O
gene1s	O
insulin	O
gene1e	O
signaling	O
pathways	O
to	O
control	O
this	O
developmental	O
decision	O
.	O
Four	O
mutant	O
alleles	O
of	O
gene1s	O
daf-25	O
gene1e	O
(	O
abnormal	O
DAuer	O
Formation	O
)	O
were	O
isolated	O
from	O
screens	O
for	O
mutants	O
exhibiting	O
constitutive	O
dauer	O
formation	O
and	O
found	O
to	O
be	O
defective	O
in	O
olfaction	O
.	O
The	O
gene1s	O
daf-25	O
gene1e	O
dauer	O
phenotype	O
is	O
suppressed	O
by	O
gene1s	O
daf-10	O
gene1e	O
/	O
gene1s	O
IFT122	O
gene1e	O
mutations	O
(	O
which	O
disrupt	O
ciliogenesis	O
)	O
,	O
but	O
not	O
by	O
gene1s	O
daf-6	O
gene1e	O
/	O
gene1s	O
PTCHD3	O
gene1e	O
mutations	O
(	O
which	O
prevent	O
environmental	O
exposure	O
of	O
sensory	O
cilia	O
)	O
,	O
implying	O
that	O
gene1s	O
DAF-25	O
gene1e	O
functions	O
in	O
the	O
cilia	O
themselves	O
.	O
gene1s	O
daf-25	O
gene1e	O
encodes	O
the	O
species1s	O
C.	O
elegans	O
species1e	O
ortholog	O
of	O
species1s	O
mammalian	O
species1e	O
gene1s	ARG2
Ankmy2	ARG2
gene1e	ARG2
,	O
a	O
MYND	O
domain	O
protein	O
of	O
unknown	O
function	O
.	O
Disruption	O
of	O
gene1s	O
DAF-25	O
gene1e	O
,	O
which	O
localizes	O
to	O
sensory	O
cilia	O
,	O
produces	O
no	O
apparent	O
cilia	O
structure	O
anomalies	O
,	O
as	O
determined	O
by	O
light	O
and	O
electron	O
microscopy	O
.	O
Hinting	O
at	O
its	O
potential	O
function	O
,	O
the	O
dauer	O
phenotype	O
,	O
epistatic	O
order	O
,	O
and	O
expression	O
profile	O
of	O
gene1s	O
daf-25	O
gene1e	O
are	O
similar	O
to	O
gene1s	O
daf-11	O
gene1e	O
,	O
which	O
encodes	O
a	O
cilium	O
-	O
localized	O
gene1s	ARG2
guanylyl	ARG2
cyclase	ARG2
gene1e	ARG2
.	O
Indeed	O
,	O
we	O
demonstrate	O
that	O
gene1s	O
DAF-25	O
gene1e	O
is	O
required	O
for	O
proper	O
gene1s	O
DAF-11	O
gene1e	O
ciliary	O
localization	O
.	O
Furthermore	O
,	O
the	O
functional	O
interaction	O
is	O
evolutionarily	O
conserved	O
,	O
as	O
arg1s	O
mouse	O
arg1e	O
gene1s	ARG2
Ankmy2	ARG2
gene1e	ARG2
interacts	O
with	O
gene1s	ARG2
guanylyl	ARG2
cyclase	ARG2
gene1e	ARG2
gene1s	ARG2
GC1	ARG2
gene1e	ARG2
from	O
ciliary	O
photoreceptors	O
.	O
The	O
interaction	O
may	O
be	O
specific	O
because	O
gene1s	O
daf-25	O
gene1e	O
mutants	O
have	O
normally	O
-	O
localized	O
gene1s	O
OSM-9	O
gene1e	O
/	O
gene1s	O
TRPV4	O
gene1e	O
,	O
gene1s	O
TAX-4	O
gene1e	O
/	O
gene1s	O
CNGA1	O
gene1e	O
,	O
gene1s	O
CHE-2	O
gene1e	O
/	O
gene1s	O
IFT80	O
gene1e	O
,	O
gene1s	O
CHE-11	O
gene1e	O
/	O
gene1s	O
IFT140	O
gene1e	O
,	O
gene1s	O
CHE-13	O
gene1e	O
/	O
gene1s	O
IFT57	O
gene1e	O
,	O
gene1s	O
BBS-8	O
gene1e	O
,	O
gene1s	O
OSM-5	O
gene1e	O
/	O
gene1s	O
IFT88	O
gene1e	O
,	O
and	O
gene1s	O
XBX-1	O
gene1e	O
/	O
gene1s	O
D2LIC	O
gene1e	O
in	O
the	O
cilia	O
.	O
Intraflagellar	O
transport	O
(	O
IFT	O
)	O
(	O
required	O
to	O
build	O
cilia	O
)	O
is	O
not	O
defective	O
in	O
gene1s	O
daf-25	O
gene1e	O
mutants	O
,	O
although	O
the	O
ciliary	O
localization	O
of	O
gene1s	O
DAF-25	O
gene1e	O
itself	O
is	O
influenced	O
in	O
gene1s	O
che-11	O
gene1e	O
mutants	O
,	O
which	O
are	O
defective	O
in	O
retrograde	O
IFT	O
.	O
In	O
summary	O
,	O
we	O
have	O
discovered	O
a	O
novel	O
ciliary	O
protein	O
that	O
plays	O
an	O
important	O
role	O
in	O
cGMP	O
signaling	O
by	O
localizing	O
a	O
gene1s	ARG2
guanylyl	ARG2
cyclase	ARG2
gene1e	ARG2
to	O
the	O
sensory	O
organelle	O
.	O

gene1s	ARG2
Voltage	ARG2
-	ARG2
Dependent	ARG2
Anion	ARG2
Channel	ARG2
1	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
VDAC1	ARG2
gene1e	ARG2
)	O
Participates	O
the	O
Apoptosis	O
of	O
the	O
Mitochondrial	O
Dysfunction	O
in	O
Desminopathy	O
.	O
Desminopathies	O
caused	O
by	O
the	O
mutation	O
in	O
the	O
gene	O
coding	O
for	O
gene1s	O
desmin	O
gene1e	O
are	O
genetically	O
protein	O
aggregation	O
myopathies	O
.	O
Mitochondrial	O
dysfunction	O
is	O
one	O
of	O
pathological	O
changes	O
in	O
the	O
desminopathies	O
at	O
the	O
earliest	O
stage	O
.	O
The	O
molecular	O
mechanisms	O
of	O
mitochondria	O
dysfunction	O
in	O
desminopathies	O
remain	O
exclusive	O
.	O
gene1s	O
VDAC1	O
gene1e	O
regulates	O
mitochondrial	O
uptake	O
across	O
the	O
outer	O
membrane	O
and	O
mitochondrial	O
outer	O
membrane	O
permeabilization	O
(	O
MOMP	O
)	O
.	O
Relationships	O
between	O
desminopathies	O
and	O
gene1s	O
Voltage	O
-	O
dependent	O
anion	O
channel	O
1	O
gene1e	O
(	O
gene1s	O
VDAC1	O
gene1e	O
)	O
remain	O
unclear	O
.	O
Here	O
we	O
successfully	O
constructed	O
the	O
desminopathy	O
arg1s	O
rat	O
arg1e	O
model	O
,	O
evaluated	O
with	O
conventional	O
stains	O
,	O
containing	O
hematoxylin	O
and	O
eosin	O
(	O
HE	O
)	O
,	O
Gomori	O
Trichrome	O
(	O
MGT	O
)	O
,	O
(	O
PAS	O
)	O
,	O
red	O
oil	O
(	O
ORO	O
)	O
,	O
NADH	O
-	O
TR	O
,	O
SDH	O
staining	O
and	O
immunohistochemistry	O
.	O
Immunofluorescence	O
results	O
showed	O
that	O
gene1s	ARG2
VDAC1	ARG2
gene1e	ARG2
was	O
accumulated	O
in	O
the	O
gene1s	ARG2
desmin	ARG2
gene1e	ARG2
highly	O
stained	O
area	O
of	O
muscle	O
fibers	O
of	O
desminopathy	O
species1s	O
patients	O
species1e	O
or	O
desminopathy	O
arg1s	O
rat	O
arg1e	O
model	O
compared	O
to	O
the	O
normal	O
ones	O
.	O
Meanwhile	O
apoptosis	O
related	O
proteins	O
gene1s	ARG2
bax	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
ATF2	ARG2
gene1e	ARG2
were	O
involved	O
in	O
desminopathy	O
species1s	O
patients	O
species1e	O
and	O
desminopathy	O
arg1s	O
rat	O
arg1e	O
model	O
,	O
but	O
not	O
gene1s	ARG2
bcl-2	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
bcl	ARG2
-	ARG2
xl	ARG2
gene1e	ARG2
or	O
gene1s	ARG2
HK2	ARG2
gene1e	ARG2
.	O
gene1s	ARG2
VDAC1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
desmin	ARG2
gene1e	ARG2
are	O
closely	O
relevant	O
in	O
the	O
tissue	O
splices	O
of	O
deminopathies	O
species1s	O
patients	O
species1e	O
and	O
arg1s	O
rats	O
arg1e	O
with	O
desminopathy	O
at	O
protein	O
lever	O
.	O
Moreover	O
,	O
apoptotic	O
proteins	O
are	O
also	O
involved	O
in	O
the	O
desminopathies	O
,	O
like	O
gene1s	ARG2
bax	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
ATF2	ARG2
gene1e	ARG2
,	O
but	O
not	O
gene1s	ARG2
bcl-2	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
bcl	ARG2
-	ARG2
xl	ARG2
gene1e	ARG2
or	O
gene1s	ARG2
HK2	ARG2
gene1e	ARG2
.	O
This	O
pathological	O
analysis	O
presents	O
the	O
correlation	O
between	O
gene1s	ARG2
VDAC1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
desmin	ARG2
gene1e	ARG2
,	O
and	O
apoptosis	O
related	O
proteins	O
are	O
correlated	O
in	O
the	O
desminopathy	O
.	O
Furthermore	O
,	O
we	O
provide	O
a	O
arg1s	O
rat	O
arg1e	O
model	O
of	O
desminopathy	O
for	O
the	O
investigation	O
of	O
gene1s	ARG2
desmin	ARG2
gene1e	ARG2
related	O
myopathy	O
.	O

gene1s	ARG2
Voltage	ARG2
-	ARG2
Dependent	ARG2
Anion	ARG2
Channel	ARG2
1	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
VDAC1	ARG2
gene1e	ARG2
)	O
Participates	O
the	O
Apoptosis	O
of	O
the	O
Mitochondrial	O
Dysfunction	O
in	O
Desminopathy	O
.	O
Desminopathies	O
caused	O
by	O
the	O
mutation	O
in	O
the	O
gene	O
coding	O
for	O
gene1s	ARG2
desmin	ARG2
gene1e	ARG2
are	O
genetically	O
protein	O
aggregation	O
myopathies	O
.	O
Mitochondrial	O
dysfunction	O
is	O
one	O
of	O
pathological	O
changes	O
in	O
the	O
desminopathies	O
at	O
the	O
earliest	O
stage	O
.	O
The	O
molecular	O
mechanisms	O
of	O
mitochondria	O
dysfunction	O
in	O
desminopathies	O
remain	O
exclusive	O
.	O
gene1s	ARG2
VDAC1	ARG2
gene1e	ARG2
regulates	O
mitochondrial	O
uptake	O
across	O
the	O
outer	O
membrane	O
and	O
mitochondrial	O
outer	O
membrane	O
permeabilization	O
(	O
MOMP	O
)	O
.	O
Relationships	O
between	O
desminopathies	O
and	O
gene1s	ARG2
Voltage	ARG2
-	ARG2
dependent	ARG2
anion	ARG2
channel	ARG2
1	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
VDAC1	ARG2
gene1e	ARG2
)	O
remain	O
unclear	O
.	O
Here	O
we	O
successfully	O
constructed	O
the	O
desminopathy	O
species1s	O
rat	O
species1e	O
model	O
,	O
evaluated	O
with	O
conventional	O
stains	O
,	O
containing	O
hematoxylin	O
and	O
eosin	O
(	O
HE	O
)	O
,	O
Gomori	O
Trichrome	O
(	O
MGT	O
)	O
,	O
(	O
PAS	O
)	O
,	O
red	O
oil	O
(	O
ORO	O
)	O
,	O
NADH	O
-	O
TR	O
,	O
SDH	O
staining	O
and	O
immunohistochemistry	O
.	O
Immunofluorescence	O
results	O
showed	O
that	O
gene1s	ARG2
VDAC1	ARG2
gene1e	ARG2
was	O
accumulated	O
in	O
the	O
gene1s	ARG2
desmin	ARG2
gene1e	ARG2
highly	O
stained	O
area	O
of	O
muscle	O
fibers	O
of	O
desminopathy	O
arg1s	O
patients	O
arg1e	O
or	O
desminopathy	O
species1s	O
rat	O
species1e	O
model	O
compared	O
to	O
the	O
normal	O
ones	O
.	O
Meanwhile	O
apoptosis	O
related	O
proteins	O
gene1s	ARG2
bax	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
ATF2	ARG2
gene1e	ARG2
were	O
involved	O
in	O
desminopathy	O
arg1s	O
patients	O
arg1e	O
and	O
desminopathy	O
species1s	O
rat	O
species1e	O
model	O
,	O
but	O
not	O
gene1s	ARG2
bcl-2	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
bcl	ARG2
-	ARG2
xl	ARG2
gene1e	ARG2
or	O
gene1s	ARG2
HK2	ARG2
gene1e	ARG2
.	O
gene1s	ARG2
VDAC1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
desmin	ARG2
gene1e	ARG2
are	O
closely	O
relevant	O
in	O
the	O
tissue	O
splices	O
of	O
deminopathies	O
arg1s	O
patients	O
arg1e	O
and	O
species1s	O
rats	O
species1e	O
with	O
desminopathy	O
at	O
protein	O
lever	O
.	O
Moreover	O
,	O
apoptotic	O
proteins	O
are	O
also	O
involved	O
in	O
the	O
desminopathies	O
,	O
like	O
gene1s	ARG2
bax	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
ATF2	ARG2
gene1e	ARG2
,	O
but	O
not	O
gene1s	ARG2
bcl-2	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
bcl	ARG2
-	ARG2
xl	ARG2
gene1e	ARG2
or	O
gene1s	ARG2
HK2	ARG2
gene1e	ARG2
.	O
This	O
pathological	O
analysis	O
presents	O
the	O
correlation	O
between	O
gene1s	ARG2
VDAC1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
desmin	ARG2
gene1e	ARG2
,	O
and	O
apoptosis	O
related	O
proteins	O
are	O
correlated	O
in	O
the	O
desminopathy	O
.	O
Furthermore	O
,	O
we	O
provide	O
a	O
species1s	O
rat	O
species1e	O
model	O
of	O
desminopathy	O
for	O
the	O
investigation	O
of	O
gene1s	O
desmin	O
gene1e	O
related	O
myopathy	O
.	O

Oncogenic	O
activity	O
of	O
amplified	O
gene1s	ARG2
miniature	ARG2
chromosome	ARG2
maintenance	ARG2
8	ARG2
gene1e	ARG2
in	O
arg1s	O
human	O
arg1e	O
malignancies	O
.	O
gene1s	ARG2
Miniature	ARG2
chromosome	ARG2
maintenance	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
MCM	ARG2
gene1e	ARG2
)	O
proteins	O
play	O
critical	O
roles	O
in	O
DNA	O
replication	O
licensing	O
,	O
initiation	O
and	O
elongation	O
.	O
gene1s	ARG2
MCM8	ARG2
gene1e	ARG2
,	O
one	O
of	O
the	O
gene1s	ARG2
MCM	ARG2
gene1e	ARG2
proteins	O
playing	O
a	O
critical	O
role	O
in	O
DNA	O
repairing	O
and	O
recombination	O
,	O
was	O
found	O
to	O
have	O
overexpression	O
and	O
increased	O
DNA	O
copy	O
number	O
in	O
a	O
variety	O
of	O
arg1s	O
human	O
arg1e	O
malignancies	O
.	O
The	O
gain	O
of	O
gene1s	ARG2
MCM8	ARG2
gene1e	ARG2
is	O
associated	O
with	O
aggressive	O
clinical	O
features	O
of	O
several	O
arg1s	O
human	O
arg1e	O
cancers	O
.	O
Increased	O
expression	O
of	O
gene1s	ARG2
MCM8	ARG2
gene1e	ARG2
in	O
prostate	O
cancer	O
is	O
associated	O
with	O
cancer	O
recurrence	O
.	O
Forced	O
expression	O
of	O
gene1s	ARG2
MCM8	ARG2
gene1e	ARG2
in	O
arg1s	O
RWPE1	O
arg1e	O
cells	O
,	O
the	O
immortalized	O
but	O
non	O
-	O
transformed	O
arg1s	O
prostate	O
epithelial	O
cell	O
arg1e	O
line	O
,	O
exhibited	O
fast	O
cell	O
growth	O
and	O
transformation	O
,	O
while	O
knock	O
down	O
of	O
gene1s	ARG2
MCM8	ARG2
gene1e	ARG2
in	O
PC3	O
,	O
arg1s	O
DU145	O
arg1e	O
and	O
arg1s	O
LNCaP	O
arg1e	O
cells	O
induced	O
cell	O
growth	O
arrest	O
,	O
and	O
decreased	O
tumour	O
volumes	O
and	O
mortality	O
of	O
severe	O
combined	O
immunodeficiency	O
species1s	O
mice	O
species1e	O
xenografted	O
with	O
PC3	O
and	O
arg1s	O
DU145	O
arg1e	O
cells	O
.	O
gene1s	ARG2
MCM8	ARG2
gene1e	ARG2
bound	O
gene1s	ARG2
cyclin	ARG2
D1	ARG2
gene1e	ARG2
and	O
activated	O
gene1s	ARG2
Rb	ARG2
gene1e	ARG2
protein	O
phosphorylation	O
by	O
gene1s	ARG2
cyclin	ARG2
-	ARG2
dependent	ARG2
kinase	ARG2
4	ARG2
gene1e	ARG2
in	O
vitro	O
and	O
in	O
vivo	O
.	O
The	O
gene1s	ARG2
cyclin	ARG2
D1	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
MCM8	ARG2
gene1e	ARG2
interaction	O
is	O
required	O
for	O
gene1s	ARG2
Rb	ARG2
gene1e	ARG2
phosphorylation	O
and	O
S	O
-	O
phase	O
entry	O
in	O
cancer	O
cells	O
.	O
As	O
a	O
result	O
,	O
our	O
study	O
showed	O
that	O
copy	O
number	O
increase	O
and	O
overexpression	O
of	O
gene1s	ARG2
MCM8	ARG2
gene1e	ARG2
may	O
play	O
critical	O
roles	O
in	O
arg1s	O
human	O
arg1e	O
cancer	O
development	O
.	O

Oncogenic	O
activity	O
of	O
amplified	O
gene1s	O
miniature	O
chromosome	O
maintenance	O
8	O
gene1e	O
in	O
species1s	O
human	O
species1e	O
malignancies	O
.	O
gene1s	O
Miniature	O
chromosome	O
maintenance	O
gene1e	O
(	O
gene1s	O
MCM	O
gene1e	O
)	O
proteins	O
play	O
critical	O
roles	O
in	O
DNA	O
replication	O
licensing	O
,	O
initiation	O
and	O
elongation	O
.	O
gene1s	O
MCM8	O
gene1e	O
,	O
one	O
of	O
the	O
gene1s	O
MCM	O
gene1e	O
proteins	O
playing	O
a	O
critical	O
role	O
in	O
DNA	O
repairing	O
and	O
recombination	O
,	O
was	O
found	O
to	O
have	O
overexpression	O
and	O
increased	O
DNA	O
copy	O
number	O
in	O
a	O
variety	O
of	O
species1s	O
human	O
species1e	O
malignancies	O
.	O
The	O
gain	O
of	O
gene1s	O
MCM8	O
gene1e	O
is	O
associated	O
with	O
aggressive	O
clinical	O
features	O
of	O
several	O
species1s	O
human	O
species1e	O
cancers	O
.	O
Increased	O
expression	O
of	O
gene1s	O
MCM8	O
gene1e	O
in	O
prostate	O
cancer	O
is	O
associated	O
with	O
cancer	O
recurrence	O
.	O
Forced	O
expression	O
of	O
gene1s	O
MCM8	O
gene1e	O
in	O
species1s	O
RWPE1	O
species1e	O
cells	O
,	O
the	O
immortalized	O
but	O
non	O
-	O
transformed	O
species1s	O
prostate	O
epithelial	O
cell	O
species1e	O
line	O
,	O
exhibited	O
fast	O
cell	O
growth	O
and	O
transformation	O
,	O
while	O
knock	O
down	O
of	O
gene1s	O
MCM8	O
gene1e	O
in	O
PC3	O
,	O
species1s	O
DU145	O
species1e	O
and	O
species1s	O
LNCaP	O
species1e	O
cells	O
induced	O
cell	O
growth	O
arrest	O
,	O
and	O
decreased	O
tumour	O
volumes	O
and	O
mortality	O
of	O
severe	O
combined	O
immunodeficiency	O
arg1s	O
mice	O
arg1e	O
xenografted	O
with	O
PC3	O
and	O
species1s	O
DU145	O
species1e	O
cells	O
.	O
gene1s	O
MCM8	O
gene1e	O
bound	O
gene1s	O
cyclin	O
D1	O
gene1e	O
and	O
activated	O
gene1s	O
Rb	O
gene1e	O
protein	O
phosphorylation	O
by	O
gene1s	O
cyclin	O
-	O
dependent	O
kinase	O
4	O
gene1e	O
in	O
vitro	O
and	O
in	O
vivo	O
.	O
The	O
gene1s	O
cyclin	O
D1	O
gene1e	O
/	O
gene1s	O
MCM8	O
gene1e	O
interaction	O
is	O
required	O
for	O
gene1s	O
Rb	O
gene1e	O
phosphorylation	O
and	O
S	O
-	O
phase	O
entry	O
in	O
cancer	O
cells	O
.	O
As	O
a	O
result	O
,	O
our	O
study	O
showed	O
that	O
copy	O
number	O
increase	O
and	O
overexpression	O
of	O
gene1s	O
MCM8	O
gene1e	O
may	O
play	O
critical	O
roles	O
in	O
species1s	O
human	O
species1e	O
cancer	O
development	O
.	O

Large	O
multiethnic	O
Candidate	O
Gene	O
Study	O
for	O
gene1s	ARG2
C	ARG2
-	ARG2
reactive	ARG2
protein	ARG2
gene1e	ARG2
levels	O
:	O
identification	O
of	O
a	O
novel	O
association	O
at	O
gene1s	ARG2
CD36	ARG2
gene1e	ARG2
in	O
African	O
Americans	O
.	O
gene1s	ARG2
C	ARG2
-	ARG2
reactive	ARG2
protein	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
CRP	ARG2
gene1e	ARG2
)	O
is	O
a	O
heritable	O
biomarker	O
of	O
systemic	O
inflammation	O
and	O
a	O
predictor	O
of	O
cardiovascular	O
disease	O
(	O
CVD	O
)	O
.	O
Large	O
-	O
scale	O
genetic	O
association	O
studies	O
for	O
gene1s	ARG2
CRP	ARG2
gene1e	ARG2
have	O
largely	O
focused	O
on	O
individuals	O
of	O
European	O
descent	O
.	O
We	O
sought	O
to	O
uncover	O
novel	O
genetic	O
variants	O
for	O
gene1s	ARG2
CRP	ARG2
gene1e	ARG2
in	O
a	O
multiethnic	O
sample	O
using	O
the	O
ITMAT	O
Broad	O
-	O
CARe	O
(	O
IBC	O
)	O
array	O
,	O
a	O
custom	O
50,000	O
SNP	O
gene	O
-	O
centric	O
array	O
having	O
dense	O
coverage	O
of	O
over	O
2,000	O
candidate	O
CVD	O
genes	O
.	O
We	O
performed	O
analyses	O
on	O
7,570	O
African	O
Americans	O
(	O
AA	O
)	O
from	O
the	O
Candidate	O
gene	O
Association	O
Resource	O
(	O
CARe	O
)	O
study	O
and	O
race	O
-	O
combined	O
meta	O
-	O
analyses	O
that	O
included	O
29,939	O
additional	O
individuals	O
of	O
European	O
descent	O
from	O
CARe	O
,	O
the	O
arg1s	O
Women	O
arg1e	O
's	O
Health	O
Initiative	O
(	O
WHI	O
)	O
and	O
KORA	O
studies	O
.	O
We	O
observed	O
array	O
-	O
wide	O
significance	O
(	O
p	O
<	O
2.2	O
x	O
10(-6	O
)	O
)	O
for	O
four	O
loci	O
in	O
AA	O
,	O
three	O
of	O
which	O
have	O
been	O
reported	O
previously	O
in	O
individuals	O
of	O
European	O
descent	O
(	O
gene1s	ARG2
IL6R	ARG2
gene1e	ARG2
,	O
p	O
=	O
2.0	O
x	O
10(-6	O
)	O
;	O
gene1s	ARG2
CRP	ARG2
gene1e	ARG2
,	O
p	O
=	O
4.2	O
x	O
10(-71	O
)	O
;	O
gene1s	ARG2
APOE	ARG2
gene1e	ARG2
,	O
p	O
=	O
1.6	O
x	O
10(-6	O
)	O
)	O
.	O
The	O
fourth	O
significant	O
locus	O
,	O
gene1s	ARG2
CD36	ARG2
gene1e	ARG2
(	O
p	O
=	O
1.6	O
x	O
10(-6	O
)	O
)	O
,	O
was	O
observed	O
at	O
a	O
functional	O
variant	O
(	O
rs3211938	O
)	O
that	O
is	O
extremely	O
rare	O
in	O
individuals	O
of	O
European	O
descent	O
.	O
We	O
replicated	O
the	O
gene1s	ARG2
CD36	ARG2
gene1e	ARG2
finding	O
(	O
p	O
=	O
1.8	O
x	O
10(-5	O
)	O
)	O
in	O
an	O
independent	O
sample	O
of	O
8,041	O
AA	O
arg1s	O
women	O
arg1e	O
from	O
WHI	O
;	O
a	O
meta	O
-	O
analysis	O
combining	O
the	O
CARe	O
and	O
WHI	O
AA	O
results	O
at	O
rs3211938	O
reached	O
genome	O
-	O
wide	O
significance	O
(	O
p	O
=	O
1.5	O
x	O
10(-10	O
)	O
)	O
.	O
In	O
the	O
race	O
-	O
combined	O
meta	O
-	O
analyses	O
,	O
13	O
loci	O
reached	O
significance	O
,	O
including	O
ten	O
(	O
gene1s	ARG2
CRP	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
TOMM40	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
APOE	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
APOC1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
HNF1A	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
LEPR	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
GCKR	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IL6R	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IL1RN	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
NLRP3	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
HNF4A	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
BAZ1B	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
BCL7B	ARG2
gene1e	ARG2
)	O
previously	O
associated	O
with	O
gene1s	ARG2
CRP	ARG2
gene1e	ARG2
,	O
and	O
one	O
(	O
gene1s	ARG2
ARNTL	ARG2
gene1e	ARG2
)	O
previously	O
reported	O
to	O
be	O
nominally	O
associated	O
with	O
gene1s	ARG2
CRP	ARG2
gene1e	ARG2
.	O
Two	O
novel	O
loci	O
were	O
also	O
detected	O
(	O
gene1s	ARG2
RPS6KB1	ARG2
gene1e	ARG2
,	O
p	O
=	O
2.0	O
x	O
10(-6	O
)	O
;	O
gene1s	ARG2
CD36	ARG2
gene1e	ARG2
,	O
p	O
=	O
1.4	O
x	O
10(-6	O
)	O
)	O
.	O
These	O
results	O
highlight	O
both	O
shared	O
and	O
unique	O
genetic	O
risk	O
factors	O
for	O
gene1s	ARG2
CRP	ARG2
gene1e	ARG2
in	O
AA	O
compared	O
to	O
populations	O
of	O
European	O
descent	O
.	O

Loss	O
of	O
gene1s	O
PPARg	O
gene1e	O
expression	O
in	O
mammary	O
secretory	O
epithelial	O
cells	O
creates	O
a	O
pro	O
-	O
breast	O
tumorigenic	O
environment	O
.	O
Breast	O
cancer	O
is	O
the	O
leading	O
cause	O
of	O
new	O
cancer	O
diagnoses	O
among	O
arg1s	O
women	O
arg1e	O
.	O
Using	O
gene1s	O
peroxisome	O
proliferator	O
-	O
activated	O
receptor	O
(	O
PPAR)g	O
gene1e	O
((+/-	O
)	O
)	O
species1s	O
mice	O
species1e	O
,	O
we	O
showed	O
normal	O
expression	O
of	O
gene1s	O
PPARg	O
gene1e	O
was	O
critical	O
to	O
stop	O
7,12-dimethylbenz[a]anthracene	O
(	O
DMBA)-induced	O
breast	O
tumorigenesis	O
.	O
gene1s	O
PPARg	O
gene1e	O
is	O
expressed	O
in	O
many	O
breast	O
cell	O
types	O
including	O
mammary	O
secretory	O
epithelial	O
(	O
MSE	O
)	O
cells	O
.	O
MSEs	O
proliferate	O
as	O
required	O
during	O
pregnancy	O
,	O
and	O
undergo	O
apoptosis	O
or	O
reversible	O
transdifferentiation	O
during	O
involution	O
once	O
lactation	O
is	O
complete	O
.	O
Thus	O
,	O
MSE	O
-	O
specific	O
loss	O
of	O
gene1s	O
PPARg	O
gene1e	O
was	O
hypothesized	O
to	O
enhance	O
DMBA	O
-	O
mediated	O
breast	O
tumorigenesis	O
.	O
To	O
test	O
this	O
,	O
MSE	O
cell	O
-	O
specific	O
gene1s	O
PPARg	O
gene1e	O
knockout	O
(	O
gene1s	O
PPARg	O
gene1e	O
-	O
MSE	O
KO	O
)	O
and	O
control	O
(	O
gene1s	O
PPARg	O
gene1e	O
-	O
WT	O
)	O
species1s	O
mice	O
species1e	O
were	O
generated	O
,	O
mated	O
and	O
allowed	O
to	O
nurse	O
for	O
three	O
days	O
.	O
One	O
week	O
after	O
involution	O
,	O
dams	O
were	O
treated	O
with	O
DMBA	O
to	O
initiate	O
breast	O
tumors	O
,	O
and	O
randomized	O
on	O
week	O
7	O
to	O
continue	O
receiving	O
a	O
normal	O
chow	O
diet	O
(	O
DMBA	O
Only	O
:	O
gene1s	O
PPARg	O
gene1e	O
-	O
WT	O
,	O
n	O
=	O
15	O
;	O
gene1s	O
PPARg	O
gene1e	O
-	O
MSE	O
KO	O
,	O
n	O
=	O
25	O
)	O
or	O
one	O
supplemented	O
with	O
a	O
gene1s	O
PPARg	O
gene1e	O
activating	O
drug	O
(	O
DMBA	O
+	O
ROSI	O
:	O
gene1s	O
PPARg	O
gene1e	O
-	O
WT	O
,	O
n	O
=	O
17	O
;	O
gene1s	O
PPARg	O
gene1e	O
-	O
MSE	O
KO	O
,	O
n	O
=	O
24	O
)	O
,	O
and	O
monitored	O
for	O
changes	O
in	O
breast	O
tumor	O
outcomes	O
.	O
gene1s	O
PPARg	O
gene1e	O
-	O
MSE	O
KOs	O
had	O
significantly	O
lower	O
overall	O
survival	O
and	O
decreased	O
mammary	O
tumor	O
latency	O
as	O
compared	O
to	O
gene1s	O
PPARg	O
gene1e	O
-	O
WT	O
controls	O
.	O
gene1s	O
PPARg	O
gene1e	O
activation	O
significantly	O
reduced	O
DMBA	O
-	O
mediated	O
malignant	O
mammary	O
tumor	O
volumes	O
irrespective	O
of	O
genotype	O
.	O
MSE	O
-	O
specific	O
gene1s	O
PPARg	O
gene1e	O
loss	O
resulted	O
in	O
decreased	O
mammary	O
gland	O
expression	O
of	O
gene1s	O
PTEN	O
gene1e	O
and	O
gene1s	O
Bax	O
gene1e	O
,	O
increased	O
superoxide	O
anion	O
production	O
,	O
and	O
elevated	O
serum	O
gene1s	O
eotaxin	O
gene1e	O
and	O
gene1s	O
RANTES	O
gene1e	O
,	O
creating	O
a	O
protumorigenic	O
environment	O
.	O
Moreover	O
,	O
gene1s	O
PPARg	O
gene1e	O
activation	O
in	O
MSEs	O
delayed	O
mammary	O
tumor	O
growth	O
in	O
part	O
by	O
down	O
-	O
regulating	O
gene1s	O
Cox-1	O
gene1e	O
,	O
gene1s	O
Cox-2	O
gene1e	O
and	O
gene1s	O
cyclin	O
D1	O
gene1e	O
.	O
Collectively	O
,	O
these	O
studies	O
highlight	O
a	O
protective	O
role	O
of	O
MSE	O
-	O
specific	O
gene1s	O
PPARg	O
gene1e	O
during	O
breast	O
tumorigenesis	O
,	O
and	O
support	O
a	O
novel	O
chemotherapeutic	O
role	O
of	O
gene1s	O
PPARg	O
gene1e	O
activation	O
in	O
breast	O
cancer	O
.	O

Loss	O
of	O
gene1s	ARG2
PPARg	ARG2
gene1e	ARG2
expression	O
in	O
mammary	O
secretory	O
epithelial	O
cells	O
creates	O
a	O
pro	O
-	O
breast	O
tumorigenic	O
environment	O
.	O
Breast	O
cancer	O
is	O
the	O
leading	O
cause	O
of	O
new	O
cancer	O
diagnoses	O
among	O
species1s	O
women	O
species1e	O
.	O
Using	O
gene1s	ARG2
peroxisome	ARG2
proliferator	ARG2
-	ARG2
activated	ARG2
receptor	ARG2
(	ARG2
PPAR)g	ARG2
gene1e	ARG2
((+/-	O
)	O
)	O
arg1s	O
mice	O
arg1e	O
,	O
we	O
showed	O
normal	O
expression	O
of	O
gene1s	ARG2
PPARg	ARG2
gene1e	ARG2
was	O
critical	O
to	O
stop	O
7,12-dimethylbenz[a]anthracene	O
(	O
DMBA)-induced	O
breast	O
tumorigenesis	O
.	O
gene1s	ARG2
PPARg	ARG2
gene1e	ARG2
is	O
expressed	O
in	O
many	O
breast	O
cell	O
types	O
including	O
mammary	O
secretory	O
epithelial	O
(	O
MSE	O
)	O
cells	O
.	O
MSEs	O
proliferate	O
as	O
required	O
during	O
pregnancy	O
,	O
and	O
undergo	O
apoptosis	O
or	O
reversible	O
transdifferentiation	O
during	O
involution	O
once	O
lactation	O
is	O
complete	O
.	O
Thus	O
,	O
MSE	O
-	O
specific	O
loss	O
of	O
gene1s	ARG2
PPARg	ARG2
gene1e	ARG2
was	O
hypothesized	O
to	O
enhance	O
DMBA	O
-	O
mediated	O
breast	O
tumorigenesis	O
.	O
To	O
test	O
this	O
,	O
MSE	O
cell	O
-	O
specific	O
gene1s	ARG2
PPARg	ARG2
gene1e	ARG2
knockout	O
(	O
gene1s	ARG2
PPARg	ARG2
gene1e	ARG2
-	O
MSE	O
KO	O
)	O
and	O
control	O
(	O
gene1s	ARG2
PPARg	ARG2
gene1e	ARG2
-	O
WT	O
)	O
arg1s	O
mice	O
arg1e	O
were	O
generated	O
,	O
mated	O
and	O
allowed	O
to	O
nurse	O
for	O
three	O
days	O
.	O
One	O
week	O
after	O
involution	O
,	O
dams	O
were	O
treated	O
with	O
DMBA	O
to	O
initiate	O
breast	O
tumors	O
,	O
and	O
randomized	O
on	O
week	O
7	O
to	O
continue	O
receiving	O
a	O
normal	O
chow	O
diet	O
(	O
DMBA	O
Only	O
:	O
gene1s	ARG2
PPARg	ARG2
gene1e	ARG2
-	O
WT	O
,	O
n	O
=	O
15	O
;	O
gene1s	ARG2
PPARg	ARG2
gene1e	ARG2
-	O
MSE	O
KO	O
,	O
n	O
=	O
25	O
)	O
or	O
one	O
supplemented	O
with	O
a	O
gene1s	ARG2
PPARg	ARG2
gene1e	ARG2
activating	O
drug	O
(	O
DMBA	O
+	O
ROSI	O
:	O
gene1s	ARG2
PPARg	ARG2
gene1e	ARG2
-	O
WT	O
,	O
n	O
=	O
17	O
;	O
gene1s	ARG2
PPARg	ARG2
gene1e	ARG2
-	O
MSE	O
KO	O
,	O
n	O
=	O
24	O
)	O
,	O
and	O
monitored	O
for	O
changes	O
in	O
breast	O
tumor	O
outcomes	O
.	O
gene1s	ARG2
PPARg	ARG2
gene1e	ARG2
-	O
MSE	O
KOs	O
had	O
significantly	O
lower	O
overall	O
survival	O
and	O
decreased	O
mammary	O
tumor	O
latency	O
as	O
compared	O
to	O
gene1s	ARG2
PPARg	ARG2
gene1e	ARG2
-	O
WT	O
controls	O
.	O
gene1s	ARG2
PPARg	ARG2
gene1e	ARG2
activation	O
significantly	O
reduced	O
DMBA	O
-	O
mediated	O
malignant	O
mammary	O
tumor	O
volumes	O
irrespective	O
of	O
genotype	O
.	O
MSE	O
-	O
specific	O
gene1s	ARG2
PPARg	ARG2
gene1e	ARG2
loss	O
resulted	O
in	O
decreased	O
mammary	O
gland	O
expression	O
of	O
gene1s	ARG2
PTEN	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
Bax	ARG2
gene1e	ARG2
,	O
increased	O
superoxide	O
anion	O
production	O
,	O
and	O
elevated	O
serum	O
gene1s	ARG2
eotaxin	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
RANTES	ARG2
gene1e	ARG2
,	O
creating	O
a	O
protumorigenic	O
environment	O
.	O
Moreover	O
,	O
gene1s	ARG2
PPARg	ARG2
gene1e	ARG2
activation	O
in	O
MSEs	O
delayed	O
mammary	O
tumor	O
growth	O
in	O
part	O
by	O
down	O
-	O
regulating	O
gene1s	ARG2
Cox-1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Cox-2	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
cyclin	ARG2
D1	ARG2
gene1e	ARG2
.	O
Collectively	O
,	O
these	O
studies	O
highlight	O
a	O
protective	O
role	O
of	O
MSE	O
-	O
specific	O
gene1s	ARG2
PPARg	ARG2
gene1e	ARG2
during	O
breast	O
tumorigenesis	O
,	O
and	O
support	O
a	O
novel	O
chemotherapeutic	O
role	O
of	O
gene1s	ARG2
PPARg	ARG2
gene1e	ARG2
activation	O
in	O
breast	O
cancer	O
.	O

gene1s	ARG2
HBEGF	ARG2
gene1e	ARG2
promotes	O
gliomagenesis	O
in	O
the	O
context	O
of	O
gene1s	ARG2
Ink4a	ARG2
/	ARG2
Arf	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
Pten	ARG2
gene1e	ARG2
loss	O
.	O
gene1s	O
Heparin	O
-	O
binding	O
epidermal	O
growth	O
factor	O
(	O
EGF)-like	O
growth	O
factor	O
gene1e	O
(	O
gene1s	O
HBEGF	O
gene1e	O
)	O
is	O
a	O
ligand	O
for	O
the	O
gene1s	O
EGF	O
receptor	O
gene1e	O
(	O
gene1s	O
EGFR	O
gene1e	O
)	O
,	O
one	O
of	O
the	O
most	O
commonly	O
amplified	O
gene1s	ARG2
receptor	ARG2
tyrosine	ARG2
kinases	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
RTKs	ARG2
gene1e	ARG2
)	O
in	O
glioblastoma	O
(	O
GBM	O
)	O
.	O
While	O
gene1s	O
HBEGF	O
gene1e	O
has	O
been	O
found	O
to	O
be	O
expressed	O
in	O
a	O
subset	O
of	O
malignant	O
gliomas	O
,	O
its	O
sufficiency	O
for	O
glioma	O
initiation	O
has	O
not	O
been	O
evaluated	O
.	O
In	O
this	O
study	O
,	O
we	O
demonstrate	O
that	O
gene1s	ARG2
HBEGF	ARG2
gene1e	ARG2
can	O
initiate	O
GBM	O
in	O
arg1s	O
mice	O
arg1e	O
in	O
the	O
context	O
of	O
gene1s	ARG2
Ink4a	ARG2
/	ARG2
Arf	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
Pten	ARG2
gene1e	ARG2
loss	O
,	O
and	O
that	O
these	O
tumors	O
are	O
similar	O
to	O
the	O
classical	O
GBM	O
subtype	O
observed	O
in	O
species1s	O
patients	O
species1e	O
.	O
Isogenic	O
astrocytes	O
from	O
these	O
arg1s	O
mice	O
arg1e	O
showed	O
activation	O
not	O
only	O
of	O
gene1s	ARG2
Egfr	ARG2
gene1e	ARG2
but	O
also	O
the	O
gene1s	ARG2
RTK	ARG2
gene1e	ARG2
gene1s	ARG2
Axl	ARG2
gene1e	ARG2
in	O
response	O
to	O
gene1s	ARG2
HBEGF	ARG2
gene1e	ARG2
stimulation	O
.	O
Deletion	O
of	O
either	O
gene1s	ARG2
Egfr	ARG2
gene1e	ARG2
or	O
gene1s	ARG2
Axl	ARG2
gene1e	ARG2
decreased	O
the	O
tumorigenic	O
properties	O
of	O
gene1s	ARG2
HBEGF	ARG2
gene1e	ARG2
-	O
transformed	O
cells	O
;	O
however	O
,	O
only	O
gene1s	ARG2
EGFR	ARG2
gene1e	ARG2
was	O
able	O
to	O
rescue	O
the	O
phenotype	O
in	O
cells	O
lacking	O
both	O
gene1s	ARG2
RTKs	ARG2
gene1e	ARG2
indicating	O
that	O
gene1s	ARG2
Egfr	ARG2
gene1e	ARG2
is	O
required	O
for	O
activation	O
of	O
gene1s	ARG2
Axl	ARG2
gene1e	ARG2
in	O
this	O
context	O
.	O
Silencing	O
of	O
gene1s	ARG2
HBEGF	ARG2
gene1e	ARG2
in	O
vivo	O
resulted	O
in	O
tumor	O
regression	O
and	O
significantly	O
increased	O
survival	O
,	O
suggesting	O
that	O
gene1s	O
HBEGF	O
gene1e	O
may	O
be	O
a	O
clinically	O
relevant	O
target	O
.	O

gene1s	O
HBEGF	O
gene1e	O
promotes	O
gliomagenesis	O
in	O
the	O
context	O
of	O
gene1s	O
Ink4a	O
/	O
Arf	O
gene1e	O
and	O
gene1s	O
Pten	O
gene1e	O
loss	O
.	O
gene1s	ARG2
Heparin	ARG2
-	ARG2
binding	ARG2
epidermal	ARG2
growth	ARG2
factor	ARG2
(	ARG2
EGF)-like	ARG2
growth	ARG2
factor	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
HBEGF	ARG2
gene1e	ARG2
)	O
is	O
a	O
ligand	O
for	O
the	O
gene1s	ARG2
EGF	ARG2
receptor	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
EGFR	ARG2
gene1e	ARG2
)	O
,	O
one	O
of	O
the	O
most	O
commonly	O
amplified	O
gene1s	ARG2
receptor	ARG2
tyrosine	ARG2
kinases	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
RTKs	ARG2
gene1e	ARG2
)	O
in	O
glioblastoma	O
(	O
GBM	O
)	O
.	O
While	O
gene1s	ARG2
HBEGF	ARG2
gene1e	ARG2
has	O
been	O
found	O
to	O
be	O
expressed	O
in	O
a	O
subset	O
of	O
malignant	O
gliomas	O
,	O
its	O
sufficiency	O
for	O
glioma	O
initiation	O
has	O
not	O
been	O
evaluated	O
.	O
In	O
this	O
study	O
,	O
we	O
demonstrate	O
that	O
gene1s	O
HBEGF	O
gene1e	O
can	O
initiate	O
GBM	O
in	O
species1s	O
mice	O
species1e	O
in	O
the	O
context	O
of	O
gene1s	O
Ink4a	O
/	O
Arf	O
gene1e	O
and	O
gene1s	O
Pten	O
gene1e	O
loss	O
,	O
and	O
that	O
these	O
tumors	O
are	O
similar	O
to	O
the	O
classical	O
GBM	O
subtype	O
observed	O
in	O
arg1s	O
patients	O
arg1e	O
.	O
Isogenic	O
astrocytes	O
from	O
these	O
species1s	O
mice	O
species1e	O
showed	O
activation	O
not	O
only	O
of	O
gene1s	O
Egfr	O
gene1e	O
but	O
also	O
the	O
gene1s	O
RTK	O
gene1e	O
gene1s	O
Axl	O
gene1e	O
in	O
response	O
to	O
gene1s	O
HBEGF	O
gene1e	O
stimulation	O
.	O
Deletion	O
of	O
either	O
gene1s	O
Egfr	O
gene1e	O
or	O
gene1s	O
Axl	O
gene1e	O
decreased	O
the	O
tumorigenic	O
properties	O
of	O
gene1s	O
HBEGF	O
gene1e	O
-	O
transformed	O
cells	O
;	O
however	O
,	O
only	O
gene1s	O
EGFR	O
gene1e	O
was	O
able	O
to	O
rescue	O
the	O
phenotype	O
in	O
cells	O
lacking	O
both	O
gene1s	O
RTKs	O
gene1e	O
indicating	O
that	O
gene1s	O
Egfr	O
gene1e	O
is	O
required	O
for	O
activation	O
of	O
gene1s	O
Axl	O
gene1e	O
in	O
this	O
context	O
.	O
Silencing	O
of	O
gene1s	O
HBEGF	O
gene1e	O
in	O
vivo	O
resulted	O
in	O
tumor	O
regression	O
and	O
significantly	O
increased	O
survival	O
,	O
suggesting	O
that	O
gene1s	ARG2
HBEGF	ARG2
gene1e	ARG2
may	O
be	O
a	O
clinically	O
relevant	O
target	O
.	O

gene1s	O
IRF-8	O
gene1e	O
regulates	O
expansion	O
of	O
myeloid	O
-	O
derived	O
suppressor	O
cells	O
and	O
gene1s	O
Foxp3	O
gene1e	O
+	O
regulatory	O
T	O
cells	O
and	O
modulates	O
Th2	O
immune	O
responses	O
to	O
gastrointestinal	O
nematode	O
infection	O
.	O
gene1s	O
Interferon	O
regulatory	O
factor-8	O
gene1e	O
(	O
gene1s	O
IRF-8	O
gene1e	O
)	O
is	O
critical	O
for	O
Th1	O
cell	O
differentiation	O
and	O
negatively	O
regulates	O
myeloid	O
cell	O
development	O
including	O
myeloid	O
-	O
derived	O
suppressor	O
cells	O
(	O
MDSC	O
)	O
.	O
MDSC	O
expand	O
during	O
infection	O
with	O
various	O
pathogens	O
including	O
the	O
gastrointestinal	O
(	O
GI	O
)	O
nematode	O
arg1s	O
Heligmosomoides	O
polygyrus	O
bakeri	O
arg1e	O
(	O
arg1s	O
Hpb	O
arg1e	O
)	O
.	O
We	O
investigated	O
if	O
gene1s	O
IRF-8	O
gene1e	O
contributes	O
to	O
Th2	O
immunity	O
to	O
arg1s	O
Hpb	O
arg1e	O
infection	O
.	O
gene1s	O
Irf8	O
gene1e	O
expression	O
was	O
down	O
-	O
regulated	O
in	O
MDSC	O
from	O
arg1s	O
Hpb	O
arg1e	O
-	O
infected	O
C57BL/6	O
(	O
B6	O
)	O
species1s	O
mice	O
species1e	O
.	O
gene1s	O
IRF-8	O
gene1e	O
deficient	O
gene1s	O
Irf8	O
gene1e	O
-/-	O
and	O
BXH-2	O
species1s	O
mice	O
species1e	O
had	O
significantly	O
higher	O
adult	O
worm	O
burdens	O
than	O
B6	O
species1s	O
mice	O
species1e	O
after	O
primary	O
or	O
challenge	O
arg1s	O
Hpb	O
arg1e	O
infection	O
.	O
During	O
primary	O
infection	O
,	O
MDSC	O
expanded	O
to	O
a	O
significantly	O
greater	O
extent	O
in	O
mesenteric	O
lymph	O
nodes	O
(	O
MLN	O
)	O
and	O
spleens	O
of	O
gene1s	O
Irf8	O
gene1e	O
-/-	O
and	O
BXH-2	O
than	O
B6	O
species1s	O
mice	O
species1e	O
.	O
gene1s	O
CD4	O
gene1e	O
+	O
gene1s	O
GATA3	O
gene1e	O
+	O
T	O
cells	O
numbers	O
were	O
comparable	O
in	O
MLN	O
of	O
infected	O
B6	O
and	O
gene1s	O
IRF-8	O
gene1e	O
deficient	O
species1s	O
mice	O
species1e	O
,	O
but	O
MLN	O
cells	O
from	O
infected	O
gene1s	O
IRF-8	O
gene1e	O
deficient	O
species1s	O
mice	O
species1e	O
secreted	O
significantly	O
less	O
parasite	O
-	O
specific	O
gene1s	O
IL-4	O
gene1e	O
ex	O
vivo	O
.	O
The	O
numbers	O
of	O
alternatively	O
activated	O
macrophages	O
in	O
MLN	O
and	O
serum	O
levels	O
of	O
arg1s	O
Hpb	O
arg1e	O
-	O
specific	O
gene1s	O
IgG1	O
gene1e	O
and	O
gene1s	O
IgE	O
gene1e	O
were	O
also	O
significantly	O
less	O
in	O
infected	O
gene1s	O
Irf8	O
gene1e	O
-/-	O
than	O
B6	O
species1s	O
mice	O
species1e	O
.	O
The	O
frequencies	O
of	O
antigen	O
-	O
experienced	O
gene1s	O
CD4	O
gene1e	O
+	O
gene1s	O
CD11a	O
gene1e	O
hi	O
gene1s	O
CD49d	O
gene1e	O
hi	O
cells	O
that	O
were	O
gene1s	O
CD44	O
gene1e	O
hi	O
gene1s	O
CD62L	O
gene1e	O
-	O
were	O
similar	O
in	O
MLN	O
of	O
infected	O
gene1s	O
Irf8	O
gene1e	O
-/-	O
and	O
B6	O
species1s	O
mice	O
species1e	O
,	O
but	O
the	O
proportions	O
of	O
gene1s	O
CD4	O
gene1e	O
+	O
gene1s	O
GATA3	O
gene1e	O
+	O
and	O
gene1s	O
CD4	O
gene1e	O
+	O
gene1s	O
IL-4	O
gene1e	O
+	O
T	O
cells	O
were	O
lower	O
in	O
infected	O
gene1s	O
Irf8	O
gene1e	O
-/-	O
species1s	O
mice	O
species1e	O
.	O
gene1s	O
CD11b	O
gene1e	O
+	O
gene1s	O
Gr1	O
gene1e	O
+	O
cells	O
from	O
naive	O
or	O
infected	O
gene1s	O
Irf8	O
gene1e	O
-/-	O
species1s	O
mice	O
species1e	O
suppressed	O
gene1s	O
CD4	O
gene1e	O
+	O
T	O
cell	O
proliferation	O
and	O
parasite	O
-	O
specific	O
gene1s	O
IL-4	O
gene1e	O
secretion	O
in	O
vitro	O
albeit	O
less	O
efficiently	O
than	O
B6	O
species1s	O
mice	O
species1e	O
.	O
Surprisingly	O
,	O
there	O
were	O
significantly	O
more	O
gene1s	O
CD4	O
gene1e	O
+	O
T	O
cells	O
in	O
infected	O
gene1s	O
Irf8	O
gene1e	O
-/-	O
species1s	O
mice	O
species1e	O
,	O
with	O
a	O
higher	O
frequency	O
of	O
gene1s	O
CD4	O
gene1e	O
+	O
gene1s	O
CD25	O
gene1e	O
+	O
gene1s	O
Foxp3	O
gene1e	O
+	O
T	O
(	O
Tregs	O
)	O
cells	O
and	O
significantly	O
higher	O
numbers	O
of	O
Tregs	O
than	O
B6	O
species1s	O
mice	O
species1e	O
.	O
In	O
vivo	O
depletion	O
of	O
MDSC	O
and/or	O
Tregs	O
in	O
gene1s	O
Irf8	O
gene1e	O
-/-	O
species1s	O
mice	O
species1e	O
did	O
not	O
affect	O
adult	O
worm	O
burdens	O
,	O
but	O
Treg	O
depletion	O
resulted	O
in	O
higher	O
egg	O
production	O
and	O
enhanced	O
parasite	O
-	O
specific	O
gene1s	O
IL-5	O
gene1e	O
,	O
gene1s	O
IL-13	O
gene1e	O
,	O
and	O
gene1s	O
IL-6	O
gene1e	O
secretion	O
ex	O
vivo	O
.	O
Our	O
data	O
thus	O
provide	O
a	O
previously	O
unrecognized	O
role	O
for	O
gene1s	O
IRF-8	O
gene1e	O
in	O
Th2	O
immunity	O
to	O
a	O
GI	O
nematode	O
.	O

gene1s	ARG2
IRF-8	ARG2
gene1e	ARG2
regulates	O
expansion	O
of	O
myeloid	O
-	O
derived	O
suppressor	O
cells	O
and	O
gene1s	ARG2
Foxp3	ARG2
gene1e	ARG2
+	O
regulatory	O
T	O
cells	O
and	O
modulates	O
Th2	O
immune	O
responses	O
to	O
gastrointestinal	O
nematode	O
infection	O
.	O
gene1s	ARG2
Interferon	ARG2
regulatory	ARG2
factor-8	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
IRF-8	ARG2
gene1e	ARG2
)	O
is	O
critical	O
for	O
Th1	O
cell	O
differentiation	O
and	O
negatively	O
regulates	O
myeloid	O
cell	O
development	O
including	O
myeloid	O
-	O
derived	O
suppressor	O
cells	O
(	O
MDSC	O
)	O
.	O
MDSC	O
expand	O
during	O
infection	O
with	O
various	O
pathogens	O
including	O
the	O
gastrointestinal	O
(	O
GI	O
)	O
nematode	O
species1s	O
Heligmosomoides	O
polygyrus	O
bakeri	O
species1e	O
(	O
species1s	O
Hpb	O
species1e	O
)	O
.	O
We	O
investigated	O
if	O
gene1s	ARG2
IRF-8	ARG2
gene1e	ARG2
contributes	O
to	O
Th2	O
immunity	O
to	O
species1s	O
Hpb	O
species1e	O
infection	O
.	O
gene1s	ARG2
Irf8	ARG2
gene1e	ARG2
expression	O
was	O
down	O
-	O
regulated	O
in	O
MDSC	O
from	O
species1s	O
Hpb	O
species1e	O
-	O
infected	O
C57BL/6	O
(	O
B6	O
)	O
arg1s	O
mice	O
arg1e	O
.	O
gene1s	ARG2
IRF-8	ARG2
gene1e	ARG2
deficient	O
gene1s	ARG2
Irf8	ARG2
gene1e	ARG2
-/-	O
and	O
BXH-2	O
arg1s	O
mice	O
arg1e	O
had	O
significantly	O
higher	O
adult	O
worm	O
burdens	O
than	O
B6	O
arg1s	O
mice	O
arg1e	O
after	O
primary	O
or	O
challenge	O
species1s	O
Hpb	O
species1e	O
infection	O
.	O
During	O
primary	O
infection	O
,	O
MDSC	O
expanded	O
to	O
a	O
significantly	O
greater	O
extent	O
in	O
mesenteric	O
lymph	O
nodes	O
(	O
MLN	O
)	O
and	O
spleens	O
of	O
gene1s	ARG2
Irf8	ARG2
gene1e	ARG2
-/-	O
and	O
BXH-2	O
than	O
B6	O
arg1s	O
mice	O
arg1e	O
.	O
gene1s	ARG2
CD4	ARG2
gene1e	ARG2
+	O
gene1s	ARG2
GATA3	ARG2
gene1e	ARG2
+	O
T	O
cells	O
numbers	O
were	O
comparable	O
in	O
MLN	O
of	O
infected	O
B6	O
and	O
gene1s	ARG2
IRF-8	ARG2
gene1e	ARG2
deficient	O
arg1s	O
mice	O
arg1e	O
,	O
but	O
MLN	O
cells	O
from	O
infected	O
gene1s	ARG2
IRF-8	ARG2
gene1e	ARG2
deficient	O
arg1s	O
mice	O
arg1e	O
secreted	O
significantly	O
less	O
parasite	O
-	O
specific	O
gene1s	ARG2
IL-4	ARG2
gene1e	ARG2
ex	O
vivo	O
.	O
The	O
numbers	O
of	O
alternatively	O
activated	O
macrophages	O
in	O
MLN	O
and	O
serum	O
levels	O
of	O
species1s	O
Hpb	O
species1e	O
-	O
specific	O
gene1s	ARG2
IgG1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
IgE	ARG2
gene1e	ARG2
were	O
also	O
significantly	O
less	O
in	O
infected	O
gene1s	ARG2
Irf8	ARG2
gene1e	ARG2
-/-	O
than	O
B6	O
arg1s	O
mice	O
arg1e	O
.	O
The	O
frequencies	O
of	O
antigen	O
-	O
experienced	O
gene1s	ARG2
CD4	ARG2
gene1e	ARG2
+	O
gene1s	ARG2
CD11a	ARG2
gene1e	ARG2
hi	O
gene1s	ARG2
CD49d	ARG2
gene1e	ARG2
hi	O
cells	O
that	O
were	O
gene1s	ARG2
CD44	ARG2
gene1e	ARG2
hi	O
gene1s	ARG2
CD62L	ARG2
gene1e	ARG2
-	O
were	O
similar	O
in	O
MLN	O
of	O
infected	O
gene1s	ARG2
Irf8	ARG2
gene1e	ARG2
-/-	O
and	O
B6	O
arg1s	O
mice	O
arg1e	O
,	O
but	O
the	O
proportions	O
of	O
gene1s	ARG2
CD4	ARG2
gene1e	ARG2
+	O
gene1s	ARG2
GATA3	ARG2
gene1e	ARG2
+	O
and	O
gene1s	ARG2
CD4	ARG2
gene1e	ARG2
+	O
gene1s	ARG2
IL-4	ARG2
gene1e	ARG2
+	O
T	O
cells	O
were	O
lower	O
in	O
infected	O
gene1s	ARG2
Irf8	ARG2
gene1e	ARG2
-/-	O
arg1s	O
mice	O
arg1e	O
.	O
gene1s	ARG2
CD11b	ARG2
gene1e	ARG2
+	O
gene1s	ARG2
Gr1	ARG2
gene1e	ARG2
+	O
cells	O
from	O
naive	O
or	O
infected	O
gene1s	ARG2
Irf8	ARG2
gene1e	ARG2
-/-	O
arg1s	O
mice	O
arg1e	O
suppressed	O
gene1s	ARG2
CD4	ARG2
gene1e	ARG2
+	O
T	O
cell	O
proliferation	O
and	O
parasite	O
-	O
specific	O
gene1s	ARG2
IL-4	ARG2
gene1e	ARG2
secretion	O
in	O
vitro	O
albeit	O
less	O
efficiently	O
than	O
B6	O
arg1s	O
mice	O
arg1e	O
.	O
Surprisingly	O
,	O
there	O
were	O
significantly	O
more	O
gene1s	ARG2
CD4	ARG2
gene1e	ARG2
+	O
T	O
cells	O
in	O
infected	O
gene1s	ARG2
Irf8	ARG2
gene1e	ARG2
-/-	O
arg1s	O
mice	O
arg1e	O
,	O
with	O
a	O
higher	O
frequency	O
of	O
gene1s	ARG2
CD4	ARG2
gene1e	ARG2
+	O
gene1s	ARG2
CD25	ARG2
gene1e	ARG2
+	O
gene1s	ARG2
Foxp3	ARG2
gene1e	ARG2
+	O
T	O
(	O
Tregs	O
)	O
cells	O
and	O
significantly	O
higher	O
numbers	O
of	O
Tregs	O
than	O
B6	O
arg1s	O
mice	O
arg1e	O
.	O
In	O
vivo	O
depletion	O
of	O
MDSC	O
and/or	O
Tregs	O
in	O
gene1s	ARG2
Irf8	ARG2
gene1e	ARG2
-/-	O
arg1s	O
mice	O
arg1e	O
did	O
not	O
affect	O
adult	O
worm	O
burdens	O
,	O
but	O
Treg	O
depletion	O
resulted	O
in	O
higher	O
egg	O
production	O
and	O
enhanced	O
parasite	O
-	O
specific	O
gene1s	ARG2
IL-5	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IL-13	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
IL-6	ARG2
gene1e	ARG2
secretion	O
ex	O
vivo	O
.	O
Our	O
data	O
thus	O
provide	O
a	O
previously	O
unrecognized	O
role	O
for	O
gene1s	ARG2
IRF-8	ARG2
gene1e	ARG2
in	O
Th2	O
immunity	O
to	O
a	O
GI	O
nematode	O
.	O

Activated	O
gene1s	O
niacin	O
receptor	O
gene1e	O
gene1s	O
HCA2	O
gene1e	O
inhibits	O
chemoattractant	O
-	O
mediated	O
macrophage	O
migration	O
via	O
gene1s	O
Gbg	O
gene1e	O
/	O
gene1s	O
PKC	O
gene1e	O
/	O
gene1s	O
ERK1/2	O
gene1e	O
pathway	O
and	O
heterologous	O
receptor	O
desensitization	O
.	O
The	O
gene1s	O
niacin	O
receptor	O
gene1e	O
gene1s	O
HCA2	O
gene1e	O
is	O
implicated	O
in	O
controlling	O
inflammatory	O
host	O
responses	O
with	O
yet	O
poorly	O
understood	O
mechanistic	O
basis	O
.	O
We	O
previously	O
reported	O
that	O
gene1s	ARG2
HCA2	ARG2
gene1e	ARG2
in	O
A431	O
epithelial	O
cells	O
transduced	O
gene1s	ARG2
Gbg	ARG2
gene1e	ARG2
-	O
gene1s	ARG2
protein	ARG2
kinase	ARG2
C	ARG2
gene1e	ARG2
-	O
and	O
gene1s	ARG2
Gbg	ARG2
gene1e	ARG2
-	O
gene1s	ARG2
metalloproteinase	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
EGFR	ARG2
gene1e	ARG2
-	O
dependent	O
gene1s	ARG2
MAPK	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
ERK	ARG2
gene1e	ARG2
signaling	O
cascades	O
.	O
Here	O
,	O
we	O
investigated	O
the	O
role	O
of	O
gene1s	O
HCA2	O
gene1e	O
in	O
macrophage	O
-	O
mediated	O
inflammation	O
and	O
the	O
underlying	O
mechanisms	O
.	O
We	O
found	O
that	O
proinflammatory	O
stimulants	O
LPS	O
,	O
gene1s	O
IL-6	O
gene1e	O
and	O
gene1s	O
IL-1b	O
gene1e	O
up	O
-	O
regulated	O
the	O
expression	O
of	O
gene1s	O
HCA2	O
gene1e	O
on	O
macrophages	O
.	O
Niacin	O
significantly	O
inhibited	O
macrophage	O
chemotaxis	O
in	O
response	O
to	O
chemoattractants	O
fMLF	O
and	O
gene1s	O
CCL2	O
gene1e	O
by	O
disrupting	O
polarized	O
distribution	O
of	O
gene1s	O
F	O
-	O
actin	O
gene1e	O
and	O
gene1s	O
Gb	O
gene1e	O
protein	O
.	O
Niacin	O
showed	O
a	O
selected	O
additive	O
effect	O
on	O
chemoattractant	O
-	O
induced	O
activation	O
of	O
gene1s	O
ERK1/2	O
gene1e	O
,	O
gene1s	O
JNK	O
gene1e	O
and	O
gene1s	O
PI3	O
K	O
gene1e	O
pathways	O
,	O
but	O
only	O
the	O
gene1s	O
MEK	O
gene1e	O
inhibitor	O
UO126	O
reduced	O
niacin	O
-	O
mediated	O
inhibition	O
of	O
macrophage	O
chemotaxis	O
,	O
while	O
activation	O
of	O
gene1s	O
ERK1/2	O
gene1e	O
by	O
EGF	O
alone	O
did	O
not	O
inhibit	O
fMLF	O
-	O
mediated	O
migration	O
of	O
arg1s	O
HEK293	O
T	O
arg1e	O
cells	O
co	O
-	O
expressing	O
gene1s	ARG2
HCA2	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
fMLF	ARG2
receptor	ARG2
gene1e	ARG2
gene1s	ARG2
FPR1	ARG2
gene1e	ARG2
.	O
In	O
addition	O
,	O
niacin	O
induced	O
heterologous	O
desensitization	O
and	O
internalization	O
of	O
gene1s	ARG2
FPR1	ARG2
gene1e	ARG2
.	O
Furthermore	O
,	O
niacin	O
rescued	O
species1s	O
mice	O
species1e	O
from	O
septic	O
shock	O
by	O
diminishing	O
inflammatory	O
symptoms	O
and	O
the	O
effect	O
was	O
abrogated	O
in	O
gene1s	O
HCA2	O
gene1e	O
(-/-	O
)	O
species1s	O
mice	O
species1e	O
.	O
These	O
results	O
suggest	O
that	O
gene1s	O
Gbg	O
gene1e	O
/	O
gene1s	O
PKC	O
gene1e	O
-	O
dependent	O
gene1s	O
ERK1/2	O
gene1e	O
activation	O
and	O
heterologous	O
desensitization	O
of	O
chemoattractant	O
receptors	O
are	O
involved	O
in	O
the	O
inhibition	O
of	O
chemoattractant	O
-	O
induced	O
migration	O
of	O
macrophages	O
by	O
niacin	O
.	O
Thus	O
,	O
gene1s	O
HCA2	O
gene1e	O
plays	O
a	O
critical	O
role	O
in	O
host	O
protection	O
against	O
pro	O
-	O
inflammatory	O
insults	O
.	O

Activated	O
gene1s	ARG2
niacin	ARG2
receptor	ARG2
gene1e	ARG2
gene1s	ARG2
HCA2	ARG2
gene1e	ARG2
inhibits	O
chemoattractant	O
-	O
mediated	O
macrophage	O
migration	O
via	O
gene1s	ARG2
Gbg	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
PKC	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
ERK1/2	ARG2
gene1e	ARG2
pathway	O
and	O
heterologous	O
receptor	O
desensitization	O
.	O
The	O
gene1s	ARG2
niacin	ARG2
receptor	ARG2
gene1e	ARG2
gene1s	ARG2
HCA2	ARG2
gene1e	ARG2
is	O
implicated	O
in	O
controlling	O
inflammatory	O
host	O
responses	O
with	O
yet	O
poorly	O
understood	O
mechanistic	O
basis	O
.	O
We	O
previously	O
reported	O
that	O
gene1s	O
HCA2	O
gene1e	O
in	O
A431	O
epithelial	O
cells	O
transduced	O
gene1s	O
Gbg	O
gene1e	O
-	O
gene1s	O
protein	O
kinase	O
C	O
gene1e	O
-	O
and	O
gene1s	O
Gbg	O
gene1e	O
-	O
gene1s	O
metalloproteinase	O
gene1e	O
/	O
gene1s	O
EGFR	O
gene1e	O
-	O
dependent	O
gene1s	O
MAPK	O
gene1e	O
/	O
gene1s	O
ERK	O
gene1e	O
signaling	O
cascades	O
.	O
Here	O
,	O
we	O
investigated	O
the	O
role	O
of	O
gene1s	ARG2
HCA2	ARG2
gene1e	ARG2
in	O
macrophage	O
-	O
mediated	O
inflammation	O
and	O
the	O
underlying	O
mechanisms	O
.	O
We	O
found	O
that	O
proinflammatory	O
stimulants	O
LPS	O
,	O
gene1s	ARG2
IL-6	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
IL-1b	ARG2
gene1e	ARG2
up	O
-	O
regulated	O
the	O
expression	O
of	O
gene1s	ARG2
HCA2	ARG2
gene1e	ARG2
on	O
macrophages	O
.	O
Niacin	O
significantly	O
inhibited	O
macrophage	O
chemotaxis	O
in	O
response	O
to	O
chemoattractants	O
fMLF	O
and	O
gene1s	ARG2
CCL2	ARG2
gene1e	ARG2
by	O
disrupting	O
polarized	O
distribution	O
of	O
gene1s	ARG2
F	ARG2
-	ARG2
actin	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
Gb	ARG2
gene1e	ARG2
protein	O
.	O
Niacin	O
showed	O
a	O
selected	O
additive	O
effect	O
on	O
chemoattractant	O
-	O
induced	O
activation	O
of	O
gene1s	ARG2
ERK1/2	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
JNK	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
PI3	ARG2
K	ARG2
gene1e	ARG2
pathways	O
,	O
but	O
only	O
the	O
gene1s	ARG2
MEK	ARG2
gene1e	ARG2
inhibitor	O
UO126	O
reduced	O
niacin	O
-	O
mediated	O
inhibition	O
of	O
macrophage	O
chemotaxis	O
,	O
while	O
activation	O
of	O
gene1s	ARG2
ERK1/2	ARG2
gene1e	ARG2
by	O
EGF	O
alone	O
did	O
not	O
inhibit	O
fMLF	O
-	O
mediated	O
migration	O
of	O
species1s	O
HEK293	O
T	O
species1e	O
cells	O
co	O
-	O
expressing	O
gene1s	O
HCA2	O
gene1e	O
and	O
gene1s	O
fMLF	O
receptor	O
gene1e	O
gene1s	O
FPR1	O
gene1e	O
.	O
In	O
addition	O
,	O
niacin	O
induced	O
heterologous	O
desensitization	O
and	O
internalization	O
of	O
gene1s	O
FPR1	O
gene1e	O
.	O
Furthermore	O
,	O
niacin	O
rescued	O
arg1s	O
mice	O
arg1e	O
from	O
septic	O
shock	O
by	O
diminishing	O
inflammatory	O
symptoms	O
and	O
the	O
effect	O
was	O
abrogated	O
in	O
gene1s	ARG2
HCA2	ARG2
gene1e	ARG2
(-/-	O
)	O
arg1s	O
mice	O
arg1e	O
.	O
These	O
results	O
suggest	O
that	O
gene1s	ARG2
Gbg	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
PKC	ARG2
gene1e	ARG2
-	O
dependent	O
gene1s	ARG2
ERK1/2	ARG2
gene1e	ARG2
activation	O
and	O
heterologous	O
desensitization	O
of	O
chemoattractant	O
receptors	O
are	O
involved	O
in	O
the	O
inhibition	O
of	O
chemoattractant	O
-	O
induced	O
migration	O
of	O
macrophages	O
by	O
niacin	O
.	O
Thus	O
,	O
gene1s	ARG2
HCA2	ARG2
gene1e	ARG2
plays	O
a	O
critical	O
role	O
in	O
host	O
protection	O
against	O
pro	O
-	O
inflammatory	O
insults	O
.	O

gene1s	ARG2
Dclk1	ARG2
gene1e	ARG2
,	O
a	O
tumor	O
stem	O
cell	O
marker	O
,	O
regulates	O
pro	O
-	O
survival	O
signaling	O
and	O
self	O
-	O
renewal	O
of	O
intestinal	O
tumor	O
cells	O
.	O
BACKGROUND	O
:	O
More	O
than	O
80	O
%	O
of	O
intestinal	O
neoplasia	O
is	O
associated	O
with	O
the	O
gene1s	O
adenomatous	O
polyposis	O
coli	O
gene1e	O
(	O
gene1s	O
APC	O
gene1e	O
)	O
mutation	O
.	O
gene1s	ARG2
Doublecortin	ARG2
-	ARG2
like	ARG2
kinase	ARG2
1	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
Dclk1	ARG2
gene1e	ARG2
)	O
,	O
a	O
kinase	O
protein	O
,	O
is	O
overexpressed	O
in	O
colorectal	O
cancer	O
and	O
specifically	O
marks	O
tumor	O
stem	O
cells	O
(	O
TSCs	O
)	O
that	O
self	O
-	O
renew	O
and	O
increased	O
the	O
tumor	O
progeny	O
in	O
gene1s	ARG2
Apc	ARG2
gene1e	ARG2
(	O
Min/+	O
)	O
arg1s	O
mice	O
arg1e	O
.	O
However	O
,	O
the	O
role	O
of	O
gene1s	ARG2
Dclk1	ARG2
gene1e	ARG2
expression	O
and	O
its	O
contribution	O
to	O
regulating	O
pro	O
-	O
survival	O
signaling	O
for	O
tumor	O
progression	O
in	O
gene1s	ARG2
Apc	ARG2
gene1e	ARG2
mutant	O
cancer	O
is	O
poorly	O
understood	O
.	O
METHODS	O
:	O
We	O
analyzed	O
gene1s	O
DCLK1	O
gene1e	O
and	O
pro	O
-	O
survival	O
signaling	O
gene	O
expression	O
datasets	O
of	O
329	O
specimens	O
from	O
TCGA	O
Colon	O
Adenocarcinoma	O
Cancer	O
Data	O
.	O
The	O
network	O
of	O
gene1s	O
DCLK1	O
gene1e	O
and	O
pro	O
-	O
survival	O
signaling	O
was	O
analyzed	O
utilizing	O
the	O
GeneMANIA	O
database	O
.	O
We	O
examined	O
the	O
expression	O
levels	O
of	O
gene1s	ARG2
Dclk1	ARG2
gene1e	ARG2
and	O
other	O
stem	O
cell	O
-	O
associated	O
markers	O
,	O
pro	O
-	O
survival	O
signaling	O
pathways	O
,	O
cell	O
self	O
-	O
renewal	O
in	O
the	O
isolated	O
intestinal	O
epithelial	O
cells	O
of	O
gene1s	ARG2
Apc	ARG2
gene1e	ARG2
(	O
Min/+	O
)	O
arg1s	O
mice	O
arg1e	O
with	O
high	O
-	O
grade	O
dysplasia	O
and	O
adenocarcinoma	O
.	O
To	O
determine	O
the	O
functional	O
role	O
of	O
gene1s	ARG2
Dclk1	ARG2
gene1e	ARG2
for	O
tumor	O
progression	O
,	O
we	O
knocked	O
down	O
gene1s	ARG2
Dclk1	ARG2
gene1e	ARG2
and	O
determined	O
the	O
pro	O
-	O
survival	O
signaling	O
pathways	O
and	O
stemness	O
.	O
We	O
used	O
siRNA	O
technology	O
to	O
gene	O
silence	O
pro	O
-	O
survival	O
signaling	O
in	O
colon	O
cancer	O
cells	O
in	O
vitro	O
.	O
We	O
utilized	O
FACS	O
,	O
IHC	O
,	O
western	O
blot	O
,	O
RT	O
-	O
PCR	O
,	O
and	O
clonogenic	O
(	O
self	O
-	O
renewal	O
)	O
assays	O
.	O
RESULTS	O
:	O
We	O
found	O
a	O
correlation	O
between	O
gene1s	O
DCLK1	O
gene1e	O
and	O
pro	O
-	O
survival	O
signaling	O
expression	O
.	O
The	O
expression	O
of	O
gene1s	ARG2
Dclk1	ARG2
gene1e	ARG2
and	O
stem	O
cell	O
-	O
associated	O
markers	O
gene1s	ARG2
Lgr5	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Bmi1	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
Musashi1	ARG2
gene1e	ARG2
were	O
significantly	O
higher	O
in	O
the	O
intestinal	O
epithelial	O
cells	O
of	O
gene1s	ARG2
Apc	ARG2
gene1e	ARG2
(	O
Min/+	O
)	O
arg1s	O
mice	O
arg1e	O
than	O
in	O
wild	O
-	O
type	O
controls	O
.	O
Intestinal	O
epithelial	O
cells	O
of	O
gene1s	ARG2
Apc	ARG2
gene1e	ARG2
(	O
Min/+	O
)	O
arg1s	O
mice	O
arg1e	O
showed	O
increased	O
expression	O
of	O
pro	O
-	O
survival	O
signaling	O
,	O
pluripotency	O
and	O
self	O
-	O
renewal	O
ability	O
.	O
Furthermore	O
,	O
the	O
enteroids	O
formed	O
from	O
the	O
intestinal	O
gene1s	ARG2
Dclk1	ARG2
gene1e	ARG2
(+	O
)	O
cells	O
of	O
gene1s	ARG2
Apc	ARG2
gene1e	ARG2
(	O
Min/+	O
)	O
arg1s	O
mice	O
arg1e	O
display	O
higher	O
pluripotency	O
and	O
pro	O
-	O
survival	O
signaling	O
.	O
gene1s	ARG2
Dclk1	ARG2
gene1e	ARG2
knockdown	O
in	O
gene1s	ARG2
Apc	ARG2
gene1e	ARG2
(	O
Min/+	O
)	O
arg1s	O
mice	O
arg1e	O
attenuates	O
intestinal	O
adenomas	O
and	O
adenocarcinoma	O
,	O
and	O
decreases	O
pro	O
-	O
survival	O
signaling	O
and	O
self	O
-	O
renewal	O
.	O
Knocking	O
down	O
gene1s	O
RELA	O
gene1e	O
and	O
gene1s	O
NOTCH1	O
gene1e	O
pro	O
-	O
survival	O
signaling	O
and	O
gene1s	O
DCLK1	O
gene1e	O
in	O
species1s	O
HT29	O
species1e	O
and	O
species1s	O
DLD1	O
species1e	O
colon	O
cancer	O
cells	O
in	O
vitro	O
reduced	O
the	O
tumor	O
cells	O
'	O
ability	O
to	O
self	O
-	O
renew	O
and	O
survive	O
.	O
CONCLUSION	O
:	O
Our	O
results	O
indicate	O
that	O
gene1s	ARG2
Dclk1	ARG2
gene1e	ARG2
is	O
essential	O
in	O
advancing	O
intestinal	O
tumorigenesis	O
.	O
Knocking	O
down	O
gene1s	ARG2
Dclk1	ARG2
gene1e	ARG2
decreases	O
tumor	O
stemness	O
and	O
progression	O
and	O
is	O
thus	O
predicted	O
to	O
regulate	O
pro	O
-	O
survival	O
signaling	O
and	O
tumor	O
cell	O
pluripotency	O
.	O
This	O
study	O
provides	O
a	O
strong	O
rationale	O
to	O
target	O
gene1s	O
Dclk1	O
gene1e	O
as	O
a	O
treatment	O
strategy	O
for	O
colorectal	O
cancer	O
.	O

gene1s	ARG2
Dclk1	ARG2
gene1e	ARG2
,	O
a	O
tumor	O
stem	O
cell	O
marker	O
,	O
regulates	O
pro	O
-	O
survival	O
signaling	O
and	O
self	O
-	O
renewal	O
of	O
intestinal	O
tumor	O
cells	O
.	O
BACKGROUND	O
:	O
More	O
than	O
80	O
%	O
of	O
intestinal	O
neoplasia	O
is	O
associated	O
with	O
the	O
gene1s	ARG2
adenomatous	ARG2
polyposis	ARG2
coli	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
APC	ARG2
gene1e	ARG2
)	O
mutation	O
.	O
gene1s	ARG2
Doublecortin	ARG2
-	ARG2
like	ARG2
kinase	ARG2
1	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
Dclk1	ARG2
gene1e	ARG2
)	O
,	O
a	O
kinase	O
protein	O
,	O
is	O
overexpressed	O
in	O
colorectal	O
cancer	O
and	O
specifically	O
marks	O
tumor	O
stem	O
cells	O
(	O
TSCs	O
)	O
that	O
self	O
-	O
renew	O
and	O
increased	O
the	O
tumor	O
progeny	O
in	O
gene1s	O
Apc	O
gene1e	O
(	O
Min/+	O
)	O
species1s	O
mice	O
species1e	O
.	O
However	O
,	O
the	O
role	O
of	O
gene1s	O
Dclk1	O
gene1e	O
expression	O
and	O
its	O
contribution	O
to	O
regulating	O
pro	O
-	O
survival	O
signaling	O
for	O
tumor	O
progression	O
in	O
gene1s	O
Apc	O
gene1e	O
mutant	O
cancer	O
is	O
poorly	O
understood	O
.	O
METHODS	O
:	O
We	O
analyzed	O
gene1s	ARG2
DCLK1	ARG2
gene1e	ARG2
and	O
pro	O
-	O
survival	O
signaling	O
gene	O
expression	O
datasets	O
of	O
329	O
specimens	O
from	O
TCGA	O
Colon	O
Adenocarcinoma	O
Cancer	O
Data	O
.	O
The	O
network	O
of	O
gene1s	ARG2
DCLK1	ARG2
gene1e	ARG2
and	O
pro	O
-	O
survival	O
signaling	O
was	O
analyzed	O
utilizing	O
the	O
GeneMANIA	O
database	O
.	O
We	O
examined	O
the	O
expression	O
levels	O
of	O
gene1s	O
Dclk1	O
gene1e	O
and	O
other	O
stem	O
cell	O
-	O
associated	O
markers	O
,	O
pro	O
-	O
survival	O
signaling	O
pathways	O
,	O
cell	O
self	O
-	O
renewal	O
in	O
the	O
isolated	O
intestinal	O
epithelial	O
cells	O
of	O
gene1s	O
Apc	O
gene1e	O
(	O
Min/+	O
)	O
species1s	O
mice	O
species1e	O
with	O
high	O
-	O
grade	O
dysplasia	O
and	O
adenocarcinoma	O
.	O
To	O
determine	O
the	O
functional	O
role	O
of	O
gene1s	O
Dclk1	O
gene1e	O
for	O
tumor	O
progression	O
,	O
we	O
knocked	O
down	O
gene1s	O
Dclk1	O
gene1e	O
and	O
determined	O
the	O
pro	O
-	O
survival	O
signaling	O
pathways	O
and	O
stemness	O
.	O
We	O
used	O
siRNA	O
technology	O
to	O
gene	O
silence	O
pro	O
-	O
survival	O
signaling	O
in	O
colon	O
cancer	O
cells	O
in	O
vitro	O
.	O
We	O
utilized	O
FACS	O
,	O
IHC	O
,	O
western	O
blot	O
,	O
RT	O
-	O
PCR	O
,	O
and	O
clonogenic	O
(	O
self	O
-	O
renewal	O
)	O
assays	O
.	O
RESULTS	O
:	O
We	O
found	O
a	O
correlation	O
between	O
gene1s	ARG2
DCLK1	ARG2
gene1e	ARG2
and	O
pro	O
-	O
survival	O
signaling	O
expression	O
.	O
The	O
expression	O
of	O
gene1s	O
Dclk1	O
gene1e	O
and	O
stem	O
cell	O
-	O
associated	O
markers	O
gene1s	O
Lgr5	O
gene1e	O
,	O
gene1s	O
Bmi1	O
gene1e	O
,	O
and	O
gene1s	O
Musashi1	O
gene1e	O
were	O
significantly	O
higher	O
in	O
the	O
intestinal	O
epithelial	O
cells	O
of	O
gene1s	O
Apc	O
gene1e	O
(	O
Min/+	O
)	O
species1s	O
mice	O
species1e	O
than	O
in	O
wild	O
-	O
type	O
controls	O
.	O
Intestinal	O
epithelial	O
cells	O
of	O
gene1s	O
Apc	O
gene1e	O
(	O
Min/+	O
)	O
species1s	O
mice	O
species1e	O
showed	O
increased	O
expression	O
of	O
pro	O
-	O
survival	O
signaling	O
,	O
pluripotency	O
and	O
self	O
-	O
renewal	O
ability	O
.	O
Furthermore	O
,	O
the	O
enteroids	O
formed	O
from	O
the	O
intestinal	O
gene1s	O
Dclk1	O
gene1e	O
(+	O
)	O
cells	O
of	O
gene1s	O
Apc	O
gene1e	O
(	O
Min/+	O
)	O
species1s	O
mice	O
species1e	O
display	O
higher	O
pluripotency	O
and	O
pro	O
-	O
survival	O
signaling	O
.	O
gene1s	O
Dclk1	O
gene1e	O
knockdown	O
in	O
gene1s	O
Apc	O
gene1e	O
(	O
Min/+	O
)	O
species1s	O
mice	O
species1e	O
attenuates	O
intestinal	O
adenomas	O
and	O
adenocarcinoma	O
,	O
and	O
decreases	O
pro	O
-	O
survival	O
signaling	O
and	O
self	O
-	O
renewal	O
.	O
Knocking	O
down	O
gene1s	ARG2
RELA	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
NOTCH1	ARG2
gene1e	ARG2
pro	O
-	O
survival	O
signaling	O
and	O
gene1s	ARG2
DCLK1	ARG2
gene1e	ARG2
in	O
arg1s	O
HT29	O
arg1e	O
and	O
arg1s	O
DLD1	O
arg1e	O
colon	O
cancer	O
cells	O
in	O
vitro	O
reduced	O
the	O
tumor	O
cells	O
'	O
ability	O
to	O
self	O
-	O
renew	O
and	O
survive	O
.	O
CONCLUSION	O
:	O
Our	O
results	O
indicate	O
that	O
gene1s	ARG2
Dclk1	ARG2
gene1e	ARG2
is	O
essential	O
in	O
advancing	O
intestinal	O
tumorigenesis	O
.	O
Knocking	O
down	O
gene1s	ARG2
Dclk1	ARG2
gene1e	ARG2
decreases	O
tumor	O
stemness	O
and	O
progression	O
and	O
is	O
thus	O
predicted	O
to	O
regulate	O
pro	O
-	O
survival	O
signaling	O
and	O
tumor	O
cell	O
pluripotency	O
.	O
This	O
study	O
provides	O
a	O
strong	O
rationale	O
to	O
target	O
gene1s	ARG2
Dclk1	ARG2
gene1e	ARG2
as	O
a	O
treatment	O
strategy	O
for	O
colorectal	O
cancer	O
.	O

Search	O
for	O
regulatory	O
factors	O
of	O
the	O
pituitary	O
-	O
specific	O
transcription	O
factor	O
gene1s	O
PROP1	O
gene1e	O
gene	O
.	O
Pituitary	O
-	O
specific	O
transcription	O
factor	O
gene1s	ARG2
PROP1	ARG2
gene1e	ARG2
,	O
a	O
factor	O
important	O
for	O
pituitary	O
organogenesis	O
,	O
appears	O
on	O
arg1s	O
rat	O
arg1e	O
embryonic	O
day	O
11.5	O
(	O
E11.5	O
)	O
in	O
gene1s	ARG2
SOX2	ARG2
gene1e	ARG2
-expressing	O
stem	O
/	O
progenitor	O
cells	O
and	O
always	O
coexists	O
with	O
gene1s	ARG2
SOX2	ARG2
gene1e	ARG2
throughout	O
life	O
.	O
gene1s	ARG2
PROP1	ARG2
gene1e	ARG2
-positive	O
cells	O
at	O
one	O
point	O
occupy	O
all	O
cells	O
in	O
Rathke	O
's	O
pouch	O
,	O
followed	O
by	O
a	O
rapid	O
decrease	O
in	O
their	O
number	O
.	O
Their	O
regulatory	O
factors	O
,	O
except	O
for	O
gene1s	ARG2
RBP	ARG2
-	ARG2
J	ARG2
gene1e	ARG2
,	O
have	O
not	O
yet	O
been	O
clarified	O
.	O
This	O
study	O
aimed	O
to	O
use	O
the	O
3	O
kb	O
upstream	O
region	O
and	O
1st	O
intron	O
of	O
species1s	O
mouse	O
species1e	O
gene1s	O
prop1	O
gene1e	O
to	O
pinpoint	O
a	O
group	O
of	O
factors	O
selected	O
on	O
the	O
basis	O
of	O
expression	O
in	O
the	O
early	O
pituitary	O
gland	O
for	O
expression	O
of	O
gene1s	O
Prop1	O
gene1e	O
.	O
Reporter	O
assays	O
for	O
gene1s	ARG2
SOX2	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
RBP	ARG2
-	ARG2
J	ARG2
gene1e	ARG2
showed	O
that	O
the	O
stem	O
/	O
progenitor	O
marker	O
gene1s	ARG2
SOX2	ARG2
gene1e	ARG2
has	O
cell	O
type	O
-	O
dependent	O
inhibitory	O
and	O
activating	O
functions	O
through	O
the	O
proximal	O
and	O
distal	O
upstream	O
regions	O
of	O
gene1s	O
Prop1	O
gene1e	O
,	O
respectively	O
,	O
while	O
gene1s	O
RBP	O
-	O
J	O
gene1e	O
had	O
small	O
regulatory	O
activity	O
in	O
some	O
cell	O
lines	O
.	O
Reporter	O
assays	O
for	O
another	O
39	O
factors	O
using	O
the	O
3	O
kb	O
upstream	O
regions	O
in	O
species1s	O
CHO	O
species1e	O
cells	O
ultimately	O
revealed	O
that	O
8	O
factors	O
,	O
gene1s	O
MSX2	O
gene1e	O
,	O
gene1s	O
PAX6	O
gene1e	O
,	O
gene1s	O
PIT1	O
gene1e	O
,	O
gene1s	O
PITX1	O
gene1e	O
,	O
gene1s	O
PITX2	O
gene1e	O
,	O
gene1s	O
RPF1	O
gene1e	O
,	O
gene1s	O
SOX8	O
gene1e	O
and	O
gene1s	ARG2
SOX11	ARG2
gene1e	ARG2
,	O
but	O
not	O
gene1s	O
RBP	O
-	O
J	O
gene1e	O
,	O
regulate	O
gene1s	O
Prop1	O
gene1e	O
expression	O
.	O
Furthermore	O
,	O
a	O
synergy	O
effect	O
with	O
gene1s	ARG2
SOX2	ARG2
gene1e	ARG2
was	O
observed	O
for	O
an	O
additional	O
10	O
factors	O
,	O
gene1s	O
FOXJ1	O
gene1e	O
,	O
gene1s	O
HES1	O
gene1e	O
,	O
gene1s	O
HEY1	O
gene1e	O
,	O
gene1s	O
HEY2	O
gene1e	O
,	O
gene1s	O
KLF6	O
gene1e	O
,	O
gene1s	O
MSX1	O
gene1e	O
,	O
gene1s	O
RUNX1	O
gene1e	O
,	O
gene1s	O
TEAD2	O
gene1e	O
,	O
gene1s	O
YBX2	O
gene1e	O
and	O
gene1s	O
ZFP36Ll	O
gene1e	O
,	O
which	O
did	O
not	O
show	O
substantial	O
independent	O
action	O
.	O
Thus	O
,	O
we	O
demonstrated	O
19	O
candidates	O
,	O
including	O
gene1s	ARG2
SOX2	ARG2
gene1e	ARG2
,	O
to	O
be	O
regulatory	O
factors	O
of	O
gene1s	O
Prop1	O
gene1e	O
expression	O
.	O

Search	O
for	O
regulatory	O
factors	O
of	O
the	O
pituitary	O
-	O
specific	O
transcription	O
factor	O
gene1s	ARG2
PROP1	ARG2
gene1e	ARG2
gene	O
.	O
Pituitary	O
-	O
specific	O
transcription	O
factor	O
gene1s	O
PROP1	O
gene1e	O
,	O
a	O
factor	O
important	O
for	O
pituitary	O
organogenesis	O
,	O
appears	O
on	O
species1s	O
rat	O
species1e	O
embryonic	O
day	O
11.5	O
(	O
E11.5	O
)	O
in	O
gene1s	O
SOX2	O
gene1e	O
-expressing	O
stem	O
/	O
progenitor	O
cells	O
and	O
always	O
coexists	O
with	O
gene1s	O
SOX2	O
gene1e	O
throughout	O
life	O
.	O
gene1s	O
PROP1	O
gene1e	O
-positive	O
cells	O
at	O
one	O
point	O
occupy	O
all	O
cells	O
in	O
Rathke	O
's	O
pouch	O
,	O
followed	O
by	O
a	O
rapid	O
decrease	O
in	O
their	O
number	O
.	O
Their	O
regulatory	O
factors	O
,	O
except	O
for	O
gene1s	O
RBP	O
-	O
J	O
gene1e	O
,	O
have	O
not	O
yet	O
been	O
clarified	O
.	O
This	O
study	O
aimed	O
to	O
use	O
the	O
3	O
kb	O
upstream	O
region	O
and	O
1st	O
intron	O
of	O
arg1s	O
mouse	O
arg1e	O
gene1s	ARG2
prop1	ARG2
gene1e	ARG2
to	O
pinpoint	O
a	O
group	O
of	O
factors	O
selected	O
on	O
the	O
basis	O
of	O
expression	O
in	O
the	O
early	O
pituitary	O
gland	O
for	O
expression	O
of	O
gene1s	ARG2
Prop1	ARG2
gene1e	ARG2
.	O
Reporter	O
assays	O
for	O
gene1s	O
SOX2	O
gene1e	O
and	O
gene1s	O
RBP	O
-	O
J	O
gene1e	O
showed	O
that	O
the	O
stem	O
/	O
progenitor	O
marker	O
gene1s	O
SOX2	O
gene1e	O
has	O
cell	O
type	O
-	O
dependent	O
inhibitory	O
and	O
activating	O
functions	O
through	O
the	O
proximal	O
and	O
distal	O
upstream	O
regions	O
of	O
gene1s	ARG2
Prop1	ARG2
gene1e	ARG2
,	O
respectively	O
,	O
while	O
gene1s	ARG2
RBP	ARG2
-	ARG2
J	ARG2
gene1e	ARG2
had	O
small	O
regulatory	O
activity	O
in	O
some	O
cell	O
lines	O
.	O
Reporter	O
assays	O
for	O
another	O
39	O
factors	O
using	O
the	O
3	O
kb	O
upstream	O
regions	O
in	O
species1s	O
CHO	O
species1e	O
cells	O
ultimately	O
revealed	O
that	O
8	O
factors	O
,	O
gene1s	O
MSX2	O
gene1e	O
,	O
gene1s	O
PAX6	O
gene1e	O
,	O
gene1s	O
PIT1	O
gene1e	O
,	O
gene1s	O
PITX1	O
gene1e	O
,	O
gene1s	O
PITX2	O
gene1e	O
,	O
gene1s	O
RPF1	O
gene1e	O
,	O
gene1s	O
SOX8	O
gene1e	O
and	O
gene1s	O
SOX11	O
gene1e	O
,	O
but	O
not	O
gene1s	O
RBP	O
-	O
J	O
gene1e	O
,	O
regulate	O
gene1s	ARG2
Prop1	ARG2
gene1e	ARG2
expression	O
.	O
Furthermore	O
,	O
a	O
synergy	O
effect	O
with	O
gene1s	O
SOX2	O
gene1e	O
was	O
observed	O
for	O
an	O
additional	O
10	O
factors	O
,	O
gene1s	O
FOXJ1	O
gene1e	O
,	O
gene1s	O
HES1	O
gene1e	O
,	O
gene1s	O
HEY1	O
gene1e	O
,	O
gene1s	O
HEY2	O
gene1e	O
,	O
gene1s	O
KLF6	O
gene1e	O
,	O
gene1s	O
MSX1	O
gene1e	O
,	O
gene1s	O
RUNX1	O
gene1e	O
,	O
gene1s	O
TEAD2	O
gene1e	O
,	O
gene1s	O
YBX2	O
gene1e	O
and	O
gene1s	ARG2
ZFP36Ll	ARG2
gene1e	ARG2
,	O
which	O
did	O
not	O
show	O
substantial	O
independent	O
action	O
.	O
Thus	O
,	O
we	O
demonstrated	O
19	O
candidates	O
,	O
including	O
gene1s	O
SOX2	O
gene1e	O
,	O
to	O
be	O
regulatory	O
factors	O
of	O
gene1s	ARG2
Prop1	ARG2
gene1e	ARG2
expression	O
.	O

Search	O
for	O
regulatory	O
factors	O
of	O
the	O
pituitary	O
-	O
specific	O
transcription	O
factor	O
gene1s	O
PROP1	O
gene1e	O
gene	O
.	O
Pituitary	O
-	O
specific	O
transcription	O
factor	O
gene1s	O
PROP1	O
gene1e	O
,	O
a	O
factor	O
important	O
for	O
pituitary	O
organogenesis	O
,	O
appears	O
on	O
species1s	O
rat	O
species1e	O
embryonic	O
day	O
11.5	O
(	O
E11.5	O
)	O
in	O
gene1s	O
SOX2	O
gene1e	O
-expressing	O
stem	O
/	O
progenitor	O
cells	O
and	O
always	O
coexists	O
with	O
gene1s	O
SOX2	O
gene1e	O
throughout	O
life	O
.	O
gene1s	O
PROP1	O
gene1e	O
-positive	O
cells	O
at	O
one	O
point	O
occupy	O
all	O
cells	O
in	O
Rathke	O
's	O
pouch	O
,	O
followed	O
by	O
a	O
rapid	O
decrease	O
in	O
their	O
number	O
.	O
Their	O
regulatory	O
factors	O
,	O
except	O
for	O
gene1s	O
RBP	O
-	O
J	O
gene1e	O
,	O
have	O
not	O
yet	O
been	O
clarified	O
.	O
This	O
study	O
aimed	O
to	O
use	O
the	O
3	O
kb	O
upstream	O
region	O
and	O
1st	O
intron	O
of	O
species1s	O
mouse	O
species1e	O
gene1s	O
prop1	O
gene1e	O
to	O
pinpoint	O
a	O
group	O
of	O
factors	O
selected	O
on	O
the	O
basis	O
of	O
expression	O
in	O
the	O
early	O
pituitary	O
gland	O
for	O
expression	O
of	O
gene1s	O
Prop1	O
gene1e	O
.	O
Reporter	O
assays	O
for	O
gene1s	O
SOX2	O
gene1e	O
and	O
gene1s	O
RBP	O
-	O
J	O
gene1e	O
showed	O
that	O
the	O
stem	O
/	O
progenitor	O
marker	O
gene1s	O
SOX2	O
gene1e	O
has	O
cell	O
type	O
-	O
dependent	O
inhibitory	O
and	O
activating	O
functions	O
through	O
the	O
proximal	O
and	O
distal	O
upstream	O
regions	O
of	O
gene1s	O
Prop1	O
gene1e	O
,	O
respectively	O
,	O
while	O
gene1s	O
RBP	O
-	O
J	O
gene1e	O
had	O
small	O
regulatory	O
activity	O
in	O
some	O
cell	O
lines	O
.	O
Reporter	O
assays	O
for	O
another	O
39	O
factors	O
using	O
the	O
3	O
kb	O
upstream	O
regions	O
in	O
arg1s	O
CHO	O
arg1e	O
cells	O
ultimately	O
revealed	O
that	O
8	O
factors	O
,	O
gene1s	ARG2
MSX2	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
PAX6	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
PIT1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
PITX1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
PITX2	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
RPF1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
SOX8	ARG2
gene1e	ARG2
and	O
gene1s	O
SOX11	O
gene1e	O
,	O
but	O
not	O
gene1s	ARG2
RBP	ARG2
-	ARG2
J	ARG2
gene1e	ARG2
,	O
regulate	O
gene1s	O
Prop1	O
gene1e	O
expression	O
.	O
Furthermore	O
,	O
a	O
synergy	O
effect	O
with	O
gene1s	O
SOX2	O
gene1e	O
was	O
observed	O
for	O
an	O
additional	O
10	O
factors	O
,	O
gene1s	ARG2
FOXJ1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
HES1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
HEY1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
HEY2	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
KLF6	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
MSX1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
RUNX1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
TEAD2	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
YBX2	ARG2
gene1e	ARG2
and	O
gene1s	O
ZFP36Ll	O
gene1e	O
,	O
which	O
did	O
not	O
show	O
substantial	O
independent	O
action	O
.	O
Thus	O
,	O
we	O
demonstrated	O
19	O
candidates	O
,	O
including	O
gene1s	O
SOX2	O
gene1e	O
,	O
to	O
be	O
regulatory	O
factors	O
of	O
gene1s	O
Prop1	O
gene1e	O
expression	O
.	O

Neuroprotective	O
effect	O
of	O
neuroserpin	O
in	O
oxygen	O
-	O
glucose	O
deprivation-	O
and	O
reoxygenation	O
-	O
treated	O
arg1s	O
rat	O
arg1e	O
astrocytes	O
in	O
vitro	O
.	O
Neuroserpin	O
(	O
NSP	O
)	O
reportedly	O
exerts	O
neuroprotective	O
effects	O
in	O
cerebral	O
ischemic	O
animal	O
models	O
and	O
species1s	O
patients	O
species1e	O
;	O
however	O
,	O
the	O
mechanism	O
of	O
protection	O
is	O
poorly	O
understood	O
.	O
We	O
thus	O
attempted	O
to	O
confirm	O
neuroprotective	O
effects	O
of	O
NSP	O
on	O
astrocytes	O
in	O
the	O
ischemic	O
state	O
and	O
then	O
explored	O
the	O
relative	O
mechanisms	O
.	O
Astrocytes	O
from	O
neonatal	O
arg1s	O
rats	O
arg1e	O
were	O
treated	O
with	O
oxygen	O
-	O
glucose	O
deprivation	O
(	O
OGD	O
)	O
followed	O
by	O
reoxygenation	O
(	O
OGD	O
/	O
R	O
)	O
.	O
To	O
confirm	O
the	O
neuroprotective	O
effects	O
of	O
NSP	O
,	O
we	O
measured	O
the	O
cell	O
survival	O
rate	O
,	O
relative	O
gene1s	ARG2
lactate	ARG2
dehydrogenase	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
LDH	ARG2
gene1e	ARG2
)	O
release	O
;	O
we	O
also	O
performed	O
morphological	O
methods	O
,	O
namely	O
Hoechst	O
33342	O
staining	O
and	O
gene1s	ARG2
Annexin	ARG2
V	ARG2
gene1e	ARG2
assay	O
.	O
To	O
explore	O
the	O
potential	O
mechanisms	O
of	O
NSP	O
,	O
the	O
release	O
of	O
nitric	O
oxide	O
(	O
NO	O
)	O
and	O
gene1s	ARG2
TNF	ARG2
-	ARG2
alpha	ARG2
gene1e	ARG2
related	O
to	O
NSP	O
administration	O
were	O
measured	O
by	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
.	O
The	O
proteins	O
related	O
to	O
the	O
gene1s	ARG2
NF	ARG2
-	ARG2
kappaB	ARG2
gene1e	ARG2
,	O
gene1s	O
ERK1/2	O
gene1e	O
,	O
and	O
gene1s	ARG2
PI3K	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
Akt	ARG2
gene1e	ARG2
pathways	O
were	O
investigated	O
by	O
Western	O
blotting	O
.	O
To	O
verify	O
the	O
cause	O
-	O
and	O
-	O
effect	O
relationship	O
between	O
neuroprotection	O
and	O
the	O
gene1s	ARG2
NF	ARG2
-	ARG2
kappaB	ARG2
gene1e	ARG2
pathway	O
,	O
a	O
gene1s	ARG2
NF	ARG2
-	ARG2
kappaB	ARG2
gene1e	ARG2
pathway	O
inhibitor	O
sc3060	O
was	O
employed	O
to	O
observe	O
the	O
effects	O
of	O
NSP	O
-	O
induced	O
neuroprotection	O
.	O
We	O
found	O
that	O
NSP	O
significantly	O
increased	O
the	O
cell	O
survival	O
rate	O
and	O
reduced	O
gene1s	ARG2
LDH	ARG2
gene1e	ARG2
release	O
in	O
OGD	O
/	O
R	O
-	O
treated	O
astrocytes	O
.	O
It	O
also	O
reduced	O
NO	O
/	O
gene1s	ARG2
TNF	ARG2
-	ARG2
alpha	ARG2
gene1e	ARG2
release	O
.	O
Western	O
blotting	O
showed	O
that	O
the	O
protein	O
levels	O
of	O
p	O
-	O
gene1s	ARG2
IKKBalpha	ARG2
/	ARG2
beta	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
P65	ARG2
gene1e	ARG2
were	O
upregulated	O
by	O
the	O
OGD	O
/	O
R	O
treatment	O
and	O
such	O
effects	O
were	O
significantly	O
inhibited	O
by	O
NSP	O
administration	O
.	O
The	O
NSP	O
-	O
induced	O
inhibition	O
could	O
be	O
significantly	O
reversed	O
by	O
administration	O
of	O
the	O
gene1s	ARG2
NF	ARG2
-	ARG2
kappaB	ARG2
gene1e	ARG2
pathway	O
inhibitor	O
sc3060	O
,	O
whereas	O
,	O
expressions	O
of	O
p	O
-	O
gene1s	ARG2
ERK1	ARG2
gene1e	ARG2
,	O
p	O
-	O
gene1s	ARG2
ERK2	ARG2
gene1e	ARG2
,	O
and	O
p	O
-	O
gene1s	ARG2
AKT	ARG2
gene1e	ARG2
were	O
upregulated	O
by	O
the	O
OGD	O
/	O
R	O
treatment	O
;	O
however	O
,	O
their	O
levels	O
were	O
unchanged	O
by	O
NSP	O
administration	O
.	O
Our	O
results	O
thus	O
verified	O
the	O
neuroprotective	O
effects	O
of	O
NSP	O
in	O
ischemic	O
astrocytes	O
.	O
The	O
potential	O
mechanisms	O
include	O
inhibition	O
of	O
the	O
release	O
of	O
NO	O
/	O
gene1s	ARG2
TNF	ARG2
-	ARG2
alpha	ARG2
gene1e	ARG2
and	O
repression	O
of	O
the	O
gene1s	ARG2
NF	ARG2
-	ARG2
kappaB	ARG2
gene1e	ARG2
signaling	O
pathways	O
.	O
Our	O
data	O
also	O
indicated	O
that	O
NSP	O
has	O
little	O
influence	O
on	O
the	O
gene1s	ARG2
MAPK	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
PI3K	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
Akt	ARG2
gene1e	ARG2
pathways	O
.	O

Neuroprotective	O
effect	O
of	O
neuroserpin	O
in	O
oxygen	O
-	O
glucose	O
deprivation-	O
and	O
reoxygenation	O
-	O
treated	O
species1s	O
rat	O
species1e	O
astrocytes	O
in	O
vitro	O
.	O
Neuroserpin	O
(	O
NSP	O
)	O
reportedly	O
exerts	O
neuroprotective	O
effects	O
in	O
cerebral	O
ischemic	O
animal	O
models	O
and	O
arg1s	O
patients	O
arg1e	O
;	O
however	O
,	O
the	O
mechanism	O
of	O
protection	O
is	O
poorly	O
understood	O
.	O
We	O
thus	O
attempted	O
to	O
confirm	O
neuroprotective	O
effects	O
of	O
NSP	O
on	O
astrocytes	O
in	O
the	O
ischemic	O
state	O
and	O
then	O
explored	O
the	O
relative	O
mechanisms	O
.	O
Astrocytes	O
from	O
neonatal	O
species1s	O
rats	O
species1e	O
were	O
treated	O
with	O
oxygen	O
-	O
glucose	O
deprivation	O
(	O
OGD	O
)	O
followed	O
by	O
reoxygenation	O
(	O
OGD	O
/	O
R	O
)	O
.	O
To	O
confirm	O
the	O
neuroprotective	O
effects	O
of	O
NSP	O
,	O
we	O
measured	O
the	O
cell	O
survival	O
rate	O
,	O
relative	O
gene1s	O
lactate	O
dehydrogenase	O
gene1e	O
(	O
gene1s	O
LDH	O
gene1e	O
)	O
release	O
;	O
we	O
also	O
performed	O
morphological	O
methods	O
,	O
namely	O
Hoechst	O
33342	O
staining	O
and	O
gene1s	O
Annexin	O
V	O
gene1e	O
assay	O
.	O
To	O
explore	O
the	O
potential	O
mechanisms	O
of	O
NSP	O
,	O
the	O
release	O
of	O
nitric	O
oxide	O
(	O
NO	O
)	O
and	O
gene1s	O
TNF	O
-	O
alpha	O
gene1e	O
related	O
to	O
NSP	O
administration	O
were	O
measured	O
by	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
.	O
The	O
proteins	O
related	O
to	O
the	O
gene1s	O
NF	O
-	O
kappaB	O
gene1e	O
,	O
gene1s	ARG2
ERK1/2	ARG2
gene1e	ARG2
,	O
and	O
gene1s	O
PI3K	O
gene1e	O
/	O
gene1s	O
Akt	O
gene1e	O
pathways	O
were	O
investigated	O
by	O
Western	O
blotting	O
.	O
To	O
verify	O
the	O
cause	O
-	O
and	O
-	O
effect	O
relationship	O
between	O
neuroprotection	O
and	O
the	O
gene1s	O
NF	O
-	O
kappaB	O
gene1e	O
pathway	O
,	O
a	O
gene1s	O
NF	O
-	O
kappaB	O
gene1e	O
pathway	O
inhibitor	O
sc3060	O
was	O
employed	O
to	O
observe	O
the	O
effects	O
of	O
NSP	O
-	O
induced	O
neuroprotection	O
.	O
We	O
found	O
that	O
NSP	O
significantly	O
increased	O
the	O
cell	O
survival	O
rate	O
and	O
reduced	O
gene1s	O
LDH	O
gene1e	O
release	O
in	O
OGD	O
/	O
R	O
-	O
treated	O
astrocytes	O
.	O
It	O
also	O
reduced	O
NO	O
/	O
gene1s	O
TNF	O
-	O
alpha	O
gene1e	O
release	O
.	O
Western	O
blotting	O
showed	O
that	O
the	O
protein	O
levels	O
of	O
p	O
-	O
gene1s	O
IKKBalpha	O
/	O
beta	O
gene1e	O
and	O
gene1s	O
P65	O
gene1e	O
were	O
upregulated	O
by	O
the	O
OGD	O
/	O
R	O
treatment	O
and	O
such	O
effects	O
were	O
significantly	O
inhibited	O
by	O
NSP	O
administration	O
.	O
The	O
NSP	O
-	O
induced	O
inhibition	O
could	O
be	O
significantly	O
reversed	O
by	O
administration	O
of	O
the	O
gene1s	O
NF	O
-	O
kappaB	O
gene1e	O
pathway	O
inhibitor	O
sc3060	O
,	O
whereas	O
,	O
expressions	O
of	O
p	O
-	O
gene1s	O
ERK1	O
gene1e	O
,	O
p	O
-	O
gene1s	O
ERK2	O
gene1e	O
,	O
and	O
p	O
-	O
gene1s	O
AKT	O
gene1e	O
were	O
upregulated	O
by	O
the	O
OGD	O
/	O
R	O
treatment	O
;	O
however	O
,	O
their	O
levels	O
were	O
unchanged	O
by	O
NSP	O
administration	O
.	O
Our	O
results	O
thus	O
verified	O
the	O
neuroprotective	O
effects	O
of	O
NSP	O
in	O
ischemic	O
astrocytes	O
.	O
The	O
potential	O
mechanisms	O
include	O
inhibition	O
of	O
the	O
release	O
of	O
NO	O
/	O
gene1s	O
TNF	O
-	O
alpha	O
gene1e	O
and	O
repression	O
of	O
the	O
gene1s	O
NF	O
-	O
kappaB	O
gene1e	O
signaling	O
pathways	O
.	O
Our	O
data	O
also	O
indicated	O
that	O
NSP	O
has	O
little	O
influence	O
on	O
the	O
gene1s	O
MAPK	O
gene1e	O
and	O
gene1s	O
PI3K	O
gene1e	O
/	O
gene1s	O
Akt	O
gene1e	O
pathways	O
.	O

Transcriptional	O
profiling	O
in	O
arg1s	O
C.	O
elegans	O
arg1e	O
suggests	O
DNA	O
damage	O
dependent	O
apoptosis	O
as	O
an	O
ancient	O
function	O
of	O
the	O
gene1s	ARG2
p53	ARG2
gene1e	ARG2
family	O
.	O
BACKGROUND	O
:	O
In	O
contrast	O
to	O
the	O
three	O
species1s	O
mammalian	O
species1e	O
gene1s	O
p53	O
family	O
gene1e	O
members	O
,	O
gene1s	O
p53	O
gene1e	O
,	O
which	O
is	O
generally	O
involved	O
in	O
DNA	O
damage	O
responses	O
,	O
and	O
gene1s	O
p63	O
gene1e	O
and	O
gene1s	O
p73	O
gene1e	O
which	O
are	O
primarily	O
needed	O
for	O
developmental	O
regulation	O
,	O
gene1s	ARG2
cep-1	ARG2
gene1e	ARG2
encodes	O
for	O
the	O
single	O
arg1s	O
C.	O
elegans	O
arg1e	O
gene1s	ARG2
p53	ARG2
gene1e	ARG2
-like	O
gene	O
.	O
gene1s	ARG2
cep-1	ARG2
gene1e	ARG2
acts	O
as	O
a	O
transcription	O
activator	O
in	O
a	O
primordial	O
gene1s	O
p53	O
gene1e	O
pathway	O
that	O
involves	O
gene1s	ARG2
CEP-1	ARG2
gene1e	ARG2
activation	O
and	O
the	O
gene1s	ARG2
CEP-1	ARG2
gene1e	ARG2
dependent	O
transcriptional	O
induction	O
of	O
the	O
worm	O
BH3	O
only	O
domain	O
encoding	O
genes	O
gene1s	ARG2
egl-1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
ced-13	ARG2
gene1e	ARG2
to	O
induce	O
germ	O
cell	O
apoptosis	O
.	O
gene1s	ARG2
EGL-1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
CED-13	ARG2
gene1e	ARG2
proteins	O
inactivate	O
Bcl-2	O
like	O
gene1s	ARG2
CED-9	ARG2
gene1e	ARG2
to	O
trigger	O
gene1s	ARG2
CED-4	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
CED-3	ARG2
caspase	ARG2
gene1e	ARG2
dependent	O
germ	O
cell	O
apoptosis	O
.	O
To	O
address	O
the	O
function	O
of	O
gene1s	O
p53	O
gene1e	O
in	O
global	O
transcriptional	O
regulation	O
we	O
investigate	O
genome	O
-	O
wide	O
transcriptional	O
responses	O
upon	O
DNA	O
damage	O
and	O
gene1s	ARG2
cep-1	ARG2
gene1e	ARG2
deficiency	O
.	O
RESULTS	O
:	O
Examining	O
arg1s	O
C.	O
elegans	O
arg1e	O
expression	O
profiles	O
using	O
whole	O
genome	O
Affymetrix	O
GeneChip	O
arrays	O
,	O
we	O
found	O
that	O
83	O
genes	O
were	O
induced	O
more	O
than	O
two	O
fold	O
upon	O
ionizing	O
radiation	O
(	O
IR	O
)	O
.	O
None	O
of	O
these	O
genes	O
,	O
with	O
exception	O
of	O
an	O
ATP	O
ribosylase	O
homolog	O
,	O
encode	O
for	O
known	O
DNA	O
repair	O
genes	O
.	O
Using	O
two	O
independent	O
gene1s	ARG2
cep-1	ARG2
gene1e	ARG2
loss	O
of	O
function	O
alleles	O
we	O
did	O
not	O
find	O
genes	O
regulated	O
by	O
gene1s	ARG2
cep-1	ARG2
gene1e	ARG2
in	O
the	O
absence	O
of	O
IR	O
.	O
Among	O
the	O
IR	O
-	O
induced	O
genes	O
only	O
three	O
are	O
dependent	O
on	O
gene1s	ARG2
cep-1	ARG2
gene1e	ARG2
,	O
namely	O
gene1s	ARG2
egl-1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
ced-13	ARG2
gene1e	ARG2
and	O
a	O
novel	O
arg1s	O
C.	O
elegans	O
arg1e	O
specific	O
gene	O
.	O
The	O
majority	O
of	O
IR	O
-	O
induced	O
genes	O
appear	O
to	O
be	O
involved	O
in	O
general	O
stress	O
responses	O
,	O
and	O
qRT	O
-	O
PCR	O
experiments	O
indicate	O
that	O
they	O
are	O
mainly	O
expressed	O
in	O
somatic	O
tissues	O
.	O
Interestingly	O
,	O
we	O
reveal	O
an	O
extensive	O
overlap	O
of	O
gene	O
expression	O
changes	O
occurring	O
in	O
response	O
to	O
DNA	O
damage	O
and	O
in	O
response	O
to	O
bacterial	O
infection	O
.	O
Furthermore	O
,	O
many	O
genes	O
induced	O
by	O
IR	O
are	O
also	O
transcriptionally	O
regulated	O
in	O
longevity	O
mutants	O
suggesting	O
that	O
DNA	O
damage	O
and	O
aging	O
induce	O
an	O
overlapping	O
stress	O
response	O
.	O
CONCLUSION	O
:	O
We	O
performed	O
genome	O
-	O
wide	O
gene	O
expression	O
analyses	O
which	O
indicate	O
that	O
only	O
a	O
surprisingly	O
small	O
number	O
of	O
genes	O
are	O
regulated	O
by	O
gene1s	ARG2
CEP-1	ARG2
gene1e	ARG2
and	O
that	O
DNA	O
damage	O
induced	O
apoptosis	O
via	O
the	O
transcriptional	O
induction	O
of	O
BH3	O
domain	O
proteins	O
is	O
likely	O
to	O
be	O
an	O
ancient	O
DNA	O
damage	O
response	O
function	O
of	O
the	O
gene1s	ARG2
p53	ARG2
gene1e	ARG2
family	O
.	O
Interestingly	O
,	O
although	O
the	O
apoptotic	O
response	O
to	O
DNA	O
damage	O
is	O
regulated	O
through	O
the	O
transcriptional	O
activity	O
of	O
gene1s	ARG2
CEP-1	ARG2
gene1e	ARG2
,	O
other	O
DNA	O
damage	O
responses	O
do	O
not	O
appear	O
to	O
be	O
regulated	O
on	O
the	O
transcriptional	O
level	O
and	O
do	O
not	O
require	O
the	O
gene1s	ARG2
p53	ARG2
gene1e	ARG2
like	O
gene	O
gene1s	ARG2
cep-1	ARG2
gene1e	ARG2
.	O

Transcriptional	O
profiling	O
in	O
species1s	O
C.	O
elegans	O
species1e	O
suggests	O
DNA	O
damage	O
dependent	O
apoptosis	O
as	O
an	O
ancient	O
function	O
of	O
the	O
gene1s	O
p53	O
gene1e	O
family	O
.	O
BACKGROUND	O
:	O
In	O
contrast	O
to	O
the	O
three	O
arg1s	O
mammalian	O
arg1e	O
gene1s	ARG2
p53	ARG2
family	ARG2
gene1e	ARG2
members	O
,	O
gene1s	ARG2
p53	ARG2
gene1e	ARG2
,	O
which	O
is	O
generally	O
involved	O
in	O
DNA	O
damage	O
responses	O
,	O
and	O
gene1s	ARG2
p63	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
p73	ARG2
gene1e	ARG2
which	O
are	O
primarily	O
needed	O
for	O
developmental	O
regulation	O
,	O
gene1s	O
cep-1	O
gene1e	O
encodes	O
for	O
the	O
single	O
species1s	O
C.	O
elegans	O
species1e	O
gene1s	O
p53	O
gene1e	O
-like	O
gene	O
.	O
gene1s	O
cep-1	O
gene1e	O
acts	O
as	O
a	O
transcription	O
activator	O
in	O
a	O
primordial	O
gene1s	ARG2
p53	ARG2
gene1e	ARG2
pathway	O
that	O
involves	O
gene1s	O
CEP-1	O
gene1e	O
activation	O
and	O
the	O
gene1s	O
CEP-1	O
gene1e	O
dependent	O
transcriptional	O
induction	O
of	O
the	O
worm	O
BH3	O
only	O
domain	O
encoding	O
genes	O
gene1s	O
egl-1	O
gene1e	O
and	O
gene1s	O
ced-13	O
gene1e	O
to	O
induce	O
germ	O
cell	O
apoptosis	O
.	O
gene1s	O
EGL-1	O
gene1e	O
and	O
gene1s	O
CED-13	O
gene1e	O
proteins	O
inactivate	O
Bcl-2	O
like	O
gene1s	O
CED-9	O
gene1e	O
to	O
trigger	O
gene1s	O
CED-4	O
gene1e	O
and	O
gene1s	O
CED-3	O
caspase	O
gene1e	O
dependent	O
germ	O
cell	O
apoptosis	O
.	O
To	O
address	O
the	O
function	O
of	O
gene1s	ARG2
p53	ARG2
gene1e	ARG2
in	O
global	O
transcriptional	O
regulation	O
we	O
investigate	O
genome	O
-	O
wide	O
transcriptional	O
responses	O
upon	O
DNA	O
damage	O
and	O
gene1s	O
cep-1	O
gene1e	O
deficiency	O
.	O
RESULTS	O
:	O
Examining	O
species1s	O
C.	O
elegans	O
species1e	O
expression	O
profiles	O
using	O
whole	O
genome	O
Affymetrix	O
GeneChip	O
arrays	O
,	O
we	O
found	O
that	O
83	O
genes	O
were	O
induced	O
more	O
than	O
two	O
fold	O
upon	O
ionizing	O
radiation	O
(	O
IR	O
)	O
.	O
None	O
of	O
these	O
genes	O
,	O
with	O
exception	O
of	O
an	O
ATP	O
ribosylase	O
homolog	O
,	O
encode	O
for	O
known	O
DNA	O
repair	O
genes	O
.	O
Using	O
two	O
independent	O
gene1s	O
cep-1	O
gene1e	O
loss	O
of	O
function	O
alleles	O
we	O
did	O
not	O
find	O
genes	O
regulated	O
by	O
gene1s	O
cep-1	O
gene1e	O
in	O
the	O
absence	O
of	O
IR	O
.	O
Among	O
the	O
IR	O
-	O
induced	O
genes	O
only	O
three	O
are	O
dependent	O
on	O
gene1s	O
cep-1	O
gene1e	O
,	O
namely	O
gene1s	O
egl-1	O
gene1e	O
,	O
gene1s	O
ced-13	O
gene1e	O
and	O
a	O
novel	O
species1s	O
C.	O
elegans	O
species1e	O
specific	O
gene	O
.	O
The	O
majority	O
of	O
IR	O
-	O
induced	O
genes	O
appear	O
to	O
be	O
involved	O
in	O
general	O
stress	O
responses	O
,	O
and	O
qRT	O
-	O
PCR	O
experiments	O
indicate	O
that	O
they	O
are	O
mainly	O
expressed	O
in	O
somatic	O
tissues	O
.	O
Interestingly	O
,	O
we	O
reveal	O
an	O
extensive	O
overlap	O
of	O
gene	O
expression	O
changes	O
occurring	O
in	O
response	O
to	O
DNA	O
damage	O
and	O
in	O
response	O
to	O
bacterial	O
infection	O
.	O
Furthermore	O
,	O
many	O
genes	O
induced	O
by	O
IR	O
are	O
also	O
transcriptionally	O
regulated	O
in	O
longevity	O
mutants	O
suggesting	O
that	O
DNA	O
damage	O
and	O
aging	O
induce	O
an	O
overlapping	O
stress	O
response	O
.	O
CONCLUSION	O
:	O
We	O
performed	O
genome	O
-	O
wide	O
gene	O
expression	O
analyses	O
which	O
indicate	O
that	O
only	O
a	O
surprisingly	O
small	O
number	O
of	O
genes	O
are	O
regulated	O
by	O
gene1s	O
CEP-1	O
gene1e	O
and	O
that	O
DNA	O
damage	O
induced	O
apoptosis	O
via	O
the	O
transcriptional	O
induction	O
of	O
BH3	O
domain	O
proteins	O
is	O
likely	O
to	O
be	O
an	O
ancient	O
DNA	O
damage	O
response	O
function	O
of	O
the	O
gene1s	O
p53	O
gene1e	O
family	O
.	O
Interestingly	O
,	O
although	O
the	O
apoptotic	O
response	O
to	O
DNA	O
damage	O
is	O
regulated	O
through	O
the	O
transcriptional	O
activity	O
of	O
gene1s	O
CEP-1	O
gene1e	O
,	O
other	O
DNA	O
damage	O
responses	O
do	O
not	O
appear	O
to	O
be	O
regulated	O
on	O
the	O
transcriptional	O
level	O
and	O
do	O
not	O
require	O
the	O
gene1s	O
p53	O
gene1e	O
like	O
gene	O
gene1s	O
cep-1	O
gene1e	O
.	O

Lipopolysaccharide	O
potentiates	O
platelet	O
responses	O
via	O
gene1s	O
toll	O
-	O
like	O
receptor	O
4	O
gene1e	O
-stimulated	O
gene1s	O
Akt	O
gene1e	O
-	O
gene1s	O
Erk	O
gene1e	O
-	O
gene1s	O
PLA2	O
gene1e	O
signalling	O
.	O
Lipopolysaccharide	O
(	O
LPS	O
)	O
from	O
the	O
cell	O
envelope	O
of	O
Gram	O
-	O
negative	O
bacteria	O
is	O
a	O
principal	O
cause	O
of	O
the	O
symptoms	O
of	O
sepsis	O
.	O
LPS	O
has	O
been	O
reported	O
to	O
modulate	O
the	O
function	O
of	O
platelets	O
although	O
the	O
underlying	O
mechanisms	O
of	O
LPS	O
action	O
in	O
these	O
cells	O
remain	O
unclear	O
.	O
Platelets	O
express	O
the	O
gene1s	O
Toll	O
-	O
like	O
receptor	O
4	O
gene1e	O
(	O
gene1s	O
TLR4	O
gene1e	O
)	O
which	O
serves	O
as	O
a	O
receptor	O
for	O
LPS	O
,	O
although	O
the	O
potential	O
role	O
of	O
gene1s	O
TLR4	O
gene1e	O
and	O
associated	O
cell	O
signalling	O
in	O
controlling	O
platelet	O
responses	O
to	O
LPS	O
has	O
not	O
been	O
extensively	O
explored	O
.	O
In	O
this	O
study	O
,	O
we	O
therefore	O
investigated	O
the	O
actions	O
of	O
LPS	O
prepared	O
from	O
different	O
strains	O
of	O
arg1s	O
Escherichia	O
coli	O
arg1e	O
on	O
platelet	O
function	O
,	O
the	O
underlying	O
signalling	O
mechanisms	O
,	O
and	O
the	O
potential	O
role	O
of	O
gene1s	O
TLR4	O
gene1e	O
in	O
orchestrating	O
these	O
.	O
We	O
report	O
that	O
LPS	O
increased	O
the	O
aggregation	O
of	O
washed	O
platelets	O
stimulated	O
by	O
thromboxane	O
(	O
U46619	O
)	O
or	O
gene1s	O
GPVI	O
collagen	O
receptor	O
gene1e	O
agonists	O
,	O
effects	O
that	O
were	O
prevented	O
by	O
a	O
gene1s	O
TLR4	O
gene1e	O
antagonist	O
.	O
Associated	O
with	O
this	O
,	O
LPS	O
enhanced	O
gene1s	O
fibrinogen	O
gene1e	O
binding	O
,	O
gene1s	O
P	O
-	O
selectin	O
gene1e	O
exposure	O
and	O
reactive	O
oxygen	O
species	O
(	O
ROS	O
)	O
release	O
.	O
Increase	O
of	O
ROS	O
was	O
found	O
to	O
be	O
important	O
for	O
the	O
actions	O
of	O
LPS	O
on	O
platelets	O
,	O
since	O
these	O
were	O
inhibited	O
in	O
the	O
presence	O
of	O
gene1s	O
superoxide	O
dismutase	O
gene1e	O
or	O
gene1s	O
catalase	O
gene1e	O
.	O
The	O
effects	O
of	O
LPS	O
were	O
associated	O
with	O
phosphorylation	O
of	O
gene1s	O
Akt	O
gene1e	O
,	O
gene1s	O
ERK1/2	O
gene1e	O
and	O
gene1s	O
PLA2	O
gene1e	O
in	O
stimulated	O
platelets	O
,	O
and	O
inhibitors	O
of	O
gene1s	O
PI3-kinase	O
gene1e	O
,	O
gene1s	O
Akt	O
gene1e	O
and	O
gene1s	O
ERK1/2	O
gene1e	O
reduced	O
significantly	O
LPS	O
enhanced	O
platelet	O
function	O
and	O
associated	O
ROS	O
production	O
.	O
Furthermore	O
,	O
inhibition	O
of	O
platelet	O
gene1s	O
cyclooxygenase	O
gene1e	O
or	O
the	O
gene1s	O
thromboxane	O
receptor	O
gene1e	O
,	O
revealed	O
an	O
important	O
role	O
for	O
thromboxane	O
A2	O
.	O
We	O
therefore	O
conclude	O
that	O
LPS	O
increases	O
species1s	O
human	O
species1e	O
platelet	O
activation	O
through	O
a	O
gene1s	O
TLR4	O
gene1e	O
-	O
gene1s	O
PI3K	O
gene1e	O
-	O
gene1s	O
Akt	O
gene1e	O
-	O
gene1s	O
ERK1/2	O
gene1e	O
-	O
gene1s	O
PLA2	O
gene1e	O
-dependent	O
pathway	O
that	O
is	O
dependent	O
on	O
ROS	O
and	O
TXA2	O
formation	O
.	O

Lipopolysaccharide	O
potentiates	O
platelet	O
responses	O
via	O
gene1s	ARG2
toll	ARG2
-	ARG2
like	ARG2
receptor	ARG2
4	ARG2
gene1e	ARG2
-stimulated	O
gene1s	ARG2
Akt	ARG2
gene1e	ARG2
-	O
gene1s	ARG2
Erk	ARG2
gene1e	ARG2
-	O
gene1s	ARG2
PLA2	ARG2
gene1e	ARG2
signalling	O
.	O
Lipopolysaccharide	O
(	O
LPS	O
)	O
from	O
the	O
cell	O
envelope	O
of	O
Gram	O
-	O
negative	O
bacteria	O
is	O
a	O
principal	O
cause	O
of	O
the	O
symptoms	O
of	O
sepsis	O
.	O
LPS	O
has	O
been	O
reported	O
to	O
modulate	O
the	O
function	O
of	O
platelets	O
although	O
the	O
underlying	O
mechanisms	O
of	O
LPS	O
action	O
in	O
these	O
cells	O
remain	O
unclear	O
.	O
Platelets	O
express	O
the	O
gene1s	ARG2
Toll	ARG2
-	ARG2
like	ARG2
receptor	ARG2
4	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
TLR4	ARG2
gene1e	ARG2
)	O
which	O
serves	O
as	O
a	O
receptor	O
for	O
LPS	O
,	O
although	O
the	O
potential	O
role	O
of	O
gene1s	ARG2
TLR4	ARG2
gene1e	ARG2
and	O
associated	O
cell	O
signalling	O
in	O
controlling	O
platelet	O
responses	O
to	O
LPS	O
has	O
not	O
been	O
extensively	O
explored	O
.	O
In	O
this	O
study	O
,	O
we	O
therefore	O
investigated	O
the	O
actions	O
of	O
LPS	O
prepared	O
from	O
different	O
strains	O
of	O
species1s	O
Escherichia	O
coli	O
species1e	O
on	O
platelet	O
function	O
,	O
the	O
underlying	O
signalling	O
mechanisms	O
,	O
and	O
the	O
potential	O
role	O
of	O
gene1s	ARG2
TLR4	ARG2
gene1e	ARG2
in	O
orchestrating	O
these	O
.	O
We	O
report	O
that	O
LPS	O
increased	O
the	O
aggregation	O
of	O
washed	O
platelets	O
stimulated	O
by	O
thromboxane	O
(	O
U46619	O
)	O
or	O
gene1s	ARG2
GPVI	ARG2
collagen	ARG2
receptor	ARG2
gene1e	ARG2
agonists	O
,	O
effects	O
that	O
were	O
prevented	O
by	O
a	O
gene1s	ARG2
TLR4	ARG2
gene1e	ARG2
antagonist	O
.	O
Associated	O
with	O
this	O
,	O
LPS	O
enhanced	O
gene1s	ARG2
fibrinogen	ARG2
gene1e	ARG2
binding	O
,	O
gene1s	ARG2
P	ARG2
-	ARG2
selectin	ARG2
gene1e	ARG2
exposure	O
and	O
reactive	O
oxygen	O
species	O
(	O
ROS	O
)	O
release	O
.	O
Increase	O
of	O
ROS	O
was	O
found	O
to	O
be	O
important	O
for	O
the	O
actions	O
of	O
LPS	O
on	O
platelets	O
,	O
since	O
these	O
were	O
inhibited	O
in	O
the	O
presence	O
of	O
gene1s	ARG2
superoxide	ARG2
dismutase	ARG2
gene1e	ARG2
or	O
gene1s	ARG2
catalase	ARG2
gene1e	ARG2
.	O
The	O
effects	O
of	O
LPS	O
were	O
associated	O
with	O
phosphorylation	O
of	O
gene1s	ARG2
Akt	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
ERK1/2	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
PLA2	ARG2
gene1e	ARG2
in	O
stimulated	O
platelets	O
,	O
and	O
inhibitors	O
of	O
gene1s	ARG2
PI3-kinase	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Akt	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
ERK1/2	ARG2
gene1e	ARG2
reduced	O
significantly	O
LPS	O
enhanced	O
platelet	O
function	O
and	O
associated	O
ROS	O
production	O
.	O
Furthermore	O
,	O
inhibition	O
of	O
platelet	O
gene1s	ARG2
cyclooxygenase	ARG2
gene1e	ARG2
or	O
the	O
gene1s	ARG2
thromboxane	ARG2
receptor	ARG2
gene1e	ARG2
,	O
revealed	O
an	O
important	O
role	O
for	O
thromboxane	O
A2	O
.	O
We	O
therefore	O
conclude	O
that	O
LPS	O
increases	O
arg1s	O
human	O
arg1e	O
platelet	O
activation	O
through	O
a	O
gene1s	ARG2
TLR4	ARG2
gene1e	ARG2
-	O
gene1s	ARG2
PI3K	ARG2
gene1e	ARG2
-	O
gene1s	ARG2
Akt	ARG2
gene1e	ARG2
-	O
gene1s	ARG2
ERK1/2	ARG2
gene1e	ARG2
-	O
gene1s	ARG2
PLA2	ARG2
gene1e	ARG2
-dependent	O
pathway	O
that	O
is	O
dependent	O
on	O
ROS	O
and	O
TXA2	O
formation	O
.	O

Conditional	O
knockdown	O
of	O
gene1s	O
BCL2A1	O
gene1e	O
reveals	O
rate	O
-	O
limiting	O
roles	O
in	O
gene1s	O
BCR	O
gene1e	O
-	O
dependent	O
B	O
-	O
cell	O
survival	O
.	O
gene1s	ARG2
Bcl2	ARG2
gene1e	ARG2
family	O
proteins	O
control	O
mitochondrial	O
apoptosis	O
and	O
its	O
members	O
exert	O
critical	O
cell	O
type	O
and	O
differentiation	O
stage	O
-	O
specific	O
functions	O
,	O
acting	O
as	O
barriers	O
against	O
autoimmunity	O
or	O
transformation	O
.	O
Anti	O
-	O
apoptotic	O
gene1s	ARG2
Bcl2a1	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
Bfl1	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
A1	ARG2
gene1e	ARG2
is	O
frequently	O
deregulated	O
in	O
different	O
types	O
of	O
blood	O
cancers	O
in	O
arg1s	O
humans	O
arg1e	O
but	O
its	O
physiological	O
role	O
is	O
poorly	O
understood	O
as	O
quadruplication	O
of	O
the	O
gene1s	O
Bcl2a1	O
gene1e	O
gene	O
locus	O
in	O
species1s	O
mice	O
species1e	O
hampers	O
conventional	O
gene	O
targeting	O
strategies	O
.	O
Transgenic	O
overexpression	O
of	O
gene1s	O
A1	O
gene1e	O
,	O
deletion	O
of	O
the	O
gene1s	O
A1	O
gene1e	O
-a	O
paralogue	O
or	O
constitutive	O
knockdown	O
in	O
the	O
hematopoietic	O
compartment	O
of	O
species1s	O
mice	O
species1e	O
by	O
RNAi	O
suggested	O
rate	O
-	O
limiting	O
roles	O
in	O
lymphocyte	O
development	O
,	O
granulopoiesis	O
and	O
mast	O
cell	O
activation	O
.	O
Here	O
we	O
report	O
on	O
the	O
consequences	O
of	O
conditional	O
knockdown	O
of	O
gene1s	O
A1	O
gene1e	O
protein	O
expression	O
using	O
a	O
reverse	O
transactivator	O
(	O
rtTA)-driven	O
approach	O
that	O
highlights	O
a	O
critical	O
role	O
for	O
this	O
gene1s	ARG2
Bcl2	ARG2
gene1e	ARG2
family	O
member	O
in	O
the	O
maintenance	O
of	O
mature	O
B	O
-	O
cell	O
homeostasis	O
.	O
Furthermore	O
,	O
we	O
define	O
the	O
gene1s	O
A1	O
gene1e	O
/	O
gene1s	O
Bim	O
gene1e	O
(	O
gene1s	O
Bcl-2	O
interacting	O
mediator	O
of	O
cell	O
death	O
gene1e	O
)	O
axis	O
as	O
a	O
target	O
of	O
key	O
kinases	O
mediating	O
gene1s	O
B	O
-	O
cell	O
receptor	O
gene1e	O
(	O
gene1s	O
BCR	O
gene1e	O
)-dependent	O
survival	O
signals	O
,	O
such	O
as	O
,	O
gene1s	O
spleen	O
tyrosine	O
kinase	O
gene1e	O
(	O
gene1s	O
Syk	O
gene1e	O
)	O
and	O
gene1s	O
Brutons	O
tyrosine	O
kinase	O
gene1e	O
(	O
gene1s	O
Btk	O
gene1e	O
)	O
.	O
As	O
such	O
,	O
gene1s	ARG2
A1	ARG2
gene1e	ARG2
represents	O
a	O
putative	O
target	O
for	O
the	O
treatment	O
of	O
B	O
-	O
cell	O
-	O
related	O
pathologies	O
depending	O
on	O
hyperactivation	O
of	O
BCR	O
-	O
emanating	O
survival	O
signals	O
and	O
loss	O
of	O
gene1s	O
A1	O
gene1e	O
expression	O
accounts	O
,	O
in	O
part	O
,	O
for	O
the	O
pro	O
-	O
apoptotic	O
effects	O
of	O
gene1s	O
Syk	O
gene1e	O
-	O
or	O
gene1s	O
Btk	O
gene1e	O
inhibitors	O
that	O
rely	O
on	O
the	O
'	O
BH3-only	O
'	O
protein	O
gene1s	O
Bim	O
gene1e	O
for	O
cell	O
killing	O
.	O

Conditional	O
knockdown	O
of	O
gene1s	ARG2
BCL2A1	ARG2
gene1e	ARG2
reveals	O
rate	O
-	O
limiting	O
roles	O
in	O
gene1s	ARG2
BCR	ARG2
gene1e	ARG2
-	O
dependent	O
B	O
-	O
cell	O
survival	O
.	O
gene1s	ARG2
Bcl2	ARG2
gene1e	ARG2
family	O
proteins	O
control	O
mitochondrial	O
apoptosis	O
and	O
its	O
members	O
exert	O
critical	O
cell	O
type	O
and	O
differentiation	O
stage	O
-	O
specific	O
functions	O
,	O
acting	O
as	O
barriers	O
against	O
autoimmunity	O
or	O
transformation	O
.	O
Anti	O
-	O
apoptotic	O
gene1s	O
Bcl2a1	O
gene1e	O
/	O
gene1s	O
Bfl1	O
gene1e	O
/	O
gene1s	O
A1	O
gene1e	O
is	O
frequently	O
deregulated	O
in	O
different	O
types	O
of	O
blood	O
cancers	O
in	O
species1s	O
humans	O
species1e	O
but	O
its	O
physiological	O
role	O
is	O
poorly	O
understood	O
as	O
quadruplication	O
of	O
the	O
gene1s	ARG2
Bcl2a1	ARG2
gene1e	ARG2
gene	O
locus	O
in	O
arg1s	O
mice	O
arg1e	O
hampers	O
conventional	O
gene	O
targeting	O
strategies	O
.	O
Transgenic	O
overexpression	O
of	O
gene1s	ARG2
A1	ARG2
gene1e	ARG2
,	O
deletion	O
of	O
the	O
gene1s	ARG2
A1	ARG2
gene1e	ARG2
-a	O
paralogue	O
or	O
constitutive	O
knockdown	O
in	O
the	O
hematopoietic	O
compartment	O
of	O
arg1s	O
mice	O
arg1e	O
by	O
RNAi	O
suggested	O
rate	O
-	O
limiting	O
roles	O
in	O
lymphocyte	O
development	O
,	O
granulopoiesis	O
and	O
mast	O
cell	O
activation	O
.	O
Here	O
we	O
report	O
on	O
the	O
consequences	O
of	O
conditional	O
knockdown	O
of	O
gene1s	ARG2
A1	ARG2
gene1e	ARG2
protein	O
expression	O
using	O
a	O
reverse	O
transactivator	O
(	O
rtTA)-driven	O
approach	O
that	O
highlights	O
a	O
critical	O
role	O
for	O
this	O
gene1s	ARG2
Bcl2	ARG2
gene1e	ARG2
family	O
member	O
in	O
the	O
maintenance	O
of	O
mature	O
B	O
-	O
cell	O
homeostasis	O
.	O
Furthermore	O
,	O
we	O
define	O
the	O
gene1s	ARG2
A1	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
Bim	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
Bcl-2	ARG2
interacting	ARG2
mediator	ARG2
of	ARG2
cell	ARG2
death	ARG2
gene1e	ARG2
)	O
axis	O
as	O
a	O
target	O
of	O
key	O
kinases	O
mediating	O
gene1s	ARG2
B	ARG2
-	ARG2
cell	ARG2
receptor	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
BCR	ARG2
gene1e	ARG2
)-dependent	O
survival	O
signals	O
,	O
such	O
as	O
,	O
gene1s	ARG2
spleen	ARG2
tyrosine	ARG2
kinase	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
Syk	ARG2
gene1e	ARG2
)	O
and	O
gene1s	ARG2
Brutons	ARG2
tyrosine	ARG2
kinase	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
Btk	ARG2
gene1e	ARG2
)	O
.	O
As	O
such	O
,	O
gene1s	O
A1	O
gene1e	O
represents	O
a	O
putative	O
target	O
for	O
the	O
treatment	O
of	O
B	O
-	O
cell	O
-	O
related	O
pathologies	O
depending	O
on	O
hyperactivation	O
of	O
BCR	O
-	O
emanating	O
survival	O
signals	O
and	O
loss	O
of	O
gene1s	ARG2
A1	ARG2
gene1e	ARG2
expression	O
accounts	O
,	O
in	O
part	O
,	O
for	O
the	O
pro	O
-	O
apoptotic	O
effects	O
of	O
gene1s	ARG2
Syk	ARG2
gene1e	ARG2
-	O
or	O
gene1s	ARG2
Btk	ARG2
gene1e	ARG2
inhibitors	O
that	O
rely	O
on	O
the	O
'	O
BH3-only	O
'	O
protein	O
gene1s	ARG2
Bim	ARG2
gene1e	ARG2
for	O
cell	O
killing	O
.	O

A	O
Critical	O
Role	O
for	O
gene1s	O
CD200R	O
gene1e	O
Signaling	O
in	O
Limiting	O
the	O
Growth	O
and	O
Metastasis	O
of	O
gene1s	O
CD200	O
gene1e	O
+	O
Melanoma	O
.	O
gene1s	ARG2
CD200	ARG2
gene1e	ARG2
is	O
a	O
cell	O
surface	O
glycoprotein	O
that	O
functions	O
through	O
engaging	O
gene1s	ARG2
CD200R	ARG2
gene1e	ARG2
on	O
cells	O
of	O
the	O
myeloid	O
lineage	O
and	O
inhibits	O
their	O
functions	O
.	O
Expression	O
of	O
gene1s	ARG2
CD200	ARG2
gene1e	ARG2
was	O
implicated	O
in	O
a	O
variety	O
of	O
arg1s	O
human	O
arg1e	O
cancer	O
cells	O
,	O
including	O
melanoma	O
cells	O
;	O
however	O
,	O
its	O
roles	O
in	O
tumor	O
growth	O
and	O
immunity	O
are	O
not	O
clearly	O
understood	O
.	O
In	O
this	O
study	O
,	O
we	O
used	O
gene1s	O
CD200R	O
gene1e	O
-	O
deficient	O
species1s	O
mice	O
species1e	O
and	O
the	O
B16	O
tumor	O
model	O
to	O
evaluate	O
this	O
issue	O
.	O
We	O
found	O
that	O
gene1s	O
CD200R	O
gene1e	O
-	O
deficient	O
species1s	O
mice	O
species1e	O
exhibited	O
accelerated	O
growth	O
of	O
gene1s	O
CD200	O
gene1e	O
(+	O
)	O
,	O
but	O
not	O
gene1s	O
CD200	O
gene1e	O
(-	O
)	O
,	O
B16	O
tumors	O
.	O
Strikingly	O
,	O
gene1s	O
CD200R	O
gene1e	O
-	O
deficient	O
species1s	O
mice	O
species1e	O
receiving	O
gene1s	O
CD200	O
gene1e	O
(+	O
)	O
B16	O
cells	O
i.v	O
.	O
exhibited	O
massive	O
tumor	O
growth	O
in	O
multiple	O
organs	O
,	O
including	O
liver	O
,	O
lung	O
,	O
kidney	O
,	O
and	O
peritoneal	O
cavity	O
,	O
whereas	O
the	O
growth	O
of	O
the	O
same	O
tumors	O
in	O
wild	O
-	O
type	O
species1s	O
mice	O
species1e	O
was	O
limited	O
.	O
gene1s	O
CD200	O
gene1e	O
(+	O
)	O
tumors	O
grown	O
in	O
gene1s	O
CD200R	O
gene1e	O
-	O
deficient	O
species1s	O
mice	O
species1e	O
contained	O
higher	O
numbers	O
of	O
gene1s	O
CD11b	O
gene1e	O
(+)	O
gene1s	O
Ly6C	O
gene1e	O
(+	O
)	O
myeloid	O
cells	O
,	O
exhibited	O
increased	O
expression	O
of	O
gene1s	O
VEGF	O
gene1e	O
and	O
gene1s	O
HIF1a	O
gene1e	O
genes	O
with	O
increased	O
angiogenesis	O
,	O
and	O
showed	O
significantly	O
reduced	O
infiltration	O
of	O
gene1s	O
CD4	O
gene1e	O
(+	O
)	O
and	O
gene1s	O
CD8	O
gene1e	O
(+	O
)	O
T	O
cells	O
,	O
presumably	O
as	O
the	O
result	O
of	O
reduced	O
expression	O
of	O
T	O
cell	O
gene1s	O
chemokines	O
gene1e	O
,	O
such	O
as	O
gene1s	O
CXCL9	O
gene1e	O
and	O
gene1s	O
CXCL16	O
gene1e	O
.	O
The	O
liver	O
from	O
gene1s	O
CD200R	O
gene1e	O
-	O
deficient	O
species1s	O
mice	O
species1e	O
,	O
under	O
metastatic	O
growth	O
of	O
gene1s	O
CD200	O
gene1e	O
(+	O
)	O
tumors	O
,	O
contained	O
significantly	O
increased	O
numbers	O
of	O
gene1s	O
CD11b	O
gene1e	O
(+)	O
gene1s	O
Gr1	O
gene1e	O
(-	O
)	O
myeloid	O
cells	O
and	O
gene1s	O
Foxp3	O
gene1e	O
(+	O
)	O
regulatory	O
T	O
cells	O
and	O
reduced	O
numbers	O
of	O
NK	O
cells	O
.	O
Liver	O
T	O
cells	O
also	O
had	O
a	O
reduced	O
capacity	O
to	O
produce	O
gene1s	O
IFN	O
-	O
g	O
gene1e	O
or	O
gene1s	O
TNF	O
-	O
a	O
gene1e	O
.	O
Taken	O
together	O
,	O
we	O
revealed	O
a	O
critical	O
role	O
for	O
gene1s	O
CD200R	O
gene1e	O
signaling	O
in	O
limiting	O
the	O
growth	O
and	O
metastasis	O
of	O
gene1s	O
CD200	O
gene1e	O
(+	O
)	O
tumors	O
.	O
Thus	O
,	O
targeting	O
gene1s	O
CD200R	O
gene1e	O
signaling	O
may	O
potentially	O
interfere	O
with	O
the	O
metastatic	O
growth	O
of	O
gene1s	O
CD200	O
gene1e	O
(+	O
)	O
tumors	O
,	O
like	O
melanoma	O
.	O

A	O
Critical	O
Role	O
for	O
gene1s	ARG2
CD200R	ARG2
gene1e	ARG2
Signaling	O
in	O
Limiting	O
the	O
Growth	O
and	O
Metastasis	O
of	O
gene1s	ARG2
CD200	ARG2
gene1e	ARG2
+	O
Melanoma	O
.	O
gene1s	O
CD200	O
gene1e	O
is	O
a	O
cell	O
surface	O
glycoprotein	O
that	O
functions	O
through	O
engaging	O
gene1s	O
CD200R	O
gene1e	O
on	O
cells	O
of	O
the	O
myeloid	O
lineage	O
and	O
inhibits	O
their	O
functions	O
.	O
Expression	O
of	O
gene1s	O
CD200	O
gene1e	O
was	O
implicated	O
in	O
a	O
variety	O
of	O
species1s	O
human	O
species1e	O
cancer	O
cells	O
,	O
including	O
melanoma	O
cells	O
;	O
however	O
,	O
its	O
roles	O
in	O
tumor	O
growth	O
and	O
immunity	O
are	O
not	O
clearly	O
understood	O
.	O
In	O
this	O
study	O
,	O
we	O
used	O
gene1s	ARG2
CD200R	ARG2
gene1e	ARG2
-	O
deficient	O
arg1s	O
mice	O
arg1e	O
and	O
the	O
B16	O
tumor	O
model	O
to	O
evaluate	O
this	O
issue	O
.	O
We	O
found	O
that	O
gene1s	ARG2
CD200R	ARG2
gene1e	ARG2
-	O
deficient	O
arg1s	O
mice	O
arg1e	O
exhibited	O
accelerated	O
growth	O
of	O
gene1s	ARG2
CD200	ARG2
gene1e	ARG2
(+	O
)	O
,	O
but	O
not	O
gene1s	ARG2
CD200	ARG2
gene1e	ARG2
(-	O
)	O
,	O
B16	O
tumors	O
.	O
Strikingly	O
,	O
gene1s	ARG2
CD200R	ARG2
gene1e	ARG2
-	O
deficient	O
arg1s	O
mice	O
arg1e	O
receiving	O
gene1s	ARG2
CD200	ARG2
gene1e	ARG2
(+	O
)	O
B16	O
cells	O
i.v	O
.	O
exhibited	O
massive	O
tumor	O
growth	O
in	O
multiple	O
organs	O
,	O
including	O
liver	O
,	O
lung	O
,	O
kidney	O
,	O
and	O
peritoneal	O
cavity	O
,	O
whereas	O
the	O
growth	O
of	O
the	O
same	O
tumors	O
in	O
wild	O
-	O
type	O
arg1s	O
mice	O
arg1e	O
was	O
limited	O
.	O
gene1s	ARG2
CD200	ARG2
gene1e	ARG2
(+	O
)	O
tumors	O
grown	O
in	O
gene1s	ARG2
CD200R	ARG2
gene1e	ARG2
-	O
deficient	O
arg1s	O
mice	O
arg1e	O
contained	O
higher	O
numbers	O
of	O
gene1s	ARG2
CD11b	ARG2
gene1e	ARG2
(+)	O
gene1s	ARG2
Ly6C	ARG2
gene1e	ARG2
(+	O
)	O
myeloid	O
cells	O
,	O
exhibited	O
increased	O
expression	O
of	O
gene1s	ARG2
VEGF	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
HIF1a	ARG2
gene1e	ARG2
genes	O
with	O
increased	O
angiogenesis	O
,	O
and	O
showed	O
significantly	O
reduced	O
infiltration	O
of	O
gene1s	ARG2
CD4	ARG2
gene1e	ARG2
(+	O
)	O
and	O
gene1s	ARG2
CD8	ARG2
gene1e	ARG2
(+	O
)	O
T	O
cells	O
,	O
presumably	O
as	O
the	O
result	O
of	O
reduced	O
expression	O
of	O
T	O
cell	O
gene1s	ARG2
chemokines	ARG2
gene1e	ARG2
,	O
such	O
as	O
gene1s	ARG2
CXCL9	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
CXCL16	ARG2
gene1e	ARG2
.	O
The	O
liver	O
from	O
gene1s	ARG2
CD200R	ARG2
gene1e	ARG2
-	O
deficient	O
arg1s	O
mice	O
arg1e	O
,	O
under	O
metastatic	O
growth	O
of	O
gene1s	ARG2
CD200	ARG2
gene1e	ARG2
(+	O
)	O
tumors	O
,	O
contained	O
significantly	O
increased	O
numbers	O
of	O
gene1s	ARG2
CD11b	ARG2
gene1e	ARG2
(+)	O
gene1s	ARG2
Gr1	ARG2
gene1e	ARG2
(-	O
)	O
myeloid	O
cells	O
and	O
gene1s	ARG2
Foxp3	ARG2
gene1e	ARG2
(+	O
)	O
regulatory	O
T	O
cells	O
and	O
reduced	O
numbers	O
of	O
NK	O
cells	O
.	O
Liver	O
T	O
cells	O
also	O
had	O
a	O
reduced	O
capacity	O
to	O
produce	O
gene1s	ARG2
IFN	ARG2
-	ARG2
g	ARG2
gene1e	ARG2
or	O
gene1s	ARG2
TNF	ARG2
-	ARG2
a	ARG2
gene1e	ARG2
.	O
Taken	O
together	O
,	O
we	O
revealed	O
a	O
critical	O
role	O
for	O
gene1s	ARG2
CD200R	ARG2
gene1e	ARG2
signaling	O
in	O
limiting	O
the	O
growth	O
and	O
metastasis	O
of	O
gene1s	ARG2
CD200	ARG2
gene1e	ARG2
(+	O
)	O
tumors	O
.	O
Thus	O
,	O
targeting	O
gene1s	ARG2
CD200R	ARG2
gene1e	ARG2
signaling	O
may	O
potentially	O
interfere	O
with	O
the	O
metastatic	O
growth	O
of	O
gene1s	ARG2
CD200	ARG2
gene1e	ARG2
(+	O
)	O
tumors	O
,	O
like	O
melanoma	O
.	O

arg1s	O
Arabidopsis	O
arg1e	O
gene1s	ARG2
CHROMOSOME	ARG2
TRANSMISSION	ARG2
FIDELITY	ARG2
7	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
AtCTF7	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
ECO1	ARG2
gene1e	ARG2
)	O
is	O
required	O
for	O
DNA	O
repair	O
,	O
mitosis	O
and	O
meiosis	O
.	O
The	O
proper	O
transmission	O
of	O
DNA	O
in	O
dividing	O
cells	O
is	O
crucial	O
for	O
the	O
survival	O
of	O
eukaryotic	O
organisms	O
.	O
During	O
cell	O
division	O
,	O
faithful	O
segregation	O
of	O
replicated	O
chromosomes	O
requires	O
their	O
tight	O
attachment	O
,	O
known	O
as	O
sister	O
chromatid	O
cohesion	O
,	O
until	O
anaphase	O
.	O
Sister	O
chromatid	O
cohesion	O
is	O
established	O
during	O
S	O
-	O
phase	O
in	O
a	O
process	O
requiring	O
an	O
gene1s	O
acetyltransferase	O
gene1e	O
that	O
in	O
species1s	O
yeast	O
species1e	O
is	O
known	O
as	O
gene1s	O
Establishment	O
of	O
cohesion	O
1	O
gene1e	O
(	O
gene1s	O
Eco1	O
gene1e	O
)	O
.	O
Inactivation	O
of	O
gene1s	O
Eco1	O
gene1e	O
typically	O
disrupts	O
chromosome	O
segregation	O
and	O
homologous	O
recombination	O
-	O
dependent	O
DNA	O
repair	O
in	O
dividing	O
cells	O
,	O
ultimately	O
resulting	O
in	O
lethality	O
.	O
We	O
report	O
here	O
the	O
isolation	O
and	O
detailed	O
characterization	O
of	O
two	O
homozygous	O
T	O
-	O
DNA	O
insertion	O
mutants	O
for	O
the	O
arg1s	O
Arabidopsis	O
thaliana	O
arg1e	O
gene1s	ARG2
Eco1	ARG2
gene1e	ARG2
homolog	O
,	O
gene1s	ARG2
CHROMOSOME	ARG2
TRANSMISSION	ARG2
FIDELITY	ARG2
7	ARG2
/	ARG2
ESTABLISHMENT	ARG2
OF	ARG2
COHESION	ARG2
1	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
CTF7	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
ECO1	ARG2
gene1e	ARG2
)	O
,	O
called	O
gene1s	ARG2
ctf7	ARG2
-	ARG2
1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
ctf7	ARG2
-	ARG2
2	ARG2
gene1e	ARG2
.	O
Mutants	O
exhibited	O
dwarfism	O
,	O
poor	O
anther	O
development	O
and	O
sterility	O
.	O
Analysis	O
of	O
somatic	O
tissues	O
by	O
flow	O
cytometry	O
,	O
scanning	O
electron	O
microscopy	O
and	O
quantitative	O
real	O
-	O
time	O
PCR	O
identified	O
defects	O
in	O
DNA	O
repair	O
and	O
cell	O
division	O
,	O
including	O
an	O
increase	O
in	O
the	O
area	O
of	O
leaf	O
epidermal	O
cells	O
,	O
an	O
increase	O
in	O
DNA	O
content	O
and	O
the	O
upregulation	O
of	O
genes	O
involved	O
in	O
DNA	O
repair	O
including	O
gene1s	ARG2
BRCA1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
PARP2	ARG2
gene1e	ARG2
.	O
No	O
significant	O
change	O
was	O
observed	O
in	O
the	O
expression	O
of	O
genes	O
that	O
influence	O
entry	O
into	O
the	O
endocycle	O
.	O
Analysis	O
of	O
meiocytes	O
identified	O
changes	O
in	O
chromosome	O
morphology	O
and	O
defective	O
segregation	O
;	O
the	O
abundance	O
of	O
chromosomal	O
-	O
bound	O
cohesion	O
subunits	O
was	O
also	O
reduced	O
.	O
Transcript	O
levels	O
for	O
several	O
meiotic	O
genes	O
,	O
including	O
the	O
recombinase	O
genes	O
gene1s	ARG2
DMC1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
RAD51C	ARG2
gene1e	ARG2
and	O
the	O
S	O
-	O
phase	O
licensing	O
factor	O
gene1s	ARG2
CDC45	ARG2
gene1e	ARG2
were	O
elevated	O
in	O
mutant	O
anthers	O
.	O
Taken	O
together	O
our	O
results	O
demonstrate	O
that	O
arg1s	O
Arabidopsis	O
arg1e	O
gene1s	ARG2
CTF7	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
ECO1	ARG2
gene1e	ARG2
plays	O
important	O
roles	O
in	O
the	O
preservation	O
of	O
genome	O
integrity	O
and	O
meiosis	O
.	O

species1s	O
Arabidopsis	O
species1e	O
gene1s	O
CHROMOSOME	O
TRANSMISSION	O
FIDELITY	O
7	O
gene1e	O
(	O
gene1s	O
AtCTF7	O
gene1e	O
/	O
gene1s	O
ECO1	O
gene1e	O
)	O
is	O
required	O
for	O
DNA	O
repair	O
,	O
mitosis	O
and	O
meiosis	O
.	O
The	O
proper	O
transmission	O
of	O
DNA	O
in	O
dividing	O
cells	O
is	O
crucial	O
for	O
the	O
survival	O
of	O
eukaryotic	O
organisms	O
.	O
During	O
cell	O
division	O
,	O
faithful	O
segregation	O
of	O
replicated	O
chromosomes	O
requires	O
their	O
tight	O
attachment	O
,	O
known	O
as	O
sister	O
chromatid	O
cohesion	O
,	O
until	O
anaphase	O
.	O
Sister	O
chromatid	O
cohesion	O
is	O
established	O
during	O
S	O
-	O
phase	O
in	O
a	O
process	O
requiring	O
an	O
gene1s	ARG2
acetyltransferase	ARG2
gene1e	ARG2
that	O
in	O
arg1s	O
yeast	O
arg1e	O
is	O
known	O
as	O
gene1s	ARG2
Establishment	ARG2
of	ARG2
cohesion	ARG2
1	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
Eco1	ARG2
gene1e	ARG2
)	O
.	O
Inactivation	O
of	O
gene1s	ARG2
Eco1	ARG2
gene1e	ARG2
typically	O
disrupts	O
chromosome	O
segregation	O
and	O
homologous	O
recombination	O
-	O
dependent	O
DNA	O
repair	O
in	O
dividing	O
cells	O
,	O
ultimately	O
resulting	O
in	O
lethality	O
.	O
We	O
report	O
here	O
the	O
isolation	O
and	O
detailed	O
characterization	O
of	O
two	O
homozygous	O
T	O
-	O
DNA	O
insertion	O
mutants	O
for	O
the	O
species1s	O
Arabidopsis	O
thaliana	O
species1e	O
gene1s	O
Eco1	O
gene1e	O
homolog	O
,	O
gene1s	O
CHROMOSOME	O
TRANSMISSION	O
FIDELITY	O
7	O
/	O
ESTABLISHMENT	O
OF	O
COHESION	O
1	O
gene1e	O
(	O
gene1s	O
CTF7	O
gene1e	O
/	O
gene1s	O
ECO1	O
gene1e	O
)	O
,	O
called	O
gene1s	O
ctf7	O
-	O
1	O
gene1e	O
and	O
gene1s	O
ctf7	O
-	O
2	O
gene1e	O
.	O
Mutants	O
exhibited	O
dwarfism	O
,	O
poor	O
anther	O
development	O
and	O
sterility	O
.	O
Analysis	O
of	O
somatic	O
tissues	O
by	O
flow	O
cytometry	O
,	O
scanning	O
electron	O
microscopy	O
and	O
quantitative	O
real	O
-	O
time	O
PCR	O
identified	O
defects	O
in	O
DNA	O
repair	O
and	O
cell	O
division	O
,	O
including	O
an	O
increase	O
in	O
the	O
area	O
of	O
leaf	O
epidermal	O
cells	O
,	O
an	O
increase	O
in	O
DNA	O
content	O
and	O
the	O
upregulation	O
of	O
genes	O
involved	O
in	O
DNA	O
repair	O
including	O
gene1s	O
BRCA1	O
gene1e	O
and	O
gene1s	O
PARP2	O
gene1e	O
.	O
No	O
significant	O
change	O
was	O
observed	O
in	O
the	O
expression	O
of	O
genes	O
that	O
influence	O
entry	O
into	O
the	O
endocycle	O
.	O
Analysis	O
of	O
meiocytes	O
identified	O
changes	O
in	O
chromosome	O
morphology	O
and	O
defective	O
segregation	O
;	O
the	O
abundance	O
of	O
chromosomal	O
-	O
bound	O
cohesion	O
subunits	O
was	O
also	O
reduced	O
.	O
Transcript	O
levels	O
for	O
several	O
meiotic	O
genes	O
,	O
including	O
the	O
recombinase	O
genes	O
gene1s	O
DMC1	O
gene1e	O
and	O
gene1s	O
RAD51C	O
gene1e	O
and	O
the	O
S	O
-	O
phase	O
licensing	O
factor	O
gene1s	O
CDC45	O
gene1e	O
were	O
elevated	O
in	O
mutant	O
anthers	O
.	O
Taken	O
together	O
our	O
results	O
demonstrate	O
that	O
species1s	O
Arabidopsis	O
species1e	O
gene1s	O
CTF7	O
gene1e	O
/	O
gene1s	O
ECO1	O
gene1e	O
plays	O
important	O
roles	O
in	O
the	O
preservation	O
of	O
genome	O
integrity	O
and	O
meiosis	O
.	O

Bacterial	O
DNA	O
Protects	O
Monocytic	O
Cells	O
against	O
HIV	O
-	O
Vpr	O
-	O
Induced	O
Mitochondrial	O
Membrane	O
Depolarization	O
.	O
Monocytes	O
and	O
macrophages	O
are	O
important	O
HIV	O
reservoirs	O
,	O
as	O
they	O
exhibit	O
marked	O
resistance	O
to	O
apoptosis	O
upon	O
infection	O
.	O
However	O
,	O
the	O
mechanism	O
underlying	O
resistance	O
to	O
apoptosis	O
in	O
these	O
cells	O
is	O
poorly	O
understood	O
.	O
Using	O
HIV	O
-	O
viral	O
protein	O
R-52	O
-	O
96	O
aa	O
peptide	O
(	O
Vpr	O
)	O
,	O
we	O
show	O
that	O
primary	O
monocytes	O
and	O
arg1s	O
THP-1	O
arg1e	O
cells	O
treated	O
with	O
Vpr	O
are	O
highly	O
susceptible	O
to	O
mitochondrial	O
depolarization	O
,	O
but	O
develop	O
resistance	O
following	O
stimulation	O
with	O
bacterial	O
DNA	O
or	O
CpG	O
oligodeoxynucleotide	O
.	O
We	O
have	O
shown	O
that	O
Vpr	O
-	O
induced	O
mitochondrial	O
depolarization	O
is	O
mediated	O
by	O
gene1s	ARG2
TNFR	ARG2
-	ARG2
associated	ARG2
factor-1	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
TRAF-1	ARG2
gene1e	ARG2
)	O
and	O
gene1s	ARG2
TRAF-2	ARG2
gene1e	ARG2
degradation	O
and	O
subsequent	O
activation	O
of	O
gene1s	ARG2
caspase-8	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Bid	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
Bax	ARG2
gene1e	ARG2
.	O
To	O
provide	O
the	O
mechanism	O
governing	O
such	O
resistance	O
to	O
mitochondrial	O
depolarization	O
,	O
our	O
results	O
show	O
that	O
prior	O
stimulation	O
with	O
CpG	O
oligodeoxynucleotide	O
or	O
species1s	O
Escherichia	O
coli	O
species1e	O
DNA	O
prevented	O
:	O
1	O
)	O
gene1s	ARG2
TRAF-1/2	ARG2
gene1e	ARG2
downregulation	O
;	O
2	O
)	O
activation	O
of	O
gene1s	ARG2
caspase-8	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Bid	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
Bax	ARG2
gene1e	ARG2
;	O
and	O
3	O
)	O
subsequent	O
mitochondrial	O
depolarization	O
and	O
release	O
of	O
gene1s	ARG2
apoptosis	ARG2
-	ARG2
inducing	ARG2
factor	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
cytochrome	ARG2
c	ARG2
gene1e	ARG2
Furthermore	O
,	O
this	O
protection	O
was	O
mediated	O
by	O
upregulation	O
of	O
gene1s	ARG2
antiapoptotic	ARG2
protein	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
c	ARG2
-	ARG2
IAP-2	ARG2
gene1e	ARG2
)	O
through	O
gene1s	ARG2
calmodulin	ARG2
-	ARG2
dependent	ARG2
kinase	ARG2
-	ARG2
II	ARG2
gene1e	ARG2
activation	O
.	O
Thus	O
,	O
gene1s	ARG2
c	ARG2
-	ARG2
IAP-2	ARG2
gene1e	ARG2
may	O
prevent	O
Vpr	O
-	O
mediated	O
mitochondrial	O
depolarization	O
through	O
stabilizing	O
gene1s	ARG2
TRAF-1/2	ARG2
gene1e	ARG2
expression	O
and	O
sequential	O
inhibition	O
of	O
gene1s	ARG2
caspase-8	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Bid	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
Bax	ARG2
gene1e	ARG2
.	O

Bacterial	O
DNA	O
Protects	O
Monocytic	O
Cells	O
against	O
HIV	O
-	O
Vpr	O
-	O
Induced	O
Mitochondrial	O
Membrane	O
Depolarization	O
.	O
Monocytes	O
and	O
macrophages	O
are	O
important	O
HIV	O
reservoirs	O
,	O
as	O
they	O
exhibit	O
marked	O
resistance	O
to	O
apoptosis	O
upon	O
infection	O
.	O
However	O
,	O
the	O
mechanism	O
underlying	O
resistance	O
to	O
apoptosis	O
in	O
these	O
cells	O
is	O
poorly	O
understood	O
.	O
Using	O
HIV	O
-	O
viral	O
protein	O
R-52	O
-	O
96	O
aa	O
peptide	O
(	O
Vpr	O
)	O
,	O
we	O
show	O
that	O
primary	O
monocytes	O
and	O
species1s	O
THP-1	O
species1e	O
cells	O
treated	O
with	O
Vpr	O
are	O
highly	O
susceptible	O
to	O
mitochondrial	O
depolarization	O
,	O
but	O
develop	O
resistance	O
following	O
stimulation	O
with	O
bacterial	O
DNA	O
or	O
CpG	O
oligodeoxynucleotide	O
.	O
We	O
have	O
shown	O
that	O
Vpr	O
-	O
induced	O
mitochondrial	O
depolarization	O
is	O
mediated	O
by	O
gene1s	O
TNFR	O
-	O
associated	O
factor-1	O
gene1e	O
(	O
gene1s	O
TRAF-1	O
gene1e	O
)	O
and	O
gene1s	O
TRAF-2	O
gene1e	O
degradation	O
and	O
subsequent	O
activation	O
of	O
gene1s	O
caspase-8	O
gene1e	O
,	O
gene1s	O
Bid	O
gene1e	O
,	O
and	O
gene1s	O
Bax	O
gene1e	O
.	O
To	O
provide	O
the	O
mechanism	O
governing	O
such	O
resistance	O
to	O
mitochondrial	O
depolarization	O
,	O
our	O
results	O
show	O
that	O
prior	O
stimulation	O
with	O
CpG	O
oligodeoxynucleotide	O
or	O
arg1s	O
Escherichia	O
coli	O
arg1e	O
DNA	O
prevented	O
:	O
1	O
)	O
gene1s	O
TRAF-1/2	O
gene1e	O
downregulation	O
;	O
2	O
)	O
activation	O
of	O
gene1s	O
caspase-8	O
gene1e	O
,	O
gene1s	O
Bid	O
gene1e	O
,	O
and	O
gene1s	O
Bax	O
gene1e	O
;	O
and	O
3	O
)	O
subsequent	O
mitochondrial	O
depolarization	O
and	O
release	O
of	O
gene1s	O
apoptosis	O
-	O
inducing	O
factor	O
gene1e	O
and	O
gene1s	O
cytochrome	O
c	O
gene1e	O
Furthermore	O
,	O
this	O
protection	O
was	O
mediated	O
by	O
upregulation	O
of	O
gene1s	O
antiapoptotic	O
protein	O
gene1e	O
(	O
gene1s	O
c	O
-	O
IAP-2	O
gene1e	O
)	O
through	O
gene1s	O
calmodulin	O
-	O
dependent	O
kinase	O
-	O
II	O
gene1e	O
activation	O
.	O
Thus	O
,	O
gene1s	O
c	O
-	O
IAP-2	O
gene1e	O
may	O
prevent	O
Vpr	O
-	O
mediated	O
mitochondrial	O
depolarization	O
through	O
stabilizing	O
gene1s	O
TRAF-1/2	O
gene1e	O
expression	O
and	O
sequential	O
inhibition	O
of	O
gene1s	O
caspase-8	O
gene1e	O
,	O
gene1s	O
Bid	O
gene1e	O
,	O
and	O
gene1s	O
Bax	O
gene1e	O
.	O

Overexpression	O
of	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
selenoprotein	ARG2
H	ARG2
gene1e	ARG2
in	O
neuronal	O
cells	O
enhances	O
mitochondrial	O
biogenesis	O
and	O
function	O
through	O
activation	O
of	O
gene1s	O
protein	O
kinase	O
A	O
gene1e	O
,	O
gene1s	O
protein	O
kinase	O
B	O
gene1e	O
,	O
and	O
gene1s	O
cyclic	O
adenosine	O
monophosphate	O
response	O
element	O
-	O
binding	O
protein	O
gene1e	O
pathway	O
.	O
Mitochondrial	O
biogenesis	O
is	O
activated	O
by	O
gene1s	O
nuclear	O
encoded	O
transcription	O
co	O
-	O
activator	O
peroxisome	O
proliferator	O
-	O
activated	O
receptor	O
g	O
coactivator-1a	O
gene1e	O
(	O
gene1s	O
PGC-1a	O
gene1e	O
)	O
,	O
which	O
is	O
regulated	O
by	O
several	O
upstream	O
factors	O
including	O
gene1s	O
protein	O
kinase	O
A	O
gene1e	O
and	O
gene1s	O
Akt	O
gene1e	O
/	O
gene1s	O
protein	O
kinase	O
B	O
gene1e	O
.	O
We	O
have	O
previously	O
shown	O
that	O
gene1s	ARG2
selenoprotein	ARG2
H	ARG2
gene1e	ARG2
enhances	O
the	O
levels	O
of	O
nuclear	O
regulators	O
for	O
mitochondrial	O
biogenesis	O
,	O
increases	O
mitochondrial	O
mass	O
and	O
improves	O
mitochondrial	O
respiratory	O
rate	O
,	O
under	O
physiological	O
condition	O
.	O
Furthermore	O
,	O
overexpression	O
of	O
gene1s	ARG2
selenoprotein	ARG2
H	ARG2
gene1e	ARG2
protects	O
neuronal	O
species1s	O
HT22	O
species1e	O
cells	O
from	O
ultraviolet	O
B	O
irradiation	O
-	O
induced	O
cell	O
damage	O
by	O
lowering	O
reactive	O
oxygen	O
species	O
production	O
,	O
and	O
inhibiting	O
activation	O
of	O
gene1s	O
caspase-3	O
and	O
-9	O
gene1e	O
,	O
as	O
well	O
as	O
gene1s	O
p53	O
gene1e	O
.	O
The	O
objective	O
of	O
this	O
study	O
is	O
to	O
identify	O
the	O
cell	O
signaling	O
pathways	O
by	O
which	O
gene1s	ARG2
selenoprotein	ARG2
H	ARG2
gene1e	ARG2
initiates	O
mitochondrial	O
biogenesis	O
.	O
We	O
first	O
confirmed	O
our	O
previous	O
observation	O
that	O
gene1s	ARG2
selenoprotein	ARG2
H	ARG2
gene1e	ARG2
transfected	O
species1s	O
HT22	O
species1e	O
cells	O
increased	O
the	O
protein	O
levels	O
of	O
nuclear	O
-	O
encoded	O
mitochondrial	O
biogenesis	O
factors	O
,	O
gene1s	O
peroxisome	O
proliferator	O
-	O
activated	O
receptor	O
g	O
coactivator-1a	O
,	O
gene1e	O
gene1s	O
nuclear	O
respiratory	O
factor	O
1	O
gene1e	O
and	O
gene1s	O
mitochondrial	O
transcription	O
factor	O
A	O
gene1e	O
.	O
We	O
then	O
observed	O
that	O
total	O
and	O
phosphorylation	O
of	O
gene1s	O
protein	O
kinase	O
A	O
gene1e	O
,	O
gene1s	O
Akt	O
gene1e	O
/	O
gene1s	O
protein	O
kinase	O
B	O
gene1e	O
and	O
gene1s	O
cyclic	O
adenosine	O
monophosphate	O
response	O
element	O
-	O
binding	O
protein	O
gene1e	O
(	O
gene1s	O
CREB	O
gene1e	O
)	O
were	O
significantly	O
increased	O
in	O
gene1s	ARG2
selenoprotein	ARG2
H	ARG2
gene1e	ARG2
transfected	O
cells	O
compared	O
to	O
vector	O
transfected	O
species1s	O
HT22	O
species1e	O
cells	O
.	O
To	O
verify	O
whether	O
the	O
observed	O
stimulating	O
effects	O
on	O
mitochondrial	O
biogenesis	O
pathways	O
are	O
caused	O
by	O
gene1s	ARG2
selenoprotein	ARG2
H	ARG2
gene1e	ARG2
and	O
mediated	O
through	O
gene1s	O
CREB	O
gene1e	O
,	O
we	O
knocked	O
down	O
gene1s	ARG2
selenoprotein	ARG2
H	ARG2
gene1e	ARG2
mRNA	O
level	O
using	O
siRNA	O
and	O
inhibited	O
gene1s	O
CREB	O
gene1e	O
with	O
napthol	O
AS	O
-	O
E	O
phosphate	O
in	O
gene1s	ARG2
selenoprotein	ARG2
H	ARG2
gene1e	ARG2
transfected	O
cells	O
and	O
repeated	O
the	O
measurements	O
of	O
the	O
aforementioned	O
biomarkers	O
.	O
Our	O
results	O
revealed	O
that	O
silencing	O
of	O
gene1s	ARG2
selenoprotein	ARG2
H	ARG2
gene1e	ARG2
not	O
only	O
decreased	O
the	O
protein	O
levels	O
of	O
gene1s	O
PGC-1a	O
gene1e	O
,	O
gene1s	O
nuclear	O
respiratory	O
factor	O
1	O
gene1e	O
and	O
gene1s	O
mitochondrial	O
transcription	O
factor	O
A	O
gene1e	O
,	O
but	O
also	O
decreased	O
the	O
total	O
and	O
phosphorylation	O
levels	O
of	O
gene1s	O
protein	O
kinase	O
A	O
gene1e	O
,	O
gene1s	O
protein	O
kinase	O
B	O
gene1e	O
,	O
and	O
gene1s	O
CREB	O
gene1e	O
.	O
Similarly	O
,	O
gene1s	O
CREB	O
gene1e	O
inhibition	O
reduced	O
gene1s	O
CREB	O
gene1e	O
activation	O
and	O
gene1s	O
PGC-1a	O
gene1e	O
protein	O
levels	O
in	O
gene1s	ARG2
selenoprotein	ARG2
H	ARG2
gene1e	ARG2
transfected	O
cells	O
.	O
Moreover	O
,	O
gene1s	ARG2
selenoprotein	ARG2
H	ARG2
gene1e	ARG2
transfection	O
increased	O
the	O
activity	O
of	O
mitochondrial	O
complexes	O
and	O
prevented	O
the	O
ultraviolet	O
B	O
induced	O
fall	O
of	O
mitochondrial	O
membrane	O
potential	O
.	O
We	O
conclude	O
that	O
the	O
effects	O
of	O
gene1s	ARG2
selenoprotein	ARG2
H	ARG2
gene1e	ARG2
on	O
mitochondrial	O
biogenesis	O
and	O
mitochondrial	O
function	O
are	O
probably	O
mediated	O
through	O
gene1s	O
protein	O
kinase	O
A	O
gene1e	O
-	O
gene1s	O
CREB	O
gene1e	O
-	O
gene1s	O
PGC-1a	O
gene1e	O
and	O
gene1s	O
Akt	O
gene1e	O
/	O
gene1s	O
protein	O
kinase	O
B	O
gene1e	O
-	O
gene1s	O
CREB	O
gene1e	O
-	O
gene1s	ARG2
PGC-1a	ARG2
gene1e	ARG2
pathways	O
.	O

Overexpression	O
of	O
species1s	O
human	O
species1e	O
gene1s	O
selenoprotein	O
H	O
gene1e	O
in	O
neuronal	O
cells	O
enhances	O
mitochondrial	O
biogenesis	O
and	O
function	O
through	O
activation	O
of	O
gene1s	ARG2
protein	ARG2
kinase	ARG2
A	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
protein	ARG2
kinase	ARG2
B	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
cyclic	ARG2
adenosine	ARG2
monophosphate	ARG2
response	ARG2
element	ARG2
-	ARG2
binding	ARG2
protein	ARG2
gene1e	ARG2
pathway	O
.	O
Mitochondrial	O
biogenesis	O
is	O
activated	O
by	O
gene1s	ARG2
nuclear	ARG2
encoded	ARG2
transcription	ARG2
co	ARG2
-	ARG2
activator	ARG2
peroxisome	ARG2
proliferator	ARG2
-	ARG2
activated	ARG2
receptor	ARG2
g	ARG2
coactivator-1a	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
PGC-1a	ARG2
gene1e	ARG2
)	O
,	O
which	O
is	O
regulated	O
by	O
several	O
upstream	O
factors	O
including	O
gene1s	ARG2
protein	ARG2
kinase	ARG2
A	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
Akt	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
protein	ARG2
kinase	ARG2
B	ARG2
gene1e	ARG2
.	O
We	O
have	O
previously	O
shown	O
that	O
gene1s	O
selenoprotein	O
H	O
gene1e	O
enhances	O
the	O
levels	O
of	O
nuclear	O
regulators	O
for	O
mitochondrial	O
biogenesis	O
,	O
increases	O
mitochondrial	O
mass	O
and	O
improves	O
mitochondrial	O
respiratory	O
rate	O
,	O
under	O
physiological	O
condition	O
.	O
Furthermore	O
,	O
overexpression	O
of	O
gene1s	O
selenoprotein	O
H	O
gene1e	O
protects	O
neuronal	O
arg1s	O
HT22	O
arg1e	O
cells	O
from	O
ultraviolet	O
B	O
irradiation	O
-	O
induced	O
cell	O
damage	O
by	O
lowering	O
reactive	O
oxygen	O
species	O
production	O
,	O
and	O
inhibiting	O
activation	O
of	O
gene1s	ARG2
caspase-3	ARG2
and	ARG2
-9	ARG2
gene1e	ARG2
,	O
as	O
well	O
as	O
gene1s	ARG2
p53	ARG2
gene1e	ARG2
.	O
The	O
objective	O
of	O
this	O
study	O
is	O
to	O
identify	O
the	O
cell	O
signaling	O
pathways	O
by	O
which	O
gene1s	O
selenoprotein	O
H	O
gene1e	O
initiates	O
mitochondrial	O
biogenesis	O
.	O
We	O
first	O
confirmed	O
our	O
previous	O
observation	O
that	O
gene1s	O
selenoprotein	O
H	O
gene1e	O
transfected	O
arg1s	O
HT22	O
arg1e	O
cells	O
increased	O
the	O
protein	O
levels	O
of	O
nuclear	O
-	O
encoded	O
mitochondrial	O
biogenesis	O
factors	O
,	O
gene1s	ARG2
peroxisome	ARG2
proliferator	ARG2
-	ARG2
activated	ARG2
receptor	ARG2
g	ARG2
coactivator-1a	ARG2
,	ARG2
gene1e	ARG2
gene1s	ARG2
nuclear	ARG2
respiratory	ARG2
factor	ARG2
1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
mitochondrial	ARG2
transcription	ARG2
factor	ARG2
A	ARG2
gene1e	ARG2
.	O
We	O
then	O
observed	O
that	O
total	O
and	O
phosphorylation	O
of	O
gene1s	ARG2
protein	ARG2
kinase	ARG2
A	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Akt	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
protein	ARG2
kinase	ARG2
B	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
cyclic	ARG2
adenosine	ARG2
monophosphate	ARG2
response	ARG2
element	ARG2
-	ARG2
binding	ARG2
protein	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
CREB	ARG2
gene1e	ARG2
)	O
were	O
significantly	O
increased	O
in	O
gene1s	O
selenoprotein	O
H	O
gene1e	O
transfected	O
cells	O
compared	O
to	O
vector	O
transfected	O
arg1s	O
HT22	O
arg1e	O
cells	O
.	O
To	O
verify	O
whether	O
the	O
observed	O
stimulating	O
effects	O
on	O
mitochondrial	O
biogenesis	O
pathways	O
are	O
caused	O
by	O
gene1s	O
selenoprotein	O
H	O
gene1e	O
and	O
mediated	O
through	O
gene1s	ARG2
CREB	ARG2
gene1e	ARG2
,	O
we	O
knocked	O
down	O
gene1s	O
selenoprotein	O
H	O
gene1e	O
mRNA	O
level	O
using	O
siRNA	O
and	O
inhibited	O
gene1s	ARG2
CREB	ARG2
gene1e	ARG2
with	O
napthol	O
AS	O
-	O
E	O
phosphate	O
in	O
gene1s	O
selenoprotein	O
H	O
gene1e	O
transfected	O
cells	O
and	O
repeated	O
the	O
measurements	O
of	O
the	O
aforementioned	O
biomarkers	O
.	O
Our	O
results	O
revealed	O
that	O
silencing	O
of	O
gene1s	O
selenoprotein	O
H	O
gene1e	O
not	O
only	O
decreased	O
the	O
protein	O
levels	O
of	O
gene1s	ARG2
PGC-1a	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
nuclear	ARG2
respiratory	ARG2
factor	ARG2
1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
mitochondrial	ARG2
transcription	ARG2
factor	ARG2
A	ARG2
gene1e	ARG2
,	O
but	O
also	O
decreased	O
the	O
total	O
and	O
phosphorylation	O
levels	O
of	O
gene1s	ARG2
protein	ARG2
kinase	ARG2
A	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
protein	ARG2
kinase	ARG2
B	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
CREB	ARG2
gene1e	ARG2
.	O
Similarly	O
,	O
gene1s	ARG2
CREB	ARG2
gene1e	ARG2
inhibition	O
reduced	O
gene1s	ARG2
CREB	ARG2
gene1e	ARG2
activation	O
and	O
gene1s	ARG2
PGC-1a	ARG2
gene1e	ARG2
protein	O
levels	O
in	O
gene1s	O
selenoprotein	O
H	O
gene1e	O
transfected	O
cells	O
.	O
Moreover	O
,	O
gene1s	O
selenoprotein	O
H	O
gene1e	O
transfection	O
increased	O
the	O
activity	O
of	O
mitochondrial	O
complexes	O
and	O
prevented	O
the	O
ultraviolet	O
B	O
induced	O
fall	O
of	O
mitochondrial	O
membrane	O
potential	O
.	O
We	O
conclude	O
that	O
the	O
effects	O
of	O
gene1s	O
selenoprotein	O
H	O
gene1e	O
on	O
mitochondrial	O
biogenesis	O
and	O
mitochondrial	O
function	O
are	O
probably	O
mediated	O
through	O
gene1s	ARG2
protein	ARG2
kinase	ARG2
A	ARG2
gene1e	ARG2
-	O
gene1s	ARG2
CREB	ARG2
gene1e	ARG2
-	O
gene1s	ARG2
PGC-1a	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
Akt	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
protein	ARG2
kinase	ARG2
B	ARG2
gene1e	ARG2
-	O
gene1s	ARG2
CREB	ARG2
gene1e	ARG2
-	O
gene1s	O
PGC-1a	O
gene1e	O
pathways	O
.	O

No	O
evidence	O
for	O
association	O
between	O
gene1s	ARG2
APOL1	ARG2
gene1e	ARG2
kidney	O
disease	O
risk	O
alleles	O
and	O
arg1s	O
Human	O
arg1e	O
African	O
Trypanosomiasis	O
in	O
two	O
Ugandan	O
populations	O
.	O
BACKGROUND	O
:	O
arg1s	O
Human	O
arg1e	O
African	O
trypanosomiasis	O
(	O
HAT	O
)	O
manifests	O
as	O
an	O
acute	O
form	O
caused	O
by	O
species1s	O
Trypanosoma	O
brucei	O
rhodesiense	O
species1e	O
(	O
species1s	O
Tbr	O
species1e	O
)	O
and	O
a	O
chronic	O
form	O
caused	O
by	O
species1s	O
Trypanosoma	O
brucei	O
gambiense	O
species1e	O
(	O
species1s	O
Tbg	O
species1e	O
)	O
.	O
Previous	O
studies	O
have	O
suggested	O
a	O
host	O
genetic	O
role	O
in	O
infection	O
outcomes	O
,	O
particularly	O
for	O
gene1s	ARG2
APOL1	ARG2
gene1e	ARG2
.	O
We	O
have	O
undertaken	O
candidate	O
gene	O
association	O
studies	O
(	O
CGAS	O
)	O
in	O
a	O
Ugandan	O
species1s	O
Tbr	O
species1e	O
and	O
a	O
species1s	O
Tbg	O
species1e	O
HAT	O
endemic	O
area	O
,	O
to	O
determine	O
whether	O
polymorphisms	O
in	O
gene1s	ARG2
IL10	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IL8	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IL4	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
HLAG	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
TNFA	ARG2
gene1e	ARG2
,	O
TNX4LB	O
,	O
gene1s	ARG2
IL6	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IFNG	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
MIF	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
APOL1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
HLAA	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IL1B	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IL4R	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IL12B	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IL12R	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
HP	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
HPR	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
CFH	ARG2
gene1e	ARG2
have	O
a	O
role	O
in	O
HAT	O
.	O
METHODOLOGY	O
AND	O
RESULTS	O
:	O
We	O
included	O
238	O
and	O
202	O
arg1s	O
participants	O
arg1e	O
from	O
the	O
Busoga	O
species1s	O
Tbr	O
species1e	O
and	O
Northwest	O
Uganda	O
species1s	O
Tbg	O
species1e	O
endemic	O
areas	O
respectively	O
.	O
Single	O
Nucleotide	O
Polymorphism	O
(	O
SNP	O
)	O
genotype	O
data	O
were	O
analysed	O
in	O
the	O
CGAS	O
.	O
The	O
study	O
was	O
powered	O
to	O
find	O
odds	O
ratios	O
>	O
2	O
but	O
association	O
testing	O
of	O
the	O
SNPs	O
with	O
HAT	O
yielded	O
no	O
positive	O
associations	O
i.e.	O
none	O
significant	O
after	O
correction	O
for	O
multiple	O
testing	O
.	O
However	O
there	O
was	O
strong	O
evidence	O
for	O
no	O
association	O
with	O
species1s	O
Tbr	O
species1e	O
HAT	O
and	O
gene1s	ARG2
APOL1	ARG2
gene1e	ARG2
G2	O
of	O
the	O
size	O
previously	O
reported	O
in	O
the	O
Kabermaido	O
district	O
of	O
Uganda	O
.	O
CONCLUSIONS	O
/	O
SIGNIFICANCE	O
:	O
A	O
recent	O
study	O
in	O
the	O
Soroti	O
and	O
Kaberamaido	O
focus	O
in	O
Central	O
Uganda	O
found	O
that	O
the	O
gene1s	ARG2
APOL1	ARG2
gene1e	ARG2
G2	O
allele	O
was	O
strongly	O
associated	O
with	O
protection	O
against	O
species1s	O
Tbr	O
species1e	O
HAT	O
(	O
odds	O
ratio	O
=	O
0.2	O
,	O
95	O
%	O
CI	O
:	O
0.07	O
to	O
0.48	O
,	O
p	O
=	O
0.0001	O
)	O
.	O
However	O
,	O
in	O
our	O
study	O
no	O
effect	O
of	O
G2	O
on	O
species1s	O
Tbr	O
species1e	O
HAT	O
was	O
found	O
,	O
despite	O
being	O
well	O
powered	O
to	O
find	O
a	O
similar	O
sized	O
effect	O
(	O
OR	O
=	O
0.9281	O
,	O
95	O
%	O
CI	O
:	O
0.482	O
to	O
1.788	O
,	O
p	O
=	O
0.8035	O
)	O
.	O
It	O
is	O
possible	O
that	O
the	O
G2	O
allele	O
is	O
protective	O
from	O
species1s	O
Tbr	O
species1e	O
in	O
the	O
Soroti	O
/	O
Kabermaido	O
focus	O
but	O
not	O
in	O
the	O
Iganga	O
district	O
of	O
Busoga	O
,	O
which	O
differ	O
in	O
ethnicity	O
and	O
infection	O
history	O
.	O
Mechanisms	O
underlying	O
HAT	O
infection	O
outcome	O
and	O
virulence	O
are	O
complex	O
and	O
might	O
differ	O
between	O
populations	O
,	O
and	O
likely	O
involve	O
several	O
host	O
,	O
parasite	O
or	O
even	O
environmental	O
factors	O
.	O

No	O
evidence	O
for	O
association	O
between	O
gene1s	O
APOL1	O
gene1e	O
kidney	O
disease	O
risk	O
alleles	O
and	O
species1s	O
Human	O
species1e	O
African	O
Trypanosomiasis	O
in	O
two	O
Ugandan	O
populations	O
.	O
BACKGROUND	O
:	O
species1s	O
Human	O
species1e	O
African	O
trypanosomiasis	O
(	O
HAT	O
)	O
manifests	O
as	O
an	O
acute	O
form	O
caused	O
by	O
arg1s	O
Trypanosoma	O
brucei	O
rhodesiense	O
arg1e	O
(	O
arg1s	O
Tbr	O
arg1e	O
)	O
and	O
a	O
chronic	O
form	O
caused	O
by	O
species1s	O
Trypanosoma	O
brucei	O
gambiense	O
species1e	O
(	O
species1s	O
Tbg	O
species1e	O
)	O
.	O
Previous	O
studies	O
have	O
suggested	O
a	O
host	O
genetic	O
role	O
in	O
infection	O
outcomes	O
,	O
particularly	O
for	O
gene1s	O
APOL1	O
gene1e	O
.	O
We	O
have	O
undertaken	O
candidate	O
gene	O
association	O
studies	O
(	O
CGAS	O
)	O
in	O
a	O
Ugandan	O
arg1s	O
Tbr	O
arg1e	O
and	O
a	O
species1s	O
Tbg	O
species1e	O
HAT	O
endemic	O
area	O
,	O
to	O
determine	O
whether	O
polymorphisms	O
in	O
gene1s	O
IL10	O
gene1e	O
,	O
gene1s	O
IL8	O
gene1e	O
,	O
gene1s	O
IL4	O
gene1e	O
,	O
gene1s	O
HLAG	O
gene1e	O
,	O
gene1s	O
TNFA	O
gene1e	O
,	O
TNX4LB	O
,	O
gene1s	O
IL6	O
gene1e	O
,	O
gene1s	O
IFNG	O
gene1e	O
,	O
gene1s	O
MIF	O
gene1e	O
,	O
gene1s	O
APOL1	O
gene1e	O
,	O
gene1s	O
HLAA	O
gene1e	O
,	O
gene1s	O
IL1B	O
gene1e	O
,	O
gene1s	O
IL4R	O
gene1e	O
,	O
gene1s	O
IL12B	O
gene1e	O
,	O
gene1s	O
IL12R	O
gene1e	O
,	O
gene1s	O
HP	O
gene1e	O
,	O
gene1s	O
HPR	O
gene1e	O
,	O
and	O
gene1s	O
CFH	O
gene1e	O
have	O
a	O
role	O
in	O
HAT	O
.	O
METHODOLOGY	O
AND	O
RESULTS	O
:	O
We	O
included	O
238	O
and	O
202	O
species1s	O
participants	O
species1e	O
from	O
the	O
Busoga	O
arg1s	O
Tbr	O
arg1e	O
and	O
Northwest	O
Uganda	O
species1s	O
Tbg	O
species1e	O
endemic	O
areas	O
respectively	O
.	O
Single	O
Nucleotide	O
Polymorphism	O
(	O
SNP	O
)	O
genotype	O
data	O
were	O
analysed	O
in	O
the	O
CGAS	O
.	O
The	O
study	O
was	O
powered	O
to	O
find	O
odds	O
ratios	O
>	O
2	O
but	O
association	O
testing	O
of	O
the	O
SNPs	O
with	O
HAT	O
yielded	O
no	O
positive	O
associations	O
i.e.	O
none	O
significant	O
after	O
correction	O
for	O
multiple	O
testing	O
.	O
However	O
there	O
was	O
strong	O
evidence	O
for	O
no	O
association	O
with	O
arg1s	O
Tbr	O
arg1e	O
HAT	O
and	O
gene1s	O
APOL1	O
gene1e	O
G2	O
of	O
the	O
size	O
previously	O
reported	O
in	O
the	O
Kabermaido	O
district	O
of	O
Uganda	O
.	O
CONCLUSIONS	O
/	O
SIGNIFICANCE	O
:	O
A	O
recent	O
study	O
in	O
the	O
Soroti	O
and	O
Kaberamaido	O
focus	O
in	O
Central	O
Uganda	O
found	O
that	O
the	O
gene1s	O
APOL1	O
gene1e	O
G2	O
allele	O
was	O
strongly	O
associated	O
with	O
protection	O
against	O
arg1s	O
Tbr	O
arg1e	O
HAT	O
(	O
odds	O
ratio	O
=	O
0.2	O
,	O
95	O
%	O
CI	O
:	O
0.07	O
to	O
0.48	O
,	O
p	O
=	O
0.0001	O
)	O
.	O
However	O
,	O
in	O
our	O
study	O
no	O
effect	O
of	O
G2	O
on	O
arg1s	O
Tbr	O
arg1e	O
HAT	O
was	O
found	O
,	O
despite	O
being	O
well	O
powered	O
to	O
find	O
a	O
similar	O
sized	O
effect	O
(	O
OR	O
=	O
0.9281	O
,	O
95	O
%	O
CI	O
:	O
0.482	O
to	O
1.788	O
,	O
p	O
=	O
0.8035	O
)	O
.	O
It	O
is	O
possible	O
that	O
the	O
G2	O
allele	O
is	O
protective	O
from	O
arg1s	O
Tbr	O
arg1e	O
in	O
the	O
Soroti	O
/	O
Kabermaido	O
focus	O
but	O
not	O
in	O
the	O
Iganga	O
district	O
of	O
Busoga	O
,	O
which	O
differ	O
in	O
ethnicity	O
and	O
infection	O
history	O
.	O
Mechanisms	O
underlying	O
HAT	O
infection	O
outcome	O
and	O
virulence	O
are	O
complex	O
and	O
might	O
differ	O
between	O
populations	O
,	O
and	O
likely	O
involve	O
several	O
host	O
,	O
parasite	O
or	O
even	O
environmental	O
factors	O
.	O

No	O
evidence	O
for	O
association	O
between	O
gene1s	O
APOL1	O
gene1e	O
kidney	O
disease	O
risk	O
alleles	O
and	O
species1s	O
Human	O
species1e	O
African	O
Trypanosomiasis	O
in	O
two	O
Ugandan	O
populations	O
.	O
BACKGROUND	O
:	O
species1s	O
Human	O
species1e	O
African	O
trypanosomiasis	O
(	O
HAT	O
)	O
manifests	O
as	O
an	O
acute	O
form	O
caused	O
by	O
species1s	O
Trypanosoma	O
brucei	O
rhodesiense	O
species1e	O
(	O
species1s	O
Tbr	O
species1e	O
)	O
and	O
a	O
chronic	O
form	O
caused	O
by	O
arg1s	O
Trypanosoma	O
brucei	O
gambiense	O
arg1e	O
(	O
arg1s	O
Tbg	O
arg1e	O
)	O
.	O
Previous	O
studies	O
have	O
suggested	O
a	O
host	O
genetic	O
role	O
in	O
infection	O
outcomes	O
,	O
particularly	O
for	O
gene1s	O
APOL1	O
gene1e	O
.	O
We	O
have	O
undertaken	O
candidate	O
gene	O
association	O
studies	O
(	O
CGAS	O
)	O
in	O
a	O
Ugandan	O
species1s	O
Tbr	O
species1e	O
and	O
a	O
arg1s	O
Tbg	O
arg1e	O
HAT	O
endemic	O
area	O
,	O
to	O
determine	O
whether	O
polymorphisms	O
in	O
gene1s	O
IL10	O
gene1e	O
,	O
gene1s	O
IL8	O
gene1e	O
,	O
gene1s	O
IL4	O
gene1e	O
,	O
gene1s	O
HLAG	O
gene1e	O
,	O
gene1s	O
TNFA	O
gene1e	O
,	O
TNX4LB	O
,	O
gene1s	O
IL6	O
gene1e	O
,	O
gene1s	O
IFNG	O
gene1e	O
,	O
gene1s	O
MIF	O
gene1e	O
,	O
gene1s	O
APOL1	O
gene1e	O
,	O
gene1s	O
HLAA	O
gene1e	O
,	O
gene1s	O
IL1B	O
gene1e	O
,	O
gene1s	O
IL4R	O
gene1e	O
,	O
gene1s	O
IL12B	O
gene1e	O
,	O
gene1s	O
IL12R	O
gene1e	O
,	O
gene1s	O
HP	O
gene1e	O
,	O
gene1s	O
HPR	O
gene1e	O
,	O
and	O
gene1s	O
CFH	O
gene1e	O
have	O
a	O
role	O
in	O
HAT	O
.	O
METHODOLOGY	O
AND	O
RESULTS	O
:	O
We	O
included	O
238	O
and	O
202	O
species1s	O
participants	O
species1e	O
from	O
the	O
Busoga	O
species1s	O
Tbr	O
species1e	O
and	O
Northwest	O
Uganda	O
arg1s	O
Tbg	O
arg1e	O
endemic	O
areas	O
respectively	O
.	O
Single	O
Nucleotide	O
Polymorphism	O
(	O
SNP	O
)	O
genotype	O
data	O
were	O
analysed	O
in	O
the	O
CGAS	O
.	O
The	O
study	O
was	O
powered	O
to	O
find	O
odds	O
ratios	O
>	O
2	O
but	O
association	O
testing	O
of	O
the	O
SNPs	O
with	O
HAT	O
yielded	O
no	O
positive	O
associations	O
i.e.	O
none	O
significant	O
after	O
correction	O
for	O
multiple	O
testing	O
.	O
However	O
there	O
was	O
strong	O
evidence	O
for	O
no	O
association	O
with	O
species1s	O
Tbr	O
species1e	O
HAT	O
and	O
gene1s	O
APOL1	O
gene1e	O
G2	O
of	O
the	O
size	O
previously	O
reported	O
in	O
the	O
Kabermaido	O
district	O
of	O
Uganda	O
.	O
CONCLUSIONS	O
/	O
SIGNIFICANCE	O
:	O
A	O
recent	O
study	O
in	O
the	O
Soroti	O
and	O
Kaberamaido	O
focus	O
in	O
Central	O
Uganda	O
found	O
that	O
the	O
gene1s	O
APOL1	O
gene1e	O
G2	O
allele	O
was	O
strongly	O
associated	O
with	O
protection	O
against	O
species1s	O
Tbr	O
species1e	O
HAT	O
(	O
odds	O
ratio	O
=	O
0.2	O
,	O
95	O
%	O
CI	O
:	O
0.07	O
to	O
0.48	O
,	O
p	O
=	O
0.0001	O
)	O
.	O
However	O
,	O
in	O
our	O
study	O
no	O
effect	O
of	O
G2	O
on	O
species1s	O
Tbr	O
species1e	O
HAT	O
was	O
found	O
,	O
despite	O
being	O
well	O
powered	O
to	O
find	O
a	O
similar	O
sized	O
effect	O
(	O
OR	O
=	O
0.9281	O
,	O
95	O
%	O
CI	O
:	O
0.482	O
to	O
1.788	O
,	O
p	O
=	O
0.8035	O
)	O
.	O
It	O
is	O
possible	O
that	O
the	O
G2	O
allele	O
is	O
protective	O
from	O
species1s	O
Tbr	O
species1e	O
in	O
the	O
Soroti	O
/	O
Kabermaido	O
focus	O
but	O
not	O
in	O
the	O
Iganga	O
district	O
of	O
Busoga	O
,	O
which	O
differ	O
in	O
ethnicity	O
and	O
infection	O
history	O
.	O
Mechanisms	O
underlying	O
HAT	O
infection	O
outcome	O
and	O
virulence	O
are	O
complex	O
and	O
might	O
differ	O
between	O
populations	O
,	O
and	O
likely	O
involve	O
several	O
host	O
,	O
parasite	O
or	O
even	O
environmental	O
factors	O
.	O

The	O
impact	O
of	O
gene1s	ARG2
PPARa	ARG2
gene1e	ARG2
activation	O
on	O
whole	O
genome	O
gene	O
expression	O
in	O
arg1s	O
human	O
arg1e	O
precision	O
cut	O
liver	O
slices	O
.	O
BACKGROUND	O
:	O
Studies	O
in	O
species1s	O
mice	O
species1e	O
have	O
shown	O
that	O
gene1s	O
PPARa	O
gene1e	O
is	O
an	O
important	O
regulator	O
of	O
lipid	O
metabolism	O
in	O
liver	O
and	O
key	O
transcription	O
factor	O
involved	O
in	O
the	O
adaptive	O
response	O
to	O
fasting	O
.	O
However	O
,	O
much	O
less	O
is	O
known	O
about	O
the	O
role	O
of	O
gene1s	ARG2
PPARa	ARG2
gene1e	ARG2
in	O
arg1s	O
human	O
arg1e	O
liver	O
.	O
METHODS	O
:	O
Here	O
we	O
set	O
out	O
to	O
study	O
the	O
function	O
of	O
gene1s	ARG2
PPARa	ARG2
gene1e	ARG2
in	O
arg1s	O
human	O
arg1e	O
liver	O
via	O
analysis	O
of	O
whole	O
genome	O
gene	O
regulation	O
in	O
arg1s	O
human	O
arg1e	O
liver	O
slices	O
treated	O
with	O
the	O
gene1s	ARG2
PPARa	ARG2
gene1e	ARG2
agonist	O
Wy14643	O
.	O
RESULTS	O
:	O
Quantitative	O
PCR	O
indicated	O
that	O
gene1s	ARG2
PPARa	ARG2
gene1e	ARG2
is	O
well	O
expressed	O
in	O
arg1s	O
human	O
arg1e	O
liver	O
and	O
arg1s	O
human	O
arg1e	O
liver	O
slices	O
and	O
that	O
the	O
classical	O
gene1s	ARG2
PPARa	ARG2
gene1e	ARG2
targets	O
gene1s	ARG2
PLIN2	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
VLDLR	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
ANGPTL4	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
CPT1A	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
PDK4	ARG2
gene1e	ARG2
are	O
robustly	O
induced	O
by	O
gene1s	ARG2
PPARa	ARG2
gene1e	ARG2
activation	O
.	O
Transcriptomics	O
analysis	O
indicated	O
that	O
617	O
genes	O
were	O
upregulated	O
and	O
665	O
genes	O
were	O
downregulated	O
by	O
gene1s	ARG2
PPARa	ARG2
gene1e	ARG2
activation	O
(	O
q	O
value	O
<	O
0.05	O
)	O
.	O
Many	O
genes	O
induced	O
by	O
gene1s	ARG2
PPARa	ARG2
gene1e	ARG2
activation	O
were	O
involved	O
in	O
lipid	O
metabolism	O
(	O
gene1s	ARG2
ACSL5	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
AGPAT9	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
FADS1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
SLC27A4	ARG2
gene1e	ARG2
)	O
,	O
xenobiotic	O
metabolism	O
(	O
gene1s	ARG2
POR	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
ABCC2	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
CYP3A5	ARG2
gene1e	ARG2
)	O
or	O
the	O
unfolded	O
protein	O
response	O
,	O
whereas	O
most	O
of	O
the	O
downregulated	O
genes	O
were	O
involved	O
in	O
immune	O
-	O
related	O
pathways	O
.	O
Among	O
the	O
most	O
highly	O
repressed	O
genes	O
upon	O
gene1s	ARG2
PPARa	ARG2
gene1e	ARG2
activation	O
were	O
several	O
chemokines	O
(	O
e.g.	O
gene1s	ARG2
CXCL9	ARG2
-	ARG2
11	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
CCL8	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
CX3CL1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
CXCL6	ARG2
gene1e	ARG2
)	O
,	O
gene1s	ARG2
interferon	ARG2
g	ARG2
gene1e	ARG2
-	O
induced	O
genes	O
(	O
e.g.	O
gene1s	ARG2
IFITM1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IFIT1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IFIT2	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IFIT3	ARG2
gene1e	ARG2
)	O
and	O
numerous	O
other	O
immune	O
-	O
related	O
genes	O
(	O
e.g.	O
gene1s	ARG2
TLR3	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
NOS2	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
LCN2	ARG2
gene1e	ARG2
)	O
.	O
Comparative	O
analysis	O
of	O
gene	O
regulation	O
by	O
Wy14643	O
between	O
arg1s	O
human	O
arg1e	O
liver	O
slices	O
and	O
primary	O
arg1s	O
human	O
arg1e	O
hepatocytes	O
showed	O
that	O
down	O
-	O
regulation	O
of	O
gene	O
expression	O
by	O
gene1s	ARG2
PPARa	ARG2
gene1e	ARG2
is	O
much	O
better	O
captured	O
by	O
liver	O
slices	O
as	O
compared	O
to	O
primary	O
hepatocytes	O
.	O
In	O
particular	O
,	O
gene1s	ARG2
PPARa	ARG2
gene1e	ARG2
activation	O
markedly	O
suppressed	O
immunity	O
/	O
inflammation	O
-	O
related	O
genes	O
in	O
arg1s	O
human	O
arg1e	O
liver	O
slices	O
but	O
not	O
in	O
primary	O
hepatocytes	O
.	O
Finally	O
,	O
several	O
putative	O
new	O
target	O
genes	O
of	O
gene1s	ARG2
PPARa	ARG2
gene1e	ARG2
were	O
identified	O
that	O
were	O
commonly	O
induced	O
by	O
gene1s	ARG2
PPARa	ARG2
gene1e	ARG2
activation	O
in	O
the	O
two	O
arg1s	O
human	O
arg1e	O
liver	O
model	O
systems	O
,	O
including	O
gene1s	ARG2
TSKU	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
RHOF	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
CA12	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
VSIG10L	ARG2
gene1e	ARG2
.	O
CONCLUSION	O
:	O
Our	O
paper	O
demonstrates	O
the	O
suitability	O
and	O
superiority	O
of	O
arg1s	O
human	O
arg1e	O
liver	O
slices	O
over	O
primary	O
hepatocytes	O
for	O
studying	O
the	O
functional	O
role	O
of	O
gene1s	ARG2
PPARa	ARG2
gene1e	ARG2
in	O
arg1s	O
human	O
arg1e	O
liver	O
.	O
Our	O
data	O
underscore	O
the	O
major	O
role	O
of	O
gene1s	ARG2
PPARa	ARG2
gene1e	ARG2
in	O
regulation	O
of	O
hepatic	O
lipid	O
and	O
xenobiotic	O
metabolism	O
in	O
arg1s	O
human	O
arg1e	O
liver	O
and	O
reveal	O
a	O
marked	O
immuno	O
-	O
suppressive	O
/	O
anti	O
-	O
inflammatory	O
effect	O
of	O
gene1s	ARG2
PPARa	ARG2
gene1e	ARG2
in	O
arg1s	O
human	O
arg1e	O
liver	O
slices	O
that	O
may	O
be	O
therapeutically	O
relevant	O
for	O
non	O
-	O
alcoholic	O
fatty	O
liver	O
disease	O
.	O

The	O
impact	O
of	O
gene1s	O
PPARa	O
gene1e	O
activation	O
on	O
whole	O
genome	O
gene	O
expression	O
in	O
species1s	O
human	O
species1e	O
precision	O
cut	O
liver	O
slices	O
.	O
BACKGROUND	O
:	O
Studies	O
in	O
arg1s	O
mice	O
arg1e	O
have	O
shown	O
that	O
gene1s	ARG2
PPARa	ARG2
gene1e	ARG2
is	O
an	O
important	O
regulator	O
of	O
lipid	O
metabolism	O
in	O
liver	O
and	O
key	O
transcription	O
factor	O
involved	O
in	O
the	O
adaptive	O
response	O
to	O
fasting	O
.	O
However	O
,	O
much	O
less	O
is	O
known	O
about	O
the	O
role	O
of	O
gene1s	O
PPARa	O
gene1e	O
in	O
species1s	O
human	O
species1e	O
liver	O
.	O
METHODS	O
:	O
Here	O
we	O
set	O
out	O
to	O
study	O
the	O
function	O
of	O
gene1s	O
PPARa	O
gene1e	O
in	O
species1s	O
human	O
species1e	O
liver	O
via	O
analysis	O
of	O
whole	O
genome	O
gene	O
regulation	O
in	O
species1s	O
human	O
species1e	O
liver	O
slices	O
treated	O
with	O
the	O
gene1s	O
PPARa	O
gene1e	O
agonist	O
Wy14643	O
.	O
RESULTS	O
:	O
Quantitative	O
PCR	O
indicated	O
that	O
gene1s	O
PPARa	O
gene1e	O
is	O
well	O
expressed	O
in	O
species1s	O
human	O
species1e	O
liver	O
and	O
species1s	O
human	O
species1e	O
liver	O
slices	O
and	O
that	O
the	O
classical	O
gene1s	O
PPARa	O
gene1e	O
targets	O
gene1s	O
PLIN2	O
gene1e	O
,	O
gene1s	O
VLDLR	O
gene1e	O
,	O
gene1s	O
ANGPTL4	O
gene1e	O
,	O
gene1s	O
CPT1A	O
gene1e	O
and	O
gene1s	O
PDK4	O
gene1e	O
are	O
robustly	O
induced	O
by	O
gene1s	O
PPARa	O
gene1e	O
activation	O
.	O
Transcriptomics	O
analysis	O
indicated	O
that	O
617	O
genes	O
were	O
upregulated	O
and	O
665	O
genes	O
were	O
downregulated	O
by	O
gene1s	O
PPARa	O
gene1e	O
activation	O
(	O
q	O
value	O
<	O
0.05	O
)	O
.	O
Many	O
genes	O
induced	O
by	O
gene1s	O
PPARa	O
gene1e	O
activation	O
were	O
involved	O
in	O
lipid	O
metabolism	O
(	O
gene1s	O
ACSL5	O
gene1e	O
,	O
gene1s	O
AGPAT9	O
gene1e	O
,	O
gene1s	O
FADS1	O
gene1e	O
,	O
gene1s	O
SLC27A4	O
gene1e	O
)	O
,	O
xenobiotic	O
metabolism	O
(	O
gene1s	O
POR	O
gene1e	O
,	O
gene1s	O
ABCC2	O
gene1e	O
,	O
gene1s	O
CYP3A5	O
gene1e	O
)	O
or	O
the	O
unfolded	O
protein	O
response	O
,	O
whereas	O
most	O
of	O
the	O
downregulated	O
genes	O
were	O
involved	O
in	O
immune	O
-	O
related	O
pathways	O
.	O
Among	O
the	O
most	O
highly	O
repressed	O
genes	O
upon	O
gene1s	O
PPARa	O
gene1e	O
activation	O
were	O
several	O
chemokines	O
(	O
e.g.	O
gene1s	O
CXCL9	O
-	O
11	O
gene1e	O
,	O
gene1s	O
CCL8	O
gene1e	O
,	O
gene1s	O
CX3CL1	O
gene1e	O
,	O
gene1s	O
CXCL6	O
gene1e	O
)	O
,	O
gene1s	O
interferon	O
g	O
gene1e	O
-	O
induced	O
genes	O
(	O
e.g.	O
gene1s	O
IFITM1	O
gene1e	O
,	O
gene1s	O
IFIT1	O
gene1e	O
,	O
gene1s	O
IFIT2	O
gene1e	O
,	O
gene1s	O
IFIT3	O
gene1e	O
)	O
and	O
numerous	O
other	O
immune	O
-	O
related	O
genes	O
(	O
e.g.	O
gene1s	O
TLR3	O
gene1e	O
,	O
gene1s	O
NOS2	O
gene1e	O
,	O
and	O
gene1s	O
LCN2	O
gene1e	O
)	O
.	O
Comparative	O
analysis	O
of	O
gene	O
regulation	O
by	O
Wy14643	O
between	O
species1s	O
human	O
species1e	O
liver	O
slices	O
and	O
primary	O
species1s	O
human	O
species1e	O
hepatocytes	O
showed	O
that	O
down	O
-	O
regulation	O
of	O
gene	O
expression	O
by	O
gene1s	O
PPARa	O
gene1e	O
is	O
much	O
better	O
captured	O
by	O
liver	O
slices	O
as	O
compared	O
to	O
primary	O
hepatocytes	O
.	O
In	O
particular	O
,	O
gene1s	O
PPARa	O
gene1e	O
activation	O
markedly	O
suppressed	O
immunity	O
/	O
inflammation	O
-	O
related	O
genes	O
in	O
species1s	O
human	O
species1e	O
liver	O
slices	O
but	O
not	O
in	O
primary	O
hepatocytes	O
.	O
Finally	O
,	O
several	O
putative	O
new	O
target	O
genes	O
of	O
gene1s	O
PPARa	O
gene1e	O
were	O
identified	O
that	O
were	O
commonly	O
induced	O
by	O
gene1s	O
PPARa	O
gene1e	O
activation	O
in	O
the	O
two	O
species1s	O
human	O
species1e	O
liver	O
model	O
systems	O
,	O
including	O
gene1s	O
TSKU	O
gene1e	O
,	O
gene1s	O
RHOF	O
gene1e	O
,	O
gene1s	O
CA12	O
gene1e	O
and	O
gene1s	O
VSIG10L	O
gene1e	O
.	O
CONCLUSION	O
:	O
Our	O
paper	O
demonstrates	O
the	O
suitability	O
and	O
superiority	O
of	O
species1s	O
human	O
species1e	O
liver	O
slices	O
over	O
primary	O
hepatocytes	O
for	O
studying	O
the	O
functional	O
role	O
of	O
gene1s	O
PPARa	O
gene1e	O
in	O
species1s	O
human	O
species1e	O
liver	O
.	O
Our	O
data	O
underscore	O
the	O
major	O
role	O
of	O
gene1s	O
PPARa	O
gene1e	O
in	O
regulation	O
of	O
hepatic	O
lipid	O
and	O
xenobiotic	O
metabolism	O
in	O
species1s	O
human	O
species1e	O
liver	O
and	O
reveal	O
a	O
marked	O
immuno	O
-	O
suppressive	O
/	O
anti	O
-	O
inflammatory	O
effect	O
of	O
gene1s	O
PPARa	O
gene1e	O
in	O
species1s	O
human	O
species1e	O
liver	O
slices	O
that	O
may	O
be	O
therapeutically	O
relevant	O
for	O
non	O
-	O
alcoholic	O
fatty	O
liver	O
disease	O
.	O

Identification	O
of	O
novel	O
gene	O
amplifications	O
in	O
breast	O
cancer	O
and	O
coexistence	O
of	O
gene	O
amplification	O
with	O
an	O
activating	O
mutation	O
of	O
gene1s	ARG2
PIK3CA	ARG2
gene1e	ARG2
.	O
To	O
identify	O
genetic	O
events	O
that	O
characterize	O
cancer	O
progression	O
,	O
we	O
conducted	O
a	O
comprehensive	O
genetic	O
evaluation	O
of	O
161	O
primary	O
breast	O
tumors	O
.	O
Similar	O
to	O
the	O
"	O
mountain	O
-	O
and	O
-	O
hill	O
"	O
view	O
of	O
mutations	O
,	O
gene	O
amplification	O
also	O
shows	O
high-	O
and	O
low	O
-	O
frequency	O
alterations	O
in	O
breast	O
cancers	O
.	O
The	O
frequently	O
amplified	O
genes	O
include	O
the	O
well	O
-	O
known	O
gene1s	ARG2
oncogenes	ARG2
gene1e	ARG2
gene1s	ARG2
ERBB2	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
FGFR1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
MYC	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
CCND1	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
PIK3CA	ARG2
gene1e	ARG2
,	O
whereas	O
other	O
known	O
gene1s	ARG2
oncogenes	ARG2
gene1e	ARG2
that	O
are	O
amplified	O
,	O
although	O
less	O
frequently	O
,	O
include	O
gene1s	ARG2
CCND2	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
EGFR	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
FGFR2	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
NOTCH3	ARG2
gene1e	ARG2
.	O
More	O
importantly	O
,	O
by	O
honing	O
in	O
on	O
minimally	O
amplified	O
regions	O
containing	O
three	O
or	O
fewer	O
genes	O
,	O
we	O
identified	O
six	O
new	O
amplified	O
genes	O
:	O
gene1s	ARG2
POLD3	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IRAK4	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IRX2	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
TBL1XR1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
ASPH	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
BRD4	ARG2
gene1e	ARG2
.	O
We	O
found	O
that	O
both	O
the	O
gene1s	ARG2
IRX2	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
TBL1XR1	ARG2
gene1e	ARG2
proteins	O
showed	O
higher	O
expression	O
in	O
the	O
malignant	O
cell	O
lines	O
MCF10CA1h	O
and	O
MCF10CA1a	O
than	O
in	O
their	O
precursor	O
,	O
MCF10A	O
,	O
a	O
normal	O
immortalized	O
mammary	O
epithelial	O
cell	O
line	O
.	O
To	O
study	O
oncogenic	O
roles	O
of	O
gene1s	ARG2
TBL1XR1	ARG2
gene1e	ARG2
,	O
we	O
performed	O
knockdown	O
experiments	O
using	O
a	O
short	O
hairpin	O
RNA	O
approach	O
and	O
found	O
that	O
depletion	O
of	O
gene1s	ARG2
TBL1XR1	ARG2
gene1e	ARG2
in	O
arg1s	O
MCF10CA1h	O
arg1e	O
cells	O
resulted	O
in	O
reduction	O
of	O
cell	O
migration	O
and	O
invasion	O
as	O
well	O
as	O
suppression	O
of	O
tumorigenesis	O
in	O
species1s	O
mouse	O
species1e	O
xenografts	O
.	O
Intriguingly	O
,	O
our	O
mutation	O
analysis	O
showed	O
the	O
presence	O
of	O
activation	O
mutations	O
in	O
the	O
gene1s	ARG2
PIK3CA	ARG2
gene1e	ARG2
gene	O
in	O
a	O
subset	O
of	O
tumors	O
that	O
also	O
had	O
DNA	O
copy	O
number	O
increases	O
in	O
the	O
gene1s	ARG2
PIK3CA	ARG2
gene1e	ARG2
locus	O
,	O
suggesting	O
an	O
additive	O
effect	O
of	O
coexisting	O
activating	O
amino	O
acid	O
substitution	O
and	O
dosage	O
increase	O
from	O
amplification	O
.	O
Our	O
gene	O
amplification	O
and	O
somatic	O
mutation	O
analysis	O
of	O
breast	O
primary	O
tumors	O
provides	O
a	O
coherent	O
picture	O
of	O
genetic	O
events	O
,	O
both	O
corroborating	O
and	O
novel	O
,	O
offering	O
insight	O
into	O
the	O
genetic	O
underpinnings	O
of	O
breast	O
cancer	O
progression	O
.	O

Identification	O
of	O
novel	O
gene	O
amplifications	O
in	O
breast	O
cancer	O
and	O
coexistence	O
of	O
gene	O
amplification	O
with	O
an	O
activating	O
mutation	O
of	O
gene1s	O
PIK3CA	O
gene1e	O
.	O
To	O
identify	O
genetic	O
events	O
that	O
characterize	O
cancer	O
progression	O
,	O
we	O
conducted	O
a	O
comprehensive	O
genetic	O
evaluation	O
of	O
161	O
primary	O
breast	O
tumors	O
.	O
Similar	O
to	O
the	O
"	O
mountain	O
-	O
and	O
-	O
hill	O
"	O
view	O
of	O
mutations	O
,	O
gene	O
amplification	O
also	O
shows	O
high-	O
and	O
low	O
-	O
frequency	O
alterations	O
in	O
breast	O
cancers	O
.	O
The	O
frequently	O
amplified	O
genes	O
include	O
the	O
well	O
-	O
known	O
gene1s	O
oncogenes	O
gene1e	O
gene1s	O
ERBB2	O
gene1e	O
,	O
gene1s	O
FGFR1	O
gene1e	O
,	O
gene1s	O
MYC	O
gene1e	O
,	O
gene1s	O
CCND1	O
gene1e	O
,	O
and	O
gene1s	O
PIK3CA	O
gene1e	O
,	O
whereas	O
other	O
known	O
gene1s	O
oncogenes	O
gene1e	O
that	O
are	O
amplified	O
,	O
although	O
less	O
frequently	O
,	O
include	O
gene1s	O
CCND2	O
gene1e	O
,	O
gene1s	O
EGFR	O
gene1e	O
,	O
gene1s	O
FGFR2	O
gene1e	O
,	O
and	O
gene1s	O
NOTCH3	O
gene1e	O
.	O
More	O
importantly	O
,	O
by	O
honing	O
in	O
on	O
minimally	O
amplified	O
regions	O
containing	O
three	O
or	O
fewer	O
genes	O
,	O
we	O
identified	O
six	O
new	O
amplified	O
genes	O
:	O
gene1s	O
POLD3	O
gene1e	O
,	O
gene1s	O
IRAK4	O
gene1e	O
,	O
gene1s	O
IRX2	O
gene1e	O
,	O
gene1s	O
TBL1XR1	O
gene1e	O
,	O
gene1s	O
ASPH	O
gene1e	O
,	O
and	O
gene1s	O
BRD4	O
gene1e	O
.	O
We	O
found	O
that	O
both	O
the	O
gene1s	O
IRX2	O
gene1e	O
and	O
gene1s	O
TBL1XR1	O
gene1e	O
proteins	O
showed	O
higher	O
expression	O
in	O
the	O
malignant	O
cell	O
lines	O
MCF10CA1h	O
and	O
MCF10CA1a	O
than	O
in	O
their	O
precursor	O
,	O
MCF10A	O
,	O
a	O
normal	O
immortalized	O
mammary	O
epithelial	O
cell	O
line	O
.	O
To	O
study	O
oncogenic	O
roles	O
of	O
gene1s	O
TBL1XR1	O
gene1e	O
,	O
we	O
performed	O
knockdown	O
experiments	O
using	O
a	O
short	O
hairpin	O
RNA	O
approach	O
and	O
found	O
that	O
depletion	O
of	O
gene1s	O
TBL1XR1	O
gene1e	O
in	O
species1s	O
MCF10CA1h	O
species1e	O
cells	O
resulted	O
in	O
reduction	O
of	O
cell	O
migration	O
and	O
invasion	O
as	O
well	O
as	O
suppression	O
of	O
tumorigenesis	O
in	O
arg1s	O
mouse	O
arg1e	O
xenografts	O
.	O
Intriguingly	O
,	O
our	O
mutation	O
analysis	O
showed	O
the	O
presence	O
of	O
activation	O
mutations	O
in	O
the	O
gene1s	O
PIK3CA	O
gene1e	O
gene	O
in	O
a	O
subset	O
of	O
tumors	O
that	O
also	O
had	O
DNA	O
copy	O
number	O
increases	O
in	O
the	O
gene1s	O
PIK3CA	O
gene1e	O
locus	O
,	O
suggesting	O
an	O
additive	O
effect	O
of	O
coexisting	O
activating	O
amino	O
acid	O
substitution	O
and	O
dosage	O
increase	O
from	O
amplification	O
.	O
Our	O
gene	O
amplification	O
and	O
somatic	O
mutation	O
analysis	O
of	O
breast	O
primary	O
tumors	O
provides	O
a	O
coherent	O
picture	O
of	O
genetic	O
events	O
,	O
both	O
corroborating	O
and	O
novel	O
,	O
offering	O
insight	O
into	O
the	O
genetic	O
underpinnings	O
of	O
breast	O
cancer	O
progression	O
.	O

Dysregulation	O
of	O
gene1s	O
Wnt	O
inhibitory	O
factor	O
1	O
gene1e	O
(	O
gene1s	O
Wif1	O
gene1e	O
)	O
expression	O
resulted	O
in	O
aberrant	O
gene1s	O
Wnt	O
gene1e	O
-	O
gene1s	O
b	O
-	O
catenin	O
gene1e	O
signaling	O
and	O
cell	O
death	O
of	O
the	O
cloaca	O
endoderm	O
,	O
and	O
anorectal	O
malformations	O
.	O
In	O
arg1s	O
mammalian	O
arg1e	O
urorectal	O
development	O
,	O
the	O
urorectal	O
septum	O
(	O
urs	O
)	O
descends	O
from	O
the	O
ventral	O
body	O
wall	O
to	O
the	O
cloaca	O
membrane	O
(	O
cm	O
)	O
to	O
partition	O
the	O
cloaca	O
into	O
urogenital	O
sinus	O
and	O
rectum	O
.	O
Defective	O
urs	O
growth	O
results	O
in	O
arg1s	O
human	O
arg1e	O
congenital	O
anorectal	O
malformations	O
(	O
ARMs	O
)	O
,	O
and	O
their	O
pathogenic	O
mechanisms	O
are	O
unclear	O
.	O
Recent	O
studies	O
only	O
focused	O
on	O
the	O
importance	O
of	O
urs	O
mesenchyme	O
proliferation	O
,	O
which	O
is	O
induced	O
by	O
endoderm	O
-	O
derived	O
gene1s	O
Sonic	O
Hedgehog	O
gene1e	O
(	O
gene1s	O
Shh	O
gene1e	O
)	O
.	O
Here	O
,	O
we	O
showed	O
that	O
the	O
programmed	O
cell	O
death	O
of	O
the	O
apical	O
urs	O
and	O
proximal	O
cm	O
endoderm	O
is	O
particularly	O
crucial	O
for	O
the	O
growth	O
of	O
urs	O
during	O
septation	O
.	O
The	O
apoptotic	O
endoderm	O
was	O
closely	O
associated	O
with	O
the	O
tempo	O
-	O
spatial	O
expression	O
of	O
gene1s	O
Wnt	O
inhibitory	O
factor	O
1	O
gene1e	O
(	O
gene1s	O
Wif1	O
gene1e	O
)	O
,	O
which	O
is	O
an	O
inhibitor	O
of	O
gene1s	O
Wnt	O
gene1e	O
-	O
gene1s	O
b	O
-	O
catenin	O
gene1e	O
signaling	O
.	O
In	O
gene1s	O
Wif1	O
gene1e	O
(lacZ	O
/	O
lacZ	O
)	O
mutant	O
species1s	O
mice	O
species1e	O
and	O
cultured	O
urorectum	O
with	O
exogenous	O
gene1s	O
Wif1	O
gene1e	O
,	O
cloaca	O
septation	O
was	O
defective	O
with	O
undescended	O
urs	O
and	O
hypospadias	O
-	O
like	O
phenotypes	O
,	O
and	O
such	O
septation	O
defects	O
were	O
also	O
observed	O
in	O
gene1s	O
Shh	O
gene1e	O
(-/-	O
)	O
mutants	O
and	O
in	O
endodermal	O
gene1s	O
b	O
-	O
catenin	O
gene1e	O
gain	O
-	O
of	O
-	O
function	O
(	O
GOF	O
)	O
mutants	O
.	O
In	O
addition	O
,	O
gene1s	O
Wif1	O
gene1e	O
and	O
gene1s	O
Shh	O
gene1e	O
were	O
expressed	O
in	O
a	O
complementary	O
manner	O
in	O
the	O
cloaca	O
endoderm	O
,	O
and	O
gene1s	O
Wif1	O
gene1e	O
was	O
ectopically	O
expressed	O
in	O
the	O
urs	O
and	O
cm	O
associated	O
with	O
excessive	O
endodermal	O
apoptosis	O
and	O
septation	O
defects	O
in	O
gene1s	O
Shh	O
gene1e	O
(-/-	O
)	O
mutants	O
.	O
Furthermore	O
,	O
apoptotic	O
cells	O
were	O
markedly	O
reduced	O
in	O
the	O
endodermal	O
gene1s	O
b	O
-	O
catenin	O
gene1e	O
GOF	O
mutant	O
embryos	O
,	O
which	O
counteracted	O
the	O
inhibitory	O
effects	O
of	O
gene1s	O
Wif1	O
gene1e	O
.	O
Taken	O
altogether	O
,	O
these	O
data	O
suggest	O
that	O
regulated	O
expression	O
of	O
gene1s	O
Wif1	O
gene1e	O
is	O
critical	O
for	O
the	O
growth	O
of	O
the	O
urs	O
during	O
cloaca	O
septation	O
.	O
Hence	O
,	O
gene1s	O
Wif1	O
gene1e	O
governs	O
cell	O
apoptosis	O
of	O
urs	O
endoderm	O
by	O
repressing	O
gene1s	O
b	O
-	O
catenin	O
gene1e	O
signal	O
,	O
which	O
may	O
facilitate	O
the	O
protrusion	O
of	O
the	O
underlying	O
proliferating	O
mesenchymal	O
cells	O
towards	O
the	O
cm	O
for	O
cloaca	O
septation	O
.	O
Dysregulation	O
of	O
this	O
endodermal	O
gene1s	O
Shh	O
gene1e	O
-	O
gene1s	O
Wif1	O
gene1e	O
-	O
gene1s	O
b	O
-	O
catenin	O
gene1e	O
signaling	O
axis	O
contributes	O
to	O
ARM	O
pathogenesis	O
.	O

Dysregulation	O
of	O
gene1s	ARG2
Wnt	ARG2
inhibitory	ARG2
factor	ARG2
1	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
Wif1	ARG2
gene1e	ARG2
)	O
expression	O
resulted	O
in	O
aberrant	O
gene1s	ARG2
Wnt	ARG2
gene1e	ARG2
-	O
gene1s	ARG2
b	ARG2
-	ARG2
catenin	ARG2
gene1e	ARG2
signaling	O
and	O
cell	O
death	O
of	O
the	O
cloaca	O
endoderm	O
,	O
and	O
anorectal	O
malformations	O
.	O
In	O
species1s	O
mammalian	O
species1e	O
urorectal	O
development	O
,	O
the	O
urorectal	O
septum	O
(	O
urs	O
)	O
descends	O
from	O
the	O
ventral	O
body	O
wall	O
to	O
the	O
cloaca	O
membrane	O
(	O
cm	O
)	O
to	O
partition	O
the	O
cloaca	O
into	O
urogenital	O
sinus	O
and	O
rectum	O
.	O
Defective	O
urs	O
growth	O
results	O
in	O
species1s	O
human	O
species1e	O
congenital	O
anorectal	O
malformations	O
(	O
ARMs	O
)	O
,	O
and	O
their	O
pathogenic	O
mechanisms	O
are	O
unclear	O
.	O
Recent	O
studies	O
only	O
focused	O
on	O
the	O
importance	O
of	O
urs	O
mesenchyme	O
proliferation	O
,	O
which	O
is	O
induced	O
by	O
endoderm	O
-	O
derived	O
gene1s	ARG2
Sonic	ARG2
Hedgehog	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
Shh	ARG2
gene1e	ARG2
)	O
.	O
Here	O
,	O
we	O
showed	O
that	O
the	O
programmed	O
cell	O
death	O
of	O
the	O
apical	O
urs	O
and	O
proximal	O
cm	O
endoderm	O
is	O
particularly	O
crucial	O
for	O
the	O
growth	O
of	O
urs	O
during	O
septation	O
.	O
The	O
apoptotic	O
endoderm	O
was	O
closely	O
associated	O
with	O
the	O
tempo	O
-	O
spatial	O
expression	O
of	O
gene1s	ARG2
Wnt	ARG2
inhibitory	ARG2
factor	ARG2
1	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
Wif1	ARG2
gene1e	ARG2
)	O
,	O
which	O
is	O
an	O
inhibitor	O
of	O
gene1s	ARG2
Wnt	ARG2
gene1e	ARG2
-	O
gene1s	ARG2
b	ARG2
-	ARG2
catenin	ARG2
gene1e	ARG2
signaling	O
.	O
In	O
gene1s	ARG2
Wif1	ARG2
gene1e	ARG2
(lacZ	O
/	O
lacZ	O
)	O
mutant	O
arg1s	O
mice	O
arg1e	O
and	O
cultured	O
urorectum	O
with	O
exogenous	O
gene1s	ARG2
Wif1	ARG2
gene1e	ARG2
,	O
cloaca	O
septation	O
was	O
defective	O
with	O
undescended	O
urs	O
and	O
hypospadias	O
-	O
like	O
phenotypes	O
,	O
and	O
such	O
septation	O
defects	O
were	O
also	O
observed	O
in	O
gene1s	ARG2
Shh	ARG2
gene1e	ARG2
(-/-	O
)	O
mutants	O
and	O
in	O
endodermal	O
gene1s	ARG2
b	ARG2
-	ARG2
catenin	ARG2
gene1e	ARG2
gain	O
-	O
of	O
-	O
function	O
(	O
GOF	O
)	O
mutants	O
.	O
In	O
addition	O
,	O
gene1s	ARG2
Wif1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
Shh	ARG2
gene1e	ARG2
were	O
expressed	O
in	O
a	O
complementary	O
manner	O
in	O
the	O
cloaca	O
endoderm	O
,	O
and	O
gene1s	ARG2
Wif1	ARG2
gene1e	ARG2
was	O
ectopically	O
expressed	O
in	O
the	O
urs	O
and	O
cm	O
associated	O
with	O
excessive	O
endodermal	O
apoptosis	O
and	O
septation	O
defects	O
in	O
gene1s	ARG2
Shh	ARG2
gene1e	ARG2
(-/-	O
)	O
mutants	O
.	O
Furthermore	O
,	O
apoptotic	O
cells	O
were	O
markedly	O
reduced	O
in	O
the	O
endodermal	O
gene1s	ARG2
b	ARG2
-	ARG2
catenin	ARG2
gene1e	ARG2
GOF	O
mutant	O
embryos	O
,	O
which	O
counteracted	O
the	O
inhibitory	O
effects	O
of	O
gene1s	ARG2
Wif1	ARG2
gene1e	ARG2
.	O
Taken	O
altogether	O
,	O
these	O
data	O
suggest	O
that	O
regulated	O
expression	O
of	O
gene1s	ARG2
Wif1	ARG2
gene1e	ARG2
is	O
critical	O
for	O
the	O
growth	O
of	O
the	O
urs	O
during	O
cloaca	O
septation	O
.	O
Hence	O
,	O
gene1s	ARG2
Wif1	ARG2
gene1e	ARG2
governs	O
cell	O
apoptosis	O
of	O
urs	O
endoderm	O
by	O
repressing	O
gene1s	ARG2
b	ARG2
-	ARG2
catenin	ARG2
gene1e	ARG2
signal	O
,	O
which	O
may	O
facilitate	O
the	O
protrusion	O
of	O
the	O
underlying	O
proliferating	O
mesenchymal	O
cells	O
towards	O
the	O
cm	O
for	O
cloaca	O
septation	O
.	O
Dysregulation	O
of	O
this	O
endodermal	O
gene1s	ARG2
Shh	ARG2
gene1e	ARG2
-	O
gene1s	ARG2
Wif1	ARG2
gene1e	ARG2
-	O
gene1s	ARG2
b	ARG2
-	ARG2
catenin	ARG2
gene1e	ARG2
signaling	O
axis	O
contributes	O
to	O
ARM	O
pathogenesis	O
.	O

A	O
novel	O
combination	O
of	O
factors	O
,	O
termed	O
gene1s	O
SPIE	O
gene1e	O
,	O
which	O
promotes	O
dopaminergic	O
neuron	O
differentiation	O
from	O
arg1s	O
human	O
arg1e	O
embryonic	O
stem	O
cells	O
.	O
BACKGROUND	O
:	O
Stromal	O
-	O
Derived	O
Inducing	O
Activity	O
(	O
SDIA	O
)	O
is	O
one	O
of	O
the	O
most	O
efficient	O
methods	O
of	O
generating	O
dopaminergic	O
(	O
DA	O
)	O
neurons	O
from	O
embryonic	O
stem	O
cells	O
(	O
ESC	O
)	O
.	O
DA	O
neuron	O
induction	O
can	O
be	O
achieved	O
by	O
co	O
-	O
culturing	O
ESC	O
with	O
the	O
species1s	O
mouse	O
species1e	O
stromal	O
cell	O
lines	O
PA6	O
or	O
MS5	O
.	O
The	O
molecular	O
nature	O
of	O
this	O
effect	O
,	O
which	O
has	O
been	O
termed	O
"	O
SDIA	O
"	O
is	O
so	O
far	O
unknown	O
.	O
Recently	O
,	O
we	O
found	O
that	O
factors	O
secreted	O
by	O
species1s	O
PA6	O
species1e	O
cells	O
provided	O
lineage	O
-	O
specific	O
instructions	O
to	O
induce	O
DA	O
differentiation	O
of	O
arg1s	O
human	O
arg1e	O
ESC	O
(	O
hESC	O
)	O
.	O
METHODOLOGY	O
/	O
PRINCIPAL	O
FINDINGS	O
:	O
In	O
the	O
present	O
study	O
,	O
we	O
compared	O
species1s	O
PA6	O
species1e	O
cells	O
to	O
various	O
cell	O
lines	O
lacking	O
the	O
SDIA	O
effect	O
,	O
and	O
employed	O
genome	O
expression	O
analysis	O
to	O
identify	O
differentially	O
-	O
expressed	O
signaling	O
molecules	O
.	O
Among	O
the	O
factors	O
highly	O
expressed	O
by	O
species1s	O
PA6	O
species1e	O
cells	O
,	O
and	O
known	O
to	O
be	O
associated	O
with	O
CNS	O
development	O
,	O
were	O
gene1s	O
stromal	O
cell	O
-	O
derived	O
factor	O
1	O
gene1e	O
(	O
gene1s	O
SDF-1	O
gene1e	O
/	O
gene1s	O
CXCL12	O
gene1e	O
)	O
,	O
gene1s	O
pleiotrophin	O
gene1e	O
(	O
gene1s	O
PTN	O
gene1e	O
)	O
,	O
gene1s	O
insulin	O
-	O
like	O
growth	O
factor	O
2	O
gene1e	O
(	O
gene1s	O
IGF2	O
gene1e	O
)	O
,	O
and	O
gene1s	O
ephrin	O
B1	O
gene1e	O
(	O
gene1s	O
EFNB1	O
gene1e	O
)	O
.	O
When	O
these	O
four	O
factors	O
,	O
the	O
combination	O
of	O
which	O
was	O
termed	O
gene1s	O
SPIE	O
gene1e	O
,	O
were	O
applied	O
to	O
hESC	O
,	O
they	O
induced	O
differentiation	O
to	O
TH	O
-	O
positive	O
neurons	O
in	O
vitro	O
.	O
RT	O
-	O
PCR	O
and	O
western	O
blot	O
analysis	O
confirmed	O
the	O
expression	O
of	O
midbrain	O
specific	O
markers	O
,	O
including	O
gene1s	ARG2
engrailed	ARG2
1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Nurr1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Pitx3	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
dopamine	ARG2
transporter	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
DAT	ARG2
gene1e	ARG2
)	O
in	O
cultures	O
influenced	O
by	O
these	O
four	O
molecules	O
.	O
Electrophysiological	O
recordings	O
showed	O
that	O
treatment	O
of	O
hESC	O
with	O
gene1s	O
SPIE	O
gene1e	O
induced	O
differentiation	O
of	O
neurons	O
that	O
were	O
capable	O
of	O
generating	O
action	O
potentials	O
and	O
forming	O
functional	O
synaptic	O
connections	O
.	O
CONCLUSIONS	O
/	O
SIGNIFICANCE	O
:	O
The	O
combination	O
of	O
gene1s	O
SDF-1	O
gene1e	O
,	O
gene1s	O
PTN	O
gene1e	O
,	O
gene1s	O
IGF2	O
gene1e	O
,	O
and	O
gene1s	O
EFNB1	O
gene1e	O
mimics	O
the	O
DA	O
phenotype	O
-	O
inducing	O
property	O
of	O
SDIA	O
and	O
was	O
sufficient	O
to	O
promote	O
differentiation	O
of	O
hESC	O
to	O
functional	O
midbrain	O
DA	O
neurons	O
.	O
These	O
findings	O
provide	O
a	O
method	O
for	O
differentiating	O
hESC	O
to	O
form	O
DA	O
neurons	O
,	O
without	O
a	O
requirement	O
for	O
the	O
use	O
of	O
animal	O
-	O
derived	O
cell	O
lines	O
or	O
products	O
.	O

A	O
novel	O
combination	O
of	O
factors	O
,	O
termed	O
gene1s	ARG2
SPIE	ARG2
gene1e	ARG2
,	O
which	O
promotes	O
dopaminergic	O
neuron	O
differentiation	O
from	O
species1s	O
human	O
species1e	O
embryonic	O
stem	O
cells	O
.	O
BACKGROUND	O
:	O
Stromal	O
-	O
Derived	O
Inducing	O
Activity	O
(	O
SDIA	O
)	O
is	O
one	O
of	O
the	O
most	O
efficient	O
methods	O
of	O
generating	O
dopaminergic	O
(	O
DA	O
)	O
neurons	O
from	O
embryonic	O
stem	O
cells	O
(	O
ESC	O
)	O
.	O
DA	O
neuron	O
induction	O
can	O
be	O
achieved	O
by	O
co	O
-	O
culturing	O
ESC	O
with	O
the	O
arg1s	O
mouse	O
arg1e	O
stromal	O
cell	O
lines	O
PA6	O
or	O
MS5	O
.	O
The	O
molecular	O
nature	O
of	O
this	O
effect	O
,	O
which	O
has	O
been	O
termed	O
"	O
SDIA	O
"	O
is	O
so	O
far	O
unknown	O
.	O
Recently	O
,	O
we	O
found	O
that	O
factors	O
secreted	O
by	O
arg1s	O
PA6	O
arg1e	O
cells	O
provided	O
lineage	O
-	O
specific	O
instructions	O
to	O
induce	O
DA	O
differentiation	O
of	O
species1s	O
human	O
species1e	O
ESC	O
(	O
hESC	O
)	O
.	O
METHODOLOGY	O
/	O
PRINCIPAL	O
FINDINGS	O
:	O
In	O
the	O
present	O
study	O
,	O
we	O
compared	O
arg1s	O
PA6	O
arg1e	O
cells	O
to	O
various	O
cell	O
lines	O
lacking	O
the	O
SDIA	O
effect	O
,	O
and	O
employed	O
genome	O
expression	O
analysis	O
to	O
identify	O
differentially	O
-	O
expressed	O
signaling	O
molecules	O
.	O
Among	O
the	O
factors	O
highly	O
expressed	O
by	O
arg1s	O
PA6	O
arg1e	O
cells	O
,	O
and	O
known	O
to	O
be	O
associated	O
with	O
CNS	O
development	O
,	O
were	O
gene1s	ARG2
stromal	ARG2
cell	ARG2
-	ARG2
derived	ARG2
factor	ARG2
1	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
SDF-1	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
CXCL12	ARG2
gene1e	ARG2
)	O
,	O
gene1s	ARG2
pleiotrophin	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
PTN	ARG2
gene1e	ARG2
)	O
,	O
gene1s	ARG2
insulin	ARG2
-	ARG2
like	ARG2
growth	ARG2
factor	ARG2
2	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
IGF2	ARG2
gene1e	ARG2
)	O
,	O
and	O
gene1s	ARG2
ephrin	ARG2
B1	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
EFNB1	ARG2
gene1e	ARG2
)	O
.	O
When	O
these	O
four	O
factors	O
,	O
the	O
combination	O
of	O
which	O
was	O
termed	O
gene1s	ARG2
SPIE	ARG2
gene1e	ARG2
,	O
were	O
applied	O
to	O
hESC	O
,	O
they	O
induced	O
differentiation	O
to	O
TH	O
-	O
positive	O
neurons	O
in	O
vitro	O
.	O
RT	O
-	O
PCR	O
and	O
western	O
blot	O
analysis	O
confirmed	O
the	O
expression	O
of	O
midbrain	O
specific	O
markers	O
,	O
including	O
gene1s	O
engrailed	O
1	O
gene1e	O
,	O
gene1s	O
Nurr1	O
gene1e	O
,	O
gene1s	O
Pitx3	O
gene1e	O
,	O
and	O
gene1s	O
dopamine	O
transporter	O
gene1e	O
(	O
gene1s	O
DAT	O
gene1e	O
)	O
in	O
cultures	O
influenced	O
by	O
these	O
four	O
molecules	O
.	O
Electrophysiological	O
recordings	O
showed	O
that	O
treatment	O
of	O
hESC	O
with	O
gene1s	ARG2
SPIE	ARG2
gene1e	ARG2
induced	O
differentiation	O
of	O
neurons	O
that	O
were	O
capable	O
of	O
generating	O
action	O
potentials	O
and	O
forming	O
functional	O
synaptic	O
connections	O
.	O
CONCLUSIONS	O
/	O
SIGNIFICANCE	O
:	O
The	O
combination	O
of	O
gene1s	ARG2
SDF-1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
PTN	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IGF2	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
EFNB1	ARG2
gene1e	ARG2
mimics	O
the	O
DA	O
phenotype	O
-	O
inducing	O
property	O
of	O
SDIA	O
and	O
was	O
sufficient	O
to	O
promote	O
differentiation	O
of	O
hESC	O
to	O
functional	O
midbrain	O
DA	O
neurons	O
.	O
These	O
findings	O
provide	O
a	O
method	O
for	O
differentiating	O
hESC	O
to	O
form	O
DA	O
neurons	O
,	O
without	O
a	O
requirement	O
for	O
the	O
use	O
of	O
animal	O
-	O
derived	O
cell	O
lines	O
or	O
products	O
.	O

gene1s	ARG2
CYP4A	ARG2
gene1e	ARG2
in	O
tumor	O
-	O
associated	O
macrophages	O
promotes	O
pre	O
-	O
metastatic	O
niche	O
formation	O
and	O
metastasis	O
.	O
Tumor	O
-	O
associated	O
macrophages	O
(	O
TAMs	O
)	O
play	O
an	O
essential	O
role	O
in	O
metastasis	O
.	O
However	O
,	O
what	O
enables	O
TAMs	O
to	O
have	O
a	O
superior	O
capacity	O
to	O
establish	O
pre	O
-	O
metastatic	O
microenvironment	O
in	O
distant	O
organs	O
is	O
unclear	O
.	O
Here	O
we	O
have	O
begun	O
to	O
uncover	O
the	O
effects	O
of	O
gene1s	O
cytochrome	O
P450	O
(	O
CYP	O
)	O
4A	O
gene1e	O
in	O
TAMs	O
on	O
lung	O
pre	O
-	O
metastatic	O
niche	O
formation	O
and	O
metastasis	O
.	O
gene1s	ARG2
CYP4A	ARG2
gene1e	ARG2
(+	O
)	O
TAM	O
infiltration	O
was	O
positively	O
associated	O
with	O
metastasis	O
,	O
pre	O
-	O
metastatic	O
niche	O
formation	O
and	O
poor	O
prognosis	O
in	O
breast	O
cancer	O
arg1s	O
patients	O
arg1e	O
.	O
The	O
pharmacological	O
inhibition	O
of	O
gene1s	O
CYP4A	O
gene1e	O
reduced	O
lung	O
pre	O
-	O
metastatic	O
niche	O
formation	O
(	O
evidenced	O
by	O
a	O
decrease	O
in	O
gene1s	O
vascular	O
endothelial	O
growth	O
factor	O
receptor	O
1	O
gene1e	O
positive	O
(	O
gene1s	O
VEGFR1	O
gene1e	O
(+	O
)	O
)	O
myeloid	O
cell	O
recruitment	O
and	O
pro	O
-	O
metastatic	O
protein	O
expression	O
)	O
and	O
metastatic	O
burden	O
,	O
accompanied	O
with	O
TAM	O
polarization	O
away	O
from	O
the	O
M2	O
phenotype	O
in	O
spontaneous	O
metastasis	O
models	O
of	O
4T1	O
breast	O
cancer	O
and	O
species1s	O
B16F10	O
species1e	O
melanoma	O
.	O
Co	O
-	O
implantation	O
of	O
species1s	O
4T1	O
species1e	O
cells	O
with	O
gene1s	O
CYP4A10	O
gene1e	O
(high	O
)	O
macrophages	O
promoted	O
lung	O
pre	O
-	O
metastatic	O
niche	O
formation	O
and	O
metastasis	O
.	O
Depletion	O
of	O
TAMs	O
disrupted	O
lung	O
pre	O
-	O
metastatic	O
niches	O
and	O
thereby	O
prevented	O
metastasis	O
.	O
Treatment	O
with	O
the	O
CM	O
from	O
gene1s	O
CYP4A10	O
gene1e	O
(high	O
)	O
M2	O
macrophages	O
(	O
M2	O
)	O
increased	O
pre	O
-	O
metastatic	O
niche	O
formation	O
and	O
metastatic	O
burden	O
in	O
the	O
lungs	O
,	O
whereas	O
gene1s	O
CYP4A	O
gene1e	O
inhibition	O
attenuated	O
these	O
effects	O
.	O
In	O
vitro	O
TAM	O
polarization	O
away	O
from	O
the	O
M2	O
phenotype	O
induced	O
by	O
gene1s	ARG2
CYP4A	ARG2
gene1e	ARG2
inhibition	O
decreased	O
gene1s	ARG2
VEGFR1	ARG2
gene1e	ARG2
(+	O
)	O
myeloid	O
cell	O
migration	O
and	O
gene1s	ARG2
fibronectin	ARG2
gene1e	ARG2
expression	O
,	O
accompanied	O
with	O
downregulation	O
of	O
gene1s	ARG2
STAT3	ARG2
gene1e	ARG2
signaling	O
.	O
Conversely	O
,	O
overexpression	O
of	O
gene1s	ARG2
CYP4A	ARG2
gene1e	ARG2
or	O
exogenous	O
addition	O
of	O
20-hydroxyeicosatetraenoic	O
acid	O
promoted	O
M2	O
polarization	O
and	O
cytokine	O
production	O
of	O
macrophages	O
and	O
thereby	O
enhanced	O
migration	O
of	O
gene1s	ARG2
VEGFR1	ARG2
gene1e	ARG2
(+	O
)	O
myeloid	O
cells	O
,	O
which	O
were	O
reversed	O
by	O
siRNA	O
or	O
pharmacological	O
inhibition	O
of	O
gene1s	ARG2
STAT3	ARG2
gene1e	ARG2
.	O
Importantly	O
,	O
a	O
combined	O
blocking	O
M2	O
macrophage	O
-	O
derived	O
factors	O
gene1s	O
TGF	O
-	O
b	O
gene1e	O
,	O
gene1s	O
VEGF	O
gene1e	O
and	O
gene1s	O
SDF-1	O
gene1e	O
abolished	O
gene1s	ARG2
VEGFR1	ARG2
gene1e	ARG2
(+	O
)	O
myeloid	O
cell	O
migration	O
and	O
fibroblast	O
activation	O
induced	O
by	O
gene1s	O
CYP4A	O
gene1e	O
.	O
In	O
summary	O
,	O
gene1s	ARG2
CYP4A	ARG2
gene1e	ARG2
in	O
TAMs	O
is	O
crucial	O
for	O
lung	O
pre	O
-	O
metastatic	O
niche	O
formation	O
and	O
metastasis	O
,	O
and	O
may	O
serve	O
as	O
a	O
potential	O
therapeutic	O
target	O
in	O
arg1s	O
human	O
arg1e	O
cancer	O
.	O

gene1s	O
CYP4A	O
gene1e	O
in	O
tumor	O
-	O
associated	O
macrophages	O
promotes	O
pre	O
-	O
metastatic	O
niche	O
formation	O
and	O
metastasis	O
.	O
Tumor	O
-	O
associated	O
macrophages	O
(	O
TAMs	O
)	O
play	O
an	O
essential	O
role	O
in	O
metastasis	O
.	O
However	O
,	O
what	O
enables	O
TAMs	O
to	O
have	O
a	O
superior	O
capacity	O
to	O
establish	O
pre	O
-	O
metastatic	O
microenvironment	O
in	O
distant	O
organs	O
is	O
unclear	O
.	O
Here	O
we	O
have	O
begun	O
to	O
uncover	O
the	O
effects	O
of	O
gene1s	ARG2
cytochrome	ARG2
P450	ARG2
(	ARG2
CYP	ARG2
)	ARG2
4A	ARG2
gene1e	ARG2
in	O
TAMs	O
on	O
lung	O
pre	O
-	O
metastatic	O
niche	O
formation	O
and	O
metastasis	O
.	O
gene1s	O
CYP4A	O
gene1e	O
(+	O
)	O
TAM	O
infiltration	O
was	O
positively	O
associated	O
with	O
metastasis	O
,	O
pre	O
-	O
metastatic	O
niche	O
formation	O
and	O
poor	O
prognosis	O
in	O
breast	O
cancer	O
species1s	O
patients	O
species1e	O
.	O
The	O
pharmacological	O
inhibition	O
of	O
gene1s	ARG2
CYP4A	ARG2
gene1e	ARG2
reduced	O
lung	O
pre	O
-	O
metastatic	O
niche	O
formation	O
(	O
evidenced	O
by	O
a	O
decrease	O
in	O
gene1s	ARG2
vascular	ARG2
endothelial	ARG2
growth	ARG2
factor	ARG2
receptor	ARG2
1	ARG2
gene1e	ARG2
positive	O
(	O
gene1s	ARG2
VEGFR1	ARG2
gene1e	ARG2
(+	O
)	O
)	O
myeloid	O
cell	O
recruitment	O
and	O
pro	O
-	O
metastatic	O
protein	O
expression	O
)	O
and	O
metastatic	O
burden	O
,	O
accompanied	O
with	O
TAM	O
polarization	O
away	O
from	O
the	O
M2	O
phenotype	O
in	O
spontaneous	O
metastasis	O
models	O
of	O
4T1	O
breast	O
cancer	O
and	O
arg1s	O
B16F10	O
arg1e	O
melanoma	O
.	O
Co	O
-	O
implantation	O
of	O
arg1s	O
4T1	O
arg1e	O
cells	O
with	O
gene1s	ARG2
CYP4A10	ARG2
gene1e	ARG2
(high	O
)	O
macrophages	O
promoted	O
lung	O
pre	O
-	O
metastatic	O
niche	O
formation	O
and	O
metastasis	O
.	O
Depletion	O
of	O
TAMs	O
disrupted	O
lung	O
pre	O
-	O
metastatic	O
niches	O
and	O
thereby	O
prevented	O
metastasis	O
.	O
Treatment	O
with	O
the	O
CM	O
from	O
gene1s	ARG2
CYP4A10	ARG2
gene1e	ARG2
(high	O
)	O
M2	O
macrophages	O
(	O
M2	O
)	O
increased	O
pre	O
-	O
metastatic	O
niche	O
formation	O
and	O
metastatic	O
burden	O
in	O
the	O
lungs	O
,	O
whereas	O
gene1s	ARG2
CYP4A	ARG2
gene1e	ARG2
inhibition	O
attenuated	O
these	O
effects	O
.	O
In	O
vitro	O
TAM	O
polarization	O
away	O
from	O
the	O
M2	O
phenotype	O
induced	O
by	O
gene1s	ARG2
CYP4A	ARG2
gene1e	ARG2
inhibition	O
decreased	O
gene1s	ARG2
VEGFR1	ARG2
gene1e	ARG2
(+	O
)	O
myeloid	O
cell	O
migration	O
and	O
gene1s	O
fibronectin	O
gene1e	O
expression	O
,	O
accompanied	O
with	O
downregulation	O
of	O
gene1s	ARG2
STAT3	ARG2
gene1e	ARG2
signaling	O
.	O
Conversely	O
,	O
overexpression	O
of	O
gene1s	ARG2
CYP4A	ARG2
gene1e	ARG2
or	O
exogenous	O
addition	O
of	O
20-hydroxyeicosatetraenoic	O
acid	O
promoted	O
M2	O
polarization	O
and	O
cytokine	O
production	O
of	O
macrophages	O
and	O
thereby	O
enhanced	O
migration	O
of	O
gene1s	O
VEGFR1	O
gene1e	O
(+	O
)	O
myeloid	O
cells	O
,	O
which	O
were	O
reversed	O
by	O
siRNA	O
or	O
pharmacological	O
inhibition	O
of	O
gene1s	O
STAT3	O
gene1e	O
.	O
Importantly	O
,	O
a	O
combined	O
blocking	O
M2	O
macrophage	O
-	O
derived	O
factors	O
gene1s	ARG2
TGF	ARG2
-	ARG2
b	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
VEGF	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
SDF-1	ARG2
gene1e	ARG2
abolished	O
gene1s	O
VEGFR1	O
gene1e	O
(+	O
)	O
myeloid	O
cell	O
migration	O
and	O
fibroblast	O
activation	O
induced	O
by	O
gene1s	ARG2
CYP4A	ARG2
gene1e	ARG2
.	O
In	O
summary	O
,	O
gene1s	O
CYP4A	O
gene1e	O
in	O
TAMs	O
is	O
crucial	O
for	O
lung	O
pre	O
-	O
metastatic	O
niche	O
formation	O
and	O
metastasis	O
,	O
and	O
may	O
serve	O
as	O
a	O
potential	O
therapeutic	O
target	O
in	O
species1s	O
human	O
species1e	O
cancer	O
.	O

Novel	O
gene1s	ARG2
nesprin-1	ARG2
gene1e	ARG2
mutations	O
associated	O
with	O
dilated	O
cardiomyopathy	O
cause	O
nuclear	O
envelope	O
disruption	O
and	O
defects	O
in	O
myogenesis	O
.	O
gene1s	ARG2
Nesprins-1	ARG2
and	ARG2
-2	ARG2
gene1e	ARG2
are	O
highly	O
expressed	O
in	O
skeletal	O
and	O
cardiac	O
muscle	O
and	O
together	O
with	O
SUN	O
(	O
Sad1p	O
/	O
UNC84)-domain	O
containing	O
proteins	O
and	O
gene1s	ARG2
lamin	ARG2
A	ARG2
/	ARG2
C	ARG2
gene1e	ARG2
form	O
the	O
LInker	O
of	O
Nucleoskeleton	O
-	O
and	O
-	O
Cytoskeleton	O
(	O
LINC	O
)	O
bridging	O
complex	O
at	O
the	O
nuclear	O
envelope	O
(	O
NE	O
)	O
.	O
Mutations	O
in	O
gene1s	ARG2
nesprin-1/2	ARG2
gene1e	ARG2
have	O
previously	O
been	O
found	O
in	O
arg1s	O
patients	O
arg1e	O
with	O
autosomal	O
dominant	O
Emery	O
-	O
Dreifuss	O
muscular	O
dystrophy	O
(	O
EDMD	O
)	O
as	O
well	O
as	O
dilated	O
cardiomyopathy	O
(	O
DCM	O
)	O
.	O
In	O
this	O
study	O
,	O
three	O
novel	O
rare	O
variants	O
(	O
R8272Q	O
,	O
S8381C	O
and	O
N8406	O
K	O
)	O
in	O
the	O
C	O
-	O
terminus	O
of	O
the	O
gene1s	ARG2
SYNE1	ARG2
gene1e	ARG2
gene	O
(	O
gene1s	ARG2
nesprin-1	ARG2
gene1e	ARG2
)	O
were	O
identified	O
in	O
seven	O
DCM	O
arg1s	O
patients	O
arg1e	O
by	O
mutation	O
screening	O
.	O
Expression	O
of	O
these	O
mutants	O
caused	O
nuclear	O
morphology	O
defects	O
and	O
reduced	O
gene1s	ARG2
lamin	ARG2
A	ARG2
/	ARG2
C	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
SUN2	ARG2
gene1e	ARG2
staining	O
at	O
the	O
NE	O
.	O
GST	O
pull	O
-	O
down	O
indicated	O
that	O
gene1s	ARG2
nesprin-1	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
lamin	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
SUN	ARG2
gene1e	ARG2
interactions	O
were	O
disrupted	O
.	O
gene1s	ARG2
Nesprin-1	ARG2
gene1e	ARG2
mutations	O
were	O
also	O
associated	O
with	O
augmented	O
activation	O
of	O
the	O
gene1s	ARG2
ERK	ARG2
gene1e	ARG2
pathway	O
in	O
vitro	O
and	O
in	O
hearts	O
in	O
vivo	O
.	O
During	O
species1s	O
C2C12	O
species1e	O
muscle	O
cell	O
differentiation	O
,	O
gene1s	O
nesprin-1	O
gene1e	O
levels	O
are	O
increased	O
concomitantly	O
with	O
gene1s	O
kinesin	O
light	O
chain	O
gene1e	O
(	O
gene1s	O
KLC-1/2	O
gene1e	O
)	O
and	O
immunoprecipitation	O
and	O
GST	O
pull	O
-	O
down	O
showed	O
that	O
these	O
proteins	O
interacted	O
via	O
a	O
recently	O
identified	O
LEWD	O
domain	O
in	O
the	O
C	O
-	O
terminus	O
of	O
gene1s	O
nesprin-1	O
gene1e	O
.	O
Expression	O
of	O
gene1s	ARG2
nesprin-1	ARG2
gene1e	ARG2
mutants	O
in	O
species1s	O
C2C12	O
species1e	O
cells	O
caused	O
defects	O
in	O
myoblast	O
differentiation	O
and	O
fusion	O
associated	O
with	O
dysregulation	O
of	O
myogenic	O
transcription	O
factors	O
and	O
disruption	O
of	O
the	O
gene1s	O
nesprin-1	O
gene1e	O
and	O
gene1s	O
KLC-1/2	O
gene1e	O
interaction	O
at	O
the	O
outer	O
nuclear	O
membrane	O
.	O
Expression	O
of	O
gene1s	ARG2
nesprin-1a2	ARG2
gene1e	ARG2
WT	O
and	O
mutants	O
in	O
species1s	O
zebrafish	O
species1e	O
embryos	O
caused	O
heart	O
developmental	O
defects	O
that	O
varied	O
in	O
severity	O
.	O
These	O
findings	O
support	O
a	O
role	O
for	O
gene1s	ARG2
nesprin-1	ARG2
gene1e	ARG2
in	O
myogenesis	O
and	O
muscle	O
disease	O
,	O
and	O
uncover	O
a	O
novel	O
mechanism	O
whereby	O
disruption	O
of	O
the	O
LINC	O
complex	O
may	O
contribute	O
to	O
the	O
pathogenesis	O
of	O
DCM	O
.	O

Novel	O
gene1s	O
nesprin-1	O
gene1e	O
mutations	O
associated	O
with	O
dilated	O
cardiomyopathy	O
cause	O
nuclear	O
envelope	O
disruption	O
and	O
defects	O
in	O
myogenesis	O
.	O
gene1s	O
Nesprins-1	O
and	O
-2	O
gene1e	O
are	O
highly	O
expressed	O
in	O
skeletal	O
and	O
cardiac	O
muscle	O
and	O
together	O
with	O
SUN	O
(	O
Sad1p	O
/	O
UNC84)-domain	O
containing	O
proteins	O
and	O
gene1s	O
lamin	O
A	O
/	O
C	O
gene1e	O
form	O
the	O
LInker	O
of	O
Nucleoskeleton	O
-	O
and	O
-	O
Cytoskeleton	O
(	O
LINC	O
)	O
bridging	O
complex	O
at	O
the	O
nuclear	O
envelope	O
(	O
NE	O
)	O
.	O
Mutations	O
in	O
gene1s	O
nesprin-1/2	O
gene1e	O
have	O
previously	O
been	O
found	O
in	O
species1s	O
patients	O
species1e	O
with	O
autosomal	O
dominant	O
Emery	O
-	O
Dreifuss	O
muscular	O
dystrophy	O
(	O
EDMD	O
)	O
as	O
well	O
as	O
dilated	O
cardiomyopathy	O
(	O
DCM	O
)	O
.	O
In	O
this	O
study	O
,	O
three	O
novel	O
rare	O
variants	O
(	O
R8272Q	O
,	O
S8381C	O
and	O
N8406	O
K	O
)	O
in	O
the	O
C	O
-	O
terminus	O
of	O
the	O
gene1s	O
SYNE1	O
gene1e	O
gene	O
(	O
gene1s	O
nesprin-1	O
gene1e	O
)	O
were	O
identified	O
in	O
seven	O
DCM	O
species1s	O
patients	O
species1e	O
by	O
mutation	O
screening	O
.	O
Expression	O
of	O
these	O
mutants	O
caused	O
nuclear	O
morphology	O
defects	O
and	O
reduced	O
gene1s	O
lamin	O
A	O
/	O
C	O
gene1e	O
and	O
gene1s	O
SUN2	O
gene1e	O
staining	O
at	O
the	O
NE	O
.	O
GST	O
pull	O
-	O
down	O
indicated	O
that	O
gene1s	O
nesprin-1	O
gene1e	O
/	O
gene1s	O
lamin	O
gene1e	O
/	O
gene1s	O
SUN	O
gene1e	O
interactions	O
were	O
disrupted	O
.	O
gene1s	O
Nesprin-1	O
gene1e	O
mutations	O
were	O
also	O
associated	O
with	O
augmented	O
activation	O
of	O
the	O
gene1s	O
ERK	O
gene1e	O
pathway	O
in	O
vitro	O
and	O
in	O
hearts	O
in	O
vivo	O
.	O
During	O
arg1s	O
C2C12	O
arg1e	O
muscle	O
cell	O
differentiation	O
,	O
gene1s	ARG2
nesprin-1	ARG2
gene1e	ARG2
levels	O
are	O
increased	O
concomitantly	O
with	O
gene1s	ARG2
kinesin	ARG2
light	ARG2
chain	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
KLC-1/2	ARG2
gene1e	ARG2
)	O
and	O
immunoprecipitation	O
and	O
GST	O
pull	O
-	O
down	O
showed	O
that	O
these	O
proteins	O
interacted	O
via	O
a	O
recently	O
identified	O
LEWD	O
domain	O
in	O
the	O
C	O
-	O
terminus	O
of	O
gene1s	ARG2
nesprin-1	ARG2
gene1e	ARG2
.	O
Expression	O
of	O
gene1s	O
nesprin-1	O
gene1e	O
mutants	O
in	O
arg1s	O
C2C12	O
arg1e	O
cells	O
caused	O
defects	O
in	O
myoblast	O
differentiation	O
and	O
fusion	O
associated	O
with	O
dysregulation	O
of	O
myogenic	O
transcription	O
factors	O
and	O
disruption	O
of	O
the	O
gene1s	ARG2
nesprin-1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
KLC-1/2	ARG2
gene1e	ARG2
interaction	O
at	O
the	O
outer	O
nuclear	O
membrane	O
.	O
Expression	O
of	O
gene1s	O
nesprin-1a2	O
gene1e	O
WT	O
and	O
mutants	O
in	O
species1s	O
zebrafish	O
species1e	O
embryos	O
caused	O
heart	O
developmental	O
defects	O
that	O
varied	O
in	O
severity	O
.	O
These	O
findings	O
support	O
a	O
role	O
for	O
gene1s	O
nesprin-1	O
gene1e	O
in	O
myogenesis	O
and	O
muscle	O
disease	O
,	O
and	O
uncover	O
a	O
novel	O
mechanism	O
whereby	O
disruption	O
of	O
the	O
LINC	O
complex	O
may	O
contribute	O
to	O
the	O
pathogenesis	O
of	O
DCM	O
.	O

Novel	O
gene1s	O
nesprin-1	O
gene1e	O
mutations	O
associated	O
with	O
dilated	O
cardiomyopathy	O
cause	O
nuclear	O
envelope	O
disruption	O
and	O
defects	O
in	O
myogenesis	O
.	O
gene1s	O
Nesprins-1	O
and	O
-2	O
gene1e	O
are	O
highly	O
expressed	O
in	O
skeletal	O
and	O
cardiac	O
muscle	O
and	O
together	O
with	O
SUN	O
(	O
Sad1p	O
/	O
UNC84)-domain	O
containing	O
proteins	O
and	O
gene1s	O
lamin	O
A	O
/	O
C	O
gene1e	O
form	O
the	O
LInker	O
of	O
Nucleoskeleton	O
-	O
and	O
-	O
Cytoskeleton	O
(	O
LINC	O
)	O
bridging	O
complex	O
at	O
the	O
nuclear	O
envelope	O
(	O
NE	O
)	O
.	O
Mutations	O
in	O
gene1s	O
nesprin-1/2	O
gene1e	O
have	O
previously	O
been	O
found	O
in	O
species1s	O
patients	O
species1e	O
with	O
autosomal	O
dominant	O
Emery	O
-	O
Dreifuss	O
muscular	O
dystrophy	O
(	O
EDMD	O
)	O
as	O
well	O
as	O
dilated	O
cardiomyopathy	O
(	O
DCM	O
)	O
.	O
In	O
this	O
study	O
,	O
three	O
novel	O
rare	O
variants	O
(	O
R8272Q	O
,	O
S8381C	O
and	O
N8406	O
K	O
)	O
in	O
the	O
C	O
-	O
terminus	O
of	O
the	O
gene1s	O
SYNE1	O
gene1e	O
gene	O
(	O
gene1s	O
nesprin-1	O
gene1e	O
)	O
were	O
identified	O
in	O
seven	O
DCM	O
species1s	O
patients	O
species1e	O
by	O
mutation	O
screening	O
.	O
Expression	O
of	O
these	O
mutants	O
caused	O
nuclear	O
morphology	O
defects	O
and	O
reduced	O
gene1s	O
lamin	O
A	O
/	O
C	O
gene1e	O
and	O
gene1s	O
SUN2	O
gene1e	O
staining	O
at	O
the	O
NE	O
.	O
GST	O
pull	O
-	O
down	O
indicated	O
that	O
gene1s	O
nesprin-1	O
gene1e	O
/	O
gene1s	O
lamin	O
gene1e	O
/	O
gene1s	O
SUN	O
gene1e	O
interactions	O
were	O
disrupted	O
.	O
gene1s	O
Nesprin-1	O
gene1e	O
mutations	O
were	O
also	O
associated	O
with	O
augmented	O
activation	O
of	O
the	O
gene1s	O
ERK	O
gene1e	O
pathway	O
in	O
vitro	O
and	O
in	O
hearts	O
in	O
vivo	O
.	O
During	O
species1s	O
C2C12	O
species1e	O
muscle	O
cell	O
differentiation	O
,	O
gene1s	O
nesprin-1	O
gene1e	O
levels	O
are	O
increased	O
concomitantly	O
with	O
gene1s	O
kinesin	O
light	O
chain	O
gene1e	O
(	O
gene1s	O
KLC-1/2	O
gene1e	O
)	O
and	O
immunoprecipitation	O
and	O
GST	O
pull	O
-	O
down	O
showed	O
that	O
these	O
proteins	O
interacted	O
via	O
a	O
recently	O
identified	O
LEWD	O
domain	O
in	O
the	O
C	O
-	O
terminus	O
of	O
gene1s	O
nesprin-1	O
gene1e	O
.	O
Expression	O
of	O
gene1s	O
nesprin-1	O
gene1e	O
mutants	O
in	O
species1s	O
C2C12	O
species1e	O
cells	O
caused	O
defects	O
in	O
myoblast	O
differentiation	O
and	O
fusion	O
associated	O
with	O
dysregulation	O
of	O
myogenic	O
transcription	O
factors	O
and	O
disruption	O
of	O
the	O
gene1s	O
nesprin-1	O
gene1e	O
and	O
gene1s	O
KLC-1/2	O
gene1e	O
interaction	O
at	O
the	O
outer	O
nuclear	O
membrane	O
.	O
Expression	O
of	O
gene1s	O
nesprin-1a2	O
gene1e	O
WT	O
and	O
mutants	O
in	O
arg1s	O
zebrafish	O
arg1e	O
embryos	O
caused	O
heart	O
developmental	O
defects	O
that	O
varied	O
in	O
severity	O
.	O
These	O
findings	O
support	O
a	O
role	O
for	O
gene1s	O
nesprin-1	O
gene1e	O
in	O
myogenesis	O
and	O
muscle	O
disease	O
,	O
and	O
uncover	O
a	O
novel	O
mechanism	O
whereby	O
disruption	O
of	O
the	O
LINC	O
complex	O
may	O
contribute	O
to	O
the	O
pathogenesis	O
of	O
DCM	O
.	O

The	O
gene1s	ARG2
autotaxin	ARG2
gene1e	ARG2
-	O
gene1s	ARG2
LPA2	ARG2
gene1e	ARG2
gene1s	ARG2
GPCR	ARG2
gene1e	ARG2
axis	O
is	O
modulated	O
by	O
gamma	O
-	O
irradiation	O
and	O
facilitates	O
DNA	O
damage	O
repair	O
.	O
In	O
this	O
study	O
we	O
characterized	O
the	O
effects	O
of	O
radiation	O
injury	O
on	O
the	O
expression	O
and	O
function	O
of	O
the	O
gene1s	ARG2
autotaxin	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
ATX	ARG2
gene1e	ARG2
)-	O
gene1s	ARG2
LPA2	ARG2
gene1e	ARG2
gene1s	ARG2
GPCR	ARG2
gene1e	ARG2
axis	O
.	O
In	O
arg1s	O
IEC-6	O
arg1e	O
crypt	O
cells	O
and	O
jejunum	O
enteroids	O
quantitative	O
RT	O
-	O
PCR	O
showed	O
a	O
time-	O
and	O
dose	O
-	O
dependent	O
upregulation	O
of	O
gene1s	ARG2
lpa2	ARG2
gene1e	ARG2
in	O
response	O
to	O
gamma	O
-	O
irradiation	O
that	O
was	O
abolished	O
by	O
mutation	O
of	O
the	O
gene1s	ARG2
NF	ARG2
-	ARG2
kappaB	ARG2
gene1e	ARG2
site	O
in	O
the	O
gene1s	ARG2
lpa2	ARG2
gene1e	ARG2
promoter	O
or	O
by	O
inhibition	O
of	O
gene1s	ARG2
ATM	ARG2
/	ARG2
ATR	ARG2
kinases	ARG2
gene1e	ARG2
with	O
CGK-733	O
,	O
suggesting	O
that	O
gene1s	ARG2
lpa2	ARG2
gene1e	ARG2
is	O
a	O
DNA	O
damage	O
response	O
gene	O
upregulated	O
by	O
gene1s	ARG2
ATM	ARG2
gene1e	ARG2
via	O
gene1s	ARG2
NF	ARG2
-	ARG2
kappaB	ARG2
gene1e	ARG2
.	O
The	O
resolution	O
kinetics	O
of	O
the	O
DNA	O
damage	O
marker	O
gene1s	ARG2
gamma	ARG2
-	ARG2
H2AX	ARG2
gene1e	ARG2
in	O
gene1s	O
LPA	O
gene1e	O
-	O
treated	O
arg1s	O
IEC-6	O
arg1e	O
cells	O
exposed	O
to	O
gamma	O
-	O
irradiation	O
was	O
accelerated	O
compared	O
to	O
vehicle	O
,	O
whereas	O
pharmacological	O
inhibition	O
of	O
gene1s	ARG2
LPA2	ARG2
gene1e	ARG2
delayed	O
the	O
resolution	O
of	O
gene1s	ARG2
gamma	ARG2
-	ARG2
H2AX	ARG2
gene1e	ARG2
.	O
In	O
gene1s	O
LPA2	O
gene1e	O
-reconstituted	O
MEF	O
cells	O
lacking	O
gene1s	O
LPA1	O
'	O
3	O
gene1e	O
the	O
levels	O
of	O
gene1s	O
gamma	O
-	O
H2AX	O
gene1e	O
decreased	O
rapidly	O
,	O
whereas	O
in	O
Vector	O
MEF	O
were	O
high	O
and	O
remained	O
sustained	O
.	O
Inhibition	O
of	O
gene1s	O
ERK1	O
'	O
2	O
gene1e	O
or	O
gene1s	O
PI3K	O
gene1e	O
/	O
gene1s	O
AKT	O
gene1e	O
signaling	O
axis	O
by	O
pertussis	O
toxin	O
or	O
the	O
C311A	O
/	O
C314A	O
/	O
L351A	O
mutation	O
in	O
the	O
C	O
-	O
terminus	O
of	O
gene1s	O
LPA2	O
gene1e	O
abrogated	O
the	O
effect	O
of	O
gene1s	O
LPA	O
gene1e	O
on	O
DNA	O
repair	O
.	O
gene1s	O
LPA2	O
gene1e	O
transcripts	O
in	O
gene1s	O
Lin	O
gene1e	O
(-)	O
gene1s	O
Sca-1	O
gene1e	O
(+)	O
gene1s	O
c	O
-	O
Kit	O
gene1e	O
(+	O
)	O
enriched	O
for	O
bone	O
marrow	O
stem	O
cells	O
were	O
27-	O
and	O
5-fold	O
higher	O
than	O
in	O
common	O
myeloid	O
or	O
lymphoid	O
progenitors	O
,	O
respectively	O
.	O
Furthermore	O
,	O
after	O
irradiation	O
higher	O
residual	O
gene1s	O
gamma	O
-	O
H2AX	O
gene1e	O
levels	O
were	O
detected	O
in	O
the	O
bone	O
marrow	O
or	O
jejunum	O
of	O
irradiated	O
gene1s	O
LPA2	O
gene1e	O
-KO	O
species1s	O
mice	O
species1e	O
compared	O
to	O
WT	O
species1s	O
mice	O
species1e	O
.	O
We	O
found	O
that	O
gamma	O
-	O
irradiation	O
increases	O
plasma	O
gene1s	ARG2
ATX	ARG2
gene1e	ARG2
activity	O
and	O
gene1s	O
LPA	O
gene1e	O
level	O
that	O
is	O
in	O
part	O
due	O
to	O
the	O
previously	O
established	O
radiation	O
-	O
induced	O
upregulation	O
of	O
gene1s	O
TNFalpha	O
gene1e	O
.	O
These	O
findings	O
identify	O
gene1s	ARG2
ATX	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
LPA2	ARG2
gene1e	ARG2
as	O
radiation	O
-	O
regulated	O
genes	O
that	O
appear	O
to	O
play	O
a	O
physiological	O
role	O
in	O
DNA	O
repair	O
.	O

The	O
gene1s	O
autotaxin	O
gene1e	O
-	O
gene1s	ARG2
LPA2	ARG2
gene1e	ARG2
gene1s	O
GPCR	O
gene1e	O
axis	O
is	O
modulated	O
by	O
gamma	O
-	O
irradiation	O
and	O
facilitates	O
DNA	O
damage	O
repair	O
.	O
In	O
this	O
study	O
we	O
characterized	O
the	O
effects	O
of	O
radiation	O
injury	O
on	O
the	O
expression	O
and	O
function	O
of	O
the	O
gene1s	O
autotaxin	O
gene1e	O
(	O
gene1s	O
ATX	O
gene1e	O
)-	O
gene1s	O
LPA2	O
gene1e	O
gene1s	O
GPCR	O
gene1e	O
axis	O
.	O
In	O
species1s	O
IEC-6	O
species1e	O
crypt	O
cells	O
and	O
jejunum	O
enteroids	O
quantitative	O
RT	O
-	O
PCR	O
showed	O
a	O
time-	O
and	O
dose	O
-	O
dependent	O
upregulation	O
of	O
gene1s	O
lpa2	O
gene1e	O
in	O
response	O
to	O
gamma	O
-	O
irradiation	O
that	O
was	O
abolished	O
by	O
mutation	O
of	O
the	O
gene1s	O
NF	O
-	O
kappaB	O
gene1e	O
site	O
in	O
the	O
gene1s	O
lpa2	O
gene1e	O
promoter	O
or	O
by	O
inhibition	O
of	O
gene1s	O
ATM	O
/	O
ATR	O
kinases	O
gene1e	O
with	O
CGK-733	O
,	O
suggesting	O
that	O
gene1s	O
lpa2	O
gene1e	O
is	O
a	O
DNA	O
damage	O
response	O
gene	O
upregulated	O
by	O
gene1s	O
ATM	O
gene1e	O
via	O
gene1s	O
NF	O
-	O
kappaB	O
gene1e	O
.	O
The	O
resolution	O
kinetics	O
of	O
the	O
DNA	O
damage	O
marker	O
gene1s	O
gamma	O
-	O
H2AX	O
gene1e	O
in	O
gene1s	ARG2
LPA	ARG2
gene1e	ARG2
-	O
treated	O
species1s	O
IEC-6	O
species1e	O
cells	O
exposed	O
to	O
gamma	O
-	O
irradiation	O
was	O
accelerated	O
compared	O
to	O
vehicle	O
,	O
whereas	O
pharmacological	O
inhibition	O
of	O
gene1s	O
LPA2	O
gene1e	O
delayed	O
the	O
resolution	O
of	O
gene1s	O
gamma	O
-	O
H2AX	O
gene1e	O
.	O
In	O
gene1s	ARG2
LPA2	ARG2
gene1e	ARG2
-reconstituted	O
MEF	O
cells	O
lacking	O
gene1s	ARG2
LPA1	ARG2
'	ARG2
3	ARG2
gene1e	ARG2
the	O
levels	O
of	O
gene1s	ARG2
gamma	ARG2
-	ARG2
H2AX	ARG2
gene1e	ARG2
decreased	O
rapidly	O
,	O
whereas	O
in	O
Vector	O
MEF	O
were	O
high	O
and	O
remained	O
sustained	O
.	O
Inhibition	O
of	O
gene1s	ARG2
ERK1	ARG2
'	ARG2
2	ARG2
gene1e	ARG2
or	O
gene1s	ARG2
PI3K	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
AKT	ARG2
gene1e	ARG2
signaling	O
axis	O
by	O
pertussis	O
toxin	O
or	O
the	O
C311A	O
/	O
C314A	O
/	O
L351A	O
mutation	O
in	O
the	O
C	O
-	O
terminus	O
of	O
gene1s	ARG2
LPA2	ARG2
gene1e	ARG2
abrogated	O
the	O
effect	O
of	O
gene1s	ARG2
LPA	ARG2
gene1e	ARG2
on	O
DNA	O
repair	O
.	O
gene1s	ARG2
LPA2	ARG2
gene1e	ARG2
transcripts	O
in	O
gene1s	ARG2
Lin	ARG2
gene1e	ARG2
(-)	O
gene1s	ARG2
Sca-1	ARG2
gene1e	ARG2
(+)	O
gene1s	ARG2
c	ARG2
-	ARG2
Kit	ARG2
gene1e	ARG2
(+	O
)	O
enriched	O
for	O
bone	O
marrow	O
stem	O
cells	O
were	O
27-	O
and	O
5-fold	O
higher	O
than	O
in	O
common	O
myeloid	O
or	O
lymphoid	O
progenitors	O
,	O
respectively	O
.	O
Furthermore	O
,	O
after	O
irradiation	O
higher	O
residual	O
gene1s	ARG2
gamma	ARG2
-	ARG2
H2AX	ARG2
gene1e	ARG2
levels	O
were	O
detected	O
in	O
the	O
bone	O
marrow	O
or	O
jejunum	O
of	O
irradiated	O
gene1s	ARG2
LPA2	ARG2
gene1e	ARG2
-KO	O
arg1s	O
mice	O
arg1e	O
compared	O
to	O
WT	O
arg1s	O
mice	O
arg1e	O
.	O
We	O
found	O
that	O
gamma	O
-	O
irradiation	O
increases	O
plasma	O
gene1s	O
ATX	O
gene1e	O
activity	O
and	O
gene1s	ARG2
LPA	ARG2
gene1e	ARG2
level	O
that	O
is	O
in	O
part	O
due	O
to	O
the	O
previously	O
established	O
radiation	O
-	O
induced	O
upregulation	O
of	O
gene1s	ARG2
TNFalpha	ARG2
gene1e	ARG2
.	O
These	O
findings	O
identify	O
gene1s	ARG2
ATX	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
LPA2	ARG2
gene1e	ARG2
as	O
radiation	O
-	O
regulated	O
genes	O
that	O
appear	O
to	O
play	O
a	O
physiological	O
role	O
in	O
DNA	O
repair	O
.	O

gene1s	ARG2
Pannexin3	ARG2
gene1e	ARG2
inhibits	O
gene1s	ARG2
TNF	ARG2
-	ARG2
a	ARG2
gene1e	ARG2
-	O
induced	O
inflammatory	O
response	O
by	O
suppressing	O
gene1s	ARG2
NF	ARG2
-	ARG2
kB	ARG2
gene1e	ARG2
signalling	O
pathway	O
in	O
arg1s	O
human	O
arg1e	O
dental	O
pulp	O
cells	O
.	O
arg1s	O
Human	O
arg1e	O
dental	O
pulp	O
cells	O
(	O
HDPCs	O
)	O
play	O
a	O
crucial	O
role	O
in	O
dental	O
pulp	O
inflammation	O
.	O
gene1s	ARG2
Pannexin	ARG2
3	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
Panx3	ARG2
gene1e	ARG2
)	O
,	O
a	O
member	O
of	O
gene1s	ARG2
Panxs	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
Pannexins	ARG2
gene1e	ARG2
)	O
,	O
has	O
been	O
recently	O
found	O
to	O
be	O
involved	O
in	O
inflammation	O
.	O
However	O
,	O
the	O
mechanism	O
of	O
gene1s	ARG2
Panx3	ARG2
gene1e	ARG2
in	O
arg1s	O
human	O
arg1e	O
dental	O
pulp	O
inflammation	O
remains	O
unclear	O
.	O
In	O
this	O
study	O
,	O
the	O
role	O
of	O
gene1s	ARG2
Panx3	ARG2
gene1e	ARG2
in	O
inflammatory	O
response	O
was	O
firstly	O
explored	O
,	O
and	O
its	O
potential	O
mechanism	O
was	O
proposed	O
.	O
Immunohistochemical	O
staining	O
showed	O
that	O
gene1s	ARG2
Panx3	ARG2
gene1e	ARG2
levels	O
were	O
diminished	O
in	O
inflamed	O
arg1s	O
human	O
arg1e	O
and	O
species1s	O
rat	O
species1e	O
dental	O
pulp	O
tissues	O
.	O
In	O
vitro	O
,	O
gene1s	ARG2
Panx3	ARG2
gene1e	ARG2
expression	O
was	O
significantly	O
down	O
-	O
regulated	O
in	O
HDPCs	O
following	O
a	O
gene1s	ARG2
TNF	ARG2
-	ARG2
a	ARG2
gene1e	ARG2
challenge	O
in	O
a	O
concentration	O
-	O
dependent	O
way	O
,	O
which	O
reached	O
the	O
lowest	O
level	O
at	O
10	O
ng	O
/	O
ml	O
of	O
gene1s	ARG2
TNF	ARG2
-	ARG2
a	ARG2
gene1e	ARG2
.	O
Such	O
decrease	O
could	O
be	O
reversed	O
by	O
MG132	O
,	O
a	O
proteasome	O
inhibitor	O
.	O
Unlike	O
MG132	O
,	O
BAY	O
11	O
-	O
7082	O
,	O
a	O
gene1s	ARG2
NF	ARG2
-	ARG2
kB	ARG2
gene1e	ARG2
inhibitor	O
,	O
even	O
reinforced	O
the	O
inhibitory	O
effect	O
of	O
gene1s	ARG2
TNF	ARG2
-	ARG2
a	ARG2
gene1e	ARG2
.	O
Quantitative	O
real	O
-	O
time	O
PCR	O
(	O
qRT	O
-	O
PCR	O
)	O
and	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
(	O
ELISA	O
)	O
were	O
used	O
to	O
investigate	O
the	O
role	O
of	O
gene1s	ARG2
Panx3	ARG2
gene1e	ARG2
in	O
inflammatory	O
response	O
of	O
HDPCs	O
.	O
gene1s	ARG2
TNF	ARG2
-	ARG2
a	ARG2
gene1e	ARG2
-	O
induced	O
pro	O
-	O
inflammatory	O
cytokines	O
,	O
gene1s	ARG2
interleukin	ARG2
(	ARG2
IL)-1b	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
IL-6	ARG2
gene1e	ARG2
,	O
were	O
significantly	O
lessened	O
when	O
gene1s	ARG2
Panx3	ARG2
gene1e	ARG2
was	O
overexpressed	O
in	O
HDPCs	O
.	O
Conversely	O
,	O
gene1s	ARG2
Panx3	ARG2
gene1e	ARG2
knockdown	O
exacerbated	O
the	O
expression	O
of	O
pro	O
-	O
inflammatory	O
cytokines	O
.	O
Moreover	O
,	O
Western	O
blot	O
,	O
dual	O
-	O
luciferase	O
reporter	O
assay	O
,	O
immunofluorescence	O
staining	O
,	O
qRT	O
-	O
PCR	O
and	O
ELISA	O
results	O
showed	O
that	O
gene1s	ARG2
Panx3	ARG2
gene1e	ARG2
participated	O
in	O
dental	O
pulp	O
inflammation	O
in	O
a	O
gene1s	ARG2
NF	ARG2
-	ARG2
kB	ARG2
gene1e	ARG2
-	O
dependent	O
manner	O
.	O
These	O
findings	O
suggested	O
that	O
gene1s	ARG2
Panx3	ARG2
gene1e	ARG2
has	O
a	O
defensive	O
role	O
in	O
dental	O
pulp	O
inflammation	O
,	O
serving	O
as	O
a	O
potential	O
target	O
to	O
be	O
exploited	O
for	O
the	O
intervention	O
of	O
arg1s	O
human	O
arg1e	O
dental	O
pulp	O
inflammation	O
.	O

gene1s	O
Pannexin3	O
gene1e	O
inhibits	O
gene1s	O
TNF	O
-	O
a	O
gene1e	O
-	O
induced	O
inflammatory	O
response	O
by	O
suppressing	O
gene1s	O
NF	O
-	O
kB	O
gene1e	O
signalling	O
pathway	O
in	O
species1s	O
human	O
species1e	O
dental	O
pulp	O
cells	O
.	O
species1s	O
Human	O
species1e	O
dental	O
pulp	O
cells	O
(	O
HDPCs	O
)	O
play	O
a	O
crucial	O
role	O
in	O
dental	O
pulp	O
inflammation	O
.	O
gene1s	O
Pannexin	O
3	O
gene1e	O
(	O
gene1s	O
Panx3	O
gene1e	O
)	O
,	O
a	O
member	O
of	O
gene1s	O
Panxs	O
gene1e	O
(	O
gene1s	O
Pannexins	O
gene1e	O
)	O
,	O
has	O
been	O
recently	O
found	O
to	O
be	O
involved	O
in	O
inflammation	O
.	O
However	O
,	O
the	O
mechanism	O
of	O
gene1s	O
Panx3	O
gene1e	O
in	O
species1s	O
human	O
species1e	O
dental	O
pulp	O
inflammation	O
remains	O
unclear	O
.	O
In	O
this	O
study	O
,	O
the	O
role	O
of	O
gene1s	O
Panx3	O
gene1e	O
in	O
inflammatory	O
response	O
was	O
firstly	O
explored	O
,	O
and	O
its	O
potential	O
mechanism	O
was	O
proposed	O
.	O
Immunohistochemical	O
staining	O
showed	O
that	O
gene1s	O
Panx3	O
gene1e	O
levels	O
were	O
diminished	O
in	O
inflamed	O
species1s	O
human	O
species1e	O
and	O
arg1s	O
rat	O
arg1e	O
dental	O
pulp	O
tissues	O
.	O
In	O
vitro	O
,	O
gene1s	O
Panx3	O
gene1e	O
expression	O
was	O
significantly	O
down	O
-	O
regulated	O
in	O
HDPCs	O
following	O
a	O
gene1s	O
TNF	O
-	O
a	O
gene1e	O
challenge	O
in	O
a	O
concentration	O
-	O
dependent	O
way	O
,	O
which	O
reached	O
the	O
lowest	O
level	O
at	O
10	O
ng	O
/	O
ml	O
of	O
gene1s	O
TNF	O
-	O
a	O
gene1e	O
.	O
Such	O
decrease	O
could	O
be	O
reversed	O
by	O
MG132	O
,	O
a	O
proteasome	O
inhibitor	O
.	O
Unlike	O
MG132	O
,	O
BAY	O
11	O
-	O
7082	O
,	O
a	O
gene1s	O
NF	O
-	O
kB	O
gene1e	O
inhibitor	O
,	O
even	O
reinforced	O
the	O
inhibitory	O
effect	O
of	O
gene1s	O
TNF	O
-	O
a	O
gene1e	O
.	O
Quantitative	O
real	O
-	O
time	O
PCR	O
(	O
qRT	O
-	O
PCR	O
)	O
and	O
enzyme	O
-	O
linked	O
immunosorbent	O
assay	O
(	O
ELISA	O
)	O
were	O
used	O
to	O
investigate	O
the	O
role	O
of	O
gene1s	O
Panx3	O
gene1e	O
in	O
inflammatory	O
response	O
of	O
HDPCs	O
.	O
gene1s	O
TNF	O
-	O
a	O
gene1e	O
-	O
induced	O
pro	O
-	O
inflammatory	O
cytokines	O
,	O
gene1s	O
interleukin	O
(	O
IL)-1b	O
gene1e	O
and	O
gene1s	O
IL-6	O
gene1e	O
,	O
were	O
significantly	O
lessened	O
when	O
gene1s	O
Panx3	O
gene1e	O
was	O
overexpressed	O
in	O
HDPCs	O
.	O
Conversely	O
,	O
gene1s	O
Panx3	O
gene1e	O
knockdown	O
exacerbated	O
the	O
expression	O
of	O
pro	O
-	O
inflammatory	O
cytokines	O
.	O
Moreover	O
,	O
Western	O
blot	O
,	O
dual	O
-	O
luciferase	O
reporter	O
assay	O
,	O
immunofluorescence	O
staining	O
,	O
qRT	O
-	O
PCR	O
and	O
ELISA	O
results	O
showed	O
that	O
gene1s	O
Panx3	O
gene1e	O
participated	O
in	O
dental	O
pulp	O
inflammation	O
in	O
a	O
gene1s	O
NF	O
-	O
kB	O
gene1e	O
-	O
dependent	O
manner	O
.	O
These	O
findings	O
suggested	O
that	O
gene1s	O
Panx3	O
gene1e	O
has	O
a	O
defensive	O
role	O
in	O
dental	O
pulp	O
inflammation	O
,	O
serving	O
as	O
a	O
potential	O
target	O
to	O
be	O
exploited	O
for	O
the	O
intervention	O
of	O
species1s	O
human	O
species1e	O
dental	O
pulp	O
inflammation	O
.	O

Expression	O
of	O
novel	O
gene1s	O
opsins	O
gene1e	O
and	O
intrinsic	O
light	O
responses	O
in	O
the	O
arg1s	O
mammalian	O
arg1e	O
retinal	O
ganglion	O
cell	O
line	O
RGC-5	O
.	O
Presence	O
of	O
gene1s	O
OPN5	O
gene1e	O
in	O
the	O
species1s	O
rat	O
species1e	O
retina	O
.	O
The	O
vertebrate	O
retina	O
is	O
known	O
to	O
contain	O
three	O
classes	O
of	O
photoreceptor	O
cells	O
:	O
cones	O
and	O
rods	O
responsible	O
for	O
vision	O
,	O
and	O
intrinsically	O
photoresponsive	O
retinal	O
ganglion	O
cells	O
(	O
RGCs	O
)	O
involved	O
in	O
diverse	O
non	O
-	O
visual	O
functions	O
such	O
as	O
photic	O
entrainment	O
of	O
daily	O
rhythms	O
and	O
pupillary	O
light	O
responses	O
.	O
In	O
this	O
paper	O
we	O
investigated	O
the	O
potential	O
intrinsic	O
photoresponsiveness	O
of	O
the	O
species1s	O
rat	O
species1e	O
RGC	O
line	O
,	O
RGC-5	O
,	O
by	O
testing	O
for	O
the	O
presence	O
of	O
visual	O
and	O
non	O
-	O
visual	O
gene1s	O
opsins	O
gene1e	O
and	O
assessing	O
expression	O
of	O
the	O
immediate	O
-	O
early	O
gene	O
protein	O
gene1s	O
c	O
-	O
Fos	O
gene1e	O
and	O
changes	O
in	O
intracellular	O
Ca(2	O
+	O
)	O
mobilization	O
in	O
response	O
to	O
brief	O
light	O
pulses	O
.	O
Cultured	O
species1s	O
RGC-5	O
species1e	O
cells	O
express	O
a	O
number	O
of	O
photopigment	O
mRNAs	O
such	O
as	O
gene1s	O
retinal	O
G	O
protein	O
coupled	O
receptor	O
gene1e	O
(	O
gene1s	O
RGR	O
gene1e	O
)	O
,	O
gene1s	O
encephalopsin	O
gene1e	O
/	O
gene1s	O
panopsin	O
gene1e	O
(	O
gene1s	O
Opn3	O
gene1e	O
)	O
,	O
gene1s	O
neuropsin	O
gene1e	O
(	O
gene1s	O
Opn5	O
gene1e	O
)	O
and	O
gene1s	O
cone	O
opsin	O
gene1e	O
(	O
gene1s	O
Opn1mw	O
gene1e	O
)	O
but	O
not	O
gene1s	O
melanopsin	O
gene1e	O
(	O
gene1s	O
Opn4	O
gene1e	O
)	O
or	O
gene1s	O
rhodopsin	O
gene1e	O
.	O
gene1s	O
Opn5	O
gene1e	O
immunoreactivity	O
was	O
observed	O
in	O
species1s	O
RGC-5	O
species1e	O
cells	O
and	O
in	O
the	O
inner	O
retina	O
of	O
species1s	O
rat	O
species1e	O
,	O
mainly	O
localized	O
in	O
the	O
ganglion	O
cell	O
layer	O
(	O
GCL	O
)	O
.	O
Furthermore	O
,	O
white	O
light	O
pulses	O
of	O
different	O
intensities	O
and	O
durations	O
elicited	O
changes	O
both	O
in	O
intracellular	O
Ca(2	O
+	O
)	O
levels	O
and	O
in	O
the	O
induction	O
of	O
gene1s	O
c	O
-	O
Fos	O
gene1e	O
protein	O
in	O
species1s	O
RGC-5	O
species1e	O
cell	O
cultures	O
.	O
The	O
results	O
demonstrate	O
that	O
species1s	O
RGC-5	O
species1e	O
cells	O
expressing	O
diverse	O
putative	O
functional	O
photopigments	O
display	O
intrinsic	O
photosensitivity	O
which	O
accounts	O
for	O
the	O
photic	O
induction	O
of	O
gene1s	O
c	O
-	O
Fos	O
gene1e	O
protein	O
and	O
changes	O
in	O
intracellular	O
Ca(2	O
+	O
)	O
mobilization	O
.	O
The	O
presence	O
of	O
gene1s	O
Opn5	O
gene1e	O
in	O
the	O
GCL	O
of	O
the	O
species1s	O
rat	O
species1e	O
retina	O
suggests	O
the	O
existence	O
of	O
a	O
novel	O
type	O
of	O
photoreceptor	O
cell	O
.	O

Expression	O
of	O
novel	O
gene1s	ARG2
opsins	ARG2
gene1e	ARG2
and	O
intrinsic	O
light	O
responses	O
in	O
the	O
species1s	O
mammalian	O
species1e	O
retinal	O
ganglion	O
cell	O
line	O
RGC-5	O
.	O
Presence	O
of	O
gene1s	ARG2
OPN5	ARG2
gene1e	ARG2
in	O
the	O
arg1s	O
rat	O
arg1e	O
retina	O
.	O
The	O
vertebrate	O
retina	O
is	O
known	O
to	O
contain	O
three	O
classes	O
of	O
photoreceptor	O
cells	O
:	O
cones	O
and	O
rods	O
responsible	O
for	O
vision	O
,	O
and	O
intrinsically	O
photoresponsive	O
retinal	O
ganglion	O
cells	O
(	O
RGCs	O
)	O
involved	O
in	O
diverse	O
non	O
-	O
visual	O
functions	O
such	O
as	O
photic	O
entrainment	O
of	O
daily	O
rhythms	O
and	O
pupillary	O
light	O
responses	O
.	O
In	O
this	O
paper	O
we	O
investigated	O
the	O
potential	O
intrinsic	O
photoresponsiveness	O
of	O
the	O
arg1s	O
rat	O
arg1e	O
RGC	O
line	O
,	O
RGC-5	O
,	O
by	O
testing	O
for	O
the	O
presence	O
of	O
visual	O
and	O
non	O
-	O
visual	O
gene1s	ARG2
opsins	ARG2
gene1e	ARG2
and	O
assessing	O
expression	O
of	O
the	O
immediate	O
-	O
early	O
gene	O
protein	O
gene1s	ARG2
c	ARG2
-	ARG2
Fos	ARG2
gene1e	ARG2
and	O
changes	O
in	O
intracellular	O
Ca(2	O
+	O
)	O
mobilization	O
in	O
response	O
to	O
brief	O
light	O
pulses	O
.	O
Cultured	O
species1s	O
RGC-5	O
species1e	O
cells	O
express	O
a	O
number	O
of	O
photopigment	O
mRNAs	O
such	O
as	O
gene1s	ARG2
retinal	ARG2
G	ARG2
protein	ARG2
coupled	ARG2
receptor	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
RGR	ARG2
gene1e	ARG2
)	O
,	O
gene1s	ARG2
encephalopsin	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
panopsin	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
Opn3	ARG2
gene1e	ARG2
)	O
,	O
gene1s	ARG2
neuropsin	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
Opn5	ARG2
gene1e	ARG2
)	O
and	O
gene1s	ARG2
cone	ARG2
opsin	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
Opn1mw	ARG2
gene1e	ARG2
)	O
but	O
not	O
gene1s	ARG2
melanopsin	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
Opn4	ARG2
gene1e	ARG2
)	O
or	O
gene1s	ARG2
rhodopsin	ARG2
gene1e	ARG2
.	O
gene1s	ARG2
Opn5	ARG2
gene1e	ARG2
immunoreactivity	O
was	O
observed	O
in	O
species1s	O
RGC-5	O
species1e	O
cells	O
and	O
in	O
the	O
inner	O
retina	O
of	O
arg1s	O
rat	O
arg1e	O
,	O
mainly	O
localized	O
in	O
the	O
ganglion	O
cell	O
layer	O
(	O
GCL	O
)	O
.	O
Furthermore	O
,	O
white	O
light	O
pulses	O
of	O
different	O
intensities	O
and	O
durations	O
elicited	O
changes	O
both	O
in	O
intracellular	O
Ca(2	O
+	O
)	O
levels	O
and	O
in	O
the	O
induction	O
of	O
gene1s	ARG2
c	ARG2
-	ARG2
Fos	ARG2
gene1e	ARG2
protein	O
in	O
species1s	O
RGC-5	O
species1e	O
cell	O
cultures	O
.	O
The	O
results	O
demonstrate	O
that	O
species1s	O
RGC-5	O
species1e	O
cells	O
expressing	O
diverse	O
putative	O
functional	O
photopigments	O
display	O
intrinsic	O
photosensitivity	O
which	O
accounts	O
for	O
the	O
photic	O
induction	O
of	O
gene1s	ARG2
c	ARG2
-	ARG2
Fos	ARG2
gene1e	ARG2
protein	O
and	O
changes	O
in	O
intracellular	O
Ca(2	O
+	O
)	O
mobilization	O
.	O
The	O
presence	O
of	O
gene1s	ARG2
Opn5	ARG2
gene1e	ARG2
in	O
the	O
GCL	O
of	O
the	O
arg1s	O
rat	O
arg1e	O
retina	O
suggests	O
the	O
existence	O
of	O
a	O
novel	O
type	O
of	O
photoreceptor	O
cell	O
.	O

Expression	O
of	O
novel	O
gene1s	O
opsins	O
gene1e	O
and	O
intrinsic	O
light	O
responses	O
in	O
the	O
species1s	O
mammalian	O
species1e	O
retinal	O
ganglion	O
cell	O
line	O
RGC-5	O
.	O
Presence	O
of	O
gene1s	O
OPN5	O
gene1e	O
in	O
the	O
species1s	O
rat	O
species1e	O
retina	O
.	O
The	O
vertebrate	O
retina	O
is	O
known	O
to	O
contain	O
three	O
classes	O
of	O
photoreceptor	O
cells	O
:	O
cones	O
and	O
rods	O
responsible	O
for	O
vision	O
,	O
and	O
intrinsically	O
photoresponsive	O
retinal	O
ganglion	O
cells	O
(	O
RGCs	O
)	O
involved	O
in	O
diverse	O
non	O
-	O
visual	O
functions	O
such	O
as	O
photic	O
entrainment	O
of	O
daily	O
rhythms	O
and	O
pupillary	O
light	O
responses	O
.	O
In	O
this	O
paper	O
we	O
investigated	O
the	O
potential	O
intrinsic	O
photoresponsiveness	O
of	O
the	O
species1s	O
rat	O
species1e	O
RGC	O
line	O
,	O
RGC-5	O
,	O
by	O
testing	O
for	O
the	O
presence	O
of	O
visual	O
and	O
non	O
-	O
visual	O
gene1s	O
opsins	O
gene1e	O
and	O
assessing	O
expression	O
of	O
the	O
immediate	O
-	O
early	O
gene	O
protein	O
gene1s	O
c	O
-	O
Fos	O
gene1e	O
and	O
changes	O
in	O
intracellular	O
Ca(2	O
+	O
)	O
mobilization	O
in	O
response	O
to	O
brief	O
light	O
pulses	O
.	O
Cultured	O
arg1s	O
RGC-5	O
arg1e	O
cells	O
express	O
a	O
number	O
of	O
photopigment	O
mRNAs	O
such	O
as	O
gene1s	O
retinal	O
G	O
protein	O
coupled	O
receptor	O
gene1e	O
(	O
gene1s	O
RGR	O
gene1e	O
)	O
,	O
gene1s	O
encephalopsin	O
gene1e	O
/	O
gene1s	O
panopsin	O
gene1e	O
(	O
gene1s	O
Opn3	O
gene1e	O
)	O
,	O
gene1s	O
neuropsin	O
gene1e	O
(	O
gene1s	O
Opn5	O
gene1e	O
)	O
and	O
gene1s	O
cone	O
opsin	O
gene1e	O
(	O
gene1s	O
Opn1mw	O
gene1e	O
)	O
but	O
not	O
gene1s	O
melanopsin	O
gene1e	O
(	O
gene1s	O
Opn4	O
gene1e	O
)	O
or	O
gene1s	O
rhodopsin	O
gene1e	O
.	O
gene1s	O
Opn5	O
gene1e	O
immunoreactivity	O
was	O
observed	O
in	O
arg1s	O
RGC-5	O
arg1e	O
cells	O
and	O
in	O
the	O
inner	O
retina	O
of	O
species1s	O
rat	O
species1e	O
,	O
mainly	O
localized	O
in	O
the	O
ganglion	O
cell	O
layer	O
(	O
GCL	O
)	O
.	O
Furthermore	O
,	O
white	O
light	O
pulses	O
of	O
different	O
intensities	O
and	O
durations	O
elicited	O
changes	O
both	O
in	O
intracellular	O
Ca(2	O
+	O
)	O
levels	O
and	O
in	O
the	O
induction	O
of	O
gene1s	O
c	O
-	O
Fos	O
gene1e	O
protein	O
in	O
arg1s	O
RGC-5	O
arg1e	O
cell	O
cultures	O
.	O
The	O
results	O
demonstrate	O
that	O
arg1s	O
RGC-5	O
arg1e	O
cells	O
expressing	O
diverse	O
putative	O
functional	O
photopigments	O
display	O
intrinsic	O
photosensitivity	O
which	O
accounts	O
for	O
the	O
photic	O
induction	O
of	O
gene1s	O
c	O
-	O
Fos	O
gene1e	O
protein	O
and	O
changes	O
in	O
intracellular	O
Ca(2	O
+	O
)	O
mobilization	O
.	O
The	O
presence	O
of	O
gene1s	O
Opn5	O
gene1e	O
in	O
the	O
GCL	O
of	O
the	O
species1s	O
rat	O
species1e	O
retina	O
suggests	O
the	O
existence	O
of	O
a	O
novel	O
type	O
of	O
photoreceptor	O
cell	O
.	O

Erythropoietin	O
does	O
not	O
activate	O
gene1s	ARG2
erythropoietin	ARG2
receptor	ARG2
gene1e	ARG2
signaling	O
or	O
lipolytic	O
pathways	O
in	O
arg1s	O
human	O
arg1e	O
subcutaneous	O
white	O
adipose	O
tissue	O
in	O
vivo	O
.	O
BACKGROUND	O
:	O
Erythropoietin	O
(	O
Epo	O
)	O
exerts	O
direct	O
effects	O
on	O
white	O
adipose	O
tissue	O
(	O
WAT	O
)	O
in	O
species1s	O
mice	O
species1e	O
in	O
addition	O
to	O
its	O
erythropoietic	O
effects	O
,	O
and	O
in	O
arg1s	O
humans	O
arg1e	O
Epo	O
increases	O
resting	O
energy	O
expenditure	O
and	O
affect	O
serum	O
lipid	O
levels	O
,	O
but	O
direct	O
effects	O
of	O
Epo	O
in	O
arg1s	O
human	O
arg1e	O
WAT	O
have	O
not	O
been	O
documented	O
.	O
We	O
therefore	O
investigated	O
the	O
effects	O
of	O
acute	O
and	O
prolonged	O
Epo	O
exposure	O
on	O
arg1s	O
human	O
arg1e	O
WAT	O
in	O
vivo	O
.	O
METHOD	O
:	O
Data	O
were	O
obtained	O
from	O
two	O
clinical	O
trials	O
:	O
1	O
)	O
acute	O
Epo	O
exposure	O
(	O
rHuEpo	O
,	O
400	O
IU	O
/	O
kg	O
)	O
followed	O
by	O
WAT	O
biopsies	O
after	O
1	O
h	O
and	O
2	O
)	O
10	O
weeks	O
treatment	O
with	O
the	O
erythropoiesis	O
-	O
stimulating	O
agent	O
(	O
ESA	O
)	O
Darbepoietin	O
-	O
alpha	O
.	O
Biopsies	O
were	O
analyzed	O
by	O
PCR	O
for	O
gene1s	ARG2
Epo	ARG2
receptor	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
Epo	ARG2
-	ARG2
R	ARG2
gene1e	ARG2
)	O
mRNA	O
.	O
A	O
new	O
and	O
highly	O
specific	O
antibody	O
(	O
A82	O
,	O
Amgen	O
)	O
was	O
used	O
to	O
evaluate	O
the	O
presence	O
of	O
gene1s	ARG2
Epo	ARG2
-	ARG2
R	ARG2
gene1e	ARG2
by	O
western	O
blot	O
analysis	O
in	O
addition	O
to	O
gene1s	ARG2
Epo	ARG2
-	ARG2
R	ARG2
gene1e	ARG2
signaling	O
proteins	O
(	O
gene1s	ARG2
Akt	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
STAT5	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
p70s6k	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
LYN	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
p38MAPK	ARG2
gene1e	ARG2
)	O
,	O
activation	O
of	O
lipolytic	O
pathways	O
(	O
gene1s	ARG2
ATGL	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
HSL	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
CGI-58	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
G0S2	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Perilipin	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Cidea	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Cidec	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
AMPK	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
ACC	ARG2
gene1e	ARG2
)	O
,	O
and	O
mitochondrial	O
biogenesis	O
(	O
gene1s	ARG2
VDAC	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
HSP90	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
PDH	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
SDHA	ARG2
gene1e	ARG2
)	O
.	O
RESULTS	O
:	O
No	O
evidence	O
of	O
in	O
vivo	O
activation	O
of	O
the	O
gene1s	ARG2
Epo	ARG2
-	ARG2
R	ARG2
gene1e	ARG2
in	O
WAT	O
could	O
be	O
documented	O
despite	O
detectable	O
levels	O
of	O
gene1s	ARG2
Epo	ARG2
-	ARG2
R	ARG2
gene1e	ARG2
mRNA	O
.	O
CONCLUSION	O
:	O
Thus	O
,	O
in	O
contradiction	O
to	O
animal	O
studies	O
,	O
Epo	O
treatment	O
within	O
a	O
physiological	O
relevant	O
range	O
in	O
arg1s	O
humans	O
arg1e	O
does	O
not	O
exert	O
direct	O
effects	O
in	O
a	O
subcutaneous	O
WAT	O
.	O

Erythropoietin	O
does	O
not	O
activate	O
gene1s	O
erythropoietin	O
receptor	O
gene1e	O
signaling	O
or	O
lipolytic	O
pathways	O
in	O
species1s	O
human	O
species1e	O
subcutaneous	O
white	O
adipose	O
tissue	O
in	O
vivo	O
.	O
BACKGROUND	O
:	O
Erythropoietin	O
(	O
Epo	O
)	O
exerts	O
direct	O
effects	O
on	O
white	O
adipose	O
tissue	O
(	O
WAT	O
)	O
in	O
arg1s	O
mice	O
arg1e	O
in	O
addition	O
to	O
its	O
erythropoietic	O
effects	O
,	O
and	O
in	O
species1s	O
humans	O
species1e	O
Epo	O
increases	O
resting	O
energy	O
expenditure	O
and	O
affect	O
serum	O
lipid	O
levels	O
,	O
but	O
direct	O
effects	O
of	O
Epo	O
in	O
species1s	O
human	O
species1e	O
WAT	O
have	O
not	O
been	O
documented	O
.	O
We	O
therefore	O
investigated	O
the	O
effects	O
of	O
acute	O
and	O
prolonged	O
Epo	O
exposure	O
on	O
species1s	O
human	O
species1e	O
WAT	O
in	O
vivo	O
.	O
METHOD	O
:	O
Data	O
were	O
obtained	O
from	O
two	O
clinical	O
trials	O
:	O
1	O
)	O
acute	O
Epo	O
exposure	O
(	O
rHuEpo	O
,	O
400	O
IU	O
/	O
kg	O
)	O
followed	O
by	O
WAT	O
biopsies	O
after	O
1	O
h	O
and	O
2	O
)	O
10	O
weeks	O
treatment	O
with	O
the	O
erythropoiesis	O
-	O
stimulating	O
agent	O
(	O
ESA	O
)	O
Darbepoietin	O
-	O
alpha	O
.	O
Biopsies	O
were	O
analyzed	O
by	O
PCR	O
for	O
gene1s	O
Epo	O
receptor	O
gene1e	O
(	O
gene1s	O
Epo	O
-	O
R	O
gene1e	O
)	O
mRNA	O
.	O
A	O
new	O
and	O
highly	O
specific	O
antibody	O
(	O
A82	O
,	O
Amgen	O
)	O
was	O
used	O
to	O
evaluate	O
the	O
presence	O
of	O
gene1s	O
Epo	O
-	O
R	O
gene1e	O
by	O
western	O
blot	O
analysis	O
in	O
addition	O
to	O
gene1s	O
Epo	O
-	O
R	O
gene1e	O
signaling	O
proteins	O
(	O
gene1s	O
Akt	O
gene1e	O
,	O
gene1s	O
STAT5	O
gene1e	O
,	O
gene1s	O
p70s6k	O
gene1e	O
,	O
gene1s	O
LYN	O
gene1e	O
,	O
and	O
gene1s	O
p38MAPK	O
gene1e	O
)	O
,	O
activation	O
of	O
lipolytic	O
pathways	O
(	O
gene1s	O
ATGL	O
gene1e	O
,	O
gene1s	O
HSL	O
gene1e	O
,	O
gene1s	O
CGI-58	O
gene1e	O
,	O
gene1s	O
G0S2	O
gene1e	O
,	O
gene1s	O
Perilipin	O
gene1e	O
,	O
gene1s	O
Cidea	O
gene1e	O
,	O
gene1s	O
Cidec	O
gene1e	O
,	O
gene1s	O
AMPK	O
gene1e	O
,	O
and	O
gene1s	O
ACC	O
gene1e	O
)	O
,	O
and	O
mitochondrial	O
biogenesis	O
(	O
gene1s	O
VDAC	O
gene1e	O
,	O
gene1s	O
HSP90	O
gene1e	O
,	O
gene1s	O
PDH	O
gene1e	O
,	O
and	O
gene1s	O
SDHA	O
gene1e	O
)	O
.	O
RESULTS	O
:	O
No	O
evidence	O
of	O
in	O
vivo	O
activation	O
of	O
the	O
gene1s	O
Epo	O
-	O
R	O
gene1e	O
in	O
WAT	O
could	O
be	O
documented	O
despite	O
detectable	O
levels	O
of	O
gene1s	O
Epo	O
-	O
R	O
gene1e	O
mRNA	O
.	O
CONCLUSION	O
:	O
Thus	O
,	O
in	O
contradiction	O
to	O
animal	O
studies	O
,	O
Epo	O
treatment	O
within	O
a	O
physiological	O
relevant	O
range	O
in	O
species1s	O
humans	O
species1e	O
does	O
not	O
exert	O
direct	O
effects	O
in	O
a	O
subcutaneous	O
WAT	O
.	O

gene1s	ARG2
TNFR	ARG2
-	ARG2
associated	ARG2
factor	ARG2
2	ARG2
gene1e	ARG2
deficiency	O
in	O
B	O
lymphocytes	O
predisposes	O
to	O
chronic	O
lymphocytic	O
leukemia	O
/	O
small	O
lymphocytic	O
lymphoma	O
in	O
arg1s	O
mice	O
arg1e	O
.	O
We	O
have	O
previously	O
shown	O
that	O
transgenic	O
(	O
tg	O
)	O
arg1s	O
mice	O
arg1e	O
expressing	O
in	O
B	O
lymphocytes	O
both	O
gene1s	O
BCL-2	O
gene1e	O
and	O
a	O
gene1s	ARG2
TNFR	ARG2
-	ARG2
associated	ARG2
factor	ARG2
2	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
TRAF2	ARG2
gene1e	ARG2
)	O
mutant	O
lacking	O
the	O
really	O
interesting	O
new	O
gene	O
and	O
zinc	O
finger	O
domains	O
(	O
gene1s	O
TRAF2DN	O
gene1e	O
)	O
develop	O
small	O
lymphocytic	O
lymphoma	O
and	O
chronic	O
lymphocytic	O
leukemia	O
with	O
high	O
incidence	O
(	O
Zapata	O
et	O
al	O
.	O
2004	O
.	O
Proc	O
.	O
Nat	O
.	O
Acad	O
.	O
Sci	O
.	O
USA	O
101	O
:	O
16600	O
-	O
16605	O
)	O
.	O
Further	O
analysis	O
of	O
the	O
expression	O
of	O
gene1s	ARG2
TRAF2	ARG2
gene1e	ARG2
and	O
gene1s	O
TRAF2DN	O
gene1e	O
in	O
purified	O
B	O
cells	O
demonstrated	O
that	O
expression	O
of	O
both	O
endogenous	O
gene1s	ARG2
TRAF2	ARG2
gene1e	ARG2
and	O
tg	O
gene1s	O
TRAF2DN	O
gene1e	O
was	O
negligible	O
in	O
gene1s	O
Traf2DN	O
gene1e	O
-	O
tg	O
B	O
cells	O
compared	O
with	O
wild	O
-	O
type	O
arg1s	O
mice	O
arg1e	O
.	O
This	O
was	O
the	O
result	O
of	O
gene1s	ARG2
proteasome	ARG2
gene1e	ARG2
-	O
dependent	O
degradation	O
,	O
and	O
rendered	O
gene1s	O
TRAF2DN	O
gene1e	O
B	O
cells	O
as	O
species1s	O
bona	O
species1e	O
fide	O
gene1s	ARG2
TRAF2	ARG2
gene1e	ARG2
-deficient	O
B	O
cells	O
.	O
Similar	O
to	O
B	O
cells	O
with	O
targeted	O
gene1s	ARG2
Traf2	ARG2
gene1e	ARG2
deletion	O
,	O
gene1s	O
Traf2DN	O
gene1e	O
-	O
tg	O
arg1s	O
mice	O
arg1e	O
show	O
expanded	O
marginal	O
zone	O
B	O
cell	O
population	O
and	O
have	O
constitutive	O
gene1s	ARG2
p100	ARG2
NF	ARG2
-	ARG2
kappaB2	ARG2
gene1e	ARG2
processing	O
.	O
Also	O
,	O
gene1s	ARG2
TRAF3	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
X	ARG2
-	ARG2
linked	ARG2
inhibitor	ARG2
of	ARG2
apoptosis	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
Bcl	ARG2
-	ARG2
X(L	ARG2
)	ARG2
gene1e	ARG2
expression	O
levels	O
were	O
increased	O
,	O
whereas	O
gene1s	ARG2
cellular	ARG2
inhibitors	ARG2
of	ARG2
apoptosis	ARG2
1	ARG2
and	ARG2
2	ARG2
gene1e	ARG2
levels	O
were	O
drastically	O
reduced	O
compared	O
with	O
those	O
found	O
in	O
wild	O
-	O
type	O
B	O
cells	O
.	O
Moreover	O
,	O
consistent	O
with	O
previous	O
results	O
,	O
we	O
also	O
show	O
that	O
gene1s	ARG2
TRAF2	ARG2
gene1e	ARG2
was	O
required	O
for	O
efficient	O
gene1s	ARG2
JNK	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
ERK	ARG2
gene1e	ARG2
activation	O
in	O
response	O
to	O
gene1s	ARG2
CD40	ARG2
gene1e	ARG2
engagement	O
.	O
However	O
,	O
gene1s	ARG2
TRAF2	ARG2
gene1e	ARG2
was	O
deleterious	O
for	O
gene1s	ARG2
BCR	ARG2
gene1e	ARG2
-	O
mediated	O
activation	O
of	O
these	O
gene1s	ARG2
kinases	ARG2
gene1e	ARG2
.	O
In	O
contrast	O
,	O
gene1s	ARG2
TRAF2	ARG2
gene1e	ARG2
deficiency	O
had	O
no	O
effect	O
on	O
gene1s	ARG2
CD40	ARG2
gene1e	ARG2
-mediated	O
gene1s	ARG2
p38	ARG2
MAPK	ARG2
gene1e	ARG2
activation	O
but	O
significantly	O
reduced	O
gene1s	ARG2
BCR	ARG2
gene1e	ARG2
-	O
mediated	O
gene1s	ARG2
p38	ARG2
gene1e	ARG2
activation	O
.	O
Finally	O
,	O
we	O
further	O
confirm	O
that	O
gene1s	ARG2
TRAF2	ARG2
gene1e	ARG2
was	O
required	O
for	O
gene1s	ARG2
CD40	ARG2
gene1e	ARG2
-mediated	O
proliferation	O
,	O
but	O
its	O
absence	O
relieved	O
B	O
cells	O
of	O
the	O
need	O
for	O
gene1s	ARG2
B	ARG2
cell	ARG2
activating	ARG2
factor	ARG2
gene1e	ARG2
for	O
survival	O
.	O
Altogether	O
,	O
our	O
results	O
suggest	O
that	O
gene1s	ARG2
TRAF2	ARG2
gene1e	ARG2
deficiency	O
cooperates	O
with	O
gene1s	O
BCL-2	O
gene1e	O
in	O
promoting	O
chronic	O
lymphocytic	O
leukemia	O
/	O
small	O
lymphocytic	O
lymphoma	O
in	O
arg1s	O
mice	O
arg1e	O
,	O
possibly	O
by	O
specifically	O
enforcing	O
marginal	O
zone	O
B	O
cell	O
accumulation	O
,	O
increasing	O
gene1s	ARG2
X	ARG2
-	ARG2
linked	ARG2
inhibitor	ARG2
of	ARG2
apoptosis	ARG2
gene1e	ARG2
expression	O
,	O
and	O
rendering	O
B	O
cells	O
independent	O
of	O
gene1s	ARG2
B	ARG2
cell	ARG2
activating	ARG2
factor	ARG2
gene1e	ARG2
for	O
survival	O
.	O

gene1s	O
TNFR	O
-	O
associated	O
factor	O
2	O
gene1e	O
deficiency	O
in	O
B	O
lymphocytes	O
predisposes	O
to	O
chronic	O
lymphocytic	O
leukemia	O
/	O
small	O
lymphocytic	O
lymphoma	O
in	O
species1s	O
mice	O
species1e	O
.	O
We	O
have	O
previously	O
shown	O
that	O
transgenic	O
(	O
tg	O
)	O
species1s	O
mice	O
species1e	O
expressing	O
in	O
B	O
lymphocytes	O
both	O
gene1s	ARG2
BCL-2	ARG2
gene1e	ARG2
and	O
a	O
gene1s	O
TNFR	O
-	O
associated	O
factor	O
2	O
gene1e	O
(	O
gene1s	O
TRAF2	O
gene1e	O
)	O
mutant	O
lacking	O
the	O
really	O
interesting	O
new	O
gene	O
and	O
zinc	O
finger	O
domains	O
(	O
gene1s	ARG2
TRAF2DN	ARG2
gene1e	ARG2
)	O
develop	O
small	O
lymphocytic	O
lymphoma	O
and	O
chronic	O
lymphocytic	O
leukemia	O
with	O
high	O
incidence	O
(	O
Zapata	O
et	O
al	O
.	O
2004	O
.	O
Proc	O
.	O
Nat	O
.	O
Acad	O
.	O
Sci	O
.	O
USA	O
101	O
:	O
16600	O
-	O
16605	O
)	O
.	O
Further	O
analysis	O
of	O
the	O
expression	O
of	O
gene1s	O
TRAF2	O
gene1e	O
and	O
gene1s	ARG2
TRAF2DN	ARG2
gene1e	ARG2
in	O
purified	O
B	O
cells	O
demonstrated	O
that	O
expression	O
of	O
both	O
endogenous	O
gene1s	O
TRAF2	O
gene1e	O
and	O
tg	O
gene1s	ARG2
TRAF2DN	ARG2
gene1e	ARG2
was	O
negligible	O
in	O
gene1s	ARG2
Traf2DN	ARG2
gene1e	ARG2
-	O
tg	O
B	O
cells	O
compared	O
with	O
wild	O
-	O
type	O
species1s	O
mice	O
species1e	O
.	O
This	O
was	O
the	O
result	O
of	O
gene1s	O
proteasome	O
gene1e	O
-	O
dependent	O
degradation	O
,	O
and	O
rendered	O
gene1s	ARG2
TRAF2DN	ARG2
gene1e	ARG2
B	O
cells	O
as	O
arg1s	O
bona	O
arg1e	O
fide	O
gene1s	O
TRAF2	O
gene1e	O
-deficient	O
B	O
cells	O
.	O
Similar	O
to	O
B	O
cells	O
with	O
targeted	O
gene1s	O
Traf2	O
gene1e	O
deletion	O
,	O
gene1s	ARG2
Traf2DN	ARG2
gene1e	ARG2
-	O
tg	O
species1s	O
mice	O
species1e	O
show	O
expanded	O
marginal	O
zone	O
B	O
cell	O
population	O
and	O
have	O
constitutive	O
gene1s	O
p100	O
NF	O
-	O
kappaB2	O
gene1e	O
processing	O
.	O
Also	O
,	O
gene1s	O
TRAF3	O
gene1e	O
,	O
gene1s	O
X	O
-	O
linked	O
inhibitor	O
of	O
apoptosis	O
gene1e	O
,	O
and	O
gene1s	O
Bcl	O
-	O
X(L	O
)	O
gene1e	O
expression	O
levels	O
were	O
increased	O
,	O
whereas	O
gene1s	O
cellular	O
inhibitors	O
of	O
apoptosis	O
1	O
and	O
2	O
gene1e	O
levels	O
were	O
drastically	O
reduced	O
compared	O
with	O
those	O
found	O
in	O
wild	O
-	O
type	O
B	O
cells	O
.	O
Moreover	O
,	O
consistent	O
with	O
previous	O
results	O
,	O
we	O
also	O
show	O
that	O
gene1s	O
TRAF2	O
gene1e	O
was	O
required	O
for	O
efficient	O
gene1s	O
JNK	O
gene1e	O
and	O
gene1s	O
ERK	O
gene1e	O
activation	O
in	O
response	O
to	O
gene1s	O
CD40	O
gene1e	O
engagement	O
.	O
However	O
,	O
gene1s	O
TRAF2	O
gene1e	O
was	O
deleterious	O
for	O
gene1s	O
BCR	O
gene1e	O
-	O
mediated	O
activation	O
of	O
these	O
gene1s	O
kinases	O
gene1e	O
.	O
In	O
contrast	O
,	O
gene1s	O
TRAF2	O
gene1e	O
deficiency	O
had	O
no	O
effect	O
on	O
gene1s	O
CD40	O
gene1e	O
-mediated	O
gene1s	O
p38	O
MAPK	O
gene1e	O
activation	O
but	O
significantly	O
reduced	O
gene1s	O
BCR	O
gene1e	O
-	O
mediated	O
gene1s	O
p38	O
gene1e	O
activation	O
.	O
Finally	O
,	O
we	O
further	O
confirm	O
that	O
gene1s	O
TRAF2	O
gene1e	O
was	O
required	O
for	O
gene1s	O
CD40	O
gene1e	O
-mediated	O
proliferation	O
,	O
but	O
its	O
absence	O
relieved	O
B	O
cells	O
of	O
the	O
need	O
for	O
gene1s	O
B	O
cell	O
activating	O
factor	O
gene1e	O
for	O
survival	O
.	O
Altogether	O
,	O
our	O
results	O
suggest	O
that	O
gene1s	O
TRAF2	O
gene1e	O
deficiency	O
cooperates	O
with	O
gene1s	ARG2
BCL-2	ARG2
gene1e	ARG2
in	O
promoting	O
chronic	O
lymphocytic	O
leukemia	O
/	O
small	O
lymphocytic	O
lymphoma	O
in	O
species1s	O
mice	O
species1e	O
,	O
possibly	O
by	O
specifically	O
enforcing	O
marginal	O
zone	O
B	O
cell	O
accumulation	O
,	O
increasing	O
gene1s	O
X	O
-	O
linked	O
inhibitor	O
of	O
apoptosis	O
gene1e	O
expression	O
,	O
and	O
rendering	O
B	O
cells	O
independent	O
of	O
gene1s	O
B	O
cell	O
activating	O
factor	O
gene1e	O
for	O
survival	O
.	O

gene1s	O
MyD88	O
gene1e	O
is	O
crucial	O
for	O
the	O
development	O
of	O
a	O
protective	O
CNS	O
immune	O
response	O
to	O
arg1s	O
Toxoplasma	O
gondii	O
arg1e	O
infection	O
.	O
BACKGROUND	O
:	O
Toxoplasmosis	O
is	O
one	O
of	O
the	O
most	O
common	O
parasitic	O
infections	O
in	O
species1s	O
humans	O
species1e	O
.	O
It	O
can	O
establish	O
chronic	O
infection	O
and	O
is	O
characterized	O
by	O
the	O
formation	O
of	O
tissue	O
cysts	O
in	O
the	O
brain	O
.	O
The	O
cysts	O
remain	O
largely	O
quiescent	O
for	O
the	O
life	O
of	O
the	O
host	O
,	O
but	O
can	O
reactivate	O
and	O
cause	O
life	O
-	O
threatening	O
toxoplasmic	O
encephalitis	O
in	O
immunocompromised	O
species1s	O
patients	O
species1e	O
,	O
such	O
as	O
those	O
with	O
AIDS	O
,	O
neoplastic	O
diseases	O
and	O
organ	O
transplants	O
.	O
gene1s	O
Toll	O
-	O
like	O
receptor	O
gene1e	O
(	O
gene1s	O
TLR	O
gene1e	O
)	O
adaptor	O
gene1s	O
MyD88	O
gene1e	O
activation	O
is	O
required	O
for	O
the	O
innate	O
sensing	O
of	O
arg1s	O
Toxoplasma	O
gondii	O
arg1e	O
.	O
species1s	O
Mice	O
species1e	O
deficient	O
in	O
gene1s	O
MyD88	O
gene1e	O
have	O
defective	O
gene1s	O
IL-12	O
gene1e	O
and	O
Th1	O
effector	O
responses	O
,	O
and	O
are	O
highly	O
susceptible	O
to	O
the	O
acute	O
phase	O
of	O
arg1s	O
T.	O
gondii	O
arg1e	O
infection	O
.	O
However	O
,	O
the	O
role	O
of	O
this	O
signaling	O
pathway	O
during	O
cerebral	O
infection	O
is	O
poorly	O
understood	O
and	O
requires	O
examination	O
.	O
METHOD	O
:	O
gene1s	O
MyD88	O
gene1e	O
-deficient	O
species1s	O
mice	O
species1e	O
and	O
control	O
species1s	O
mice	O
species1e	O
were	O
orally	O
infected	O
with	O
arg1s	O
T.	O
gondii	O
arg1e	O
cysts	O
.	O
Cellular	O
and	O
parasite	O
infiltration	O
in	O
the	O
peripheral	O
organs	O
and	O
in	O
the	O
brain	O
were	O
determined	O
by	O
histology	O
and	O
immunohistochemistry	O
.	O
gene1s	O
Cytokine	O
gene1e	O
levels	O
were	O
determined	O
by	O
ELISA	O
and	O
gene1s	O
chemokine	O
gene1e	O
mRNA	O
levels	O
were	O
quantified	O
by	O
real	O
-	O
time	O
PCR	O
(	O
qPCR	O
)	O
.	O
RESULTS	O
:	O
Thirteen	O
days	O
after	O
infection	O
,	O
a	O
higher	O
parasite	O
burden	O
was	O
observed	O
but	O
there	O
was	O
no	O
histological	O
change	O
in	O
the	O
liver	O
,	O
heart	O
,	O
lungs	O
and	O
small	O
intestine	O
of	O
gene1s	O
MyD88	O
gene1e	O
-/-	O
and	O
gene1s	O
MyD88	O
gene1e	O
+/+	O
species1s	O
mice	O
species1e	O
.	O
However	O
,	O
gene1s	O
MyD88	O
gene1e	O
-/-	O
species1s	O
mice	O
species1e	O
compared	O
to	O
gene1s	O
MyD88	O
gene1e	O
+/+	O
species1s	O
mice	O
species1e	O
were	O
highly	O
susceptible	O
to	O
cerebral	O
infection	O
,	O
displayed	O
high	O
parasite	O
migration	O
to	O
the	O
brain	O
,	O
severe	O
neuropathological	O
signs	O
of	O
encephalitis	O
and	O
succumbed	O
within	O
2	O
weeks	O
of	O
oral	O
infection	O
.	O
Susceptibility	O
was	O
primarily	O
associated	O
with	O
lower	O
expression	O
of	O
gene1s	O
Th1	O
cytokines	O
gene1e	O
,	O
especially	O
gene1s	O
IL-12	O
gene1e	O
,	O
gene1s	O
IFN	O
-	O
g	O
gene1e	O
and	O
gene1s	O
TNF	O
-	O
a	O
gene1e	O
,	O
significant	O
decrease	O
in	O
the	O
expression	O
of	O
gene1s	O
CCL3	O
gene1e	O
,	O
gene1s	O
CCL5	O
gene1e	O
,	O
gene1s	O
CCL7	O
gene1e	O
and	O
gene1s	O
CCL19	O
gene1e	O
gene1s	O
chemokines	O
gene1e	O
,	O
marked	O
defect	O
of	O
CD8	O
+	O
T	O
cells	O
,	O
and	O
infiltration	O
of	O
gene1s	O
CD11b	O
gene1e	O
+	O
and	O
gene1s	O
F4/80	O
gene1e	O
+	O
cells	O
in	O
the	O
brain	O
.	O
CONCLUSION	O
:	O
gene1s	O
MyD88	O
gene1e	O
is	O
essential	O
for	O
the	O
protection	O
of	O
species1s	O
mice	O
species1e	O
during	O
the	O
cerebral	O
installation	O
of	O
arg1s	O
T.	O
gondii	O
arg1e	O
infection	O
.	O
These	O
results	O
establish	O
a	O
role	O
for	O
gene1s	O
MyD88	O
gene1e	O
in	O
T	O
cell	O
-	O
mediated	O
control	O
of	O
arg1s	O
T.	O
gondii	O
arg1e	O
in	O
the	O
central	O
nervous	O
system	O
(	O
CNS	O
)	O
.	O

gene1s	O
MyD88	O
gene1e	O
is	O
crucial	O
for	O
the	O
development	O
of	O
a	O
protective	O
CNS	O
immune	O
response	O
to	O
species1s	O
Toxoplasma	O
gondii	O
species1e	O
infection	O
.	O
BACKGROUND	O
:	O
Toxoplasmosis	O
is	O
one	O
of	O
the	O
most	O
common	O
parasitic	O
infections	O
in	O
arg1s	O
humans	O
arg1e	O
.	O
It	O
can	O
establish	O
chronic	O
infection	O
and	O
is	O
characterized	O
by	O
the	O
formation	O
of	O
tissue	O
cysts	O
in	O
the	O
brain	O
.	O
The	O
cysts	O
remain	O
largely	O
quiescent	O
for	O
the	O
life	O
of	O
the	O
host	O
,	O
but	O
can	O
reactivate	O
and	O
cause	O
life	O
-	O
threatening	O
toxoplasmic	O
encephalitis	O
in	O
immunocompromised	O
arg1s	O
patients	O
arg1e	O
,	O
such	O
as	O
those	O
with	O
AIDS	O
,	O
neoplastic	O
diseases	O
and	O
organ	O
transplants	O
.	O
gene1s	O
Toll	O
-	O
like	O
receptor	O
gene1e	O
(	O
gene1s	O
TLR	O
gene1e	O
)	O
adaptor	O
gene1s	O
MyD88	O
gene1e	O
activation	O
is	O
required	O
for	O
the	O
innate	O
sensing	O
of	O
species1s	O
Toxoplasma	O
gondii	O
species1e	O
.	O
species1s	O
Mice	O
species1e	O
deficient	O
in	O
gene1s	O
MyD88	O
gene1e	O
have	O
defective	O
gene1s	O
IL-12	O
gene1e	O
and	O
Th1	O
effector	O
responses	O
,	O
and	O
are	O
highly	O
susceptible	O
to	O
the	O
acute	O
phase	O
of	O
species1s	O
T.	O
gondii	O
species1e	O
infection	O
.	O
However	O
,	O
the	O
role	O
of	O
this	O
signaling	O
pathway	O
during	O
cerebral	O
infection	O
is	O
poorly	O
understood	O
and	O
requires	O
examination	O
.	O
METHOD	O
:	O
gene1s	O
MyD88	O
gene1e	O
-deficient	O
species1s	O
mice	O
species1e	O
and	O
control	O
species1s	O
mice	O
species1e	O
were	O
orally	O
infected	O
with	O
species1s	O
T.	O
gondii	O
species1e	O
cysts	O
.	O
Cellular	O
and	O
parasite	O
infiltration	O
in	O
the	O
peripheral	O
organs	O
and	O
in	O
the	O
brain	O
were	O
determined	O
by	O
histology	O
and	O
immunohistochemistry	O
.	O
gene1s	O
Cytokine	O
gene1e	O
levels	O
were	O
determined	O
by	O
ELISA	O
and	O
gene1s	O
chemokine	O
gene1e	O
mRNA	O
levels	O
were	O
quantified	O
by	O
real	O
-	O
time	O
PCR	O
(	O
qPCR	O
)	O
.	O
RESULTS	O
:	O
Thirteen	O
days	O
after	O
infection	O
,	O
a	O
higher	O
parasite	O
burden	O
was	O
observed	O
but	O
there	O
was	O
no	O
histological	O
change	O
in	O
the	O
liver	O
,	O
heart	O
,	O
lungs	O
and	O
small	O
intestine	O
of	O
gene1s	O
MyD88	O
gene1e	O
-/-	O
and	O
gene1s	O
MyD88	O
gene1e	O
+/+	O
species1s	O
mice	O
species1e	O
.	O
However	O
,	O
gene1s	O
MyD88	O
gene1e	O
-/-	O
species1s	O
mice	O
species1e	O
compared	O
to	O
gene1s	O
MyD88	O
gene1e	O
+/+	O
species1s	O
mice	O
species1e	O
were	O
highly	O
susceptible	O
to	O
cerebral	O
infection	O
,	O
displayed	O
high	O
parasite	O
migration	O
to	O
the	O
brain	O
,	O
severe	O
neuropathological	O
signs	O
of	O
encephalitis	O
and	O
succumbed	O
within	O
2	O
weeks	O
of	O
oral	O
infection	O
.	O
Susceptibility	O
was	O
primarily	O
associated	O
with	O
lower	O
expression	O
of	O
gene1s	O
Th1	O
cytokines	O
gene1e	O
,	O
especially	O
gene1s	O
IL-12	O
gene1e	O
,	O
gene1s	O
IFN	O
-	O
g	O
gene1e	O
and	O
gene1s	O
TNF	O
-	O
a	O
gene1e	O
,	O
significant	O
decrease	O
in	O
the	O
expression	O
of	O
gene1s	O
CCL3	O
gene1e	O
,	O
gene1s	O
CCL5	O
gene1e	O
,	O
gene1s	O
CCL7	O
gene1e	O
and	O
gene1s	O
CCL19	O
gene1e	O
gene1s	O
chemokines	O
gene1e	O
,	O
marked	O
defect	O
of	O
CD8	O
+	O
T	O
cells	O
,	O
and	O
infiltration	O
of	O
gene1s	O
CD11b	O
gene1e	O
+	O
and	O
gene1s	O
F4/80	O
gene1e	O
+	O
cells	O
in	O
the	O
brain	O
.	O
CONCLUSION	O
:	O
gene1s	O
MyD88	O
gene1e	O
is	O
essential	O
for	O
the	O
protection	O
of	O
species1s	O
mice	O
species1e	O
during	O
the	O
cerebral	O
installation	O
of	O
species1s	O
T.	O
gondii	O
species1e	O
infection	O
.	O
These	O
results	O
establish	O
a	O
role	O
for	O
gene1s	O
MyD88	O
gene1e	O
in	O
T	O
cell	O
-	O
mediated	O
control	O
of	O
species1s	O
T.	O
gondii	O
species1e	O
in	O
the	O
central	O
nervous	O
system	O
(	O
CNS	O
)	O
.	O

gene1s	ARG2
MyD88	ARG2
gene1e	ARG2
is	O
crucial	O
for	O
the	O
development	O
of	O
a	O
protective	O
CNS	O
immune	O
response	O
to	O
species1s	O
Toxoplasma	O
gondii	O
species1e	O
infection	O
.	O
BACKGROUND	O
:	O
Toxoplasmosis	O
is	O
one	O
of	O
the	O
most	O
common	O
parasitic	O
infections	O
in	O
species1s	O
humans	O
species1e	O
.	O
It	O
can	O
establish	O
chronic	O
infection	O
and	O
is	O
characterized	O
by	O
the	O
formation	O
of	O
tissue	O
cysts	O
in	O
the	O
brain	O
.	O
The	O
cysts	O
remain	O
largely	O
quiescent	O
for	O
the	O
life	O
of	O
the	O
host	O
,	O
but	O
can	O
reactivate	O
and	O
cause	O
life	O
-	O
threatening	O
toxoplasmic	O
encephalitis	O
in	O
immunocompromised	O
species1s	O
patients	O
species1e	O
,	O
such	O
as	O
those	O
with	O
AIDS	O
,	O
neoplastic	O
diseases	O
and	O
organ	O
transplants	O
.	O
gene1s	ARG2
Toll	ARG2
-	ARG2
like	ARG2
receptor	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
TLR	ARG2
gene1e	ARG2
)	O
adaptor	O
gene1s	ARG2
MyD88	ARG2
gene1e	ARG2
activation	O
is	O
required	O
for	O
the	O
innate	O
sensing	O
of	O
species1s	O
Toxoplasma	O
gondii	O
species1e	O
.	O
arg1s	O
Mice	O
arg1e	O
deficient	O
in	O
gene1s	ARG2
MyD88	ARG2
gene1e	ARG2
have	O
defective	O
gene1s	ARG2
IL-12	ARG2
gene1e	ARG2
and	O
Th1	O
effector	O
responses	O
,	O
and	O
are	O
highly	O
susceptible	O
to	O
the	O
acute	O
phase	O
of	O
species1s	O
T.	O
gondii	O
species1e	O
infection	O
.	O
However	O
,	O
the	O
role	O
of	O
this	O
signaling	O
pathway	O
during	O
cerebral	O
infection	O
is	O
poorly	O
understood	O
and	O
requires	O
examination	O
.	O
METHOD	O
:	O
gene1s	ARG2
MyD88	ARG2
gene1e	ARG2
-deficient	O
arg1s	O
mice	O
arg1e	O
and	O
control	O
arg1s	O
mice	O
arg1e	O
were	O
orally	O
infected	O
with	O
species1s	O
T.	O
gondii	O
species1e	O
cysts	O
.	O
Cellular	O
and	O
parasite	O
infiltration	O
in	O
the	O
peripheral	O
organs	O
and	O
in	O
the	O
brain	O
were	O
determined	O
by	O
histology	O
and	O
immunohistochemistry	O
.	O
gene1s	ARG2
Cytokine	ARG2
gene1e	ARG2
levels	O
were	O
determined	O
by	O
ELISA	O
and	O
gene1s	ARG2
chemokine	ARG2
gene1e	ARG2
mRNA	O
levels	O
were	O
quantified	O
by	O
real	O
-	O
time	O
PCR	O
(	O
qPCR	O
)	O
.	O
RESULTS	O
:	O
Thirteen	O
days	O
after	O
infection	O
,	O
a	O
higher	O
parasite	O
burden	O
was	O
observed	O
but	O
there	O
was	O
no	O
histological	O
change	O
in	O
the	O
liver	O
,	O
heart	O
,	O
lungs	O
and	O
small	O
intestine	O
of	O
gene1s	ARG2
MyD88	ARG2
gene1e	ARG2
-/-	O
and	O
gene1s	ARG2
MyD88	ARG2
gene1e	ARG2
+/+	O
arg1s	O
mice	O
arg1e	O
.	O
However	O
,	O
gene1s	ARG2
MyD88	ARG2
gene1e	ARG2
-/-	O
arg1s	O
mice	O
arg1e	O
compared	O
to	O
gene1s	ARG2
MyD88	ARG2
gene1e	ARG2
+/+	O
arg1s	O
mice	O
arg1e	O
were	O
highly	O
susceptible	O
to	O
cerebral	O
infection	O
,	O
displayed	O
high	O
parasite	O
migration	O
to	O
the	O
brain	O
,	O
severe	O
neuropathological	O
signs	O
of	O
encephalitis	O
and	O
succumbed	O
within	O
2	O
weeks	O
of	O
oral	O
infection	O
.	O
Susceptibility	O
was	O
primarily	O
associated	O
with	O
lower	O
expression	O
of	O
gene1s	ARG2
Th1	ARG2
cytokines	ARG2
gene1e	ARG2
,	O
especially	O
gene1s	ARG2
IL-12	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IFN	ARG2
-	ARG2
g	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
TNF	ARG2
-	ARG2
a	ARG2
gene1e	ARG2
,	O
significant	O
decrease	O
in	O
the	O
expression	O
of	O
gene1s	ARG2
CCL3	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
CCL5	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
CCL7	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
CCL19	ARG2
gene1e	ARG2
gene1s	ARG2
chemokines	ARG2
gene1e	ARG2
,	O
marked	O
defect	O
of	O
CD8	O
+	O
T	O
cells	O
,	O
and	O
infiltration	O
of	O
gene1s	ARG2
CD11b	ARG2
gene1e	ARG2
+	O
and	O
gene1s	ARG2
F4/80	ARG2
gene1e	ARG2
+	O
cells	O
in	O
the	O
brain	O
.	O
CONCLUSION	O
:	O
gene1s	ARG2
MyD88	ARG2
gene1e	ARG2
is	O
essential	O
for	O
the	O
protection	O
of	O
arg1s	O
mice	O
arg1e	O
during	O
the	O
cerebral	O
installation	O
of	O
species1s	O
T.	O
gondii	O
species1e	O
infection	O
.	O
These	O
results	O
establish	O
a	O
role	O
for	O
gene1s	ARG2
MyD88	ARG2
gene1e	ARG2
in	O
T	O
cell	O
-	O
mediated	O
control	O
of	O
species1s	O
T.	O
gondii	O
species1e	O
in	O
the	O
central	O
nervous	O
system	O
(	O
CNS	O
)	O
.	O

Liver	O
fibrosis	O
occurs	O
through	O
dysregulation	O
of	O
gene1s	ARG2
MyD88	ARG2
gene1e	ARG2
-dependent	O
innate	O
B	O
-	O
cell	O
activity	O
.	O
Chronic	O
liver	O
disease	O
mediated	O
by	O
activation	O
of	O
hepatic	O
stellate	O
cells	O
(	O
HSCs	O
)	O
leads	O
to	O
liver	O
fibrosis	O
.	O
Here	O
,	O
we	O
postulated	O
that	O
the	O
immune	O
regulatory	O
properties	O
of	O
HSCs	O
might	O
promote	O
the	O
profibrogenic	O
activity	O
of	O
B	O
cells	O
.	O
Fibrosis	O
is	O
completely	O
attenuated	O
in	O
carbon	O
tetrachloride	O
-	O
treated	O
,	O
B	O
cell	O
-	O
deficient	O
uMT	O
arg1s	O
mice	O
arg1e	O
,	O
showing	O
that	O
B	O
cells	O
are	O
required	O
.	O
The	O
retinoic	O
acid	O
produced	O
by	O
HSCs	O
augmented	O
B	O
-	O
cell	O
survival	O
,	O
plasma	O
cell	O
marker	O
gene1s	ARG2
CD138	ARG2
gene1e	ARG2
expression	O
,	O
and	O
gene1s	ARG2
immunoglobulin	ARG2
G	ARG2
gene1e	ARG2
production	O
.	O
These	O
activities	O
were	O
reversed	O
following	O
addition	O
of	O
the	O
retinoic	O
acid	O
inhibitor	O
LE540	O
.	O
Transcriptional	O
profiling	O
of	O
fibrotic	O
liver	O
B	O
cells	O
revealed	O
increased	O
expression	O
of	O
genes	O
related	O
to	O
activation	O
of	O
gene1s	ARG2
nuclear	ARG2
factor	ARG2
k	ARG2
light	ARG2
chain	ARG2
enhancer	ARG2
of	ARG2
activated	ARG2
B	ARG2
cells	ARG2
gene1e	ARG2
,	O
proinflammatory	O
gene1s	ARG2
cytokine	ARG2
gene1e	ARG2
production	O
,	O
and	O
gene1s	ARG2
CD40	ARG2
gene1e	ARG2
signaling	O
,	O
suggesting	O
that	O
these	O
B	O
cells	O
are	O
activated	O
and	O
may	O
be	O
acting	O
as	O
inflammatory	O
cells	O
.	O
Biological	O
validation	O
experiments	O
also	O
revealed	O
increased	O
activation	O
(	O
gene1s	ARG2
CD44	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
CD86	ARG2
gene1e	ARG2
expression	O
)	O
,	O
constitutive	O
gene1s	ARG2
immunoglobulin	ARG2
G	ARG2
gene1e	ARG2
production	O
,	O
and	O
secretion	O
of	O
the	O
gene1s	ARG2
proinflammatory	ARG2
cytokines	ARG2
gene1e	ARG2
gene1s	ARG2
tumor	ARG2
necrosis	ARG2
factor	ARG2
-	ARG2
a	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
monocyte	ARG2
chemoattractant	ARG2
protein-1	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
macrophage	ARG2
inflammatory	ARG2
protein-1a	ARG2
gene1e	ARG2
.	O
Likewise	O
,	O
targeted	O
deletion	O
of	O
B	O
-	O
cell	O
-	O
intrinsic	O
gene1s	ARG2
myeloid	ARG2
differentiation	ARG2
primary	ARG2
response	ARG2
gene	ARG2
88	ARG2
gene1e	ARG2
signaling	O
,	O
an	O
innate	O
adaptor	O
with	O
involvement	O
in	O
retinoic	O
acid	O
signaling	O
,	O
resulted	O
in	O
reduced	O
infiltration	O
of	O
migratory	O
gene1s	ARG2
CD11c	ARG2
gene1e	ARG2
(+	O
)	O
dendritic	O
cells	O
and	O
gene1s	ARG2
Ly6C	ARG2
gene1e	ARG2
(++	O
)	O
monocytes	O
and	O
,	O
hence	O
,	O
reduced	O
liver	O
pathology	O
.	O
CONCLUSION	O
:	O
Liver	O
fibrosis	O
occurs	O
through	O
a	O
mechanism	O
of	O
HSC	O
-	O
mediated	O
augmentation	O
of	O
innate	O
B	O
-	O
cell	O
activity	O
.	O
These	O
findings	O
highlight	O
B	O
cells	O
as	O
important	O
"	O
first	O
responders	O
"	O
of	O
the	O
intrahepatic	O
immune	O
environment	O
.	O

gene1s	ARG2
Nrf2	ARG2
gene1e	ARG2
is	O
controlled	O
by	O
two	O
distinct	O
gene1s	ARG2
beta	ARG2
-	ARG2
TrCP	ARG2
gene1e	ARG2
recognition	O
motifs	O
in	O
its	O
Neh6	O
domain	O
,	O
one	O
of	O
which	O
can	O
be	O
modulated	O
by	O
gene1s	ARG2
GSK-3	ARG2
gene1e	ARG2
activity	O
.	O
Identification	O
of	O
regulatable	O
mechanisms	O
by	O
which	O
transcription	O
factor	O
gene1s	ARG2
NF	ARG2
-	ARG2
E2	ARG2
p45-related	ARG2
factor	ARG2
2	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
Nrf2	ARG2
gene1e	ARG2
)	O
is	O
repressed	O
will	O
allow	O
strategies	O
to	O
be	O
designed	O
that	O
counter	O
drug	O
resistance	O
associated	O
with	O
its	O
upregulation	O
in	O
tumours	O
that	O
harbour	O
somatic	O
mutations	O
in	O
gene1s	ARG2
Kelch	ARG2
-	ARG2
like	ARG2
ECH	ARG2
-	ARG2
associated	ARG2
protein-1	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
Keap1	ARG2
gene1e	ARG2
)	O
,	O
a	O
gene	O
that	O
encodes	O
a	O
joint	O
adaptor	O
and	O
substrate	O
receptor	O
for	O
the	O
gene1s	ARG2
Cul3	ARG2
gene1e	ARG2
-	O
gene1s	ARG2
Rbx1	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
Roc1	ARG2
gene1e	ARG2
gene1s	ARG2
ubiquitin	ARG2
ligase	ARG2
gene1e	ARG2
.	O
We	O
now	O
show	O
that	O
arg1s	O
mouse	O
arg1e	O
gene1s	ARG2
Nrf2	ARG2
gene1e	ARG2
contains	O
two	O
binding	O
sites	O
for	O
gene1s	ARG2
beta	ARG2
-	ARG2
transducin	ARG2
repeat	ARG2
-	ARG2
containing	ARG2
protein	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
beta	ARG2
-	ARG2
TrCP	ARG2
gene1e	ARG2
)	O
,	O
which	O
acts	O
as	O
a	O
substrate	O
receptor	O
for	O
the	O
gene1s	ARG2
Skp1	ARG2
gene1e	ARG2
-	O
gene1s	ARG2
Cul1	ARG2
gene1e	ARG2
-	O
gene1s	ARG2
Rbx1	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
Roc1	ARG2
gene1e	ARG2
gene1s	ARG2
ubiquitin	ARG2
ligase	ARG2
complex	ARG2
gene1e	ARG2
.	O
Deletion	O
of	O
either	O
binding	O
site	O
in	O
gene1s	ARG2
Nrf2	ARG2
gene1e	ARG2
decreased	O
gene1s	ARG2
beta	ARG2
-	ARG2
TrCP	ARG2
gene1e	ARG2
-	O
mediated	O
ubiquitylation	O
of	O
the	O
transcription	O
factor	O
.	O
The	O
ability	O
of	O
one	O
of	O
the	O
two	O
gene1s	ARG2
beta	ARG2
-	ARG2
TrCP	ARG2
gene1e	ARG2
-	O
binding	O
sites	O
to	O
serve	O
as	O
a	O
degron	O
could	O
be	O
both	O
increased	O
and	O
decreased	O
by	O
manipulation	O
of	O
gene1s	ARG2
glycogen	ARG2
synthase	ARG2
kinase-3	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
GSK-3	ARG2
gene1e	ARG2
)	O
activity	O
.	O
Biotinylated	O
-	O
peptide	O
pull	O
-	O
down	O
assays	O
identified	O
DSGIS(338	O
)	O
and	O
DSAPGS(378	O
)	O
as	O
the	O
two	O
gene1s	ARG2
beta	ARG2
-	ARG2
TrCP	ARG2
gene1e	ARG2
-	O
binding	O
motifs	O
in	O
gene1s	ARG2
Nrf2	ARG2
gene1e	ARG2
.	O
Significantly	O
,	O
our	O
pull	O
-	O
down	O
assays	O
indicated	O
that	O
gene1s	ARG2
beta	ARG2
-	ARG2
TrCP	ARG2
gene1e	ARG2
binds	O
a	O
phosphorylated	O
version	O
of	O
DSGIS	O
more	O
tightly	O
than	O
its	O
non	O
-	O
phosphorylated	O
counterpart	O
,	O
whereas	O
this	O
was	O
not	O
the	O
case	O
for	O
DSAPGS	O
.	O
These	O
data	O
suggest	O
that	O
DSGIS	O
,	O
but	O
not	O
DSAPGS	O
,	O
contains	O
a	O
functional	O
gene1s	ARG2
GSK-3	ARG2
gene1e	ARG2
phosphorylation	O
site	O
.	O
Activation	O
of	O
gene1s	ARG2
GSK-3	ARG2
gene1e	ARG2
in	O
gene1s	ARG2
Keap1	ARG2
gene1e	ARG2
-null	O
arg1s	O
mouse	O
arg1e	O
embryonic	O
fibroblasts	O
(	O
MEFs	O
)	O
,	O
or	O
in	O
species1s	O
human	O
species1e	O
lung	O
A549	O
cells	O
that	O
contain	O
mutant	O
gene1s	O
Keap1	O
gene1e	O
,	O
by	O
inhibition	O
of	O
the	O
gene1s	ARG2
phosphoinositide	ARG2
3-kinase	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
PI3K	ARG2
gene1e	ARG2
)-	O
gene1s	ARG2
protein	ARG2
kinase	ARG2
B	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
PKB	ARG2
gene1e	ARG2
)/	O
gene1s	ARG2
Akt	ARG2
gene1e	ARG2
pathway	O
markedly	O
reduced	O
endogenous	O
gene1s	ARG2
Nrf2	ARG2
gene1e	ARG2
protein	O
and	O
decreased	O
to	O
10	O
-	O
50	O
%	O
of	O
normal	O
the	O
levels	O
of	O
mRNA	O
for	O
prototypic	O
gene1s	ARG2
Nrf2	ARG2
gene1e	ARG2
-regulated	O
enzymes	O
,	O
including	O
the	O
glutamate	O
-	O
cysteine	O
ligase	O
catalytic	O
and	O
modifier	O
subunits	O
,	O
gene1s	ARG2
glutathione	ARG2
S	ARG2
-	ARG2
transferases	ARG2
Alpha-1	ARG2
and	ARG2
Mu-1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
haem	ARG2
oxygenase-1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
NAD(P)H	ARG2
:	ARG2
quinone	ARG2
oxidoreductase-1	ARG2
gene1e	ARG2
.	O
Pre	O
-	O
treatment	O
of	O
gene1s	ARG2
Keap1	ARG2
gene1e	ARG2
(-/-	O
)	O
MEFs	O
or	O
A549	O
cells	O
with	O
the	O
LY294002	O
gene1s	ARG2
PI3	ARG2
K	ARG2
gene1e	ARG2
inhibitor	O
or	O
the	O
MK-2206	O
gene1s	ARG2
PKB	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
Akt	ARG2
gene1e	ARG2
inhibitor	O
increased	O
their	O
sensitivity	O
to	O
acrolein	O
,	O
chlorambucil	O
and	O
cisplatin	O
between	O
1.9-fold	O
and	O
3.1-fold	O
,	O
and	O
this	O
was	O
substantially	O
attenuated	O
by	O
simultaneous	O
pre	O
-	O
treatment	O
with	O
the	O
gene1s	ARG2
GSK-3	ARG2
gene1e	ARG2
inhibitor	O
CT99021	O
.	O

gene1s	O
Nrf2	O
gene1e	O
is	O
controlled	O
by	O
two	O
distinct	O
gene1s	O
beta	O
-	O
TrCP	O
gene1e	O
recognition	O
motifs	O
in	O
its	O
Neh6	O
domain	O
,	O
one	O
of	O
which	O
can	O
be	O
modulated	O
by	O
gene1s	O
GSK-3	O
gene1e	O
activity	O
.	O
Identification	O
of	O
regulatable	O
mechanisms	O
by	O
which	O
transcription	O
factor	O
gene1s	O
NF	O
-	O
E2	O
p45-related	O
factor	O
2	O
gene1e	O
(	O
gene1s	O
Nrf2	O
gene1e	O
)	O
is	O
repressed	O
will	O
allow	O
strategies	O
to	O
be	O
designed	O
that	O
counter	O
drug	O
resistance	O
associated	O
with	O
its	O
upregulation	O
in	O
tumours	O
that	O
harbour	O
somatic	O
mutations	O
in	O
gene1s	O
Kelch	O
-	O
like	O
ECH	O
-	O
associated	O
protein-1	O
gene1e	O
(	O
gene1s	O
Keap1	O
gene1e	O
)	O
,	O
a	O
gene	O
that	O
encodes	O
a	O
joint	O
adaptor	O
and	O
substrate	O
receptor	O
for	O
the	O
gene1s	O
Cul3	O
gene1e	O
-	O
gene1s	O
Rbx1	O
gene1e	O
/	O
gene1s	O
Roc1	O
gene1e	O
gene1s	O
ubiquitin	O
ligase	O
gene1e	O
.	O
We	O
now	O
show	O
that	O
species1s	O
mouse	O
species1e	O
gene1s	O
Nrf2	O
gene1e	O
contains	O
two	O
binding	O
sites	O
for	O
gene1s	O
beta	O
-	O
transducin	O
repeat	O
-	O
containing	O
protein	O
gene1e	O
(	O
gene1s	O
beta	O
-	O
TrCP	O
gene1e	O
)	O
,	O
which	O
acts	O
as	O
a	O
substrate	O
receptor	O
for	O
the	O
gene1s	O
Skp1	O
gene1e	O
-	O
gene1s	O
Cul1	O
gene1e	O
-	O
gene1s	O
Rbx1	O
gene1e	O
/	O
gene1s	O
Roc1	O
gene1e	O
gene1s	O
ubiquitin	O
ligase	O
complex	O
gene1e	O
.	O
Deletion	O
of	O
either	O
binding	O
site	O
in	O
gene1s	O
Nrf2	O
gene1e	O
decreased	O
gene1s	O
beta	O
-	O
TrCP	O
gene1e	O
-	O
mediated	O
ubiquitylation	O
of	O
the	O
transcription	O
factor	O
.	O
The	O
ability	O
of	O
one	O
of	O
the	O
two	O
gene1s	O
beta	O
-	O
TrCP	O
gene1e	O
-	O
binding	O
sites	O
to	O
serve	O
as	O
a	O
degron	O
could	O
be	O
both	O
increased	O
and	O
decreased	O
by	O
manipulation	O
of	O
gene1s	O
glycogen	O
synthase	O
kinase-3	O
gene1e	O
(	O
gene1s	O
GSK-3	O
gene1e	O
)	O
activity	O
.	O
Biotinylated	O
-	O
peptide	O
pull	O
-	O
down	O
assays	O
identified	O
DSGIS(338	O
)	O
and	O
DSAPGS(378	O
)	O
as	O
the	O
two	O
gene1s	O
beta	O
-	O
TrCP	O
gene1e	O
-	O
binding	O
motifs	O
in	O
gene1s	O
Nrf2	O
gene1e	O
.	O
Significantly	O
,	O
our	O
pull	O
-	O
down	O
assays	O
indicated	O
that	O
gene1s	O
beta	O
-	O
TrCP	O
gene1e	O
binds	O
a	O
phosphorylated	O
version	O
of	O
DSGIS	O
more	O
tightly	O
than	O
its	O
non	O
-	O
phosphorylated	O
counterpart	O
,	O
whereas	O
this	O
was	O
not	O
the	O
case	O
for	O
DSAPGS	O
.	O
These	O
data	O
suggest	O
that	O
DSGIS	O
,	O
but	O
not	O
DSAPGS	O
,	O
contains	O
a	O
functional	O
gene1s	O
GSK-3	O
gene1e	O
phosphorylation	O
site	O
.	O
Activation	O
of	O
gene1s	ARG2
GSK-3	ARG2
gene1e	ARG2
in	O
gene1s	O
Keap1	O
gene1e	O
-null	O
species1s	O
mouse	O
species1e	O
embryonic	O
fibroblasts	O
(	O
MEFs	O
)	O
,	O
or	O
in	O
arg1s	O
human	O
arg1e	O
lung	O
A549	O
cells	O
that	O
contain	O
mutant	O
gene1s	ARG2
Keap1	ARG2
gene1e	ARG2
,	O
by	O
inhibition	O
of	O
the	O
gene1s	ARG2
phosphoinositide	ARG2
3-kinase	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
PI3K	ARG2
gene1e	ARG2
)-	O
gene1s	ARG2
protein	ARG2
kinase	ARG2
B	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
PKB	ARG2
gene1e	ARG2
)/	O
gene1s	ARG2
Akt	ARG2
gene1e	ARG2
pathway	O
markedly	O
reduced	O
endogenous	O
gene1s	ARG2
Nrf2	ARG2
gene1e	ARG2
protein	O
and	O
decreased	O
to	O
10	O
-	O
50	O
%	O
of	O
normal	O
the	O
levels	O
of	O
mRNA	O
for	O
prototypic	O
gene1s	ARG2
Nrf2	ARG2
gene1e	ARG2
-regulated	O
enzymes	O
,	O
including	O
the	O
glutamate	O
-	O
cysteine	O
ligase	O
catalytic	O
and	O
modifier	O
subunits	O
,	O
gene1s	ARG2
glutathione	ARG2
S	ARG2
-	ARG2
transferases	ARG2
Alpha-1	ARG2
and	ARG2
Mu-1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
haem	ARG2
oxygenase-1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
NAD(P)H	ARG2
:	ARG2
quinone	ARG2
oxidoreductase-1	ARG2
gene1e	ARG2
.	O
Pre	O
-	O
treatment	O
of	O
gene1s	O
Keap1	O
gene1e	O
(-/-	O
)	O
MEFs	O
or	O
A549	O
cells	O
with	O
the	O
LY294002	O
gene1s	O
PI3	O
K	O
gene1e	O
inhibitor	O
or	O
the	O
MK-2206	O
gene1s	O
PKB	O
gene1e	O
/	O
gene1s	O
Akt	O
gene1e	O
inhibitor	O
increased	O
their	O
sensitivity	O
to	O
acrolein	O
,	O
chlorambucil	O
and	O
cisplatin	O
between	O
1.9-fold	O
and	O
3.1-fold	O
,	O
and	O
this	O
was	O
substantially	O
attenuated	O
by	O
simultaneous	O
pre	O
-	O
treatment	O
with	O
the	O
gene1s	O
GSK-3	O
gene1e	O
inhibitor	O
CT99021	O
.	O

gene1s	ARG2
MRE11	ARG2
gene1e	ARG2
stability	O
is	O
regulated	O
by	O
gene1s	ARG2
CK2	ARG2
gene1e	ARG2
-dependent	O
interaction	O
with	O
gene1s	ARG2
R2TP	ARG2
gene1e	ARG2
complex	O
.	O
The	O
gene1s	ARG2
MRN	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
MRE11	ARG2
gene1e	ARG2
-	O
gene1s	ARG2
RAD50	ARG2
gene1e	ARG2
-	O
gene1s	ARG2
NBS1	ARG2
gene1e	ARG2
)	O
complex	O
is	O
essential	O
for	O
repair	O
of	O
DNA	O
double	O
-	O
strand	O
breaks	O
and	O
stalled	O
replication	O
forks	O
.	O
Mutations	O
of	O
the	O
gene1s	ARG2
MRN	ARG2
gene1e	ARG2
complex	O
subunit	O
gene1s	ARG2
MRE11	ARG2
gene1e	ARG2
cause	O
the	O
hereditary	O
cancer	O
-	O
susceptibility	O
disease	O
ataxia	O
-	O
telangiectasia	O
-	O
like	O
disorder	O
(	O
ATLD	O
)	O
.	O
Here	O
we	O
show	O
that	O
gene1s	ARG2
MRE11	ARG2
gene1e	ARG2
directly	O
interacts	O
with	O
gene1s	ARG2
PIH1D1	ARG2
gene1e	ARG2
,	O
a	O
subunit	O
of	O
heat	O
-	O
shock	O
protein	O
90	O
cochaperone	O
gene1s	ARG2
R2TP	ARG2
gene1e	ARG2
complex	O
,	O
which	O
is	O
required	O
for	O
the	O
assembly	O
of	O
large	O
protein	O
complexes	O
,	O
such	O
as	O
gene1s	ARG2
RNA	ARG2
polymerase	ARG2
II	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
small	ARG2
nucleolar	ARG2
ribonucleoproteins	ARG2
gene1e	ARG2
and	O
arg1s	O
mammalian	O
arg1e	O
target	O
of	O
rapamycin	O
complex	O
1	O
.	O
The	O
gene1s	ARG2
MRE11	ARG2
gene1e	ARG2
-	O
gene1s	ARG2
PIH1D1	ARG2
gene1e	ARG2
interaction	O
is	O
dependent	O
on	O
gene1s	ARG2
casein	ARG2
kinase	ARG2
2	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
CK2	ARG2
gene1e	ARG2
)	O
phosphorylation	O
of	O
two	O
acidic	O
sequences	O
within	O
the	O
gene1s	ARG2
MRE11	ARG2
gene1e	ARG2
C	O
terminus	O
containing	O
serines	O
558/561	O
and	O
688/689	O
.	O
Conversely	O
,	O
the	O
gene1s	ARG2
PIH1D1	ARG2
gene1e	ARG2
phospho	O
-	O
binding	O
domain	O
PIH	O
-	O
N	O
is	O
required	O
for	O
association	O
with	O
gene1s	ARG2
MRE11	ARG2
gene1e	ARG2
phosphorylated	O
by	O
gene1s	ARG2
CK2	ARG2
gene1e	ARG2
.	O
Consistent	O
with	O
these	O
findings	O
,	O
depletion	O
of	O
gene1s	ARG2
PIH1D1	ARG2
gene1e	ARG2
resulted	O
in	O
gene1s	ARG2
MRE11	ARG2
gene1e	ARG2
destabilization	O
and	O
affected	O
DNA	O
-	O
damage	O
repair	O
processes	O
dependent	O
on	O
gene1s	ARG2
MRE11	ARG2
gene1e	ARG2
.	O
Additionally	O
,	O
mutations	O
of	O
serines	O
688/689	O
,	O
which	O
abolish	O
gene1s	ARG2
PIH1D1	ARG2
gene1e	ARG2
binding	O
,	O
also	O
resulted	O
in	O
decreased	O
gene1s	ARG2
MRE11	ARG2
gene1e	ARG2
stability	O
.	O
As	O
depletion	O
of	O
gene1s	ARG2
R2TP	ARG2
gene1e	ARG2
frequently	O
leads	O
to	O
instability	O
of	O
its	O
substrates	O
and	O
as	O
truncation	O
mutation	O
of	O
gene1s	ARG2
MRE11	ARG2
gene1e	ARG2
lacking	O
serines	O
688/689	O
leads	O
to	O
decreased	O
levels	O
of	O
the	O
gene1s	O
MRN	O
gene1e	O
complex	O
both	O
in	O
ATLD	O
arg1s	O
patients	O
arg1e	O
and	O
an	O
ATLD	O
species1s	O
mouse	O
species1e	O
model	O
,	O
our	O
results	O
suggest	O
that	O
the	O
gene1s	ARG2
MRN	ARG2
gene1e	ARG2
complex	O
is	O
a	O
novel	O
gene1s	ARG2
R2TP	ARG2
gene1e	ARG2
complex	O
substrate	O
and	O
that	O
their	O
interaction	O
is	O
regulated	O
by	O
gene1s	ARG2
CK2	ARG2
gene1e	ARG2
phosphorylation	O
.	O

gene1s	O
MRE11	O
gene1e	O
stability	O
is	O
regulated	O
by	O
gene1s	O
CK2	O
gene1e	O
-dependent	O
interaction	O
with	O
gene1s	O
R2TP	O
gene1e	O
complex	O
.	O
The	O
gene1s	O
MRN	O
gene1e	O
(	O
gene1s	O
MRE11	O
gene1e	O
-	O
gene1s	O
RAD50	O
gene1e	O
-	O
gene1s	O
NBS1	O
gene1e	O
)	O
complex	O
is	O
essential	O
for	O
repair	O
of	O
DNA	O
double	O
-	O
strand	O
breaks	O
and	O
stalled	O
replication	O
forks	O
.	O
Mutations	O
of	O
the	O
gene1s	O
MRN	O
gene1e	O
complex	O
subunit	O
gene1s	O
MRE11	O
gene1e	O
cause	O
the	O
hereditary	O
cancer	O
-	O
susceptibility	O
disease	O
ataxia	O
-	O
telangiectasia	O
-	O
like	O
disorder	O
(	O
ATLD	O
)	O
.	O
Here	O
we	O
show	O
that	O
gene1s	O
MRE11	O
gene1e	O
directly	O
interacts	O
with	O
gene1s	O
PIH1D1	O
gene1e	O
,	O
a	O
subunit	O
of	O
heat	O
-	O
shock	O
protein	O
90	O
cochaperone	O
gene1s	O
R2TP	O
gene1e	O
complex	O
,	O
which	O
is	O
required	O
for	O
the	O
assembly	O
of	O
large	O
protein	O
complexes	O
,	O
such	O
as	O
gene1s	O
RNA	O
polymerase	O
II	O
gene1e	O
,	O
gene1s	O
small	O
nucleolar	O
ribonucleoproteins	O
gene1e	O
and	O
species1s	O
mammalian	O
species1e	O
target	O
of	O
rapamycin	O
complex	O
1	O
.	O
The	O
gene1s	O
MRE11	O
gene1e	O
-	O
gene1s	O
PIH1D1	O
gene1e	O
interaction	O
is	O
dependent	O
on	O
gene1s	O
casein	O
kinase	O
2	O
gene1e	O
(	O
gene1s	O
CK2	O
gene1e	O
)	O
phosphorylation	O
of	O
two	O
acidic	O
sequences	O
within	O
the	O
gene1s	O
MRE11	O
gene1e	O
C	O
terminus	O
containing	O
serines	O
558/561	O
and	O
688/689	O
.	O
Conversely	O
,	O
the	O
gene1s	O
PIH1D1	O
gene1e	O
phospho	O
-	O
binding	O
domain	O
PIH	O
-	O
N	O
is	O
required	O
for	O
association	O
with	O
gene1s	O
MRE11	O
gene1e	O
phosphorylated	O
by	O
gene1s	O
CK2	O
gene1e	O
.	O
Consistent	O
with	O
these	O
findings	O
,	O
depletion	O
of	O
gene1s	O
PIH1D1	O
gene1e	O
resulted	O
in	O
gene1s	O
MRE11	O
gene1e	O
destabilization	O
and	O
affected	O
DNA	O
-	O
damage	O
repair	O
processes	O
dependent	O
on	O
gene1s	O
MRE11	O
gene1e	O
.	O
Additionally	O
,	O
mutations	O
of	O
serines	O
688/689	O
,	O
which	O
abolish	O
gene1s	O
PIH1D1	O
gene1e	O
binding	O
,	O
also	O
resulted	O
in	O
decreased	O
gene1s	O
MRE11	O
gene1e	O
stability	O
.	O
As	O
depletion	O
of	O
gene1s	O
R2TP	O
gene1e	O
frequently	O
leads	O
to	O
instability	O
of	O
its	O
substrates	O
and	O
as	O
truncation	O
mutation	O
of	O
gene1s	O
MRE11	O
gene1e	O
lacking	O
serines	O
688/689	O
leads	O
to	O
decreased	O
levels	O
of	O
the	O
gene1s	ARG2
MRN	ARG2
gene1e	ARG2
complex	O
both	O
in	O
ATLD	O
species1s	O
patients	O
species1e	O
and	O
an	O
ATLD	O
arg1s	O
mouse	O
arg1e	O
model	O
,	O
our	O
results	O
suggest	O
that	O
the	O
gene1s	O
MRN	O
gene1e	O
complex	O
is	O
a	O
novel	O
gene1s	O
R2TP	O
gene1e	O
complex	O
substrate	O
and	O
that	O
their	O
interaction	O
is	O
regulated	O
by	O
gene1s	O
CK2	O
gene1e	O
phosphorylation	O
.	O

gene1s	O
MUC13	O
gene1e	O
gene1s	O
mucin	O
gene1e	O
augments	O
pancreatic	O
tumorigenesis	O
.	O
The	O
high	O
death	O
rate	O
of	O
pancreatic	O
cancer	O
is	O
attributed	O
to	O
the	O
lack	O
of	O
reliable	O
methods	O
for	O
early	O
detection	O
and	O
underlying	O
molecular	O
mechanisms	O
of	O
its	O
aggressive	O
pathogenesis	O
.	O
Although	O
gene1s	O
MUC13	O
gene1e	O
,	O
a	O
newly	O
identified	O
transmembrane	O
gene1s	O
mucin	O
gene1e	O
,	O
is	O
known	O
to	O
be	O
aberrantly	O
expressed	O
in	O
ovarian	O
and	O
gastro	O
-	O
intestinal	O
cancers	O
,	O
its	O
role	O
in	O
pancreatic	O
cancer	O
is	O
unknown	O
.	O
Herein	O
,	O
we	O
investigated	O
the	O
expression	O
profile	O
and	O
functions	O
of	O
gene1s	O
MUC13	O
gene1e	O
in	O
pancreatic	O
cancer	O
progression	O
.	O
The	O
expression	O
profile	O
of	O
gene1s	O
MUC13	O
gene1e	O
in	O
pancreatic	O
cancer	O
was	O
investigated	O
using	O
a	O
recently	O
generated	O
monoclonal	O
antibody	O
(	O
clone	O
PPZ0020	O
)	O
and	O
pancreatic	O
tissue	O
microarrays	O
.	O
The	O
expression	O
of	O
gene1s	O
MUC13	O
gene1e	O
was	O
significantly	O
(	O
P	O
<	O
0.005	O
)	O
higher	O
in	O
cancer	O
samples	O
compared	O
with	O
normal	O
/	O
nonneoplastic	O
pancreatic	O
tissues	O
.	O
For	O
functional	O
analyses	O
,	O
full	O
-	O
length	O
gene1s	O
MUC13	O
gene1e	O
was	O
expressed	O
in	O
gene1s	O
MUC13	O
gene1e	O
null	O
pancreatic	O
cancer	O
cell	O
lines	O
,	O
MiaPaca	O
and	O
Panc1	O
.	O
gene1s	O
MUC13	O
gene1e	O
overexpression	O
caused	O
a	O
significant	O
(	O
P	O
<	O
0.05	O
)	O
increase	O
in	O
cell	O
motility	O
,	O
invasion	O
,	O
proliferation	O
,	O
and	O
anchorage	O
-	O
dependent	O
or	O
-independent	O
clonogenicity	O
while	O
decreasing	O
cell	O
-	O
cell	O
and	O
cell	O
-	O
substratum	O
adhesion	O
.	O
Exogenous	O
gene1s	O
MUC13	O
gene1e	O
expression	O
significantly	O
(	O
P	O
<	O
0.05	O
)	O
enhanced	O
pancreatic	O
tumor	O
growth	O
and	O
reduced	O
animal	O
survival	O
in	O
a	O
xenograft	O
arg1s	O
mouse	O
arg1e	O
model	O
.	O
These	O
tumorigenic	O
characteristics	O
correlated	O
with	O
the	O
upregulation	O
/	O
phosphorylation	O
of	O
gene1s	O
HER2	O
gene1e	O
,	O
gene1s	O
p21-activated	O
kinase	O
1	O
gene1e	O
(	O
gene1s	O
PAK1	O
gene1e	O
)	O
,	O
gene1s	O
extracellular	O
signal	O
-	O
regulated	O
kinase	O
gene1e	O
(	O
gene1s	O
ERK	O
gene1e	O
)	O
,	O
gene1s	O
Akt	O
gene1e	O
,	O
and	O
gene1s	O
metastasin	O
gene1e	O
(	O
gene1s	O
S100A4	O
gene1e	O
)	O
,	O
and	O
the	O
suppression	O
of	O
gene1s	O
p53	O
gene1e	O
.	O
Conversely	O
,	O
suppression	O
of	O
gene1s	O
MUC13	O
gene1e	O
in	O
species1s	O
HPAFII	O
species1e	O
pancreatic	O
cancer	O
cells	O
by	O
short	O
hairpin	O
RNA	O
resulted	O
in	O
suppression	O
of	O
tumorigenic	O
characteristics	O
,	O
repression	O
of	O
gene1s	O
HER2	O
gene1e	O
,	O
gene1s	O
PAK1	O
gene1e	O
,	O
gene1s	O
ERK	O
gene1e	O
,	O
and	O
gene1s	O
S100A4	O
gene1e	O
,	O
and	O
upregulation	O
of	O
gene1s	O
p53	O
gene1e	O
.	O
gene1s	O
MUC13	O
gene1e	O
suppression	O
also	O
significantly	O
(	O
P	O
<	O
0.05	O
)	O
reduced	O
tumor	O
growth	O
and	O
increased	O
animal	O
survival	O
.	O
These	O
results	O
imply	O
a	O
role	O
of	O
gene1s	O
MUC13	O
gene1e	O
in	O
pancreatic	O
cancer	O
and	O
suggest	O
its	O
potential	O
use	O
as	O
a	O
diagnostic	O
and	O
therapeutic	O
target	O
.	O

gene1s	ARG2
MUC13	ARG2
gene1e	ARG2
gene1s	ARG2
mucin	ARG2
gene1e	ARG2
augments	O
pancreatic	O
tumorigenesis	O
.	O
The	O
high	O
death	O
rate	O
of	O
pancreatic	O
cancer	O
is	O
attributed	O
to	O
the	O
lack	O
of	O
reliable	O
methods	O
for	O
early	O
detection	O
and	O
underlying	O
molecular	O
mechanisms	O
of	O
its	O
aggressive	O
pathogenesis	O
.	O
Although	O
gene1s	ARG2
MUC13	ARG2
gene1e	ARG2
,	O
a	O
newly	O
identified	O
transmembrane	O
gene1s	ARG2
mucin	ARG2
gene1e	ARG2
,	O
is	O
known	O
to	O
be	O
aberrantly	O
expressed	O
in	O
ovarian	O
and	O
gastro	O
-	O
intestinal	O
cancers	O
,	O
its	O
role	O
in	O
pancreatic	O
cancer	O
is	O
unknown	O
.	O
Herein	O
,	O
we	O
investigated	O
the	O
expression	O
profile	O
and	O
functions	O
of	O
gene1s	ARG2
MUC13	ARG2
gene1e	ARG2
in	O
pancreatic	O
cancer	O
progression	O
.	O
The	O
expression	O
profile	O
of	O
gene1s	ARG2
MUC13	ARG2
gene1e	ARG2
in	O
pancreatic	O
cancer	O
was	O
investigated	O
using	O
a	O
recently	O
generated	O
monoclonal	O
antibody	O
(	O
clone	O
PPZ0020	O
)	O
and	O
pancreatic	O
tissue	O
microarrays	O
.	O
The	O
expression	O
of	O
gene1s	ARG2
MUC13	ARG2
gene1e	ARG2
was	O
significantly	O
(	O
P	O
<	O
0.005	O
)	O
higher	O
in	O
cancer	O
samples	O
compared	O
with	O
normal	O
/	O
nonneoplastic	O
pancreatic	O
tissues	O
.	O
For	O
functional	O
analyses	O
,	O
full	O
-	O
length	O
gene1s	ARG2
MUC13	ARG2
gene1e	ARG2
was	O
expressed	O
in	O
gene1s	ARG2
MUC13	ARG2
gene1e	ARG2
null	O
pancreatic	O
cancer	O
cell	O
lines	O
,	O
MiaPaca	O
and	O
Panc1	O
.	O
gene1s	ARG2
MUC13	ARG2
gene1e	ARG2
overexpression	O
caused	O
a	O
significant	O
(	O
P	O
<	O
0.05	O
)	O
increase	O
in	O
cell	O
motility	O
,	O
invasion	O
,	O
proliferation	O
,	O
and	O
anchorage	O
-	O
dependent	O
or	O
-independent	O
clonogenicity	O
while	O
decreasing	O
cell	O
-	O
cell	O
and	O
cell	O
-	O
substratum	O
adhesion	O
.	O
Exogenous	O
gene1s	ARG2
MUC13	ARG2
gene1e	ARG2
expression	O
significantly	O
(	O
P	O
<	O
0.05	O
)	O
enhanced	O
pancreatic	O
tumor	O
growth	O
and	O
reduced	O
animal	O
survival	O
in	O
a	O
xenograft	O
species1s	O
mouse	O
species1e	O
model	O
.	O
These	O
tumorigenic	O
characteristics	O
correlated	O
with	O
the	O
upregulation	O
/	O
phosphorylation	O
of	O
gene1s	ARG2
HER2	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
p21-activated	ARG2
kinase	ARG2
1	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
PAK1	ARG2
gene1e	ARG2
)	O
,	O
gene1s	ARG2
extracellular	ARG2
signal	ARG2
-	ARG2
regulated	ARG2
kinase	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
ERK	ARG2
gene1e	ARG2
)	O
,	O
gene1s	ARG2
Akt	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
metastasin	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
S100A4	ARG2
gene1e	ARG2
)	O
,	O
and	O
the	O
suppression	O
of	O
gene1s	ARG2
p53	ARG2
gene1e	ARG2
.	O
Conversely	O
,	O
suppression	O
of	O
gene1s	ARG2
MUC13	ARG2
gene1e	ARG2
in	O
arg1s	O
HPAFII	O
arg1e	O
pancreatic	O
cancer	O
cells	O
by	O
short	O
hairpin	O
RNA	O
resulted	O
in	O
suppression	O
of	O
tumorigenic	O
characteristics	O
,	O
repression	O
of	O
gene1s	ARG2
HER2	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
PAK1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
ERK	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
S100A4	ARG2
gene1e	ARG2
,	O
and	O
upregulation	O
of	O
gene1s	ARG2
p53	ARG2
gene1e	ARG2
.	O
gene1s	ARG2
MUC13	ARG2
gene1e	ARG2
suppression	O
also	O
significantly	O
(	O
P	O
<	O
0.05	O
)	O
reduced	O
tumor	O
growth	O
and	O
increased	O
animal	O
survival	O
.	O
These	O
results	O
imply	O
a	O
role	O
of	O
gene1s	ARG2
MUC13	ARG2
gene1e	ARG2
in	O
pancreatic	O
cancer	O
and	O
suggest	O
its	O
potential	O
use	O
as	O
a	O
diagnostic	O
and	O
therapeutic	O
target	O
.	O

gene1s	ARG2
A	ARG2
-	ARG2
kinase	ARG2
anchor	ARG2
protein	ARG2
4	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
AKAP4	ARG2
gene1e	ARG2
)	O
a	O
promising	O
therapeutic	O
target	O
of	O
colorectal	O
cancer	O
.	O
BACKGROUND	O
:	O
Colorectal	O
cancer	O
(	O
CRC	O
)	O
ranks	O
third	O
among	O
the	O
estimated	O
cancer	O
cases	O
and	O
cancer	O
related	O
mortalities	O
in	O
the	O
Western	O
world	O
.	O
Early	O
detection	O
and	O
efficient	O
therapy	O
of	O
CRC	O
remains	O
a	O
major	O
health	O
challenge	O
.	O
Therefore	O
,	O
there	O
is	O
a	O
need	O
to	O
identify	O
novel	O
tumor	O
markers	O
for	O
early	O
diagnosis	O
and	O
treatment	O
of	O
CRC	O
.	O
METHODS	O
:	O
gene1s	ARG2
A	ARG2
-	ARG2
kinase	ARG2
anchor	ARG2
protein	ARG2
4	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
AKAP4	ARG2
gene1e	ARG2
)	O
gene	O
and	O
protein	O
expression	O
was	O
monitored	O
by	O
quantitative	O
polymerase	O
chain	O
reaction	O
(	O
qPCR	O
)	O
,	O
reverse	O
transcription	O
(	O
RT)-PCR	O
and	O
Western	O
blotting	O
in	O
normal	O
colon	O
tissue	O
lysate	O
,	O
normal	O
colon	O
epithelial	O
cells	O
and	O
in	O
colon	O
cancer	O
cell	O
lines	O
viz	O
.	O
,	O
Caco-2	O
,	O
COLO205	O
,	O
COLO320DM	O
,	O
HCT-15	O
,	O
HCT116	O
,	O
HT-29	O
,	O
SW480	O
,	O
and	O
SW620	O
.	O
The	O
effect	O
of	O
gene1s	ARG2
AKAP4	ARG2
gene1e	ARG2
on	O
cellular	O
growth	O
,	O
migration	O
and	O
invasion	O
abilities	O
was	O
studied	O
using	O
gene	O
silencing	O
approach	O
.	O
The	O
role	O
of	O
gene1s	ARG2
AKAP4	ARG2
gene1e	ARG2
in	O
various	O
pathways	O
involved	O
in	O
cell	O
cycle	O
,	O
apoptosis	O
,	O
senescence	O
was	O
investigated	O
in	O
in	O
vitro	O
and	O
in	O
arg1s	O
human	O
arg1e	O
xenograft	O
species1s	O
mouse	O
species1e	O
model	O
.	O
RESULTS	O
:	O
Our	O
studies	O
showed	O
that	O
gene1s	ARG2
AKAP4	ARG2
gene1e	ARG2
gene	O
and	O
protein	O
expression	O
was	O
expressed	O
in	O
all	O
colon	O
cancer	O
cells	O
while	O
no	O
expression	O
was	O
detectable	O
in	O
normal	O
colon	O
cells	O
.	O
Ablation	O
of	O
gene1s	ARG2
AKAP4	ARG2
gene1e	ARG2
led	O
to	O
reduced	O
cellular	O
growth	O
,	O
migration	O
,	O
invasion	O
and	O
increased	O
apoptosis	O
and	O
senescence	O
of	O
CRC	O
cells	O
in	O
in	O
vitro	O
assays	O
and	O
tumor	O
growth	O
in	O
arg1s	O
human	O
arg1e	O
xenograft	O
species1s	O
mouse	O
species1e	O
.	O
arg1s	O
Human	O
arg1e	O
colon	O
xenograft	O
studies	O
showed	O
a	O
significant	O
decrease	O
in	O
the	O
levels	O
of	O
cyclins	O
B1	O
,	O
D	O
and	O
E	O
and	O
gene1s	ARG2
cyclin	ARG2
dependent	ARG2
kinases	ARG2
gene1e	ARG2
such	O
as	O
gene1s	ARG2
CDK1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
CDK2	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
CDK4	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
CDK6	ARG2
gene1e	ARG2
.	O
Interestingly	O
,	O
an	O
up	O
-	O
regulation	O
in	O
the	O
levels	O
of	O
gene1s	ARG2
p16	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
p21	ARG2
gene1e	ARG2
was	O
also	O
observed	O
.	O
Besides	O
,	O
an	O
increase	O
in	O
the	O
levels	O
of	O
pro	O
-	O
apoptotic	O
molecules	O
gene1s	ARG2
AIF	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
APAF1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
BAD	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
BID	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
BAK	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
BAX	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
PARP1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
NOXA	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
PUMA	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
cyt	ARG2
-	ARG2
C	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
Caspase	ARG2
3	ARG2
,	ARG2
7	ARG2
,	ARG2
8	ARG2
and	ARG2
9	ARG2
gene1e	ARG2
was	O
also	O
found	O
in	O
cancer	O
cells	O
as	O
well	O
as	O
in	O
xenograft	O
tissue	O
sections	O
.	O
However	O
,	O
anti	O
-	O
apoptotic	O
molecules	O
gene1s	ARG2
BCL2	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Bcl	ARG2
-	ARG2
xL	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
cIAP2	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
XIAP	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Axin2	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
Survivin	ARG2
gene1e	ARG2
were	O
down	O
regulated	O
in	O
these	O
samples	O
.	O
Our	O
data	O
also	O
revealed	O
elevated	O
expression	O
of	O
epithelial	O
marker	O
gene1s	ARG2
E	ARG2
-	ARG2
cadherin	ARG2
gene1e	ARG2
and	O
down	O
regulation	O
of	O
EMT	O
markers	O
gene1s	ARG2
N	ARG2
-	ARG2
cadherin	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
P	ARG2
-	ARG2
cadherin	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
SLUG	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
a	ARG2
-	ARG2
SMA	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
SNAIL	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
TWIST	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
Vimentin	ARG2
gene1e	ARG2
.	O
Further	O
ablation	O
of	O
gene1s	ARG2
AKAP4	ARG2
gene1e	ARG2
resulted	O
in	O
the	O
down	O
regulation	O
of	O
invasion	O
molecules	O
gene1s	ARG2
matrix	ARG2
metalloproteinase	ARG2
gene1e	ARG2
gene1s	ARG2
MMP2	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
MMP3	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
MMP9	ARG2
gene1e	ARG2
.	O
CONCLUSION	O
:	O
gene1s	ARG2
AKAP4	ARG2
gene1e	ARG2
appears	O
to	O
be	O
a	O
novel	O
CRC	O
-	O
associated	O
antigen	O
with	O
a	O
potential	O
for	O
developing	O
as	O
a	O
new	O
clinical	O
therapeutic	O
target	O
.	O

gene1s	O
A	O
-	O
kinase	O
anchor	O
protein	O
4	O
gene1e	O
(	O
gene1s	O
AKAP4	O
gene1e	O
)	O
a	O
promising	O
therapeutic	O
target	O
of	O
colorectal	O
cancer	O
.	O
BACKGROUND	O
:	O
Colorectal	O
cancer	O
(	O
CRC	O
)	O
ranks	O
third	O
among	O
the	O
estimated	O
cancer	O
cases	O
and	O
cancer	O
related	O
mortalities	O
in	O
the	O
Western	O
world	O
.	O
Early	O
detection	O
and	O
efficient	O
therapy	O
of	O
CRC	O
remains	O
a	O
major	O
health	O
challenge	O
.	O
Therefore	O
,	O
there	O
is	O
a	O
need	O
to	O
identify	O
novel	O
tumor	O
markers	O
for	O
early	O
diagnosis	O
and	O
treatment	O
of	O
CRC	O
.	O
METHODS	O
:	O
gene1s	O
A	O
-	O
kinase	O
anchor	O
protein	O
4	O
gene1e	O
(	O
gene1s	O
AKAP4	O
gene1e	O
)	O
gene	O
and	O
protein	O
expression	O
was	O
monitored	O
by	O
quantitative	O
polymerase	O
chain	O
reaction	O
(	O
qPCR	O
)	O
,	O
reverse	O
transcription	O
(	O
RT)-PCR	O
and	O
Western	O
blotting	O
in	O
normal	O
colon	O
tissue	O
lysate	O
,	O
normal	O
colon	O
epithelial	O
cells	O
and	O
in	O
colon	O
cancer	O
cell	O
lines	O
viz	O
.	O
,	O
Caco-2	O
,	O
COLO205	O
,	O
COLO320DM	O
,	O
HCT-15	O
,	O
HCT116	O
,	O
HT-29	O
,	O
SW480	O
,	O
and	O
SW620	O
.	O
The	O
effect	O
of	O
gene1s	O
AKAP4	O
gene1e	O
on	O
cellular	O
growth	O
,	O
migration	O
and	O
invasion	O
abilities	O
was	O
studied	O
using	O
gene	O
silencing	O
approach	O
.	O
The	O
role	O
of	O
gene1s	O
AKAP4	O
gene1e	O
in	O
various	O
pathways	O
involved	O
in	O
cell	O
cycle	O
,	O
apoptosis	O
,	O
senescence	O
was	O
investigated	O
in	O
in	O
vitro	O
and	O
in	O
species1s	O
human	O
species1e	O
xenograft	O
arg1s	O
mouse	O
arg1e	O
model	O
.	O
RESULTS	O
:	O
Our	O
studies	O
showed	O
that	O
gene1s	O
AKAP4	O
gene1e	O
gene	O
and	O
protein	O
expression	O
was	O
expressed	O
in	O
all	O
colon	O
cancer	O
cells	O
while	O
no	O
expression	O
was	O
detectable	O
in	O
normal	O
colon	O
cells	O
.	O
Ablation	O
of	O
gene1s	O
AKAP4	O
gene1e	O
led	O
to	O
reduced	O
cellular	O
growth	O
,	O
migration	O
,	O
invasion	O
and	O
increased	O
apoptosis	O
and	O
senescence	O
of	O
CRC	O
cells	O
in	O
in	O
vitro	O
assays	O
and	O
tumor	O
growth	O
in	O
species1s	O
human	O
species1e	O
xenograft	O
arg1s	O
mouse	O
arg1e	O
.	O
species1s	O
Human	O
species1e	O
colon	O
xenograft	O
studies	O
showed	O
a	O
significant	O
decrease	O
in	O
the	O
levels	O
of	O
cyclins	O
B1	O
,	O
D	O
and	O
E	O
and	O
gene1s	O
cyclin	O
dependent	O
kinases	O
gene1e	O
such	O
as	O
gene1s	O
CDK1	O
gene1e	O
,	O
gene1s	O
CDK2	O
gene1e	O
,	O
gene1s	O
CDK4	O
gene1e	O
and	O
gene1s	O
CDK6	O
gene1e	O
.	O
Interestingly	O
,	O
an	O
up	O
-	O
regulation	O
in	O
the	O
levels	O
of	O
gene1s	O
p16	O
gene1e	O
and	O
gene1s	O
p21	O
gene1e	O
was	O
also	O
observed	O
.	O
Besides	O
,	O
an	O
increase	O
in	O
the	O
levels	O
of	O
pro	O
-	O
apoptotic	O
molecules	O
gene1s	O
AIF	O
gene1e	O
,	O
gene1s	O
APAF1	O
gene1e	O
,	O
gene1s	O
BAD	O
gene1e	O
,	O
gene1s	O
BID	O
gene1e	O
,	O
gene1s	O
BAK	O
gene1e	O
,	O
gene1s	O
BAX	O
gene1e	O
,	O
gene1s	O
PARP1	O
gene1e	O
,	O
gene1s	O
NOXA	O
gene1e	O
,	O
gene1s	O
PUMA	O
gene1e	O
and	O
gene1s	O
cyt	O
-	O
C	O
gene1e	O
and	O
gene1s	O
Caspase	O
3	O
,	O
7	O
,	O
8	O
and	O
9	O
gene1e	O
was	O
also	O
found	O
in	O
cancer	O
cells	O
as	O
well	O
as	O
in	O
xenograft	O
tissue	O
sections	O
.	O
However	O
,	O
anti	O
-	O
apoptotic	O
molecules	O
gene1s	O
BCL2	O
gene1e	O
,	O
gene1s	O
Bcl	O
-	O
xL	O
gene1e	O
,	O
gene1s	O
cIAP2	O
gene1e	O
,	O
gene1s	O
XIAP	O
gene1e	O
,	O
gene1s	O
Axin2	O
gene1e	O
and	O
gene1s	O
Survivin	O
gene1e	O
were	O
down	O
regulated	O
in	O
these	O
samples	O
.	O
Our	O
data	O
also	O
revealed	O
elevated	O
expression	O
of	O
epithelial	O
marker	O
gene1s	O
E	O
-	O
cadherin	O
gene1e	O
and	O
down	O
regulation	O
of	O
EMT	O
markers	O
gene1s	O
N	O
-	O
cadherin	O
gene1e	O
,	O
gene1s	O
P	O
-	O
cadherin	O
gene1e	O
,	O
gene1s	O
SLUG	O
gene1e	O
,	O
gene1s	O
a	O
-	O
SMA	O
gene1e	O
,	O
gene1s	O
SNAIL	O
gene1e	O
,	O
gene1s	O
TWIST	O
gene1e	O
and	O
gene1s	O
Vimentin	O
gene1e	O
.	O
Further	O
ablation	O
of	O
gene1s	O
AKAP4	O
gene1e	O
resulted	O
in	O
the	O
down	O
regulation	O
of	O
invasion	O
molecules	O
gene1s	O
matrix	O
metalloproteinase	O
gene1e	O
gene1s	O
MMP2	O
gene1e	O
,	O
gene1s	O
MMP3	O
gene1e	O
and	O
gene1s	O
MMP9	O
gene1e	O
.	O
CONCLUSION	O
:	O
gene1s	O
AKAP4	O
gene1e	O
appears	O
to	O
be	O
a	O
novel	O
CRC	O
-	O
associated	O
antigen	O
with	O
a	O
potential	O
for	O
developing	O
as	O
a	O
new	O
clinical	O
therapeutic	O
target	O
.	O

Functional	O
characterization	O
of	O
obesity	O
-	O
associated	O
variants	O
involving	O
the	O
a	O
and	O
b	O
isoforms	O
of	O
arg1s	O
human	O
arg1e	O
gene1s	ARG2
SH2B1	ARG2
gene1e	ARG2
.	O
We	O
have	O
previously	O
reported	O
rare	O
variants	O
in	O
sarcoma	O
gene1s	ARG2
(	ARG2
Src	ARG2
)	ARG2
homology	ARG2
2	ARG2
(	ARG2
SH2	ARG2
)	ARG2
B	ARG2
adaptor	ARG2
protein	ARG2
1	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
SH2B1	ARG2
gene1e	ARG2
)	O
in	O
individuals	O
with	O
obesity	O
,	O
gene1s	ARG2
insulin	ARG2
gene1e	ARG2
resistance	O
,	O
and	O
maladaptive	O
behavior	O
.	O
Here	O
,	O
we	O
identify	O
4	O
additional	O
gene1s	ARG2
SH2B1	ARG2
gene1e	ARG2
variants	O
by	O
sequencing	O
500	O
individuals	O
with	O
severe	O
early	O
-	O
onset	O
obesity	O
.	O
gene1s	ARG2
SH2B1	ARG2
gene1e	ARG2
has	O
4	O
alternatively	O
spliced	O
isoforms	O
.	O
One	O
variant	O
(	O
T546A	O
)	O
lies	O
within	O
the	O
N	O
-	O
terminal	O
region	O
common	O
to	O
all	O
isoforms	O
.	O
As	O
shown	O
for	O
past	O
variants	O
in	O
this	O
region	O
,	O
T546A	O
impairs	O
gene1s	ARG2
SH2B1b	ARG2
gene1e	ARG2
enhancement	O
of	O
nerve	O
growth	O
factor	O
-	O
induced	O
neurite	O
outgrowth	O
,	O
and	O
the	O
individual	O
with	O
the	O
T546A	O
variant	O
exhibits	O
mild	O
developmental	O
delay	O
.	O
The	O
other	O
3	O
variants	O
(	O
A663V	O
,	O
V695	O
M	O
,	O
and	O
A723V	O
)	O
lie	O
in	O
the	O
C	O
-	O
terminal	O
tail	O
of	O
gene1s	ARG2
SH2B1a	ARG2
gene1e	ARG2
.	O
gene1s	ARG2
SH2B1a	ARG2
gene1e	ARG2
variant	O
carriers	O
were	O
hyperinsulinemic	O
but	O
did	O
not	O
exhibit	O
the	O
behavioral	O
phenotype	O
observed	O
in	O
individuals	O
with	O
gene1s	ARG2
SH2B1	ARG2
gene1e	ARG2
variants	O
that	O
disrupt	O
all	O
isoforms	O
.	O
In	O
in	O
vitro	O
assays	O
,	O
gene1s	ARG2
SH2B1a	ARG2
gene1e	ARG2
,	O
like	O
gene1s	ARG2
SH2B1b	ARG2
gene1e	ARG2
,	O
enhances	O
gene1s	ARG2
insulin	ARG2
gene1e	ARG2
-	O
and	O
gene1s	ARG2
leptin	ARG2
gene1e	ARG2
-	O
induced	O
gene1s	ARG2
insulin	ARG2
receptor	ARG2
substrate	ARG2
2	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
IRS2	ARG2
gene1e	ARG2
)	O
phosphorylation	O
and	O
GH	O
-	O
induced	O
cell	O
motility	O
.	O
None	O
of	O
the	O
variants	O
affect	O
gene1s	ARG2
SH2B1a	ARG2
gene1e	ARG2
enhancement	O
of	O
gene1s	ARG2
insulin	ARG2
gene1e	ARG2
-	O
and	O
gene1s	ARG2
leptin	ARG2
gene1e	ARG2
-	O
induced	O
gene1s	ARG2
IRS2	ARG2
gene1e	ARG2
phosphorylation	O
.	O
However	O
,	O
T546A	O
,	O
A663V	O
,	O
and	O
A723V	O
all	O
impair	O
the	O
ability	O
of	O
gene1s	ARG2
SH2B1a	ARG2
gene1e	ARG2
to	O
enhance	O
GH	O
-	O
induced	O
cell	O
motility	O
.	O
In	O
contrast	O
to	O
gene1s	ARG2
SH2B1b	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
SH2B1a	ARG2
gene1e	ARG2
does	O
not	O
enhance	O
nerve	O
growth	O
factor	O
-	O
induced	O
neurite	O
outgrowth	O
.	O
These	O
studies	O
suggest	O
that	O
genetic	O
variants	O
that	O
disrupt	O
isoforms	O
other	O
than	O
gene1s	ARG2
SH2B1b	ARG2
gene1e	ARG2
may	O
be	O
functionally	O
significant	O
.	O
Further	O
studies	O
are	O
needed	O
to	O
understand	O
the	O
mechanism	O
by	O
which	O
the	O
individual	O
isoforms	O
regulate	O
energy	O
homeostasis	O
and	O
behavior	O
.	O

gene1s	O
Calcium	O
sensing	O
receptor	O
gene1e	O
protects	O
high	O
glucose	O
-	O
induced	O
energy	O
metabolism	O
disorder	O
via	O
blocking	O
gene1s	O
gp78	O
gene1e	O
-ubiquitin	O
proteasome	O
pathway	O
.	O
Diabetic	O
cardiomyopathy	O
(	O
DCM	O
)	O
is	O
a	O
major	O
complication	O
and	O
fatal	O
cause	O
of	O
the	O
arg1s	O
patients	O
arg1e	O
with	O
diabetes	O
.	O
The	O
gene1s	O
calcium	O
sensing	O
receptor	O
gene1e	O
(	O
gene1s	O
CaSR	O
gene1e	O
)	O
is	O
a	O
gene1s	O
G	O
protein	O
-	O
coupled	O
receptor	O
gene1e	O
,	O
which	O
is	O
involved	O
in	O
maintaining	O
calcium	O
homeostasis	O
,	O
regulating	O
cell	O
proliferation	O
and	O
apoptosis	O
,	O
and	O
so	O
on	O
.	O
In	O
our	O
previous	O
study	O
,	O
we	O
found	O
that	O
gene1s	O
CaSR	O
gene1e	O
expression	O
,	O
intracellular	O
calcium	O
levels	O
and	O
cardiac	O
function	O
were	O
all	O
significantly	O
decreased	O
in	O
DCM	O
species1s	O
rats	O
species1e	O
;	O
however	O
,	O
the	O
exact	O
mechanism	O
are	O
not	O
clear	O
yet	O
.	O
The	O
present	O
study	O
revealed	O
the	O
protective	O
role	O
of	O
gene1s	O
CaSR	O
gene1e	O
in	O
myocardial	O
energy	O
metabolism	O
disorder	O
induced	O
by	O
high	O
glucose	O
(	O
HG	O
)	O
as	O
well	O
as	O
the	O
underlying	O
mechanism	O
.	O
Here	O
,	O
we	O
demonstrated	O
that	O
HG	O
decreased	O
the	O
expression	O
of	O
gene1s	O
CaSR	O
gene1e	O
,	O
mitochondrial	O
fusion	O
proteins	O
(	O
gene1s	O
Mfn1	O
gene1e	O
,	O
gene1s	O
Mfn2	O
gene1e	O
)	O
,	O
cell	O
gap	O
junction	O
related	O
proteins	O
(	O
gene1s	O
Cx43	O
gene1e	O
,	O
gene1s	O
beta	O
-	O
catenin	O
gene1e	O
,	O
gene1s	O
N	O
-	O
cadherin	O
gene1e	O
)	O
,	O
and	O
intracellular	O
ATP	O
concentration	O
.	O
In	O
contrast	O
,	O
HG	O
increased	O
extracellular	O
ATP	O
concentration	O
,	O
the	O
expression	O
of	O
gene1s	O
gp78	O
gene1e	O
,	O
mitochondrial	O
fission	O
proteins	O
(	O
gene1s	O
Fis1	O
gene1e	O
,	O
gene1s	O
Drp1	O
gene1e	O
)	O
,	O
and	O
the	O
ubiquitination	O
levels	O
of	O
gene1s	O
Mfn1	O
gene1e	O
,	O
gene1s	O
Mfn2	O
gene1e	O
and	O
gene1s	O
Cx43	O
gene1e	O
.	O
Moreover	O
,	O
gene1s	O
CaSR	O
gene1e	O
agonist	O
and	O
gene1s	O
gp78	O
gene1e	O
-siRNA	O
significantly	O
reduced	O
the	O
above	O
changes	O
.	O
Taken	O
together	O
,	O
these	O
results	O
suggest	O
that	O
HG	O
induces	O
myocardial	O
energy	O
metabolism	O
disorder	O
via	O
decrease	O
of	O
gene1s	O
CaSR	O
gene1e	O
expression	O
,	O
and	O
activation	O
of	O
gene1s	O
gp78	O
gene1e	O
-ubiquitin	O
proteasome	O
system	O
.	O
In	O
turn	O
,	O
these	O
effects	O
disrupt	O
the	O
structure	O
and	O
function	O
of	O
the	O
mitochondria	O
and	O
the	O
cell	O
gap	O
junction	O
,	O
result	O
in	O
the	O
reduced	O
ATP	O
synthesis	O
and	O
the	O
increased	O
ATP	O
leakage	O
.	O
Stimulation	O
of	O
gene1s	O
CaSR	O
gene1e	O
significantly	O
attenuates	O
HG	O
-	O
induced	O
abnormal	O
myocardial	O
energy	O
metabolism	O
,	O
suggesting	O
gene1s	O
CaSR	O
gene1e	O
would	O
be	O
a	O
promising	O
potential	O
therapeutic	O
target	O
for	O
DCM	O
.	O

gene1s	ARG2
Calcium	ARG2
sensing	ARG2
receptor	ARG2
gene1e	ARG2
protects	O
high	O
glucose	O
-	O
induced	O
energy	O
metabolism	O
disorder	O
via	O
blocking	O
gene1s	ARG2
gp78	ARG2
gene1e	ARG2
-ubiquitin	O
proteasome	O
pathway	O
.	O
Diabetic	O
cardiomyopathy	O
(	O
DCM	O
)	O
is	O
a	O
major	O
complication	O
and	O
fatal	O
cause	O
of	O
the	O
species1s	O
patients	O
species1e	O
with	O
diabetes	O
.	O
The	O
gene1s	ARG2
calcium	ARG2
sensing	ARG2
receptor	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
CaSR	ARG2
gene1e	ARG2
)	O
is	O
a	O
gene1s	ARG2
G	ARG2
protein	ARG2
-	ARG2
coupled	ARG2
receptor	ARG2
gene1e	ARG2
,	O
which	O
is	O
involved	O
in	O
maintaining	O
calcium	O
homeostasis	O
,	O
regulating	O
cell	O
proliferation	O
and	O
apoptosis	O
,	O
and	O
so	O
on	O
.	O
In	O
our	O
previous	O
study	O
,	O
we	O
found	O
that	O
gene1s	ARG2
CaSR	ARG2
gene1e	ARG2
expression	O
,	O
intracellular	O
calcium	O
levels	O
and	O
cardiac	O
function	O
were	O
all	O
significantly	O
decreased	O
in	O
DCM	O
arg1s	O
rats	O
arg1e	O
;	O
however	O
,	O
the	O
exact	O
mechanism	O
are	O
not	O
clear	O
yet	O
.	O
The	O
present	O
study	O
revealed	O
the	O
protective	O
role	O
of	O
gene1s	ARG2
CaSR	ARG2
gene1e	ARG2
in	O
myocardial	O
energy	O
metabolism	O
disorder	O
induced	O
by	O
high	O
glucose	O
(	O
HG	O
)	O
as	O
well	O
as	O
the	O
underlying	O
mechanism	O
.	O
Here	O
,	O
we	O
demonstrated	O
that	O
HG	O
decreased	O
the	O
expression	O
of	O
gene1s	ARG2
CaSR	ARG2
gene1e	ARG2
,	O
mitochondrial	O
fusion	O
proteins	O
(	O
gene1s	ARG2
Mfn1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Mfn2	ARG2
gene1e	ARG2
)	O
,	O
cell	O
gap	O
junction	O
related	O
proteins	O
(	O
gene1s	ARG2
Cx43	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
beta	ARG2
-	ARG2
catenin	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
N	ARG2
-	ARG2
cadherin	ARG2
gene1e	ARG2
)	O
,	O
and	O
intracellular	O
ATP	O
concentration	O
.	O
In	O
contrast	O
,	O
HG	O
increased	O
extracellular	O
ATP	O
concentration	O
,	O
the	O
expression	O
of	O
gene1s	ARG2
gp78	ARG2
gene1e	ARG2
,	O
mitochondrial	O
fission	O
proteins	O
(	O
gene1s	ARG2
Fis1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Drp1	ARG2
gene1e	ARG2
)	O
,	O
and	O
the	O
ubiquitination	O
levels	O
of	O
gene1s	ARG2
Mfn1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Mfn2	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
Cx43	ARG2
gene1e	ARG2
.	O
Moreover	O
,	O
gene1s	ARG2
CaSR	ARG2
gene1e	ARG2
agonist	O
and	O
gene1s	ARG2
gp78	ARG2
gene1e	ARG2
-siRNA	O
significantly	O
reduced	O
the	O
above	O
changes	O
.	O
Taken	O
together	O
,	O
these	O
results	O
suggest	O
that	O
HG	O
induces	O
myocardial	O
energy	O
metabolism	O
disorder	O
via	O
decrease	O
of	O
gene1s	ARG2
CaSR	ARG2
gene1e	ARG2
expression	O
,	O
and	O
activation	O
of	O
gene1s	ARG2
gp78	ARG2
gene1e	ARG2
-ubiquitin	O
proteasome	O
system	O
.	O
In	O
turn	O
,	O
these	O
effects	O
disrupt	O
the	O
structure	O
and	O
function	O
of	O
the	O
mitochondria	O
and	O
the	O
cell	O
gap	O
junction	O
,	O
result	O
in	O
the	O
reduced	O
ATP	O
synthesis	O
and	O
the	O
increased	O
ATP	O
leakage	O
.	O
Stimulation	O
of	O
gene1s	ARG2
CaSR	ARG2
gene1e	ARG2
significantly	O
attenuates	O
HG	O
-	O
induced	O
abnormal	O
myocardial	O
energy	O
metabolism	O
,	O
suggesting	O
gene1s	ARG2
CaSR	ARG2
gene1e	ARG2
would	O
be	O
a	O
promising	O
potential	O
therapeutic	O
target	O
for	O
DCM	O
.	O

gene1s	ARG2
Sphingosine	ARG2
kinase	ARG2
1	ARG2
gene1e	ARG2
is	O
required	O
for	O
mesothelioma	O
cell	O
proliferation	O
:	O
role	O
of	O
gene1s	ARG2
histone	ARG2
gene1e	ARG2
acetylation	O
.	O
BACKGROUND	O
:	O
Malignant	O
pleural	O
mesothelioma	O
(	O
MPM	O
)	O
is	O
a	O
devastating	O
disease	O
with	O
an	O
overall	O
poor	O
prognosis	O
.	O
Despite	O
the	O
recent	O
advances	O
in	O
targeted	O
molecular	O
therapies	O
,	O
there	O
is	O
a	O
clear	O
and	O
urgent	O
need	O
for	O
the	O
identification	O
of	O
novel	O
mesothelioma	O
targets	O
for	O
the	O
development	O
of	O
highly	O
efficacious	O
therapeutics	O
.	O
METHODOLOGY	O
/	O
PRINCIPAL	O
FINDINGS	O
:	O
In	O
this	O
study	O
,	O
we	O
report	O
that	O
the	O
expression	O
of	O
gene1s	ARG2
Sphingosine	ARG2
Kinase	ARG2
1	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
SphK1	ARG2
gene1e	ARG2
)	O
protein	O
was	O
preferentially	O
elevated	O
in	O
MPM	O
tumor	O
tissues	O
(	O
49	O
epithelioid	O
and	O
13	O
sarcomatoid	O
)	O
compared	O
to	O
normal	O
tissue	O
(	O
n	O
=	O
13	O
)	O
.	O
In	O
addition	O
,	O
we	O
also	O
observed	O
significantly	O
elevated	O
levels	O
of	O
gene1s	ARG2
SphK1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
SphK2	ARG2
gene1e	ARG2
mRNA	O
and	O
gene1s	ARG2
SphK1	ARG2
gene1e	ARG2
protein	O
expression	O
in	O
MPM	O
cell	O
lines	O
such	O
as	O
H2691	O
,	O
H513	O
and	O
H2461	O
compared	O
to	O
the	O
non	O
-	O
malignant	O
mesothelial	O
Met5	O
cells	O
.	O
The	O
underlying	O
mechanism	O
appears	O
to	O
be	O
mediated	O
by	O
gene1s	ARG2
SphK1	ARG2
gene1e	ARG2
induced	O
upregulation	O
of	O
select	O
gene	O
transcription	O
programs	O
such	O
as	O
that	O
of	O
gene1s	ARG2
CBP	ARG2
/	ARG2
p300	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
PCAF	ARG2
gene1e	ARG2
,	O
two	O
gene1s	ARG2
histone	ARG2
acetyl	ARG2
transferases	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
HAT	ARG2
gene1e	ARG2
)	O
,	O
and	O
the	O
down	O
regulation	O
of	O
gene1s	ARG2
cell	ARG2
cycle	ARG2
dependent	ARG2
kinase	ARG2
inhibitor	ARG2
gene1e	ARG2
genes	O
such	O
as	O
gene1s	ARG2
p27Kip1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
p21Cip1	ARG2
gene1e	ARG2
.	O
In	O
addition	O
,	O
using	O
immunoprecipitates	O
of	O
anti	O
-	O
acetylated	O
gene1s	ARG2
histone	ARG2
gene1e	ARG2
antibody	O
from	O
gene1s	ARG2
SphK	ARG2
gene1e	ARG2
inhibitor	O
,	O
gene1s	ARG2
SphK	ARG2
gene1e	ARG2
-	O
I2	O
treated	O
arg1s	O
Met5A	O
arg1e	O
and	O
arg1s	O
H2691	O
arg1e	O
cell	O
lysates	O
,	O
we	O
also	O
showed	O
activation	O
of	O
other	O
cell	O
proliferation	O
related	O
genes	O
,	O
such	O
as	O
gene1s	ARG2
Top2A	ARG2
gene1e	ARG2
(	O
DNA	O
replication	O
)	O
,	O
gene1s	ARG2
AKB	ARG2
gene1e	ARG2
(	O
chromosome	O
remodeling	O
and	O
mitotic	O
spindle	O
formation	O
)	O
,	O
and	O
suppression	O
of	O
gene1s	ARG2
p21	ARG2
CIP1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
p27KIP1	ARG2
gene1e	ARG2
.	O
The	O
gene1s	ARG2
CDK2	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
HAT1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
MYST2	ARG2
gene1e	ARG2
were	O
,	O
however	O
,	O
unaffected	O
in	O
the	O
above	O
study	O
.	O
Using	O
gene1s	ARG2
SphK	ARG2
gene1e	ARG2
inhibitor	O
and	O
specific	O
siRNA	O
targeting	O
either	O
gene1s	ARG2
SphK1	ARG2
gene1e	ARG2
or	O
gene1s	ARG2
SphK2	ARG2
gene1e	ARG2
,	O
we	O
also	O
unequivocally	O
established	O
that	O
gene1s	ARG2
SphK1	ARG2
gene1e	ARG2
,	O
but	O
not	O
gene1s	ARG2
SphK2	ARG2
gene1e	ARG2
,	O
promotes	O
arg1s	O
H2691	O
arg1e	O
mesothelioma	O
cell	O
proliferation	O
.	O
Using	O
a	O
multi	O
-	O
walled	O
carbon	O
nanotubes	O
induced	O
peritoneal	O
mesothelioma	O
species1s	O
mouse	O
species1e	O
model	O
,	O
we	O
showed	O
that	O
the	O
gene1s	O
SphK1	O
gene1e	O
-/-	O
null	O
species1s	O
mice	O
species1e	O
exhibited	O
significantly	O
less	O
inflammation	O
and	O
granulamatous	O
nodules	O
compared	O
to	O
their	O
wild	O
type	O
counterparts	O
.	O
CONCLUSIONS	O
/	O
SIGNIFICANCE	O
:	O
The	O
gene1s	ARG2
lipid	ARG2
kinase	ARG2
gene1e	ARG2
gene1s	ARG2
SphK1	ARG2
gene1e	ARG2
plays	O
a	O
positive	O
and	O
essential	O
role	O
in	O
the	O
growth	O
and	O
development	O
of	O
malignant	O
mesothelioma	O
and	O
is	O
therefore	O
a	O
likely	O
therapeutic	O
target	O
.	O

gene1s	O
Sphingosine	O
kinase	O
1	O
gene1e	O
is	O
required	O
for	O
mesothelioma	O
cell	O
proliferation	O
:	O
role	O
of	O
gene1s	O
histone	O
gene1e	O
acetylation	O
.	O
BACKGROUND	O
:	O
Malignant	O
pleural	O
mesothelioma	O
(	O
MPM	O
)	O
is	O
a	O
devastating	O
disease	O
with	O
an	O
overall	O
poor	O
prognosis	O
.	O
Despite	O
the	O
recent	O
advances	O
in	O
targeted	O
molecular	O
therapies	O
,	O
there	O
is	O
a	O
clear	O
and	O
urgent	O
need	O
for	O
the	O
identification	O
of	O
novel	O
mesothelioma	O
targets	O
for	O
the	O
development	O
of	O
highly	O
efficacious	O
therapeutics	O
.	O
METHODOLOGY	O
/	O
PRINCIPAL	O
FINDINGS	O
:	O
In	O
this	O
study	O
,	O
we	O
report	O
that	O
the	O
expression	O
of	O
gene1s	O
Sphingosine	O
Kinase	O
1	O
gene1e	O
(	O
gene1s	O
SphK1	O
gene1e	O
)	O
protein	O
was	O
preferentially	O
elevated	O
in	O
MPM	O
tumor	O
tissues	O
(	O
49	O
epithelioid	O
and	O
13	O
sarcomatoid	O
)	O
compared	O
to	O
normal	O
tissue	O
(	O
n	O
=	O
13	O
)	O
.	O
In	O
addition	O
,	O
we	O
also	O
observed	O
significantly	O
elevated	O
levels	O
of	O
gene1s	O
SphK1	O
gene1e	O
and	O
gene1s	O
SphK2	O
gene1e	O
mRNA	O
and	O
gene1s	O
SphK1	O
gene1e	O
protein	O
expression	O
in	O
MPM	O
cell	O
lines	O
such	O
as	O
H2691	O
,	O
H513	O
and	O
H2461	O
compared	O
to	O
the	O
non	O
-	O
malignant	O
mesothelial	O
Met5	O
cells	O
.	O
The	O
underlying	O
mechanism	O
appears	O
to	O
be	O
mediated	O
by	O
gene1s	O
SphK1	O
gene1e	O
induced	O
upregulation	O
of	O
select	O
gene	O
transcription	O
programs	O
such	O
as	O
that	O
of	O
gene1s	O
CBP	O
/	O
p300	O
gene1e	O
and	O
gene1s	O
PCAF	O
gene1e	O
,	O
two	O
gene1s	O
histone	O
acetyl	O
transferases	O
gene1e	O
(	O
gene1s	O
HAT	O
gene1e	O
)	O
,	O
and	O
the	O
down	O
regulation	O
of	O
gene1s	O
cell	O
cycle	O
dependent	O
kinase	O
inhibitor	O
gene1e	O
genes	O
such	O
as	O
gene1s	O
p27Kip1	O
gene1e	O
and	O
gene1s	O
p21Cip1	O
gene1e	O
.	O
In	O
addition	O
,	O
using	O
immunoprecipitates	O
of	O
anti	O
-	O
acetylated	O
gene1s	O
histone	O
gene1e	O
antibody	O
from	O
gene1s	O
SphK	O
gene1e	O
inhibitor	O
,	O
gene1s	O
SphK	O
gene1e	O
-	O
I2	O
treated	O
species1s	O
Met5A	O
species1e	O
and	O
species1s	O
H2691	O
species1e	O
cell	O
lysates	O
,	O
we	O
also	O
showed	O
activation	O
of	O
other	O
cell	O
proliferation	O
related	O
genes	O
,	O
such	O
as	O
gene1s	O
Top2A	O
gene1e	O
(	O
DNA	O
replication	O
)	O
,	O
gene1s	O
AKB	O
gene1e	O
(	O
chromosome	O
remodeling	O
and	O
mitotic	O
spindle	O
formation	O
)	O
,	O
and	O
suppression	O
of	O
gene1s	O
p21	O
CIP1	O
gene1e	O
and	O
gene1s	O
p27KIP1	O
gene1e	O
.	O
The	O
gene1s	O
CDK2	O
gene1e	O
,	O
gene1s	O
HAT1	O
gene1e	O
and	O
gene1s	O
MYST2	O
gene1e	O
were	O
,	O
however	O
,	O
unaffected	O
in	O
the	O
above	O
study	O
.	O
Using	O
gene1s	O
SphK	O
gene1e	O
inhibitor	O
and	O
specific	O
siRNA	O
targeting	O
either	O
gene1s	O
SphK1	O
gene1e	O
or	O
gene1s	O
SphK2	O
gene1e	O
,	O
we	O
also	O
unequivocally	O
established	O
that	O
gene1s	O
SphK1	O
gene1e	O
,	O
but	O
not	O
gene1s	O
SphK2	O
gene1e	O
,	O
promotes	O
species1s	O
H2691	O
species1e	O
mesothelioma	O
cell	O
proliferation	O
.	O
Using	O
a	O
multi	O
-	O
walled	O
carbon	O
nanotubes	O
induced	O
peritoneal	O
mesothelioma	O
arg1s	O
mouse	O
arg1e	O
model	O
,	O
we	O
showed	O
that	O
the	O
gene1s	ARG2
SphK1	ARG2
gene1e	ARG2
-/-	O
null	O
arg1s	O
mice	O
arg1e	O
exhibited	O
significantly	O
less	O
inflammation	O
and	O
granulamatous	O
nodules	O
compared	O
to	O
their	O
wild	O
type	O
counterparts	O
.	O
CONCLUSIONS	O
/	O
SIGNIFICANCE	O
:	O
The	O
gene1s	O
lipid	O
kinase	O
gene1e	O
gene1s	O
SphK1	O
gene1e	O
plays	O
a	O
positive	O
and	O
essential	O
role	O
in	O
the	O
growth	O
and	O
development	O
of	O
malignant	O
mesothelioma	O
and	O
is	O
therefore	O
a	O
likely	O
therapeutic	O
target	O
.	O

Aberrant	O
gene1s	ARG2
caveolin-1	ARG2
gene1e	ARG2
-mediated	O
gene1s	ARG2
Smad	ARG2
gene1e	ARG2
signaling	O
and	O
proliferation	O
identified	O
by	O
analysis	O
of	O
adenine	O
474	O
deletion	O
mutation	O
(	O
c.474delA	O
)	O
in	O
arg1s	O
patient	O
arg1e	O
fibroblasts	O
:	O
a	O
new	O
perspective	O
on	O
the	O
mechanism	O
of	O
pulmonary	O
hypertension	O
.	O
A	O
heterozygous	O
gene1s	ARG2
caveolin-1	ARG2
gene1e	ARG2
c.474delA	O
mutation	O
has	O
been	O
identified	O
in	O
a	O
family	O
with	O
heritable	O
pulmonary	O
arterial	O
hypertension	O
(	O
PAH	O
)	O
.	O
This	O
frameshift	O
mutation	O
leads	O
to	O
a	O
gene1s	ARG2
caveolin-1	ARG2
gene1e	ARG2
protein	O
that	O
contains	O
all	O
known	O
functional	O
domains	O
but	O
has	O
a	O
change	O
in	O
only	O
the	O
final	O
20	O
amino	O
acids	O
of	O
the	O
C	O
-	O
terminus	O
.	O
Here	O
we	O
studied	O
how	O
this	O
mutation	O
alters	O
gene1s	ARG2
caveolin-1	ARG2
gene1e	ARG2
function	O
,	O
using	O
arg1s	O
patient	O
arg1e	O
-	O
derived	O
fibroblasts	O
.	O
Transmission	O
electron	O
microscopy	O
showed	O
that	O
fibroblasts	O
carrying	O
the	O
c.474delA	O
mutation	O
form	O
typical	O
caveolae	O
.	O
Expression	O
of	O
mutated	O
gene1s	ARG2
caveolin-1	ARG2
gene1e	ARG2
in	O
gene1s	O
caveolin-1	O
gene1e	O
-null	O
species1s	O
mouse	O
species1e	O
fibroblasts	O
failed	O
to	O
induce	O
formation	O
of	O
caveolae	O
due	O
to	O
retention	O
of	O
the	O
mutated	O
protein	O
in	O
the	O
endoplasmic	O
reticulum	O
.	O
However	O
,	O
coexpression	O
of	O
wild	O
-	O
type	O
gene1s	ARG2
caveolin-1	ARG2
gene1e	ARG2
with	O
mutated	O
gene1s	ARG2
caveolin-1	ARG2
gene1e	ARG2
restored	O
the	O
ability	O
to	O
form	O
caveolae	O
.	O
Importantly	O
,	O
fibroblasts	O
carrying	O
the	O
mutation	O
showed	O
twofold	O
increase	O
in	O
proliferation	O
rate	O
associated	O
with	O
hyperphosphorylation	O
of	O
gene1s	ARG2
Smad1/5/8	ARG2
gene1e	ARG2
.	O
This	O
mutation	O
impaired	O
the	O
antiproliferative	O
function	O
of	O
gene1s	ARG2
caveolin-1	ARG2
gene1e	ARG2
.	O
Inhibition	O
of	O
gene1s	ARG2
type	ARG2
I	ARG2
TGFb	ARG2
receptors	ARG2
gene1e	ARG2
gene1s	ARG2
ALK1/2/3/6	ARG2
gene1e	ARG2
responsible	O
for	O
phosphorylation	O
of	O
gene1s	ARG2
Smad1/5/8	ARG2
gene1e	ARG2
reduced	O
the	O
hyperproliferation	O
seen	O
in	O
c.474delA	O
fibroblasts	O
.	O
These	O
results	O
demonstrate	O
the	O
critical	O
role	O
of	O
the	O
final	O
20	O
amino	O
acids	O
of	O
gene1s	ARG2
caveolin-1	ARG2
gene1e	ARG2
in	O
modulating	O
fibroblast	O
proliferation	O
by	O
dampening	O
gene1s	ARG2
Smad	ARG2
gene1e	ARG2
signaling	O
and	O
suggest	O
that	O
augmented	O
gene1s	ARG2
Smad	ARG2
gene1e	ARG2
signaling	O
and	O
fibroblast	O
hyperproliferation	O
are	O
contributing	O
factors	O
in	O
the	O
pathogenesis	O
of	O
PAH	O
in	O
arg1s	O
patients	O
arg1e	O
with	O
gene1s	ARG2
caveolin-1	ARG2
gene1e	ARG2
c.474delA	O
mutation	O
.	O

Aberrant	O
gene1s	O
caveolin-1	O
gene1e	O
-mediated	O
gene1s	O
Smad	O
gene1e	O
signaling	O
and	O
proliferation	O
identified	O
by	O
analysis	O
of	O
adenine	O
474	O
deletion	O
mutation	O
(	O
c.474delA	O
)	O
in	O
species1s	O
patient	O
species1e	O
fibroblasts	O
:	O
a	O
new	O
perspective	O
on	O
the	O
mechanism	O
of	O
pulmonary	O
hypertension	O
.	O
A	O
heterozygous	O
gene1s	O
caveolin-1	O
gene1e	O
c.474delA	O
mutation	O
has	O
been	O
identified	O
in	O
a	O
family	O
with	O
heritable	O
pulmonary	O
arterial	O
hypertension	O
(	O
PAH	O
)	O
.	O
This	O
frameshift	O
mutation	O
leads	O
to	O
a	O
gene1s	O
caveolin-1	O
gene1e	O
protein	O
that	O
contains	O
all	O
known	O
functional	O
domains	O
but	O
has	O
a	O
change	O
in	O
only	O
the	O
final	O
20	O
amino	O
acids	O
of	O
the	O
C	O
-	O
terminus	O
.	O
Here	O
we	O
studied	O
how	O
this	O
mutation	O
alters	O
gene1s	O
caveolin-1	O
gene1e	O
function	O
,	O
using	O
species1s	O
patient	O
species1e	O
-	O
derived	O
fibroblasts	O
.	O
Transmission	O
electron	O
microscopy	O
showed	O
that	O
fibroblasts	O
carrying	O
the	O
c.474delA	O
mutation	O
form	O
typical	O
caveolae	O
.	O
Expression	O
of	O
mutated	O
gene1s	O
caveolin-1	O
gene1e	O
in	O
gene1s	ARG2
caveolin-1	ARG2
gene1e	ARG2
-null	O
arg1s	O
mouse	O
arg1e	O
fibroblasts	O
failed	O
to	O
induce	O
formation	O
of	O
caveolae	O
due	O
to	O
retention	O
of	O
the	O
mutated	O
protein	O
in	O
the	O
endoplasmic	O
reticulum	O
.	O
However	O
,	O
coexpression	O
of	O
wild	O
-	O
type	O
gene1s	O
caveolin-1	O
gene1e	O
with	O
mutated	O
gene1s	O
caveolin-1	O
gene1e	O
restored	O
the	O
ability	O
to	O
form	O
caveolae	O
.	O
Importantly	O
,	O
fibroblasts	O
carrying	O
the	O
mutation	O
showed	O
twofold	O
increase	O
in	O
proliferation	O
rate	O
associated	O
with	O
hyperphosphorylation	O
of	O
gene1s	O
Smad1/5/8	O
gene1e	O
.	O
This	O
mutation	O
impaired	O
the	O
antiproliferative	O
function	O
of	O
gene1s	O
caveolin-1	O
gene1e	O
.	O
Inhibition	O
of	O
gene1s	O
type	O
I	O
TGFb	O
receptors	O
gene1e	O
gene1s	O
ALK1/2/3/6	O
gene1e	O
responsible	O
for	O
phosphorylation	O
of	O
gene1s	O
Smad1/5/8	O
gene1e	O
reduced	O
the	O
hyperproliferation	O
seen	O
in	O
c.474delA	O
fibroblasts	O
.	O
These	O
results	O
demonstrate	O
the	O
critical	O
role	O
of	O
the	O
final	O
20	O
amino	O
acids	O
of	O
gene1s	O
caveolin-1	O
gene1e	O
in	O
modulating	O
fibroblast	O
proliferation	O
by	O
dampening	O
gene1s	O
Smad	O
gene1e	O
signaling	O
and	O
suggest	O
that	O
augmented	O
gene1s	O
Smad	O
gene1e	O
signaling	O
and	O
fibroblast	O
hyperproliferation	O
are	O
contributing	O
factors	O
in	O
the	O
pathogenesis	O
of	O
PAH	O
in	O
species1s	O
patients	O
species1e	O
with	O
gene1s	O
caveolin-1	O
gene1e	O
c.474delA	O
mutation	O
.	O

gene1s	O
Scribble	O
gene1e	O
is	O
required	O
for	O
normal	O
epithelial	O
cell	O
-	O
cell	O
contacts	O
and	O
lumen	O
morphogenesis	O
in	O
the	O
arg1s	O
mammalian	O
arg1e	O
lung	O
.	O
During	O
lung	O
development	O
,	O
proper	O
epithelial	O
cell	O
arrangements	O
are	O
critical	O
for	O
the	O
formation	O
of	O
an	O
arborized	O
network	O
of	O
tubes	O
.	O
Each	O
tube	O
requires	O
a	O
lumen	O
,	O
the	O
diameter	O
of	O
which	O
must	O
be	O
tightly	O
regulated	O
to	O
enable	O
optimal	O
lung	O
function	O
.	O
Lung	O
branching	O
and	O
lumen	O
morphogenesis	O
require	O
close	O
epithelial	O
cell	O
-	O
cell	O
contacts	O
that	O
are	O
maintained	O
as	O
a	O
result	O
of	O
adherens	O
junctions	O
,	O
tight	O
junctions	O
and	O
by	O
intact	O
apical	O
-	O
basal	O
(	O
A	O
/	O
B	O
)	O
polarity	O
.	O
However	O
,	O
the	O
molecular	O
mechanisms	O
that	O
maintain	O
epithelial	O
cohesion	O
and	O
lumen	O
diameter	O
in	O
the	O
arg1s	O
mammalian	O
arg1e	O
lung	O
are	O
unknown	O
.	O
Here	O
we	O
show	O
that	O
gene1s	O
Scribble	O
gene1e	O
,	O
a	O
protein	O
implicated	O
in	O
planar	O
cell	O
polarity	O
(	O
PCP	O
)	O
signalling	O
,	O
is	O
necessary	O
for	O
normal	O
lung	O
morphogenesis	O
.	O
Lungs	O
of	O
the	O
gene1s	O
Scrib	O
gene1e	O
species1s	O
mouse	O
species1e	O
mutant	O
gene1s	O
Circletail	O
(	O
Crc	O
)	O
gene1e	O
are	O
abnormally	O
shaped	O
with	O
fewer	O
airways	O
,	O
and	O
these	O
airways	O
often	O
lack	O
a	O
visible	O
,	O
'	O
open	O
'	O
lumen	O
.	O
Mechanistically	O
we	O
show	O
that	O
gene1s	O
Scrib	O
gene1e	O
genetically	O
interacts	O
with	O
the	O
core	O
PCP	O
gene	O
gene1s	O
Vangl2	O
gene1e	O
in	O
the	O
developing	O
lung	O
and	O
that	O
the	O
distribution	O
of	O
PCP	O
pathway	O
proteins	O
and	O
gene1s	O
Rho	O
gene1e	O
mediated	O
cytoskeletal	O
modification	O
is	O
perturbed	O
in	O
gene1s	O
Scrib	O
gene1e	O
(	O
gene1s	O
Crc	O
gene1e	O
/	O
gene1s	O
Crc	O
gene1e	O
)	O
lungs	O
.	O
However	O
A	O
/	O
B	O
polarity	O
,	O
which	O
is	O
disrupted	O
in	O
species1s	O
Drosophila	O
species1e	O
gene1s	O
Scrib	O
gene1e	O
mutants	O
,	O
is	O
largely	O
unaffected	O
.	O
Notably	O
,	O
we	O
find	O
that	O
gene1s	O
Scrib	O
gene1e	O
mediates	O
functions	O
not	O
attributed	O
to	O
other	O
PCP	O
proteins	O
in	O
the	O
lung	O
.	O
Specifically	O
,	O
gene1s	O
Scrib	O
gene1e	O
localises	O
to	O
both	O
adherens	O
and	O
tight	O
junctions	O
of	O
lung	O
epithelia	O
and	O
knockdown	O
of	O
gene1s	O
Scrib	O
gene1e	O
in	O
lung	O
explants	O
and	O
organotypic	O
cultures	O
leads	O
to	O
reduced	O
cohesion	O
of	O
lung	O
epithelial	O
cells	O
.	O
Live	O
imaging	O
of	O
gene1s	O
Scrib	O
gene1e	O
knockdown	O
lungs	O
shows	O
that	O
gene1s	O
Scrib	O
gene1e	O
does	O
not	O
affect	O
bud	O
bifurcation	O
,	O
as	O
previously	O
shown	O
for	O
the	O
PCP	O
protein	O
gene1s	O
Celsr1	O
gene1e	O
,	O
but	O
is	O
required	O
to	O
maintain	O
epithelial	O
cohesion	O
.	O
To	O
understand	O
the	O
mechanism	O
leading	O
to	O
reduced	O
cell	O
-	O
cell	O
association	O
,	O
we	O
show	O
that	O
gene1s	O
Scrib	O
gene1e	O
associates	O
with	O
gene1s	O
b	O
-	O
catenin	O
gene1e	O
in	O
embryonic	O
lung	O
and	O
the	O
sub	O
-	O
cellular	O
distribution	O
of	O
adherens	O
and	O
tight	O
junction	O
proteins	O
is	O
perturbed	O
in	O
mutant	O
lung	O
epithelia	O
.	O
Our	O
data	O
reveal	O
that	O
gene1s	O
Scrib	O
gene1e	O
is	O
required	O
for	O
normal	O
lung	O
epithelial	O
organisation	O
and	O
lumen	O
morphogenesis	O
by	O
maintaining	O
cell	O
-	O
cell	O
contacts	O
.	O
Thus	O
we	O
reveal	O
novel	O
and	O
important	O
roles	O
for	O
gene1s	O
Scrib	O
gene1e	O
in	O
lung	O
development	O
operating	O
via	O
the	O
PCP	O
pathway	O
,	O
and	O
in	O
regulating	O
junctional	O
complexes	O
and	O
cell	O
cohesion	O
.	O

gene1s	ARG2
Scribble	ARG2
gene1e	ARG2
is	O
required	O
for	O
normal	O
epithelial	O
cell	O
-	O
cell	O
contacts	O
and	O
lumen	O
morphogenesis	O
in	O
the	O
species1s	O
mammalian	O
species1e	O
lung	O
.	O
During	O
lung	O
development	O
,	O
proper	O
epithelial	O
cell	O
arrangements	O
are	O
critical	O
for	O
the	O
formation	O
of	O
an	O
arborized	O
network	O
of	O
tubes	O
.	O
Each	O
tube	O
requires	O
a	O
lumen	O
,	O
the	O
diameter	O
of	O
which	O
must	O
be	O
tightly	O
regulated	O
to	O
enable	O
optimal	O
lung	O
function	O
.	O
Lung	O
branching	O
and	O
lumen	O
morphogenesis	O
require	O
close	O
epithelial	O
cell	O
-	O
cell	O
contacts	O
that	O
are	O
maintained	O
as	O
a	O
result	O
of	O
adherens	O
junctions	O
,	O
tight	O
junctions	O
and	O
by	O
intact	O
apical	O
-	O
basal	O
(	O
A	O
/	O
B	O
)	O
polarity	O
.	O
However	O
,	O
the	O
molecular	O
mechanisms	O
that	O
maintain	O
epithelial	O
cohesion	O
and	O
lumen	O
diameter	O
in	O
the	O
species1s	O
mammalian	O
species1e	O
lung	O
are	O
unknown	O
.	O
Here	O
we	O
show	O
that	O
gene1s	ARG2
Scribble	ARG2
gene1e	ARG2
,	O
a	O
protein	O
implicated	O
in	O
planar	O
cell	O
polarity	O
(	O
PCP	O
)	O
signalling	O
,	O
is	O
necessary	O
for	O
normal	O
lung	O
morphogenesis	O
.	O
Lungs	O
of	O
the	O
gene1s	ARG2
Scrib	ARG2
gene1e	ARG2
arg1s	O
mouse	O
arg1e	O
mutant	O
gene1s	ARG2
Circletail	ARG2
(	ARG2
Crc	ARG2
)	ARG2
gene1e	ARG2
are	O
abnormally	O
shaped	O
with	O
fewer	O
airways	O
,	O
and	O
these	O
airways	O
often	O
lack	O
a	O
visible	O
,	O
'	O
open	O
'	O
lumen	O
.	O
Mechanistically	O
we	O
show	O
that	O
gene1s	ARG2
Scrib	ARG2
gene1e	ARG2
genetically	O
interacts	O
with	O
the	O
core	O
PCP	O
gene	O
gene1s	ARG2
Vangl2	ARG2
gene1e	ARG2
in	O
the	O
developing	O
lung	O
and	O
that	O
the	O
distribution	O
of	O
PCP	O
pathway	O
proteins	O
and	O
gene1s	ARG2
Rho	ARG2
gene1e	ARG2
mediated	O
cytoskeletal	O
modification	O
is	O
perturbed	O
in	O
gene1s	ARG2
Scrib	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
Crc	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
Crc	ARG2
gene1e	ARG2
)	O
lungs	O
.	O
However	O
A	O
/	O
B	O
polarity	O
,	O
which	O
is	O
disrupted	O
in	O
species1s	O
Drosophila	O
species1e	O
gene1s	O
Scrib	O
gene1e	O
mutants	O
,	O
is	O
largely	O
unaffected	O
.	O
Notably	O
,	O
we	O
find	O
that	O
gene1s	ARG2
Scrib	ARG2
gene1e	ARG2
mediates	O
functions	O
not	O
attributed	O
to	O
other	O
PCP	O
proteins	O
in	O
the	O
lung	O
.	O
Specifically	O
,	O
gene1s	ARG2
Scrib	ARG2
gene1e	ARG2
localises	O
to	O
both	O
adherens	O
and	O
tight	O
junctions	O
of	O
lung	O
epithelia	O
and	O
knockdown	O
of	O
gene1s	ARG2
Scrib	ARG2
gene1e	ARG2
in	O
lung	O
explants	O
and	O
organotypic	O
cultures	O
leads	O
to	O
reduced	O
cohesion	O
of	O
lung	O
epithelial	O
cells	O
.	O
Live	O
imaging	O
of	O
gene1s	ARG2
Scrib	ARG2
gene1e	ARG2
knockdown	O
lungs	O
shows	O
that	O
gene1s	ARG2
Scrib	ARG2
gene1e	ARG2
does	O
not	O
affect	O
bud	O
bifurcation	O
,	O
as	O
previously	O
shown	O
for	O
the	O
PCP	O
protein	O
gene1s	ARG2
Celsr1	ARG2
gene1e	ARG2
,	O
but	O
is	O
required	O
to	O
maintain	O
epithelial	O
cohesion	O
.	O
To	O
understand	O
the	O
mechanism	O
leading	O
to	O
reduced	O
cell	O
-	O
cell	O
association	O
,	O
we	O
show	O
that	O
gene1s	ARG2
Scrib	ARG2
gene1e	ARG2
associates	O
with	O
gene1s	ARG2
b	ARG2
-	ARG2
catenin	ARG2
gene1e	ARG2
in	O
embryonic	O
lung	O
and	O
the	O
sub	O
-	O
cellular	O
distribution	O
of	O
adherens	O
and	O
tight	O
junction	O
proteins	O
is	O
perturbed	O
in	O
mutant	O
lung	O
epithelia	O
.	O
Our	O
data	O
reveal	O
that	O
gene1s	ARG2
Scrib	ARG2
gene1e	ARG2
is	O
required	O
for	O
normal	O
lung	O
epithelial	O
organisation	O
and	O
lumen	O
morphogenesis	O
by	O
maintaining	O
cell	O
-	O
cell	O
contacts	O
.	O
Thus	O
we	O
reveal	O
novel	O
and	O
important	O
roles	O
for	O
gene1s	ARG2
Scrib	ARG2
gene1e	ARG2
in	O
lung	O
development	O
operating	O
via	O
the	O
PCP	O
pathway	O
,	O
and	O
in	O
regulating	O
junctional	O
complexes	O
and	O
cell	O
cohesion	O
.	O

gene1s	O
Scribble	O
gene1e	O
is	O
required	O
for	O
normal	O
epithelial	O
cell	O
-	O
cell	O
contacts	O
and	O
lumen	O
morphogenesis	O
in	O
the	O
species1s	O
mammalian	O
species1e	O
lung	O
.	O
During	O
lung	O
development	O
,	O
proper	O
epithelial	O
cell	O
arrangements	O
are	O
critical	O
for	O
the	O
formation	O
of	O
an	O
arborized	O
network	O
of	O
tubes	O
.	O
Each	O
tube	O
requires	O
a	O
lumen	O
,	O
the	O
diameter	O
of	O
which	O
must	O
be	O
tightly	O
regulated	O
to	O
enable	O
optimal	O
lung	O
function	O
.	O
Lung	O
branching	O
and	O
lumen	O
morphogenesis	O
require	O
close	O
epithelial	O
cell	O
-	O
cell	O
contacts	O
that	O
are	O
maintained	O
as	O
a	O
result	O
of	O
adherens	O
junctions	O
,	O
tight	O
junctions	O
and	O
by	O
intact	O
apical	O
-	O
basal	O
(	O
A	O
/	O
B	O
)	O
polarity	O
.	O
However	O
,	O
the	O
molecular	O
mechanisms	O
that	O
maintain	O
epithelial	O
cohesion	O
and	O
lumen	O
diameter	O
in	O
the	O
species1s	O
mammalian	O
species1e	O
lung	O
are	O
unknown	O
.	O
Here	O
we	O
show	O
that	O
gene1s	O
Scribble	O
gene1e	O
,	O
a	O
protein	O
implicated	O
in	O
planar	O
cell	O
polarity	O
(	O
PCP	O
)	O
signalling	O
,	O
is	O
necessary	O
for	O
normal	O
lung	O
morphogenesis	O
.	O
Lungs	O
of	O
the	O
gene1s	O
Scrib	O
gene1e	O
species1s	O
mouse	O
species1e	O
mutant	O
gene1s	O
Circletail	O
(	O
Crc	O
)	O
gene1e	O
are	O
abnormally	O
shaped	O
with	O
fewer	O
airways	O
,	O
and	O
these	O
airways	O
often	O
lack	O
a	O
visible	O
,	O
'	O
open	O
'	O
lumen	O
.	O
Mechanistically	O
we	O
show	O
that	O
gene1s	O
Scrib	O
gene1e	O
genetically	O
interacts	O
with	O
the	O
core	O
PCP	O
gene	O
gene1s	O
Vangl2	O
gene1e	O
in	O
the	O
developing	O
lung	O
and	O
that	O
the	O
distribution	O
of	O
PCP	O
pathway	O
proteins	O
and	O
gene1s	O
Rho	O
gene1e	O
mediated	O
cytoskeletal	O
modification	O
is	O
perturbed	O
in	O
gene1s	O
Scrib	O
gene1e	O
(	O
gene1s	O
Crc	O
gene1e	O
/	O
gene1s	O
Crc	O
gene1e	O
)	O
lungs	O
.	O
However	O
A	O
/	O
B	O
polarity	O
,	O
which	O
is	O
disrupted	O
in	O
arg1s	O
Drosophila	O
arg1e	O
gene1s	ARG2
Scrib	ARG2
gene1e	ARG2
mutants	O
,	O
is	O
largely	O
unaffected	O
.	O
Notably	O
,	O
we	O
find	O
that	O
gene1s	O
Scrib	O
gene1e	O
mediates	O
functions	O
not	O
attributed	O
to	O
other	O
PCP	O
proteins	O
in	O
the	O
lung	O
.	O
Specifically	O
,	O
gene1s	O
Scrib	O
gene1e	O
localises	O
to	O
both	O
adherens	O
and	O
tight	O
junctions	O
of	O
lung	O
epithelia	O
and	O
knockdown	O
of	O
gene1s	O
Scrib	O
gene1e	O
in	O
lung	O
explants	O
and	O
organotypic	O
cultures	O
leads	O
to	O
reduced	O
cohesion	O
of	O
lung	O
epithelial	O
cells	O
.	O
Live	O
imaging	O
of	O
gene1s	O
Scrib	O
gene1e	O
knockdown	O
lungs	O
shows	O
that	O
gene1s	O
Scrib	O
gene1e	O
does	O
not	O
affect	O
bud	O
bifurcation	O
,	O
as	O
previously	O
shown	O
for	O
the	O
PCP	O
protein	O
gene1s	O
Celsr1	O
gene1e	O
,	O
but	O
is	O
required	O
to	O
maintain	O
epithelial	O
cohesion	O
.	O
To	O
understand	O
the	O
mechanism	O
leading	O
to	O
reduced	O
cell	O
-	O
cell	O
association	O
,	O
we	O
show	O
that	O
gene1s	O
Scrib	O
gene1e	O
associates	O
with	O
gene1s	O
b	O
-	O
catenin	O
gene1e	O
in	O
embryonic	O
lung	O
and	O
the	O
sub	O
-	O
cellular	O
distribution	O
of	O
adherens	O
and	O
tight	O
junction	O
proteins	O
is	O
perturbed	O
in	O
mutant	O
lung	O
epithelia	O
.	O
Our	O
data	O
reveal	O
that	O
gene1s	O
Scrib	O
gene1e	O
is	O
required	O
for	O
normal	O
lung	O
epithelial	O
organisation	O
and	O
lumen	O
morphogenesis	O
by	O
maintaining	O
cell	O
-	O
cell	O
contacts	O
.	O
Thus	O
we	O
reveal	O
novel	O
and	O
important	O
roles	O
for	O
gene1s	O
Scrib	O
gene1e	O
in	O
lung	O
development	O
operating	O
via	O
the	O
PCP	O
pathway	O
,	O
and	O
in	O
regulating	O
junctional	O
complexes	O
and	O
cell	O
cohesion	O
.	O

gene1s	O
CCL20	O
gene1e	O
is	O
elevated	O
during	O
obesity	O
and	O
differentially	O
regulated	O
by	O
gene1s	ARG2
NF	ARG2
-	ARG2
kB	ARG2
subunits	ARG2
gene1e	ARG2
in	O
pancreatic	O
b	O
-	O
cells	O
.	O
Enhanced	O
leukocytic	O
infiltration	O
into	O
pancreatic	O
islets	O
contributes	O
to	O
inflammation	O
-	O
based	O
diminutions	O
in	O
functional	O
b	O
-	O
cell	O
mass	O
.	O
Insulitis	O
(	O
aka	O
islet	O
inflammation	O
)	O
,	O
which	O
can	O
be	O
present	O
in	O
both	O
T1DM	O
and	O
T2DM	O
,	O
is	O
one	O
factor	O
influencing	O
pancreatic	O
b	O
-	O
cell	O
death	O
and	O
dysfunction	O
.	O
gene1s	ARG2
IL-1b	ARG2
gene1e	ARG2
,	O
an	O
inflammatory	O
mediator	O
in	O
both	O
T1DM	O
and	O
T2DM	O
,	O
acutely	O
(	O
within	O
1h	O
)	O
induced	O
expression	O
of	O
the	O
gene1s	ARG2
CCL20	ARG2
gene1e	ARG2
gene	O
in	O
arg1s	O
rat	O
arg1e	O
and	O
species1s	O
human	O
species1e	O
islets	O
and	O
clonal	O
b	O
-	O
cell	O
lines	O
.	O
Transcriptional	O
induction	O
of	O
gene1s	ARG2
CCL20	ARG2
gene1e	ARG2
required	O
the	O
gene1s	ARG2
p65	ARG2
subunit	ARG2
of	ARG2
NF	ARG2
-	ARG2
kB	ARG2
gene1e	ARG2
to	O
replace	O
the	O
gene1s	ARG2
p50	ARG2
subunit	ARG2
gene1e	ARG2
at	O
two	O
functional	O
kB	O
sites	O
within	O
the	O
gene1s	ARG2
CCL20	ARG2
gene1e	ARG2
proximal	O
gene	O
promoter	O
.	O
The	O
gene1s	ARG2
NF	ARG2
-	ARG2
kB	ARG2
p50	ARG2
subunit	ARG2
gene1e	ARG2
prevents	O
gene1s	ARG2
CCL20	ARG2
gene1e	ARG2
gene	O
expression	O
during	O
unstimulated	O
conditions	O
and	O
overexpression	O
of	O
gene1s	ARG2
p50	ARG2
gene1e	ARG2
reduces	O
gene1s	ARG2
CCL20	ARG2
gene1e	ARG2
,	O
but	O
enhances	O
gene1s	ARG2
cyclooxygenase-2	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
COX-2	ARG2
gene1e	ARG2
)	O
,	O
transcript	O
accumulation	O
after	O
exposure	O
to	O
gene1s	ARG2
IL-1b	ARG2
gene1e	ARG2
.	O
We	O
also	O
identified	O
differential	O
recruitment	O
of	O
specific	O
co	O
-	O
activator	O
molecules	O
to	O
the	O
gene1s	ARG2
CCL20	ARG2
gene1e	ARG2
gene	O
promoter	O
,	O
when	O
compared	O
with	O
the	O
gene1s	ARG2
CCL2	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
COX2	ARG2
gene1e	ARG2
genes	O
,	O
revealing	O
distinct	O
transcriptional	O
requirements	O
for	O
individual	O
gene1s	ARG2
NF	ARG2
-	ARG2
kB	ARG2
gene1e	ARG2
responsive	O
genes	O
.	O
Moreover	O
,	O
gene1s	O
IL-1b	O
gene1e	O
,	O
gene1s	O
TNF	O
-	O
a	O
gene1e	O
and	O
gene1s	O
IFN	O
-	O
g	O
gene1e	O
individually	O
increased	O
the	O
expression	O
of	O
gene1s	O
CCR6	O
gene1e	O
,	O
the	O
receptor	O
for	O
gene1s	O
CCL20	O
gene1e	O
,	O
on	O
the	O
surface	O
of	O
species1s	O
human	O
species1e	O
neutrophils	O
.	O
We	O
further	O
found	O
that	O
the	O
gene1s	ARG2
chemokine	ARG2
gene1e	ARG2
gene1s	O
CCL20	O
gene1e	O
is	O
elevated	O
in	O
serum	O
from	O
both	O
genetically	O
obese	O
db	O
/	O
db	O
species1s	O
mice	O
species1e	O
and	O
in	O
C57BL6	O
/	O
J	O
species1s	O
mice	O
species1e	O
fed	O
a	O
high	O
-	O
fat	O
diet	O
.	O
Taken	O
together	O
,	O
these	O
results	O
are	O
consistent	O
with	O
a	O
possible	O
activation	O
of	O
the	O
gene1s	O
CCL20	O
gene1e	O
-	O
gene1s	O
CCR6	O
gene1e	O
axis	O
in	O
diseases	O
with	O
inflammatory	O
components	O
.	O
Thus	O
,	O
interfering	O
with	O
this	O
signaling	O
pathway	O
,	O
either	O
at	O
the	O
level	O
of	O
gene1s	ARG2
NF	ARG2
-	ARG2
kB	ARG2
gene1e	ARG2
-	O
mediated	O
gene1s	ARG2
chemokine	ARG2
gene1e	ARG2
production	O
,	O
or	O
downstream	O
receptor	O
activation	O
,	O
could	O
be	O
a	O
potential	O
therapeutic	O
target	O
to	O
offset	O
inflammation	O
-	O
associated	O
tissue	O
dysfunction	O
in	O
obesity	O
and	O
diabetes	O
.	O

gene1s	O
CCL20	O
gene1e	O
is	O
elevated	O
during	O
obesity	O
and	O
differentially	O
regulated	O
by	O
gene1s	ARG2
NF	ARG2
-	ARG2
kB	ARG2
subunits	ARG2
gene1e	ARG2
in	O
pancreatic	O
b	O
-	O
cells	O
.	O
Enhanced	O
leukocytic	O
infiltration	O
into	O
pancreatic	O
islets	O
contributes	O
to	O
inflammation	O
-	O
based	O
diminutions	O
in	O
functional	O
b	O
-	O
cell	O
mass	O
.	O
Insulitis	O
(	O
aka	O
islet	O
inflammation	O
)	O
,	O
which	O
can	O
be	O
present	O
in	O
both	O
T1DM	O
and	O
T2DM	O
,	O
is	O
one	O
factor	O
influencing	O
pancreatic	O
b	O
-	O
cell	O
death	O
and	O
dysfunction	O
.	O
gene1s	ARG2
IL-1b	ARG2
gene1e	ARG2
,	O
an	O
inflammatory	O
mediator	O
in	O
both	O
T1DM	O
and	O
T2DM	O
,	O
acutely	O
(	O
within	O
1h	O
)	O
induced	O
expression	O
of	O
the	O
gene1s	ARG2
CCL20	ARG2
gene1e	ARG2
gene	O
in	O
species1s	O
rat	O
species1e	O
and	O
arg1s	O
human	O
arg1e	O
islets	O
and	O
clonal	O
b	O
-	O
cell	O
lines	O
.	O
Transcriptional	O
induction	O
of	O
gene1s	O
CCL20	O
gene1e	O
required	O
the	O
gene1s	O
p65	O
subunit	O
of	O
NF	O
-	O
kB	O
gene1e	O
to	O
replace	O
the	O
gene1s	O
p50	O
subunit	O
gene1e	O
at	O
two	O
functional	O
kB	O
sites	O
within	O
the	O
gene1s	ARG2
CCL20	ARG2
gene1e	ARG2
proximal	O
gene	O
promoter	O
.	O
The	O
gene1s	O
NF	O
-	O
kB	O
p50	O
subunit	O
gene1e	O
prevents	O
gene1s	ARG2
CCL20	ARG2
gene1e	ARG2
gene	O
expression	O
during	O
unstimulated	O
conditions	O
and	O
overexpression	O
of	O
gene1s	ARG2
p50	ARG2
gene1e	ARG2
reduces	O
gene1s	ARG2
CCL20	ARG2
gene1e	ARG2
,	O
but	O
enhances	O
gene1s	O
cyclooxygenase-2	O
gene1e	O
(	O
gene1s	O
COX-2	O
gene1e	O
)	O
,	O
transcript	O
accumulation	O
after	O
exposure	O
to	O
gene1s	O
IL-1b	O
gene1e	O
.	O
We	O
also	O
identified	O
differential	O
recruitment	O
of	O
specific	O
co	O
-	O
activator	O
molecules	O
to	O
the	O
gene1s	ARG2
CCL20	ARG2
gene1e	ARG2
gene	O
promoter	O
,	O
when	O
compared	O
with	O
the	O
gene1s	O
CCL2	O
gene1e	O
and	O
gene1s	O
COX2	O
gene1e	O
genes	O
,	O
revealing	O
distinct	O
transcriptional	O
requirements	O
for	O
individual	O
gene1s	O
NF	O
-	O
kB	O
gene1e	O
responsive	O
genes	O
.	O
Moreover	O
,	O
gene1s	ARG2
IL-1b	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
TNF	ARG2
-	ARG2
a	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
IFN	ARG2
-	ARG2
g	ARG2
gene1e	ARG2
individually	O
increased	O
the	O
expression	O
of	O
gene1s	ARG2
CCR6	ARG2
gene1e	ARG2
,	O
the	O
receptor	O
for	O
gene1s	ARG2
CCL20	ARG2
gene1e	ARG2
,	O
on	O
the	O
surface	O
of	O
arg1s	O
human	O
arg1e	O
neutrophils	O
.	O
We	O
further	O
found	O
that	O
the	O
gene1s	ARG2
chemokine	ARG2
gene1e	ARG2
gene1s	O
CCL20	O
gene1e	O
is	O
elevated	O
in	O
serum	O
from	O
both	O
genetically	O
obese	O
db	O
/	O
db	O
species1s	O
mice	O
species1e	O
and	O
in	O
C57BL6	O
/	O
J	O
species1s	O
mice	O
species1e	O
fed	O
a	O
high	O
-	O
fat	O
diet	O
.	O
Taken	O
together	O
,	O
these	O
results	O
are	O
consistent	O
with	O
a	O
possible	O
activation	O
of	O
the	O
gene1s	O
CCL20	O
gene1e	O
-	O
gene1s	O
CCR6	O
gene1e	O
axis	O
in	O
diseases	O
with	O
inflammatory	O
components	O
.	O
Thus	O
,	O
interfering	O
with	O
this	O
signaling	O
pathway	O
,	O
either	O
at	O
the	O
level	O
of	O
gene1s	O
NF	O
-	O
kB	O
gene1e	O
-	O
mediated	O
gene1s	ARG2
chemokine	ARG2
gene1e	ARG2
production	O
,	O
or	O
downstream	O
receptor	O
activation	O
,	O
could	O
be	O
a	O
potential	O
therapeutic	O
target	O
to	O
offset	O
inflammation	O
-	O
associated	O
tissue	O
dysfunction	O
in	O
obesity	O
and	O
diabetes	O
.	O

gene1s	ARG2
CCL20	ARG2
gene1e	ARG2
is	O
elevated	O
during	O
obesity	O
and	O
differentially	O
regulated	O
by	O
gene1s	O
NF	O
-	O
kB	O
subunits	O
gene1e	O
in	O
pancreatic	O
b	O
-	O
cells	O
.	O
Enhanced	O
leukocytic	O
infiltration	O
into	O
pancreatic	O
islets	O
contributes	O
to	O
inflammation	O
-	O
based	O
diminutions	O
in	O
functional	O
b	O
-	O
cell	O
mass	O
.	O
Insulitis	O
(	O
aka	O
islet	O
inflammation	O
)	O
,	O
which	O
can	O
be	O
present	O
in	O
both	O
T1DM	O
and	O
T2DM	O
,	O
is	O
one	O
factor	O
influencing	O
pancreatic	O
b	O
-	O
cell	O
death	O
and	O
dysfunction	O
.	O
gene1s	O
IL-1b	O
gene1e	O
,	O
an	O
inflammatory	O
mediator	O
in	O
both	O
T1DM	O
and	O
T2DM	O
,	O
acutely	O
(	O
within	O
1h	O
)	O
induced	O
expression	O
of	O
the	O
gene1s	O
CCL20	O
gene1e	O
gene	O
in	O
species1s	O
rat	O
species1e	O
and	O
species1s	O
human	O
species1e	O
islets	O
and	O
clonal	O
b	O
-	O
cell	O
lines	O
.	O
Transcriptional	O
induction	O
of	O
gene1s	O
CCL20	O
gene1e	O
required	O
the	O
gene1s	O
p65	O
subunit	O
of	O
NF	O
-	O
kB	O
gene1e	O
to	O
replace	O
the	O
gene1s	O
p50	O
subunit	O
gene1e	O
at	O
two	O
functional	O
kB	O
sites	O
within	O
the	O
gene1s	O
CCL20	O
gene1e	O
proximal	O
gene	O
promoter	O
.	O
The	O
gene1s	O
NF	O
-	O
kB	O
p50	O
subunit	O
gene1e	O
prevents	O
gene1s	O
CCL20	O
gene1e	O
gene	O
expression	O
during	O
unstimulated	O
conditions	O
and	O
overexpression	O
of	O
gene1s	O
p50	O
gene1e	O
reduces	O
gene1s	O
CCL20	O
gene1e	O
,	O
but	O
enhances	O
gene1s	O
cyclooxygenase-2	O
gene1e	O
(	O
gene1s	O
COX-2	O
gene1e	O
)	O
,	O
transcript	O
accumulation	O
after	O
exposure	O
to	O
gene1s	O
IL-1b	O
gene1e	O
.	O
We	O
also	O
identified	O
differential	O
recruitment	O
of	O
specific	O
co	O
-	O
activator	O
molecules	O
to	O
the	O
gene1s	O
CCL20	O
gene1e	O
gene	O
promoter	O
,	O
when	O
compared	O
with	O
the	O
gene1s	O
CCL2	O
gene1e	O
and	O
gene1s	O
COX2	O
gene1e	O
genes	O
,	O
revealing	O
distinct	O
transcriptional	O
requirements	O
for	O
individual	O
gene1s	O
NF	O
-	O
kB	O
gene1e	O
responsive	O
genes	O
.	O
Moreover	O
,	O
gene1s	O
IL-1b	O
gene1e	O
,	O
gene1s	O
TNF	O
-	O
a	O
gene1e	O
and	O
gene1s	O
IFN	O
-	O
g	O
gene1e	O
individually	O
increased	O
the	O
expression	O
of	O
gene1s	O
CCR6	O
gene1e	O
,	O
the	O
receptor	O
for	O
gene1s	O
CCL20	O
gene1e	O
,	O
on	O
the	O
surface	O
of	O
species1s	O
human	O
species1e	O
neutrophils	O
.	O
We	O
further	O
found	O
that	O
the	O
gene1s	ARG2
chemokine	ARG2
gene1e	ARG2
gene1s	ARG2
CCL20	ARG2
gene1e	ARG2
is	O
elevated	O
in	O
serum	O
from	O
both	O
genetically	O
obese	O
db	O
/	O
db	O
arg1s	O
mice	O
arg1e	O
and	O
in	O
C57BL6	O
/	O
J	O
arg1s	O
mice	O
arg1e	O
fed	O
a	O
high	O
-	O
fat	O
diet	O
.	O
Taken	O
together	O
,	O
these	O
results	O
are	O
consistent	O
with	O
a	O
possible	O
activation	O
of	O
the	O
gene1s	ARG2
CCL20	ARG2
gene1e	ARG2
-	O
gene1s	ARG2
CCR6	ARG2
gene1e	ARG2
axis	O
in	O
diseases	O
with	O
inflammatory	O
components	O
.	O
Thus	O
,	O
interfering	O
with	O
this	O
signaling	O
pathway	O
,	O
either	O
at	O
the	O
level	O
of	O
gene1s	O
NF	O
-	O
kB	O
gene1e	O
-	O
mediated	O
gene1s	ARG2
chemokine	ARG2
gene1e	ARG2
production	O
,	O
or	O
downstream	O
receptor	O
activation	O
,	O
could	O
be	O
a	O
potential	O
therapeutic	O
target	O
to	O
offset	O
inflammation	O
-	O
associated	O
tissue	O
dysfunction	O
in	O
obesity	O
and	O
diabetes	O
.	O

Lower	O
gene1s	ARG2
PRDM2	ARG2
gene1e	ARG2
expression	O
is	O
associated	O
with	O
dopamine	O
-	O
agonist	O
resistance	O
and	O
tumor	O
recurrence	O
in	O
prolactinomas	O
.	O
BACKGROUND	O
:	O
Dopamine	O
agonists	O
(	O
DAs	O
)	O
are	O
the	O
first	O
-	O
line	O
treatment	O
for	O
prolactinomas	O
,	O
which	O
account	O
for	O
25	O
-	O
30	O
%	O
of	O
functioning	O
pituitary	O
adenomas	O
,	O
and	O
bromocriptine	O
(	O
BRC	O
)	O
is	O
the	O
only	O
commercially	O
available	O
DAs	O
in	O
China	O
.	O
However	O
,	O
tumors	O
are	O
resistant	O
to	O
therapy	O
in	O
5	O
-	O
18	O
%	O
of	O
arg1s	O
patients	O
arg1e	O
.	O
METHODS	O
:	O
The	O
exomes	O
of	O
six	O
responsive	O
prolactinomas	O
and	O
six	O
resistant	O
prolactinomas	O
were	O
analyzed	O
by	O
whole	O
-	O
exome	O
sequencing	O
.	O
RESULTS	O
:	O
Using	O
stringent	O
variant	O
calling	O
and	O
filtering	O
parameters	O
,	O
ten	O
somatic	O
variants	O
that	O
were	O
mainly	O
associated	O
with	O
DNA	O
repair	O
or	O
protein	O
metabolic	O
processes	O
were	O
identified	O
.	O
New	O
resistant	O
variants	O
were	O
identified	O
in	O
multiple	O
genes	O
including	O
gene1s	ARG2
PRDM2	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
PRG4	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
MUC4	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
DSPP	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
DPCR1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
RP1L1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
MX2	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
POTEF	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
C1orf170	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
KRTAP10	ARG2
-	ARG2
3	ARG2
gene1e	ARG2
.	O
The	O
expression	O
of	O
these	O
genes	O
was	O
then	O
quantified	O
by	O
real	O
-	O
time	O
reverse	O
-	O
transcription	O
PCR	O
(	O
RT	O
-	O
qPCR	O
)	O
in	O
12	O
prolactinomas	O
and	O
3	O
normal	O
pituitary	O
glands	O
.	O
The	O
mRNA	O
levels	O
of	O
gene1s	ARG2
PRDM2	ARG2
gene1e	ARG2
were	O
approximately	O
five	O
-	O
fold	O
lower	O
in	O
resistant	O
prolactinomas	O
than	O
in	O
responsive	O
tumors	O
(	O
p	O
<	O
0.05	O
)	O
.	O
gene1s	ARG2
PRDM2	ARG2
gene1e	ARG2
protein	O
levels	O
were	O
lower	O
in	O
resistant	O
prolactinomas	O
than	O
in	O
responsive	O
tumors	O
,	O
as	O
determined	O
by	O
Western	O
blotting	O
and	O
immunohistochemical	O
analysis	O
(	O
p	O
<	O
0.05	O
)	O
.	O
Overexpression	O
of	O
gene1s	ARG2
PRDM2	ARG2
gene1e	ARG2
upregulated	O
gene1s	ARG2
dopamine	ARG2
receptor	ARG2
D2	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
D2DR	ARG2
gene1e	ARG2
)	O
and	O
inhibited	O
the	O
phosphorylation	O
of	O
gene1s	ARG2
ERK1/2	ARG2
gene1e	ARG2
in	O
species1s	O
MMQ	O
species1e	O
cells	O
.	O
gene1s	ARG2
PRDM2	ARG2
gene1e	ARG2
showed	O
a	O
synergistic	O
effect	O
with	O
BRC	O
on	O
the	O
inhibition	O
of	O
gene1s	ARG2
prolactin	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
PRL	ARG2
gene1e	ARG2
)	O
secretion	O
and	O
species1s	O
MMQ	O
species1e	O
cell	O
viability	O
,	O
and	O
low	O
gene1s	ARG2
PRDM2	ARG2
gene1e	ARG2
expression	O
was	O
associated	O
with	O
tumor	O
recurrence	O
.	O
CONCLUSIONS	O
:	O
gene1s	ARG2
PRDM2	ARG2
gene1e	ARG2
downregulation	O
may	O
play	O
a	O
role	O
in	O
dopamine	O
-	O
agonist	O
resistance	O
and	O
tumor	O
recurrence	O
in	O
prolactinomas	O
.	O

Lower	O
gene1s	O
PRDM2	O
gene1e	O
expression	O
is	O
associated	O
with	O
dopamine	O
-	O
agonist	O
resistance	O
and	O
tumor	O
recurrence	O
in	O
prolactinomas	O
.	O
BACKGROUND	O
:	O
Dopamine	O
agonists	O
(	O
DAs	O
)	O
are	O
the	O
first	O
-	O
line	O
treatment	O
for	O
prolactinomas	O
,	O
which	O
account	O
for	O
25	O
-	O
30	O
%	O
of	O
functioning	O
pituitary	O
adenomas	O
,	O
and	O
bromocriptine	O
(	O
BRC	O
)	O
is	O
the	O
only	O
commercially	O
available	O
DAs	O
in	O
China	O
.	O
However	O
,	O
tumors	O
are	O
resistant	O
to	O
therapy	O
in	O
5	O
-	O
18	O
%	O
of	O
species1s	O
patients	O
species1e	O
.	O
METHODS	O
:	O
The	O
exomes	O
of	O
six	O
responsive	O
prolactinomas	O
and	O
six	O
resistant	O
prolactinomas	O
were	O
analyzed	O
by	O
whole	O
-	O
exome	O
sequencing	O
.	O
RESULTS	O
:	O
Using	O
stringent	O
variant	O
calling	O
and	O
filtering	O
parameters	O
,	O
ten	O
somatic	O
variants	O
that	O
were	O
mainly	O
associated	O
with	O
DNA	O
repair	O
or	O
protein	O
metabolic	O
processes	O
were	O
identified	O
.	O
New	O
resistant	O
variants	O
were	O
identified	O
in	O
multiple	O
genes	O
including	O
gene1s	O
PRDM2	O
gene1e	O
,	O
gene1s	O
PRG4	O
gene1e	O
,	O
gene1s	O
MUC4	O
gene1e	O
,	O
gene1s	O
DSPP	O
gene1e	O
,	O
gene1s	O
DPCR1	O
gene1e	O
,	O
gene1s	O
RP1L1	O
gene1e	O
,	O
gene1s	O
MX2	O
gene1e	O
,	O
gene1s	O
POTEF	O
gene1e	O
,	O
gene1s	O
C1orf170	O
gene1e	O
,	O
and	O
gene1s	O
KRTAP10	O
-	O
3	O
gene1e	O
.	O
The	O
expression	O
of	O
these	O
genes	O
was	O
then	O
quantified	O
by	O
real	O
-	O
time	O
reverse	O
-	O
transcription	O
PCR	O
(	O
RT	O
-	O
qPCR	O
)	O
in	O
12	O
prolactinomas	O
and	O
3	O
normal	O
pituitary	O
glands	O
.	O
The	O
mRNA	O
levels	O
of	O
gene1s	O
PRDM2	O
gene1e	O
were	O
approximately	O
five	O
-	O
fold	O
lower	O
in	O
resistant	O
prolactinomas	O
than	O
in	O
responsive	O
tumors	O
(	O
p	O
<	O
0.05	O
)	O
.	O
gene1s	O
PRDM2	O
gene1e	O
protein	O
levels	O
were	O
lower	O
in	O
resistant	O
prolactinomas	O
than	O
in	O
responsive	O
tumors	O
,	O
as	O
determined	O
by	O
Western	O
blotting	O
and	O
immunohistochemical	O
analysis	O
(	O
p	O
<	O
0.05	O
)	O
.	O
Overexpression	O
of	O
gene1s	O
PRDM2	O
gene1e	O
upregulated	O
gene1s	O
dopamine	O
receptor	O
D2	O
gene1e	O
(	O
gene1s	O
D2DR	O
gene1e	O
)	O
and	O
inhibited	O
the	O
phosphorylation	O
of	O
gene1s	O
ERK1/2	O
gene1e	O
in	O
arg1s	O
MMQ	O
arg1e	O
cells	O
.	O
gene1s	O
PRDM2	O
gene1e	O
showed	O
a	O
synergistic	O
effect	O
with	O
BRC	O
on	O
the	O
inhibition	O
of	O
gene1s	O
prolactin	O
gene1e	O
(	O
gene1s	O
PRL	O
gene1e	O
)	O
secretion	O
and	O
arg1s	O
MMQ	O
arg1e	O
cell	O
viability	O
,	O
and	O
low	O
gene1s	O
PRDM2	O
gene1e	O
expression	O
was	O
associated	O
with	O
tumor	O
recurrence	O
.	O
CONCLUSIONS	O
:	O
gene1s	O
PRDM2	O
gene1e	O
downregulation	O
may	O
play	O
a	O
role	O
in	O
dopamine	O
-	O
agonist	O
resistance	O
and	O
tumor	O
recurrence	O
in	O
prolactinomas	O
.	O

gene1s	O
Leptin	O
gene1e	O
Matures	O
Aspects	O
of	O
Lung	O
Structure	O
and	O
Function	O
in	O
the	O
Ovine	O
Fetus	O
.	O
In	O
arg1s	O
human	O
arg1e	O
and	O
ovine	O
fetuses	O
,	O
glucocorticoids	O
stimulate	O
gene1s	O
leptin	O
gene1e	O
secretion	O
,	O
although	O
the	O
extent	O
to	O
which	O
gene1s	O
leptin	O
gene1e	O
mediates	O
the	O
maturational	O
effects	O
of	O
glucocorticoids	O
on	O
pulmonary	O
development	O
is	O
unclear	O
.	O
This	O
study	O
investigated	O
the	O
effects	O
of	O
gene1s	O
leptin	O
gene1e	O
administration	O
on	O
indices	O
of	O
lung	O
structure	O
and	O
function	O
before	O
birth	O
.	O
Chronically	O
catheterized	O
singleton	O
species1s	O
sheep	O
species1e	O
fetuses	O
were	O
infused	O
iv	O
for	O
5	O
days	O
with	O
either	O
saline	O
or	O
recombinant	O
ovine	O
gene1s	O
leptin	O
gene1e	O
(	O
0.5	O
mg	O
/	O
kg	O
.	O
d	O
gene1s	O
leptin	O
gene1e	O
(	O
gene1s	O
LEP	O
gene1e	O
)	O
,	O
0.5	O
gene1s	O
LEP	O
gene1e	O
or	O
1.0	O
mg	O
/	O
kg	O
.	O
d	O
,	O
1.0	O
gene1s	O
LEP	O
gene1e	O
)	O
from	O
125	O
days	O
of	O
gestation	O
(	O
term	O
145	O
d	O
)	O
.	O
Over	O
the	O
infusion	O
,	O
gene1s	O
leptin	O
gene1e	O
administration	O
increased	O
plasma	O
gene1s	O
leptin	O
gene1e	O
,	O
but	O
not	O
cortisol	O
,	O
concentrations	O
.	O
On	O
the	O
fifth	O
day	O
of	O
infusion	O
,	O
0.5	O
gene1s	O
LEP	O
gene1e	O
reduced	O
alveolar	O
wall	O
thickness	O
and	O
increased	O
the	O
volume	O
at	O
closing	O
pressure	O
of	O
the	O
pressure	O
-	O
volume	O
deflation	O
curve	O
,	O
interalveolar	O
septal	O
gene1s	O
elastin	O
gene1e	O
content	O
,	O
secondary	O
septal	O
crest	O
density	O
,	O
and	O
the	O
mRNA	O
abundance	O
of	O
the	O
gene1s	O
leptin	O
receptor	O
gene1e	O
(	O
gene1s	O
Ob	O
-	O
R	O
gene1e	O
)	O
and	O
gene1s	O
surfactant	O
protein	O
(	O
SP	O
)	O
B	O
gene1e	O
.	O
Neither	O
treatment	O
influenced	O
static	O
lung	O
compliance	O
,	O
maximal	O
lung	O
volume	O
at	O
40	O
cmH2O	O
,	O
lung	O
compartment	O
volumes	O
,	O
alveolar	O
surface	O
area	O
,	O
pulmonary	O
glycogen	O
,	O
protein	O
content	O
of	O
the	O
gene1s	O
long	O
form	O
signaling	O
Ob	O
-	O
Rb	O
gene1e	O
or	O
phosphorylated	O
gene1s	O
signal	O
transducers	O
and	O
activators	O
of	O
transcription-3	O
gene1e	O
,	O
or	O
mRNA	O
levels	O
of	O
gene1s	O
SP	O
-	O
A	O
,	O
C	O
,	O
or	O
D	O
gene1e	O
,	O
gene1s	O
elastin	O
gene1e	O
,	O
gene1s	O
vascular	O
endothelial	O
growth	O
factor	O
-	O
A	O
gene1e	O
,	O
the	O
gene1s	O
vascular	O
endothelial	O
growth	O
factor	O
receptor	O
2	O
gene1e	O
,	O
gene1s	O
angiotensin	O
-	O
converting	O
enzyme	O
gene1e	O
,	O
gene1s	O
peroxisome	O
proliferator	O
-	O
activated	O
receptor	O
g	O
gene1e	O
,	O
or	O
gene1s	O
parathyroid	O
hormone	O
-	O
related	O
peptide	O
gene1e	O
.	O
gene1s	O
Leptin	O
gene1e	O
administration	O
in	O
the	O
ovine	O
fetus	O
during	O
late	O
gestation	O
promotes	O
aspects	O
of	O
lung	O
maturation	O
,	O
including	O
up	O
-	O
regulation	O
of	O
gene1s	O
SP	O
-	O
B	O
gene1e	O
.	O

gene1s	ARG2
Leptin	ARG2
gene1e	ARG2
Matures	O
Aspects	O
of	O
Lung	O
Structure	O
and	O
Function	O
in	O
the	O
Ovine	O
Fetus	O
.	O
In	O
species1s	O
human	O
species1e	O
and	O
ovine	O
fetuses	O
,	O
glucocorticoids	O
stimulate	O
gene1s	ARG2
leptin	ARG2
gene1e	ARG2
secretion	O
,	O
although	O
the	O
extent	O
to	O
which	O
gene1s	ARG2
leptin	ARG2
gene1e	ARG2
mediates	O
the	O
maturational	O
effects	O
of	O
glucocorticoids	O
on	O
pulmonary	O
development	O
is	O
unclear	O
.	O
This	O
study	O
investigated	O
the	O
effects	O
of	O
gene1s	ARG2
leptin	ARG2
gene1e	ARG2
administration	O
on	O
indices	O
of	O
lung	O
structure	O
and	O
function	O
before	O
birth	O
.	O
Chronically	O
catheterized	O
singleton	O
arg1s	O
sheep	O
arg1e	O
fetuses	O
were	O
infused	O
iv	O
for	O
5	O
days	O
with	O
either	O
saline	O
or	O
recombinant	O
ovine	O
gene1s	ARG2
leptin	ARG2
gene1e	ARG2
(	O
0.5	O
mg	O
/	O
kg	O
.	O
d	O
gene1s	ARG2
leptin	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
LEP	ARG2
gene1e	ARG2
)	O
,	O
0.5	O
gene1s	ARG2
LEP	ARG2
gene1e	ARG2
or	O
1.0	O
mg	O
/	O
kg	O
.	O
d	O
,	O
1.0	O
gene1s	ARG2
LEP	ARG2
gene1e	ARG2
)	O
from	O
125	O
days	O
of	O
gestation	O
(	O
term	O
145	O
d	O
)	O
.	O
Over	O
the	O
infusion	O
,	O
gene1s	ARG2
leptin	ARG2
gene1e	ARG2
administration	O
increased	O
plasma	O
gene1s	ARG2
leptin	ARG2
gene1e	ARG2
,	O
but	O
not	O
cortisol	O
,	O
concentrations	O
.	O
On	O
the	O
fifth	O
day	O
of	O
infusion	O
,	O
0.5	O
gene1s	ARG2
LEP	ARG2
gene1e	ARG2
reduced	O
alveolar	O
wall	O
thickness	O
and	O
increased	O
the	O
volume	O
at	O
closing	O
pressure	O
of	O
the	O
pressure	O
-	O
volume	O
deflation	O
curve	O
,	O
interalveolar	O
septal	O
gene1s	ARG2
elastin	ARG2
gene1e	ARG2
content	O
,	O
secondary	O
septal	O
crest	O
density	O
,	O
and	O
the	O
mRNA	O
abundance	O
of	O
the	O
gene1s	ARG2
leptin	ARG2
receptor	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
Ob	ARG2
-	ARG2
R	ARG2
gene1e	ARG2
)	O
and	O
gene1s	ARG2
surfactant	ARG2
protein	ARG2
(	ARG2
SP	ARG2
)	ARG2
B	ARG2
gene1e	ARG2
.	O
Neither	O
treatment	O
influenced	O
static	O
lung	O
compliance	O
,	O
maximal	O
lung	O
volume	O
at	O
40	O
cmH2O	O
,	O
lung	O
compartment	O
volumes	O
,	O
alveolar	O
surface	O
area	O
,	O
pulmonary	O
glycogen	O
,	O
protein	O
content	O
of	O
the	O
gene1s	ARG2
long	ARG2
form	ARG2
signaling	ARG2
Ob	ARG2
-	ARG2
Rb	ARG2
gene1e	ARG2
or	O
phosphorylated	O
gene1s	ARG2
signal	ARG2
transducers	ARG2
and	ARG2
activators	ARG2
of	ARG2
transcription-3	ARG2
gene1e	ARG2
,	O
or	O
mRNA	O
levels	O
of	O
gene1s	ARG2
SP	ARG2
-	ARG2
A	ARG2
,	ARG2
C	ARG2
,	ARG2
or	ARG2
D	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
elastin	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
vascular	ARG2
endothelial	ARG2
growth	ARG2
factor	ARG2
-	ARG2
A	ARG2
gene1e	ARG2
,	O
the	O
gene1s	ARG2
vascular	ARG2
endothelial	ARG2
growth	ARG2
factor	ARG2
receptor	ARG2
2	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
angiotensin	ARG2
-	ARG2
converting	ARG2
enzyme	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
peroxisome	ARG2
proliferator	ARG2
-	ARG2
activated	ARG2
receptor	ARG2
g	ARG2
gene1e	ARG2
,	O
or	O
gene1s	ARG2
parathyroid	ARG2
hormone	ARG2
-	ARG2
related	ARG2
peptide	ARG2
gene1e	ARG2
.	O
gene1s	ARG2
Leptin	ARG2
gene1e	ARG2
administration	O
in	O
the	O
ovine	O
fetus	O
during	O
late	O
gestation	O
promotes	O
aspects	O
of	O
lung	O
maturation	O
,	O
including	O
up	O
-	O
regulation	O
of	O
gene1s	ARG2
SP	ARG2
-	ARG2
B	ARG2
gene1e	ARG2
.	O

Changes	O
in	O
microRNA	O
(	O
miRNA	O
)	O
expression	O
during	O
pancreatic	O
cancer	O
development	O
and	O
progression	O
in	O
a	O
genetically	O
engineered	O
KrasG12D;Pdx1-Cre	O
arg1s	O
mouse	O
arg1e	O
(	O
KC	O
)	O
model	O
.	O
Differential	O
expression	O
of	O
microRNAs	O
(	O
miRNAs	O
)	O
has	O
been	O
demonstrated	O
in	O
various	O
cancers	O
,	O
including	O
pancreatic	O
cancer	O
(	O
PC	O
)	O
.	O
Due	O
to	O
the	O
lack	O
of	O
tissue	O
samples	O
from	O
early	O
-	O
stages	O
of	O
PC	O
,	O
the	O
stage	O
-	O
specific	O
alteration	O
of	O
miRNAs	O
during	O
PC	O
initiation	O
and	O
progression	O
is	O
largely	O
unknown	O
.	O
In	O
this	O
study	O
,	O
we	O
investigated	O
the	O
global	O
miRNA	O
expression	O
profile	O
and	O
their	O
processing	O
machinery	O
during	O
PC	O
progression	O
using	O
the	O
KrasG12D;Pdx1-Cre	O
(	O
KC	O
)	O
arg1s	O
mouse	O
arg1e	O
model	O
.	O
At	O
25	O
weeks	O
,	O
the	O
miRNA	O
microarray	O
analysis	O
revealed	O
significant	O
downregulation	O
of	O
gene1s	ARG2
miR-150	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
miR-494	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
miR-138	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
miR-148a	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
miR-216a	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
miR-217	ARG2
gene1e	ARG2
and	O
upregulation	O
of	O
gene1s	ARG2
miR-146b	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
miR-205	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
miR-31	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
miR-192	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
miR-21	ARG2
gene1e	ARG2
in	O
KC	O
arg1s	O
mice	O
arg1e	O
compared	O
to	O
controls	O
.	O
Further	O
,	O
expression	O
of	O
miRNA	O
biosynthetic	O
machinery	O
including	O
gene1s	ARG2
Dicer	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Exportin-5	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
TRKRA	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
TARBP2	ARG2
gene1e	ARG2
were	O
downregulated	O
,	O
while	O
gene1s	ARG2
DGCR8	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
Ago2	ARG2
gene1e	ARG2
were	O
upregulated	O
in	O
KC	O
arg1s	O
mice	O
arg1e	O
.	O
In	O
addition	O
,	O
from	O
10	O
to	O
50	O
weeks	O
of	O
age	O
,	O
stage	O
-	O
specific	O
expression	O
profiling	O
of	O
miRNA	O
in	O
KC	O
arg1s	O
mice	O
arg1e	O
revealed	O
downregulation	O
of	O
gene1s	ARG2
miR-216	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
miR-217	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
miR-100	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
miR-345	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
miR-141	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
miR-483	ARG2
-	ARG2
3p	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
miR-26b	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
miR-150	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
miR-195	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Let-7b	ARG2
gene1e	ARG2
and	O
Let-96	O
and	O
upregulation	O
of	O
gene1s	ARG2
miR-21	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
miR-205	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
miR-146b	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
miR-34c	ARG2
gene1e	ARG2
,	O
gene1s	O
miR-1273	O
gene1e	O
,	O
gene1s	ARG2
miR-223	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
miR-195	ARG2
gene1e	ARG2
compared	O
to	O
control	O
arg1s	O
mice	O
arg1e	O
.	O
Interestingly	O
,	O
the	O
differential	O
expression	O
of	O
miRNA	O
in	O
arg1s	O
mice	O
arg1e	O
also	O
corroborated	O
with	O
the	O
miRNA	O
expression	O
in	O
species1s	O
human	O
species1e	O
PC	O
cell	O
lines	O
and	O
tissue	O
samples	O
;	O
ectopic	O
expression	O
of	O
gene1s	O
Let-7b	O
gene1e	O
in	O
species1s	O
CD18	O
/	O
HPAF	O
species1e	O
and	O
species1s	O
Capan1	O
species1e	O
cells	O
resulted	O
in	O
the	O
downregulation	O
of	O
gene1s	O
KRAS	O
gene1e	O
and	O
MSST1	O
expression	O
.	O
Overall	O
,	O
the	O
present	O
study	O
aids	O
an	O
understanding	O
of	O
miRNA	O
expression	O
patterns	O
during	O
PC	O
pathogenesis	O
and	O
helps	O
to	O
facilitate	O
the	O
identification	O
of	O
promising	O
and	O
novel	O
early	O
diagnostic	O
/	O
prognostic	O
markers	O
and	O
therapeutic	O
targets	O
.	O

Changes	O
in	O
microRNA	O
(	O
miRNA	O
)	O
expression	O
during	O
pancreatic	O
cancer	O
development	O
and	O
progression	O
in	O
a	O
genetically	O
engineered	O
KrasG12D;Pdx1-Cre	O
species1s	O
mouse	O
species1e	O
(	O
KC	O
)	O
model	O
.	O
Differential	O
expression	O
of	O
microRNAs	O
(	O
miRNAs	O
)	O
has	O
been	O
demonstrated	O
in	O
various	O
cancers	O
,	O
including	O
pancreatic	O
cancer	O
(	O
PC	O
)	O
.	O
Due	O
to	O
the	O
lack	O
of	O
tissue	O
samples	O
from	O
early	O
-	O
stages	O
of	O
PC	O
,	O
the	O
stage	O
-	O
specific	O
alteration	O
of	O
miRNAs	O
during	O
PC	O
initiation	O
and	O
progression	O
is	O
largely	O
unknown	O
.	O
In	O
this	O
study	O
,	O
we	O
investigated	O
the	O
global	O
miRNA	O
expression	O
profile	O
and	O
their	O
processing	O
machinery	O
during	O
PC	O
progression	O
using	O
the	O
KrasG12D;Pdx1-Cre	O
(	O
KC	O
)	O
species1s	O
mouse	O
species1e	O
model	O
.	O
At	O
25	O
weeks	O
,	O
the	O
miRNA	O
microarray	O
analysis	O
revealed	O
significant	O
downregulation	O
of	O
gene1s	O
miR-150	O
gene1e	O
,	O
gene1s	O
miR-494	O
gene1e	O
,	O
gene1s	O
miR-138	O
gene1e	O
,	O
gene1s	O
miR-148a	O
gene1e	O
,	O
gene1s	O
miR-216a	O
gene1e	O
,	O
and	O
gene1s	O
miR-217	O
gene1e	O
and	O
upregulation	O
of	O
gene1s	O
miR-146b	O
gene1e	O
,	O
gene1s	O
miR-205	O
gene1e	O
,	O
gene1s	O
miR-31	O
gene1e	O
,	O
gene1s	O
miR-192	O
gene1e	O
,	O
and	O
gene1s	O
miR-21	O
gene1e	O
in	O
KC	O
species1s	O
mice	O
species1e	O
compared	O
to	O
controls	O
.	O
Further	O
,	O
expression	O
of	O
miRNA	O
biosynthetic	O
machinery	O
including	O
gene1s	O
Dicer	O
gene1e	O
,	O
gene1s	O
Exportin-5	O
gene1e	O
,	O
gene1s	O
TRKRA	O
gene1e	O
,	O
and	O
gene1s	O
TARBP2	O
gene1e	O
were	O
downregulated	O
,	O
while	O
gene1s	O
DGCR8	O
gene1e	O
and	O
gene1s	O
Ago2	O
gene1e	O
were	O
upregulated	O
in	O
KC	O
species1s	O
mice	O
species1e	O
.	O
In	O
addition	O
,	O
from	O
10	O
to	O
50	O
weeks	O
of	O
age	O
,	O
stage	O
-	O
specific	O
expression	O
profiling	O
of	O
miRNA	O
in	O
KC	O
species1s	O
mice	O
species1e	O
revealed	O
downregulation	O
of	O
gene1s	O
miR-216	O
gene1e	O
,	O
gene1s	O
miR-217	O
gene1e	O
,	O
gene1s	O
miR-100	O
gene1e	O
,	O
gene1s	O
miR-345	O
gene1e	O
,	O
gene1s	O
miR-141	O
gene1e	O
,	O
gene1s	O
miR-483	O
-	O
3p	O
gene1e	O
,	O
gene1s	O
miR-26b	O
gene1e	O
,	O
gene1s	O
miR-150	O
gene1e	O
,	O
gene1s	O
miR-195	O
gene1e	O
,	O
gene1s	O
Let-7b	O
gene1e	O
and	O
Let-96	O
and	O
upregulation	O
of	O
gene1s	O
miR-21	O
gene1e	O
,	O
gene1s	O
miR-205	O
gene1e	O
,	O
gene1s	O
miR-146b	O
gene1e	O
,	O
gene1s	O
miR-34c	O
gene1e	O
,	O
gene1s	ARG2
miR-1273	ARG2
gene1e	ARG2
,	O
gene1s	O
miR-223	O
gene1e	O
and	O
gene1s	O
miR-195	O
gene1e	O
compared	O
to	O
control	O
species1s	O
mice	O
species1e	O
.	O
Interestingly	O
,	O
the	O
differential	O
expression	O
of	O
miRNA	O
in	O
species1s	O
mice	O
species1e	O
also	O
corroborated	O
with	O
the	O
miRNA	O
expression	O
in	O
arg1s	O
human	O
arg1e	O
PC	O
cell	O
lines	O
and	O
tissue	O
samples	O
;	O
ectopic	O
expression	O
of	O
gene1s	ARG2
Let-7b	ARG2
gene1e	ARG2
in	O
arg1s	O
CD18	O
/	O
HPAF	O
arg1e	O
and	O
arg1s	O
Capan1	O
arg1e	O
cells	O
resulted	O
in	O
the	O
downregulation	O
of	O
gene1s	ARG2
KRAS	ARG2
gene1e	ARG2
and	O
MSST1	O
expression	O
.	O
Overall	O
,	O
the	O
present	O
study	O
aids	O
an	O
understanding	O
of	O
miRNA	O
expression	O
patterns	O
during	O
PC	O
pathogenesis	O
and	O
helps	O
to	O
facilitate	O
the	O
identification	O
of	O
promising	O
and	O
novel	O
early	O
diagnostic	O
/	O
prognostic	O
markers	O
and	O
therapeutic	O
targets	O
.	O

gene1s	ARG2
TIPE2	ARG2
gene1e	ARG2
Inhibits	O
Lung	O
Cancer	O
Growth	O
Attributing	O
to	O
Promotion	O
of	O
Apoptosis	O
by	O
Regulating	O
Some	O
Apoptotic	O
Molecules	O
Expression	O
.	O
Recent	O
studies	O
found	O
that	O
gene1s	ARG2
TIPE2	ARG2
gene1e	ARG2
was	O
involved	O
in	O
cancer	O
development	O
.	O
However	O
,	O
little	O
is	O
known	O
about	O
gene1s	ARG2
TIPE2	ARG2
gene1e	ARG2
in	O
lung	O
cancer	O
.	O
Our	O
study	O
aims	O
to	O
clarify	O
the	O
role	O
of	O
gene1s	ARG2
TIPE2	ARG2
gene1e	ARG2
in	O
lung	O
carcinogenesis	O
.	O
We	O
examined	O
the	O
expression	O
of	O
gene1s	ARG2
TIPE2	ARG2
gene1e	ARG2
in	O
lung	O
squamous	O
cancer	O
(	O
LSC	O
)	O
,	O
small	O
cell	O
lung	O
cancer	O
and	O
lung	O
adenocarcinoma	O
(	O
AdC	O
)	O
tissues	O
and	O
found	O
that	O
gene1s	ARG2
TIPE2	ARG2
gene1e	ARG2
expression	O
was	O
lost	O
in	O
small	O
cell	O
lung	O
cancer	O
,	O
compared	O
with	O
adjacent	O
non	O
-	O
tumor	O
tissues	O
.	O
Overexpression	O
of	O
gene1s	ARG2
TIPE2	ARG2
gene1e	ARG2
significantly	O
inhibited	O
the	O
growth	O
of	O
lung	O
cancer	O
cell	O
H446	O
in	O
vitro	O
and	O
even	O
suppressed	O
tumor	O
formation	O
in	O
vivo	O
.	O
Flow	O
cytometry	O
analysis	O
found	O
gene1s	ARG2
TIPE2	ARG2
gene1e	ARG2
overexpression	O
promoted	O
apoptosis	O
of	O
arg1s	O
H446	O
arg1e	O
.	O
In	O
gene1s	ARG2
TIPE2	ARG2
gene1e	ARG2
over	O
-	O
expression	O
cells	O
,	O
gene1s	ARG2
caspase-3	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
caspase-9	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
Bax	ARG2
gene1e	ARG2
were	O
significantly	O
up	O
-	O
regulated	O
while	O
gene1s	ARG2
Bcl-2	ARG2
gene1e	ARG2
was	O
down	O
-	O
regulated	O
.	O
Moreover	O
,	O
coincident	O
results	O
were	O
shown	O
by	O
immunohistochemistry	O
in	O
tumors	O
from	O
species1s	O
nude	O
mice	O
species1e	O
.	O
gene1s	ARG2
TIPE2	ARG2
gene1e	ARG2
inhibited	O
the	O
phosphorylation	O
of	O
gene1s	ARG2
Akt	ARG2
gene1e	ARG2
,	O
while	O
promoting	O
the	O
phosphorylation	O
of	O
gene1s	ARG2
P38	ARG2
gene1e	ARG2
,	O
but	O
had	O
no	O
effect	O
on	O
gene1s	ARG2
IkBa	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
ERK	ARG2
gene1e	ARG2
pathway	O
.	O
Taken	O
together	O
,	O
gene1s	ARG2
TIPE2	ARG2
gene1e	ARG2
promoted	O
lung	O
cancer	O
cell	O
apoptosis	O
through	O
affecting	O
apoptosis	O
-	O
related	O
molecules	O
gene1s	ARG2
caspase-3	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
caspase-9	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Bcl-2	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
Bax	ARG2
gene1e	ARG2
,	O
possibly	O
via	O
regulating	O
gene1s	ARG2
P38	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
Akt	ARG2
gene1e	ARG2
pathways	O
,	O
indicating	O
that	O
gene1s	ARG2
TIPE2	ARG2
gene1e	ARG2
might	O
be	O
a	O
novel	O
marker	O
for	O
lung	O
cancer	O
diagnosis	O
and	O
therapy	O
.	O

gene1s	O
TIPE2	O
gene1e	O
Inhibits	O
Lung	O
Cancer	O
Growth	O
Attributing	O
to	O
Promotion	O
of	O
Apoptosis	O
by	O
Regulating	O
Some	O
Apoptotic	O
Molecules	O
Expression	O
.	O
Recent	O
studies	O
found	O
that	O
gene1s	O
TIPE2	O
gene1e	O
was	O
involved	O
in	O
cancer	O
development	O
.	O
However	O
,	O
little	O
is	O
known	O
about	O
gene1s	O
TIPE2	O
gene1e	O
in	O
lung	O
cancer	O
.	O
Our	O
study	O
aims	O
to	O
clarify	O
the	O
role	O
of	O
gene1s	O
TIPE2	O
gene1e	O
in	O
lung	O
carcinogenesis	O
.	O
We	O
examined	O
the	O
expression	O
of	O
gene1s	O
TIPE2	O
gene1e	O
in	O
lung	O
squamous	O
cancer	O
(	O
LSC	O
)	O
,	O
small	O
cell	O
lung	O
cancer	O
and	O
lung	O
adenocarcinoma	O
(	O
AdC	O
)	O
tissues	O
and	O
found	O
that	O
gene1s	O
TIPE2	O
gene1e	O
expression	O
was	O
lost	O
in	O
small	O
cell	O
lung	O
cancer	O
,	O
compared	O
with	O
adjacent	O
non	O
-	O
tumor	O
tissues	O
.	O
Overexpression	O
of	O
gene1s	O
TIPE2	O
gene1e	O
significantly	O
inhibited	O
the	O
growth	O
of	O
lung	O
cancer	O
cell	O
H446	O
in	O
vitro	O
and	O
even	O
suppressed	O
tumor	O
formation	O
in	O
vivo	O
.	O
Flow	O
cytometry	O
analysis	O
found	O
gene1s	O
TIPE2	O
gene1e	O
overexpression	O
promoted	O
apoptosis	O
of	O
species1s	O
H446	O
species1e	O
.	O
In	O
gene1s	O
TIPE2	O
gene1e	O
over	O
-	O
expression	O
cells	O
,	O
gene1s	O
caspase-3	O
gene1e	O
,	O
gene1s	O
caspase-9	O
gene1e	O
,	O
and	O
gene1s	O
Bax	O
gene1e	O
were	O
significantly	O
up	O
-	O
regulated	O
while	O
gene1s	O
Bcl-2	O
gene1e	O
was	O
down	O
-	O
regulated	O
.	O
Moreover	O
,	O
coincident	O
results	O
were	O
shown	O
by	O
immunohistochemistry	O
in	O
tumors	O
from	O
arg1s	O
nude	O
mice	O
arg1e	O
.	O
gene1s	O
TIPE2	O
gene1e	O
inhibited	O
the	O
phosphorylation	O
of	O
gene1s	O
Akt	O
gene1e	O
,	O
while	O
promoting	O
the	O
phosphorylation	O
of	O
gene1s	O
P38	O
gene1e	O
,	O
but	O
had	O
no	O
effect	O
on	O
gene1s	O
IkBa	O
gene1e	O
and	O
gene1s	O
ERK	O
gene1e	O
pathway	O
.	O
Taken	O
together	O
,	O
gene1s	O
TIPE2	O
gene1e	O
promoted	O
lung	O
cancer	O
cell	O
apoptosis	O
through	O
affecting	O
apoptosis	O
-	O
related	O
molecules	O
gene1s	O
caspase-3	O
gene1e	O
,	O
gene1s	O
caspase-9	O
gene1e	O
,	O
gene1s	O
Bcl-2	O
gene1e	O
and	O
gene1s	O
Bax	O
gene1e	O
,	O
possibly	O
via	O
regulating	O
gene1s	O
P38	O
gene1e	O
and	O
gene1s	O
Akt	O
gene1e	O
pathways	O
,	O
indicating	O
that	O
gene1s	O
TIPE2	O
gene1e	O
might	O
be	O
a	O
novel	O
marker	O
for	O
lung	O
cancer	O
diagnosis	O
and	O
therapy	O
.	O

Increased	O
frequency	O
of	O
peripheral	O
blood	O
follicular	O
helper	O
T	O
cells	O
and	O
elevated	O
serum	O
gene1s	ARG2
IL-21	ARG2
gene1e	ARG2
levels	O
in	O
arg1s	O
patients	O
arg1e	O
with	O
knee	O
osteoarthritis	O
.	O
An	O
aberrant	O
immune	O
response	O
has	O
been	O
implicated	O
in	O
the	O
pathogenesis	O
of	O
osteoarthritis	O
(	O
OA	O
)	O
.	O
However	O
,	O
the	O
role	O
of	O
peripheral	O
blood	O
follicular	O
helper	O
T	O
(	O
TFH	O
)	O
cells	O
in	O
the	O
pathogenesis	O
of	O
OA	O
has	O
yet	O
to	O
be	O
elucidated	O
.	O
The	O
purpose	O
of	O
the	O
present	O
study	O
was	O
to	O
examine	O
the	O
role	O
of	O
TFH	O
cells	O
and	O
serum	O
gene1s	ARG2
interleukin-21	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
IL-21	ARG2
gene1e	ARG2
)	O
in	O
the	O
pathogenesis	O
of	O
OA	O
.	O
Frequency	O
of	O
peripheral	O
blood	O
gene1s	O
inducible	O
costimulator	O
gene1e	O
(	O
gene1s	ARG2
ICOS	ARG2
gene1e	ARG2
)+	O
,	O
gene1s	ARG2
programmed	ARG2
death	ARG2
1	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
PD-1	ARG2
gene1e	ARG2
)+	O
,	O
and	O
gene1s	ARG2
IL-21	ARG2
gene1e	ARG2
+	O
gene1s	ARG2
CXCR5	ARG2
gene1e	ARG2
+	O
gene1s	ARG2
CD4	ARG2
gene1e	ARG2
+	O
T	O
cells	O
in	O
40	O
arg1s	O
patients	O
arg1e	O
with	O
OA	O
and	O
13	O
healthy	O
controls	O
(	O
HCs	O
)	O
were	O
examined	O
by	O
flow	O
cytometry	O
.	O
The	O
disease	O
state	O
in	O
individual	O
arg1s	O
patients	O
arg1e	O
was	O
assessed	O
using	O
the	O
Western	O
Ontario	O
and	O
McMaster	O
Universities	O
Osteoarthritis	O
Index	O
(	O
WOMAC	O
)	O
.	O
Concentrations	O
of	O
serum	O
gene1s	ARG2
IL-21	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
interferon	ARG2
-	ARG2
g	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
INF	ARG2
-	ARG2
g	ARG2
gene1e	ARG2
)	O
,	O
gene1s	ARG2
IL-4	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IL-17A	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
C	ARG2
-	ARG2
reactive	ARG2
protein	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
CRP	ARG2
gene1e	ARG2
)	O
were	O
determined	O
,	O
and	O
the	O
erythrocyte	O
sedimentation	O
rate	O
(	O
ESR	O
)	O
was	O
measured	O
.	O
The	O
percentages	O
of	O
gene1s	ARG2
CXCR5	ARG2
gene1e	ARG2
+	O
gene1s	ARG2
CD4	ARG2
gene1e	ARG2
+	O
cells	O
,	O
gene1s	ARG2
PD-1	ARG2
gene1e	ARG2
+	O
gene1s	ARG2
CXCR5	ARG2
gene1e	ARG2
+	O
gene1s	ARG2
CD4	ARG2
gene1e	ARG2
+	O
,	O
gene1s	ARG2
ICOS	ARG2
gene1e	ARG2
+	O
gene1s	ARG2
CXCR5	ARG2
gene1e	ARG2
+	O
gene1s	ARG2
CD4	ARG2
gene1e	ARG2
+	O
and	O
gene1s	ARG2
IL-21	ARG2
gene1e	ARG2
+	O
gene1s	ARG2
CXCR5	ARG2
gene1e	ARG2
+	O
gene1s	ARG2
CD4	ARG2
gene1e	ARG2
+	O
T	O
cells	O
in	O
OA	O
arg1s	O
patients	O
arg1e	O
were	O
signifcantly	O
higher	O
than	O
those	O
in	O
the	O
HCs	O
.	O
Furthermore	O
,	O
serum	O
gene1s	ARG2
IL-21	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IL-17A	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
IFN	ARG2
-	ARG2
g	ARG2
gene1e	ARG2
levels	O
in	O
OA	O
arg1s	O
patients	O
arg1e	O
were	O
significantly	O
higher	O
than	O
those	O
in	O
HCs	O
.	O
Expression	O
of	O
gene1s	ARG2
IL-21	ARG2
gene1e	ARG2
+TFH	O
cells	O
in	O
OA	O
arg1s	O
patients	O
arg1e	O
demonstrated	O
a	O
positive	O
correlation	O
with	O
OA	O
disease	O
activity	O
,	O
gene1s	ARG2
CRP	ARG2
gene1e	ARG2
levels	O
and	O
WOMAC	O
.	O
TFH	O
cells	O
and	O
gene1s	ARG2
IL-21	ARG2
gene1e	ARG2
appear	O
to	O
serve	O
an	O
important	O
role	O
in	O
the	O
progression	O
of	O
OA	O
.	O
gene1s	ARG2
IL-21	ARG2
gene1e	ARG2
+TFH	O
cells	O
may	O
prove	O
to	O
be	O
a	O
marker	O
of	O
OA	O
disease	O
activity	O
.	O

gene1s	ARG2
Interferon	ARG2
regulatory	ARG2
factor	ARG2
3	ARG2
gene1e	ARG2
plays	O
an	O
anti	O
-	O
inflammatory	O
role	O
in	O
microglia	O
by	O
activating	O
the	O
gene1s	ARG2
PI3K	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
Akt	ARG2
gene1e	ARG2
pathway	O
.	O
BACKGROUND	O
:	O
Microglia	O
are	O
the	O
principal	O
cells	O
involved	O
in	O
the	O
innate	O
immune	O
response	O
in	O
the	O
CNS	O
.	O
Activated	O
microglia	O
produce	O
a	O
number	O
of	O
proinflammatory	O
gene1s	ARG2
cytokines	ARG2
gene1e	ARG2
implicated	O
in	O
neurotoxicity	O
but	O
they	O
also	O
are	O
a	O
major	O
source	O
of	O
anti	O
-	O
inflammatory	O
gene1s	ARG2
cytokines	ARG2
gene1e	ARG2
,	O
antiviral	O
proteins	O
and	O
growth	O
factors	O
.	O
Therefore	O
,	O
an	O
immune	O
therapy	O
aiming	O
at	O
suppressing	O
the	O
proinflammatory	O
phenotype	O
while	O
enhancing	O
the	O
anti	O
-	O
inflammatory	O
,	O
growth	O
promoting	O
phenotype	O
would	O
be	O
of	O
great	O
benefit	O
.	O
In	O
the	O
current	O
study	O
,	O
we	O
tested	O
the	O
hypothesis	O
that	O
gene1s	ARG2
interferon	ARG2
regulatory	ARG2
factor	ARG2
3	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
IRF3	ARG2
gene1e	ARG2
)	O
,	O
a	O
gene1s	ARG2
transcription	ARG2
factor	ARG2
gene1e	ARG2
required	O
for	O
the	O
induction	O
of	O
gene1s	ARG2
IFNbeta	ARG2
gene1e	ARG2
following	O
gene1s	ARG2
TLR3	ARG2
gene1e	ARG2
or	O
gene1s	ARG2
TLR4	ARG2
gene1e	ARG2
activation	O
,	O
is	O
critical	O
to	O
the	O
microglial	O
phenotype	O
change	O
from	O
proinflammatory	O
to	O
anti	O
-	O
inflammatory	O
,	O
and	O
that	O
this	O
phenotype	O
change	O
can	O
be	O
greatly	O
facilitated	O
by	O
gene1s	ARG2
IRF3	ARG2
gene1e	ARG2
gene	O
transfer	O
.	O
METHODS	O
:	O
Cultures	O
of	O
primary	O
arg1s	O
human	O
arg1e	O
fetal	O
microglia	O
were	O
transduced	O
with	O
gene1s	ARG2
IRF3	ARG2
gene1e	ARG2
using	O
recombinant	O
species1s	O
adenovirus	O
species1e	O
(	O
Ad	O
-	O
gene1s	ARG2
IRF3	ARG2
gene1e	ARG2
)	O
and	O
subjected	O
to	O
microarray	O
analysis	O
,	O
real	O
-	O
time	O
PCR	O
,	O
immunoblotting	O
and	O
ELISA	O
to	O
determine	O
inflammatory	O
gene	O
expression	O
.	O
Two	O
different	O
types	O
of	O
immune	O
stimuli	O
were	O
tested	O
,	O
the	O
TLR	O
ligands	O
,	O
poly	O
IC	O
(	O
PIC	O
)	O
and	O
LPS	O
,	O
and	O
the	O
proinflammatory	O
gene1s	ARG2
cytokines	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IL-1	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
IFNgamma	ARG2
gene1e	ARG2
.	O
In	O
addition	O
,	O
the	O
role	O
of	O
the	O
gene1s	ARG2
PI3K	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
Akt	ARG2
gene1e	ARG2
pathway	O
was	O
examined	O
by	O
use	O
of	O
a	O
pharmacological	O
inhibitor	O
,	O
LY294002	O
.	O
RESULTS	O
:	O
Our	O
results	O
show	O
that	O
Ad	O
-	O
gene1s	ARG2
IRF3	ARG2
gene1e	ARG2
suppressed	O
proinflammatory	O
genes	O
(	O
gene1s	ARG2
IL-1alpha	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IL-1beta	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
TNFalpha	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IL-6	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IL-8	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
CXCL1	ARG2
gene1e	ARG2
)	O
and	O
enhanced	O
anti	O
-	O
inflammatory	O
genes	O
(	O
gene1s	ARG2
IL-1	ARG2
receptor	ARG2
antagonist	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IL-10	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
IFNbeta	ARG2
gene1e	ARG2
)	O
in	O
microglia	O
,	O
regardless	O
of	O
the	O
cell	O
stimuli	O
applied	O
.	O
Furthermore	O
,	O
Ad	O
-	O
gene1s	ARG2
IRF3	ARG2
gene1e	ARG2
activated	O
gene1s	ARG2
Akt	ARG2
gene1e	ARG2
,	O
and	O
LY294002	O
reversed	O
the	O
effects	O
of	O
Ad	O
-	O
gene1s	ARG2
IRF3	ARG2
gene1e	ARG2
on	O
microglial	O
inflammatory	O
gene	O
expression	O
.	O
gene1s	ARG2
pAkt	ARG2
gene1e	ARG2
was	O
critical	O
in	O
LPS-	O
or	O
PIC	O
-	O
induced	O
production	O
of	O
gene1s	ARG2
IL-10	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
IL-1ra	ARG2
gene1e	ARG2
.	O
Significantly	O
,	O
microglial	O
gene1s	ARG2
IFNbeta	ARG2
gene1e	ARG2
protein	O
production	O
was	O
also	O
dependent	O
on	O
gene1s	ARG2
pAkt	ARG2
gene1e	ARG2
and	O
required	O
both	O
Ad	O
-	O
gene1s	ARG2
IRF3	ARG2
gene1e	ARG2
and	O
immunological	O
stimuli	O
(	O
PIC	O
>	O
gene1s	ARG2
IL-1	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
IFNgamma	ARG2
gene1e	ARG2
)	O
.	O
p	O
gene1s	ARG2
Akt	ARG2
gene1e	ARG2
played	O
much	O
less	O
prominent	O
and	O
variable	O
roles	O
in	O
microglial	O
proinflammatory	O
gene	O
expression	O
.	O
This	O
anti	O
-	O
inflammatory	O
promoting	O
role	O
of	O
gene1s	ARG2
PI3K	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
Akt	ARG2
gene1e	ARG2
appeared	O
to	O
be	O
specific	O
to	O
microglia	O
,	O
since	O
astrocyte	O
proinflammatory	O
gene	O
expression	O
(	O
as	O
well	O
as	O
gene1s	ARG2
IFNbeta	ARG2
gene1e	ARG2
expression	O
)	O
required	O
gene1s	ARG2
PI3K	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
Akt	ARG2
gene1e	ARG2
.	O
CONCLUSIONS	O
:	O
Our	O
results	O
show	O
a	O
novel	O
anti	O
-	O
inflammatory	O
role	O
for	O
the	O
gene1s	ARG2
PI3K	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
Akt	ARG2
gene1e	ARG2
signaling	O
pathway	O
in	O
microglia	O
.	O
They	O
further	O
suggest	O
that	O
gene1s	ARG2
IRF3	ARG2
gene1e	ARG2
gene	O
therapy	O
could	O
facilitate	O
the	O
microglial	O
phenotype	O
switch	O
from	O
proinflammatory	O
(	O
"	O
M1-like	O
"	O
)	O
to	O
anti	O
-	O
inflammatory	O
and	O
immunomodulatory	O
(	O
"	O
M2-like	O
"	O
)	O
,	O
in	O
part	O
,	O
by	O
augmenting	O
the	O
level	O
of	O
gene1s	ARG2
pAkt	ARG2
gene1e	ARG2
.	O

gene1s	O
Interferon	O
regulatory	O
factor	O
3	O
gene1e	O
plays	O
an	O
anti	O
-	O
inflammatory	O
role	O
in	O
microglia	O
by	O
activating	O
the	O
gene1s	O
PI3K	O
gene1e	O
/	O
gene1s	O
Akt	O
gene1e	O
pathway	O
.	O
BACKGROUND	O
:	O
Microglia	O
are	O
the	O
principal	O
cells	O
involved	O
in	O
the	O
innate	O
immune	O
response	O
in	O
the	O
CNS	O
.	O
Activated	O
microglia	O
produce	O
a	O
number	O
of	O
proinflammatory	O
gene1s	O
cytokines	O
gene1e	O
implicated	O
in	O
neurotoxicity	O
but	O
they	O
also	O
are	O
a	O
major	O
source	O
of	O
anti	O
-	O
inflammatory	O
gene1s	O
cytokines	O
gene1e	O
,	O
antiviral	O
proteins	O
and	O
growth	O
factors	O
.	O
Therefore	O
,	O
an	O
immune	O
therapy	O
aiming	O
at	O
suppressing	O
the	O
proinflammatory	O
phenotype	O
while	O
enhancing	O
the	O
anti	O
-	O
inflammatory	O
,	O
growth	O
promoting	O
phenotype	O
would	O
be	O
of	O
great	O
benefit	O
.	O
In	O
the	O
current	O
study	O
,	O
we	O
tested	O
the	O
hypothesis	O
that	O
gene1s	O
interferon	O
regulatory	O
factor	O
3	O
gene1e	O
(	O
gene1s	O
IRF3	O
gene1e	O
)	O
,	O
a	O
gene1s	O
transcription	O
factor	O
gene1e	O
required	O
for	O
the	O
induction	O
of	O
gene1s	O
IFNbeta	O
gene1e	O
following	O
gene1s	O
TLR3	O
gene1e	O
or	O
gene1s	O
TLR4	O
gene1e	O
activation	O
,	O
is	O
critical	O
to	O
the	O
microglial	O
phenotype	O
change	O
from	O
proinflammatory	O
to	O
anti	O
-	O
inflammatory	O
,	O
and	O
that	O
this	O
phenotype	O
change	O
can	O
be	O
greatly	O
facilitated	O
by	O
gene1s	O
IRF3	O
gene1e	O
gene	O
transfer	O
.	O
METHODS	O
:	O
Cultures	O
of	O
primary	O
species1s	O
human	O
species1e	O
fetal	O
microglia	O
were	O
transduced	O
with	O
gene1s	O
IRF3	O
gene1e	O
using	O
recombinant	O
arg1s	O
adenovirus	O
arg1e	O
(	O
Ad	O
-	O
gene1s	O
IRF3	O
gene1e	O
)	O
and	O
subjected	O
to	O
microarray	O
analysis	O
,	O
real	O
-	O
time	O
PCR	O
,	O
immunoblotting	O
and	O
ELISA	O
to	O
determine	O
inflammatory	O
gene	O
expression	O
.	O
Two	O
different	O
types	O
of	O
immune	O
stimuli	O
were	O
tested	O
,	O
the	O
TLR	O
ligands	O
,	O
poly	O
IC	O
(	O
PIC	O
)	O
and	O
LPS	O
,	O
and	O
the	O
proinflammatory	O
gene1s	O
cytokines	O
gene1e	O
,	O
gene1s	O
IL-1	O
gene1e	O
/	O
gene1s	O
IFNgamma	O
gene1e	O
.	O
In	O
addition	O
,	O
the	O
role	O
of	O
the	O
gene1s	O
PI3K	O
gene1e	O
/	O
gene1s	O
Akt	O
gene1e	O
pathway	O
was	O
examined	O
by	O
use	O
of	O
a	O
pharmacological	O
inhibitor	O
,	O
LY294002	O
.	O
RESULTS	O
:	O
Our	O
results	O
show	O
that	O
Ad	O
-	O
gene1s	O
IRF3	O
gene1e	O
suppressed	O
proinflammatory	O
genes	O
(	O
gene1s	O
IL-1alpha	O
gene1e	O
,	O
gene1s	O
IL-1beta	O
gene1e	O
,	O
gene1s	O
TNFalpha	O
gene1e	O
,	O
gene1s	O
IL-6	O
gene1e	O
,	O
gene1s	O
IL-8	O
gene1e	O
and	O
gene1s	O
CXCL1	O
gene1e	O
)	O
and	O
enhanced	O
anti	O
-	O
inflammatory	O
genes	O
(	O
gene1s	O
IL-1	O
receptor	O
antagonist	O
gene1e	O
,	O
gene1s	O
IL-10	O
gene1e	O
and	O
gene1s	O
IFNbeta	O
gene1e	O
)	O
in	O
microglia	O
,	O
regardless	O
of	O
the	O
cell	O
stimuli	O
applied	O
.	O
Furthermore	O
,	O
Ad	O
-	O
gene1s	O
IRF3	O
gene1e	O
activated	O
gene1s	O
Akt	O
gene1e	O
,	O
and	O
LY294002	O
reversed	O
the	O
effects	O
of	O
Ad	O
-	O
gene1s	O
IRF3	O
gene1e	O
on	O
microglial	O
inflammatory	O
gene	O
expression	O
.	O
gene1s	O
pAkt	O
gene1e	O
was	O
critical	O
in	O
LPS-	O
or	O
PIC	O
-	O
induced	O
production	O
of	O
gene1s	O
IL-10	O
gene1e	O
and	O
gene1s	O
IL-1ra	O
gene1e	O
.	O
Significantly	O
,	O
microglial	O
gene1s	O
IFNbeta	O
gene1e	O
protein	O
production	O
was	O
also	O
dependent	O
on	O
gene1s	O
pAkt	O
gene1e	O
and	O
required	O
both	O
Ad	O
-	O
gene1s	O
IRF3	O
gene1e	O
and	O
immunological	O
stimuli	O
(	O
PIC	O
>	O
gene1s	O
IL-1	O
gene1e	O
/	O
gene1s	O
IFNgamma	O
gene1e	O
)	O
.	O
p	O
gene1s	O
Akt	O
gene1e	O
played	O
much	O
less	O
prominent	O
and	O
variable	O
roles	O
in	O
microglial	O
proinflammatory	O
gene	O
expression	O
.	O
This	O
anti	O
-	O
inflammatory	O
promoting	O
role	O
of	O
gene1s	O
PI3K	O
gene1e	O
/	O
gene1s	O
Akt	O
gene1e	O
appeared	O
to	O
be	O
specific	O
to	O
microglia	O
,	O
since	O
astrocyte	O
proinflammatory	O
gene	O
expression	O
(	O
as	O
well	O
as	O
gene1s	O
IFNbeta	O
gene1e	O
expression	O
)	O
required	O
gene1s	O
PI3K	O
gene1e	O
/	O
gene1s	O
Akt	O
gene1e	O
.	O
CONCLUSIONS	O
:	O
Our	O
results	O
show	O
a	O
novel	O
anti	O
-	O
inflammatory	O
role	O
for	O
the	O
gene1s	O
PI3K	O
gene1e	O
/	O
gene1s	O
Akt	O
gene1e	O
signaling	O
pathway	O
in	O
microglia	O
.	O
They	O
further	O
suggest	O
that	O
gene1s	O
IRF3	O
gene1e	O
gene	O
therapy	O
could	O
facilitate	O
the	O
microglial	O
phenotype	O
switch	O
from	O
proinflammatory	O
(	O
"	O
M1-like	O
"	O
)	O
to	O
anti	O
-	O
inflammatory	O
and	O
immunomodulatory	O
(	O
"	O
M2-like	O
"	O
)	O
,	O
in	O
part	O
,	O
by	O
augmenting	O
the	O
level	O
of	O
gene1s	O
pAkt	O
gene1e	O
.	O

gene1s	ARG2
Metalloprotease	ARG2
-	ARG2
disintegrin	ARG2
gene1e	ARG2
gene1s	ARG2
ADAM12	ARG2
gene1e	ARG2
actively	O
promotes	O
the	O
stem	O
cell	O
-	O
like	O
phenotype	O
in	O
gene1s	ARG2
claudin	ARG2
gene1e	ARG2
-	O
low	O
breast	O
cancer	O
.	O
BACKGROUND	O
:	O
gene1s	ARG2
ADAM12	ARG2
gene1e	ARG2
is	O
upregulated	O
in	O
arg1s	O
human	O
arg1e	O
breast	O
cancers	O
and	O
is	O
a	O
predictor	O
of	O
chemoresistance	O
in	O
gene1s	ARG2
estrogen	ARG2
receptor	ARG2
gene1e	ARG2
-	O
negative	O
tumors	O
.	O
gene1s	ARG2
ADAM12	ARG2
gene1e	ARG2
is	O
induced	O
during	O
epithelial	O
-	O
to	O
-	O
mesenchymal	O
transition	O
,	O
a	O
feature	O
associated	O
with	O
gene1s	ARG2
claudin	ARG2
gene1e	ARG2
-	O
low	O
breast	O
tumors	O
,	O
which	O
are	O
enriched	O
in	O
cancer	O
stem	O
cell	O
(	O
CSC	O
)	O
markers	O
.	O
It	O
is	O
currently	O
unknown	O
whether	O
gene1s	ARG2
ADAM12	ARG2
gene1e	ARG2
plays	O
an	O
active	O
role	O
in	O
promoting	O
the	O
CSC	O
phenotype	O
in	O
breast	O
cancer	O
cells	O
.	O
METHODS	O
:	O
gene1s	ARG2
ADAM12	ARG2
gene1e	ARG2
expression	O
was	O
downregulated	O
in	O
representative	O
gene1s	ARG2
claudin	ARG2
gene1e	ARG2
-	O
low	O
breast	O
cancer	O
cell	O
lines	O
,	O
SUM159PT	O
and	O
Hs578	O
T	O
,	O
using	O
siRNA	O
transfection	O
or	O
inducible	O
shRNA	O
expression	O
.	O
Cell	O
characteristics	O
commonly	O
associated	O
with	O
the	O
CSC	O
phenotype	O
in	O
vitro	O
(	O
cell	O
migration	O
,	O
invasion	O
,	O
anoikis	O
resistance	O
,	O
mammosphere	O
formation	O
,	O
gene1s	ARG2
ALDH	ARG2
gene1e	ARG2
activity	O
,	O
and	O
expression	O
of	O
the	O
gene1s	ARG2
CD44	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
CD24	ARG2
gene1e	ARG2
cell	O
surface	O
markers	O
)	O
and	O
in	O
vivo	O
(	O
tumor	O
formation	O
in	O
species1s	O
mice	O
species1e	O
using	O
limiting	O
dilution	O
transplantation	O
assays	O
)	O
were	O
evaluated	O
.	O
RNA	O
sequencing	O
was	O
performed	O
to	O
identify	O
global	O
gene	O
expression	O
changes	O
after	O
gene1s	ARG2
ADAM12	ARG2
gene1e	ARG2
knockdown	O
.	O
RESULTS	O
:	O
We	O
found	O
that	O
sorted	O
arg1s	O
SUM159PT	O
arg1e	O
cell	O
populations	O
with	O
high	O
gene1s	ARG2
ADAM12	ARG2
gene1e	ARG2
levels	O
had	O
elevated	O
expression	O
of	O
CSC	O
markers	O
and	O
an	O
increased	O
ability	O
to	O
form	O
mammospheres	O
.	O
gene1s	ARG2
ADAM12	ARG2
gene1e	ARG2
knockdown	O
reduced	O
cell	O
migration	O
and	O
invasion	O
,	O
decreased	O
anoikis	O
resistance	O
,	O
and	O
compromised	O
mammosphere	O
formation	O
.	O
gene1s	ARG2
ADAM12	ARG2
gene1e	ARG2
knockdown	O
also	O
diminished	O
ALDEFLUOR(+	O
)	O
and	O
gene1s	ARG2
CD44	ARG2
gene1e	ARG2
(hi)/	O
gene1s	ARG2
CD24	ARG2
gene1e	ARG2
(-/lo	O
)	O
CSC	O
-	O
enriched	O
populations	O
in	O
vitro	O
and	O
reduced	O
tumorigenesis	O
in	O
species1s	O
mice	O
species1e	O
in	O
vivo	O
.	O
RNA	O
sequencing	O
identified	O
a	O
significant	O
overlap	O
between	O
gene1s	ARG2
ADAM12	ARG2
gene1e	ARG2
-	O
and	O
gene1s	ARG2
Epidermal	ARG2
Growth	ARG2
Factor	ARG2
Receptor	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
EGFR	ARG2
gene1e	ARG2
)-regulated	O
genes	O
.	O
Consequently	O
,	O
gene1s	ARG2
ADAM12	ARG2
gene1e	ARG2
knockdown	O
lowered	O
the	O
basal	O
activation	O
level	O
of	O
gene1s	ARG2
EGFR	ARG2
gene1e	ARG2
,	O
and	O
this	O
effect	O
was	O
abolished	O
by	O
batimastat	O
,	O
a	O
metalloproteinase	O
inhibitor	O
.	O
Furthermore	O
,	O
incubation	O
of	O
cells	O
with	O
exogenously	O
added	O
EGF	O
prevented	O
the	O
downregulation	O
of	O
gene1s	ARG2
CD44	ARG2
gene1e	ARG2
(hi)/	O
gene1s	ARG2
CD24	ARG2
gene1e	ARG2
(-/lo	O
)	O
cell	O
population	O
by	O
gene1s	ARG2
ADAM12	ARG2
gene1e	ARG2
knockdown	O
.	O
CONCLUSIONS	O
:	O
These	O
results	O
indicate	O
that	O
gene1s	ARG2
ADAM12	ARG2
gene1e	ARG2
actively	O
supports	O
the	O
CSC	O
phenotype	O
in	O
gene1s	ARG2
claudin	ARG2
gene1e	ARG2
-	O
low	O
breast	O
cancer	O
cells	O
via	O
modulation	O
of	O
the	O
gene1s	ARG2
EGFR	ARG2
gene1e	ARG2
pathway	O
.	O

gene1s	O
Metalloprotease	O
-	O
disintegrin	O
gene1e	O
gene1s	O
ADAM12	O
gene1e	O
actively	O
promotes	O
the	O
stem	O
cell	O
-	O
like	O
phenotype	O
in	O
gene1s	O
claudin	O
gene1e	O
-	O
low	O
breast	O
cancer	O
.	O
BACKGROUND	O
:	O
gene1s	O
ADAM12	O
gene1e	O
is	O
upregulated	O
in	O
species1s	O
human	O
species1e	O
breast	O
cancers	O
and	O
is	O
a	O
predictor	O
of	O
chemoresistance	O
in	O
gene1s	O
estrogen	O
receptor	O
gene1e	O
-	O
negative	O
tumors	O
.	O
gene1s	O
ADAM12	O
gene1e	O
is	O
induced	O
during	O
epithelial	O
-	O
to	O
-	O
mesenchymal	O
transition	O
,	O
a	O
feature	O
associated	O
with	O
gene1s	O
claudin	O
gene1e	O
-	O
low	O
breast	O
tumors	O
,	O
which	O
are	O
enriched	O
in	O
cancer	O
stem	O
cell	O
(	O
CSC	O
)	O
markers	O
.	O
It	O
is	O
currently	O
unknown	O
whether	O
gene1s	O
ADAM12	O
gene1e	O
plays	O
an	O
active	O
role	O
in	O
promoting	O
the	O
CSC	O
phenotype	O
in	O
breast	O
cancer	O
cells	O
.	O
METHODS	O
:	O
gene1s	O
ADAM12	O
gene1e	O
expression	O
was	O
downregulated	O
in	O
representative	O
gene1s	O
claudin	O
gene1e	O
-	O
low	O
breast	O
cancer	O
cell	O
lines	O
,	O
SUM159PT	O
and	O
Hs578	O
T	O
,	O
using	O
siRNA	O
transfection	O
or	O
inducible	O
shRNA	O
expression	O
.	O
Cell	O
characteristics	O
commonly	O
associated	O
with	O
the	O
CSC	O
phenotype	O
in	O
vitro	O
(	O
cell	O
migration	O
,	O
invasion	O
,	O
anoikis	O
resistance	O
,	O
mammosphere	O
formation	O
,	O
gene1s	O
ALDH	O
gene1e	O
activity	O
,	O
and	O
expression	O
of	O
the	O
gene1s	O
CD44	O
gene1e	O
and	O
gene1s	O
CD24	O
gene1e	O
cell	O
surface	O
markers	O
)	O
and	O
in	O
vivo	O
(	O
tumor	O
formation	O
in	O
arg1s	O
mice	O
arg1e	O
using	O
limiting	O
dilution	O
transplantation	O
assays	O
)	O
were	O
evaluated	O
.	O
RNA	O
sequencing	O
was	O
performed	O
to	O
identify	O
global	O
gene	O
expression	O
changes	O
after	O
gene1s	O
ADAM12	O
gene1e	O
knockdown	O
.	O
RESULTS	O
:	O
We	O
found	O
that	O
sorted	O
species1s	O
SUM159PT	O
species1e	O
cell	O
populations	O
with	O
high	O
gene1s	O
ADAM12	O
gene1e	O
levels	O
had	O
elevated	O
expression	O
of	O
CSC	O
markers	O
and	O
an	O
increased	O
ability	O
to	O
form	O
mammospheres	O
.	O
gene1s	O
ADAM12	O
gene1e	O
knockdown	O
reduced	O
cell	O
migration	O
and	O
invasion	O
,	O
decreased	O
anoikis	O
resistance	O
,	O
and	O
compromised	O
mammosphere	O
formation	O
.	O
gene1s	O
ADAM12	O
gene1e	O
knockdown	O
also	O
diminished	O
ALDEFLUOR(+	O
)	O
and	O
gene1s	O
CD44	O
gene1e	O
(hi)/	O
gene1s	O
CD24	O
gene1e	O
(-/lo	O
)	O
CSC	O
-	O
enriched	O
populations	O
in	O
vitro	O
and	O
reduced	O
tumorigenesis	O
in	O
arg1s	O
mice	O
arg1e	O
in	O
vivo	O
.	O
RNA	O
sequencing	O
identified	O
a	O
significant	O
overlap	O
between	O
gene1s	O
ADAM12	O
gene1e	O
-	O
and	O
gene1s	O
Epidermal	O
Growth	O
Factor	O
Receptor	O
gene1e	O
(	O
gene1s	O
EGFR	O
gene1e	O
)-regulated	O
genes	O
.	O
Consequently	O
,	O
gene1s	O
ADAM12	O
gene1e	O
knockdown	O
lowered	O
the	O
basal	O
activation	O
level	O
of	O
gene1s	O
EGFR	O
gene1e	O
,	O
and	O
this	O
effect	O
was	O
abolished	O
by	O
batimastat	O
,	O
a	O
metalloproteinase	O
inhibitor	O
.	O
Furthermore	O
,	O
incubation	O
of	O
cells	O
with	O
exogenously	O
added	O
EGF	O
prevented	O
the	O
downregulation	O
of	O
gene1s	O
CD44	O
gene1e	O
(hi)/	O
gene1s	O
CD24	O
gene1e	O
(-/lo	O
)	O
cell	O
population	O
by	O
gene1s	O
ADAM12	O
gene1e	O
knockdown	O
.	O
CONCLUSIONS	O
:	O
These	O
results	O
indicate	O
that	O
gene1s	O
ADAM12	O
gene1e	O
actively	O
supports	O
the	O
CSC	O
phenotype	O
in	O
gene1s	O
claudin	O
gene1e	O
-	O
low	O
breast	O
cancer	O
cells	O
via	O
modulation	O
of	O
the	O
gene1s	O
EGFR	O
gene1e	O
pathway	O
.	O

gene1s	ARG2
Protein	ARG2
kinase	ARG2
C	ARG2
alpha	ARG2
gene1e	ARG2
-	O
dependent	O
signaling	O
mediates	O
endometrial	O
cancer	O
cell	O
growth	O
and	O
tumorigenesis	O
.	O
Endometrial	O
cancer	O
is	O
the	O
most	O
common	O
invasive	O
gynecologic	O
malignancy	O
,	O
yet	O
molecular	O
mechanisms	O
and	O
signaling	O
pathways	O
underlying	O
its	O
etiology	O
and	O
pathophysiology	O
remain	O
poorly	O
characterized	O
.	O
We	O
sought	O
to	O
define	O
a	O
functional	O
role	O
for	O
the	O
gene1s	ARG2
protein	ARG2
kinase	ARG2
C	ARG2
gene1e	ARG2
(	O
PKC	O
)	O
isoform	O
,	O
gene1s	ARG2
PKCalpha	ARG2
gene1e	ARG2
,	O
in	O
an	O
established	O
cell	O
model	O
of	O
endometrial	O
adenocarcinoma	O
.	O
arg1s	O
Ishikawa	O
arg1e	O
cells	O
depleted	O
of	O
gene1s	ARG2
PKCalpha	ARG2
gene1e	ARG2
protein	O
grew	O
slower	O
,	O
formed	O
fewer	O
colonies	O
in	O
anchorage	O
-	O
independent	O
growth	O
assays	O
and	O
exhibited	O
impaired	O
xenograft	O
tumor	O
formation	O
in	O
species1s	O
nude	O
mice	O
species1e	O
.	O
Consistent	O
with	O
impaired	O
growth	O
,	O
gene1s	ARG2
PKCalpha	ARG2
gene1e	ARG2
knockdown	O
increased	O
levels	O
of	O
the	O
gene1s	ARG2
cyclin	ARG2
-	ARG2
dependent	ARG2
kinase	ARG2
(	ARG2
CDK	ARG2
)	ARG2
inhibitors	ARG2
gene1e	ARG2
gene1s	ARG2
p21(Cip1	ARG2
/	ARG2
WAF1	ARG2
)	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
p21	ARG2
gene1e	ARG2
)	O
and	O
gene1s	ARG2
p27(Kip1	ARG2
)	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
p27	ARG2
gene1e	ARG2
)	O
.	O
Despite	O
the	O
absence	O
of	O
functional	O
gene1s	ARG2
phosphatase	ARG2
and	ARG2
tensin	ARG2
homolog	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
PTEN	ARG2
gene1e	ARG2
)	O
protein	O
in	O
arg1s	O
Ishikawa	O
arg1e	O
cells	O
,	O
gene1s	ARG2
PKCalpha	ARG2
gene1e	ARG2
knockdown	O
reduced	O
gene1s	ARG2
Akt	ARG2
gene1e	ARG2
phosphorylation	O
at	O
serine	O
473	O
and	O
concomitantly	O
inhibited	O
phosphorylation	O
of	O
the	O
gene1s	ARG2
Akt	ARG2
gene1e	ARG2
target	O
,	O
gene1s	ARG2
glycogen	ARG2
synthase	ARG2
kinase-3beta	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
GSK-3beta	ARG2
gene1e	ARG2
)	O
.	O
gene1s	ARG2
PKCalpha	ARG2
gene1e	ARG2
knockdown	O
also	O
resulted	O
in	O
decreased	O
basal	O
gene1s	ARG2
ERK	ARG2
gene1e	ARG2
phosphorylation	O
and	O
attenuated	O
gene1s	ARG2
ERK	ARG2
gene1e	ARG2
activation	O
following	O
EGF	O
stimulation	O
.	O
gene1s	ARG2
p21	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
p27	ARG2
gene1e	ARG2
expression	O
was	O
not	O
increased	O
by	O
treatment	O
of	O
arg1s	O
Ishikawa	O
arg1e	O
cells	O
with	O
gene1s	ARG2
ERK	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
Akt	ARG2
gene1e	ARG2
inhibitors	O
,	O
suggesting	O
that	O
gene1s	ARG2
PKCalpha	ARG2
gene1e	ARG2
regulates	O
gene1s	ARG2
CDK	ARG2
gene1e	ARG2
expression	O
independently	O
of	O
gene1s	ARG2
Akt	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
ERK	ARG2
gene1e	ARG2
.	O
Immunohistochemical	O
analysis	O
of	O
Grade	O
1	O
endometrioid	O
adenocarcinoma	O
revealed	O
aberrant	O
gene1s	ARG2
PKCalpha	ARG2
gene1e	ARG2
expression	O
,	O
with	O
foci	O
of	O
elevated	O
gene1s	ARG2
PKCalpha	ARG2
gene1e	ARG2
staining	O
,	O
not	O
observed	O
in	O
normal	O
endometrium	O
.	O
These	O
studies	O
demonstrate	O
a	O
critical	O
role	O
for	O
gene1s	ARG2
PKCalpha	ARG2
gene1e	ARG2
signaling	O
in	O
endometrial	O
tumorigenesis	O
by	O
regulating	O
expression	O
of	O
CDK	O
inhibitors	O
gene1s	ARG2
p21	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
p27	ARG2
gene1e	ARG2
and	O
activation	O
of	O
gene1s	ARG2
Akt	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
ERK	ARG2
gene1e	ARG2
-	O
dependent	O
proliferative	O
pathways	O
.	O
Thus	O
,	O
targeting	O
gene1s	ARG2
PKCalpha	ARG2
gene1e	ARG2
may	O
provide	O
novel	O
therapeutic	O
options	O
in	O
endometrial	O
tumors	O
.	O

gene1s	O
Protein	O
kinase	O
C	O
alpha	O
gene1e	O
-	O
dependent	O
signaling	O
mediates	O
endometrial	O
cancer	O
cell	O
growth	O
and	O
tumorigenesis	O
.	O
Endometrial	O
cancer	O
is	O
the	O
most	O
common	O
invasive	O
gynecologic	O
malignancy	O
,	O
yet	O
molecular	O
mechanisms	O
and	O
signaling	O
pathways	O
underlying	O
its	O
etiology	O
and	O
pathophysiology	O
remain	O
poorly	O
characterized	O
.	O
We	O
sought	O
to	O
define	O
a	O
functional	O
role	O
for	O
the	O
gene1s	O
protein	O
kinase	O
C	O
gene1e	O
(	O
PKC	O
)	O
isoform	O
,	O
gene1s	O
PKCalpha	O
gene1e	O
,	O
in	O
an	O
established	O
cell	O
model	O
of	O
endometrial	O
adenocarcinoma	O
.	O
species1s	O
Ishikawa	O
species1e	O
cells	O
depleted	O
of	O
gene1s	O
PKCalpha	O
gene1e	O
protein	O
grew	O
slower	O
,	O
formed	O
fewer	O
colonies	O
in	O
anchorage	O
-	O
independent	O
growth	O
assays	O
and	O
exhibited	O
impaired	O
xenograft	O
tumor	O
formation	O
in	O
arg1s	O
nude	O
mice	O
arg1e	O
.	O
Consistent	O
with	O
impaired	O
growth	O
,	O
gene1s	O
PKCalpha	O
gene1e	O
knockdown	O
increased	O
levels	O
of	O
the	O
gene1s	O
cyclin	O
-	O
dependent	O
kinase	O
(	O
CDK	O
)	O
inhibitors	O
gene1e	O
gene1s	O
p21(Cip1	O
/	O
WAF1	O
)	O
gene1e	O
(	O
gene1s	O
p21	O
gene1e	O
)	O
and	O
gene1s	O
p27(Kip1	O
)	O
gene1e	O
(	O
gene1s	O
p27	O
gene1e	O
)	O
.	O
Despite	O
the	O
absence	O
of	O
functional	O
gene1s	O
phosphatase	O
and	O
tensin	O
homolog	O
gene1e	O
(	O
gene1s	O
PTEN	O
gene1e	O
)	O
protein	O
in	O
species1s	O
Ishikawa	O
species1e	O
cells	O
,	O
gene1s	O
PKCalpha	O
gene1e	O
knockdown	O
reduced	O
gene1s	O
Akt	O
gene1e	O
phosphorylation	O
at	O
serine	O
473	O
and	O
concomitantly	O
inhibited	O
phosphorylation	O
of	O
the	O
gene1s	O
Akt	O
gene1e	O
target	O
,	O
gene1s	O
glycogen	O
synthase	O
kinase-3beta	O
gene1e	O
(	O
gene1s	O
GSK-3beta	O
gene1e	O
)	O
.	O
gene1s	O
PKCalpha	O
gene1e	O
knockdown	O
also	O
resulted	O
in	O
decreased	O
basal	O
gene1s	O
ERK	O
gene1e	O
phosphorylation	O
and	O
attenuated	O
gene1s	O
ERK	O
gene1e	O
activation	O
following	O
EGF	O
stimulation	O
.	O
gene1s	O
p21	O
gene1e	O
and	O
gene1s	O
p27	O
gene1e	O
expression	O
was	O
not	O
increased	O
by	O
treatment	O
of	O
species1s	O
Ishikawa	O
species1e	O
cells	O
with	O
gene1s	O
ERK	O
gene1e	O
and	O
gene1s	O
Akt	O
gene1e	O
inhibitors	O
,	O
suggesting	O
that	O
gene1s	O
PKCalpha	O
gene1e	O
regulates	O
gene1s	O
CDK	O
gene1e	O
expression	O
independently	O
of	O
gene1s	O
Akt	O
gene1e	O
and	O
gene1s	O
ERK	O
gene1e	O
.	O
Immunohistochemical	O
analysis	O
of	O
Grade	O
1	O
endometrioid	O
adenocarcinoma	O
revealed	O
aberrant	O
gene1s	O
PKCalpha	O
gene1e	O
expression	O
,	O
with	O
foci	O
of	O
elevated	O
gene1s	O
PKCalpha	O
gene1e	O
staining	O
,	O
not	O
observed	O
in	O
normal	O
endometrium	O
.	O
These	O
studies	O
demonstrate	O
a	O
critical	O
role	O
for	O
gene1s	O
PKCalpha	O
gene1e	O
signaling	O
in	O
endometrial	O
tumorigenesis	O
by	O
regulating	O
expression	O
of	O
CDK	O
inhibitors	O
gene1s	O
p21	O
gene1e	O
and	O
gene1s	O
p27	O
gene1e	O
and	O
activation	O
of	O
gene1s	O
Akt	O
gene1e	O
and	O
gene1s	O
ERK	O
gene1e	O
-	O
dependent	O
proliferative	O
pathways	O
.	O
Thus	O
,	O
targeting	O
gene1s	O
PKCalpha	O
gene1e	O
may	O
provide	O
novel	O
therapeutic	O
options	O
in	O
endometrial	O
tumors	O
.	O

gene1s	ARG2
H3	ARG2
histamine	ARG2
receptor	ARG2
gene1e	ARG2
-	O
mediated	O
activation	O
of	O
gene1s	ARG2
protein	ARG2
kinase	ARG2
Calpha	ARG2
gene1e	ARG2
inhibits	O
the	O
growth	O
of	O
cholangiocarcinoma	O
in	O
vitro	O
and	O
in	O
vivo	O
.	O
Histamine	O
regulates	O
functions	O
via	O
four	O
receptors	O
(	O
gene1s	ARG2
HRH1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
HRH2	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
HRH3	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
HRH4	ARG2
gene1e	ARG2
)	O
.	O
The	O
d	O
-	O
myo	O
-	O
inositol	O
1,4,5-trisphosphate	O
(	O
IP(3))/Ca(2+)/	O
gene1s	ARG2
protein	ARG2
kinase	ARG2
C	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
PKC	ARG2
gene1e	ARG2
)/	O
gene1s	ARG2
mitogen	ARG2
-	ARG2
activated	ARG2
protein	ARG2
kinase	ARG2
gene1e	ARG2
pathway	O
regulates	O
cholangiocarcinoma	O
growth	O
.	O
We	O
evaluated	O
the	O
role	O
of	O
gene1s	ARG2
HRH3	ARG2
gene1e	ARG2
in	O
the	O
regulation	O
of	O
cholangiocarcinoma	O
growth	O
.	O
Expression	O
of	O
gene1s	ARG2
HRH3	ARG2
gene1e	ARG2
in	O
intrahepatic	O
and	O
extrahepatic	O
cell	O
lines	O
,	O
normal	O
cholangiocytes	O
,	O
and	O
arg1s	O
human	O
arg1e	O
tissue	O
arrays	O
was	O
measured	O
.	O
In	O
arg1s	O
Mz	O
-	O
ChA-1	O
arg1e	O
cells	O
stimulated	O
with	O
(	O
R)-(alpha)-(-)-methylhistamine	O
dihydrobromide	O
(	O
RAMH	O
)	O
,	O
we	O
measured	O
(	O
a	O
)	O
cell	O
growth	O
,	O
(	O
b	O
)	O
IP(3	O
)	O
and	O
cyclic	O
AMP	O
levels	O
,	O
and	O
(	O
c	O
)	O
phosphorylation	O
of	O
gene1s	ARG2
PKC	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
mitogen	ARG2
-	ARG2
activated	ARG2
protein	ARG2
kinase	ARG2
gene1e	ARG2
isoforms	O
.	O
Localization	O
of	O
gene1s	ARG2
PKCalpha	ARG2
gene1e	ARG2
was	O
visualized	O
by	O
immunofluorescence	O
in	O
cell	O
smears	O
and	O
immunoblotting	O
for	O
gene1s	ARG2
PKCalpha	ARG2
gene1e	ARG2
in	O
cytosol	O
and	O
membrane	O
fractions	O
.	O
Following	O
knockdown	O
of	O
gene1s	ARG2
PKCalpha	ARG2
gene1e	ARG2
,	O
arg1s	O
Mz	O
-	O
ChA-1	O
arg1e	O
cells	O
were	O
stimulated	O
with	O
RAMH	O
before	O
evaluating	O
cell	O
growth	O
and	O
gene1s	ARG2
extracellular	ARG2
signal	ARG2
-	ARG2
regulated	ARG2
kinase	ARG2
(	ARG2
ERK)-1/2	ARG2
gene1e	ARG2
phosphorylation	O
.	O
In	O
vivo	O
experiments	O
were	O
done	O
in	O
BALB	O
/	O
c	O
species1s	O
nude	O
mice	O
species1e	O
.	O
species1s	O
Mice	O
species1e	O
were	O
treated	O
with	O
saline	O
or	O
RAMH	O
for	O
44	O
days	O
and	O
tumor	O
volume	O
was	O
measured	O
.	O
Tumors	O
were	O
excised	O
and	O
evaluated	O
for	O
proliferation	O
,	O
apoptosis	O
,	O
and	O
expression	O
of	O
gene1s	ARG2
PKCalpha	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
vascular	ARG2
endothelial	ARG2
growth	ARG2
factor	ARG2
(	ARG2
VEGF)-A	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
VEGF	ARG2
-	ARG2
C	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
VEGF	ARG2
receptor	ARG2
2	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
VEGF	ARG2
receptor	ARG2
3	ARG2
gene1e	ARG2
.	O
gene1s	ARG2
HRH3	ARG2
gene1e	ARG2
expression	O
was	O
found	O
in	O
all	O
cells	O
.	O
RAMH	O
inhibited	O
the	O
growth	O
of	O
cholangiocarcinoma	O
cells	O
.	O
RAMH	O
increased	O
IP(3	O
)	O
levels	O
and	O
gene1s	ARG2
PKCalpha	ARG2
gene1e	ARG2
phosphorylation	O
and	O
decreased	O
gene1s	ARG2
ERK1/2	ARG2
gene1e	ARG2
phosphorylation	O
.	O
RAMH	O
induced	O
a	O
shift	O
in	O
the	O
localization	O
of	O
gene1s	ARG2
PKCalpha	ARG2
gene1e	ARG2
expression	O
from	O
the	O
cytosolic	O
domain	O
into	O
the	O
membrane	O
region	O
of	O
arg1s	O
Mz	O
-	O
ChA-1	O
arg1e	O
cells	O
.	O
Silencing	O
of	O
gene1s	ARG2
PKCalpha	ARG2
gene1e	ARG2
prevented	O
RAMH	O
inhibition	O
of	O
arg1s	O
Mz	O
-	O
ChA-1	O
arg1e	O
cell	O
growth	O
and	O
ablated	O
RAMH	O
effects	O
on	O
gene1s	ARG2
ERK1/2	ARG2
gene1e	ARG2
phosphorylation	O
.	O
In	O
vivo	O
,	O
RAMH	O
decreased	O
tumor	O
growth	O
and	O
expression	O
of	O
gene1s	ARG2
VEGF	ARG2
gene1e	ARG2
and	O
its	O
receptors	O
;	O
gene1s	ARG2
PKCalpha	ARG2
gene1e	ARG2
expression	O
was	O
increased	O
.	O
RAMH	O
inhibits	O
cholangiocarcinoma	O
growth	O
by	O
gene1s	ARG2
PKCalpha	ARG2
gene1e	ARG2
-	O
dependent	O
gene1s	ARG2
ERK1/2	ARG2
gene1e	ARG2
dephosphorylation	O
.	O
Modulation	O
of	O
gene1s	ARG2
PKCalpha	ARG2
gene1e	ARG2
by	O
gene1s	ARG2
histamine	ARG2
receptors	ARG2
gene1e	ARG2
may	O
be	O
important	O
in	O
regulating	O
cholangiocarcinoma	O
growth	O
.	O

gene1s	O
H3	O
histamine	O
receptor	O
gene1e	O
-	O
mediated	O
activation	O
of	O
gene1s	O
protein	O
kinase	O
Calpha	O
gene1e	O
inhibits	O
the	O
growth	O
of	O
cholangiocarcinoma	O
in	O
vitro	O
and	O
in	O
vivo	O
.	O
Histamine	O
regulates	O
functions	O
via	O
four	O
receptors	O
(	O
gene1s	O
HRH1	O
gene1e	O
,	O
gene1s	O
HRH2	O
gene1e	O
,	O
gene1s	O
HRH3	O
gene1e	O
,	O
and	O
gene1s	O
HRH4	O
gene1e	O
)	O
.	O
The	O
d	O
-	O
myo	O
-	O
inositol	O
1,4,5-trisphosphate	O
(	O
IP(3))/Ca(2+)/	O
gene1s	O
protein	O
kinase	O
C	O
gene1e	O
(	O
gene1s	O
PKC	O
gene1e	O
)/	O
gene1s	O
mitogen	O
-	O
activated	O
protein	O
kinase	O
gene1e	O
pathway	O
regulates	O
cholangiocarcinoma	O
growth	O
.	O
We	O
evaluated	O
the	O
role	O
of	O
gene1s	O
HRH3	O
gene1e	O
in	O
the	O
regulation	O
of	O
cholangiocarcinoma	O
growth	O
.	O
Expression	O
of	O
gene1s	O
HRH3	O
gene1e	O
in	O
intrahepatic	O
and	O
extrahepatic	O
cell	O
lines	O
,	O
normal	O
cholangiocytes	O
,	O
and	O
species1s	O
human	O
species1e	O
tissue	O
arrays	O
was	O
measured	O
.	O
In	O
species1s	O
Mz	O
-	O
ChA-1	O
species1e	O
cells	O
stimulated	O
with	O
(	O
R)-(alpha)-(-)-methylhistamine	O
dihydrobromide	O
(	O
RAMH	O
)	O
,	O
we	O
measured	O
(	O
a	O
)	O
cell	O
growth	O
,	O
(	O
b	O
)	O
IP(3	O
)	O
and	O
cyclic	O
AMP	O
levels	O
,	O
and	O
(	O
c	O
)	O
phosphorylation	O
of	O
gene1s	O
PKC	O
gene1e	O
and	O
gene1s	O
mitogen	O
-	O
activated	O
protein	O
kinase	O
gene1e	O
isoforms	O
.	O
Localization	O
of	O
gene1s	O
PKCalpha	O
gene1e	O
was	O
visualized	O
by	O
immunofluorescence	O
in	O
cell	O
smears	O
and	O
immunoblotting	O
for	O
gene1s	O
PKCalpha	O
gene1e	O
in	O
cytosol	O
and	O
membrane	O
fractions	O
.	O
Following	O
knockdown	O
of	O
gene1s	O
PKCalpha	O
gene1e	O
,	O
species1s	O
Mz	O
-	O
ChA-1	O
species1e	O
cells	O
were	O
stimulated	O
with	O
RAMH	O
before	O
evaluating	O
cell	O
growth	O
and	O
gene1s	O
extracellular	O
signal	O
-	O
regulated	O
kinase	O
(	O
ERK)-1/2	O
gene1e	O
phosphorylation	O
.	O
In	O
vivo	O
experiments	O
were	O
done	O
in	O
BALB	O
/	O
c	O
arg1s	O
nude	O
mice	O
arg1e	O
.	O
arg1s	O
Mice	O
arg1e	O
were	O
treated	O
with	O
saline	O
or	O
RAMH	O
for	O
44	O
days	O
and	O
tumor	O
volume	O
was	O
measured	O
.	O
Tumors	O
were	O
excised	O
and	O
evaluated	O
for	O
proliferation	O
,	O
apoptosis	O
,	O
and	O
expression	O
of	O
gene1s	O
PKCalpha	O
gene1e	O
,	O
gene1s	O
vascular	O
endothelial	O
growth	O
factor	O
(	O
VEGF)-A	O
gene1e	O
,	O
gene1s	O
VEGF	O
-	O
C	O
gene1e	O
,	O
gene1s	O
VEGF	O
receptor	O
2	O
gene1e	O
,	O
and	O
gene1s	O
VEGF	O
receptor	O
3	O
gene1e	O
.	O
gene1s	O
HRH3	O
gene1e	O
expression	O
was	O
found	O
in	O
all	O
cells	O
.	O
RAMH	O
inhibited	O
the	O
growth	O
of	O
cholangiocarcinoma	O
cells	O
.	O
RAMH	O
increased	O
IP(3	O
)	O
levels	O
and	O
gene1s	O
PKCalpha	O
gene1e	O
phosphorylation	O
and	O
decreased	O
gene1s	O
ERK1/2	O
gene1e	O
phosphorylation	O
.	O
RAMH	O
induced	O
a	O
shift	O
in	O
the	O
localization	O
of	O
gene1s	O
PKCalpha	O
gene1e	O
expression	O
from	O
the	O
cytosolic	O
domain	O
into	O
the	O
membrane	O
region	O
of	O
species1s	O
Mz	O
-	O
ChA-1	O
species1e	O
cells	O
.	O
Silencing	O
of	O
gene1s	O
PKCalpha	O
gene1e	O
prevented	O
RAMH	O
inhibition	O
of	O
species1s	O
Mz	O
-	O
ChA-1	O
species1e	O
cell	O
growth	O
and	O
ablated	O
RAMH	O
effects	O
on	O
gene1s	O
ERK1/2	O
gene1e	O
phosphorylation	O
.	O
In	O
vivo	O
,	O
RAMH	O
decreased	O
tumor	O
growth	O
and	O
expression	O
of	O
gene1s	O
VEGF	O
gene1e	O
and	O
its	O
receptors	O
;	O
gene1s	O
PKCalpha	O
gene1e	O
expression	O
was	O
increased	O
.	O
RAMH	O
inhibits	O
cholangiocarcinoma	O
growth	O
by	O
gene1s	O
PKCalpha	O
gene1e	O
-	O
dependent	O
gene1s	O
ERK1/2	O
gene1e	O
dephosphorylation	O
.	O
Modulation	O
of	O
gene1s	O
PKCalpha	O
gene1e	O
by	O
gene1s	O
histamine	O
receptors	O
gene1e	O
may	O
be	O
important	O
in	O
regulating	O
cholangiocarcinoma	O
growth	O
.	O

gene1s	ARG2
Pleomorphic	ARG2
adenoma	ARG2
gene	ARG2
like-2	ARG2
gene1e	ARG2
induces	O
epithelial	O
-	O
mesenchymal	O
transition	O
via	O
gene1s	ARG2
Wnt	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
b	ARG2
-	ARG2
catenin	ARG2
gene1e	ARG2
signaling	O
pathway	O
in	O
arg1s	O
human	O
arg1e	O
colorectal	O
adenocarcinoma	O
.	O
Epithelial	O
-	O
mesenchymal	O
transition	O
(	O
EMT	O
)	O
is	O
a	O
critical	O
step	O
in	O
the	O
acquisition	O
of	O
metastatic	O
and	O
invasive	O
power	O
for	O
tumor	O
cells	O
.	O
Colorectal	O
adenocarcinoma	O
(	O
CRC	O
)	O
is	O
a	O
common	O
cancer	O
where	O
metastasis	O
is	O
directly	O
linked	O
to	O
arg1s	O
patient	O
arg1e	O
survival	O
.	O
Recent	O
studies	O
show	O
that	O
gene1s	ARG2
pleomorphic	ARG2
adenoma	ARG2
gene	ARG2
like-2	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
PLAGL2	ARG2
gene1e	ARG2
)	O
could	O
induce	O
tumor	O
EMT	O
and	O
is	O
an	O
independent	O
predictive	O
factor	O
associated	O
with	O
poor	O
prognosis	O
in	O
cancer	O
.	O
In	O
the	O
present	O
study	O
,	O
we	O
confirmed	O
the	O
role	O
of	O
gene1s	ARG2
PLAGL2	ARG2
gene1e	ARG2
in	O
the	O
prognosis	O
of	O
CRC	O
arg1s	O
patients	O
arg1e	O
and	O
provide	O
molecular	O
evidence	O
of	O
gene1s	ARG2
PLAGL2	ARG2
gene1e	ARG2
promoted	O
EMT	O
in	O
CRC	O
cell	O
line	O
SW480	O
.	O
We	O
found	O
that	O
gene1s	ARG2
PLAGL2	ARG2
gene1e	ARG2
expression	O
was	O
upregulated	O
in	O
the	O
paraffin	O
-	O
embedded	O
CRC	O
tissues	O
compared	O
to	O
borderline	O
or	O
benign	O
tissues	O
.	O
Experimental	O
EMT	O
induced	O
by	O
gene1s	ARG2
PLAGL2	ARG2
gene1e	ARG2
plasmid	O
transfection	O
proved	O
gene1s	ARG2
PLAGL2	ARG2
gene1e	ARG2
protein	O
overexpression	O
could	O
enhance	O
the	O
cell	O
scratch	O
wound	O
-	O
healing	O
and	O
transwell	O
ability	O
and	O
significantly	O
upregulated	O
mesenchymal	O
marker	O
proteins	O
,	O
gene1s	ARG2
N	ARG2
-	ARG2
cadherin	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
vimentin	ARG2
gene1e	ARG2
and	O
concurrently	O
downregulated	O
epithelial	O
marker	O
of	O
gene1s	ARG2
E	ARG2
-	ARG2
cadherin	ARG2
gene1e	ARG2
.	O
Subsequently	O
,	O
through	O
western	O
blot	O
assay	O
,	O
we	O
found	O
that	O
gene1s	ARG2
PLAGL2	ARG2
gene1e	ARG2
could	O
activate	O
the	O
gene1s	ARG2
wnt	ARG2
gene1e	ARG2
-	O
signaling	O
component	O
gene1s	ARG2
b	ARG2
-	ARG2
catenin	ARG2
gene1e	ARG2
in	O
the	O
nuclei	O
.	O
More	O
CRC	O
cell	O
metastasis	O
to	O
the	O
lungs	O
was	O
observed	O
when	O
the	O
gene1s	ARG2
PLAGL2	ARG2
gene1e	ARG2
overexpressing	O
arg1s	O
SW480	O
arg1e	O
cells	O
were	O
injected	O
into	O
the	O
tail	O
vein	O
of	O
species1s	O
rats	O
species1e	O
,	O
compared	O
with	O
the	O
cell	O
control	O
and	O
gene1s	ARG2
PLAGL2	ARG2
gene1e	ARG2
silence	O
group	O
.	O
Our	O
findings	O
indicated	O
that	O
gene1s	ARG2
PLAGL2	ARG2
gene1e	ARG2
might	O
be	O
a	O
very	O
upstream	O
key	O
molecule	O
regulating	O
EMT	O
involved	O
in	O
gene1s	ARG2
Wnt	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
b	ARG2
-	ARG2
catenin	ARG2
gene1e	ARG2
signaling	O
pathway	O
.	O

gene1s	O
Pleomorphic	O
adenoma	O
gene	O
like-2	O
gene1e	O
induces	O
epithelial	O
-	O
mesenchymal	O
transition	O
via	O
gene1s	O
Wnt	O
gene1e	O
/	O
gene1s	O
b	O
-	O
catenin	O
gene1e	O
signaling	O
pathway	O
in	O
species1s	O
human	O
species1e	O
colorectal	O
adenocarcinoma	O
.	O
Epithelial	O
-	O
mesenchymal	O
transition	O
(	O
EMT	O
)	O
is	O
a	O
critical	O
step	O
in	O
the	O
acquisition	O
of	O
metastatic	O
and	O
invasive	O
power	O
for	O
tumor	O
cells	O
.	O
Colorectal	O
adenocarcinoma	O
(	O
CRC	O
)	O
is	O
a	O
common	O
cancer	O
where	O
metastasis	O
is	O
directly	O
linked	O
to	O
species1s	O
patient	O
species1e	O
survival	O
.	O
Recent	O
studies	O
show	O
that	O
gene1s	O
pleomorphic	O
adenoma	O
gene	O
like-2	O
gene1e	O
(	O
gene1s	O
PLAGL2	O
gene1e	O
)	O
could	O
induce	O
tumor	O
EMT	O
and	O
is	O
an	O
independent	O
predictive	O
factor	O
associated	O
with	O
poor	O
prognosis	O
in	O
cancer	O
.	O
In	O
the	O
present	O
study	O
,	O
we	O
confirmed	O
the	O
role	O
of	O
gene1s	O
PLAGL2	O
gene1e	O
in	O
the	O
prognosis	O
of	O
CRC	O
species1s	O
patients	O
species1e	O
and	O
provide	O
molecular	O
evidence	O
of	O
gene1s	O
PLAGL2	O
gene1e	O
promoted	O
EMT	O
in	O
CRC	O
cell	O
line	O
SW480	O
.	O
We	O
found	O
that	O
gene1s	O
PLAGL2	O
gene1e	O
expression	O
was	O
upregulated	O
in	O
the	O
paraffin	O
-	O
embedded	O
CRC	O
tissues	O
compared	O
to	O
borderline	O
or	O
benign	O
tissues	O
.	O
Experimental	O
EMT	O
induced	O
by	O
gene1s	O
PLAGL2	O
gene1e	O
plasmid	O
transfection	O
proved	O
gene1s	O
PLAGL2	O
gene1e	O
protein	O
overexpression	O
could	O
enhance	O
the	O
cell	O
scratch	O
wound	O
-	O
healing	O
and	O
transwell	O
ability	O
and	O
significantly	O
upregulated	O
mesenchymal	O
marker	O
proteins	O
,	O
gene1s	O
N	O
-	O
cadherin	O
gene1e	O
and	O
gene1s	O
vimentin	O
gene1e	O
and	O
concurrently	O
downregulated	O
epithelial	O
marker	O
of	O
gene1s	O
E	O
-	O
cadherin	O
gene1e	O
.	O
Subsequently	O
,	O
through	O
western	O
blot	O
assay	O
,	O
we	O
found	O
that	O
gene1s	O
PLAGL2	O
gene1e	O
could	O
activate	O
the	O
gene1s	O
wnt	O
gene1e	O
-	O
signaling	O
component	O
gene1s	O
b	O
-	O
catenin	O
gene1e	O
in	O
the	O
nuclei	O
.	O
More	O
CRC	O
cell	O
metastasis	O
to	O
the	O
lungs	O
was	O
observed	O
when	O
the	O
gene1s	O
PLAGL2	O
gene1e	O
overexpressing	O
species1s	O
SW480	O
species1e	O
cells	O
were	O
injected	O
into	O
the	O
tail	O
vein	O
of	O
arg1s	O
rats	O
arg1e	O
,	O
compared	O
with	O
the	O
cell	O
control	O
and	O
gene1s	O
PLAGL2	O
gene1e	O
silence	O
group	O
.	O
Our	O
findings	O
indicated	O
that	O
gene1s	O
PLAGL2	O
gene1e	O
might	O
be	O
a	O
very	O
upstream	O
key	O
molecule	O
regulating	O
EMT	O
involved	O
in	O
gene1s	O
Wnt	O
gene1e	O
/	O
gene1s	O
b	O
-	O
catenin	O
gene1e	O
signaling	O
pathway	O
.	O

Regulatory	O
network	O
of	O
inflammation	O
downstream	O
of	O
gene1s	O
proteinase	O
-	O
activated	O
receptors	O
gene1e	O
.	O
BACKGROUND	O
:	O
gene1s	O
Protease	O
-	O
activated	O
receptors	O
gene1e	O
(	O
gene1s	O
PAR	O
gene1e	O
)	O
are	O
present	O
in	O
the	O
urinary	O
bladder	O
,	O
and	O
their	O
expression	O
is	O
altered	O
in	O
response	O
to	O
inflammation	O
.	O
PARs	O
are	O
a	O
unique	O
class	O
of	O
G	O
protein	O
-	O
coupled	O
that	O
carry	O
their	O
own	O
ligands	O
,	O
which	O
remain	O
cryptic	O
until	O
unmasked	O
by	O
proteolytic	O
cleavage	O
.	O
Although	O
the	O
canonical	O
signal	O
transduction	O
pathway	O
downstream	O
of	O
gene1s	O
PAR	O
gene1e	O
activation	O
and	O
coupling	O
with	O
various	O
G	O
proteins	O
is	O
known	O
and	O
leads	O
to	O
the	O
rapid	O
transcription	O
of	O
genes	O
involved	O
in	O
inflammation	O
,	O
the	O
effect	O
of	O
gene1s	O
PAR	O
gene1e	O
activation	O
on	O
the	O
downstream	O
transcriptome	O
is	O
unknown	O
.	O
We	O
have	O
shown	O
that	O
intravesical	O
administration	O
of	O
gene1s	O
PAR	O
gene1e	O
-	O
activating	O
peptides	O
leads	O
to	O
an	O
inflammatory	O
reaction	O
characterized	O
by	O
edema	O
and	O
granulocyte	O
infiltration	O
.	O
Moreover	O
,	O
the	O
inflammatory	O
response	O
to	O
intravesical	O
instillation	O
of	O
known	O
pro	O
-	O
inflammatory	O
stimuli	O
such	O
as	O
arg1s	O
E.	O
coli	O
arg1e	O
lipopolysaccharide	O
(	O
LPS	O
)	O
,	O
substance	O
species1s	O
P	O
(	O
SP	O
)	O
species1e	O
,	O
and	O
antigen	O
was	O
strongly	O
attenuated	O
by	O
gene1s	O
PAR1	O
gene1e	O
-	O
and	O
to	O
a	O
lesser	O
extent	O
by	O
gene1s	O
PAR2	O
gene1e	O
-deficiency	O
.	O
RESULTS	O
:	O
Here	O
,	O
cDNA	O
array	O
experiments	O
determined	O
inflammatory	O
genes	O
whose	O
expression	O
is	O
dependent	O
on	O
gene1s	O
PAR1	O
gene1e	O
activation	O
.	O
For	O
this	O
purpose	O
,	O
we	O
compared	O
the	O
alteration	O
in	O
gene	O
expression	O
in	O
wild	O
type	O
and	O
gene1s	O
PAR1	O
gene1e	O
-/-	O
species1s	O
mice	O
species1e	O
induced	O
by	O
classical	O
pro	O
-	O
inflammatory	O
stimuli	O
(	O
LPS	O
,	O
SP	O
,	O
and	O
antigen	O
)	O
.	O
75	O
transcripts	O
were	O
considered	O
to	O
be	O
dependent	O
on	O
gene1s	O
PAR-1	O
gene1e	O
activation	O
and	O
further	O
annotated	O
in	O
silico	O
by	O
Ingenuity	O
Pathways	O
Analysis	O
(	O
IPA	O
)	O
and	O
gene	O
ontology	O
(	O
GO	O
)	O
.	O
Selected	O
transcripts	O
were	O
target	O
validated	O
by	O
quantitative	O
PCR	O
(	O
Q	O
-	O
PCR	O
)	O
.	O
Among	O
gene1s	O
PAR1	O
gene1e	O
-dependent	O
transcripts	O
,	O
the	O
following	O
have	O
been	O
implicated	O
in	O
the	O
inflammatory	O
process	O
:	O
gene1s	O
b2	O
m	O
gene1e	O
,	O
gene1s	O
ccl7	O
gene1e	O
,	O
gene1s	O
cd200	O
gene1e	O
,	O
gene1s	O
cd63	O
gene1e	O
,	O
cdbpd	O
,	O
gene1s	O
cfl1	O
gene1e	O
,	O
gene1s	O
dusp1	O
gene1e	O
,	O
gene1s	O
fkbp1a	O
gene1e	O
,	O
gene1s	O
fth1	O
gene1e	O
,	O
gene1s	O
hspb1	O
gene1e	O
,	O
gene1s	O
marcksl1	O
gene1e	O
,	O
gene1s	O
mmp2	O
gene1e	O
,	O
gene1s	O
myo5a	O
gene1e	O
,	O
gene1s	O
nfkbia	O
gene1e	O
,	O
gene1s	O
pax1	O
gene1e	O
,	O
gene1s	O
plaur	O
gene1e	O
,	O
gene1s	O
ppia	O
gene1e	O
,	O
gene1s	O
ptpn1	O
gene1e	O
,	O
gene1s	O
ptprcap	O
gene1e	O
,	O
gene1s	O
s100a10	O
gene1e	O
,	O
gene1s	O
sim2	O
gene1e	O
,	O
and	O
gene1s	O
tnfaip2	O
gene1e	O
.	O
However	O
,	O
a	O
balanced	O
response	O
to	O
signals	O
of	O
injury	O
requires	O
a	O
transient	O
cellular	O
activation	O
of	O
a	O
panel	O
of	O
genes	O
together	O
with	O
inhibitory	O
systems	O
that	O
temper	O
the	O
overwhelming	O
inflammation	O
.	O
In	O
this	O
context	O
,	O
the	O
activation	O
of	O
genes	O
such	O
as	O
gene1s	O
dusp1	O
gene1e	O
and	O
gene1s	O
nfkbia	O
gene1e	O
seems	O
to	O
counter	O
-	O
balance	O
the	O
inflammatory	O
response	O
to	O
gene1s	O
PAR	O
gene1e	O
activation	O
by	O
limiting	O
prolonged	O
activation	O
of	O
gene1s	O
p38	O
MAPK	O
gene1e	O
and	O
increased	O
cytokine	O
production	O
.	O
In	O
contrast	O
,	O
transcripts	O
such	O
as	O
gene1s	O
arf6	O
gene1e	O
and	O
gene1s	O
dcnt1	O
gene1e	O
that	O
are	O
involved	O
in	O
the	O
mechanism	O
of	O
gene1s	O
PAR	O
gene1e	O
re	O
-	O
sensitization	O
would	O
tend	O
to	O
perpetuate	O
the	O
inflammatory	O
reaction	O
in	O
response	O
to	O
common	O
pro	O
-	O
inflammatory	O
stimuli	O
.	O
CONCLUSION	O
:	O
The	O
combination	O
of	O
cDNA	O
array	O
results	O
and	O
genomic	O
networks	O
reveals	O
an	O
overriding	O
participation	O
of	O
gene1s	O
PAR1	O
gene1e	O
in	O
bladder	O
inflammation	O
,	O
provides	O
a	O
working	O
model	O
for	O
the	O
involvement	O
of	O
downstream	O
signaling	O
,	O
and	O
evokes	O
testable	O
hypotheses	O
regarding	O
the	O
transcriptome	O
downstream	O
of	O
gene1s	O
PAR1	O
gene1e	O
activation	O
.	O
It	O
remains	O
to	O
be	O
determined	O
whether	O
or	O
not	O
mechanisms	O
targeting	O
gene1s	O
PAR1	O
gene1e	O
gene	O
silencing	O
or	O
gene1s	O
PAR1	O
gene1e	O
blockade	O
will	O
ameliorate	O
the	O
clinical	O
manifestation	O
of	O
cystitis	O
.	O

Regulatory	O
network	O
of	O
inflammation	O
downstream	O
of	O
gene1s	O
proteinase	O
-	O
activated	O
receptors	O
gene1e	O
.	O
BACKGROUND	O
:	O
gene1s	O
Protease	O
-	O
activated	O
receptors	O
gene1e	O
(	O
gene1s	O
PAR	O
gene1e	O
)	O
are	O
present	O
in	O
the	O
urinary	O
bladder	O
,	O
and	O
their	O
expression	O
is	O
altered	O
in	O
response	O
to	O
inflammation	O
.	O
PARs	O
are	O
a	O
unique	O
class	O
of	O
G	O
protein	O
-	O
coupled	O
that	O
carry	O
their	O
own	O
ligands	O
,	O
which	O
remain	O
cryptic	O
until	O
unmasked	O
by	O
proteolytic	O
cleavage	O
.	O
Although	O
the	O
canonical	O
signal	O
transduction	O
pathway	O
downstream	O
of	O
gene1s	O
PAR	O
gene1e	O
activation	O
and	O
coupling	O
with	O
various	O
G	O
proteins	O
is	O
known	O
and	O
leads	O
to	O
the	O
rapid	O
transcription	O
of	O
genes	O
involved	O
in	O
inflammation	O
,	O
the	O
effect	O
of	O
gene1s	O
PAR	O
gene1e	O
activation	O
on	O
the	O
downstream	O
transcriptome	O
is	O
unknown	O
.	O
We	O
have	O
shown	O
that	O
intravesical	O
administration	O
of	O
gene1s	O
PAR	O
gene1e	O
-	O
activating	O
peptides	O
leads	O
to	O
an	O
inflammatory	O
reaction	O
characterized	O
by	O
edema	O
and	O
granulocyte	O
infiltration	O
.	O
Moreover	O
,	O
the	O
inflammatory	O
response	O
to	O
intravesical	O
instillation	O
of	O
known	O
pro	O
-	O
inflammatory	O
stimuli	O
such	O
as	O
species1s	O
E.	O
coli	O
species1e	O
lipopolysaccharide	O
(	O
LPS	O
)	O
,	O
substance	O
arg1s	O
P	O
(	O
SP	O
)	O
arg1e	O
,	O
and	O
antigen	O
was	O
strongly	O
attenuated	O
by	O
gene1s	O
PAR1	O
gene1e	O
-	O
and	O
to	O
a	O
lesser	O
extent	O
by	O
gene1s	O
PAR2	O
gene1e	O
-deficiency	O
.	O
RESULTS	O
:	O
Here	O
,	O
cDNA	O
array	O
experiments	O
determined	O
inflammatory	O
genes	O
whose	O
expression	O
is	O
dependent	O
on	O
gene1s	O
PAR1	O
gene1e	O
activation	O
.	O
For	O
this	O
purpose	O
,	O
we	O
compared	O
the	O
alteration	O
in	O
gene	O
expression	O
in	O
wild	O
type	O
and	O
gene1s	O
PAR1	O
gene1e	O
-/-	O
species1s	O
mice	O
species1e	O
induced	O
by	O
classical	O
pro	O
-	O
inflammatory	O
stimuli	O
(	O
LPS	O
,	O
SP	O
,	O
and	O
antigen	O
)	O
.	O
75	O
transcripts	O
were	O
considered	O
to	O
be	O
dependent	O
on	O
gene1s	O
PAR-1	O
gene1e	O
activation	O
and	O
further	O
annotated	O
in	O
silico	O
by	O
Ingenuity	O
Pathways	O
Analysis	O
(	O
IPA	O
)	O
and	O
gene	O
ontology	O
(	O
GO	O
)	O
.	O
Selected	O
transcripts	O
were	O
target	O
validated	O
by	O
quantitative	O
PCR	O
(	O
Q	O
-	O
PCR	O
)	O
.	O
Among	O
gene1s	O
PAR1	O
gene1e	O
-dependent	O
transcripts	O
,	O
the	O
following	O
have	O
been	O
implicated	O
in	O
the	O
inflammatory	O
process	O
:	O
gene1s	O
b2	O
m	O
gene1e	O
,	O
gene1s	O
ccl7	O
gene1e	O
,	O
gene1s	O
cd200	O
gene1e	O
,	O
gene1s	O
cd63	O
gene1e	O
,	O
cdbpd	O
,	O
gene1s	O
cfl1	O
gene1e	O
,	O
gene1s	O
dusp1	O
gene1e	O
,	O
gene1s	O
fkbp1a	O
gene1e	O
,	O
gene1s	O
fth1	O
gene1e	O
,	O
gene1s	O
hspb1	O
gene1e	O
,	O
gene1s	O
marcksl1	O
gene1e	O
,	O
gene1s	O
mmp2	O
gene1e	O
,	O
gene1s	O
myo5a	O
gene1e	O
,	O
gene1s	O
nfkbia	O
gene1e	O
,	O
gene1s	O
pax1	O
gene1e	O
,	O
gene1s	O
plaur	O
gene1e	O
,	O
gene1s	O
ppia	O
gene1e	O
,	O
gene1s	O
ptpn1	O
gene1e	O
,	O
gene1s	O
ptprcap	O
gene1e	O
,	O
gene1s	O
s100a10	O
gene1e	O
,	O
gene1s	O
sim2	O
gene1e	O
,	O
and	O
gene1s	O
tnfaip2	O
gene1e	O
.	O
However	O
,	O
a	O
balanced	O
response	O
to	O
signals	O
of	O
injury	O
requires	O
a	O
transient	O
cellular	O
activation	O
of	O
a	O
panel	O
of	O
genes	O
together	O
with	O
inhibitory	O
systems	O
that	O
temper	O
the	O
overwhelming	O
inflammation	O
.	O
In	O
this	O
context	O
,	O
the	O
activation	O
of	O
genes	O
such	O
as	O
gene1s	O
dusp1	O
gene1e	O
and	O
gene1s	O
nfkbia	O
gene1e	O
seems	O
to	O
counter	O
-	O
balance	O
the	O
inflammatory	O
response	O
to	O
gene1s	O
PAR	O
gene1e	O
activation	O
by	O
limiting	O
prolonged	O
activation	O
of	O
gene1s	O
p38	O
MAPK	O
gene1e	O
and	O
increased	O
cytokine	O
production	O
.	O
In	O
contrast	O
,	O
transcripts	O
such	O
as	O
gene1s	O
arf6	O
gene1e	O
and	O
gene1s	O
dcnt1	O
gene1e	O
that	O
are	O
involved	O
in	O
the	O
mechanism	O
of	O
gene1s	O
PAR	O
gene1e	O
re	O
-	O
sensitization	O
would	O
tend	O
to	O
perpetuate	O
the	O
inflammatory	O
reaction	O
in	O
response	O
to	O
common	O
pro	O
-	O
inflammatory	O
stimuli	O
.	O
CONCLUSION	O
:	O
The	O
combination	O
of	O
cDNA	O
array	O
results	O
and	O
genomic	O
networks	O
reveals	O
an	O
overriding	O
participation	O
of	O
gene1s	O
PAR1	O
gene1e	O
in	O
bladder	O
inflammation	O
,	O
provides	O
a	O
working	O
model	O
for	O
the	O
involvement	O
of	O
downstream	O
signaling	O
,	O
and	O
evokes	O
testable	O
hypotheses	O
regarding	O
the	O
transcriptome	O
downstream	O
of	O
gene1s	O
PAR1	O
gene1e	O
activation	O
.	O
It	O
remains	O
to	O
be	O
determined	O
whether	O
or	O
not	O
mechanisms	O
targeting	O
gene1s	O
PAR1	O
gene1e	O
gene	O
silencing	O
or	O
gene1s	O
PAR1	O
gene1e	O
blockade	O
will	O
ameliorate	O
the	O
clinical	O
manifestation	O
of	O
cystitis	O
.	O

Regulatory	O
network	O
of	O
inflammation	O
downstream	O
of	O
gene1s	ARG2
proteinase	ARG2
-	ARG2
activated	ARG2
receptors	ARG2
gene1e	ARG2
.	O
BACKGROUND	O
:	O
gene1s	ARG2
Protease	ARG2
-	ARG2
activated	ARG2
receptors	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
PAR	ARG2
gene1e	ARG2
)	O
are	O
present	O
in	O
the	O
urinary	O
bladder	O
,	O
and	O
their	O
expression	O
is	O
altered	O
in	O
response	O
to	O
inflammation	O
.	O
PARs	O
are	O
a	O
unique	O
class	O
of	O
G	O
protein	O
-	O
coupled	O
that	O
carry	O
their	O
own	O
ligands	O
,	O
which	O
remain	O
cryptic	O
until	O
unmasked	O
by	O
proteolytic	O
cleavage	O
.	O
Although	O
the	O
canonical	O
signal	O
transduction	O
pathway	O
downstream	O
of	O
gene1s	ARG2
PAR	ARG2
gene1e	ARG2
activation	O
and	O
coupling	O
with	O
various	O
G	O
proteins	O
is	O
known	O
and	O
leads	O
to	O
the	O
rapid	O
transcription	O
of	O
genes	O
involved	O
in	O
inflammation	O
,	O
the	O
effect	O
of	O
gene1s	ARG2
PAR	ARG2
gene1e	ARG2
activation	O
on	O
the	O
downstream	O
transcriptome	O
is	O
unknown	O
.	O
We	O
have	O
shown	O
that	O
intravesical	O
administration	O
of	O
gene1s	ARG2
PAR	ARG2
gene1e	ARG2
-	O
activating	O
peptides	O
leads	O
to	O
an	O
inflammatory	O
reaction	O
characterized	O
by	O
edema	O
and	O
granulocyte	O
infiltration	O
.	O
Moreover	O
,	O
the	O
inflammatory	O
response	O
to	O
intravesical	O
instillation	O
of	O
known	O
pro	O
-	O
inflammatory	O
stimuli	O
such	O
as	O
species1s	O
E.	O
coli	O
species1e	O
lipopolysaccharide	O
(	O
LPS	O
)	O
,	O
substance	O
species1s	O
P	O
(	O
SP	O
)	O
species1e	O
,	O
and	O
antigen	O
was	O
strongly	O
attenuated	O
by	O
gene1s	ARG2
PAR1	ARG2
gene1e	ARG2
-	O
and	O
to	O
a	O
lesser	O
extent	O
by	O
gene1s	ARG2
PAR2	ARG2
gene1e	ARG2
-deficiency	O
.	O
RESULTS	O
:	O
Here	O
,	O
cDNA	O
array	O
experiments	O
determined	O
inflammatory	O
genes	O
whose	O
expression	O
is	O
dependent	O
on	O
gene1s	ARG2
PAR1	ARG2
gene1e	ARG2
activation	O
.	O
For	O
this	O
purpose	O
,	O
we	O
compared	O
the	O
alteration	O
in	O
gene	O
expression	O
in	O
wild	O
type	O
and	O
gene1s	ARG2
PAR1	ARG2
gene1e	ARG2
-/-	O
arg1s	O
mice	O
arg1e	O
induced	O
by	O
classical	O
pro	O
-	O
inflammatory	O
stimuli	O
(	O
LPS	O
,	O
SP	O
,	O
and	O
antigen	O
)	O
.	O
75	O
transcripts	O
were	O
considered	O
to	O
be	O
dependent	O
on	O
gene1s	ARG2
PAR-1	ARG2
gene1e	ARG2
activation	O
and	O
further	O
annotated	O
in	O
silico	O
by	O
Ingenuity	O
Pathways	O
Analysis	O
(	O
IPA	O
)	O
and	O
gene	O
ontology	O
(	O
GO	O
)	O
.	O
Selected	O
transcripts	O
were	O
target	O
validated	O
by	O
quantitative	O
PCR	O
(	O
Q	O
-	O
PCR	O
)	O
.	O
Among	O
gene1s	ARG2
PAR1	ARG2
gene1e	ARG2
-dependent	O
transcripts	O
,	O
the	O
following	O
have	O
been	O
implicated	O
in	O
the	O
inflammatory	O
process	O
:	O
gene1s	ARG2
b2	ARG2
m	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
ccl7	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
cd200	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
cd63	ARG2
gene1e	ARG2
,	O
cdbpd	O
,	O
gene1s	ARG2
cfl1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
dusp1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
fkbp1a	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
fth1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
hspb1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
marcksl1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
mmp2	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
myo5a	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
nfkbia	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
pax1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
plaur	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
ppia	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
ptpn1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
ptprcap	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
s100a10	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
sim2	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
tnfaip2	ARG2
gene1e	ARG2
.	O
However	O
,	O
a	O
balanced	O
response	O
to	O
signals	O
of	O
injury	O
requires	O
a	O
transient	O
cellular	O
activation	O
of	O
a	O
panel	O
of	O
genes	O
together	O
with	O
inhibitory	O
systems	O
that	O
temper	O
the	O
overwhelming	O
inflammation	O
.	O
In	O
this	O
context	O
,	O
the	O
activation	O
of	O
genes	O
such	O
as	O
gene1s	ARG2
dusp1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
nfkbia	ARG2
gene1e	ARG2
seems	O
to	O
counter	O
-	O
balance	O
the	O
inflammatory	O
response	O
to	O
gene1s	ARG2
PAR	ARG2
gene1e	ARG2
activation	O
by	O
limiting	O
prolonged	O
activation	O
of	O
gene1s	ARG2
p38	ARG2
MAPK	ARG2
gene1e	ARG2
and	O
increased	O
cytokine	O
production	O
.	O
In	O
contrast	O
,	O
transcripts	O
such	O
as	O
gene1s	ARG2
arf6	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
dcnt1	ARG2
gene1e	ARG2
that	O
are	O
involved	O
in	O
the	O
mechanism	O
of	O
gene1s	ARG2
PAR	ARG2
gene1e	ARG2
re	O
-	O
sensitization	O
would	O
tend	O
to	O
perpetuate	O
the	O
inflammatory	O
reaction	O
in	O
response	O
to	O
common	O
pro	O
-	O
inflammatory	O
stimuli	O
.	O
CONCLUSION	O
:	O
The	O
combination	O
of	O
cDNA	O
array	O
results	O
and	O
genomic	O
networks	O
reveals	O
an	O
overriding	O
participation	O
of	O
gene1s	ARG2
PAR1	ARG2
gene1e	ARG2
in	O
bladder	O
inflammation	O
,	O
provides	O
a	O
working	O
model	O
for	O
the	O
involvement	O
of	O
downstream	O
signaling	O
,	O
and	O
evokes	O
testable	O
hypotheses	O
regarding	O
the	O
transcriptome	O
downstream	O
of	O
gene1s	ARG2
PAR1	ARG2
gene1e	ARG2
activation	O
.	O
It	O
remains	O
to	O
be	O
determined	O
whether	O
or	O
not	O
mechanisms	O
targeting	O
gene1s	ARG2
PAR1	ARG2
gene1e	ARG2
gene	O
silencing	O
or	O
gene1s	ARG2
PAR1	ARG2
gene1e	ARG2
blockade	O
will	O
ameliorate	O
the	O
clinical	O
manifestation	O
of	O
cystitis	O
.	O

Plasma	O
gene1s	O
IP-10	O
gene1e	O
,	O
apoptotic	O
and	O
angiogenic	O
factors	O
associated	O
with	O
fatal	O
cerebral	O
malaria	O
in	O
India	O
.	O
BACKGROUND	O
:	O
arg1s	O
Plasmodium	O
falciparum	O
arg1e	O
in	O
a	O
subset	O
of	O
species1s	O
patients	O
species1e	O
can	O
lead	O
to	O
cerebral	O
malaria	O
(	O
CM	O
)	O
,	O
a	O
major	O
contributor	O
to	O
malaria	O
-	O
associated	O
mortality	O
.	O
Despite	O
treatment	O
,	O
CM	O
mortality	O
can	O
be	O
as	O
high	O
as	O
30	O
%	O
,	O
while	O
10	O
%	O
of	O
survivors	O
of	O
the	O
disease	O
may	O
experience	O
short-	O
and	O
long	O
-	O
term	O
neurological	O
complications	O
.	O
The	O
pathogenesis	O
of	O
CM	O
is	O
mediated	O
by	O
alterations	O
in	O
cytokine	O
and	O
chemokine	O
homeostasis	O
,	O
inflammation	O
as	O
well	O
as	O
vascular	O
injury	O
and	O
repair	O
processes	O
although	O
their	O
roles	O
are	O
not	O
fully	O
understood	O
.	O
The	O
hypothesis	O
for	O
this	O
study	O
is	O
that	O
CM	O
-	O
induced	O
changes	O
in	O
inflammatory	O
,	O
apoptotic	O
and	O
angiogenic	O
factors	O
mediate	O
severity	O
of	O
CM	O
and	O
that	O
their	O
identification	O
will	O
enable	O
development	O
of	O
new	O
prognostic	O
markers	O
and	O
adjunctive	O
therapies	O
for	O
preventing	O
CM	O
mortalities	O
.	O
METHODS	O
:	O
Plasma	O
samples	O
(	O
133	O
)	O
were	O
obtained	O
from	O
healthy	O
controls	O
(	O
HC	O
,	O
25	O
)	O
,	O
mild	O
malaria	O
(	O
MM	O
,	O
48	O
)	O
,	O
cerebral	O
malaria	O
survivors	O
(	O
CMS	O
,	O
48	O
)	O
,	O
and	O
cerebral	O
malaria	O
non	O
-	O
survivors	O
(	O
CMNS	O
,	O
12	O
)	O
at	O
admission	O
to	O
the	O
hospital	O
in	O
Jabalpur	O
,	O
India	O
.	O
Plasma	O
levels	O
of	O
30	O
biomarkers	O
(	O
(	O
gene1s	O
IL-1beta	O
gene1e	O
,	O
gene1s	O
IL-1ra	O
gene1e	O
,	O
gene1s	O
IL-2	O
gene1e	O
,	O
gene1s	O
IL-4	O
gene1e	O
,	O
gene1s	O
IL-5	O
gene1e	O
,	O
gene1s	O
IL-6	O
gene1e	O
,	O
gene1s	O
IL-8	O
gene1e	O
,	O
gene1s	O
IL-9	O
gene1e	O
,	O
gene1s	O
IL-10	O
gene1e	O
,	O
gene1s	O
IL-12	O
(	O
p70	O
)	O
gene1e	O
,	O
gene1s	O
IL-13	O
gene1e	O
,	O
gene1s	O
IL-15	O
gene1e	O
,	O
gene1s	O
IL-17	O
gene1e	O
,	O
gene1s	O
Eotaxin	O
gene1e	O
,	O
gene1s	O
FGF	O
basic	O
protein	O
gene1e	O
,	O
gene1s	O
G	O
-	O
CSF	O
gene1e	O
,	O
gene1s	O
GM	O
-	O
CSF	O
gene1e	O
,	O
gene1s	O
IFN	O
-	O
gamma	O
gene1e	O
,	O
gene1s	O
IP-10	O
gene1e	O
,	O
gene1s	O
MCP-1	O
gene1e	O
(	O
gene1s	O
MCAF	O
gene1e	O
)	O
,	O
gene1s	O
MIP-1alpha	O
gene1e	O
,	O
gene1s	O
MIP-1beta	O
gene1e	O
,	O
gene1s	O
RANTES	O
gene1e	O
,	O
gene1s	O
TNF	O
-	O
alpha	O
gene1e	O
,	O
gene1s	O
Fas	O
-	O
ligand	O
gene1e	O
(	O
gene1s	O
Fas	O
-	O
L	O
gene1e	O
)	O
,	O
soluble	O
gene1s	O
Fas	O
gene1e	O
(	O
gene1s	O
sFas	O
gene1e	O
)	O
,	O
soluble	O
gene1s	O
TNF	O
receptor	O
1	O
gene1e	O
(	O
gene1s	O
sTNF	O
-	O
R1	O
gene1e	O
)	O
and	O
soluble	O
gene1s	O
TNF	O
receptor	O
2	O
gene1e	O
(	O
gene1s	O
sTNFR-2	O
gene1e	O
)	O
,	O
gene1s	O
PDGF	O
bb	O
gene1e	O
and	O
gene1s	O
VEGF	O
gene1e	O
)	O
)	O
were	O
simultaneously	O
measured	O
in	O
an	O
initial	O
subset	O
of	O
ten	O
samples	O
from	O
each	O
group	O
.	O
Only	O
those	O
biomarkers	O
which	O
showed	O
significant	O
differences	O
in	O
the	O
pilot	O
analysis	O
were	O
chosen	O
for	O
testing	O
on	O
all	O
remaining	O
samples	O
.	O
The	O
results	O
were	O
then	O
compared	O
between	O
the	O
four	O
groups	O
to	O
determine	O
their	O
role	O
in	O
CM	O
severity	O
.	O
RESULTS	O
:	O
gene1s	O
IP-10	O
gene1e	O
,	O
gene1s	O
sTNF	O
-	O
R2	O
gene1e	O
and	O
gene1s	O
sFas	O
gene1e	O
were	O
independently	O
associated	O
with	O
increased	O
risk	O
of	O
CM	O
associated	O
mortality	O
.	O
CMNS	O
species1s	O
patients	O
species1e	O
had	O
a	O
significantly	O
lower	O
level	O
of	O
the	O
neuroprotective	O
factor	O
gene1s	O
VEGF	O
gene1e	O
when	O
compared	O
to	O
other	O
groups	O
(	O
P	O
<	O
0.0045	O
)	O
.	O
The	O
ratios	O
of	O
gene1s	O
VEGF	O
gene1e	O
to	O
gene1s	O
IP-10	O
gene1e	O
,	O
gene1s	O
sTNF	O
-	O
R2	O
gene1e	O
,	O
and	O
gene1s	O
sFas	O
gene1e	O
distinguished	O
CM	O
survivors	O
from	O
non	O
survivors	O
(	O
P	O
<	O
0.0001	O
)	O
.	O
CONCLUSION	O
:	O
The	O
results	O
suggest	O
that	O
plasma	O
levels	O
of	O
gene1s	O
IP-10	O
gene1e	O
,	O
gene1s	O
sTNF	O
-	O
R2	O
gene1e	O
and	O
gene1s	O
sFas	O
gene1e	O
may	O
be	O
potential	O
biomarkers	O
of	O
CM	O
severity	O
and	O
mortality	O
.	O
gene1s	O
VEGF	O
gene1e	O
was	O
found	O
to	O
be	O
protective	O
against	O
CM	O
associated	O
mortality	O
and	O
may	O
be	O
considered	O
for	O
adjunctive	O
therapy	O
to	O
improve	O
the	O
treatment	O
outcome	O
in	O
CM	O
species1s	O
patients	O
species1e	O
.	O

Plasma	O
gene1s	ARG2
IP-10	ARG2
gene1e	ARG2
,	O
apoptotic	O
and	O
angiogenic	O
factors	O
associated	O
with	O
fatal	O
cerebral	O
malaria	O
in	O
India	O
.	O
BACKGROUND	O
:	O
species1s	O
Plasmodium	O
falciparum	O
species1e	O
in	O
a	O
subset	O
of	O
arg1s	O
patients	O
arg1e	O
can	O
lead	O
to	O
cerebral	O
malaria	O
(	O
CM	O
)	O
,	O
a	O
major	O
contributor	O
to	O
malaria	O
-	O
associated	O
mortality	O
.	O
Despite	O
treatment	O
,	O
CM	O
mortality	O
can	O
be	O
as	O
high	O
as	O
30	O
%	O
,	O
while	O
10	O
%	O
of	O
survivors	O
of	O
the	O
disease	O
may	O
experience	O
short-	O
and	O
long	O
-	O
term	O
neurological	O
complications	O
.	O
The	O
pathogenesis	O
of	O
CM	O
is	O
mediated	O
by	O
alterations	O
in	O
cytokine	O
and	O
chemokine	O
homeostasis	O
,	O
inflammation	O
as	O
well	O
as	O
vascular	O
injury	O
and	O
repair	O
processes	O
although	O
their	O
roles	O
are	O
not	O
fully	O
understood	O
.	O
The	O
hypothesis	O
for	O
this	O
study	O
is	O
that	O
CM	O
-	O
induced	O
changes	O
in	O
inflammatory	O
,	O
apoptotic	O
and	O
angiogenic	O
factors	O
mediate	O
severity	O
of	O
CM	O
and	O
that	O
their	O
identification	O
will	O
enable	O
development	O
of	O
new	O
prognostic	O
markers	O
and	O
adjunctive	O
therapies	O
for	O
preventing	O
CM	O
mortalities	O
.	O
METHODS	O
:	O
Plasma	O
samples	O
(	O
133	O
)	O
were	O
obtained	O
from	O
healthy	O
controls	O
(	O
HC	O
,	O
25	O
)	O
,	O
mild	O
malaria	O
(	O
MM	O
,	O
48	O
)	O
,	O
cerebral	O
malaria	O
survivors	O
(	O
CMS	O
,	O
48	O
)	O
,	O
and	O
cerebral	O
malaria	O
non	O
-	O
survivors	O
(	O
CMNS	O
,	O
12	O
)	O
at	O
admission	O
to	O
the	O
hospital	O
in	O
Jabalpur	O
,	O
India	O
.	O
Plasma	O
levels	O
of	O
30	O
biomarkers	O
(	O
(	O
gene1s	ARG2
IL-1beta	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IL-1ra	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IL-2	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IL-4	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IL-5	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IL-6	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IL-8	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IL-9	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IL-10	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IL-12	ARG2
(	ARG2
p70	ARG2
)	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IL-13	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IL-15	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IL-17	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Eotaxin	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
FGF	ARG2
basic	ARG2
protein	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
G	ARG2
-	ARG2
CSF	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
GM	ARG2
-	ARG2
CSF	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IFN	ARG2
-	ARG2
gamma	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IP-10	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
MCP-1	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
MCAF	ARG2
gene1e	ARG2
)	O
,	O
gene1s	ARG2
MIP-1alpha	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
MIP-1beta	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
RANTES	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
TNF	ARG2
-	ARG2
alpha	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
Fas	ARG2
-	ARG2
ligand	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
Fas	ARG2
-	ARG2
L	ARG2
gene1e	ARG2
)	O
,	O
soluble	O
gene1s	ARG2
Fas	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
sFas	ARG2
gene1e	ARG2
)	O
,	O
soluble	O
gene1s	ARG2
TNF	ARG2
receptor	ARG2
1	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
sTNF	ARG2
-	ARG2
R1	ARG2
gene1e	ARG2
)	O
and	O
soluble	O
gene1s	ARG2
TNF	ARG2
receptor	ARG2
2	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
sTNFR-2	ARG2
gene1e	ARG2
)	O
,	O
gene1s	ARG2
PDGF	ARG2
bb	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
VEGF	ARG2
gene1e	ARG2
)	O
)	O
were	O
simultaneously	O
measured	O
in	O
an	O
initial	O
subset	O
of	O
ten	O
samples	O
from	O
each	O
group	O
.	O
Only	O
those	O
biomarkers	O
which	O
showed	O
significant	O
differences	O
in	O
the	O
pilot	O
analysis	O
were	O
chosen	O
for	O
testing	O
on	O
all	O
remaining	O
samples	O
.	O
The	O
results	O
were	O
then	O
compared	O
between	O
the	O
four	O
groups	O
to	O
determine	O
their	O
role	O
in	O
CM	O
severity	O
.	O
RESULTS	O
:	O
gene1s	ARG2
IP-10	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
sTNF	ARG2
-	ARG2
R2	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
sFas	ARG2
gene1e	ARG2
were	O
independently	O
associated	O
with	O
increased	O
risk	O
of	O
CM	O
associated	O
mortality	O
.	O
CMNS	O
arg1s	O
patients	O
arg1e	O
had	O
a	O
significantly	O
lower	O
level	O
of	O
the	O
neuroprotective	O
factor	O
gene1s	ARG2
VEGF	ARG2
gene1e	ARG2
when	O
compared	O
to	O
other	O
groups	O
(	O
P	O
<	O
0.0045	O
)	O
.	O
The	O
ratios	O
of	O
gene1s	ARG2
VEGF	ARG2
gene1e	ARG2
to	O
gene1s	ARG2
IP-10	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
sTNF	ARG2
-	ARG2
R2	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
sFas	ARG2
gene1e	ARG2
distinguished	O
CM	O
survivors	O
from	O
non	O
survivors	O
(	O
P	O
<	O
0.0001	O
)	O
.	O
CONCLUSION	O
:	O
The	O
results	O
suggest	O
that	O
plasma	O
levels	O
of	O
gene1s	ARG2
IP-10	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
sTNF	ARG2
-	ARG2
R2	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
sFas	ARG2
gene1e	ARG2
may	O
be	O
potential	O
biomarkers	O
of	O
CM	O
severity	O
and	O
mortality	O
.	O
gene1s	ARG2
VEGF	ARG2
gene1e	ARG2
was	O
found	O
to	O
be	O
protective	O
against	O
CM	O
associated	O
mortality	O
and	O
may	O
be	O
considered	O
for	O
adjunctive	O
therapy	O
to	O
improve	O
the	O
treatment	O
outcome	O
in	O
CM	O
arg1s	O
patients	O
arg1e	O
.	O

Phylogenetic	O
and	O
developmental	O
study	O
of	O
gene1s	ARG2
CD4	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
CD8	ARG2
alpha	ARG2
and	ARG2
beta	ARG2
gene1e	ARG2
T	O
cell	O
co	O
-	O
receptor	O
homologs	O
in	O
two	O
amphibian	O
species	O
,	O
arg1s	O
Xenopus	O
tropicalis	O
arg1e	O
and	O
species1s	O
Xenopus	O
laevis	O
species1e	O
.	O
gene1s	ARG2
CD4	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
CD8	ARG2
gene1e	ARG2
co	O
-	O
receptors	O
play	O
critical	O
roles	O
in	O
T	O
cell	O
development	O
and	O
activation	O
by	O
interacting	O
both	O
with	O
gene1s	ARG2
T	ARG2
cell	ARG2
receptors	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
MHC	ARG2
gene1e	ARG2
molecules	O
.	O
Although	O
homologs	O
of	O
these	O
genes	O
have	O
been	O
identified	O
in	O
many	O
species1s	O
jawed	O
vertebrates	O
species1e	O
,	O
there	O
are	O
still	O
unresolved	O
gaps	O
concerning	O
their	O
evolution	O
and	O
specialization	O
in	O
gene1s	ARG2
MHC	ARG2
gene1e	ARG2
interaction	O
and	O
T	O
cell	O
function	O
.	O
Using	O
experimental	O
and	O
computational	O
procedures	O
we	O
identified	O
gene1s	ARG2
CD4	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
CD8alpha	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
CD8beta	ARG2
gene1e	ARG2
gene	O
homologs	O
both	O
in	O
arg1s	O
Xenopus	O
tropicalis	O
arg1e	O
,	O
whose	O
full	O
genome	O
has	O
been	O
sequenced	O
,	O
and	O
its	O
sister	O
species	O
species1s	O
Xenopus	O
laevis	O
species1e	O
.	O
Multiple	O
alignments	O
of	O
deduced	O
amino	O
acid	O
sequences	O
reveal	O
a	O
poor	O
conservation	O
of	O
the	O
residues	O
involved	O
in	O
binding	O
of	O
gene1s	ARG2
CD4	ARG2
gene1e	ARG2
to	O
gene1s	ARG2
MHC	ARG2
class	ARG2
II	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
CD8alpha	ARG2
gene1e	ARG2
to	O
gene1s	ARG2
class	ARG2
I	ARG2
gene1e	ARG2
in	O
non	O
-	O
species1s	O
mammalian	O
species1e	O
species	O
,	O
presumably	O
related	O
to	O
the	O
co	O
-	O
evolutionary	O
pressure	O
of	O
gene1s	ARG2
MHC	ARG2
I	ARG2
and	ARG2
II	ARG2
gene1e	ARG2
genes	O
.	O
Phylogenetic	O
study	O
suggests	O
that	O
Xenopodinae	O
co	O
-	O
receptor	O
genes	O
are	O
more	O
closely	O
related	O
to	O
their	O
homologs	O
in	O
other	O
species1s	O
tetrapods	O
species1e	O
than	O
those	O
of	O
bony	O
fish	O
.	O
Furthermore	O
,	O
the	O
developmental	O
and	O
cell	O
-	O
specific	O
expression	O
patterns	O
of	O
these	O
genes	O
in	O
species1s	O
X.	O
laevis	O
species1e	O
are	O
very	O
similar	O
to	O
that	O
of	O
mammals	O
.	O
species1s	O
X.	O
laevis	O
species1e	O
gene1s	O
CD4	O
gene1e	O
is	O
mainly	O
expressed	O
by	O
peripheral	O
non	O
-	O
gene1s	O
CD8	O
gene1e	O
T	O
cells	O
and	O
detected	O
in	O
the	O
thymus	O
as	O
early	O
as	O
four	O
days	O
post	O
-	O
fertilization	O
(	O
dpf	O
)	O
at	O
the	O
onset	O
of	O
thymic	O
organogenesis	O
.	O
gene1s	O
CD8beta	O
gene1e	O
expression	O
is	O
specific	O
to	O
adult	O
surface	O
gene1s	O
CD8	O
gene1e	O
(+	O
)	O
T	O
cells	O
and	O
thymocytes	O
,	O
and	O
is	O
first	O
detected	O
in	O
the	O
thymus	O
at	O
5	O
dpf	O
in	O
parallel	O
with	O
productive	O
gene1s	O
TCRgamma	O
gene1e	O
transrcipts	O
,	O
whereas	O
productive	O
gene1s	O
TCRbeta	O
and	O
alpha	O
gene1e	O
rearrangements	O
are	O
not	O
detected	O
before	O
7	O
-	O
9	O
dpf	O
.	O

Phylogenetic	O
and	O
developmental	O
study	O
of	O
gene1s	ARG2
CD4	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
CD8	ARG2
alpha	ARG2
and	ARG2
beta	ARG2
gene1e	ARG2
T	O
cell	O
co	O
-	O
receptor	O
homologs	O
in	O
two	O
amphibian	O
species	O
,	O
species1s	O
Xenopus	O
tropicalis	O
species1e	O
and	O
arg1s	O
Xenopus	O
laevis	O
arg1e	O
.	O
gene1s	O
CD4	O
gene1e	O
and	O
gene1s	O
CD8	O
gene1e	O
co	O
-	O
receptors	O
play	O
critical	O
roles	O
in	O
T	O
cell	O
development	O
and	O
activation	O
by	O
interacting	O
both	O
with	O
gene1s	ARG2
T	ARG2
cell	ARG2
receptors	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
MHC	ARG2
gene1e	ARG2
molecules	O
.	O
Although	O
homologs	O
of	O
these	O
genes	O
have	O
been	O
identified	O
in	O
many	O
species1s	O
jawed	O
vertebrates	O
species1e	O
,	O
there	O
are	O
still	O
unresolved	O
gaps	O
concerning	O
their	O
evolution	O
and	O
specialization	O
in	O
gene1s	ARG2
MHC	ARG2
gene1e	ARG2
interaction	O
and	O
T	O
cell	O
function	O
.	O
Using	O
experimental	O
and	O
computational	O
procedures	O
we	O
identified	O
gene1s	ARG2
CD4	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
CD8alpha	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
CD8beta	ARG2
gene1e	ARG2
gene	O
homologs	O
both	O
in	O
species1s	O
Xenopus	O
tropicalis	O
species1e	O
,	O
whose	O
full	O
genome	O
has	O
been	O
sequenced	O
,	O
and	O
its	O
sister	O
species	O
arg1s	O
Xenopus	O
laevis	O
arg1e	O
.	O
Multiple	O
alignments	O
of	O
deduced	O
amino	O
acid	O
sequences	O
reveal	O
a	O
poor	O
conservation	O
of	O
the	O
residues	O
involved	O
in	O
binding	O
of	O
gene1s	ARG2
CD4	ARG2
gene1e	ARG2
to	O
gene1s	ARG2
MHC	ARG2
class	ARG2
II	ARG2
gene1e	ARG2
,	O
and	O
gene1s	ARG2
CD8alpha	ARG2
gene1e	ARG2
to	O
gene1s	ARG2
class	ARG2
I	ARG2
gene1e	ARG2
in	O
non	O
-	O
species1s	O
mammalian	O
species1e	O
species	O
,	O
presumably	O
related	O
to	O
the	O
co	O
-	O
evolutionary	O
pressure	O
of	O
gene1s	ARG2
MHC	ARG2
I	ARG2
and	ARG2
II	ARG2
gene1e	ARG2
genes	O
.	O
Phylogenetic	O
study	O
suggests	O
that	O
Xenopodinae	O
co	O
-	O
receptor	O
genes	O
are	O
more	O
closely	O
related	O
to	O
their	O
homologs	O
in	O
other	O
species1s	O
tetrapods	O
species1e	O
than	O
those	O
of	O
bony	O
fish	O
.	O
Furthermore	O
,	O
the	O
developmental	O
and	O
cell	O
-	O
specific	O
expression	O
patterns	O
of	O
these	O
genes	O
in	O
arg1s	O
X.	O
laevis	O
arg1e	O
are	O
very	O
similar	O
to	O
that	O
of	O
mammals	O
.	O
arg1s	O
X.	O
laevis	O
arg1e	O
gene1s	ARG2
CD4	ARG2
gene1e	ARG2
is	O
mainly	O
expressed	O
by	O
peripheral	O
non	O
-	O
gene1s	ARG2
CD8	ARG2
gene1e	ARG2
T	O
cells	O
and	O
detected	O
in	O
the	O
thymus	O
as	O
early	O
as	O
four	O
days	O
post	O
-	O
fertilization	O
(	O
dpf	O
)	O
at	O
the	O
onset	O
of	O
thymic	O
organogenesis	O
.	O
gene1s	ARG2
CD8beta	ARG2
gene1e	ARG2
expression	O
is	O
specific	O
to	O
adult	O
surface	O
gene1s	ARG2
CD8	ARG2
gene1e	ARG2
(+	O
)	O
T	O
cells	O
and	O
thymocytes	O
,	O
and	O
is	O
first	O
detected	O
in	O
the	O
thymus	O
at	O
5	O
dpf	O
in	O
parallel	O
with	O
productive	O
gene1s	ARG2
TCRgamma	ARG2
gene1e	ARG2
transrcipts	O
,	O
whereas	O
productive	O
gene1s	ARG2
TCRbeta	ARG2
and	ARG2
alpha	ARG2
gene1e	ARG2
rearrangements	O
are	O
not	O
detected	O
before	O
7	O
-	O
9	O
dpf	O
.	O

Phylogenetic	O
and	O
developmental	O
study	O
of	O
gene1s	O
CD4	O
gene1e	O
,	O
gene1s	O
CD8	O
alpha	O
and	O
beta	O
gene1e	O
T	O
cell	O
co	O
-	O
receptor	O
homologs	O
in	O
two	O
amphibian	O
species	O
,	O
species1s	O
Xenopus	O
tropicalis	O
species1e	O
and	O
species1s	O
Xenopus	O
laevis	O
species1e	O
.	O
gene1s	O
CD4	O
gene1e	O
and	O
gene1s	O
CD8	O
gene1e	O
co	O
-	O
receptors	O
play	O
critical	O
roles	O
in	O
T	O
cell	O
development	O
and	O
activation	O
by	O
interacting	O
both	O
with	O
gene1s	O
T	O
cell	O
receptors	O
gene1e	O
and	O
gene1s	O
MHC	O
gene1e	O
molecules	O
.	O
Although	O
homologs	O
of	O
these	O
genes	O
have	O
been	O
identified	O
in	O
many	O
arg1s	O
jawed	O
vertebrates	O
arg1e	O
,	O
there	O
are	O
still	O
unresolved	O
gaps	O
concerning	O
their	O
evolution	O
and	O
specialization	O
in	O
gene1s	O
MHC	O
gene1e	O
interaction	O
and	O
T	O
cell	O
function	O
.	O
Using	O
experimental	O
and	O
computational	O
procedures	O
we	O
identified	O
gene1s	O
CD4	O
gene1e	O
,	O
gene1s	O
CD8alpha	O
gene1e	O
and	O
gene1s	O
CD8beta	O
gene1e	O
gene	O
homologs	O
both	O
in	O
species1s	O
Xenopus	O
tropicalis	O
species1e	O
,	O
whose	O
full	O
genome	O
has	O
been	O
sequenced	O
,	O
and	O
its	O
sister	O
species	O
species1s	O
Xenopus	O
laevis	O
species1e	O
.	O
Multiple	O
alignments	O
of	O
deduced	O
amino	O
acid	O
sequences	O
reveal	O
a	O
poor	O
conservation	O
of	O
the	O
residues	O
involved	O
in	O
binding	O
of	O
gene1s	O
CD4	O
gene1e	O
to	O
gene1s	O
MHC	O
class	O
II	O
gene1e	O
,	O
and	O
gene1s	O
CD8alpha	O
gene1e	O
to	O
gene1s	O
class	O
I	O
gene1e	O
in	O
non	O
-	O
species1s	O
mammalian	O
species1e	O
species	O
,	O
presumably	O
related	O
to	O
the	O
co	O
-	O
evolutionary	O
pressure	O
of	O
gene1s	O
MHC	O
I	O
and	O
II	O
gene1e	O
genes	O
.	O
Phylogenetic	O
study	O
suggests	O
that	O
Xenopodinae	O
co	O
-	O
receptor	O
genes	O
are	O
more	O
closely	O
related	O
to	O
their	O
homologs	O
in	O
other	O
species1s	O
tetrapods	O
species1e	O
than	O
those	O
of	O
bony	O
fish	O
.	O
Furthermore	O
,	O
the	O
developmental	O
and	O
cell	O
-	O
specific	O
expression	O
patterns	O
of	O
these	O
genes	O
in	O
species1s	O
X.	O
laevis	O
species1e	O
are	O
very	O
similar	O
to	O
that	O
of	O
mammals	O
.	O
species1s	O
X.	O
laevis	O
species1e	O
gene1s	O
CD4	O
gene1e	O
is	O
mainly	O
expressed	O
by	O
peripheral	O
non	O
-	O
gene1s	O
CD8	O
gene1e	O
T	O
cells	O
and	O
detected	O
in	O
the	O
thymus	O
as	O
early	O
as	O
four	O
days	O
post	O
-	O
fertilization	O
(	O
dpf	O
)	O
at	O
the	O
onset	O
of	O
thymic	O
organogenesis	O
.	O
gene1s	O
CD8beta	O
gene1e	O
expression	O
is	O
specific	O
to	O
adult	O
surface	O
gene1s	O
CD8	O
gene1e	O
(+	O
)	O
T	O
cells	O
and	O
thymocytes	O
,	O
and	O
is	O
first	O
detected	O
in	O
the	O
thymus	O
at	O
5	O
dpf	O
in	O
parallel	O
with	O
productive	O
gene1s	O
TCRgamma	O
gene1e	O
transrcipts	O
,	O
whereas	O
productive	O
gene1s	O
TCRbeta	O
and	O
alpha	O
gene1e	O
rearrangements	O
are	O
not	O
detected	O
before	O
7	O
-	O
9	O
dpf	O
.	O

Phylogenetic	O
and	O
developmental	O
study	O
of	O
gene1s	O
CD4	O
gene1e	O
,	O
gene1s	O
CD8	O
alpha	O
and	O
beta	O
gene1e	O
T	O
cell	O
co	O
-	O
receptor	O
homologs	O
in	O
two	O
amphibian	O
species	O
,	O
species1s	O
Xenopus	O
tropicalis	O
species1e	O
and	O
species1s	O
Xenopus	O
laevis	O
species1e	O
.	O
gene1s	O
CD4	O
gene1e	O
and	O
gene1s	O
CD8	O
gene1e	O
co	O
-	O
receptors	O
play	O
critical	O
roles	O
in	O
T	O
cell	O
development	O
and	O
activation	O
by	O
interacting	O
both	O
with	O
gene1s	O
T	O
cell	O
receptors	O
gene1e	O
and	O
gene1s	O
MHC	O
gene1e	O
molecules	O
.	O
Although	O
homologs	O
of	O
these	O
genes	O
have	O
been	O
identified	O
in	O
many	O
species1s	O
jawed	O
vertebrates	O
species1e	O
,	O
there	O
are	O
still	O
unresolved	O
gaps	O
concerning	O
their	O
evolution	O
and	O
specialization	O
in	O
gene1s	O
MHC	O
gene1e	O
interaction	O
and	O
T	O
cell	O
function	O
.	O
Using	O
experimental	O
and	O
computational	O
procedures	O
we	O
identified	O
gene1s	O
CD4	O
gene1e	O
,	O
gene1s	O
CD8alpha	O
gene1e	O
and	O
gene1s	O
CD8beta	O
gene1e	O
gene	O
homologs	O
both	O
in	O
species1s	O
Xenopus	O
tropicalis	O
species1e	O
,	O
whose	O
full	O
genome	O
has	O
been	O
sequenced	O
,	O
and	O
its	O
sister	O
species	O
species1s	O
Xenopus	O
laevis	O
species1e	O
.	O
Multiple	O
alignments	O
of	O
deduced	O
amino	O
acid	O
sequences	O
reveal	O
a	O
poor	O
conservation	O
of	O
the	O
residues	O
involved	O
in	O
binding	O
of	O
gene1s	O
CD4	O
gene1e	O
to	O
gene1s	O
MHC	O
class	O
II	O
gene1e	O
,	O
and	O
gene1s	O
CD8alpha	O
gene1e	O
to	O
gene1s	O
class	O
I	O
gene1e	O
in	O
non	O
-	O
arg1s	O
mammalian	O
arg1e	O
species	O
,	O
presumably	O
related	O
to	O
the	O
co	O
-	O
evolutionary	O
pressure	O
of	O
gene1s	O
MHC	O
I	O
and	O
II	O
gene1e	O
genes	O
.	O
Phylogenetic	O
study	O
suggests	O
that	O
Xenopodinae	O
co	O
-	O
receptor	O
genes	O
are	O
more	O
closely	O
related	O
to	O
their	O
homologs	O
in	O
other	O
species1s	O
tetrapods	O
species1e	O
than	O
those	O
of	O
bony	O
fish	O
.	O
Furthermore	O
,	O
the	O
developmental	O
and	O
cell	O
-	O
specific	O
expression	O
patterns	O
of	O
these	O
genes	O
in	O
species1s	O
X.	O
laevis	O
species1e	O
are	O
very	O
similar	O
to	O
that	O
of	O
mammals	O
.	O
species1s	O
X.	O
laevis	O
species1e	O
gene1s	O
CD4	O
gene1e	O
is	O
mainly	O
expressed	O
by	O
peripheral	O
non	O
-	O
gene1s	O
CD8	O
gene1e	O
T	O
cells	O
and	O
detected	O
in	O
the	O
thymus	O
as	O
early	O
as	O
four	O
days	O
post	O
-	O
fertilization	O
(	O
dpf	O
)	O
at	O
the	O
onset	O
of	O
thymic	O
organogenesis	O
.	O
gene1s	O
CD8beta	O
gene1e	O
expression	O
is	O
specific	O
to	O
adult	O
surface	O
gene1s	O
CD8	O
gene1e	O
(+	O
)	O
T	O
cells	O
and	O
thymocytes	O
,	O
and	O
is	O
first	O
detected	O
in	O
the	O
thymus	O
at	O
5	O
dpf	O
in	O
parallel	O
with	O
productive	O
gene1s	O
TCRgamma	O
gene1e	O
transrcipts	O
,	O
whereas	O
productive	O
gene1s	O
TCRbeta	O
and	O
alpha	O
gene1e	O
rearrangements	O
are	O
not	O
detected	O
before	O
7	O
-	O
9	O
dpf	O
.	O

Phylogenetic	O
and	O
developmental	O
study	O
of	O
gene1s	O
CD4	O
gene1e	O
,	O
gene1s	O
CD8	O
alpha	O
and	O
beta	O
gene1e	O
T	O
cell	O
co	O
-	O
receptor	O
homologs	O
in	O
two	O
amphibian	O
species	O
,	O
species1s	O
Xenopus	O
tropicalis	O
species1e	O
and	O
species1s	O
Xenopus	O
laevis	O
species1e	O
.	O
gene1s	O
CD4	O
gene1e	O
and	O
gene1s	O
CD8	O
gene1e	O
co	O
-	O
receptors	O
play	O
critical	O
roles	O
in	O
T	O
cell	O
development	O
and	O
activation	O
by	O
interacting	O
both	O
with	O
gene1s	O
T	O
cell	O
receptors	O
gene1e	O
and	O
gene1s	O
MHC	O
gene1e	O
molecules	O
.	O
Although	O
homologs	O
of	O
these	O
genes	O
have	O
been	O
identified	O
in	O
many	O
species1s	O
jawed	O
vertebrates	O
species1e	O
,	O
there	O
are	O
still	O
unresolved	O
gaps	O
concerning	O
their	O
evolution	O
and	O
specialization	O
in	O
gene1s	O
MHC	O
gene1e	O
interaction	O
and	O
T	O
cell	O
function	O
.	O
Using	O
experimental	O
and	O
computational	O
procedures	O
we	O
identified	O
gene1s	O
CD4	O
gene1e	O
,	O
gene1s	O
CD8alpha	O
gene1e	O
and	O
gene1s	O
CD8beta	O
gene1e	O
gene	O
homologs	O
both	O
in	O
species1s	O
Xenopus	O
tropicalis	O
species1e	O
,	O
whose	O
full	O
genome	O
has	O
been	O
sequenced	O
,	O
and	O
its	O
sister	O
species	O
species1s	O
Xenopus	O
laevis	O
species1e	O
.	O
Multiple	O
alignments	O
of	O
deduced	O
amino	O
acid	O
sequences	O
reveal	O
a	O
poor	O
conservation	O
of	O
the	O
residues	O
involved	O
in	O
binding	O
of	O
gene1s	O
CD4	O
gene1e	O
to	O
gene1s	O
MHC	O
class	O
II	O
gene1e	O
,	O
and	O
gene1s	O
CD8alpha	O
gene1e	O
to	O
gene1s	O
class	O
I	O
gene1e	O
in	O
non	O
-	O
species1s	O
mammalian	O
species1e	O
species	O
,	O
presumably	O
related	O
to	O
the	O
co	O
-	O
evolutionary	O
pressure	O
of	O
gene1s	O
MHC	O
I	O
and	O
II	O
gene1e	O
genes	O
.	O
Phylogenetic	O
study	O
suggests	O
that	O
Xenopodinae	O
co	O
-	O
receptor	O
genes	O
are	O
more	O
closely	O
related	O
to	O
their	O
homologs	O
in	O
other	O
arg1s	O
tetrapods	O
arg1e	O
than	O
those	O
of	O
bony	O
fish	O
.	O
Furthermore	O
,	O
the	O
developmental	O
and	O
cell	O
-	O
specific	O
expression	O
patterns	O
of	O
these	O
genes	O
in	O
species1s	O
X.	O
laevis	O
species1e	O
are	O
very	O
similar	O
to	O
that	O
of	O
mammals	O
.	O
species1s	O
X.	O
laevis	O
species1e	O
gene1s	O
CD4	O
gene1e	O
is	O
mainly	O
expressed	O
by	O
peripheral	O
non	O
-	O
gene1s	O
CD8	O
gene1e	O
T	O
cells	O
and	O
detected	O
in	O
the	O
thymus	O
as	O
early	O
as	O
four	O
days	O
post	O
-	O
fertilization	O
(	O
dpf	O
)	O
at	O
the	O
onset	O
of	O
thymic	O
organogenesis	O
.	O
gene1s	O
CD8beta	O
gene1e	O
expression	O
is	O
specific	O
to	O
adult	O
surface	O
gene1s	O
CD8	O
gene1e	O
(+	O
)	O
T	O
cells	O
and	O
thymocytes	O
,	O
and	O
is	O
first	O
detected	O
in	O
the	O
thymus	O
at	O
5	O
dpf	O
in	O
parallel	O
with	O
productive	O
gene1s	O
TCRgamma	O
gene1e	O
transrcipts	O
,	O
whereas	O
productive	O
gene1s	O
TCRbeta	O
and	O
alpha	O
gene1e	O
rearrangements	O
are	O
not	O
detected	O
before	O
7	O
-	O
9	O
dpf	O
.	O

gene1s	ARG2
HOXB13	ARG2
gene1e	ARG2
,	O
a	O
target	O
of	O
gene1s	ARG2
DNMT3B	ARG2
gene1e	ARG2
,	O
is	O
methylated	O
at	O
an	O
upstream	O
CpG	O
island	O
,	O
and	O
functions	O
as	O
a	O
tumor	O
suppressor	O
in	O
primary	O
colorectal	O
tumors	O
.	O
BACKGROUND	O
:	O
A	O
hallmark	O
of	O
cancer	O
cells	O
is	O
hypermethylation	O
of	O
CpG	O
islands	O
(	O
CGIs	O
)	O
,	O
which	O
probably	O
arises	O
from	O
upregulation	O
of	O
one	O
or	O
more	O
gene1s	ARG2
DNA	ARG2
methyltransferases	ARG2
gene1e	ARG2
.	O
The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
identify	O
the	O
targets	O
of	O
gene1s	ARG2
DNMT3B	ARG2
gene1e	ARG2
,	O
an	O
essential	O
gene1s	ARG2
DNA	ARG2
methyltransferase	ARG2
gene1e	ARG2
in	O
mammals	O
,	O
in	O
colon	O
cancer	O
.	O
METHODOLOGY	O
/	O
PRINCIPAL	O
FINDINGS	O
:	O
Chromatin	O
immunoprecipitation	O
with	O
gene1s	ARG2
DNMT3B	ARG2
gene1e	ARG2
specific	O
antibody	O
followed	O
by	O
CGI	O
microarray	O
identified	O
genes	O
with	O
or	O
without	O
CGIs	O
,	O
repeat	O
elements	O
and	O
genomic	O
contigs	O
in	O
arg1s	O
RKO	O
arg1e	O
cells	O
.	O
ChIP	O
-	O
Chop	O
analysis	O
showed	O
that	O
the	O
majority	O
of	O
the	O
target	O
genes	O
including	O
gene1s	ARG2
P16	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
DCC	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
DISC1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
SLIT1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
CAVEOLIN1	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
GNA11	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
TBX5	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
TBX18	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
HOXB13	ARG2
gene1e	ARG2
and	O
some	O
histone	O
variants	O
,	O
that	O
harbor	O
CGI	O
in	O
their	O
promoters	O
,	O
were	O
methylated	O
in	O
multiple	O
colon	O
cancer	O
cell	O
lines	O
but	O
not	O
in	O
normal	O
colon	O
epithelial	O
cells	O
.	O
Further	O
,	O
these	O
genes	O
were	O
reactivated	O
in	O
arg1s	O
RKO	O
arg1e	O
cells	O
after	O
treatment	O
with	O
5-aza-2'-deoxycytidine	O
,	O
a	O
DNA	O
hypomethylating	O
agent	O
.	O
COBRA	O
showed	O
that	O
the	O
CGIs	O
encompassing	O
the	O
promoter	O
and/or	O
coding	O
region	O
of	O
gene1s	ARG2
DCC	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
TBX5	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
TBX18	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
SLIT1	ARG2
gene1e	ARG2
were	O
methylated	O
in	O
primary	O
colorectal	O
tumors	O
but	O
not	O
in	O
matching	O
normal	O
colon	O
tissues	O
whereas	O
gene1s	ARG2
GNA11	ARG2
gene1e	ARG2
was	O
methylated	O
in	O
both	O
.	O
MassARRAY	O
analysis	O
demonstrated	O
that	O
the	O
CGI	O
located	O
approximately	O
4.5	O
kb	O
upstream	O
of	O
gene1s	ARG2
HOXB13	ARG2
gene1e	ARG2
+1	O
site	O
was	O
tumor	O
-	O
specifically	O
hypermethylated	O
in	O
primary	O
colorectal	O
cancers	O
and	O
cancer	O
cell	O
lines	O
.	O
gene1s	ARG2
HOXB13	ARG2
gene1e	ARG2
upstream	O
CGI	O
was	O
partially	O
hypomethylated	O
in	O
gene1s	ARG2
DNMT1	ARG2
gene1e	ARG2
(-/-	O
)	O
HCT	O
cells	O
but	O
was	O
almost	O
methylation	O
free	O
in	O
cells	O
lacking	O
both	O
gene1s	ARG2
DNMT1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
DNMT3B	ARG2
gene1e	ARG2
.	O
Analysis	O
of	O
tumor	O
suppressor	O
properties	O
of	O
two	O
aberrantly	O
methylated	O
transcription	O
factors	O
,	O
gene1s	ARG2
HOXB13	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
TBX18	ARG2
gene1e	ARG2
,	O
revealed	O
that	O
both	O
inhibited	O
growth	O
and	O
clonogenic	O
survival	O
of	O
colon	O
cancer	O
cells	O
in	O
vitro	O
,	O
but	O
only	O
gene1s	ARG2
HOXB13	ARG2
gene1e	ARG2
abolished	O
tumor	O
growth	O
in	O
species1s	O
nude	O
mice	O
species1e	O
.	O
CONCLUSIONS	O
/	O
SIGNIFICANCE	O
:	O
This	O
is	O
the	O
first	O
report	O
that	O
identifies	O
several	O
important	O
tumor	O
suppressors	O
and	O
transcription	O
factors	O
as	O
direct	O
gene1s	ARG2
DNMT3B	ARG2
gene1e	ARG2
targets	O
in	O
colon	O
cancer	O
and	O
as	O
potential	O
biomarkers	O
for	O
this	O
cancer	O
.	O
Further	O
,	O
this	O
study	O
shows	O
that	O
methylation	O
at	O
an	O
upstream	O
CGI	O
of	O
gene1s	ARG2
HOXB13	ARG2
gene1e	ARG2
is	O
unique	O
to	O
colon	O
cancer	O
.	O

gene1s	O
HOXB13	O
gene1e	O
,	O
a	O
target	O
of	O
gene1s	O
DNMT3B	O
gene1e	O
,	O
is	O
methylated	O
at	O
an	O
upstream	O
CpG	O
island	O
,	O
and	O
functions	O
as	O
a	O
tumor	O
suppressor	O
in	O
primary	O
colorectal	O
tumors	O
.	O
BACKGROUND	O
:	O
A	O
hallmark	O
of	O
cancer	O
cells	O
is	O
hypermethylation	O
of	O
CpG	O
islands	O
(	O
CGIs	O
)	O
,	O
which	O
probably	O
arises	O
from	O
upregulation	O
of	O
one	O
or	O
more	O
gene1s	O
DNA	O
methyltransferases	O
gene1e	O
.	O
The	O
purpose	O
of	O
this	O
study	O
was	O
to	O
identify	O
the	O
targets	O
of	O
gene1s	O
DNMT3B	O
gene1e	O
,	O
an	O
essential	O
gene1s	O
DNA	O
methyltransferase	O
gene1e	O
in	O
mammals	O
,	O
in	O
colon	O
cancer	O
.	O
METHODOLOGY	O
/	O
PRINCIPAL	O
FINDINGS	O
:	O
Chromatin	O
immunoprecipitation	O
with	O
gene1s	O
DNMT3B	O
gene1e	O
specific	O
antibody	O
followed	O
by	O
CGI	O
microarray	O
identified	O
genes	O
with	O
or	O
without	O
CGIs	O
,	O
repeat	O
elements	O
and	O
genomic	O
contigs	O
in	O
species1s	O
RKO	O
species1e	O
cells	O
.	O
ChIP	O
-	O
Chop	O
analysis	O
showed	O
that	O
the	O
majority	O
of	O
the	O
target	O
genes	O
including	O
gene1s	O
P16	O
gene1e	O
,	O
gene1s	O
DCC	O
gene1e	O
,	O
gene1s	O
DISC1	O
gene1e	O
,	O
gene1s	O
SLIT1	O
gene1e	O
,	O
gene1s	O
CAVEOLIN1	O
gene1e	O
,	O
gene1s	O
GNA11	O
gene1e	O
,	O
gene1s	O
TBX5	O
gene1e	O
,	O
gene1s	O
TBX18	O
gene1e	O
,	O
gene1s	O
HOXB13	O
gene1e	O
and	O
some	O
histone	O
variants	O
,	O
that	O
harbor	O
CGI	O
in	O
their	O
promoters	O
,	O
were	O
methylated	O
in	O
multiple	O
colon	O
cancer	O
cell	O
lines	O
but	O
not	O
in	O
normal	O
colon	O
epithelial	O
cells	O
.	O
Further	O
,	O
these	O
genes	O
were	O
reactivated	O
in	O
species1s	O
RKO	O
species1e	O
cells	O
after	O
treatment	O
with	O
5-aza-2'-deoxycytidine	O
,	O
a	O
DNA	O
hypomethylating	O
agent	O
.	O
COBRA	O
showed	O
that	O
the	O
CGIs	O
encompassing	O
the	O
promoter	O
and/or	O
coding	O
region	O
of	O
gene1s	O
DCC	O
gene1e	O
,	O
gene1s	O
TBX5	O
gene1e	O
,	O
gene1s	O
TBX18	O
gene1e	O
,	O
gene1s	O
SLIT1	O
gene1e	O
were	O
methylated	O
in	O
primary	O
colorectal	O
tumors	O
but	O
not	O
in	O
matching	O
normal	O
colon	O
tissues	O
whereas	O
gene1s	O
GNA11	O
gene1e	O
was	O
methylated	O
in	O
both	O
.	O
MassARRAY	O
analysis	O
demonstrated	O
that	O
the	O
CGI	O
located	O
approximately	O
4.5	O
kb	O
upstream	O
of	O
gene1s	O
HOXB13	O
gene1e	O
+1	O
site	O
was	O
tumor	O
-	O
specifically	O
hypermethylated	O
in	O
primary	O
colorectal	O
cancers	O
and	O
cancer	O
cell	O
lines	O
.	O
gene1s	O
HOXB13	O
gene1e	O
upstream	O
CGI	O
was	O
partially	O
hypomethylated	O
in	O
gene1s	O
DNMT1	O
gene1e	O
(-/-	O
)	O
HCT	O
cells	O
but	O
was	O
almost	O
methylation	O
free	O
in	O
cells	O
lacking	O
both	O
gene1s	O
DNMT1	O
gene1e	O
and	O
gene1s	O
DNMT3B	O
gene1e	O
.	O
Analysis	O
of	O
tumor	O
suppressor	O
properties	O
of	O
two	O
aberrantly	O
methylated	O
transcription	O
factors	O
,	O
gene1s	O
HOXB13	O
gene1e	O
and	O
gene1s	O
TBX18	O
gene1e	O
,	O
revealed	O
that	O
both	O
inhibited	O
growth	O
and	O
clonogenic	O
survival	O
of	O
colon	O
cancer	O
cells	O
in	O
vitro	O
,	O
but	O
only	O
gene1s	O
HOXB13	O
gene1e	O
abolished	O
tumor	O
growth	O
in	O
arg1s	O
nude	O
mice	O
arg1e	O
.	O
CONCLUSIONS	O
/	O
SIGNIFICANCE	O
:	O
This	O
is	O
the	O
first	O
report	O
that	O
identifies	O
several	O
important	O
tumor	O
suppressors	O
and	O
transcription	O
factors	O
as	O
direct	O
gene1s	O
DNMT3B	O
gene1e	O
targets	O
in	O
colon	O
cancer	O
and	O
as	O
potential	O
biomarkers	O
for	O
this	O
cancer	O
.	O
Further	O
,	O
this	O
study	O
shows	O
that	O
methylation	O
at	O
an	O
upstream	O
CGI	O
of	O
gene1s	O
HOXB13	O
gene1e	O
is	O
unique	O
to	O
colon	O
cancer	O
.	O

The	O
leaves	O
of	O
arg1s	O
Diospyros	O
kaki	O
arg1e	O
exert	O
beneficial	O
effects	O
on	O
a	O
benzalkonium	O
chloride	O
-	O
induced	O
species1s	O
murine	O
species1e	O
dry	O
eye	O
model	O
.	O
PURPOSE	O
:	O
In	O
this	O
study	O
,	O
the	O
beneficial	O
effects	O
of	O
the	O
oral	O
administration	O
of	O
ethanol	O
extract	O
of	O
arg1s	O
Diospyros	O
kaki	O
arg1e	O
(	O
EEDK	O
)	O
were	O
tested	O
on	O
a	O
species1s	O
mouse	O
species1e	O
dry	O
eye	O
model	O
induced	O
by	O
benzalkonium	O
chloride	O
(	O
BAC	O
)	O
.	O
METHODS	O
:	O
A	O
solution	O
of	O
0.2	O
%	O
BAC	O
was	O
administered	O
topically	O
to	O
species1s	O
mouse	O
species1e	O
eyes	O
for	O
14	O
days	O
,	O
twice	O
daily	O
,	O
to	O
induce	O
dry	O
eye	O
.	O
Various	O
concentrations	O
of	O
EEDK	O
were	O
administrated	O
daily	O
by	O
oral	O
gavage	O
for	O
14	O
days	O
after	O
BAC	O
treatment	O
.	O
Preservative	O
-	O
free	O
eye	O
drops	O
were	O
instilled	O
in	O
the	O
positive	O
-	O
control	O
group	O
.	O
The	O
tear	O
secretion	O
volume	O
(	O
Schirmer	O
's	O
test	O
)	O
,	O
tear	O
break	O
-	O
up	O
time	O
(	O
BUT	O
)	O
,	O
and	O
fluorescein	O
score	O
were	O
measured	O
on	O
the	O
ocular	O
surface	O
.	O
BAC	O
-	O
induced	O
corneal	O
damage	O
was	O
tested	O
with	O
hematoxylin	O
-	O
eosin	O
staining	O
.	O
Moreover	O
,	O
apoptotic	O
cell	O
death	O
in	O
the	O
corneal	O
epithelial	O
layer	O
was	O
investigated	O
with	O
terminal	O
deoxynucleotidyl	O
transferase	O
-	O
mediated	O
dUTP	O
nick	O
-	O
end	O
labeling	O
(	O
TUNEL	O
)	O
staining	O
.	O
The	O
protein	O
expression	O
level	O
of	O
gene1s	O
interleukin-1alpha	O
gene1e	O
(	O
gene1s	O
IL-1a	O
gene1e	O
)	O
,	O
gene1s	O
IL-1b	O
gene1e	O
,	O
gene1s	O
IL-6	O
gene1e	O
,	O
gene1s	O
tumor	O
necrosis	O
factor-	O
alpha	O
gene1e	O
(	O
gene1s	O
TNF	O
-	O
a	O
gene1e	O
)	O
,	O
and	O
gene1s	O
monocyte	O
chemotactic	O
protein-1	O
gene1e	O
(	O
gene1s	O
MCP-1	O
gene1e	O
)	O
was	O
determined	O
with	O
western	O
blot	O
analysis	O
.	O
Furthermore	O
,	O
squamous	O
metaplasia	O
in	O
the	O
corneal	O
epithelial	O
layer	O
was	O
detected	O
with	O
immunofluorescent	O
staining	O
for	O
gene1s	O
cytokeratine-10	O
gene1e	O
.	O
The	O
cellular	O
proliferation	O
in	O
the	O
cornea	O
was	O
examined	O
with	O
immunohistochemical	O
staining	O
for	O
gene1s	O
Ki-67	O
gene1e	O
.	O
RESULTS	O
:	O
EEDK	O
treatment	O
resulted	O
in	O
prolonged	O
BUT	O
,	O
decreased	O
fluorescein	O
score	O
,	O
increased	O
tear	O
volume	O
,	O
and	O
smoother	O
epithelial	O
cells	O
compared	O
with	O
BAC	O
treatment	O
alone	O
in	O
the	O
cornea	O
.	O
Moreover	O
,	O
EEDK	O
treatment	O
inhibited	O
the	O
inflammatory	O
response	O
and	O
corneal	O
epithelial	O
cell	O
death	O
in	O
a	O
BAC	O
-	O
induced	O
species1s	O
murine	O
species1e	O
dry	O
eye	O
model	O
,	O
and	O
changes	O
in	O
squamous	O
cells	O
were	O
inhibited	O
.	O
Proliferative	O
activity	O
in	O
the	O
corneal	O
epithelium	O
cells	O
was	O
improved	O
with	O
EEDK	O
.	O
CONCLUSIONS	O
:	O
EEDK	O
could	O
be	O
a	O
potential	O
therapeutic	O
agent	O
in	O
the	O
clinical	O
treatment	O
of	O
dry	O
eye	O
.	O

The	O
leaves	O
of	O
species1s	O
Diospyros	O
kaki	O
species1e	O
exert	O
beneficial	O
effects	O
on	O
a	O
benzalkonium	O
chloride	O
-	O
induced	O
arg1s	O
murine	O
arg1e	O
dry	O
eye	O
model	O
.	O
PURPOSE	O
:	O
In	O
this	O
study	O
,	O
the	O
beneficial	O
effects	O
of	O
the	O
oral	O
administration	O
of	O
ethanol	O
extract	O
of	O
species1s	O
Diospyros	O
kaki	O
species1e	O
(	O
EEDK	O
)	O
were	O
tested	O
on	O
a	O
arg1s	O
mouse	O
arg1e	O
dry	O
eye	O
model	O
induced	O
by	O
benzalkonium	O
chloride	O
(	O
BAC	O
)	O
.	O
METHODS	O
:	O
A	O
solution	O
of	O
0.2	O
%	O
BAC	O
was	O
administered	O
topically	O
to	O
arg1s	O
mouse	O
arg1e	O
eyes	O
for	O
14	O
days	O
,	O
twice	O
daily	O
,	O
to	O
induce	O
dry	O
eye	O
.	O
Various	O
concentrations	O
of	O
EEDK	O
were	O
administrated	O
daily	O
by	O
oral	O
gavage	O
for	O
14	O
days	O
after	O
BAC	O
treatment	O
.	O
Preservative	O
-	O
free	O
eye	O
drops	O
were	O
instilled	O
in	O
the	O
positive	O
-	O
control	O
group	O
.	O
The	O
tear	O
secretion	O
volume	O
(	O
Schirmer	O
's	O
test	O
)	O
,	O
tear	O
break	O
-	O
up	O
time	O
(	O
BUT	O
)	O
,	O
and	O
fluorescein	O
score	O
were	O
measured	O
on	O
the	O
ocular	O
surface	O
.	O
BAC	O
-	O
induced	O
corneal	O
damage	O
was	O
tested	O
with	O
hematoxylin	O
-	O
eosin	O
staining	O
.	O
Moreover	O
,	O
apoptotic	O
cell	O
death	O
in	O
the	O
corneal	O
epithelial	O
layer	O
was	O
investigated	O
with	O
terminal	O
deoxynucleotidyl	O
transferase	O
-	O
mediated	O
dUTP	O
nick	O
-	O
end	O
labeling	O
(	O
TUNEL	O
)	O
staining	O
.	O
The	O
protein	O
expression	O
level	O
of	O
gene1s	ARG2
interleukin-1alpha	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
IL-1a	ARG2
gene1e	ARG2
)	O
,	O
gene1s	ARG2
IL-1b	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
IL-6	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
tumor	ARG2
necrosis	ARG2
factor-	ARG2
alpha	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
TNF	ARG2
-	ARG2
a	ARG2
gene1e	ARG2
)	O
,	O
and	O
gene1s	ARG2
monocyte	ARG2
chemotactic	ARG2
protein-1	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
MCP-1	ARG2
gene1e	ARG2
)	O
was	O
determined	O
with	O
western	O
blot	O
analysis	O
.	O
Furthermore	O
,	O
squamous	O
metaplasia	O
in	O
the	O
corneal	O
epithelial	O
layer	O
was	O
detected	O
with	O
immunofluorescent	O
staining	O
for	O
gene1s	ARG2
cytokeratine-10	ARG2
gene1e	ARG2
.	O
The	O
cellular	O
proliferation	O
in	O
the	O
cornea	O
was	O
examined	O
with	O
immunohistochemical	O
staining	O
for	O
gene1s	ARG2
Ki-67	ARG2
gene1e	ARG2
.	O
RESULTS	O
:	O
EEDK	O
treatment	O
resulted	O
in	O
prolonged	O
BUT	O
,	O
decreased	O
fluorescein	O
score	O
,	O
increased	O
tear	O
volume	O
,	O
and	O
smoother	O
epithelial	O
cells	O
compared	O
with	O
BAC	O
treatment	O
alone	O
in	O
the	O
cornea	O
.	O
Moreover	O
,	O
EEDK	O
treatment	O
inhibited	O
the	O
inflammatory	O
response	O
and	O
corneal	O
epithelial	O
cell	O
death	O
in	O
a	O
BAC	O
-	O
induced	O
arg1s	O
murine	O
arg1e	O
dry	O
eye	O
model	O
,	O
and	O
changes	O
in	O
squamous	O
cells	O
were	O
inhibited	O
.	O
Proliferative	O
activity	O
in	O
the	O
corneal	O
epithelium	O
cells	O
was	O
improved	O
with	O
EEDK	O
.	O
CONCLUSIONS	O
:	O
EEDK	O
could	O
be	O
a	O
potential	O
therapeutic	O
agent	O
in	O
the	O
clinical	O
treatment	O
of	O
dry	O
eye	O
.	O

Negative	O
feedback	O
regulation	O
of	O
gene1s	O
Wnt4	O
gene1e	O
signaling	O
by	O
gene1s	O
EAF1	O
gene1e	O
and	O
gene1s	O
EAF2	O
gene1e	O
/	O
gene1s	O
U19	O
gene1e	O
.	O
Previous	O
studies	O
indicated	O
that	O
gene1s	O
EAF	O
gene1e	O
(	O
gene1s	O
ELL	O
-	O
associated	O
factor	O
gene1e	O
)	O
family	O
members	O
,	O
gene1s	O
EAF1	O
gene1e	O
and	O
gene1s	O
EAF2	O
gene1e	O
/	O
gene1s	O
U19	O
gene1e	O
,	O
play	O
a	O
role	O
in	O
cancer	O
and	O
embryogenesis	O
.	O
For	O
example	O
,	O
gene1s	O
EAF2	O
gene1e	O
/	O
gene1s	O
U19	O
gene1e	O
may	O
serve	O
as	O
a	O
tumor	O
suppressor	O
in	O
prostate	O
cancer	O
.	O
At	O
the	O
same	O
time	O
,	O
gene1s	ARG2
EAF2	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
U19	ARG2
gene1e	ARG2
is	O
a	O
downstream	O
factor	O
in	O
the	O
non	O
-	O
canonical	O
gene1s	ARG2
Wnt	ARG2
4	ARG2
gene1e	ARG2
signaling	O
pathway	O
required	O
for	O
eye	O
development	O
in	O
arg1s	O
Xenopus	O
laevis	O
arg1e	O
,	O
and	O
along	O
with	O
gene1s	O
EAF1	O
gene1e	O
,	O
contributes	O
to	O
convergence	O
and	O
extension	O
movements	O
in	O
species1s	O
zebrafish	O
species1e	O
embryos	O
through	O
gene1s	O
Wnt	O
gene1e	O
maintenance	O
.	O
Here	O
,	O
we	O
used	O
species1s	O
zebrafish	O
species1e	O
embryos	O
and	O
species1s	O
mammalian	O
species1e	O
cells	O
to	O
show	O
that	O
both	O
gene1s	O
EAF1	O
gene1e	O
and	O
gene1s	O
EAF2	O
gene1e	O
/	O
gene1s	O
U19	O
gene1e	O
were	O
up	O
-	O
regulated	O
by	O
gene1s	O
Wnt4	O
gene1e	O
(	O
gene1s	O
Wnt4a	O
gene1e	O
)	O
.	O
Furthermore	O
,	O
we	O
found	O
that	O
gene1s	O
EAF1	O
gene1e	O
and	O
gene1s	O
EAF2	O
gene1e	O
/	O
gene1s	O
U19	O
gene1e	O
suppressed	O
gene1s	O
Wnt4	O
gene1e	O
expression	O
by	O
directly	O
binding	O
to	O
the	O
gene1s	O
Wnt4	O
gene1e	O
promoter	O
as	O
seen	O
in	O
chromatin	O
immunoprecipitation	O
assays	O
.	O
These	O
findings	O
indicate	O
that	O
an	O
auto	O
-	O
regulatory	O
negative	O
feedback	O
loop	O
occurs	O
between	O
gene1s	O
Wnt4	O
gene1e	O
and	O
the	O
gene1s	O
EAF	O
gene1e	O
family	O
,	O
which	O
is	O
conserved	O
between	O
species1s	O
zebrafish	O
species1e	O
and	O
species1s	O
mammalian	O
species1e	O
.	O
The	O
rescue	O
experiments	O
in	O
species1s	O
zebrafish	O
species1e	O
embryos	O
showed	O
that	O
early	O
embryonic	O
development	O
required	O
the	O
maintenance	O
of	O
the	O
appropriate	O
levels	O
of	O
gene1s	O
Wnt4a	O
gene1e	O
through	O
the	O
feedback	O
loop	O
.	O
Others	O
have	O
demonstrated	O
that	O
the	O
tumor	O
suppressors	O
gene1s	O
p63	O
gene1e	O
,	O
gene1s	O
p73	O
gene1e	O
and	O
gene1s	O
WT1	O
gene1e	O
positively	O
regulate	O
gene1s	O
Wnt4	O
gene1e	O
expression	O
while	O
gene1s	O
p21	O
gene1e	O
has	O
the	O
opposite	O
effect	O
,	O
suggesting	O
that	O
maintenance	O
of	O
appropriate	O
gene1s	O
Wnt4	O
gene1e	O
expression	O
may	O
also	O
be	O
critical	O
for	O
adult	O
tissue	O
homeostasis	O
and	O
prevention	O
against	O
tumor	O
initiation	O
.	O
Thus	O
,	O
the	O
auto	O
-	O
regulatory	O
negative	O
feedback	O
loop	O
that	O
controls	O
expression	O
of	O
gene1s	O
Wnt4	O
gene1e	O
and	O
gene1s	O
EAF	O
gene1e	O
proteins	O
may	O
play	O
an	O
important	O
role	O
in	O
both	O
embryonic	O
development	O
and	O
tumor	O
suppression	O
.	O
Our	O
findings	O
provide	O
the	O
first	O
convincing	O
line	O
of	O
evidence	O
that	O
gene1s	O
EAF	O
gene1e	O
and	O
gene1s	O
Wnt4	O
gene1e	O
form	O
an	O
auto	O
-	O
regulatory	O
negative	O
feedback	O
loop	O
in	O
vivo	O
.	O

Negative	O
feedback	O
regulation	O
of	O
gene1s	ARG2
Wnt4	ARG2
gene1e	ARG2
signaling	O
by	O
gene1s	ARG2
EAF1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
EAF2	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
U19	ARG2
gene1e	ARG2
.	O
Previous	O
studies	O
indicated	O
that	O
gene1s	O
EAF	O
gene1e	O
(	O
gene1s	O
ELL	O
-	O
associated	O
factor	O
gene1e	O
)	O
family	O
members	O
,	O
gene1s	O
EAF1	O
gene1e	O
and	O
gene1s	O
EAF2	O
gene1e	O
/	O
gene1s	O
U19	O
gene1e	O
,	O
play	O
a	O
role	O
in	O
cancer	O
and	O
embryogenesis	O
.	O
For	O
example	O
,	O
gene1s	O
EAF2	O
gene1e	O
/	O
gene1s	O
U19	O
gene1e	O
may	O
serve	O
as	O
a	O
tumor	O
suppressor	O
in	O
prostate	O
cancer	O
.	O
At	O
the	O
same	O
time	O
,	O
gene1s	ARG2
EAF2	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
U19	ARG2
gene1e	ARG2
is	O
a	O
downstream	O
factor	O
in	O
the	O
non	O
-	O
canonical	O
gene1s	O
Wnt	O
4	O
gene1e	O
signaling	O
pathway	O
required	O
for	O
eye	O
development	O
in	O
species1s	O
Xenopus	O
laevis	O
species1e	O
,	O
and	O
along	O
with	O
gene1s	ARG2
EAF1	ARG2
gene1e	ARG2
,	O
contributes	O
to	O
convergence	O
and	O
extension	O
movements	O
in	O
arg1s	O
zebrafish	O
arg1e	O
embryos	O
through	O
gene1s	ARG2
Wnt	ARG2
gene1e	ARG2
maintenance	O
.	O
Here	O
,	O
we	O
used	O
arg1s	O
zebrafish	O
arg1e	O
embryos	O
and	O
species1s	O
mammalian	O
species1e	O
cells	O
to	O
show	O
that	O
both	O
gene1s	ARG2
EAF1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
EAF2	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
U19	ARG2
gene1e	ARG2
were	O
up	O
-	O
regulated	O
by	O
gene1s	ARG2
Wnt4	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
Wnt4a	ARG2
gene1e	ARG2
)	O
.	O
Furthermore	O
,	O
we	O
found	O
that	O
gene1s	ARG2
EAF1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
EAF2	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
U19	ARG2
gene1e	ARG2
suppressed	O
gene1s	ARG2
Wnt4	ARG2
gene1e	ARG2
expression	O
by	O
directly	O
binding	O
to	O
the	O
gene1s	ARG2
Wnt4	ARG2
gene1e	ARG2
promoter	O
as	O
seen	O
in	O
chromatin	O
immunoprecipitation	O
assays	O
.	O
These	O
findings	O
indicate	O
that	O
an	O
auto	O
-	O
regulatory	O
negative	O
feedback	O
loop	O
occurs	O
between	O
gene1s	ARG2
Wnt4	ARG2
gene1e	ARG2
and	O
the	O
gene1s	ARG2
EAF	ARG2
gene1e	ARG2
family	O
,	O
which	O
is	O
conserved	O
between	O
arg1s	O
zebrafish	O
arg1e	O
and	O
species1s	O
mammalian	O
species1e	O
.	O
The	O
rescue	O
experiments	O
in	O
arg1s	O
zebrafish	O
arg1e	O
embryos	O
showed	O
that	O
early	O
embryonic	O
development	O
required	O
the	O
maintenance	O
of	O
the	O
appropriate	O
levels	O
of	O
gene1s	ARG2
Wnt4a	ARG2
gene1e	ARG2
through	O
the	O
feedback	O
loop	O
.	O
Others	O
have	O
demonstrated	O
that	O
the	O
tumor	O
suppressors	O
gene1s	O
p63	O
gene1e	O
,	O
gene1s	O
p73	O
gene1e	O
and	O
gene1s	O
WT1	O
gene1e	O
positively	O
regulate	O
gene1s	O
Wnt4	O
gene1e	O
expression	O
while	O
gene1s	O
p21	O
gene1e	O
has	O
the	O
opposite	O
effect	O
,	O
suggesting	O
that	O
maintenance	O
of	O
appropriate	O
gene1s	O
Wnt4	O
gene1e	O
expression	O
may	O
also	O
be	O
critical	O
for	O
adult	O
tissue	O
homeostasis	O
and	O
prevention	O
against	O
tumor	O
initiation	O
.	O
Thus	O
,	O
the	O
auto	O
-	O
regulatory	O
negative	O
feedback	O
loop	O
that	O
controls	O
expression	O
of	O
gene1s	ARG2
Wnt4	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
EAF	ARG2
gene1e	ARG2
proteins	O
may	O
play	O
an	O
important	O
role	O
in	O
both	O
embryonic	O
development	O
and	O
tumor	O
suppression	O
.	O
Our	O
findings	O
provide	O
the	O
first	O
convincing	O
line	O
of	O
evidence	O
that	O
gene1s	ARG2
EAF	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
Wnt4	ARG2
gene1e	ARG2
form	O
an	O
auto	O
-	O
regulatory	O
negative	O
feedback	O
loop	O
in	O
vivo	O
.	O

Negative	O
feedback	O
regulation	O
of	O
gene1s	ARG2
Wnt4	ARG2
gene1e	ARG2
signaling	O
by	O
gene1s	ARG2
EAF1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
EAF2	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
U19	ARG2
gene1e	ARG2
.	O
Previous	O
studies	O
indicated	O
that	O
gene1s	ARG2
EAF	ARG2
gene1e	ARG2
(	O
gene1s	ARG2
ELL	ARG2
-	ARG2
associated	ARG2
factor	ARG2
gene1e	ARG2
)	O
family	O
members	O
,	O
gene1s	ARG2
EAF1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
EAF2	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
U19	ARG2
gene1e	ARG2
,	O
play	O
a	O
role	O
in	O
cancer	O
and	O
embryogenesis	O
.	O
For	O
example	O
,	O
gene1s	ARG2
EAF2	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
U19	ARG2
gene1e	ARG2
may	O
serve	O
as	O
a	O
tumor	O
suppressor	O
in	O
prostate	O
cancer	O
.	O
At	O
the	O
same	O
time	O
,	O
gene1s	O
EAF2	O
gene1e	O
/	O
gene1s	O
U19	O
gene1e	O
is	O
a	O
downstream	O
factor	O
in	O
the	O
non	O
-	O
canonical	O
gene1s	O
Wnt	O
4	O
gene1e	O
signaling	O
pathway	O
required	O
for	O
eye	O
development	O
in	O
species1s	O
Xenopus	O
laevis	O
species1e	O
,	O
and	O
along	O
with	O
gene1s	O
EAF1	O
gene1e	O
,	O
contributes	O
to	O
convergence	O
and	O
extension	O
movements	O
in	O
species1s	O
zebrafish	O
species1e	O
embryos	O
through	O
gene1s	O
Wnt	O
gene1e	O
maintenance	O
.	O
Here	O
,	O
we	O
used	O
species1s	O
zebrafish	O
species1e	O
embryos	O
and	O
arg1s	O
mammalian	O
arg1e	O
cells	O
to	O
show	O
that	O
both	O
gene1s	ARG2
EAF1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
EAF2	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
U19	ARG2
gene1e	ARG2
were	O
up	O
-	O
regulated	O
by	O
gene1s	ARG2
Wnt4	ARG2
gene1e	ARG2
(	O
gene1s	O
Wnt4a	O
gene1e	O
)	O
.	O
Furthermore	O
,	O
we	O
found	O
that	O
gene1s	ARG2
EAF1	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
EAF2	ARG2
gene1e	ARG2
/	O
gene1s	ARG2
U19	ARG2
gene1e	ARG2
suppressed	O
gene1s	ARG2
Wnt4	ARG2
gene1e	ARG2
expression	O
by	O
directly	O
binding	O
to	O
the	O
gene1s	ARG2
Wnt4	ARG2
gene1e	ARG2
promoter	O
as	O
seen	O
in	O
chromatin	O
immunoprecipitation	O
assays	O
.	O
These	O
findings	O
indicate	O
that	O
an	O
auto	O
-	O
regulatory	O
negative	O
feedback	O
loop	O
occurs	O
between	O
gene1s	ARG2
Wnt4	ARG2
gene1e	ARG2
and	O
the	O
gene1s	ARG2
EAF	ARG2
gene1e	ARG2
family	O
,	O
which	O
is	O
conserved	O
between	O
species1s	O
zebrafish	O
species1e	O
and	O
arg1s	O
mammalian	O
arg1e	O
.	O
The	O
rescue	O
experiments	O
in	O
species1s	O
zebrafish	O
species1e	O
embryos	O
showed	O
that	O
early	O
embryonic	O
development	O
required	O
the	O
maintenance	O
of	O
the	O
appropriate	O
levels	O
of	O
gene1s	O
Wnt4a	O
gene1e	O
through	O
the	O
feedback	O
loop	O
.	O
Others	O
have	O
demonstrated	O
that	O
the	O
tumor	O
suppressors	O
gene1s	ARG2
p63	ARG2
gene1e	ARG2
,	O
gene1s	ARG2
p73	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
WT1	ARG2
gene1e	ARG2
positively	O
regulate	O
gene1s	ARG2
Wnt4	ARG2
gene1e	ARG2
expression	O
while	O
gene1s	ARG2
p21	ARG2
gene1e	ARG2
has	O
the	O
opposite	O
effect	O
,	O
suggesting	O
that	O
maintenance	O
of	O
appropriate	O
gene1s	ARG2
Wnt4	ARG2
gene1e	ARG2
expression	O
may	O
also	O
be	O
critical	O
for	O
adult	O
tissue	O
homeostasis	O
and	O
prevention	O
against	O
tumor	O
initiation	O
.	O
Thus	O
,	O
the	O
auto	O
-	O
regulatory	O
negative	O
feedback	O
loop	O
that	O
controls	O
expression	O
of	O
gene1s	ARG2
Wnt4	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
EAF	ARG2
gene1e	ARG2
proteins	O
may	O
play	O
an	O
important	O
role	O
in	O
both	O
embryonic	O
development	O
and	O
tumor	O
suppression	O
.	O
Our	O
findings	O
provide	O
the	O
first	O
convincing	O
line	O
of	O
evidence	O
that	O
gene1s	ARG2
EAF	ARG2
gene1e	ARG2
and	O
gene1s	ARG2
Wnt4	ARG2
gene1e	ARG2
form	O
an	O
auto	O
-	O
regulatory	O
negative	O
feedback	O
loop	O
in	O
vivo	O
.	O
